Cluster,Size,Density,Internal weight,External weight,Quality,P-value,Members,Top GO Terms,Top GO Term p-values,Top GO FDRs,Top GO Term Fold Enrichments
1,11,0.5908,32.49,8599.0,0.0037549999999999997,0.999969,A1BG ACR ANHX MZF1 SLC27A5 ZBTB45 ZNF132 ZNF324 ZNF324B ZNF497 ZSCAN22,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",7.232e-06|6.558e-05|6.573e-05|6.644e-05|0.0001156,0.1141|0.5173|0.3456|0.262|0.3646,5.792|4.324|4.323|4.316|4.007
2,23,0.49,124.0,18380.0,0.006683,1.0,A1CF AGAP5 AGAP9 ANXA8L1 CALHM3 CFAP70 DUPD1 DUSP13 GPRIN2 HKDC1 IFIT1B NUTM2A NUTM2B PTPN20 SFTPA1 SFTPA2 SYNPO2L SYT15 UNC5B WASHC2C ZNF239 ZNF32 ZNF33B,peptidyl-tyrosine dephosphorylation|respiratory gaseous exchange by respiratory system|protein dephosphorylation|dephosphorylation|negative regulation of barbed-end actin filament capping,0.0002357|0.001526|0.001789|0.005347|0.005566,1|1|1|1|1,25.34|35.82|12.44|8.395|223.9
3,8,0.6041,16.91,6174.0,0.002725,0.9996790000000001,A2M CLEC6A GYS2 PKP2 SLCO1B1 SLCO1B3 SLCO1B7 SLCO1C1,sodium-independent organic anion transport|bile acid and bile salt transport|organic hydroxy compound transport|monocarboxylic acid transport|carboxylic acid transport,4.507e-11|6.848e-10|2.107e-07|2.162e-07|1.495e-06,7.11e-07|5.401e-06|0.001108|0.0008527|0.004718,643.6|302.9|68.2|67.75|41.36
4,7,0.6371,13.38,4921.0,0.002704,0.9992989999999999,DUS2 METTL1 NSUN2 PUS3 THUMPD1 TRMT1 XPOT,tRNA modification|tRNA processing|RNA modification|tRNA metabolic process|ncRNA processing,1.754e-18|3.321e-17|2.366e-16|3.857e-16|3.588e-13,2.766e-14|2.62e-13|1.244e-12|1.521e-12|1.132e-09,203.4|138.7|107.7|101.1|42.38
5,80,0.331,1046.0,61270.0,0.01675,1.0,ADORA2A AIFM3 APOBEC3A APOBEC3B APOBEC3C APOBEC3D APOBEC3F APOBEC3G APOL1 APOL2 APOL5 ARHGAP8 BCL2L13 C22orf15 C22orf23 CACNA1I CBY1 CCDC116 CCDC157 COMT CRYBA4 CRYBB1 CRYBB3 CYTH4 DGCR6 DGCR6L DRICH1 EMID1 FOXRED2 GAL3ST1 GGT1 GGTLC2 GSTT2B GUCD1 HIC2 HMOX1 HORMAD2 HPS1 IGLL1 IGLL5 LRRC75B MICALL1 MIF MMP11 MPPE1 MPST MTFP1 NIPSNAP1 RAC2 RASD2 RFPL2 RFPL3 RGL4 RIMBP3 RNF215 SDF2L1 SEC14L2 SEC14L3 SEC14L4 SEC14L6 SEPT5 SGSM1 SIRPA SLC5A1 SLC5A4 SPECC1L SUSD2 TBC1D10A TOP3B TPST2 TRIOBP TSSK2 TST TUBA8 UPB1 USP18 VPREB1 YPEL1 ZDHHC8 ZNF74,pyrimidine nucleoside catabolic process|DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination,2.057e-11|2.323e-11|5.353e-11|5.353e-11|5.353e-11,3.245e-07|1.832e-07|2.814e-07|2.111e-07|1.689e-07,77.38|152.6|127.1|127.1|127.1
6,18,0.5551,84.93,11820.0,0.007111,1.0,AAAS AHCTF1 CDCA3 KPNA2 NDC1 NUP133 NUP153 NUP160 NUP188 NUP35 NUP37 NUP43 NUP50 NUP98 POM121 POM121C SENP2 TMEM201,intracellular transport of virus|transport of virus|tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|multi-organism localization,1.308e-32|5.942e-32|6.164e-32|6.164e-32|8.9e-32,2.063e-28|4.687e-28|3.241e-28|2.431e-28|2.808e-28,296.6|262.6|437.5|437.5|254.3
7,4,0.6163,3.698,3353.0,0.001099,0.9929309999999999,AACS ADAMTS3 DISP1 TRAFD1,regulation of protein secretion|response to oleic acid|positive regulation of vascular endothelial growth factor signaling pathway|regulation of peptide secretion|vascular endothelial growth factor production,0.001132|0.001359|0.001359|0.001388|0.001553,1|1|1|1|1,36.26|858.1|858.1|32.69|735.5
8,4,0.6517,3.91,3137.0,0.001242,0.9929309999999999,AADAC CPA3 FGF12 TFDP2,regulation of neuronal action potential|regulation of voltage-gated sodium channel activity|positive regulation of triglyceride catabolic process|angiotensin maturation|regulation of angiotensin levels in blood,0.001456|0.00194|0.002425|0.003152|0.003152,1|1|1|1|1,823.8|588.4|457.7|343.3|343.3
9,26,0.6754,219.5,17550.0,0.012320000000000001,1.0,ACTR2 ACTR3 ARPC2 ARPC3 ARPC4 CCDC93 COMMD10 COMMD2 COMMD3 COMMD4 COMMD5 COMMD6 COMMD7 COMMD8 COMMD9 LZIC RAB21 RAB7A SNX17 VPS26C VPS29 VPS35 VPS35L WASHC3 WASHC4 WASHC5,"retrograde transport, endosome to plasma membrane|vesicle-mediated transport|endosomal transport|vesicle-mediated transport to the plasma membrane|Arp2/3 complex-mediated actin nucleation",1.376e-14|6.052e-12|9.556e-12|1.583e-11|1.106e-10,2.171e-10|4.773e-08|5.024e-08|6.243e-08|3.49e-07,198|6.877|30.6|66.01|198
10,8,0.6176,17.29,6370.0,0.0027010000000000003,0.9996790000000001,AAED1 C9orf3 FBP1 FBP2 GNA14 MUSK ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",7.913e-07|1.319e-06|2.768e-06|7.244e-06|1.027e-05,0.01248|0.0104|0.01455|0.02856|0.0324,2574|1716|1030|572.1|468.1
11,18,0.5493,84.05,11950.0,0.006962,1.0,AAGAB AGFG1 AP2A1 AP2A2 AP2B1 AP2M1 AP2S1 C10orf88 CCDC32 CLTC DNM2 FCHO2 ITSN2 PICALM RAB5C SH3GL1 SYNJ1 TFRC,clathrin-dependent endocytosis|endocytosis|receptor-mediated endocytosis|presynaptic endocytosis|synaptic vesicle endocytosis,2.76e-21|9.548e-20|1.154e-17|5.663e-17|5.663e-17,4.353e-17|7.53e-16|6.069e-14|2.233e-13|1.787e-13,363.4|30.18|53.73|193.8|193.8
12,5,0.636,6.36,3417.0,0.001853,0.996692,AAR2 CD2BP2 DDX23 NCDN USPL1,"spliceosomal tri-snRNP complex assembly|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",4.943e-06|7.986e-06|8.887e-06|3.144e-05|3.144e-05,0.07796|0.06298|0.04673|0.124|0.09919,633.7|65.04|62.73|40.92|40.92
13,15,0.544,57.12,12660.0,0.004481000000000001,0.999999,AARD C8orf76 COL14A1 ENPP2 FBXO32 GNPNAT1 KLHL38 MTSS1 NETO2 NOV RNF139 SLC22A4 SLC30A8 TRMT12 ZHX2,nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|epithelial cell proliferation|regulation of kainate selective glutamate receptor activity|negative regulation of sensory perception of pain,0.002472|0.002472|0.002511|0.003295|0.003295,1|1|1|1|1,605.7|605.7|27.22|403.8|403.8
14,11,0.6055,33.3,7834.0,0.004221,0.999969,AARS CDT1 CENPT CFDP1 EXOSC6 GINS3 NIP7 SF3B3 SLC7A6OS TANGO6 UTP4,kinetochore organization|DNA replication initiation|nuclear DNA replication|cell cycle DNA replication|ribosome biogenesis,4.43e-05|0.0002075|0.0003696|0.0003821|0.0004696,0.6988|1|1|1|1,216.8|95.79|71.02|69.81|18.61
15,95,0.4887,2182.0,65980.0,0.03192,1.0,AARS2 DAP3 EARS2 FARS2 GADD45GIP1 GATB GATC GFM1 HARS2 KIAA0391 LARS2 LRPPRC MARS2 MRPL10 MRPL11 MRPL12 MRPL13 MRPL14 MRPL15 MRPL16 MRPL17 MRPL18 MRPL19 MRPL2 MRPL20 MRPL21 MRPL22 MRPL23 MRPL28 MRPL3 MRPL30 MRPL32 MRPL33 MRPL34 MRPL35 MRPL37 MRPL38 MRPL39 MRPL4 MRPL40 MRPL41 MRPL43 MRPL44 MRPL45 MRPL46 MRPL47 MRPL48 MRPL49 MRPL53 MRPL54 MRPL55 MRPL57 MRPS10 MRPS11 MRPS12 MRPS14 MRPS16 MRPS18A MRPS18B MRPS18C MRPS2 MRPS21 MRPS22 MRPS23 MRPS24 MRPS25 MRPS26 MRPS35 MRPS5 MRPS6 MRPS7 MRPS9 MTG2 MTPAP NARS2 PNPT1 POLG POLG2 POLRMT PTCD1 PTCD3 QRSL1 RARS2 RPUSD4 SARS2 SLC25A26 SSBP1 SUPV3L1 TARS2 TFAM TFB2M TRMT10C TRUB2 TWNK VARS2,mitochondrial gene expression|mitochondrial translation|mitochondrial translational elongation|translation|mitochondrial translational termination,1.953e-146|1.505e-134|1.041e-117|1.404e-116|4.389e-115,3.081e-142|1.187e-130|5.476e-114|5.535e-113|1.385e-111,120.1|138.2|152.8|43.78|148.8
16,8,0.6115,17.12,5308.0,0.003206,0.9996790000000001,ACACA ACLY CHP1 FASN GPAT4 SLC25A1 TMEM120B VKORC1L1,acyl-CoA metabolic process|thioester metabolic process|fatty-acyl-CoA biosynthetic process|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process,3.34e-10|3.34e-10|8.735e-10|1.545e-09|1.545e-09,5.269e-06|2.634e-06|4.593e-06|6.094e-06|4.875e-06,118|118|295.3|86.03|86.03
17,11,0.609,33.49,7523.0,0.004419,0.999969,AATF CDC6 DHX8 PSMB3 PSMD11 PSMD3 RPL19 RPL23 RPL23A RPL27 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|negative regulation of cell cycle process,1.215e-09|2.041e-09|6.776e-09|8.407e-09|8.469e-09,1.916e-05|1.61e-05|3.563e-05|3.315e-05|2.672e-05,96.51|86.68|10.18|9.935|33.53
18,6,0.6,9.001,5009.0,0.001789,0.998474,AATK BAIAP2 PYCR1 RAC3 RFNG SLC25A10,"positive regulation of cell morphogenesis involved in differentiation|regulation of cell morphogenesis involved in differentiation|modification of synaptic structure, modulating synaptic transmission|regulation of cell shape|brain development",0.0003165|0.0004631|0.0006794|0.001152|0.001495,1|1|1|1|1,74.48|61.29|2942|38.46|11.85
19,11,0.5914,32.53,8813.0,0.003668,0.999969,ABCA2 AK8 DPP7 ENTPD2 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 TUBB4B,nucleoside diphosphate metabolic process|negative regulation of cholesterol esterification|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport,0.000924|0.001067|0.001601|0.001601|0.001601,1|1|1|1|1,44.58|1872|936.1|936.1|936.1
20,4,0.6156,3.694,3006.0,0.001224,0.9929309999999999,ABCA3 FLI1 KCNJ1 KCNJ5,potassium ion import across plasma membrane|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane|import across plasma membrane|potassium ion transmembrane transport,2.668e-05|0.0001004|0.0001004|0.0002574|0.0003561,0.4209|0.7921|0.528|1|1,245.2|124.1|124.1|76.85|65.17
21,11,0.6181,33.99,7721.0,0.004371,0.999969,ALG14 BCAS2 CDC7 DDX20 DNTTIP2 HEATR3 PRPF38B RNPC3 RPAP2 RPL5 WDR3,"nucleic acid metabolic process|RNA processing|RNA metabolic process|nucleobase-containing compound metabolic process|mRNA splicing, via spliceosome",2.349e-06|3.142e-06|4.301e-06|1.059e-05|1.449e-05,0.03705|0.02478|0.02261|0.04175|0.04573,6.711|12.17|8.196|5.509|24.8
22,5,0.6123,6.122999999999999,4022.0,0.001517,0.996692,ABCA8 CSH2 INSRR LIMD2 METTL2B,cellular response to alkaline pH|response to alkaline pH|cellular response to peptide hormone stimulus|sphingomyelin biosynthetic process|cellular response to peptide,0.000728|0.0009706|0.001742|0.00194|0.002568,1|1|1|1|1,2060|1373|30.07|588.4|24.66
23,5,0.6197,6.197,3865.0,0.0015970000000000001,0.996692,ABCB1 RAET1G ULBP1 ULBP2 ULBP3,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|cell killing|lymphocyte mediated immunity,1.364e-11|1.825e-11|8.214e-11|6.224e-09|1.19e-07,2.151e-07|1.439e-07|4.319e-07|2.454e-05|0.0003755,686.5|633.7|422.5|137.3|64.87
24,6,0.6614,9.921,4837.0,0.002042,0.998474,ABCB11 BBS5 CRYGA CRYGB CRYGC CRYGD,visual perception|sensory perception of light stimulus|lens development in camera-type eye|camera-type eye development|sensory perception,8.078e-10|8.841e-10|3.143e-09|8.574e-07|1.376e-06,1.274e-05|6.973e-06|1.653e-05|0.003381|0.004342,79.46|78.01|180.7|43.18|17.64
25,4,0.6088,3.653,3124.0,0.001165,0.9929309999999999,ABCB4 HOMER1 NOVA1 PIP,response to fenofibrate|phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|tissue homeostasis|cellular response to bile acid|response to bile acid,0.0004854|0.000728|0.001214|0.001456|0.001456,1|1|1|1|1,4119|2060|36.13|823.8|823.8
26,21,0.5273,110.7,16930.0,0.006483,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 DBNL DPY19L1 GHRHR HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN MYO1G NME8 NPY PHKG1 PRR15 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|lobar bronchus epithelium development|lobar bronchus development,2.7e-06|7.345e-06|9.864e-06|1.479e-05|2.069e-05,0.04259|0.05793|0.05187|0.05831|0.06527,41.73|32.15|653.8|490.4|392.3
27,57,0.4429,706.8,43790.0,0.01584,1.0,ABCC6 ACSM1 ACSM2B ACSM3 ACSM5 AHSP BCKDK BFAR C16orf45 C16orf92 CA5A CCDC189 CLN3 DCTPP1 DOC2A FAM57B HIRIP3 HS3ST2 HSD3B7 ITGAD ITGAL ITGAM ITGAX LAT METTL22 MPV17L MYH11 NFATC2IP NOMO1 NOMO2 NPIPA5 NPIPB6 PDZD9 PKD1 PLA2G10 PYCARD SBK1 SCNN1B SCNN1G SEPT1 STX1B SULT1A1 SULT1A2 SYT17 TBX6 TMC7 USP31 VKORC1 YPEL3 ZG16 ZNF688 ZNF689 ZNF747 ZNF764 ZNF771 ZNF785 ZNF843,integrin-mediated signaling pathway|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process|nucleoside bisphosphate metabolic process|long-chain fatty acid metabolic process,4.155e-07|2.283e-06|2.283e-06|2.283e-06|2.44e-05,0.006554|0.01801|0.012|0.009003|0.07697,22.12|16.3|16.3|16.3|15.05
28,4,0.6771,4.063,3409.0,0.001188,0.9929309999999999,ABCC10 HLA-DPA1 HLA-DPB1 ZNF76,positive regulation of interferon-gamma production|interferon-gamma-mediated signaling pathway|antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|positive regulation of T cell proliferation,6.606e-05|7.603e-05|0.0001419|0.0001476|0.0001476,1|0.5997|0.7462|0.582|0.4656,153.7|143|104|102|102
29,48,0.4291,484.1,38930.0,0.01225,1.0,ABCC11 ABCC12 ADGRG5 AGRP C16orf78 CA7 CES1 CES2 CES3 CES4A CES5A CETP CHST5 CLEC18A CLEC18B CLEC18C CMTM1 CPNE2 CTRB1 DPEP2 DRC7 DUS2 GLG1 HP HSD11B2 IRX5 IRX6 LCAT LDHD MMP15 MT1A MT1F MT1H MT4 MTSS1L NLRC5 NRN1L PARD6A PDP2 PDPR PLA2G15 PLLP SHCBP1 TEPP TMED6 ZDHHC1 ZNF19 ZNF23,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,1.208e-09|1.208e-09|1.99e-09|2.509e-09|8.323e-09,1.905e-05|9.525e-06|1.046e-05|9.894e-06|2.626e-05,131.3|131.3|116.8|110.6|84.06
30,4,0.6199,3.72,3343.0,0.001109,0.9929309999999999,ABCD2 ARL8B FOXI1 SLC8B1,calcium export from the mitochondrion|long-chain fatty acid import into peroxisome|very long-chain fatty acid catabolic process|regulation of cardiac muscle cell membrane potential|positive regulation of unsaturated fatty acid biosynthetic process,0.0005825|0.0009706|0.001359|0.001553|0.001941,1|1|1|1|1,2574|1287|858.1|735.5|572.1
31,28,0.541,204.5,15920.0,0.01264,1.0,ADSL ADSS ATIC CAD CTPS1 DHFR DHFR2 DHODH FPGS GART GMPS IMPDH2 MTHFD1 MTR NAMPT PAICS PFAS PGM3 PPAT PPCDC RFK RPIA SDHB TFRC TKT TYMS UMPS UXS1,nucleotide biosynthetic process|nucleoside phosphate biosynthetic process|nucleoside monophosphate biosynthetic process|nucleobase-containing small molecule metabolic process|ribonucleoside monophosphate biosynthetic process,1.161e-28|1.469e-28|2.772e-28|1.399e-27|5.47e-27,1.832e-24|1.159e-24|1.458e-24|5.519e-24|1.726e-23,51.78|51.11|198.6|26.61|231.8
32,14,0.6061,55.16,9789.0,0.005587,0.9999969999999999,ABCE1 COPB2 EIF2S1 NEDD8 PSMA1 PSMA2 PSMA4 PSMA5 PSMA6 SMU1 SNRPD1 SNU13 SRP54 VCP,proteasomal ubiquitin-independent protein catabolic process|protein deubiquitination|positive regulation of canonical Wnt signaling pathway|protein modification by small protein removal|regulation of cellular amino acid metabolic process,7.758e-12|5.259e-10|7.183e-10|7.876e-10|1.143e-09,1.224e-07|4.147e-06|3.777e-06|3.106e-06|3.606e-06,312|34.57|56.04|32.58|105.6
33,14,0.5894,53.63,9760.0,0.00545,0.9999969999999999,ABCF1 DHX16 EXOC2 MRPS18B NOL7 NUP153 PAK1IP1 PPP1R10 PRPF4B RIOK1 RPP40 SNRNP48 TUBB4B WDR46,gene expression|maturation of SSU-rRNA|RNA processing|ribosomal small subunit biogenesis|ribosome biogenesis,2.109e-06|5.73e-06|1.815e-05|1.842e-05|6.105e-05,0.03326|0.04519|0.09545|0.07265|0.1926,6.057|88.26|9.563|58.84|17.72
34,5,0.6547,6.547000000000001,3595.0,0.001813,0.996692,ABCF2 DRG1 HSPA14 TRMT2A ZC3H15,cytoplasmic translation|'de novo' cotranslational protein folding|peripheral nervous system myelin maintenance|myelin maintenance|regulation of mitotic spindle assembly,0.0002861|0.001019|0.003054|0.005763|0.006777,1|1|1|1|1,78.46|1471|367.8|183.9|154.8
35,6,0.6926,10.39,4443.0,0.002327,0.998474,ABCF3 NFIA NFIB NFIC NFIX PTGES3,DNA replication|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|positive regulation of macromolecule biosynthetic process|positive regulation of nucleobase-containing compound metabolic process,4.563e-07|1.891e-05|2.133e-05|3.296e-05|3.641e-05,0.007198|0.1492|0.1122|0.13|0.1149,50.66|10.37|10.12|9.262|9.076
36,12,0.5961,39.34,8053.0,0.004848,0.999986,ABCG1 BUB3 CNIH4 DUX4 HSPE1 OR2A25 RPL12 RPL17 RPL37 RPL4 RPLP2 RPS13,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.114e-11|2.832e-11|4.888e-11|5.999e-11|6.307e-11,3.334e-07|2.234e-07|2.57e-07|2.366e-07|1.99e-07,99.01|94.11|85.63|82.66|81.94
37,15,0.4707,49.42,11270.0,0.0043549999999999995,0.999999,ADAMTSL5 CCDC73 CYBC1 DDC DEF8 FDX1 KCNK13 NAT8L RPH3A SELE SLC5A12 TNFRSF19 TRAK1 UCKL1 WNT8A,polarity specification of proximal/distal axis|phytoalexin metabolic process|canonical Wnt signaling pathway involved in neural crest cell differentiation|polarity specification of anterior/posterior axis|establishment of animal organ orientation,0.002182|0.002182|0.002182|0.002182|0.002182,1|1|1|1|1,686.5|686.5|686.5|686.5|686.5
38,12,0.609,40.19,9239.0,0.00432,0.999986,ANO1 BBS1 FGF19 FGF4 FOLR2 GSTP1 MRGPRD MRGPRF MYEOV P2RY6 POLD4 TBX10,regulation of ERK1 and ERK2 cascade|cellular response to endogenous stimulus|response to endogenous stimulus|positive regulation of ERK1 and ERK2 cascade|cellular response to organonitrogen compound,1.861e-05|2.08e-05|6.871e-05|0.0002085|0.0002831,0.2935|0.164|0.3613|0.8222|0.8932,23.59|8.986|7.272|25.12|11.62
39,17,0.6038,82.12,12970.0,0.0062759999999999995,1.0,ABHD11 ASL CASTOR3 CLDN3 CYP3A5 GNAT3 GUSB SPDYE1 TRIM50 TYW1 ZNF138 ZNF273 ZNF479 ZNF679 ZNF727 ZNF736 ZNF92,arginine biosynthetic process via ornithine|'de novo' AMP biosynthetic process|alkaloid catabolic process|cellular response to L-arginine|glucuronoside catabolic process,0.002618|0.003489|0.003489|0.003489|0.004359,1|1|1|1|1,572.1|381.4|381.4|381.4|286
40,22,0.5583,129.0,17220.0,0.007415000000000001,1.0,ABHD12 ACSS1 APMAP BFSP1 CST1 CST11 CST2 CST3 CST4 CST5 CST7 CST8 CST9 CST9L CSTL1 GGTLC1 NANP NAPB NINL PCSK2 THBD ZNF337,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity|regulation of peptidase activity,5.455e-16|8.343e-16|2.014e-14|1.863e-13|3.677e-13,8.605e-12|6.58e-12|1.059e-10|7.347e-10|1.16e-09,42.03|40.38|29.93|24.29|22.78
41,22,0.4701,108.6,17290.0,0.006226,1.0,ABHD14A ABHD14B CACNA2D2 CAMP CCR9 DNAH1 GLYCTK GNAT1 HYAL1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 KRBOX1 MUSTN1 NISCH NT5DC2 SEMA3G TLR9 ZNF502,hyaluronan metabolic process|mucopolysaccharide metabolic process|glycosaminoglycan metabolic process|aminoglycan metabolic process|positive regulation of interleukin-8 production,8.452e-06|0.0002553|0.0006608|0.0008492|0.002093,0.1333|1|1|1|1,81.4|24.64|17.67|16.18|30.35
42,4,0.6585,3.951,3084.0,0.001276,0.9929309999999999,ABHD16A HSPA1L LY6G6F MSH5,prostaglandin catabolic process|prostanoid catabolic process|phosphatidylserine catabolic process|meiotic mismatch repair|monoacylglycerol catabolic process,0.0005825|0.0005825|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|2574|1287|1030|735.5
43,21,0.4699,98.68,16030.0,0.006104,1.0,BICDL2 C16orf90 CLDN6 CLDN9 CLUAP1 CORO7 GLIS2 HAGH HMOX2 OR1F1 OR2C1 PAQR4 PRSS21 PRSS27 PRSS33 SEPT12 TPSAB1 ZNF213 ZNF263 ZNF500 ZSCAN10,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|bicellular tight junction assembly|tight junction assembly|tight junction organization|regulation of transcription from RNA polymerase II promoter involved in kidney development,0.0002468|0.001688|0.001801|0.001918|0.002036,1|1|1|1|1,93.4|33.82|32.69|31.64|980.7
44,16,0.5555,66.66,12890.0,0.0051329999999999995,0.999999,ABHD3 B4GALT6 CELF4 CHST9 CTIF DSC1 DSG1 DSG3 DSG4 HRH4 KIAA1328 MAPRE2 SERPINB7 TPGS2 ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,1.703e-06|7.702e-06|2.474e-05|4.179e-05|4.765e-05,0.02686|0.06074|0.1301|0.1648|0.1503,45.56|30.83|22.78|19.88|19.21
45,4,0.6429,3.8569999999999998,3167.0,0.001213,0.9929309999999999,ABHD4 CSF2 FBXL15 OR10Q1,response to silicon dioxide|positive regulation of interleukin-23 production|neutrophil differentiation|histamine secretion|regulation of interleukin-23 production,0.0007766|0.001165|0.001165|0.001553|0.001747,1|1|1|1|1,1716|1030|1030|735.5|643.6
46,5,0.6044,6.044,3864.0,0.001558,0.996692,ABHD5 AVPR1A BLCAP MARCH6 TMX1,positive regulation of lipase activity|regulation of lipase activity|positive regulation of lipid metabolic process|regulation of lipid localization|maternal aggressive behavior,0.0001299|0.0002311|0.0005614|0.0007545|0.0009706,1|1|1|1|1,112.8|84.06|53.49|46.02|1373
47,4,0.6167,3.7,3441.0,0.001072,0.9929309999999999,ABI2 MTSS1 PPP1R27 TMEM86B,nephron tubule epithelial cell differentiation|zonula adherens assembly|epithelial cell proliferation involved in renal tubule morphogenesis|microspike assembly|lens fiber cell morphogenesis,0.0005825|0.0005825|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|2574|1287|1287|1030
48,8,0.6005,16.81,5500.0,0.003039,0.9996790000000001,ABL1 BCR GAB2 LMO2 MYB PTPN1 QRFP SOS1,regulation of hematopoietic progenitor cell differentiation|platelet-derived growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|enzyme linked receptor protein signaling pathway|regulation of hematopoietic stem cell differentiation,2.805e-08|3.221e-07|5.489e-07|2.842e-06|2.884e-06,0.0004424|0.00254|0.002886|0.01121|0.009097,114.4|220.7|24.8|17.73|103
49,12,0.582,38.41,9130.0,0.0041789999999999996,0.999986,ANO1 CPT1A FGF19 FGF4 GAL IGHMBP2 MRGPRD MRGPRF MYEOV POLD4 TESMIN ZNF20,regulation of hormone secretion|fibroblast growth factor receptor signaling pathway|feeding behavior|positive regulation of large conductance calcium-activated potassium channel activity|positive regulation of timing of catagen,0.0009898|0.001626|0.001665|0.002182|0.002182,1|1|1|1|1,14.92|33.9|33.49|686.5|686.5
50,7,0.6065,12.74,5666.0,0.002238,0.9992989999999999,ABR ALOX15 ALOX15B FAM57A OR3A1 P2RX5 TNFSF12,lipoxin A4 biosynthetic process|lipoxin A4 metabolic process|lipoxin biosynthetic process|lipoxin metabolic process|hepoxilin biosynthetic process,9.891e-07|1.483e-06|3.558e-06|4.447e-06|5.435e-06,0.0156|0.0117|0.01871|0.01754|0.01715,1961|1471|840.6|735.5|653.8
51,4,0.6436,3.861,3265.0,0.001179,0.9929309999999999,ABTB1 GALK1 ST3GAL6 UNC119,galactitol metabolic process|glycolytic process from galactose|negative regulation of caveolin-mediated endocytosis|glycolytic process through glucose-1-phosphate|hexitol metabolic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
52,16,0.9543,114.5,10220.0,0.01105,0.999999,ACBD5 ACOX1 HSD17B4 PEX1 PEX10 PEX12 PEX13 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PEX7 SCP2,protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome|peroxisomal transport|peroxisome organization,1.993e-36|1.993e-36|1.993e-36|2.386e-36|7.979e-36,3.143e-32|1.572e-32|1.048e-32|9.409e-33|2.517e-32,228.8|228.8|228.8|226|208
53,71,0.528,1312.0,47660.0,0.026719999999999997,1.0,ACAD9 BCS1L COA5 COA6 COA7 COQ2 COQ4 COQ7 COX10 COX16 COX19 COX4I1 COX5B COX6B1 COX6C COX7C CYC1 CYCS DMAC1 ECSIT FASTKD5 FOXRED1 GRSF1 NDUFA10 NDUFA11 NDUFA2 NDUFA3 NDUFA5 NDUFA6 NDUFA8 NDUFA9 NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFAF8 NDUFB10 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFB9 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS5 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NFU1 NUBPL PDSS1 PDSS2 PET117 PYURF RTN4IP1 SCO2 TIMMDC1 UQCR10 UQCRB UQCRC1 UQCRC2 UQCRFS1 UQCRQ,mitochondrial respiratory chain complex assembly|ATP synthesis coupled electron transport|respiratory electron transport chain|mitochondrial ATP synthesis coupled electron transport|NADH dehydrogenase complex assembly,5.361e-84|1.191e-78|3.565e-78|1.861e-76|6.172e-76,8.456e-80|9.391e-75|1.875e-74|7.34e-73|1.947e-72,132.1|138.6|118.2|136.9|175.8
54,4,0.6512,3.907,3480.0,0.001119,0.9929309999999999,ACADM BSDC1 C1QB TSSK3,"carnitine metabolic process, CoA-linked|carnitine biosynthetic process|medium-chain fatty acid catabolic process|amino-acid betaine biosynthetic process|fatty acid beta-oxidation using acyl-CoA dehydrogenase",0.0007766|0.001165|0.001165|0.001553|0.002134,1|1|1|1|1,1716|1030|1030|735.5|514.9
55,17,0.601,81.73,13720.0,0.005909,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 GHRHR HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN NME8 RBAK RSPH10B2 ZNF12,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|lobar bronchus epithelium development|lobar bronchus development,1.09e-06|2.979e-06|6.393e-06|9.585e-06|1.341e-05,0.0172|0.02349|0.03362|0.0378|0.04231,51.55|39.72|807.6|605.7|484.6
56,37,0.4515,300.7,29300.0,0.01013,1.0,AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ASGR1 ASGR2 C17orf107 CCDC144A CLEC10A DNAH9 DYNLT1 KCTD11 MFSD6L MINK1 MYH1 MYH10 MYH2 MYH3 MYH4 MYH8 P2RX1 PLD2 RCVRN SAT2 SHBG SLC16A13 SLC2A4 STX8 TBC1D28 TMEM107 TMEM256 TNFSF12 TNFSF13 VAMP2 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,6.908e-09|6.908e-09|4.638e-08|1.203e-07|6.183e-07,0.000109|5.449e-05|0.0002439|0.0004744|0.00195,240.9|240.9|135.5|103.2|65.69
57,9,0.6099,21.96,6747.0,0.003235,0.9998530000000001,ACAP1 OR1A1 OR1A2 OR1D5 OR1E2 OR3A1 OVCA2 P2RX1 SPNS3,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.451e-07|7.29e-07|8.768e-07|1.243e-06|1.494e-06,0.008598|0.00575|0.00461|0.004903|0.004713,25.94|24.45|23.54|21.92|21.11
58,8,0.6049,16.94,5386.0,0.003125,0.9996790000000001,ACAP2 ARF6 RAB35 RAB8A RABIF RALGAPB SBF1 SBF2,endocytic recycling|cellular response to nerve growth factor stimulus|endosomal transport|response to nerve growth factor|protein localization to endosome,5.051e-07|1.055e-06|1.153e-06|1.174e-06|1.198e-05,0.007968|0.00832|0.00606|0.004629|0.03779,188.4|145.7|44.2|140.4|429.1
59,9,0.6564,23.63,6110.0,0.003841,0.9998530000000001,ACAT2 FDFT1 FDPS HSD17B7 LSS MSMO1 MVD SC5D SQLE,secondary alcohol biosynthetic process|cholesterol biosynthetic process|sterol biosynthetic process|cholesterol metabolic process|secondary alcohol metabolic process,1.114e-23|1.114e-23|3.445e-23|8.895e-23|1.883e-22,1.756e-19|8.782e-20|1.812e-19|3.508e-19|5.94e-19,463.4|463.4|402.9|167.4|154.8
60,4,0.6295,3.7769999999999997,2975.0,0.001265,0.9929309999999999,ACBD3 DDHD2 FLT3 ZFP64,pro-B cell differentiation|myeloid progenitor cell differentiation|common myeloid progenitor cell proliferation|lymphoid progenitor cell differentiation|positive regulation of mitochondrial fission,0.0009706|0.001359|0.001553|0.002522|0.003491,1|1|1|1|1,1287|858.1|735.5|429.1|302.9
61,13,0.6173,48.15,8780.0,0.005438,0.999993,AFDN CDC42 CDH1 CDH2 CTNNA1 CTNND1 F11R PARD3 PARD6B PRKCI TAX1BP3 TJP1 TP53BP2,cell-cell junction organization|cell junction assembly|cell-cell junction assembly|cell junction organization|adherens junction organization,1.631e-20|1.291e-18|3.532e-17|6.812e-16|1.161e-14,2.573e-16|1.018e-14|1.857e-13|2.686e-12|3.664e-11,87|57.79|104.2|32.3|166.1
62,25,0.4117,123.5,18120.0,0.006751999999999999,1.0,ACCS ACCSL ALX4 ANO3 CHRM4 COMMD9 CRY2 ELF5 LARGE2 MRGPRX1 MRGPRX3 MYBPC3 OR4A47 OR4A5 OR4B1 OR4C12 OR4C13 OR4C3 OR4C46 OR4S1 OR4X1 PTPRJ RAPSN TP53I11 TRIM49B,detection of stimulus|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,2.838e-10|1.554e-09|2.587e-09|3.575e-09|6.587e-09,4.477e-06|1.226e-05|1.36e-05|1.41e-05|2.078e-05,12.62|16.81|15.84|15.26|14.2
63,18,0.5101,78.04,14250.0,0.0054340000000000005,1.0,ACE C17orf47 EPX HOXB5 HOXB9 LPO MKS1 MPO MTMR4 NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SCPEP1 SEPT4 SGCA,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process|response to denervation involved in regulation of muscle adaptation,2.73e-06|7.241e-06|4.729e-05|5.586e-05|5.586e-05,0.04306|0.05711|0.2486|0.2203|0.1762,118.4|83.72|228.8|208|208
64,9,0.6203,22.33,6978.0,0.003182,0.9998530000000001,ACER3 CAPN5 FCHSD2 KCTD21 OMP P2RY2 P2RY6 PLEKHB1 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|phytosphingosine metabolic process|phytosphingosine biosynthetic process,2.029e-05|0.0001973|0.0008375|0.0008734|0.0008734,0.32|1|1|1|1,326.9|97.38|46.23|2288|2288
65,6,0.647,9.704,3881.0,0.002487,0.998474,ACIN1 CCNL1 CDK11A CTNNBL1 PPP1R8 PRPF19,RNA processing|RNA splicing|mRNA processing|nucleic acid metabolic process|regulation of mRNA processing,3.572e-06|5.21e-06|1.028e-05|1.037e-05|1.147e-05,0.05634|0.04109|0.05408|0.0409|0.03618,15.94|28.92|24.32|7.909|62.6
66,16,0.6063,72.76,12540.0,0.005752,0.999999,ABHD14A ABHD14B GLYCTK GNAT1 HYAL1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 KLHDC8B MUSTN1 PFKFB4 SEMA3G TLR9,hyaluronan metabolic process|carbohydrate derivative metabolic process|fructose metabolic process|mucopolysaccharide metabolic process|glycosaminoglycan metabolic process,2.698e-06|7.227e-05|7.632e-05|8.308e-05|0.0002174,0.04256|0.57|0.4013|0.3276|0.6858,117|7.677|171.6|35.43|25.41
67,4,0.6425,3.855,2271.0,0.001689,0.9929309999999999,ACO2 SDHB SLC25A3 SOD2,response to isolation stress|tricarboxylic acid cycle|aerobic respiration|cellular respiration|regulation of systemic arterial blood pressure by neurotransmitter,1.272e-06|1.778e-05|8.67e-05|0.0003516|0.0003883,0.02007|0.1402|0.4559|1|1,1287|302.9|133.7|65.59|5149
68,5,0.6403,6.403,3567.0,0.0017870000000000002,0.996692,ASCL1 DYNC1I2 FOXA2 NKX2-1 SOX1,cell fate commitment|forebrain neuron differentiation|forebrain generation of neurons|regionalization|neuron fate commitment,9.053e-08|1.512e-07|2.46e-07|2.894e-07|3.127e-07,0.001428|0.001192|0.001294|0.001141|0.0009865,69.52|252.2|213.1|51.81|196.1
69,7,0.6238,13.1,5641.0,0.002311,0.9992989999999999,BSND C1orf123 CYP4X1 GPX7 PCSK9 PLA2G12A ZYG11B,negative regulation of low-density lipoprotein particle receptor binding|positive regulation of cellular protein catabolic process|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport,0.0005824|0.0008378|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|44.58|1716|1716|1716
70,21,0.7671,161.1,14920.0,0.01065,1.0,CD46 CD55 DPM1 DPM3 GPAA1 PGAP2 PIGC PIGH PIGK PIGL PIGM PIGN PIGO PIGP PIGQ PIGS PIGT PIGU PIGV PIGW PIGY,GPI anchor biosynthetic process|GPI anchor metabolic process|glycolipid biosynthetic process|protein lipidation|lipoprotein biosynthetic process,1.334e-49|2.102e-49|1.498e-44|6.729e-43|1.489e-42,2.104e-45|1.658e-45|7.878e-41|2.654e-39|4.696e-39,582.3|564.7|278.1|221.8|211.7
71,5,0.64,6.4,3848.0,0.001656,0.996692,ACP6 CTSK CTSS GOLPH3L TNFAIP8L2,collagen catabolic process|collagen metabolic process|extracellular matrix disassembly|toll-like receptor signaling pathway|pattern recognition receptor signaling pathway,4.647e-05|9.15e-05|0.0001067|0.0002452|0.0003843,0.733|0.7217|0.5609|0.9668|1,191.6|135|124.8|81.56|64.87
72,4,0.6297,3.778,3153.0,0.001194,0.9929309999999999,ACSBG2 DDRGK1 F2RL2 WASF1,dendritic transport of mitochondrion|positive regulation of protein localization to endoplasmic reticulum|regulation of protein localization to endoplasmic reticulum|modification of postsynaptic actin cytoskeleton|positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,0.0005825|0.0005825|0.0005825|0.0009706|0.0009706,1|1|1|1|1,2574|2574|2574|1287|1287
73,15,0.5897,61.92,11870.0,0.005175,0.999999,ACSF2 C17orf67 EPX HOXB9 LPO MKS1 MPO MYCBPAP NME1 NME2 OR4D1 OR4D2 RSAD1 SCPEP1 SEPT4,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process,1.527e-06|4.057e-06|3.249e-05|3.839e-05|4.476e-05,0.02409|0.032|0.1709|0.1514|0.1412,142|100.5|274.6|249.6|228.8
74,4,0.6032,3.6189999999999998,3269.0,0.001103,0.9929309999999999,ACSF3 DPPA4 PSTPIP2 XAF1,malonate catabolic process|dicarboxylic acid catabolic process|long-chain fatty-acyl-CoA biosynthetic process|long-chain fatty-acyl-CoA metabolic process|fatty-acyl-CoA biosynthetic process,0.0003883|0.003491|0.003878|0.00504|0.0062,1|1|1|1|1,5149|302.9|271|205.9|166.1
75,6,0.6035,9.052,4807.0,0.001875,0.998474,ACSL1 CSH2 CSHL1 GH2 LIMD2 METTL2B,growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|response to growth hormone|positive regulation of receptor signaling pathway via JAK-STAT|positive regulation of receptor signaling pathway via STAT,2.426e-08|2.772e-08|1.154e-07|1.351e-07|1.81e-07,0.0003826|0.0002186|0.0006066|0.0005327|0.000571,514.9|490.4|294.2|278.3|251.2
76,11,0.653,35.91,6845.0,0.005202,0.999969,ACSL3 AGPAT2 AMFR C12orf49 CYB5B LPIN1 MBTPS1 SCAP SCD SREBF1 TMEM41A,regulation of cholesterol biosynthetic process|regulation of sterol biosynthetic process|regulation of cholesterol metabolic process|regulation of lipid biosynthetic process|regulation of alcohol biosynthetic process,8.448e-09|8.448e-09|2.413e-08|3.794e-08|5.528e-08,0.0001333|6.663e-05|0.0001269|0.0001496|0.0001744,170.2|170.2|129.1|47.52|104
77,4,0.6212,3.727,3210.0,0.001157,0.9929309999999999,ACSL6 EMILIN1 FDXACB1 RPS6KC1,negative regulation of collagen fibril organization|regulation of collagen fibril organization|negative regulation of macrophage migration|positive regulation of extracellular matrix assembly|negative regulation of extracellular matrix organization,0.0005825|0.001359|0.001941|0.002134|0.002328,1|1|1|1|1,2574|858.1|572.1|514.9|468.1
78,35,0.5825,346.6,26790.0,0.012740000000000001,1.0,ABCC6 ACSM1 ACSM2B ACSM3 ACSM5 BFAR C16orf45 C16orf92 CA5A CLN3 CORO7 ITGAD ITGAL ITGAX LAT MPV17L MYH11 NOMO1 NOMO2 NPIPA5 NPIPB6 PYCARD SCNN1B SEPT1 SEPT12 STX1B SULT1A2 TBX6 VKORC1 YPEL3 ZNF500 ZNF747 ZNF764 ZNF771 ZNF785,purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process|nucleoside bisphosphate metabolic process|acyl-CoA metabolic process|thioester metabolic process,2.965e-06|2.965e-06|2.965e-06|2.242e-05|2.242e-05,0.04678|0.02339|0.01559|0.08842|0.07073,22.77|22.77|22.77|24.98|24.98
79,4,0.6412,3.847,3396.0,0.001129,0.9929309999999999,ACSM4 C4orf17 GCKR PURA,dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|negative regulation of glucokinase activity|negative regulation of hexokinase activity|response to fructose,0.0007766|0.0007766|0.001165|0.001165|0.001941,1|1|1|1|1,1716|1716|1030|1030|572.1
80,14,0.5719,52.04,9802.0,0.005266,0.9999969999999999,COX6C EIF3E EIF3H INTS8 MRPL13 MRPS28 MTERF3 NBN POP1 RPL30 RRS1 UQCRB UTP23 VIRMA,gene expression|ribonucleoprotein complex biogenesis|cellular nitrogen compound metabolic process|cellular metabolic process|metabolic process,5.292e-09|3.548e-07|5.73e-07|8.289e-07|3.175e-06,8.348e-05|0.002798|0.003013|0.003269|0.01002,7.402|18.98|4.75|2.721|2.471
81,8,0.6041,16.92,6553.0,0.002568,0.9996790000000001,ACTA2 DUPD1 IFIT1 LIPJ NUTM2A OPN4 PNLIPRP1 SFTPA2,intracellular transport of viral protein in host cell|thermotaxis|symbiont intracellular protein transport in host|optokinetic behavior|detection of temperature stimulus involved in thermoception,0.001164|0.001164|0.001164|0.001164|0.00194,1|1|1|1|1,1287|1287|1287|1287|643.6
82,4,0.6094,3.656,3018.0,0.001207,0.9929309999999999,ACTBL2 FST HTT RASSF4,"positive regulation of serotonin secretion|negative regulation of synaptic transmission, dopaminergic|regulation of thalamus size|negative regulation of cerebellar granule cell precursor proliferation|positive regulation of aggrephagy",0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
83,4,0.6556,3.9339999999999997,2693.0,0.001454,0.9929309999999999,ACTG1 CAP1 CORO1C IQGAP1,regulation of focal adhesion assembly|regulation of cell-substrate junction assembly|regulation of cell-substrate junction organization|regulation of cell-matrix adhesion|regulation of cell junction assembly,6.53e-07|6.53e-07|8.125e-07|4.408e-06|1.738e-05,0.0103|0.00515|0.004272|0.01738|0.05483,160.9|160.9|149.2|83.72|52.54
84,4,0.6737,4.042,3292.0,0.0012230000000000001,0.9929309999999999,ACTG2 ADORA2B REPIN1 ZNF843,mesenchyme migration|G protein-coupled adenosine receptor signaling pathway|G protein-coupled purinergic receptor signaling pathway|excretion|activation of adenylate cyclase activity,0.001165|0.001941|0.001941|0.007938|0.008131,1|1|1|1|1,1030|572.1|572.1|128.7|125.6
85,6,0.6255,9.382,4108.0,0.0022719999999999997,0.998474,ACTR10 ATP6V1D EXOC5 LIN52 TIMM9 TRMT5,tRNA N1-guanine methylation|exocytosis|retrograde axonal transport of mitochondrion|mitochondrial tRNA methylation|secretion by cell,0.0008735|0.001022|0.001165|0.001746|0.001766,1|1|1|1|1,1716|13.12|1144|686.5|10.86
86,7,0.6054,12.71,4621.0,0.002736,0.9992989999999999,ACTR1A DCTN6 DYNC1LI1 DYNC1LI2 DYNLRB1 NDE1 PAFAH1B1,mitotic spindle organization|mitotic prometaphase|microtubule cytoskeleton organization involved in mitosis|spindle organization|biological phase,7.254e-10|7.928e-10|1.309e-09|3.424e-09|6.586e-09,1.144e-05|6.253e-06|6.885e-06|1.35e-05|2.078e-05,89.7|88.09|79.52|65.38|57.24
87,32,0.4222,209.4,24230.0,0.008545,1.0,ACTR3B AGBL3 AKR1D1 CPA1 CPA2 CPA5 EPHB6 FAM71F2 HYAL4 KEL KIAA1147 MGAM OR2A12 OR2A2 OR2A5 OR2F2 OR6B1 OR6V1 OR9A2 OR9A4 PRSS1 PRSS37 PRSS58 RNF148 SPAM1 TAS2R39 TAS2R41 TAS2R60 TCAF2 TRPV5 TRPV6 ZNF783,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|detection of stimulus involved in sensory perception|detection of chemical stimulus involved in sensory perception of smell,5.28e-10|3.326e-09|6.498e-09|1.133e-08|2.504e-08,8.329e-06|2.623e-05|3.417e-05|4.468e-05|7.899e-05,12.67|12.84|11.96|11.27|12.74
88,14,0.602,54.78,9812.0,0.005536,0.9999969999999999,ACVR1 BAMBI BMPR1A FKBP1A IPO8 LEMD3 LRIG1 LRIG3 MIB1 NEO1 RGMB SMAD1 SMAD7 UBAC1,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|transforming growth factor beta receptor signaling pathway|regulation of BMP signaling pathway|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1.571e-12|2.718e-11|5.223e-11|5.223e-11|3.267e-10,2.479e-08|2.144e-07|2.746e-07|2.06e-07|1.031e-06,46.89|52.27|86.53|86.53|63.05
89,8,0.6029,16.88,5586.0,0.0030039999999999997,0.9996790000000001,ACVR1B ACVR2A CTDNEP1 FKBP1A IPO8 LEMD3 MIB1 PMEPA1,regulation of activin receptor signaling pathway|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of pathway-restricted SMAD protein phosphorylation|positive regulation of activin receptor signaling pathway|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1.902e-10|1.547e-08|1.66e-06|4.743e-06|1.787e-05,3.001e-06|0.000122|0.008726|0.0187|0.05639,429.1|51.28|124.6|735.5|55.17
90,4,0.6595,3.957,3234.0,0.001219,0.9929309999999999,ACVR1C ARL14EPL KRT71 TEX35,trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation|regulation of chorionic trophoblast cell proliferation|negative regulation of trophoblast cell migration|nodal signaling pathway,0.0005825|0.0005825|0.001165|0.001359|0.002522,1|1|1|1|1,2574|2574|1030|858.1|429.1
91,50,0.3862,473.1,37650.0,0.01238,1.0,ACVRL1 ANKRD33 AQP2 AQP5 AQP6 ASIC1 ATF7 DNAJC14 GRASP HOXC12 HOXC4 HOXC5 HOXC6 HOXC8 INHBE KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT72 KRT73 KRT74 KRT75 KRT77 KRT78 KRT79 KRT80 KRT82 KRT83 KRT84 KRT85 KRT86 LACRT METTL7B NR4A1 OR10A7 OR10P1 OR2AP1 OR6C3 OR6C4 OR6C75 OS9 POU6F1 PPP1R1A RDH16 RDH5 SDR9C7,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.37e-31|5.228e-26|1.298e-24|2.922e-23|1.113e-21,2.161e-27|4.123e-22|6.826e-21|1.152e-19|3.511e-18,72.9|36.45|30.74|26.07|21.51
92,4,0.6108,3.665,3319.0,0.0011,0.9929309999999999,ACYP1 DDX58 DIRAS2 GALNT16,regulation of type III interferon production|detection of virus|RIG-I signaling pathway|positive regulation of myeloid dendritic cell cytokine production|regulation of myeloid dendritic cell cytokine production,0.0009706|0.001359|0.001359|0.001359|0.001359,1|1|1|1|1,1287|858.1|858.1|858.1|858.1
93,6,0.6029,9.043,4809.0,0.001872,0.998474,ACYP2 CCL13 DHRS11 PPP1R1B SLFN12 SLFN12L,negative regulation of female receptivity|female mating behavior|regulation of female receptivity|estrogen biosynthetic process|behavioral response to cocaine,0.001456|0.002619|0.002619|0.004071|0.004361,1|1|1|1|1,858.1|429.1|429.1|264|245.2
94,14,0.5974,54.36,11620.0,0.004645000000000001,0.9999969999999999,ADA CNBD2 CPNE1 DUSP15 GGT7 GHRH HCK LBP MAP1LC3A MYH7B MYLK2 TM9SF4 WFDC11 XKR7,"regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|response to isoquinoline alkaloid|lipopolysaccharide-mediated signaling pathway|response to morphine",7.28e-05|0.0001075|0.0002664|0.0002664|0.0002664,1|0.8481|1|1|0.8405,173.1|140.1|86.53|86.53|86.53
95,4,0.6263,3.758,3149.0,0.001189,0.9929309999999999,ADA2 FUK NYNRIN ZNF23,inosine biosynthetic process|adenosine catabolic process|inosine metabolic process|adenosine metabolic process|purine ribonucleoside catabolic process,0.0005825|0.0005825|0.0007281|0.001456|0.001601,1|1|1|1|1,2288|2288|1716|762.8|686.5
96,17,0.4769,64.87,13170.0,0.00489,1.0,ADAL APBA2 C15orf53 CHRNA7 DUOXA1 DUOXA2 EPB42 GABRA5 NIPA2 OCA2 PLA2G4D PLA2G4E PLA2G4F RASGRP1 SNURF TGM5 TMCO5A,phosphatidylinositol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid catabolic process|phosphatidylcholine acyl-chain remodeling,7.363e-07|1.271e-06|2.014e-06|2.73e-06|3.001e-06,0.01161|0.01002|0.01059|0.01076|0.009467,190.7|156|132|118.4|114.4
97,10,0.6261,28.17,7638.0,0.0036659999999999996,0.999933,ADAM10 HES1 JAG1 METRNL NCSTN NOTCH1 POFUT1 POGLUT1 PSENEN RFNG,"regulation of Notch signaling pathway|Notch signaling pathway|positive regulation of Notch signaling pathway|Notch receptor processing, ligand-dependent|amyloid-beta formation",1.463e-14|3.016e-14|4.4e-11|9.86e-09|2.348e-08,2.307e-10|2.378e-10|2.313e-07|3.888e-05|7.408e-05,136|122.2|187.2|882.6|617.9
98,11,0.6047,33.26,8134.0,0.004061,0.999969,FCGR2B FCGR3A FCRL3 GBA HSPA6 ITLN2 OR6K6 S100A12 SLAMF7 XCL1 YY1AP1,negative regulation of production of molecular mediator of immune response|leukocyte activation|regulation of inflammatory response|regulation of immunoglobulin production|cell activation,1.284e-06|3.385e-06|4.129e-06|6.341e-06|7.935e-06,0.02026|0.0267|0.02171|0.02501|0.02503,144|12.01|18.14|82.6|10.36
99,33,0.4609,243.3,26870.0,0.008952,1.0,ADAM18 ADAM2 ADAM32 ADGRA2 ADRB3 ANK1 AP3M2 C8orf58 CHRNA6 CHRNB3 DKK4 ERLIN2 FUT10 HGSNAT HOOK3 HTRA4 KCNU1 LETM2 LSM1 NKX6-3 PLPP5 POMK RNF170 RNF5 SLC20A2 STAR STMN4 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D VDAC3 ZMAT4,TRAIL-activated apoptotic signaling pathway|sperm-egg recognition|cell-cell recognition|fertilization|extrinsic apoptotic signaling pathway via death domain receptors,3.413e-07|3.877e-06|1.03e-05|1.445e-05|2.582e-05,0.005383|0.03058|0.05418|0.05697|0.08147,302.9|39.72|30.67|16.28|56.79
100,5,0.6221,6.221,4039.0,0.001534,0.996692,ADAM20 ADAM21 RDH11 RDH12 TMEM229B,cellular detoxification of aldehyde|cellular response to aldehyde|binding of sperm to zona pellucida|retinol metabolic process|sperm-egg recognition,2.119e-06|4.284e-06|4.857e-05|5.747e-05|9.15e-05,0.03343|0.03379|0.2554|0.2266|0.2887,1030|686.5|187.2|171.6|135
101,9,0.6274,22.59,7304.0,0.003075,0.9998530000000001,ARHGEF26 CPA3 CPB1 P2RY14 PLSCR1 PLSCR2 TFDP2 TM4SF18 TM4SF4,plasma membrane phospholipid scrambling|phospholipid translocation|lipid translocation|regulation of membrane lipid distribution|phospholipid transport,4.872e-05|0.0002363|0.0002669|0.0003574|0.000924,0.7685|1|1|1|1,205.9|89.54|84.06|72.26|44.29
102,19,0.6075,103.9,15840.0,0.006501000000000001,1.0,ADAM2 ADAM28 ADAM32 ADAM7 ADRB3 AP3M2 C8orf58 CHRNA6 CHRNB3 DKK4 PEBP4 RNF170 RNF5 SARAF STC1 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D,TRAIL-activated apoptotic signaling pathway|extrinsic apoptotic signaling pathway via death domain receptors|extrinsic apoptotic signaling pathway|activation of NF-kappaB-inducing kinase activity|cell surface receptor signaling pathway,5.557e-08|4.264e-06|8.439e-05|0.0001514|0.0001622,0.0008765|0.03363|0.4437|0.5971|0.5116,542|101.6|35.73|120.4|3.924
103,4,0.6,3.6,3301.0,0.0010869999999999999,0.9929309999999999,ADAMTS10 NOX4 SLC36A4 TYR,response to cAMP|response to organophosphorus|response to purine-containing compound|alpha-amino acid metabolic process|melanin biosynthetic process from tyrosine,0.0001391|0.0002689|0.0003299|0.0005391|0.0005825,1|1|1|1|1,105.1|75.16|67.75|52.81|2574
104,7,0.6473,13.59,5390.0,0.002509,0.9992989999999999,ADAMTS15 ADAMTS8 FXYD6 KCNJ1 NTM NXPE4 TMEM136,ion transmembrane transport|phosphate ion transmembrane transport|extracellular matrix organization|extracellular structure organization|external encapsulating structure organization,0.004001|0.005425|0.006839|0.006874|0.006944,1|1|1|1|1,8.398|196.1|15.4|15.36|15.28
105,4,0.6435,3.861,2961.0,0.001299,0.9929309999999999,ADAMTS18 ARRDC4 TAC3 TMEM82,tachykinin receptor signaling pathway|extracellular vesicle biogenesis|negative regulation of platelet aggregation|positive regulation of flagellated sperm motility|positive regulation of cilium-dependent cell motility,0.001747|0.001747|0.002522|0.002716|0.002716,1|1|1|1|1,643.6|643.6|429.1|396.1|396.1
106,7,0.6194,13.01,5649.0,0.002292,0.9992989999999999,ADAMTS7 CSPG4 GOLGA6B PLEKHO2 SCAMP2 SLC24A1 UBE2Q2L,macrophage apoptotic process|myeloid cell apoptotic process|inflammatory cell apoptotic process|response to light intensity|dermatan sulfate biosynthetic process,0.001358|0.002376|0.002715|0.004071|0.004409,1|1|1|1|1,980.7|490.4|420.3|267.5|245.2
107,4,0.6404,3.842,3170.0,0.001208,0.9929309999999999,ADAMTS9 OPRL1 PRICKLE2 SNTN,endothelial cell-matrix adhesion|positive regulation of gastric acid secretion|conditioned place preference|regulation of locomotor rhythm|positive regulation of sensory perception of pain,0.0003883|0.0005825|0.0007766|0.0007766|0.001941,1|1|1|1|1,5149|2574|1716|1716|572.1
108,4,0.6377,3.826,3087.0,0.001235,0.9929309999999999,ADAMTSL2 LTF PCDHA4 PCDHB7,siderophore-dependent iron import into cell|negative regulation of tumor necrosis factor (ligand) superfamily member 11 production|homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of single-species biofilm formation in or on host organism|regulation of single-species biofilm formation in or on host organism,0.0003883|0.0003883|0.0003972|0.0005825|0.0005825,1|1|1|1|1,5149|5149|61.66|2574|2574
109,26,0.4994,162.3,19420.0,0.008267,1.0,ADAMTSL4 CD1C CD1E CIART CTSK EFNA4 FCRL3 FLG2 GBA HIST2H2AB HIST2H2BE HRNR ITLN2 LCE3E LCE5A PGLYRP3 S100A12 S100A13 S100A2 S100A4 S100A6 S100A8 S100A9 SLAMF7 YY1AP1 ZNF687,leukocyte activation|cell activation|immune system process|cytokine production|immune response,4.254e-08|1.682e-07|3.841e-06|3.846e-06|4.828e-06,0.0006711|0.001327|0.0202|0.01516|0.01523,9.178|7.916|3.916|38.57|4.787
110,4,0.6846,4.1080000000000005,3220.0,0.001271,0.9929309999999999,ADAP1 CYP2W1 DAGLB RSPH10B,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|trans-synaptic signaling by endocannabinoid|trans-synaptic signaling by lipid,0.0007766|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1030|1030
111,4,0.65,3.9,2392.0,0.001622,0.9929309999999999,ADAR DCP2 PRKRA XRN1,posttranscriptional regulation of gene expression|histone mRNA catabolic process|pre-miRNA processing|negative regulation of gene expression|negative regulation of telomere maintenance via telomerase,5.065e-07|2.204e-06|3.391e-06|4.848e-06|7.146e-06,0.00799|0.01739|0.01783|0.01912|0.02254,37.65|936.1|735.5|21.36|490.4
112,4,0.6093,3.656,3420.0,0.001065,0.9929309999999999,ADARB2 ARHGAP44 CNPY1 PDZRN3,"modification of dendritic spine|regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane|negative regulation of Rac protein signal transduction|synapse organization|negative regulation of filopodium assembly",0.0005825|0.0007766|0.0007766|0.001139|0.001165,1|1|1|1|1,2574|1716|1716|36.13|1030
113,8,0.6463,18.1,5326.0,0.0033770000000000002,0.9996790000000001,ADAT2 ADAT3 CDIPT DOLK MRE11 RTCB TRMT6 TRMT61A,tRNA processing|tRNA metabolic process|tRNA modification|ncRNA processing|RNA modification,6.658e-10|3.113e-09|2.805e-08|2.23e-07|3.351e-07,1.05e-05|2.455e-05|0.0001475|0.0008792|0.001057,97.51|71.12|114.4|29.8|60.57
114,4,0.6351,3.81,3141.0,0.001209,0.9929309999999999,ABHD16A ADCK1 HSPA1L MSH5,prostaglandin catabolic process|prostanoid catabolic process|positive regulation of cristae formation|phosphatidylserine catabolic process|regulation of cristae formation,0.0005825|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1716|1287|1287
115,9,0.6034,21.72,6356.0,0.003396,0.9998530000000001,ARGLU1 BORA CDC16 DIS3 LIG4 MZT1 PCID2 RBM27 TUBGCP3,regulation of mitotic nuclear division|regulation of nuclear division|microtubule nucleation|microtubule polymerization|cell cycle,1.317e-05|2.45e-05|5.482e-05|0.0001121|0.0001414,0.2078|0.1932|0.2883|0.4419|0.4459,62.41|50.48|190.7|130.8|8.231
116,4,0.6536,3.9219999999999997,3439.0,0.001137,0.9929309999999999,ADCY1 KIAA0895 STEAP1 STK17A,neuroinflammatory response|positive regulation of fibroblast apoptotic process|cAMP biosynthetic process|cellular response to forskolin|response to forskolin,0.001359|0.001747|0.002134|0.002134|0.002134,1|1|1|1|1,858.1|643.6|514.9|514.9|514.9
117,4,0.6172,3.7030000000000003,3162.0,0.001167,0.9929309999999999,ADCY10 HIST3H2A METTL13 TMEM184C,cAMP biosynthetic process|cAMP metabolic process|cyclic purine nucleotide metabolic process|cyclic nucleotide biosynthetic process|epithelial cilium movement involved in extracellular fluid movement,0.001068|0.002232|0.002329|0.002329|0.003396,1|1|1|1|1,1030|468.1|447.7|447.7|302.9
118,4,0.6271,3.763,3326.0,0.001127,0.9929309999999999,ADCY4 HECA MMP14 PDZD7,respiratory tube development|response to mechanical stimulus|response to odorant|astrocyte cell migration|embryonic organ morphogenesis,0.0004114|0.0006596|0.0007766|0.001165|0.001179,1|1|1|1|1,60.57|47.67|1716|1030|35.51
119,5,0.6046,6.046,3871.0,0.0015550000000000002,0.996692,ADCY6 ANKMY2 GPR3 PTGES3 RIC8B,adenylate cyclase-activating G protein-coupled receptor signaling pathway|cellular response to vasopressin|response to vasopressin|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|telomerase holoenzyme complex assembly,0.0004271|0.0009706|0.0009706|0.001132|0.001213,1|1|1|1|1,61.48|1373|1373|37.45|1030
120,17,0.5818,79.13,12990.0,0.0060409999999999995,1.0,ADCY8 FOXH1 GLI4 GML GSDMC KCNQ3 LYPD2 MAPK15 MROH6 NAPRT RHPN1 TG WISP1 ZFP41 ZNF250 ZNF696 ZNF707,pyridine nucleotide salvage|positive regulation of metaphase/anaphase transition of meiotic cell cycle|positive regulation of metaphase/anaphase transition of meiosis I|regulation of metaphase/anaphase transition of meiosis I|positive regulation of meiotic chromosome separation,0.001649|0.001649|0.001649|0.001649|0.001649,1|1|1|1|1,1211|1211|1211|1211|1211
121,8,0.6292,17.62,5241.0,0.0033399999999999997,0.9996790000000001,CNOT1 CNOT10 CNOT11 EIF3K EIF3L FAM193A GGNBP2 GPBP1,"nuclear-transcribed mRNA poly(A) tail shortening|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint|signal transduction involved in mitotic DNA integrity checkpoint|signal transduction involved in mitotic DNA damage checkpoint",9.949e-08|1.368e-06|1.438e-06|1.438e-06|1.438e-06,0.001569|0.01079|0.007559|0.00567|0.004536,335.8|133.2|130.9|130.9|130.9
122,5,0.6048,6.047999999999999,4031.0,0.0014939999999999999,0.996692,ADD3 ARHGAP21 BTBD9 SPTAN1 SPTBN1,actin filament capping|negative regulation of actin filament depolymerization|regulation of actin filament depolymerization|negative regulation of actin filament polymerization|negative regulation of protein depolymerization,6.764e-08|9.064e-08|2.223e-07|2.714e-07|3.904e-07,0.001067|0.0007149|0.001169|0.00107|0.001232,334|301.4|220.7|205.9|181.7
123,21,0.613,128.7,17200.0,0.007411,1.0,ADAM2 ADAM32 ADGRA2 ADRB3 AP3M2 C8orf58 CHRNA6 CHRNB3 DDHD2 DKK4 LETM2 NKX6-3 PLPP5 RNF170 RNF5 SLC20A2 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D VDAC3,TRAIL-activated apoptotic signaling pathway|extrinsic apoptotic signaling pathway via death domain receptors|cell surface receptor signaling pathway|extrinsic apoptotic signaling pathway|activation of NF-kappaB-inducing kinase activity,7.621e-08|5.838e-06|6.592e-05|0.000115|0.0001857,0.001202|0.04604|0.3466|0.4536|0.5858,490.4|91.94|3.945|32.33|109
124,22,0.5777,133.5,16650.0,0.007929,1.0,AIFM3 CRYBA4 DGCR6L GSTT2B HIC2 KLHL22 LZTR1 MPPE1 P2RX6 RFPL3 RIMBP3 SDF2L1 SEC14L6 SEPT5 SERPIND1 SLC5A1 SLC7A4 THAP7 USP18 VPREB1 YPEL1 ZNF74,alpha-glucoside transport|galactose transmembrane transport|fucose transmembrane transport|pentose transmembrane transport|glucoside transport,0.003198|0.003198|0.003198|0.003198|0.004262,1|1|1|1|1,468.1|468.1|468.1|468.1|312
125,4,0.6179,3.708,3350.0,0.001103,0.9929309999999999,ADGRB2 HNRNPUL2 SIX5 WFDC5,negative regulation of skeletal muscle satellite cell proliferation|negative regulation of skeletal muscle cell proliferation|calcineurin-NFAT signaling cascade|regulation of skeletal muscle satellite cell proliferation|regulation of skeletal muscle cell proliferation,0.0009706|0.0009706|0.002522|0.002522|0.002716,1|1|1|1|1,1287|1287|429.1|429.1|396.1
126,4,0.617,3.702,3269.0,0.0011279999999999999,0.9929309999999999,ADGRB3 ANPEP CRYGN DENND6A,motor learning|positive regulation of cell-cell adhesion mediated by cadherin|neuron remodeling|system process|maintenance of synapse structure,0.001359|0.002328|0.002522|0.003608|0.003878,1|1|1|1|1,858.1|468.1|429.1|7.572|271
127,8,0.6088,17.05,6302.0,0.002691,0.9996790000000001,ATP12A C1QTNF9 C1QTNF9B GJB2 GJB6 RNF6 SOHLH2 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|cell-cell junction assembly,3.69e-06|4.743e-06|5.928e-06|3.036e-05|0.001063,0.0582|0.03741|0.03117|0.1197|1,858.1|735.5|643.6|257.4|40.54
128,13,0.6005,46.84,10210.0,0.004557,0.999993,ADGRF1 ENPP4 FBXO9 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP MUT SPATS1 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,3.445e-07|3.445e-07|4.657e-06|6.518e-06|7.401e-06,0.005434|0.002717|0.02449|0.0257|0.02335,234|234|858.1|686.5|79.21
129,4,0.6014,3.608,3105.0,0.001158,0.9929309999999999,ADGRF5 C6orf226 GUCA1A NCR2,positive regulation of cGMP-mediated signaling|pharyngeal arch artery morphogenesis|positive regulation of guanylate cyclase activity|positive regulation of phospholipid biosynthetic process|regulation of guanylate cyclase activity,0.001553|0.001747|0.001941|0.002328|0.002522,1|1|1|1|1,735.5|643.6|572.1|468.1|429.1
130,16,0.553,66.36,11830.0,0.005563,0.999999,ADGRG7 ALCAM ARL13B CD200R1 CDV3 MTRNR2L8 OR5AC2 OR5H1 OR5H14 OR5H15 OR5H2 OR5K1 OR5K3 OR5K4 PROS1 SLC9C1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.265e-10|8.351e-10|1.119e-09|1.947e-09|2.606e-09,8.305e-06|6.586e-06|5.884e-06|7.68e-06|8.221e-06,23.35|22|21.19|19.73|19
131,30,0.5072,220.6,22180.0,0.009825,1.0,ADCY4 ANG BCL2L2 CEBPE CIDEB CMA1 CMTM5 CTSG DHRS2 DHRS4 FITM1 GZMB GZMH LTB4R LTB4R2 MYH6 MYH7 OR10G2 OR10G3 OR11H4 OR5AU1 RBM23 REC8 RNASE13 RNASE3 RNASE4 RNASE7 SLC7A8 TM9SF1 TSSK4,antibacterial humoral response|RNA phosphodiester bond hydrolysis|defense response to Gram-positive bacterium|defense response to fungus|leukotriene signaling pathway,1.913e-06|4.325e-06|1.511e-05|4.041e-05|4.276e-05,0.03017|0.03412|0.07946|0.1594|0.1349,47.34|20.8|27.46|47.9|274.6
132,4,0.6282,3.7689999999999997,2954.0,0.001271,0.9929309999999999,ADGRL2 GNPTAB GNPTG TMEM251,carbohydrate phosphorylation|N-glycan processing to lysosome|cellular carbohydrate metabolic process|secretion of lysosomal enzymes|carbohydrate metabolic process,1.146e-05|0.0003883|0.0004405|0.001165|0.0031,0.1808|1|1|1|1,381.4|5149|58.51|1030|21.72
133,28,0.4309,162.9,22000.0,0.00733,1.0,AFM AFP ALB AMBN CXCL1 CXCL2 CXCL3 CXCL5 FAM47E HNRNPDL HSD17B11 PF4 PF4V1 PPBP SULT1B1 SULT1E1 THEGL TMEM150C TMPRSS11B TMPRSS11D TMPRSS11E UGT2A1 UGT2A3 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7,cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|steroid metabolic process|neutrophil chemotaxis,4.177e-15|1.662e-14|1.662e-14|3.213e-12|2.718e-11,6.589e-11|1.311e-10|8.737e-11|1.267e-08|8.574e-08,252.9|200.2|200.2|26.2|62.41
134,4,0.6113,3.668,3202.0,0.001141,0.9929309999999999,ADH1A ADH4 G3BP2 UGT2A1,ethanol oxidation|ethanol metabolic process|retinol metabolic process|organic hydroxy compound metabolic process|monocarboxylic acid metabolic process,2.572e-06|7.146e-06|3.454e-05|5.161e-05|6.171e-05,0.04057|0.05636|0.1816|0.2035|0.1947,858.1|490.4|214.5|31.91|30.05
135,4,0.6487,3.892,3212.0,0.001207,0.9929309999999999,ADIPOQ C18orf63 SPAG1 ZNF670,negative regulation of metanephros development|negative regulation of metanephric mesenchymal cell migration|positive regulation of renal albumin absorption|positive regulation of metanephric glomerular visceral epithelial cell development|regulation of metanephric glomerular visceral epithelial cell development,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
136,4,0.6087,3.6519999999999997,2999.0,0.001213,0.9929309999999999,ADIPOR1 DNAJC5 MET MFAP3,regulation of epithelial cell migration|negative regulation of thrombin-activated receptor signaling pathway|regulation of thrombin-activated receptor signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|negative regulation of guanyl-nucleotide exchange factor activity,0.000753|0.0007766|0.0007766|0.001165|0.001359,1|1|1|1|1,44.58|1716|1716|1030|858.1
137,15,0.5025,52.76,10640.0,0.004922,0.999999,ADIPOR2 BCL6 CEPT1 CYB561A3 EBF1 EPS15L1 IRF8 ITSN2 MEF2B PAX5 PIK3CD POU2AF1 POU2F2 SH3GL1 TTC7A,mononuclear cell differentiation|hemopoiesis|hematopoietic or lymphoid organ development|leukocyte differentiation|immune system development,1.475e-06|1.912e-06|3.008e-06|4.002e-06|4.194e-06,0.02326|0.01508|0.01582|0.01578|0.01323,23.92|14.4|13.31|19.45|12.56
138,10,0.6164,27.74,8120.0,0.003396,0.999933,ADIRF CALHM3 DUPD1 DUSP13 FFAR4 IFIT1 IFIT1B NUTM2A SFTPA1 SFTPA2,cellular response to exogenous dsRNA|cellular response to dsRNA|response to exogenous dsRNA|respiratory gaseous exchange by respiratory system|response to dsRNA,4.43e-05|6.322e-05|0.0002669|0.0002775|0.0003336,0.6988|0.4986|1|1|1,216.8|179.1|84.06|82.38|74.89
139,4,0.6237,3.742,3087.0,0.001207,0.9929309999999999,ADNP PABPC1L POFUT2 SERINC3,nitric oxide homeostasis|positive regulation of protein folding|protein O-linked fucosylation|detection of virus|L-serine biosynthetic process,0.0007766|0.0009706|0.001165|0.001359|0.001747,1|1|1|1|1,1716|1287|1030|858.1|643.6
140,8,0.6204,17.37,5400.0,0.0031969999999999998,0.9996790000000001,ADPGK DERL1 GSR NFE2L2 SLC33A1 SLC35B4 SUCO TAPT1,cell redox homeostasis|carbohydrate derivative transport|endoplasmic reticulum unfolded protein response|acetyl-CoA transport|UDP-xylose transmembrane transport,0.0001414|0.0003706|0.0007331|0.0007765|0.0007765,1|1|1|1|1,114.4|69.58|49.04|2574|2574
141,5,0.6485,6.485,4279.0,0.00151,0.996692,ADPRHL2 DCDC2B GJA4 TSSK3 ZSCAN20,peptidyl-serine ADP-deribosylation|protein de-ADP-ribosylation|cellular response to superoxide|cellular response to oxygen radical|response to superoxide,0.0004854|0.001698|0.003878|0.003878|0.004604,1|1|1|1|1,4119|686.5|274.6|274.6|228.8
142,5,0.606,6.06,4248.0,0.0014210000000000002,0.996692,ADRA1D MATN4 PKIG RBPJL WISP2,neuron-glial cell signaling|positive regulation of heart rate by epinephrine-norepinephrine|positive regulation of blood pressure by epinephrine-norepinephrine|regulation of systemic arterial blood pressure by norepinephrine-epinephrine|negative regulation of cAMP-dependent protein kinase activity,0.001456|0.001698|0.00194|0.002425|0.002425,1|1|1|1|1,823.8|686.5|588.4|457.7|457.7
143,19,0.5536,94.67,14170.0,0.006620999999999999,1.0,B4GALT1 BEST3 CPM FAM3C FAM49A FGF8 FRS2 LFNG LRRC10 LYZ MEGF10 MYCN MYOG PDK1 PTPRG RAB3IP RAP1B SLC35E3 ST3GAL4,regulation of striated muscle tissue development|regulation of muscle tissue development|regulation of muscle organ development|tissue development|epithelial cell development,1.008e-05|1.154e-05|1.313e-05|1.522e-05|3.476e-05,0.159|0.09103|0.06906|0.06001|0.1097,75.35|71.84|68.65|5.351|21.34
144,4,0.6024,3.615,3410.0,0.001056,0.9929309999999999,ADRA2C GRXCR2 MRPS10 MTX3,negative regulation of uterine smooth muscle contraction|negative regulation of epinephrine secretion|receptor transactivation|regulation of epinephrine secretion|negative regulation of norepinephrine secretion,0.0003883|0.0009706|0.001165|0.001359|0.001747,1|1|1|1|1,5149|1287|1030|858.1|643.6
145,6,0.6392,9.588,4997.0,0.001911,0.998474,ADRB1 CALHM3 CYP17A1 GSTO2 MORN4 SORCS3,positive regulation of the force of heart contraction by epinephrine-norepinephrine|positive regulation of the force of heart contraction by chemical signal|norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure|regulation of the force of heart contraction by chemical signal|heat generation,0.0008735|0.001165|0.001165|0.001746|0.001746,1|1|1|1|1,1716|1144|1144|686.5|686.5
146,4,0.605,3.63,3042.0,0.001189,0.9929309999999999,ABLIM2 ADSSL1 BOC CDC42BPB,actin cytoskeleton organization|actin filament-based process|positive regulation of myoblast differentiation|lamellipodium assembly|lamellipodium organization,0.00192|0.002492|0.003346|0.005379|0.006395,1|1|1|1|1,26.2|22.96|312|190.7|159.7
147,9,0.6063,21.83,6829.0,0.0031780000000000003,0.9998530000000001,AES CELF5 MUM1 PLIN3 SGTA UQCR11 ZNF555 ZNF556 ZNF77,"negative regulation of transcription by RNA polymerase II|positive regulation of chaperone-mediated protein folding|negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription|negative regulation of RNA biosynthetic process",0.0003919|0.00131|0.001502|0.001511|0.00152,1|1|1|1|1,10.15|1144|7.107|7.096|7.085
148,7,0.6074,12.75,5847.0,0.002172,0.9992989999999999,AFAP1L2 CALHM3 GOLGA7B IFIT5 LIPA LIPJ PNLIP,lipid catabolic process|intestinal cholesterol absorption|positive regulation of triglyceride lipase activity|intestinal lipid absorption|lipid digestion,0.0001097|0.003732|0.003732|0.004409|0.005425,1|1|1|1|1,29.03|294.2|294.2|245.2|196.1
149,11,0.5872,32.29,7255.0,0.004418,0.999969,AFG3L2 CEP192 FAM210A NDC80 NDUFV2 PRELID3B SEH1L THOC1 TRIM37 TXNDC2 ZBTB14,attachment of mitotic spindle microtubules to kinetochore|attachment of spindle microtubules to kinetochore|mitotic spindle organization|mitotic prometaphase|microtubule cytoskeleton organization involved in mitosis,2.349e-05|7.72e-05|8.224e-05|8.671e-05|0.0001169,0.3706|0.6089|0.4324|0.3419|0.3686,312|162.8|34.25|33.63|30.36
150,10,0.6268,28.2,7388.0,0.003793,0.999933,AAGAB AFTPH AP1B1 AP1G1 AP1M1 AP1M2 AP1S1 HEATR5B RAB11A SCYL2,regulation of defense response to virus by virus|intracellular transport|antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2.253e-12|5.506e-10|7.342e-10|8.088e-10|8.482e-10,3.554e-08|4.342e-06|3.861e-06|3.189e-06|2.676e-06,355.1|12.37|104|102|101
151,9,0.6149,22.14,7236.0,0.003043,0.9998530000000001,ARHGEF26 CPA3 CPB1 GPR87 P2RY14 PLSCR1 PLSCR2 TFDP2 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|plasma membrane phospholipid scrambling|phospholipid translocation|purinergic nucleotide receptor signaling pathway|lipid translocation,2.535e-05|4.872e-05|0.0002363|0.0002463|0.0002669,0.3998|0.3842|1|0.9712|0.842,294.2|205.9|89.54|87.64|84.06
152,13,0.6006,46.84,10040.0,0.004633,0.999993,AGAP6 ALOX5 BCL11B C10orf53 C10orf71 CHAT DRGX ERCC6 FAM170B SLC18A3 TMEM273 VSTM4 WASHC2A,olfactory bulb axon guidance|leukotriene A4 biosynthetic process|neurotransmitter secretion|signal release from synapse|leukotriene production involved in inflammatory response,0.001261|0.001261|0.001587|0.001587|0.001891,1|1|1|1|1,1584|1584|34.07|34.07|792.1
153,24,0.4726,130.4,18880.0,0.006846,1.0,AGAP5 AGAP6 AGAP9 ANK3 ANXA8L1 CALHM3 CXCL12 FAM25A GDF2 GPRIN2 LRRC18 NUTM2A NUTM2B PTPN20 SFTPA1 SFTPA2 SYT15 WASHC2C ZNF22 ZNF239 ZNF32 ZNF33B ZNF37A ZNF485,regulation of dopamine secretion|respiratory gaseous exchange by respiratory system|regulation of catecholamine secretion|positive regulation of membrane depolarization during cardiac muscle cell action potential|cellular process,0.0008435|0.001662|0.001924|0.002327|0.003005,1|1|1|1|1,49.04|34.33|31.78|858.1|0.6095
154,14,0.734,66.8,11270.0,0.005878,0.9999969999999999,ATOH1 C7orf33 CHRM2 CTLA4 IK IL33 KIAA0319 KIAA0586 LLCFC1 MLF2 MMP27 PRR9 SLC44A5 TBC1D1,positive regulation of inner ear receptor cell differentiation|regulation of CD86 production|positive regulation of CD86 production|regulation of CD80 production|auditory receptor cell fate specification,0.001358|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|1471|1471
155,4,0.6469,3.8810000000000002,3143.0,0.00123,0.9929309999999999,AGER NAAA NEU1 OR2J3,lipid catabolic process|positive regulation of synaptic transmission|positive regulation of hindgut contraction|negative regulation of connective tissue replacement|negative regulation of connective tissue replacement involved in inflammatory response wound healing,3.206e-05|0.0004024|0.0004854|0.0004854|0.0004854,0.5057|1|1|1|1,40.65|63.37|4119|4119|4119
156,8,0.6254,17.51,5442.0,0.003198,0.9996790000000001,AGK FDX2 SLC25A28 SLC25A37 STARD7 STOML2 TIMM22 TIMM29,mitochondrial transport|protein insertion into mitochondrial inner membrane|protein insertion into mitochondrial membrane|establishment of protein localization to mitochondrial membrane|iron import into the mitochondrion,5.676e-11|1.396e-08|1.119e-07|1.896e-07|7.913e-07,8.953e-07|0.0001101|0.0005884|0.0007476|0.002496,67.45|702.1|321.8|266.3|2574
157,9,0.6139,22.1,7142.0,0.003077,0.9998530000000001,AGO1 AGO3 AGO4 BEST4 GJB4 LURAP1 ZFP69 ZFP69B ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",6.905e-09|9.492e-09|1.265e-08|3.218e-08|3.218e-08,0.0001089|7.486e-05|6.653e-05|0.0001269|0.0001015,980.7|858.1|762.8|528.1|528.1
158,8,0.7664,21.46,5659.0,0.0037670000000000004,0.9996790000000001,AGO2 ANKRD52 DGCR8 DICER1 DROSHA TARBP2 TNRC6A XPO5,gene silencing by miRNA|post-transcriptional gene silencing by RNA|posttranscriptional gene silencing|miRNA metabolic process|gene silencing by RNA,5.187e-18|1.779e-17|3.062e-17|7.794e-17|2.612e-16,8.182e-14|1.403e-13|1.61e-13|3.074e-13|8.24e-13,375.4|310.7|286|735.5|207.1
159,7,0.6072,12.75,5417.0,0.0023420000000000003,0.9992989999999999,AGPAT5 CFAP53 ISL2 LHX3 NEUROD1 OTP OTX2,forebrain development|central nervous system development|neuron differentiation|pattern specification process|spinal cord motor neuron cell fate specification,3.978e-06|5.062e-06|6.058e-06|6.062e-06|6.521e-06,0.06276|0.03992|0.03185|0.0239|0.02057,30.97|14.84|14.31|27.82|588.4
160,4,0.6162,3.697,3116.0,0.001182,0.9929309999999999,AGT CCDC71 FAM71A TDRD10,"positive regulation of membrane hyperpolarization|glycine biosynthetic process, by transamination of glyoxylate|G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger|renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure|maintenance of blood vessel diameter homeostasis by renin-angiotensin",0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
161,7,0.6149,12.91,4543.0,0.002825,0.9992989999999999,AHCYL1 FAM13B MAPK6 MAPKAPK5 SLC20A1 SLC4A7 XPR1,phosphate ion transmembrane transport|inorganic anion transport|phosphate ion transport|anion transmembrane transport|cellular response to phosphate starvation,1.343e-05|1.602e-05|2.279e-05|0.0003643|0.0006794,0.2118|0.1264|0.1198|1|1,392.3|55.86|294.2|19.27|2942
162,7,0.6244,13.11,4747.0,0.002747,0.9992989999999999,AHCYL1 AHCYL2 FAM13B MAPK6 MAPKAPK5 SLC20A1 SLC4A7,S-adenosylmethionine cycle|S-adenosylmethionine metabolic process|one-carbon metabolic process|sodium ion transmembrane transport|inorganic anion transport,3.558e-06|1.51e-05|8.064e-05|0.0007163|0.001227,0.05613|0.1191|0.424|1|1,840.6|367.8|150.9|49.04|37.24
163,19,0.5463,93.42,12060.0,0.007659999999999999,1.0,BCAR1 CRKL ELMO2 FERMT2 ILK ITGAV LIMS1 MYO10 NCKAP1 PTK2 PXN RAC1 RAPGEF1 RAPH1 RSU1 TLN1 TNS3 VCL YES1,vascular endothelial growth factor receptor signaling pathway|enzyme linked receptor protein signaling pathway|regulation of cell adhesion|transmembrane receptor protein tyrosine kinase signaling pathway|regulation of cell-substrate adhesion,4.095e-13|6.597e-12|6.597e-12|8.547e-12|1.212e-11,6.459e-09|5.203e-08|3.469e-08|3.37e-08|3.824e-08,106.9|16.42|16.42|20.89|39.96
164,54,0.4265,610.3,41670.0,0.0144,1.0,AOC2 AOC3 CCR7 EPOP FKBP10 GSDMA GSDMB HAP1 HSPB9 KRT10 KRT12 KRT13 KRT15 KRT16 KRT19 KRT20 KRT222 KRT23 KRT24 KRT25 KRT26 KRT27 KRT28 KRT31 KRT33A KRT33B KRT35 KRT36 KRT37 KRT39 KRT40 KRT9 KRTAP1-1 KRTAP1-3 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP3-2 KRTAP3-3 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-8 KRTAP4-9 KRTAP9-1 KRTAP9-3 KRTAP9-8 KRTAP9-9 LRRC3C P3H4 RDM1 STAT5A TUBG2,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,7.472e-62|3.414e-59|1.351e-56|1.547e-53|3.549e-52,1.179e-57|2.692e-55|7.103e-53|6.099e-50|1.12e-48,63.46|53.52|45.39|37.45|34.4
165,5,0.6918,6.917999999999999,3166.0,0.002173,0.996692,AHR ARNT HSPA4 STIP1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|xenobiotic metabolic process|cellular response to xenobiotic stimulus|response to chemical|response to xenobiotic stimulus",7.067e-07|0.0003667|0.0003963|0.0004308|0.0004397,0.01115|1|1|1|1,2060|66.44|63.86|4.714|60.57
166,5,0.6817,6.817,3191.0,0.0021260000000000003,0.996692,AHR AHSA1 ARNT STIP1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|xenobiotic metabolic process|cellular response to xenobiotic stimulus|response to xenobiotic stimulus|cellular response to 2,3,7,8-tetrachlorodibenzodioxine",7.067e-07|0.0003667|0.0003963|0.0004397|0.000728,0.01115|1|1|1|1,2060|66.44|63.86|60.57|2060
167,9,0.6032,21.72,6104.0,0.003535,0.9998530000000001,CAB39 CCM2 FRYL ITGB1BP1 KRIT1 MAP3K2 PDCD10 TAOK1 TLNRD1,intracellular signal transduction|positive regulation of protein kinase activity|negative regulation of endothelial cell migration|positive regulation of kinase activity|negative regulation of epithelial cell migration,4.871e-07|1.389e-06|1.579e-06|2.617e-06|3.53e-06,0.007684|0.01096|0.008303|0.01032|0.01114,10.17|21.43|129.5|18.82|98.07
168,4,0.6529,3.917,3162.0,0.001234,0.9929309999999999,AIF1 C6orf48 NCR3 RHEX,positive regulation of muscle hyperplasia|regulation of immune system process|regulation of muscle hyperplasia|positive regulation of smooth muscle cell chemotaxis|negative regulation of smooth muscle cell chemotaxis,0.0002913|0.0005652|0.0005825|0.0007281|0.0007281,1|1|1|1|1,6865|12.11|2288|1716|1716
169,16,0.6128,73.54,10140.0,0.007176999999999999,0.999999,ALAD ALAS1 ATIC DHODH GCLC GSS MTHFD1 NAMPT PDXK PFAS PPCDC PPCS RFK SLC5A3 TPK1 UMPS,organonitrogen compound biosynthetic process|cellular nitrogen compound biosynthetic process|heterocycle biosynthetic process|aromatic compound biosynthetic process|organophosphate biosynthetic process,4.004e-17|2.849e-16|1.127e-14|1.268e-14|1.373e-14,6.316e-13|2.247e-12|5.926e-11|5.001e-11|4.331e-11,13.99|12.26|15.55|15.41|26.82
170,12,0.6039,39.86,8990.0,0.0044020000000000005,0.999986,AIM2 CD1B CD1E FCGR2B FCGR3A FCRL3 ITLN1 ITLN2 KCNJ10 OR10J5 SLAMF7 YY1AP1,"regulation of immune response|regulation of T cell mediated cytotoxicity|regulation of immune effector process|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|negative regulation of B cell receptor signaling pathway",9.422e-07|1.588e-06|4.553e-06|6.518e-06|1.117e-05,0.01486|0.01253|0.02394|0.0257|0.03523,10.64|135.5|18.14|686.5|490.4
171,10,0.6035,27.16,6348.0,0.004247,0.999933,ATM CDKN1A CHEK2 DCLRE1B MDM2 MDM4 PPM1D PPM1G TP53 USP28,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|cell cycle checkpoint|signal transduction in response to DNA damage|DNA damage checkpoint",6.951e-17|2.042e-15|2.68e-15|1.129e-14|9.144e-14,1.097e-12|1.611e-11|1.409e-11|4.453e-11|2.885e-10,139.6|182.5|87.17|141.3|103.7
172,4,0.6412,3.847,3463.0,0.0011070000000000001,0.9929309999999999,AK1 IFI6 KLHL26 RIPOR1,negative regulation of Rho guanyl-nucleotide exchange factor activity|ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|negative regulation of mitochondrial depolarization|negative regulation of guanyl-nucleotide exchange factor activity,0.0005825|0.001165|0.001165|0.001359|0.001359,1|1|1|1|1,2574|1030|1030|858.1|858.1
173,4,0.6116,3.67,3017.0,0.001212,0.9929309999999999,ABRAXAS2 ADRA2B AK3 COX4I1,ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|ribonucleoside diphosphate biosynthetic process|purine nucleoside diphosphate biosynthetic process|nucleoside diphosphate biosynthetic process,9.893e-07|9.893e-07|1.319e-06|1.319e-06|3.108e-06,0.01561|0.007803|0.006935|0.005201|0.009804,1648|1648|1373|1373|823.8
174,17,0.5731,77.94,13500.0,0.005726,1.0,C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMB HAP1 KRT28 KRTAP4-8 LYRM9 MMP28 RDM1 SLFN12,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|regulation of natural killer cell chemotaxis,7.493e-07|8.737e-07|8.584e-06|1.426e-05|3.606e-05,0.01182|0.006891|0.04514|0.05623|0.1138,191.3|180.7|79.31|66.36|271
175,9,0.6234,22.44,6178.0,0.0036090000000000002,0.9998530000000001,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 IMP3 NOP9 WDR43,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.79e-11|2.318e-11|9.564e-11|5.824e-10|9.65e-10,2.824e-07|1.828e-07|5.029e-07|2.297e-06|3.044e-06,50.41|48.54|39.48|30.34|28.18
176,4,0.605,3.63,3130.0,0.001155,0.9929309999999999,AK7 APOPT1 BAG5 MOK,negative regulation of protein refolding|regulation of protein refolding|negative regulation of protein folding|regulation of protein folding|nucleoside monophosphate phosphorylation,0.0007281|0.0007281|0.001019|0.001892|0.002038,1|1|1|1|1,1716|1716|1144|572.1|528.1
177,15,0.5879,61.73,9981.0,0.006128,0.999999,AP3B1 AP3D1 ARFGEF2 EIPR1 HTT RAB14 RIC1 VIPAS39 VPS26A VPS33B VPS50 VPS51 VPS52 VPS53 VPS54,endosomal transport|vesicle-mediated transport|intracellular transport|cytosolic transport|establishment of localization in cell,2.117e-18|7.212e-15|1.301e-14|1.099e-13|1.188e-13,3.339e-14|5.688e-11|6.839e-11|4.333e-10|3.748e-10,60.77|9.861|12.02|69.58|8.164
178,11,0.5764,31.7,8577.0,0.0036729999999999996,0.999969,AKAP2 FAM129B KIF12 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.071e-06|1.43e-06|1.719e-06|2.434e-06|2.922e-06,0.01689|0.01128|0.009037|0.009597|0.009218,23.35|22|21.19|19.73|19
179,4,0.652,3.912,3094.0,0.001259,0.9929309999999999,AKAP6 KIF13A TRIM25 ZNFX1,heterochromatin assembly by small RNA|positive regulation of delayed rectifier potassium channel activity|plus-end-directed vesicle transport along microtubule|plus-end-directed organelle transport along microtubule|positive regulation of cell growth involved in cardiac muscle cell development,0.0009706|0.001165|0.001359|0.001553|0.001747,1|1|1|1|1,1287|1030|858.1|735.5|643.6
180,11,0.6167,33.92,8499.0,0.003964,0.999969,HTN3 SMR3A SULT1B1 TMPRSS11B TMPRSS11E UGT2A1 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7,cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|steroid metabolic process|estrogen metabolic process,7.671e-16|2.569e-15|2.569e-15|1.886e-11|4.868e-09,1.21e-11|2.026e-11|1.351e-11|7.439e-08|1.536e-05,591.2|468.1|468.1|50.02|197.1
181,12,0.6042,39.88,8383.0,0.004721,0.999986,AKIP1 CEP120 CEP135 CEP295 CEP44 HYLS1 PCM1 POC1A POC1B POC5 SPICE1 WRAP73,centrosome cycle|microtubule organizing center organization|microtubule cytoskeleton organization|centriole replication|organelle assembly,6.925e-12|1.447e-11|1.549e-10|1.148e-09|1.926e-09,1.092e-07|1.141e-07|8.147e-07|4.528e-06|6.077e-06,117|103|24.26|298.5|17.58
182,7,0.6093,12.79,4719.0,0.002696,0.9992989999999999,AKIRIN1 DDI2 INAFM1 NFE2L1 NGLY1 PLAA RAD23B,proteolysis involved in cellular protein catabolic process|cellular protein catabolic process|protein catabolic process|cellular macromolecule catabolic process|proteasomal protein catabolic process,2.324e-05|2.87e-05|3.959e-05|0.000122|0.000159,0.3667|0.2263|0.2082|0.4811|0.5017,19.75|18.71|17.23|12.9|25.58
183,47,0.3829,413.9,37280.0,0.01095,1.0,AKR7A3 AMIGO1 AMY2A AMY2B CASQ2 CD101 CHIA CYB561D1 DENND2C EXTL2 FAM19A3 FNDC7 GBP5 GNAI3 GNAT2 GPR61 GSTM2 GSTM3 GSTM4 GSTM5 HAO2 HENMT1 HSD3B1 HSD3B2 INKA2 KCNA10 KCNA2 KCNA3 MOV10 MYBPHL NGF NRBF2 OVGP1 PHTF1 PNRC2 PPM1J PSRC1 RAP1A REG4 RHOC SLC22A15 SLC25A24 SLC6A17 SYPL2 TMEM167B TRIM45 UBL4B,glutathione derivative biosynthetic process|glutathione derivative metabolic process|nitrobenzene metabolic process|xenobiotic catabolic process|glutathione metabolic process,3.113e-07|3.113e-07|3.603e-07|4.625e-06|1.678e-05,0.00491|0.002455|0.001894|0.01824|0.05295,81.4|81.4|335.8|111.9|27.55
184,18,0.5362,82.04,12360.0,0.006573000000000001,1.0,AFDN ARHGAP29 CDC42 CRB3 CTNNA1 F11R HNF1B IRF6 MPP5 PARD3 PARD6B PATJ PAX8 PRKCI RASSF7 RASSF8 TJP1 TP53BP2,cell-cell junction organization|apical junction assembly|cell-cell junction assembly|cell junction assembly|bicellular tight junction assembly,1.376e-18|3.65e-18|5.037e-18|1.071e-16|3.036e-16,2.171e-14|2.879e-14|2.649e-14|4.225e-13|9.579e-13,67.67|153.7|90.09|44.95|157.8
185,38,0.4672,328.5,29930.0,0.01083,1.0,PCDHA1 PCDHA10 PCDHA12 PCDHA13 PCDHA3 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA9 PCDHAC2 PCDHB10 PCDHB11 PCDHB12 PCDHB13 PCDHB14 PCDHB15 PCDHB16 PCDHB6 PCDHB7 PCDHB8 PCDHGA10 PCDHGA11 PCDHGA2 PCDHGA3 PCDHGA4 PCDHGA5 PCDHGA6 PCDHGA7 PCDHGA8 PCDHGB1 PCDHGB2 PCDHGB3 PCDHGB4 PCDHGC3 PCDHGC4 PCDHGC5 SLC22A5,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,7.888e-75|2.33e-68|6.761e-58|2.784e-48|3.496e-48,1.244e-70|1.838e-64|3.555e-54|1.098e-44|1.103e-44,120.1|77.42|39.01|21.09|20.95
186,6,0.6617,9.925,4532.0,0.002179,0.998474,AKR1C1 AKR1C3 AKR1E2 CALML3 CALML5 FAM208B,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,7.067e-07|7.067e-07|2.59e-06|2.59e-06|2.59e-06,0.01115|0.005574|0.01362|0.01021|0.008171,2060|2060|915.3|915.3|915.3
187,7,0.6335,13.3,5447.0,0.00243,0.9992989999999999,AKR1C1 AKR1C3 AKR1C4 CALML3 CALML5 ITIH2 NET1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,2.878e-09|2.878e-09|1.807e-08|1.807e-08|1.807e-08,4.54e-05|2.27e-05|9.5e-05|7.125e-05|5.7e-05,1545|1545|686.5|686.5|686.5
188,13,0.5717,44.59,8135.0,0.0054340000000000005,0.999993,AKT1 AKT2 LAMTOR3 MAPKAP1 MIOS MLST8 PDPK1 PIK3CA PIK3CB RICTOR SEH1L WDR24 WDR59,positive regulation of TOR signaling|regulation of TOR signaling|regulation of intracellular signal transduction|positive regulation of intracellular signal transduction|positive regulation of signal transduction,1.008e-18|5.096e-16|1.441e-14|3.148e-13|4.214e-13,1.59e-14|4.019e-12|7.578e-11|1.241e-09|1.33e-09,294.7|128|11.65|17.17|12.26
189,12,0.6044,39.89,7862.0,0.005033,0.999986,C12orf66 DDIT4 DEPDC5 ITFG2 KPTN NPRL2 PTEN SESN2 SZT2 TBC1D7 TSC1 TSC2,negative regulation of TOR signaling|regulation of TOR signaling|negative regulation of intracellular signal transduction|negative regulation of TORC1 signaling|negative regulation of signal transduction,1.613e-28|7.164e-25|4.028e-20|8.739e-16|3.388e-15,2.544e-24|5.65e-21|2.118e-16|3.446e-12|1.069e-11,439|190.7|41.86|605.7|16.14
190,4,0.6376,3.826,3186.0,0.001196,0.9929309999999999,ALDH16A1 CALM3 LHB PSG3,progesterone biosynthetic process|negative regulation of high voltage-gated calcium channel activity|positive regulation of cyclic-nucleotide phosphodiesterase activity|positive regulation of ryanodine-sensitive calcium-release channel activity|regulation of cell communication by electrical coupling involved in cardiac conduction,0.0009706|0.001165|0.001165|0.001941|0.001941,1|1|1|1|1,1287|1030|1030|572.1|572.1
191,8,0.6173,17.28,4926.0,0.0034850000000000003,0.9996790000000001,ALDH18A1 ASNS ATF4 EIF2AK4 GCN1 NADK2 SLC3A2 TRPM7,integrated stress response signaling|cellular response to starvation|L-asparagine metabolic process|response to starvation|cellular response to nutrient levels,5.094e-08|5.397e-07|7.913e-07|1.153e-06|1.294e-06,0.0008035|0.004257|0.004161|0.004545|0.004084,429.1|53.63|2574|44.2|42.91
192,5,0.6002,6.002000000000001,3959.0,0.00151,0.996692,ALDH1A1 C9orf16 PTBP3 UCK1 ZBTB6,CTP salvage|pyrimidine ribonucleotide salvage|fructose catabolic process|pyrimidine nucleotide salvage|UMP salvage,0.0009706|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,1373|823.8|823.8|823.8|823.8
193,21,0.6017,126.4,16710.0,0.0074849999999999995,1.0,ALDH3A1 ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CLEC10A GP1BA INCA1 KCTD11 MFSD6L MYH10 MYH2 MYH4 P2RX1 SHBG SLC16A13 TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,1.992e-07|1.992e-07|8.734e-07|1.818e-06|6.364e-06,0.003142|0.001571|0.004592|0.007171|0.02008,326.9|326.9|183.9|140.1|89.16
194,4,0.6021,3.613,3405.0,0.001057,0.9929309999999999,ALDH4A1 GNA14 HLA-DOB TMEM42,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|proline catabolic process to glutamate|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process,0.0005825|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1716|1287|1287
195,10,0.6211,27.95,6263.0,0.004429,0.999933,ALDOA BSG GAPDH GPI PGAM1 PGD PGP PKM RPE TPI1,carbohydrate catabolic process|monosaccharide catabolic process|pyruvate metabolic process|monosaccharide metabolic process|NADH regeneration,6.094e-17|2.368e-16|8.32e-16|1.832e-15|2.18e-15,9.613e-13|1.867e-12|4.375e-12|7.225e-12|6.877e-12,142|252.9|208.9|91.53|457.7
196,13,0.5217,40.69,9929.0,0.004071,0.999993,ALDOC ARL10 BPNT1 CCDC102A DVL3 GML OR5AU1 PIGS PLEKHG4 PM20D1 PSD4 VASH1 WFDC11,negative regulation of lymphangiogenesis|regulation of oxidative phosphorylation uncoupler activity|cellular amide catabolic process|non-canonical Wnt signaling pathway via JNK cascade|regulation of lymphangiogenesis,0.002521|0.00315|0.00315|0.003779|0.003779,1|1|1|1|1,528.1|396.1|396.1|316.8|316.8
197,8,0.6453,18.07,5165.0,0.003475,0.9996790000000001,ALG1 ALG2 DOLK DPAGT1 HYOU1 RFT1 SLC35B1 SLC39A7,dolichol-linked oligosaccharide biosynthetic process|oligosaccharide-lipid intermediate biosynthetic process|protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation,2.336e-16|2.972e-16|2.543e-13|2.333e-10|2.333e-10,3.684e-12|2.344e-12|1.337e-09|9.201e-07|7.361e-07,653.8|624.1|183.1|56.74|56.74
198,7,0.6339,13.31,4722.0,0.002803,0.9992989999999999,ALG11 DIS3 EXOSC8 GTF3A MRPS31 MZT1 ZC3H13,"rRNA catabolic process|ncRNA catabolic process|exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|RNA phosphodiester bond hydrolysis, exonucleolytic",2.072e-05|5.199e-05|5.857e-05|6.553e-05|9.729e-05,0.3268|0.41|0.3079|0.2584|0.3069,309.7|189.8|178.3|168.1|136.8
199,20,0.6069,115.3,12530.0,0.009093,1.0,ALG12 ALG3 ALG5 ALG6 ALG8 ALG9 DNAJC3 DOLPP1 DPM1 DPM2 DPM3 MPDU1 MPI OST4 PMM2 SEC63 SLC33A1 SYVN1 UBE2G2 UGP2,protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein metabolic process,1.223e-26|1.56e-22|1.56e-22|3.165e-22|4.737e-22,1.929e-22|1.231e-18|8.205e-19|1.248e-18|1.494e-18,170|56.74|56.74|53.84|39.54
200,7,0.6449,13.54,5573.0,0.002418,0.9992989999999999,ALK HAND2 INSM2 ISL1 MYT1 PHOX2B SOX11,noradrenergic neuron differentiation|neural crest cell development|stem cell development|mesenchymal cell development|neural crest cell differentiation,4.605e-09|1.693e-08|1.955e-08|2.049e-08|2.686e-08,7.264e-05|0.0001335|0.0001028|8.082e-05|8.473e-05,1103|130.3|125.6|124.1|115.7
201,4,0.6015,3.609,3342.0,0.001076,0.9929309999999999,ALKAL2 CD302 PUSL1 SOCS2,positive regulation of ERK5 cascade|regulation of ERK5 cascade|tRNA pseudouridine synthesis|negative regulation of multicellular organism growth|pseudouridine synthesis,0.0005825|0.0005825|0.001165|0.002328|0.003685,1|1|1|1|1,2574|2574|1030|468.1|286
202,37,0.4436,295.4,29200.0,0.00999,1.0,ALKBH4 ARPC1A ARPC1B C7orf43 C7orf61 CLDN15 CNPY4 CYP3A4 CYP3A43 CYP3A5 CYP3A7 DLX6 FBXO24 GJC3 MBLAC1 MOGAT3 MUC12 NYAP1 OCM2 PCOLCE PILRA PILRB PON1 PON2 PON3 PVRIG RNF148 SLC26A4 SLC26A5 STEAP2 TRIM50 WNT2 ZKSCAN1 ZNF394 ZNF804B ZSCAN21 ZSCAN25,oxidative demethylation|demethylation|lipid hydroxylation|lipoxygenase pathway|alkaloid catabolic process,5.026e-10|1.451e-07|5.806e-07|4.638e-06|2.951e-05,7.928e-06|0.001145|0.003053|0.01829|0.09309,150.5|43.34|245.2|107.3|381.4
203,11,0.8778,48.28,7035.0,0.006795000000000001,0.999969,ALKBH8 CTU1 CTU2 DPH3 ELP5 ELP6 MOCS3 NR2C2AP PUS3 RNF25 URM1,tRNA wobble uridine modification|tRNA wobble base modification|tRNA modification|tRNA processing|RNA modification,3.194e-22|8.773e-22|5.127e-20|1.38e-18|1.246e-17,5.039e-18|6.919e-18|2.696e-16|5.443e-15|3.932e-14,832.1|713.2|187.2|127.7|99.12
204,4,0.6214,3.728,3356.0,0.0011070000000000001,0.9929309999999999,ALLC HTR6 ODF3L1 TNFSF13B,allantoin catabolic process|positive regulation of germinal center formation|allantoin metabolic process|cellular amide catabolic process|B cell costimulation,0.0003883|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1716|1287|1287
205,6,0.6016,9.024,5106.0,0.00176,0.998474,ALPG BPIFA1 BPIFA3 GHRH KIAA1755 WFDC6,"positive regulation of circadian sleep/wake cycle, REM sleep|immune response in nasopharyngeal-associated lymphoid tissue|immune response in gut-associated lymphoid tissue|regulation of liquid surface tension|negative regulation of single-species biofilm formation in or on host organism",0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
206,4,0.685,4.11,3265.0,0.001254,0.9929309999999999,ALPI CHRND CHRNG PDE6D,"excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|regulation of postsynaptic membrane potential|skeletal muscle tissue growth|muscle contraction",6.041e-05|6.8e-05|0.0001447|0.0007766|0.0008321,0.953|0.5363|0.761|1|1,160.9|151.4|103|1716|42.38
207,14,0.6091,55.42,11240.0,0.004896,0.9999969999999999,GPR32 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP9 SHISA7,regulation of immune response|regulation of immune system process|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|immune response,5.955e-10|3.087e-08|5.128e-08|8.881e-08|2.011e-06,9.393e-06|0.0002435|0.0002696|0.0003502|0.006343,12.16|8.072|514.9|411.9|6.266
208,4,0.612,3.6719999999999997,3239.0,0.0011300000000000001,0.9929309999999999,ALPK2 CGNL1 SERPINB3 SERPINB8,epicardium morphogenesis|negative regulation of endopeptidase activity|negative regulation of signal transduction|negative regulation of peptidase activity|negative regulation of cell communication,0.0005825|0.0008457|0.000911|0.0009151|0.00113,1|1|1|1|1,2574|42.03|12.11|40.38|11.25
209,4,0.6248,3.7489999999999997,3505.0,0.001066,0.9929309999999999,ALPL GUCA2B HTR6 ZNF683,cellular response to organic cyclic compound|response to organic cyclic compound|cementum mineralization|regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response,5.685e-05|0.0003102|0.0005825|0.0005825|0.0007766,0.8967|1|1|1|1,30.89|17.43|2574|2574|1716
210,4,0.6177,3.7060000000000004,3382.0,0.001092,0.9929309999999999,ALS2 CCDC14 KRTAP20-3 RPH3AL,regulation of endosome size|positive regulation of Rac protein signal transduction|regulation of vesicle size|regulation of Rac protein signal transduction|protein localization to centrosome,0.001165|0.001553|0.002328|0.004072|0.004653,1|1|1|1|1,1030|735.5|468.1|257.4|223.9
211,41,0.5772,473.3,31650.0,0.0147,1.0,CBR1 CBR3 CHODL CLDN14 CLDN17 CLDN8 COL6A2 CRYZL1 DNAJC28 IFNAR2 IL10RB ITSN1 KCNJ6 KRTAP11-1 KRTAP13-1 KRTAP13-2 KRTAP13-3 KRTAP13-4 KRTAP15-1 KRTAP19-1 KRTAP19-2 KRTAP19-3 KRTAP19-4 KRTAP19-5 KRTAP19-6 KRTAP19-7 KRTAP19-8 KRTAP20-1 KRTAP20-2 KRTAP21-1 KRTAP21-2 KRTAP22-1 KRTAP6-1 KRTAP6-2 KRTAP8-1 OLIG1 SIM2 TCP10L TMEM50B TMPRSS2 TMPRSS3,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,9.184e-32|3.182e-30|9.953e-29|5.616e-27|3.354e-26,1.449e-27|2.509e-26|5.233e-25|2.215e-23|1.058e-22,47.73|40.25|34.14|28.17|25.87
212,6,0.6028,9.042,4812.0,0.001871,0.998474,AAED1 AMBP FBP2 GNA14 MUSK ZNF510,positive regulation of protein geranylgeranylation|regulation of protein geranylgeranylation|sucrose biosynthetic process|sucrose metabolic process|regulation of synaptic growth at neuromuscular junction,0.0005824|0.0005824|0.0008735|0.001165|0.001746,1|1|1|1|1,3432|3432|1716|1144|686.5
213,4,0.6122,3.673,2301.0,0.001588,0.9929309999999999,AMBRA1 CCND3 CDK6 CDKN1B,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|G1 phase|mitotic G1 phase|mitotic cell cycle phase transition,1.662e-06|2.396e-06|7.146e-06|7.146e-06|1.071e-05,0.02622|0.0189|0.03757|0.02818|0.03378,101.6|89.8|490.4|490.4|54.2
214,4,0.6066,3.639,3447.0,0.001052,0.9929309999999999,AMIGO3 CABP7 MFSD8 VDAC3,adenine transport|purine nucleobase transport|regulation of lysosomal protein catabolic process|TORC1 signaling|nucleobase transport,0.0009706|0.001747|0.001747|0.001941|0.001941,1|1|1|1|1,1287|643.6|643.6|572.1|572.1
215,4,0.6042,3.625,3628.0,0.0009960000000000001,0.9929309999999999,ACBD4 AMMECR1L HIGD1B VWA3B,mitochondrial respirasome assembly|UNCLASSIFIED|biological_process|biological regulation|regulation of biological process,0.002134|0.008539|0.008539|0.02306|0.03244,1|1|1|1|1,514.9|5.627|0.2884|0|0
216,8,0.6162,17.25,6309.0,0.0027199999999999998,0.9996790000000001,ALG10 AMN1 BICD1 ETFBKMT KIAA1551 MANSC4 SYT10 TM7SF3,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|regulation of proteinase activated receptor activity,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
217,11,0.5729,31.51,7450.0,0.0041990000000000005,0.999969,AMOTL2 DLG5 KIRREL1 LATS2 NF2 PKN2 PTPN14 RNF146 SAV1 TAOK1 TULP4,hippo signaling|regulation of hippo signaling|intracellular signal transduction|cell-cell junction organization|negative regulation of cell population proliferation,5.046e-07|5.95e-05|6.664e-05|0.0001187|0.0003465,0.007959|0.4693|0.3504|0.4681|1,200.6|187.2|7.132|30.2|10.87
218,12,0.6107,40.3,10110.0,0.00396,0.999986,C8orf58 DEFA4 DEFA5 DEFA6 NAT1 PEBP4 SARAF SCARA3 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D,TRAIL-activated apoptotic signaling pathway|membrane disruption in other organism|innate immune response in mucosa|mucosal immune response|extrinsic apoptotic signaling pathway via death domain receptors,2.613e-08|8.881e-08|8.028e-07|1.841e-06|2.013e-06,0.0004122|0.0007004|0.004221|0.007261|0.00635,686.5|411.9|179.1|132.9|128.7
219,18,0.5693,87.1,14490.0,0.005959000000000001,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 AMZ1 GHRHR HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN NME8 NPY ZNRF2,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|lung goblet cell differentiation,1.882e-08|6.59e-08|1.234e-06|4.268e-06|7.191e-06,0.0002968|0.0005198|0.006486|0.01683|0.02269,60.86|46.89|25.54|19.73|762.8
220,7,0.6033,12.67,5120.0,0.002462,0.9992989999999999,ANAPC1 DDX18 IMP4 NIFK RANBP2 WDR33 ZC3H8,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|gene expression|maturation of LSU-rRNA|nucleocytoplasmic transport|rRNA processing",1.789e-05|3.336e-05|5.708e-05|0.0001086|0.0001098,0.2822|0.2631|0.3001|0.4283|0.3465,343.2|7.066|183.9|29.82|29.7
221,4,0.6115,3.6689999999999996,2994.0,0.00122,0.9929309999999999,ANAPC1 ANAPC10 DDX19B NUTF2,protein K11-linked ubiquitination|regulation of exit from mitosis|anaphase-promoting complex-dependent catabolic process|protein export from nucleus|anaphase,1.313e-05|2.792e-05|0.0001101|0.0003299|0.0003516,0.2071|0.2202|0.5791|1|1,355.1|239.5|118.4|67.75|65.59
222,10,0.6195,27.88,7053.0,0.003926,0.999933,ANAPC11 CHMP6 EIF4A3 FTSJ3 GPS1 HGS NPLOC4 SAP30BP TBCD USP36,cellular catabolic process|multivesicular body assembly|multivesicular body organization|catabolic process|negative regulation of signal transduction,6.861e-05|0.0001043|0.000111|0.0001583|0.0001784,1|0.8229|0.5838|0.6241|0.5628,6.876|137.3|132.9|5.929|8.07
223,9,0.6362,22.9,5833.0,0.003899,0.9998530000000001,ANAPC13 ANAPC15 ANAPC5 CCNF CDC16 PRPF39 TRNAU1AP UBE2C UBE2S,protein K11-linked ubiquitination|regulation of exit from mitosis|cell division|anaphase-promoting complex-dependent catabolic process|protein polyubiquitination,1.128e-12|6.927e-12|1.618e-10|1.975e-10|1.255e-09,1.78e-08|5.464e-08|8.51e-07|7.79e-07|3.959e-06,394.5|266.1|32.56|131.5|42.64
224,6,0.6013,9.02,4391.0,0.002045,0.998474,ANAPC4 DHX15 GRPEL1 HAUS3 NOP14 STX18,"rRNA 5'-end processing|endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|positive regulation of ER to Golgi vesicle-mediated transport|endoplasmic reticulum membrane organization|biological phase",0.001746|0.001746|0.001746|0.002037|0.002284,1|1|1|1|1,686.5|686.5|686.5|572.1|26.71
225,6,0.6628,9.942,4566.0,0.002167,0.998474,ANAPC7 C17orf58 DND1 LRRC37A LRRC37A2 LRRC37A3,metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle|UNCLASSIFIED|biological_process|positive regulation of mitotic sister chromatid separation,0.002328|0.002328|0.003791|0.003791|0.004361,1|1|1|1|1,490.4|490.4|5.002|0.3846|245.2
226,4,0.6323,3.7939999999999996,3318.0,0.001139,0.9929309999999999,ANGPTL2 CCDC178 PCYOX1 VNN1,prenylcysteine metabolic process|prenylcysteine catabolic process|prenylated protein catabolic process|pantothenate metabolic process|positive regulation of T cell differentiation in thymus,0.0005825|0.0005825|0.0007766|0.001553|0.002134,1|1|1|1|1,2574|2574|1716|735.5|514.9
227,4,0.6227,3.736,3142.0,0.001185,0.9929309999999999,ANGPTL4 CDHR5 KRT16 KRTAP4-8,hair cycle|molting cycle|intermicrovillar adhesion|protein unfolding|keratinization,0.0001999|0.0001999|0.000728|0.0009706|0.001193,1|1|1|1|1,90.53|90.53|2060|1373|36.45
228,20,0.4888,92.86,14540.0,0.006327,1.0,CALR DAND5 ZNF20 ZNF433 ZNF441 ZNF442 ZNF443 ZNF490 ZNF563 ZNF564 ZNF625 ZNF627 ZNF682 ZNF69 ZNF709 ZNF763 ZNF791 ZNF799 ZNF844 ZNF878,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.63e-20|9.869e-18|9.932e-18|1.025e-17|5.24e-17,2.571e-16|7.784e-14|5.222e-14|4.042e-14|1.653e-13,7.964|5.945|5.944|5.935|5.51
229,4,0.6157,3.694,3406.0,0.0010810000000000001,0.9929309999999999,ANKAR CD37 CYP26B1 VSX2,positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|positive regulation of skeletal muscle fiber differentiation|regulation of skeletal muscle fiber differentiation|diterpenoid catabolic process,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
230,11,0.6734,37.04,7727.0,0.004757,0.999969,ATP6V1E1 CDC45 CRK DGCR8 ESS2 GNB1L MRPL40 PI4KA PPIL2 TFIP11 UFD1,cellular response to endothelin|negative regulation of DNA ligation|negative regulation of DNA ligase activity|viral replication complex formation and maintenance|mitotic DNA replication preinitiation complex assembly,0.001067|0.001067|0.001067|0.001067|0.001067,1|1|1|1|1,1872|1872|1872|1872|1872
231,11,0.6273,34.5,6944.0,0.004928,0.999969,ANKFY1 RAB5C RABGEF1 RBSN TGFBRAP1 VPS16 VPS18 VPS33A VPS39 VPS45 VPS8,lysosomal transport|vacuolar transport|vesicle-mediated transport|endosomal vesicle fusion|protein transport,4.831e-14|4.384e-13|5.913e-12|2.17e-11|3.485e-11,7.62e-10|3.458e-09|3.109e-08|8.559e-08|1.099e-07,120.2|86.79|10.52|936.1|12.8
232,13,0.5799,45.23,8774.0,0.0051140000000000005,0.999993,ANKFY1 C12orf4 PPP1R21 RAB5C RABGEF1 RBSN TBCK TGFBRAP1 VPS16 VPS18 VPS33A VPS45 VPS8,lysosomal transport|vacuolar transport|protein transport|peptide transport|intracellular transport,4.4e-11|2.917e-10|7.921e-10|9.592e-10|1.004e-09,6.94e-07|2.3e-06|4.165e-06|3.783e-06|3.167e-06,87.21|62.95|10.83|10.62|10.57
233,12,0.5894,38.9,8606.0,0.004487,0.999986,CDC26 EXOSC2 GLE1 IARS NOL8 NUP214 PRPF4 RPL35 SEC16A SPOUT1 SURF6 TXN,gene expression|cellular macromolecule localization|ribosome biogenesis|protein localization to organelle|cellular localization,5.441e-06|1.161e-05|3.099e-05|5.363e-05|5.866e-05,0.08582|0.09154|0.163|0.2115|0.1851,6.281|7.303|20.68|10.85|4.572
234,4,0.7049,4.229,3069.0,0.001373,0.9929309999999999,ANKLE2 POLE SFSWAP SNRNP35,"DNA replication proofreading|leading strand elongation|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",0.0005825|0.0009706|0.001277|0.001277|0.001302,1|1|1|1|1,2574|1287|34.1|34.1|33.76
235,4,0.6123,3.674,2957.0,0.0012380000000000002,0.9929309999999999,ANKRA2 DDX41 NHP2 RACK1,snRNA pseudouridine synthesis|rescue of stalled ribosome|positive regulation of cyclic-nucleotide phosphodiesterase activity|positive regulation of Golgi to plasma membrane protein transport|negative regulation of hydrogen peroxide-induced neuron death,0.0007766|0.0009706|0.001165|0.001165|0.001359,1|1|1|1|1,1716|1287|1030|1030|858.1
236,7,0.6201,13.02,4576.0,0.002829,0.9992989999999999,EIF3E EIF3F EIF3H EIF3M EIF4G2 PRRC2A PRRC2C,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|translational initiation|cytoplasmic translation|translation,2.256e-11|2.155e-10|3.711e-10|6.947e-09|4.762e-08,3.558e-07|1.7e-06|1.951e-06|2.739e-05|0.0001502,735.5|392.3|102.9|156.9|38.31
237,4,0.7027,4.216,3121.0,0.0013460000000000002,0.9929309999999999,ANKRD13B CHRDL2 EGFLAM SIAE,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|negative regulation of receptor internalization|negative regulation of receptor-mediated endocytosis|chondroitin sulfate metabolic process|chondroitin sulfate proteoglycan metabolic process,0.001359|0.002716|0.00562|0.007552|0.008517,1|1|1|1|1,858.1|396.1|183.9|135.5|119.7
238,6,0.6355,9.533,4654.0,0.002039,0.998474,AKR1C1 AKR1C3 AKR1E2 ANKRD16 CALML3 CALML5,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,1.06e-06|1.06e-06|3.883e-06|3.883e-06|3.883e-06,0.01672|0.008359|0.02042|0.01531|0.01225,1716|1716|762.8|762.8|762.8
239,5,0.6133,6.132999999999999,3184.0,0.001917,0.996692,ANKRD17 CNOT4 G3BP1 SERBP1 SRRD,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|positive regulation of stress granule assembly|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process,0.0005471|0.0006976|0.000728|0.0009706|0.0009706,1|1|1|1|1,54.2|47.9|2060|1373|1373
240,13,0.6069,47.33,10610.0,0.004432,0.999993,ANKRD22 CALHM3 CYP2C9 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPF LIPJ LIPK NUTM2A OPN4,cellular response to type I interferon|response to type I interferon|defense response to symbiont|defense response to virus|type I interferon signaling pathway,1.011e-07|1.393e-07|7.793e-06|7.793e-06|1.093e-05,0.001595|0.001099|0.04098|0.03073|0.03449,91.84|84.49|29.89|29.89|69.89
241,7,0.6361,13.36,5792.0,0.0022949999999999997,0.9992989999999999,ANKRD23 IL1F10 IL1RN IL36G LYG1 RNF149 SCTR,inflammatory response to antigenic stimulus|response to external stimulus|inflammatory response|defense response|cell wall macromolecule catabolic process,2.016e-07|0.0004564|0.0004597|0.0006643|0.001019,0.00318|1|1|1|1,252.2|5.866|17.8|8.311|1471
242,13,0.5743,44.79,9684.0,0.004592000000000001,0.999993,ANKRD26 C2CD3 CASP2 CEP120 CEP76 CEP83 CNTROB CRADD FOPNL KIAA0753 PCM1 PIBF1 PIDD1,protein localization to centrosome|protein localization to microtubule organizing center|cell cycle process|protein localization to microtubule cytoskeleton|protein localization to cytoskeleton,4.055e-12|4.899e-12|3.716e-11|3.953e-11|6.291e-11,6.397e-08|3.863e-08|1.954e-07|1.559e-07|1.985e-07,344.4|330|14.81|208.5|188.6
243,76,0.381,1086.0,59550.0,0.01786,1.0,APLP1 ARHGAP33 CATSPERG CEACAM21 CEACAM4 CLC CYP2A13 CYP2A6 CYP2B6 EID2 EID2B ETV2 FAM187B FAM98C FBXO27 FFAR2 FFAR3 GAPDHS GRAMD1A HKR1 IFNL1 IFNL2 IFNL3 IGFLR1 LGALS13 LGALS14 LGALS16 LGALS7B LGI4 MAG MAP4K1 NCCRP1 PLEKHF1 PLEKHG2 RASGRP4 RYR1 SBSN SERTAD3 SLC7A9 UPK1A WDR87 WDR88 ZFP14 ZFP82 ZNF181 ZNF230 ZNF285 ZNF30 ZNF302 ZNF345 ZNF382 ZNF383 ZNF45 ZNF461 ZNF527 ZNF529 ZNF536 ZNF540 ZNF546 ZNF566 ZNF567 ZNF568 ZNF569 ZNF570 ZNF571 ZNF573 ZNF585A ZNF585B ZNF599 ZNF607 ZNF780B ZNF790 ZNF792 ZNF793 ZNF829 ZNF850,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of nucleobase-containing compound metabolic process",2.401e-13|2.13e-12|2.15e-12|2.253e-12|9.911e-12,3.787e-09|1.68e-08|1.13e-08|8.886e-09|3.127e-08,3.723|3.089|3.088|3.083|2.804
244,7,0.6212,13.04,4493.0,0.002886,0.9992989999999999,BRAF DUSP4 DUSP6 ELAVL1 MAP2K1 MAP2K2 MAPK1,regulation of Golgi inheritance|activation of MAPKK activity|regulation of MAPK cascade|regulation of MAP kinase activity|activation of protein kinase activity,8.402e-10|2.26e-09|1.024e-08|1.632e-08|2.157e-08,1.325e-05|1.782e-05|5.387e-05|6.436e-05|6.805e-05,2207|210.2|25.44|47.61|44.99
245,13,0.6236,48.64,10660.0,0.004529999999999999,0.999993,ANKRD29 CABLES1 CHST9 CTIF DSG1 DSG3 DSG4 HRH4 KIAA1328 SERPINB7 TPGS2 ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,4.77e-05|0.0001484|0.0003567|0.0005287|0.0005834,0.7524|1|1|1|1,42.06|28.46|21.03|18.35|17.73
246,9,0.6084,21.9,6903.0,0.0031550000000000003,0.9998530000000001,ANKRD30A CREM MCM10 MTRNR2L7 PRPF18 ZNF248 ZNF25 ZNF33A ZNF37A,nuclear retention of unspliced pre-mRNA at the site of transcription|nuclear mRNA surveillance of spliceosomal pre-mRNA splicing|generation of catalytic spliceosome for second transesterification step|regulation of transcription by RNA polymerase II|nuclear retention of pre-mRNA at the site of transcription,0.00131|0.00131|0.00131|0.002544|0.002618,1|1|1|1|1,1144|1144|1144|4.424|457.7
247,7,0.6014,12.63,5759.0,0.002183,0.9992989999999999,ANKRD33B CDH12 DNAH5 FAM173B OTULINL ROPN1L SLC1A3,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|sperm motility|flagellated sperm motility|cilium movement involved in cell motility,4.434e-05|5.213e-05|0.0002925|0.0002925|0.0003455,0.6994|0.4112|1|1|1,201.9|185.5|76.28|76.28|70.05
248,4,0.6014,3.608,3342.0,0.001076,0.9929309999999999,ANKRD34A CHRNA9 RAP2A ZAR1,Rap protein signal transduction|microvillus assembly|microvillus organization|detection of mechanical stimulus involved in sensory perception of sound|positive regulation of protein autophosphorylation,0.002328|0.002328|0.002716|0.003297|0.00562,1|1|1|1|1,468.1|468.1|396.1|321.8|183.9
249,31,0.4505,209.5,23360.0,0.008865999999999999,1.0,CIART CTSK EFNA3 FCRL3 FLG2 GBA HIST2H2AB HIST2H2BE HRNR ITLN2 LCE3E LCE5A LCE6A MINDY1 PGLYRP3 PGLYRP4 PRR9 PRUNE1 S100A12 S100A2 S100A4 S100A5 S100A6 S100A7 S100A7A S100A8 S100A9 SELENBP1 SLAMF7 SPRR1A SPRR2G,skin development|keratinocyte differentiation|antimicrobial humoral response|epidermis development|epidermal cell differentiation,2.114e-09|8.432e-08|8.756e-08|8.942e-08|2.514e-07,3.335e-05|0.000665|0.0004604|0.0003526|0.0007932,16.69|18.55|27.31|13.62|15.73
250,6,0.6042,9.062999999999999,4568.0,0.001975,0.998474,ANKRD36B FAHD2A LYG1 MRPL30 TRIM43 TUBA3D,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,0.0008735|0.001165|0.001165|0.002037|0.002037,1|1|1|1|1,1716|1144|1144|572.1|572.1
251,5,0.6196,6.196000000000001,3231.0,0.0019079999999999998,0.996692,ANKRD49 CSNK1A1 CSNK1D FKBPL VEZT,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|regulation of proteasomal ubiquitin-dependent protein catabolic process,0.0001956|0.0002745|0.0003003|0.0004085|0.0004271,1|1|1|1|1,91.53|76.99|73.55|62.89|61.48
252,4,0.6304,3.783,3436.0,0.001097,0.9929309999999999,ANKRD50 FBXO34 NPAS3 SIPA1L1,"retrograde transport, endosome to plasma membrane|regulation of dendritic spine morphogenesis|regulation of dendrite morphogenesis|actin cytoskeleton reorganization|vesicle-mediated transport to the plasma membrane",0.00562|0.008903|0.01314|0.01314|0.0164,1|1|1|1|1,183.9|114.4|76.85|76.85|61.29
253,7,0.6302,13.23,5949.0,0.0022140000000000003,0.9992989999999999,ADGRV1 ANKRD55 CDH12 DMGDH GZMK ITGA1 ITGA2,detection of mechanical stimulus involved in sensory perception|positive regulation of phosphatase activity|detection of mechanical stimulus|cell adhesion|biological adhesion,6.2e-05|6.2e-05|0.0001404|0.0001435|0.0001471,0.978|0.489|0.7383|0.5659|0.4639,173.1|173.1|113.2|12.37|12.3
254,4,0.6047,3.628,3367.0,0.001074,0.9929309999999999,ANKRD9 DNAAF3 MEDAG TJP2,positive regulation of blood-brain barrier permeability|regulation of blood-brain barrier permeability|GDP metabolic process|establishment of endothelial intestinal barrier|GMP metabolic process,0.001165|0.001747|0.002328|0.002522|0.003104,1|1|1|1|1,1030|643.6|468.1|429.1|343.2
255,4,0.6255,3.753,3268.0,0.001144,0.9929309999999999,ANKZF1 KIAA1257 LRRN1 MYO16,phosphatidylinositol 3-kinase signaling|positive regulation of synapse assembly|cellular response to hydrogen peroxide|ubiquitin-dependent ERAD pathway|phosphatidylinositol-mediated signaling,0.009431|0.01448|0.01736|0.01831|0.01975,1|1|1|1|1,108.4|69.81|58.01|54.92|50.85
256,5,0.662,6.62,3231.0,0.002038,0.996692,ANLN DIAPH3 ECT2 FLII KIF20A,mitotic cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|cytokinetic process|cytoskeleton organization,3.904e-07|1.069e-06|1.511e-06|3.128e-05|5.61e-05,0.006158|0.008433|0.007943|0.1234|0.177,181.7|128.7|114.4|235.4|13.68
257,7,0.6028,12.66,5487.0,0.0022960000000000003,0.9992989999999999,ANO2 CCNB1IP1 INIP MCOLN3 PCDHGA9 RNF114 TMEM100,chiasma assembly|arterial endothelial cell differentiation|blood vessel endothelial cell differentiation|positive regulation of endothelial cell differentiation|epithelial to mesenchymal transition involved in endocardial cushion formation,0.002376|0.002376|0.003054|0.004071|0.004071,1|1|1|1|1,490.4|490.4|367.8|267.5|267.5
258,4,0.6293,3.7760000000000002,2921.0,0.001287,0.9929309999999999,ANO5 MRGPRX1 MRGPRX2 SAA1,acute-phase response|acute inflammatory response|response to chloroquine|G protein-coupled receptor signaling pathway|macrophage chemotaxis,2.547e-05|7.603e-05|0.0003883|0.001027|0.00291,0.4018|0.5997|1|1|1,251.2|143|5149|11.62|367.8
259,4,0.6395,3.8369999999999997,3167.0,0.001207,0.9929309999999999,ANO8 GGACT KCNK13 LY6G6C,stabilization of membrane potential|inorganic ion transmembrane transport|cellular modified amino acid catabolic process|ion transmembrane transport|chloride transmembrane transport,0.003491|0.005997|0.006393|0.01462|0.0189,1|1|1|1|1,302.9|15.51|160.9|9.798|53.08
260,4,0.6305,3.783,3263.0,0.001155,0.9929309999999999,ANTXR2 ETV3L KCNN2 TCP10,atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell signaling|atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell communication,0.001165|0.001165|0.00291|0.00291|0.003104,1|1|1|1|1,1030|1030|367.8|367.8|343.2
261,4,0.6311,3.787,3205.0,0.0011769999999999999,0.9929309999999999,ANXA1 C3orf18 MAN1C1 SLC9A3R1,monocarboxylic acid transport|regulation of cell shape|renal phosphate ion absorption|negative regulation of sodium:proton antiporter activity|Golgi apparatus mannose trimming,0.0003299|0.0003342|0.0003883|0.0005825|0.0007766,1|1|1|1|1,67.75|67.3|5149|2574|1716
262,4,0.6241,3.7439999999999998,3241.0,0.001151,0.9929309999999999,ANXA11 COL22A1 COTL1 KLHL38,endothelial cell morphogenesis|epithelial cell morphogenesis|cytokinetic process|defense response to fungus|endothelial cell development,0.002716|0.006393|0.006973|0.008517|0.01045,1|1|1|1|1,396.1|160.9|147.1|119.7|97.15
263,18,0.6008,91.92,14240.0,0.006397,1.0,APTX AQP7 CCL19 CREB3 DNAJB5 FAM205A GALT GLIPR2 IFNA1 KIF24 NPR2 OR13J1 OR2S2 SIGMAR1 SPAG8 TESK1 TOMM5 UBAP2,response to reactive oxygen species|positive regulation of dendritic cell dendrite assembly|UDP-glucose catabolic process|myeloid dendritic cell chemotaxis|polynucleotide 3' dephosphorylation,0.000669|0.001746|0.001746|0.002618|0.002618,1|1|1|1|1,17.34|1144|1144|572.1|572.1
264,11,0.575,31.63,8596.0,0.0036560000000000004,0.999969,ANXA2R C1QTNF3 CCL28 EXOC3 FGF10 HCN1 NIM1K SLC1A3 TMEM267 UGT3A1 UGT3A2,mesenchymal-epithelial cell signaling involved in lung development|lung proximal/distal axis specification|semicircular canal fusion|urothelial cell proliferation|positive regulation of urothelial cell proliferation,0.001067|0.001067|0.001067|0.001067|0.001067,1|1|1|1|1,1872|1872|1872|1872|1872
265,24,0.5426,149.8,19290.0,0.007686,1.0,ADCYAP1R1 AEBP1 AGR3 EGR3 FKBP9 GCK GHRHR GPCPD1 KIAA0895 MTURN MYL7 MYO1G NIPSNAP2 NUPR2 PHKG1 POM121L12 PSPH RNASET2 SEPT14 SUMF2 URGCP VWC2 WIPF3 ZNF713,regulation of peptide hormone secretion|cellular glucose homeostasis|positive regulation of peptide hormone secretion|regulation of hormone secretion|carbohydrate catabolic process,0.0001738|0.000221|0.0003238|0.000393|0.0004422,1|1|1|1|1,14.27|26.11|22.85|11.48|20.49
266,4,0.6342,3.805,3064.0,0.0012369999999999998,0.9929309999999999,ANXA7 NODAL PLA2G12B RPL26L1,left lung morphogenesis|transforming growth factor beta receptor signaling pathway involved in primitive streak formation|axial mesodermal cell fate specification|axial mesodermal cell fate commitment|axial mesodermal cell differentiation,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
267,4,0.6329,3.7969999999999997,3320.0,0.00114,0.9929309999999999,AP1AR ATP2C2 PARP16 WASF1,regulation of Arp2/3 complex-mediated actin nucleation|regulation of actin nucleation|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization|regulation of actin filament length,7.146e-06|1.4e-05|0.0004258|0.0005069|0.0005122,0.1127|0.1104|1|1|1,490.4|343.2|59.52|54.48|54.2
268,7,0.6009,12.62,5818.0,0.002159,0.9992989999999999,AP3B2 CELF6 GOLGA6B PLEKHO2 SCAMP2 SCAMP5 SLC24A1,macrophage apoptotic process|vesicle-mediated transport|myeloid cell apoptotic process|inflammatory cell apoptotic process|anion transport,0.001358|0.002266|0.002376|0.002715|0.004044,1|1|1|1|1,980.7|6.011|490.4|420.3|5.146
269,8,0.6158,17.24,6205.0,0.002764,0.9996790000000001,ADCY10 AP5M1 CCNB1IP1 KIF26B MCOLN3 PCDHB12 PCDHGA9 TMEM100,ureteric bud invasion|homophilic cell adhesion via plasma membrane adhesion molecules|metanephric renal vesicle formation|ureteric bud elongation|renal vesicle formation,0.001552|0.001813|0.00194|0.002328|0.002715,1|1|1|1|1,858.1|30.83|643.6|514.9|429.1
270,15,0.5808,60.99,12090.0,0.005007,0.999999,AP5S1 AVP CDC25B HSPA12B LZTS3 MAVS OXT PLCB4 PRND RSPO4 SIRPA SIRPB1 SIRPG SPEF1 TGM3,maternal aggressive behavior|positive regulation of phagocytosis|aggressive behavior|female mating behavior|hyperosmotic salinity response,4.938e-06|1.453e-05|1.775e-05|2.217e-05|2.217e-05,0.07789|0.1146|0.09331|0.08744|0.06995,915.3|64.36|392.3|343.2|343.2
271,5,0.685,6.85,4202.0,0.0016239999999999998,0.996692,APBA1 FAM189A2 FOXB2 PIP5K1B PRKACG,gamma-aminobutyric acid secretion|gamma-aminobutyric acid transport|high-density lipoprotein particle assembly|chemical synaptic transmission|anterograde trans-synaptic signaling,0.000728|0.002425|0.003394|0.004019|0.004019,1|1|1|1|1,2060|457.7|316.8|19.61|19.61
272,17,0.5704,77.57,13770.0,0.005589,1.0,APBB2 CHRNA9 CNGA1 CORIN CWH43 GABRA2 GABRA4 GABRB1 GABRG1 OCIAD2 SLC10A4 TEC TLR1 TLR10 TXK WDR19 ZAR1,"gamma-aminobutyric acid signaling pathway|regulation of postsynaptic membrane potential|synaptic transmission, GABAergic|chloride transmembrane transport|chloride transport",1.262e-08|2.532e-08|4.525e-07|1.576e-06|1.985e-06,0.000199|0.0001997|0.002379|0.006215|0.006264,169.5|57.21|228.8|47.18|44.43
273,5,0.7577,7.577000000000001,3329.0,0.002264,0.996692,APC AXIN1 CSNK1A1 CTNNBIP1 ZNRF3,negative regulation of Wnt signaling pathway|beta-catenin destruction complex assembly|cell-cell signaling by wnt|Wnt signaling pathway|regulation of Wnt signaling pathway,1.298e-10|3.843e-10|1.457e-09|1.457e-09|1.845e-09,2.047e-06|3.031e-06|7.663e-06|5.747e-06|5.821e-06,96.24|2471|59.01|59.01|56.27
274,9,0.6517,23.46,5987.0,0.003892,0.9998530000000001,APH1A IPO8 LEMD3 NCSTN PSEN1 PSENEN TGFBR1 TGFBR2 TGFBR3,"Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing|amyloid precursor protein catabolic process|membrane protein ectodomain proteolysis",5.531e-12|1.677e-11|1.677e-11|8.107e-11|1.777e-10,8.725e-08|1.323e-07|8.817e-08|3.197e-07|5.605e-07,1308|915.3|915.3|572.1|457.7
275,6,0.6973,10.46,4200.0,0.002477,0.998474,API5 CHTOP POLDIP3 SARNP THOC6 ZC3HC1,mRNA 3'-end processing|mRNA export from nucleus|mRNA-containing ribonucleoprotein complex export from nucleus|ribonucleoprotein complex export from nucleus|ribonucleoprotein complex localization,5.548e-09|1.37e-08|1.37e-08|2.319e-08|2.392e-08,8.752e-05|0.0001081|7.205e-05|9.147e-05|7.545e-05,156|123.7|123.7|108.1|107.3
276,5,0.6222,6.222,4191.0,0.0014789999999999998,0.996692,APLF F2RL2 LBH PSKH1 WASF1,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division|regulation of somatic stem cell division|dendritic transport of mitochondrion,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
277,4,0.6101,3.661,2967.0,0.0012289999999999998,0.9929309999999999,APLNR ASCL1 DYNC1I2 SOX1,cell fate commitment involved in pattern specification|ventral spinal cord interneuron fate commitment|ventral spinal cord interneuron differentiation|spinal cord dorsal/ventral patterning|spinal cord patterning,2.204e-06|2.204e-06|2.967e-06|4.831e-06|5.932e-06,0.03477|0.01739|0.0156|0.01905|0.01871,936.1|936.1|792.1|605.7|542
278,4,0.6256,3.7539999999999996,3124.0,0.0011970000000000001,0.9929309999999999,APLP2 SH2D3A SRMS UCKL1,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|UMP biosynthetic process,0.0007766|0.001165|0.001165|0.001165|0.002328,1|1|1|1|1,1716|1030|1030|1030|468.1
279,18,0.566,86.6,13580.0,0.006319,1.0,APOA2 CD1B CD1E FCGR2B FCRL3 FMO2 GBA ITLN1 ITLN2 KCNJ10 NECTIN4 OR10J5 OR6K6 OR6N1 OR6N2 S100A12 SLAMF7 YY1AP1,"regulation of T cell mediated cytotoxicity|negative regulation of production of molecular mediator of immune response|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|negative regulation of B cell receptor signaling pathway|antigen processing and presentation, exogenous lipid antigen via MHC class Ib",6.921e-06|7.45e-06|1.686e-05|2.886e-05|2.886e-05,0.1092|0.05875|0.08863|0.1138|0.09106,85.57|83.38|433.6|309.7|309.7
280,4,0.6044,3.627,3287.0,0.001099,0.9929309999999999,APOBEC3H GGT5 RCN3 RPTN,organonitrogen compound catabolic process|collagen biosynthetic process|leukotriene D4 biosynthetic process|leukotriene D4 metabolic process|DNA cytosine deamination,0.000557|0.001941|0.002134|0.002134|0.002134,1|1|1|1|1,14.3|572.1|514.9|514.9|514.9
281,14,0.6086,55.38,9337.0,0.005879,0.9999969999999999,AFDN ARHGAP29 CDC42 CDH1 CDH2 CRB3 CTNNA1 CTNND1 F11R PARD3 PARD6B PRKCI TJP1 TP53BP2,cell-cell junction organization|cell junction assembly|cell-cell junction assembly|cell junction organization|adherens junction organization,1.958e-22|2.286e-20|3.521e-19|2.118e-17|2.171e-14,3.089e-18|1.803e-16|1.851e-15|8.354e-14|6.85e-11,88.58|58.84|108.1|32.89|155
282,20,0.5297,100.6,16290.0,0.006124,1.0,ERVV-1 FPR3 KIR2DL1 SIGLEC5 SIGLEC9 VN1R4 ZNF175 ZNF28 ZNF415 ZNF432 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF613 ZNF665 ZNF701 ZNF841 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|cellular process",1.216e-08|5.227e-07|5.246e-07|5.343e-07|1.126e-06,0.0001918|0.004122|0.002758|0.002107|0.003553,5.309|3.964|3.962|3.957|0.3166
283,4,0.6803,4.082,3177.0,0.00128,0.9929309999999999,APOC2 FXR1 FXR2 KY,"regulation of filopodium assembly|regulation of alternative mRNA splicing, via spliceosome|regulation of mRNA splicing, via spliceosome|positive regulation of response to DNA damage stimulus|positive regulation of translation",3.316e-05|4.987e-05|0.0001505|0.0001746|0.000265,0.523|0.3933|0.7912|0.6883|0.836,219.1|177.5|101|93.61|75.72
284,11,0.6106,33.58,9028.0,0.0036969999999999998,0.999969,APOC2 APOC4 CCDC61 CEACAM19 EML2 IGFL1 IGFL2 IGFL3 IGFL4 PGLYRP1 SCGB2B2,plasma lipoprotein particle assembly|protein-lipid complex assembly|triglyceride homeostasis|acylglycerol homeostasis|plasma lipoprotein particle clearance,0.0001118|0.000144|0.0001802|0.0001802|0.00021,1|1|0.9477|0.7107|0.6626,133.7|117|104|104|96.01
285,4,0.6138,3.6830000000000003,3286.0,0.001117,0.9929309999999999,APOLD1 GABARAPL1 KLRC1 STYK1,"CD8-positive, gamma-delta intraepithelial T cell differentiation|gamma-delta intraepithelial T cell differentiation|natural killer cell inhibitory signaling pathway|gamma-delta T cell differentiation|immune response-inhibiting cell surface receptor signaling pathway",0.0007766|0.0007766|0.0007766|0.001359|0.001747,1|1|1|1|1,1716|1716|1716|858.1|643.6
286,4,0.6207,3.7239999999999998,3374.0,0.0011,0.9929309999999999,APOM C1QTNF12 CLEC18B PDP2,positive regulation of pyruvate dehydrogenase activity|negative regulation of plasma lipoprotein oxidation|regulation of plasma lipoprotein oxidation|regulation of pyruvate dehydrogenase activity|regulation of acetyl-CoA biosynthetic process from pyruvate,0.0005825|0.0005825|0.0005825|0.0007766|0.001747,1|1|1|1|1,2574|2574|2574|1716|643.6
287,18,0.6084,93.08,13540.0,0.006811,1.0,AQP10 CD1C CD1E CTSK EFNA4 FCGR2B FCRL3 GBA ITLN2 LCE3E PGLYRP3 S100A12 S100A2 S100A4 S100A8 S100A9 SLAMF7 YY1AP1,leukocyte activation|cell activation|neutrophil aggregation|immune system process|regulation of T cell mediated cytotoxicity,5.411e-07|1.643e-06|4.317e-06|4.459e-06|5.838e-06,0.008535|0.01296|0.0227|0.01759|0.01842,9.79|8.444|1144|4.418|90.33
288,7,0.6173,12.96,5739.0,0.002248,0.9992989999999999,AQP9 BNIP2 MYO5C PIGH PLEKHO2 PPIB SNX22,macrophage apoptotic process|purine nucleobase transmembrane transport|canalicular bile acid transport|polyphosphate catabolic process|pyrimidine nucleobase transport,0.001358|0.001698|0.001698|0.002037|0.002037,1|1|1|1|1,980.7|735.5|735.5|588.4|588.4
289,13,0.6657,51.92,8358.0,0.006155,0.999993,CHMP5 CHMP6 CLTC HGS PTPN23 SNF8 STAMBP TFG UBAP1 USP8 VPS25 VPS36 VPS37A,endosomal transport|multivesicular body assembly|multivesicular body organization|endosome organization|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,1.197e-17|5.604e-17|6.867e-17|7.56e-17|7.616e-15,1.888e-13|4.42e-13|3.611e-13|2.981e-13|2.403e-11,67.99|369.7|357.7|164.6|413.3
290,30,0.4191,182.3,22940.0,0.007863,1.0,C8orf33 C8orf82 DENND3 FAM135B FOXH1 GLI4 GSDMC GSDMD KCNQ3 LRRC24 LY6E LY6K LYPD2 MAPK15 MROH6 NAPRT PLEC PPP1R16A RHPN1 RPL8 SLURP2 TIGD5 TSNARE1 WISP1 ZFP41 ZNF16 ZNF250 ZNF623 ZNF696 ZNF707,pyroptosis|response to sodium dodecyl sulfate|cellular response to sodium dodecyl sulfate|positive regulation of meiotic chromosome separation|NAD salvage,0.0003823|0.002907|0.002907|0.002907|0.002907,1|1|1|1|1,76.28|686.5|686.5|686.5|686.5
291,8,0.6006,16.82,5121.0,0.0032630000000000003,0.9996790000000001,ARCN1 COPB1 COPB2 COPZ1 IER3IP1 SCYL1 UNC50 YIPF5,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|Golgi vesicle transport|endoplasmic reticulum to Golgi vesicle-mediated transport|intra-Golgi vesicle-mediated transport|vesicle-mediated transport",7.878e-11|1.441e-09|4.598e-09|3.221e-07|5.214e-07,1.243e-06|1.136e-05|2.418e-05|0.00127|0.001645,151.4|39.01|65.67|220.7|9.204
292,4,0.6066,3.64,3224.0,0.001125,0.9929309999999999,AREG BSPRY DEFB135 ZNF646,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis|epithelial cell proliferation involved in mammary gland duct elongation|thelarche|branch elongation involved in mammary gland duct branching|mammary gland branching involved in thelarche,0.0003883|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1287|1030|1030|1030
293,4,0.6127,3.676,2446.0,0.0014960000000000002,0.9929309999999999,ARF1 MON2 OSBPL9 VPS54,post-Golgi vesicle-mediated transport|Golgi vesicle transport|organic substance transport|anion transport|macromolecule localization,1.146e-06|2.844e-05|0.0001238|0.0001527|0.0002358,0.01807|0.2243|0.6507|0.602|0.744,115.3|39.01|9.491|9.005|8.076
294,20,0.6023,114.4,15280.0,0.0074129999999999995,1.0,ACVRL1 ANKRD33 AQP2 AQP5 ARF3 ASIC1 KRT1 KRT5 KRT6B KRT74 KRT75 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT86 OR10P1 POU6F1,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.738e-22|4.927e-19|3.561e-18|2.421e-17|2.276e-16,2.742e-18|3.886e-15|1.872e-14|9.547e-14|7.181e-13,109.4|54.68|46.11|39.1|32.26
295,4,0.604,3.6239999999999997,2671.0,0.001351,0.9929309999999999,MDM2 UBE2D1 UBE2D2 UBE2D3,TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|protein polyubiquitination|protein K48-linked ubiquitination|protein autoubiquitination,1.497e-08|1.958e-08|6.16e-08|9.378e-08|1.634e-07,0.0002361|0.0001545|0.0003239|0.0003698|0.0005154,514.9|468.1|63.96|271|223.9
296,18,0.5859,89.64,10800.0,0.008205,1.0,ARFRP1 ARL1 COG1 COG3 COG5 COG6 COG7 EIPR1 GPR107 RAB6A RGP1 RIC1 SYS1 UNC50 VPS51 VPS52 VPS53 VPS54,"intracellular transport|cytosolic transport|retrograde transport, endosome to Golgi|Golgi vesicle transport|protein transport",7.346e-18|4.567e-17|8.314e-17|1.369e-16|3.6e-16,1.159e-13|3.602e-13|4.372e-13|5.398e-13|1.136e-12,12.29|73.24|108.4|32.85|11.85
297,4,0.6276,3.766,3195.0,0.001175,0.9929309999999999,ADAM21 ARG2 NICN1 WSCD2,"negative regulation of chemokine (C-C motif) ligand 4 production|regulation of chemokine (C-C motif) ligand 4 production|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|arginine catabolic process to ornithine|negative regulation of macrophage inflammatory protein 1 alpha production",0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
298,4,0.6721,4.033,2488.0,0.0016129999999999999,0.9929309999999999,ARHGEF7 ITGB1 MARK2 PAK2,positive regulation of fibroblast migration|regulation of anatomical structure morphogenesis|plasma membrane bounded cell projection organization|cell projection organization|regulation of fibroblast migration,3.391e-06|4.67e-06|1.036e-05|1.209e-05|1.984e-05,0.05349|0.03683|0.05446|0.04767|0.06258,735.5|21.57|17.66|16.99|286
299,7,0.6313,13.26,4970.0,0.002653,0.9992989999999999,ARHGAP11A ARHGAP11B CHRFAM7A GOLGA8M GOLGA8R UBE2Q2L WHAMM,endomembrane system organization|negative regulation of acetylcholine-gated cation channel activity|Golgi organization|regulation of acetylcholine-gated cation channel activity|actin filament reorganization,0.0004384|0.0006794|0.000902|0.001019|0.003732,1|1|1|1|1,18.09|2942|43.59|1471|294.2
300,8,0.612,17.14,6190.0,0.002754,0.9996790000000001,ANKRD30A ARHGAP12 CREM MTRNR2L7 NRP1 ZNF25 ZNF33A ZNF37A,endothelial cell chemotaxis|vascular endothelial growth factor signaling pathway|semaphorin-plexin signaling pathway|cellular response to vascular endothelial growth factor stimulus|endothelial cell migration,1.32e-05|5.062e-05|0.0001312|0.0001738|0.0004033,0.2082|0.3992|0.6896|0.6854|1,416.1|199|120.4|104|67.3
301,4,0.6143,3.6860000000000004,3438.0,0.0010689999999999999,0.9929309999999999,ARHGAP25 HTR3C NOTO TRABD2A,positive regulation of protein oxidation|regulation of protein oxidation|notochord development|motile cilium assembly|serotonin receptor signaling pathway,0.0005825|0.0005825|0.003878|0.00504|0.007745,1|1|1|1|1,2574|2574|271|205.9|132
302,7,0.6013,12.63,5382.0,0.002334,0.9992989999999999,ARHGAP31 CD200R1 CD96 OR5AC2 OR5H2 OR5K3 SLC9C1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.0003262|0.0003881|0.0004332|0.0005335|0.0005952,1|1|1|1|1,20.01|18.86|18.16|16.91|16.28
303,4,0.6467,3.88,2931.0,0.0013189999999999999,0.9929309999999999,ARHGAP32 FLI1 KCNJ1 KCNJ5,potassium ion import across plasma membrane|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane|import across plasma membrane|potassium ion transmembrane transport,2.668e-05|0.0001004|0.0001004|0.0002574|0.0003561,0.4209|0.7921|0.528|1|1,245.2|124.1|124.1|76.85|65.17
304,4,0.6063,3.638,3354.0,0.0010810000000000001,0.9929309999999999,ARHGAP39 C10orf113 KLRG1 RBM43,cellular defense response|postsynapse organization|synapse organization|regulation of small GTPase mediated signal transduction|positive regulation of GTPase activity,0.01045|0.01717|0.05439|0.06219|0.07801,1|1|1|1|1,97.15|58.51|18.07|15.75|12.47
305,25,0.5358,160.7,15920.0,0.009966,1.0,ALG12 ALG3 ALG5 ALG6 ALG8 ALG9 AUP1 DERL2 DNAJB11 DNAJC3 DOLPP1 DPM1 DPM2 DPM3 FAF2 HERPUD1 MANF MPDU1 PMM2 SEC63 SEL1L SLC33A1 SYVN1 UBE2G2 UBE2J1,protein N-linked glycosylation|glycoprotein metabolic process|protein glycosylation|macromolecule glycosylation|glycosylation,3.076e-25|3.179e-22|5.306e-19|5.306e-19|1.021e-18,4.852e-21|2.508e-18|2.79e-15|2.092e-15|3.221e-15,142.8|35.43|44.25|44.25|42
306,16,0.6039,72.47,12120.0,0.005928,0.999999,GLI1 HOXC10 HOXC4 HOXC5 HOXC6 HOXC8 INHBC INHBE KRT5 KRT6B KRT79 KRT82 KRT84 KRT86 OR10A7 POU6F1,cornification|epidermal cell differentiation|keratinization|epidermis development|keratinocyte differentiation,2.492e-10|2.205e-09|1.39e-08|1.447e-08|3.743e-08,3.93e-06|1.739e-05|7.306e-05|5.705e-05|0.0001181,68.35|28.51|34.17|21.61|28.82
307,5,0.6315,6.315,3579.0,0.001757,0.996692,ARHGDIA CRK PTPN12 RHOG TRIO,regulation of small GTPase mediated signal transduction|regulation of cell shape|regulation of cell morphogenesis|regulation of actin cytoskeleton organization|generation of neurons,3.232e-07|4.213e-06|3.332e-05|5.114e-05|6.483e-05,0.005098|0.03323|0.1752|0.2017|0.2045,50.39|80.76|40.12|34.71|13.19
308,4,0.6054,3.6319999999999997,3352.0,0.00108,0.9929309999999999,ARHGDIG CD300A CD7 PTPN6,negative regulation of cell adhesion|negative regulation of antigen receptor-mediated signaling pathway|regulation of T cell receptor signaling pathway|negative regulation of peptidyl-tyrosine phosphorylation|negative regulation of leukocyte mediated immunity,1.027e-05|1.4e-05|2.547e-05|4.185e-05|4.185e-05,0.162|0.1104|0.1339|0.1651|0.132,54.97|343.2|251.2|194.3|194.3
309,4,0.6391,3.835,3233.0,0.001182,0.9929309999999999,ARHGEF10L ARMC1 STARD5 TLNRD1,cholesterol import|sterol import|intracellular distribution of mitochondria|SREBP signaling pathway|cellular response to sterol depletion,0.001359|0.001359|0.001747|0.001941|0.002134,1|1|1|1|1,858.1|858.1|643.6|572.1|514.9
310,11,0.6331,34.82,7793.0,0.004436,0.999969,ARHGAP21 ARHGEF12 BTBD9 GNA13 GRK2 LPAR2 MYO9A MYO9B RHOA RHOC RIC8A,positive regulation of hydrolase activity|regulation of small GTPase mediated signal transduction|regulation of hydrolase activity|positive regulation of catalytic activity|positive regulation of molecular function,8.395e-12|8.619e-11|8.481e-10|1.7e-09|1.201e-08,1.324e-07|6.798e-07|4.459e-06|6.702e-06|3.788e-05,21.69|40.08|12.88|11.91|9.542
311,24,0.563,155.4,18940.0,0.008119,1.0,AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ARHGEF15 ASGR1 CCDC144A CHRNB1 CLEC10A DNAH2 FBXO39 KCTD11 MFSD6L MYH10 MYH2 MYH4 MYH8 SHBG TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,1.002e-09|1.002e-09|6.754e-09|1.756e-08|9.085e-08,1.581e-05|7.904e-06|3.551e-05|6.927e-05|0.0002866,381.4|381.4|214.5|163.5|104
312,4,0.6081,3.6489999999999996,3536.0,0.001029,0.9929309999999999,ARHGEF17 CD248 DNAJC5G MDFI,dorsal/ventral axis specification|trophoblast giant cell differentiation|cytoplasmic sequestering of transcription factor|anatomical structure regression|positive regulation of endothelial cell apoptotic process,0.002328|0.00291|0.003297|0.003491|0.003685,1|1|1|1|1,468.1|367.8|321.8|302.9|286
313,4,0.6491,3.895,3165.0,0.0012259999999999999,0.9929309999999999,ARHGEF28 LHCGR POMK STON1,luteinizing hormone signaling pathway|cellular response to luteinizing hormone stimulus|response to luteinizing hormone|positive regulation of inositol trisphosphate biosynthetic process|regulation of inositol trisphosphate biosynthetic process,0.0005825|0.0007766|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|1716|1287|1030|858.1
314,8,0.6022,16.86,5875.0,0.0028539999999999998,0.9996790000000001,ARHGEF35 ARHGEF5 CPA1 CTAGE15 CTAGE9 OR2A7 OR9A2 PRSS1,vesicle cargo loading|protein secretion|establishment of protein localization to extracellular region|protein localization to extracellular region|peptide secretion,5.328e-05|0.0007331|0.0007468|0.000846|0.0009983,0.8405|1|1|1|1,190.7|49.04|48.57|45.56|41.86
315,4,0.6406,3.844,3352.0,0.001142,0.9929309999999999,ACSBG2 ARHGEF37 CPB2 RAB17,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|positive regulation of extracellular matrix constituent secretion|negative regulation of hepatocyte proliferation|negative regulation of plasminogen activation,0.0005825|0.0007766|0.0007766|0.0009706|0.001359,1|1|1|1|1,2574|1716|1716|1287|858.1
316,14,0.5487,49.93,11350.0,0.004371,0.9999969999999999,ADAMTSL1 CDC37L1 CNTLN INSL6 MPL PDCD1LG2 PLPP6 PUM3 RLN1 RLN2 SAXO1 SPATA6L TPD52L3 TYRP1,basophil homeostasis|eosinophil homeostasis|acetoacetic acid metabolic process|positive regulation of platelet formation|monocyte homeostasis,0.001358|0.001358|0.001358|0.002037|0.002037,1|1|1|1|1,1471|1471|1471|735.5|735.5
317,9,0.6257,22.53,6087.0,0.003676,0.9998530000000001,CASP8 CFLAR CHMP5 KHDRBS1 NCOA5 RNF31 TNFRSF10A TNFRSF10B ZNF638,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|TRAIL-activated apoptotic signaling pathway|regulation of extrinsic apoptotic signaling pathway via death domain receptors|activation of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of extrinsic apoptotic signaling pathway,2.056e-09|4.834e-09|8.662e-09|5.25e-08|9.149e-08,3.243e-05|3.813e-05|4.555e-05|0.000207|0.0002886,234.7|1144|160.6|100.6|87.17
318,5,0.6123,6.122999999999999,2965.0,0.002054,0.996692,ARIH1 CAND1 CUL3 KCTD10 KEAP1,protein ubiquitination|protein modification by small protein conjugation|protein modification by small protein conjugation or removal|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process,6.148e-08|1.024e-07|3.188e-07|2.237e-06|2.355e-06,0.0009698|0.000808|0.001676|0.00882|0.00743,27.79|25.09|19.98|30.91|30.51
319,9,0.6494,23.38,6028.0,0.0038520000000000004,0.9998530000000001,ARIH2 ARIH2OS CUL5 NAE1 RNF7 SENP8 SOCS6 UBE2F UBE2R2,protein modification by small protein conjugation or removal|protein modification by small protein conjugation|post-translational protein modification|protein neddylation|cellular protein modification process,1.964e-11|2.782e-10|6.061e-09|4.594e-08|2.747e-07,3.099e-07|2.194e-06|3.187e-05|0.0001812|0.0008665,17.98|20.07|34.23|475.3|6.14
320,13,0.6054,47.23,9653.0,0.004855,0.999993,ARL11 HRNR LCE1A LCE1B LCE1E LCE2A LCE3A LCE3B LCE3C LCE3D LCE3E LCE5A SPRR2G,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,5.483e-23|4.016e-22|2.772e-21|2.662e-20|7.257e-20,8.648e-19|3.167e-18|1.457e-17|1.05e-16|2.29e-16,84.12|70.94|60.16|49.64|45.59
321,4,0.6298,3.779,2685.0,0.001401,0.9929309999999999,ARL15 PTP4A1 PTP4A2 TRPM7,peptidyl-tyrosine dephosphorylation|calcium-dependent cell-matrix adhesion|protein dephosphorylation|cellular magnesium ion homeostasis|dephosphorylation,0.0001623|0.0005825|0.0006596|0.0009706|0.001432,1|1|1|1|1,97.15|2574|47.67|1287|32.18
322,6,0.6089,9.133,4110.0,0.002211,0.998474,ARL2 PFDN1 TBCB TBCC TBCD TBCE,tubulin complex assembly|post-chaperonin tubulin folding pathway|protein folding|cellular protein-containing complex assembly|regulation of microtubule polymerization,1.428e-12|7.683e-10|2.31e-07|4.288e-05|0.0001043,2.253e-08|6.06e-06|0.001215|0.1691|0.3289,1526|2060|60.22|15.98|129.5
323,4,0.6081,3.6489999999999996,3188.0,0.00114,0.9929309999999999,ARL4C CHST15 COL5A3 HRG,positive regulation of blood vessel remodeling|negative regulation of lamellipodium assembly|negative regulation of endothelial cell chemotaxis|negative regulation of lamellipodium organization|regulation of blood vessel remodeling,0.0005825|0.0007766|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|1716|1287|1030|858.1
324,5,0.6455,6.455,4063.0,0.001583,0.996692,ARL5C CSF3 EPOP KLHL11 SYNRG,protein localization to Golgi membrane|histone H2B conserved C-terminal lysine deubiquitination|positive regulation of actin cytoskeleton reorganization|histone deubiquitination|protein localization to Golgi apparatus,0.0009706|0.001213|0.004845|0.005571|0.007261,1|1|1|1|1,1373|1030|216.8|187.2|142
325,4,0.607,3.642,3002.0,0.001208,0.9929309999999999,ARL6IP1 CIB2 REEP4 RETREG3,endoplasmic reticulum tubular network organization|endoplasmic reticulum organization|positive regulation of L-glutamate import across plasma membrane|endoplasmic reticulum tubular network formation|endoplasmic reticulum tubular network membrane organization,3.843e-06|0.0001447|0.0007766|0.0009706|0.0009706,0.06061|1|1|1|1,686.5|103|1716|1287|1287
326,4,0.6341,3.805,3102.0,0.001222,0.9929309999999999,ARL6IP4 HCAR2 P2RX4 PITPNM2,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of secretion by cell,0.0005825|0.0005825|0.0005825|0.0009706|0.001132,1|1|1|1|1,2574|2574|2574|1287|36.26
327,9,0.6128,22.06,5959.0,0.0036780000000000003,0.9998530000000001,CENPE DLGAP5 GTSE1 KIF15 KNTC1 MAD2L1BP MAPRE1 TACC3 TRIP13,regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation|regulation of chromosome separation|regulation of chromosome segregation|mitotic cell cycle,1.124e-13|2.014e-13|2.014e-13|6.799e-13|3.164e-11,1.773e-09|1.588e-09|1.059e-09|2.681e-09|9.982e-08,211.2|190.7|190.7|154.3|24.06
328,6,0.6232,9.349,3599.0,0.002582,0.998474,ARMC5 EAF1 ICE2 PHAX TOE1 USPL1,"snRNA transcription|ncRNA transcription|transcription, DNA-templated|nucleic acid-templated transcription|RNA biosynthetic process",8.83e-07|2.003e-06|7.595e-06|7.65e-06|8.323e-06,0.01393|0.0158|0.03994|0.03017|0.02626,145|109.5|24.83|24.78|24.26
329,8,0.661,18.51,5264.0,0.003493,0.9996790000000001,ARMC7 CCDC84 DDX59 DHX9 PPIH RBM48 SCNM1 TXNL4B,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",3.187e-06|3.187e-06|3.313e-06|1.025e-05|2.018e-05,0.05027|0.02513|0.01742|0.04043|0.06366,34.1|34.1|33.76|25.3|21.28
330,31,0.4894,227.6,24500.0,0.009179999999999999,1.0,ALDH3A1 ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CCDC144NL DRC3 GID4 HS3ST3A1 HS3ST3B1 KRT16 MFAP4 MFSD6L MIEF2 MYH2 MYH4 MYO15A SLC16A13 SLC47A2 TBC1D28 TMEM256 TNFRSF13B TNFSF12 TNFSF13 TRPV2 ULK2 USP6 VAMP2 ZNF287 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|lipoxin A4 biosynthetic process,7.391e-07|7.391e-07|3.231e-06|6.714e-06|2.325e-05,0.01166|0.005829|0.01699|0.02648|0.07334,214.5|214.5|120.7|91.94|429.1
331,9,0.6466,23.28,6065.0,0.003811,0.9998530000000001,ARMH3 COG7 COL4A3BP PI4KB SGMS1 SPTLC1 SPTLC2 SPTSSA TM9SF2,ceramide biosynthetic process|ceramide metabolic process|sphingolipid biosynthetic process|membrane lipid biosynthetic process|sphingolipid metabolic process,3.924e-09|3.185e-08|4.06e-08|1.482e-07|2.774e-07,6.189e-05|0.0002512|0.0002135|0.0005844|0.0008753,190.7|110.7|104|74.62|63.56
332,11,0.6089,33.49,7043.0,0.004718,0.999969,AMOTL2 KIRREL1 LATS2 MAP4K4 NF2 NRP1 PDCD10 PLXNA1 PTPN14 RNF146 TAOK1,anatomical structure morphogenesis|semaphorin-plexin signaling pathway|anatomical structure formation involved in morphogenesis|regulation of cell migration|neuron projection morphogenesis,2.308e-07|1.588e-06|4.301e-06|4.745e-06|5.67e-06,0.003641|0.01253|0.02262|0.01871|0.01789,7.235|135.5|11.84|11.64|17.34
333,7,0.6193,13.01,4758.0,0.002718,0.9992989999999999,ATXN2L CNOT11 CNOT9 G3BP2 LSM12 NUFIP2 PUM1,"gene silencing by RNA|gene silencing|stress granule assembly|nuclear-transcribed mRNA poly(A) tail shortening|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",2.786e-06|1.375e-05|2.279e-05|2.958e-05|0.0001735,0.04395|0.1085|0.1198|0.1166|0.5474,101.5|58.84|294.2|255.8|101.5
334,5,0.6468,6.468,3446.0,0.0018679999999999999,0.996692,AGFG1 AP2A1 ARRDC3 SLC38A1 SLC38A2,glutamine transport|nitrogen compound transport|organic substance transport|anion transport|neutral amino acid transport,2.119e-06|5.153e-06|1.307e-05|1.698e-05|3.85e-05,0.03343|0.04064|0.06871|0.06698|0.1215,1030|11.44|9.491|9.005|211.2
335,5,0.6277,6.277,4216.0,0.001483,0.996692,ARSB BHMT CD180 DDR1 FST,regulation of homocysteine metabolic process|colon epithelial cell migration|regulation of sulfur amino acid metabolic process|intestinal epithelial cell migration|smooth muscle cell-matrix adhesion,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
336,4,0.6154,3.6919999999999997,3467.0,0.0010609999999999999,0.9929309999999999,ARSI CNNM2 IAPP TECTB,positive regulation of calcium ion import across plasma membrane|regulation of calcium ion import across plasma membrane|amylin receptor signaling pathway|calcitonin family receptor signaling pathway|magnesium ion homeostasis,0.0007766|0.001165|0.001553|0.001747|0.002328,1|1|1|1|1,1716|1030|735.5|643.6|468.1
337,4,0.6352,3.8110000000000004,3263.0,0.001164,0.9929309999999999,ASAP2 NPFFR2 POMT1 SEZ6L2,positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|positive regulation of protein glycosylation|synapse maturation|regulation of protein glycosylation,0.0007766|0.0007766|0.001941|0.002522|0.003104,1|1|1|1|1,1716|1716|572.1|429.1|343.2
338,4,0.6082,3.6489999999999996,3460.0,0.001051,0.9929309999999999,ASB13 CAT MYBPC3 PAK6,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome,3.275e-05|6.35e-05|0.0002323|0.0002323|0.0002323,0.5166|0.5008|1|0.9163|0.733,236.7|167.4|85.81|85.81|85.81
339,4,0.6731,4.039,3304.0,0.001218,0.9929309999999999,ASB5 NTN5 YIPF1 ZNF155,motor neuron axon guidance|dendrite development|positive regulation of protein catabolic process|axon guidance|neuron projection guidance,0.006007|0.02119|0.04505|0.05309|0.05328,1|1|1|1|1,171.6|47.24|21.91|18.52|18.45
340,7,0.6149,12.91,5801.0,0.002216,0.9992989999999999,AK8 ASB6 CERCAM LCN6 LCN8 NTMT1 ZNF79,peptidyl-alanine modification|N-terminal peptidyl-proline dimethylation|N-terminal peptidyl-glycine methylation|N-terminal peptidyl-alanine trimethylation|N-terminal peptidyl-alanine methylation,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
341,4,0.6993,4.196000000000001,2991.0,0.001397,0.9929309999999999,ASB7 FAM208A MORC2 PPHLN1,positive regulation of DNA methylation-dependent heterochromatin assembly|positive regulation of heterochromatin organization|positive regulation of heterochromatin assembly|positive regulation of chromatin assembly or disassembly|regulation of DNA methylation-dependent heterochromatin assembly,1.103e-06|1.484e-06|1.484e-06|1.696e-06|1.922e-06,0.01739|0.01171|0.007805|0.006689|0.006065,1248|1056|1056|980.7|915.3
342,9,0.6317,22.74,6754.0,0.0033469999999999997,0.9998530000000001,FCHSD2 FOLR1 FOLR2 KRTAP5-7 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,1.271e-06|4.446e-06|5.927e-06|9.52e-06|1.649e-05,0.02005|0.03507|0.03116|0.03754|0.05202,2060|823.8|686.5|514.9|374.5
343,15,0.5591,58.7,11700.0,0.004978,0.999999,CRISP1 CRISP2 ENPP4 ENPP5 FBXO9 GLYATL3 GSTA1 GSTA3 GSTA4 IL17A IL17F MLIP MUT TFAP2B TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|positive regulation of antimicrobial peptide production,5.689e-07|5.689e-07|6.418e-06|8.982e-06|1.197e-05,0.008974|0.004487|0.03375|0.03542|0.03777,200.6|200.6|735.5|588.4|490.4
344,7,0.6306,13.24,4277.0,0.003077,0.9992989999999999,ASNA1 CAMLG GET4 PTAR1 RBSN VPS45 WRB,maintenance of unfolded protein|maintenance of unfolded protein involved in ERAD pathway|blood coagulation|coagulation|hemostasis,0.0009706|0.0009706|0.002053|0.00208|0.002108,1|1|1|1|1,1373|1373|27.64|27.46|27.28
345,14,0.6094,55.45,11290.0,0.004877,0.9999969999999999,GPR32 KIR2DL1 KIR2DL3 KIR3DL1 KLK11 LAIR1 LAIR2 LILRA1 LILRA4 LILRB2 LILRB4 LILRB5 NLRP4 NLRP9,regulation of immune response|regulation of immune system process|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|immune response,5.955e-10|3.087e-08|5.128e-08|8.881e-08|1.263e-07,9.393e-06|0.0002435|0.0002696|0.0003502|0.0003985,12.16|8.072|514.9|411.9|6.962
346,4,0.6923,4.154,2416.0,0.0017100000000000001,0.9929309999999999,ASPM PFDN1 TUBB TUBB4B,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|microtubule cytoskeleton organization|organelle localization,9.177e-06|1.067e-05|2.313e-05|8.215e-05|0.0001056,0.1448|0.08417|0.1216|0.3239|0.3332,429.1|396.1|264|27.29|25.08
347,4,0.6077,3.6460000000000004,3171.0,0.001146,0.9929309999999999,ASPSCR1 BID CASP2 RAB19,activation of cysteine-type endopeptidase activity involved in apoptotic process|extrinsic apoptotic signaling pathway|signal transduction in response to DNA damage|positive regulation of apoptotic signaling pathway|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.0001203|0.0001203|0.0001505|0.000214|0.0002727,1|0.9486|0.7912|0.8438|0.8604,113.2|113.2|101|84.41|74.62
348,9,0.6011,21.64,7394.0,0.002911,0.9998530000000001,ASTL CNNM4 FAHD2A FAM178B IL1F10 IL1RN IL36G LYG1 SLC9A2,inflammatory response to antigenic stimulus|inflammatory response|sodium ion transmembrane transport|prevention of polyspermy|negative regulation of fertilization,4.825e-07|0.001064|0.001218|0.00131|0.00131,0.00761|1|1|1|1,196.1|13.84|38.14|1144|1144
349,4,0.6604,3.963,3212.0,0.0012289999999999998,0.9929309999999999,ASTN1 PRR9 S100A9 SPAM1,cell adhesion|biological adhesion|neutrophil aggregation|peptidyl-cysteine S-trans-nitrosylation|sequestering of zinc ion,0.0003824|0.0003896|0.0005825|0.0005825|0.0009706,1|1|1|1|1,16.24|16.14|2574|2574|1287
350,9,0.6224,22.41,5688.0,0.0039109999999999995,0.9998530000000001,ATAD3A ATAD3B CRLS1 DNAJC11 MFN2 ROMO1 TIMM13 TIMM44 YME1L1,mitochondrion organization|protein targeting to mitochondrion|establishment of protein localization to mitochondrion|protein localization to mitochondrion|mitochondrial membrane organization,5.596e-13|8.096e-09|2.485e-08|3.508e-08|2.806e-07,8.828e-09|6.385e-05|0.0001307|0.0001383|0.0008852,40.06|163.5|122|111.6|65.38
351,4,0.6783,4.07,3077.0,0.001318,0.9929309999999999,ATAD3B ATAD3C MMP23B SLC35E2B,mitochondrion organization|blastocyst hatching|organism emergence from protective structure|hatching|collagen catabolic process,0.002886|0.005233|0.005233|0.005233|0.008517,1|1|1|1|1,22.53|198|198|198|119.7
352,9,0.6357,22.89,6057.0,0.0037530000000000003,0.9998530000000001,CRNKL1 DDRGK1 ESF1 NAA20 NOP56 SIVA1 TRMT6 VPS16 XRN2,RNA processing|ncRNA processing|ribonucleoprotein complex biogenesis|ncRNA metabolic process|gene expression,1.986e-05|2.291e-05|3.05e-05|4.603e-05|9.098e-05,0.3132|0.1807|0.1604|0.1815|0.287,12.4|21.19|19.68|17.7|6.281
353,6,0.6475,9.712,4733.0,0.002043,0.998474,ATAT1 C6orf48 CLIC1 MSH5 NEU1 TNXB,positive regulation of hindgut contraction|alpha-tubulin acetylation|regulation of hindgut contraction|maternal aggressive behavior|positive regulation of female receptivity,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
354,6,0.6527,9.791,4682.0,0.002081,0.998474,ATE1 HAND2 INSM2 ISL1 PHOX2B TFAP2B,sympathetic nervous system development|autonomic nervous system development|neural crest cell migration|neural crest cell development|stem cell development,2.772e-08|2.677e-07|3.783e-07|1.205e-06|1.344e-06,0.0004373|0.002111|0.001989|0.004753|0.004239,490.4|219.1|194.3|130.3|125.6
355,19,0.609,104.1,13260.0,0.007768000000000001,1.0,ATG10 ATG101 ATG12 ATG13 ATG14 ATG16L1 ATG3 ATG4B ATG5 ATG7 ATG9A BECN1 EPG5 GABARAP PIK3C3 PIK3R4 RB1CC1 ULK1 WIPI2,macroautophagy|autophagy|process utilizing autophagic mechanism|autophagosome assembly|autophagosome organization,6.81e-39|3.368e-35|3.368e-35|3.37e-31|6.046e-31,1.074e-34|2.656e-31|1.771e-31|1.329e-27|1.908e-27,107.3|67.3|67.3|240.9|229.9
356,12,0.611,40.33,9128.0,0.004386999999999999,0.999986,ANO1 BBS1 CARNS1 CCDC36 CTTN FGF19 FGF4 FOLR2 MRGPRD MRGPRF MYEOV POLD4,fibroblast growth factor receptor signaling pathway|carnosine biosynthetic process|cellular response to folic acid|carnosine metabolic process|cellular response to fibroblast growth factor stimulus,0.0008611|0.001067|0.001601|0.001601|0.001615,1|1|1|1|1,46.23|1872|936.1|936.1|33.43
357,6,0.6617,9.926,4943.0,0.001999,0.998474,ATG4C BSND C1orf123 GPX7 PCSK9 PLA2G12A,negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport|negative regulation of receptor-mediated endocytosis involved in cholesterol transport,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
358,5,0.6758,6.757999999999999,3347.0,0.002009,0.996692,ANLN ECT2 KIF23 PRC1 RACGAP1,mitotic cytokinesis|mitotic spindle midzone assembly|spindle elongation|mitotic spindle elongation|regulation of cytokinesis,6.839e-10|1.132e-09|1.132e-09|1.132e-09|1.939e-09,1.079e-05|8.928e-06|5.952e-06|4.464e-06|6.119e-06,242.3|1545|1545|1545|185.1
359,15,0.6137,64.44,9593.0,0.006652,0.999999,ATL2 BNIP1 C19orf25 FITM2 INPP5K NBAS RAB18 RAB3GAP1 RAB3GAP2 RINT1 SCFD1 SCFD2 TBC1D20 USE1 ZW10,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|Golgi vesicle transport|regulation of ER to Golgi vesicle-mediated transport|macromolecule localization|establishment of protein localization",7.455e-11|1.703e-08|3.773e-07|6.434e-07|1.15e-06,1.176e-06|0.0001343|0.001984|0.002537|0.003629,85.52|21.41|242.3|5.226|6.998
360,5,0.6201,6.2010000000000005,3377.0,0.0018280000000000002,0.996692,ATOX1 SLC30A1 SLC39A10 SLC39A6 UBE3D,cellular transition metal ion homeostasis|transition metal ion transport|transition metal ion homeostasis|zinc ion transmembrane transport|zinc ion transport,4.92e-09|6.64e-09|9.874e-09|2.004e-08|3.079e-08,7.761e-05|5.237e-05|5.192e-05|7.904e-05|9.715e-05,145.8|135|122|514.9|441.3
361,4,0.6603,3.9619999999999997,3344.0,0.001181,0.9929309999999999,ATP11A DLEC1 ZNF19 ZNF23,aminophospholipid translocation|aminophospholipid transport|phospholipid translocation|lipid translocation|regulation of membrane lipid distribution,0.001553|0.001941|0.009096|0.009675|0.01122,1|1|1|1|1,735.5|572.1|111.9|105.1|90.33
362,9,0.6354,22.87,6159.0,0.003689,0.9998530000000001,ATP13A1 BAX BCL2L2 MARCH5 MCL1 PMAIP1 THAP3 UBE2J2 WSB2,signal transduction in absence of ligand|extrinsic apoptotic signaling pathway in absence of ligand|intrinsic apoptotic signaling pathway|regulation of intrinsic apoptotic signaling pathway|positive regulation of intrinsic apoptotic signaling pathway,3.124e-07|3.124e-07|3.395e-07|4.5e-07|2.152e-06,0.004927|0.002464|0.001785|0.001774|0.006788,228.8|228.8|62.27|57.93|116.4
363,8,0.6614,18.52,5285.0,0.003481,0.9996790000000001,CEP350 FGFR1OP JUN MAP2K4 MAP2K7 MAP3K1 PPP2R3C STK40,Fc-epsilon receptor signaling pathway|Fc receptor signaling pathway|activation of protein kinase activity|regulation of protein kinase activity|regulation of kinase activity,3.588e-07|1.253e-06|4.352e-06|4.483e-06|8.465e-06,0.00566|0.009879|0.02288|0.01768|0.02671,59.52|43.27|31.49|16.15|14.18
364,6,0.6048,9.072000000000001,3639.0,0.002478,0.998474,ATP1A1 ATP1B3 COASY GMPS TMEM161B TMX2,establishment or maintenance of transmembrane electrochemical gradient|sodium ion export across plasma membrane|cellular potassium ion homeostasis|cellular sodium ion homeostasis|membrane repolarization,7.41e-06|8.468e-06|8.468e-06|1.481e-05|1.946e-05,0.1169|0.06678|0.04452|0.0584|0.06138,528.1|490.4|490.4|361.3|312
365,8,0.6059,16.97,6136.0,0.00275,0.9996790000000001,ATP1A2 FMO3 FMO4 ITLN2 MYOC S100A2 S100A9 SLAMF7,negative regulation of calcium:sodium antiporter activity|ERBB2-ERBB3 signaling pathway|olfactory cortex development|skeletal muscle hypertrophy|glial cell development,0.0007765|0.0007765|0.0007765|0.0007765|0.0008315,1|1|1|1|1,2574|2574|2574|2574|45.97
366,7,0.6112,12.84,5242.0,0.002436,0.9992989999999999,ATP1B1 FCGR2B FCGR3A ITLN2 MNDA OR6K6 OR6N2,negative regulation of B cell proliferation|negative regulation of B cell activation|regulation of B cell proliferation|immune response-activating cell surface receptor signaling pathway|immune response-activating signal transduction,1.875e-05|6.2e-05|0.0002037|0.0003551|0.0003551,0.2957|0.489|1|1|1,326.9|173.1|93.4|19.44|19.44
367,16,0.6052,72.63,12090.0,0.005953,0.999999,HOXC10 HOXC4 HOXC5 HOXC6 HOXC8 INHBE KRT6B KRT79 KRT82 KRT84 KRT86 MARCH9 OS9 POU6F1 RDH5 TSPAN31,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,2.346e-08|6.688e-07|1.523e-06|3.37e-06|8.482e-06,0.00037|0.005275|0.00801|0.01329|0.02676,56.96|28.48|24.01|20.37|16.8
368,8,0.6096,17.07,5740.0,0.002957,0.9996790000000001,ATP2A2 B4GALT1 BEST3 MYCN MYOG PAX3 SOX8 ZBTB18,muscle structure development|muscle organ development|skeletal muscle tissue development|skeletal muscle organ development|positive regulation of transcription by RNA polymerase II,3.035e-07|2.369e-06|1.166e-05|1.471e-05|3.356e-05,0.004788|0.01868|0.06129|0.05801|0.1059,27.98|36.78|63.83|58.96|10.67
369,4,0.6725,4.035,3240.0,0.001241,0.9929309999999999,ATP2B2 FAM120A FBP1 TMEFF1,regulation of cardiac conduction|negative regulation of small molecule metabolic process|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process,7.749e-05|0.0002404|0.0004854|0.0004854|0.0004854,1|1|1|1|1,147.1|82.38|4119|4119|4119
370,14,0.6646,60.48,8987.0,0.006664,0.9999969999999999,CCDC134 CNPY2 CPD FURIN HSP90B1 IGF1R INSR IRS1 IRS2 KBTBD2 OST4 OSTC PTEN STT3A,phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling|response to insulin|phosphatidylinositol 3-kinase signaling|cellular response to insulin stimulus,2.186e-09|2.755e-09|7.01e-09|1.469e-08|8.54e-08,3.448e-05|2.173e-05|3.686e-05|5.794e-05|0.0002694,90.81|86.53|37.24|154.8|42.52
371,5,0.6154,6.154,4467.0,0.001373,0.996692,ATP4B PHOX2A TNP2 ZDHHC14 ZKSCAN2,locus ceruleus development|trochlear nerve formation|trochlear nerve morphogenesis|oculomotor nerve formation|oculomotor nerve morphogenesis,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
372,14,0.8961,81.54,9259.0,0.008704,0.9999969999999999,ATP5F1A ATP5F1B ATP5F1C ATP5F1D ATP5F1E ATP5ME ATP5MF ATP5MG ATP5MPL ATP5PB ATP5PD ATP5PF ATP5PO TMEM242,"mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|cristae formation|ATP biosynthetic process",1.049e-33|9.303e-33|9.303e-33|1.139e-31|5.173e-31,1.655e-29|7.338e-29|4.892e-29|4.493e-28|1.632e-27,929.1|735.5|735.5|569.4|490.4
373,5,0.6228,6.228,3892.0,0.001594,0.996692,AATF ATP5MD CWC25 DDX52 TEFM,transcription elongation from mitochondrial promoter|negative regulation of superoxide anion generation|embryonic cleavage|negative regulation of amyloid precursor protein biosynthetic process|ribosome biogenesis,0.0004854|0.000728|0.001698|0.00194|0.002538,1|1|1|1|1,4119|2060|686.5|588.4|24.81
374,4,0.6241,3.7439999999999998,3062.0,0.001218,0.9929309999999999,ATP5S CRYGA RSPH10B RSPH10B2,"mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|cristae formation|ATP biosynthetic process",0.003878|0.004846|0.004846|0.0062|0.007166,1|1|1|1|1,271|214.5|214.5|166.1|143
375,15,0.6155,64.63,9772.0,0.006551,0.999999,AAGAB AGFG1 AP2A1 AP2A2 AP2B1 AP2M1 AP2S1 CCDC32 FCHO2 PICALM RAB5C SLC11A2 STEAP3 TFRC WDR7,clathrin-dependent endocytosis|low-density lipoprotein particle receptor catabolic process|low-density lipoprotein receptor particle metabolic process|receptor metabolic process|receptor-mediated endocytosis,2.095e-16|2.9e-13|2.9e-13|7.184e-13|3.032e-12,3.304e-12|2.287e-09|1.525e-09|2.833e-09|9.566e-09,320.4|686.5|686.5|91.53|44.29
376,7,0.607,12.75,5226.0,0.002427,0.9992989999999999,ATP6V0A2 HMGCL KCNK5 MSI2 NOTCH1 SUCLA2 SUCLG1,tricarboxylic acid cycle|generation of precursor metabolites and energy|aerobic respiration|acyl-CoA metabolic process|thioester metabolic process,6.2e-05|0.0002489|0.0003011|0.0004726|0.0004726,0.978|1|1|1|1,173.1|21.96|76.42|60.66|60.66
377,5,0.6051,6.051,3900.0,0.001545,0.996692,ATP6V0A4 CD36 CYP3A5 GNAT3 WNT2,sensory perception of taste|response to chemical|oxidised low-density lipoprotein particle clearance|positive regulation of blood microparticle formation|regulation of blood microparticle formation,0.0001131|0.0004308|0.0004854|0.000728|0.000728,1|1|1|1|1,121.1|4.714|4119|2060|2060
378,16,0.6158,73.89,9999.0,0.007312000000000001,0.999999,ATP6V0B ATP6V0C ATP6V0D1 ATP6V1A ATP6V1B2 ATP6V1C1 ATP6V1D ATP6V1E1 ATP6V1F ATP6V1G1 ATP6V1H CCDC115 EMC3 EMC7 TMEM199 WDR7,intracellular pH reduction|pH reduction|regulation of intracellular pH|regulation of cellular pH|phagosome acidification,1.885e-31|3.77e-31|2.33e-28|5.874e-28|1.021e-27,2.973e-27|2.973e-27|1.225e-24|2.317e-24|3.222e-24,348.6|328.1|190.2|176.1|505.7
379,4,0.6205,3.7230000000000003,3247.0,0.001142,0.9929309999999999,ATP6V1C2 DGKQ MOK TIGD6,regulation of progesterone biosynthetic process|regulation of cortisol biosynthetic process|regulation of glucocorticoid biosynthetic process|thrombin-activated receptor signaling pathway|regulation of glucocorticoid metabolic process,0.0009706|0.001553|0.001747|0.001941|0.002134,1|1|1|1|1,1287|735.5|643.6|572.1|514.9
380,4,0.6345,3.807,3308.0,0.001147,0.9929309999999999,ATP6V1E2 C22orf42 C6orf226 PPP3R1,calcineurin-NFAT signaling cascade|calcineurin-mediated signaling|inositol phosphate-mediated signaling|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,0.002522|0.003104|0.004846|0.005233|0.005233,1|1|1|1|1,429.1|343.2|214.5|198|198
381,12,0.6138,40.51,9472.0,0.004248,0.999986,C1QTNF3 C7 CDH10 CDH6 FBXO4 HCN1 NIM1K OXCT1 PLCXD3 SLC45A2 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid,0.0002901|0.0006142|0.001164|0.001164|0.001164,1|1|1|1|1,81.73|55.36|1716|1716|1716
382,4,0.7437,4.462,2869.0,0.001549,0.9929309999999999,ATP8B2 FGFR3 PRDM1 REEP4,fibroblast growth factor receptor apoptotic signaling pathway|sebum secreting cell proliferation|regulation of extrathymic T cell differentiation|regulation of NK T cell differentiation|regulation of natural killer cell differentiation,0.0003883|0.0003883|0.0005825|0.001359|0.002328,1|1|1|1|1,5149|5149|2574|858.1|468.1
383,10,0.6065,27.29,7902.0,0.003433,0.999933,ATP9A CASS4 CTSZ FAM209A FAM209B OPRL1 RBM38 STX16 TFAP2C ZGPAT,regulation of protein tyrosine kinase activity|positive regulation of gastric acid secretion|conditioned place preference|regulation of locomotor rhythm|negative regulation of plasminogen activation,0.0009434|0.001455|0.00194|0.00194|0.003393,1|1|1|1|1,43.82|1030|686.5|686.5|343.3
384,7,0.6647,13.96,4936.0,0.0028120000000000003,0.9992989999999999,ATR COPB2 ISY1 SRPRB TOPBP1 U2SURP XAB2,spliceosomal conformational changes to generate catalytic conformation|DNA repair|toxin transport|DNA metabolic process|cellular response to DNA damage stimulus,4.743e-06|5.069e-05|0.0001589|0.000226|0.0002327,0.07481|0.3998|0.8357|0.8913|0.7342,762.8|17.27|109|11.72|11.63
385,10,0.6116,27.52,6531.0,0.004184,0.999933,ATR ATRIP CIP2A HUS1 RAD1 RAD17 RAD9A RFC5 RHNO1 TOPBP1,regulation of signal transduction by p53 class mediator|DNA damage checkpoint|DNA replication|DNA integrity checkpoint|cell cycle checkpoint,5.524e-16|6.905e-15|9.464e-15|1.064e-14|7.47e-14,8.713e-12|5.446e-11|4.976e-11|4.196e-11|2.357e-10,72.75|91.18|52.61|86.22|67.06
386,4,0.6679,4.008,2835.0,0.001408,0.9929309999999999,ATRN ERP44 ITGAV MGRN1,substrate adhesion-dependent cell spreading|entry into host cell by a symbiont-containing vacuole|cell-substrate adhesion|negative regulation of entry of bacterium into host cell|transforming growth factor beta production,4.658e-05|0.0003883|0.000486|0.0005825|0.0009706,0.7348|1|1|1|1,183.9|5149|55.66|2574|1287
387,6,0.6192,9.288,4751.0,0.001946,0.998474,ATRNL1 COL19A1 FAM135A KHDC1L LGSN SMAP1,glutamine biosynthetic process|muscle organ development|glutamine family amino acid biosynthetic process|regulation of clathrin-dependent endocytosis|glutamine metabolic process,0.001019|0.003747|0.006101|0.006777|0.008465,1|1|1|1|1,1471|21.02|173.1|154.8|122.6
388,5,0.6696,6.696000000000001,3528.0,0.001889,0.996692,ATXN10 RPL3 RRP7A TOMM22 TUBGCP6,organelle assembly|ribosome assembly|organelle organization|cellular protein-containing complex assembly|ribonucleoprotein complex assembly,1.015e-05|0.0001005|0.0001579|0.0006853|0.0008484,0.1601|0.7924|0.8304|1|1,21.1|128.7|5.762|14.39|43.36
389,7,0.6227,13.08,4788.0,0.002716,0.9992989999999999,ATXN2 ATXN2L LARP1 LARP4 LARP4B LSM12 PUM1,regulation of translation|regulation of cellular amide metabolic process|posttranscriptional regulation of gene expression|regulation of cytoplasmic mRNA processing body assembly|positive regulation of translation,3.861e-08|8.511e-08|2.724e-07|6.521e-06|1.031e-05,0.000609|0.0006713|0.001432|0.02571|0.03254,39.97|34.05|26.89|588.4|64.9
390,4,0.6032,3.6189999999999998,3208.0,0.001124,0.9929309999999999,ATXN7L2 NAPEPLD SLC12A9 SLC26A4,chloride transmembrane transport|chloride transport|inorganic anion transmembrane transport|monovalent inorganic cation homeostasis|inorganic anion transport,0.0001363|0.0001534|0.0001971|0.000313|0.0003561,1|1|1|1|1,106.2|99.98|88.01|69.58|65.17
391,10,0.6075,27.34,7867.0,0.003454,0.999933,ATXN7L3B CCNB1IP1 KIF26B LRRN1 LYRM1 MAP3K7CL PCDHB12 PCDHB13 PCDHGA9 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|ureteric bud invasion|cell-cell adhesion|metanephric renal vesicle formation,8.671e-05|0.0003109|0.002134|0.002229|0.002667,1|1|1|1|1,33.63|21.69|624.1|10.93|468.1
392,10,0.6653,29.94,6236.0,0.004763,0.999933,CYB5R4 LCMT1 PPME1 PPP4C PPP4R3A PPP4R3B PPP6C PPP6R3 PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|protein dephosphorylation|regulation of dephosphorylation,4.254e-07|8.33e-07|1.976e-06|3.934e-06|3.934e-06,0.006711|0.00657|0.01039|0.01551|0.01241,61.39|51.65|41.38|34.67|34.67
393,7,0.8653,18.17,4680.0,0.003856,0.9992989999999999,AVEN DIS3L FOCAD HBS1L PELO SKIV2L TTC37,RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process|cellular nitrogen compound catabolic process|aromatic compound catabolic process,5.311e-09|4.237e-08|7.236e-08|7.762e-08|9.317e-08,8.377e-05|0.0003342|0.0003804|0.0003061|0.0002939,59.8|39.23|35.19|34.7|33.43
394,21,0.6043,126.9,15880.0,0.007908,1.0,HOXC10 HOXC11 HOXC4 HOXC5 HOXC6 HOXC8 INHBE KRT1 KRT5 KRT6B KRT74 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT86 OR10A7 OR6C3 POU6F1,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,7.939e-20|1.171e-16|7.165e-16|4.14e-15|3.214e-14,1.252e-15|9.232e-13|3.767e-12|1.633e-11|1.014e-10,95.47|47.73|40.25|34.14|28.17
395,4,0.6142,3.685,3170.0,0.001158,0.9929309999999999,AXDND1 CYP11A1 RUBCNL ZNF563,autophagosome-endosome fusion|cortisol metabolic process|autophagosome-lysosome fusion|glucocorticoid biosynthetic process|tertiary alcohol metabolic process,0.0003883|0.0009706|0.001165|0.002328|0.002716,1|1|1|1|1,5149|1287|1030|468.1|396.1
396,20,0.6099,115.9,11850.0,0.009651,1.0,ADSL ADSS ATIC DHODH FPGS GART GCLC IPPK MTHFD1 NAMPT NMNAT1 PAICS PFAS PPAT PPCDC PPCS RFK RPIA TPK1 UMPS,nucleotide biosynthetic process|nucleoside phosphate biosynthetic process|organophosphate biosynthetic process|organophosphate metabolic process|small molecule metabolic process,4.135e-25|4.99e-25|6.385e-24|4.545e-22|1.865e-21,6.523e-21|3.936e-21|3.357e-20|1.792e-18|5.882e-18,64.24|63.41|31.58|19.66|12.09
397,6,0.6227,9.34,5163.0,0.001802,0.998474,AZIN2 BSDC1 C1QA C1QB PLA2G2D TSSK3,synapse pruning|cell junction disassembly|regulation of complement activation|trans-Golgi network membrane organization|regulation of humoral immune response,5.506e-06|6.423e-06|0.0004889|0.0005824|0.000695,0.08685|0.05066|1|1|1,624.1|572.1|58.68|3432|49.04
398,11,0.8248,45.36,7322.0,0.006139,0.999969,ADAR EIF2AK2 IFNAR1 IFNAR2 IRF9 ISG15 JAK1 STAT1 STAT2 TYK2 USP18,type I interferon signaling pathway|cellular response to type I interferon|response to type I interferon|innate immune response|response to virus,4.787e-21|5.411e-21|1.092e-20|1.436e-13|4.44e-13,7.551e-17|4.267e-17|5.74e-17|5.662e-10|1.401e-09,247.8|244.2|224.7|22.29|48.63
399,4,0.6264,3.759,3321.0,0.0011279999999999999,0.9929309999999999,ADGRB2 B3GALNT1 FOXRED2 SYNGR1,synaptic vesicle membrane organization|calcineurin-NFAT signaling cascade|poly-N-acetyllactosamine biosynthetic process|regulation of short-term neuronal synaptic plasticity|poly-N-acetyllactosamine metabolic process,0.0009706|0.002522|0.002522|0.002716|0.002716,1|1|1|1|1,1287|429.1|429.1|396.1|396.1
400,4,0.6019,3.612,3463.0,0.0010400000000000001,0.9929309999999999,B3GALT4 IFI6 QSOX1 SCYL3,negative regulation of mitochondrial depolarization|negative regulation of membrane depolarization|ganglioside biosynthetic process|regulation of mitochondrial depolarization|release of cytochrome c from mitochondria,0.001359|0.001553|0.003297|0.004072|0.004459,1|1|1|1|1,858.1|735.5|321.8|257.4|234
401,4,0.7041,4.224,3218.0,0.001308,0.9929309999999999,B3GALT5 BATF2 FAM107B SCGB2A2,poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process|androgen receptor signaling pathway|myeloid dendritic cell differentiation|defense response to protozoan,0.002522|0.002716|0.003685|0.004266|0.004846,1|1|1|1|1,429.1|396.1|286|245.2|214.5
402,21,0.6732,141.4,13450.0,0.01037,1.0,B3GALT6 B3GAT3 B4GALT7 C3orf58 EXT1 EXT2 EXTL3 FAM20B FGFR1 FRS2 GLCE GRB2 HS2ST1 NDST1 PTPN11 SLC35B2 SLC39A9 TM9SF3 TMEM165 UGDH XYLT2,proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan metabolic process|heparan sulfate proteoglycan metabolic process|glycoprotein biosynthetic process,3.593e-25|5.903e-24|1.65e-23|4.313e-23|3.241e-19,5.668e-21|4.656e-20|8.678e-20|1.701e-19|1.022e-15,196.1|445.8|138.5|350.3|42.5
403,4,0.6074,3.6439999999999997,3353.0,0.001083,0.9929309999999999,ACACB B3GLCT EDNRB RCBTB2,enteric smooth muscle cell differentiation|posterior midgut development|malonyl-CoA biosynthetic process|response to endothelin|malonyl-CoA metabolic process,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
404,10,0.6259,28.17,7139.0,0.003919,0.999933,B3GNT2 B3GNT5 B4GALT3 B4GALT5 SLC35A3 SPPL3 TM9SF2 TMEM165 UGCG UGP2,carbohydrate derivative metabolic process|carbohydrate derivative biosynthetic process|glycolipid biosynthetic process|protein glycosylation|macromolecule glycosylation,1.38e-09|2.164e-09|2.675e-08|5.704e-08|5.704e-08,2.176e-05|1.707e-05|0.0001407|0.0002249|0.00018,16.38|23.87|123|42.55|42.55
405,5,0.6164,6.164,3903.0,0.001573,0.996692,B3GNT4 CLDN25 HTR3A HTR3B POU2F3,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,3.85e-05|0.0001591|0.000163|0.0002265|0.0002265,0.6073|1|0.857|0.8932|0.7145,211.2|101.7|100.5|84.93|84.93
406,4,0.607,3.642,3220.0,0.001127,0.9929309999999999,B3GNT6 CEP126 FDXACB1 ZNF570,"protein O-linked glycosylation|aminoglycan biosynthetic process|O-glycan processing, core 3|aminoglycan metabolic process|protein glycosylation",0.0002597|0.0002745|0.0004854|0.0006506|0.001365,1|1|1|1|1,79.21|76.99|4119|49.63|34.04
407,4,0.6319,3.7910000000000004,3231.0,0.001169,0.9929309999999999,B3GNT7 PPOX SPTA1 TCHHL1,porphyrin-containing compound biosynthetic process|tetrapyrrole biosynthetic process|porphyrin-containing compound metabolic process|tetrapyrrole metabolic process|positive regulation of transmission of nerve impulse,2.481e-05|2.481e-05|6.219e-05|0.0001197|0.001698,0.3914|0.1957|0.327|0.4719|1,265.7|265.7|164.8|117.7|686.5
408,5,0.6041,6.041,4056.0,0.001484,0.996692,B4GAT1 NRBF2 PPM1J PSMC4 PTPN22,phosphoanandamide dephosphorylation|T cell receptor signaling pathway|cellular macromolecule metabolic process|positive regulation of granzyme B production|regulation of granzyme B production,0.0004854|0.0007628|0.0008145|0.0009706|0.0009706,1|1|1|1|1,4119|45.77|4.15|1373|1373
409,17,0.6035,82.07,13790.0,0.005901,1.0,ERVV-2 KIR2DL1 KIR2DL3 SIGLEC5 VN1R4 ZFP28 ZNF175 ZNF28 ZNF415 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF665 ZNF701 ZNF880,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",1.395e-07|3.101e-07|3.522e-06|3.534e-06|3.589e-06,0.002201|0.002445|0.01852|0.01393|0.01132,5.309|0.2216|3.964|3.962|3.957
410,4,0.7018,4.211,2728.0,0.001536,0.9929309999999999,BACH1 GLRX3 IREB2 TAX1BP1,cellular iron ion homeostasis|iron ion homeostasis|cellular transition metal ion homeostasis|transition metal ion homeostasis|spermatogonial cell division,0.0001099|0.0001669|0.0003056|0.0004334|0.000728,1|1|1|1|1,123|99.25|72.9|61.02|2060
411,28,0.5205,196.8,21300.0,0.00913,1.0,APTX AQP7 BAG1 CD274 DNAJA1 FAM205A GALT HACD4 IFNA1 IFNA10 IFNA14 IFNA16 IFNA17 IFNA2 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNB1 IFNE IFNK IFNW1 MTAP OR2S2 SIGMAR1 TOMM5,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,4.322e-39|2.227e-38|2.227e-38|3.386e-35|3.772e-34,6.818e-35|1.756e-34|1.171e-34|1.335e-31|1.19e-30,588.4|511.7|511.7|287|240.2
412,4,0.6042,3.625,3392.0,0.001065,0.9929309999999999,BAG3 LCA5 SEMA7A WNT11,movement of cell or subcellular component|protein transport along microtubule|microtubule-based protein transport|cellular response to mechanical stimulus|developmental growth involved in morphogenesis,3.582e-05|6.8e-05|6.8e-05|9.117e-05|0.000184,0.5651|0.5363|0.3575|0.3595|0.5806,12.94|151.4|151.4|130.3|91.13
413,20,0.6002,114.0,16090.0,0.007023000000000001,1.0,ALDH3A1 ALOXE3 CCDC144A CCDC144NL DRC3 FOXO3 GID4 KRT16 KRT17 MFAP4 MIEF2 MYO15A SMCR8 TBC1D28 TNFRSF13B TNFSF12 TNFSF13 TRPV2 ZNF287 ZNF624,tumor necrosis factor-mediated signaling pathway|cellular response to tumor necrosis factor|response to tumor necrosis factor|establishment of skin barrier|regulation of water loss via skin,8.063e-06|0.0001108|0.0001661|0.0003416|0.0003946,0.1272|0.8736|0.8734|1|1,31.38|15.82|14.21|78.46|72.65
414,4,0.6139,3.6830000000000003,3134.0,0.0011710000000000002,0.9929309999999999,BAIAP2L1 CD1B DPEP2 EPS8,actin crosslink formation|actin filament bundle assembly|actin filament bundle organization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization,3.391e-06|4.987e-05|5.502e-05|0.0004258|0.0005069,0.05349|0.3933|0.2893|1|1,735.5|177.5|168.8|59.52|54.48
415,4,0.603,3.6180000000000003,3194.0,0.001129,0.9929309999999999,BAIAP2L2 HOXB5 HOXB9 WNT9B,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|embryonic organ development,4.035e-07|8.687e-07|5.24e-06|1.128e-05|3.558e-05,0.006365|0.006852|0.02755|0.04446|0.1122,164.3|126.6|68.96|53.26|36.17
416,7,0.6062,12.73,4617.0,0.002742,0.9992989999999999,BAK1 BCL2L2 MARCH5 MCL1 THAP3 UBE2J2 VDAC2,signal transduction in absence of ligand|extrinsic apoptotic signaling pathway in absence of ligand|apoptotic signaling pathway|intrinsic apoptotic signaling pathway in response to DNA damage|extrinsic apoptotic signaling pathway,1.305e-07|1.305e-07|1.132e-06|1.302e-06|3.177e-06,0.002058|0.001029|0.005952|0.005135|0.01002,294.2|294.2|42.64|131.7|96.99
417,19,0.6141,105.0,15040.0,0.006915999999999999,1.0,ABHD12 ACSS1 APMAP BANF2 BFSP1 CST1 CST11 CST2 CST3 CST4 CST5 CST7 CST8 CST9 CST9L CSTL1 NAPB TGM3 ZNF337,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity|regulation of peptidase activity,6.05e-17|9.265e-17|2.263e-15|2.117e-14|4.194e-14,9.543e-13|7.307e-13|1.19e-11|8.347e-11|1.323e-10,48.67|46.76|34.66|28.12|26.38
418,8,0.6204,17.37,5088.0,0.003392,0.9996790000000001,CIP2A H2AFX HUS1 MAD2L2 PALB2 RAD17 RHNO1 TOPBP1,cell cycle checkpoint|DNA repair|mitotic DNA replication checkpoint|DNA metabolic process|cellular response to DNA damage stimulus,1.454e-09|2.066e-09|6.859e-09|2.066e-08|2.162e-08,2.294e-05|1.629e-05|3.607e-05|8.148e-05|6.821e-05,77.83|33.31|882.6|22.6|22.43
419,5,0.6318,6.318,3912.0,0.0016079999999999998,0.996692,BARHL1 OR13C3 PALM2 RALGAPA1 TXNDC8,acrosome assembly|secretory granule organization|sensory perception|midbrain development|cellular component assembly involved in morphogenesis,0.00412|0.008708|0.02034|0.02094|0.02237,1|1|1|1|1,257.4|117.7|8.467|47.9|44.77
420,11,0.5996,32.98,7494.0,0.004368,0.999969,CCND2 IKBKB IKZF3 IRF4 NFKB1 POU2AF1 PRDM1 RELA RELB SMAD7 TCF3,"regulation of transcription by RNA polymerase II|positive regulation of macromolecule metabolic process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of immune system process",1.328e-09|2.833e-08|3.141e-08|3.151e-08|3.194e-08,2.094e-05|0.0002234|0.0001652|0.0001243|0.0001008,7.3|5.502|5.45|5.448|9.081
421,7,0.6215,13.05,4725.0,0.002747,0.9992989999999999,BATF3 IKZF1 IRF4 JUNB RORC SBNO2 STAT3,leukocyte differentiation|hemopoiesis|hematopoietic or lymphoid organ development|immune system development|myeloid cell differentiation,4.696e-13|1.337e-11|2.315e-11|3.466e-11|3.424e-09,7.407e-09|1.054e-07|1.217e-07|1.367e-07|1.08e-05,58.34|36.01|33.27|31.39|65.38
422,4,0.601,3.6060000000000003,3496.0,0.0010279999999999998,0.9929309999999999,BBIP1 KLHL31 KRTAP24-1 LIM2,receptor localization to non-motile cilium|protein localization to non-motile cilium|protein localization to ciliary membrane|negative regulation of JNK cascade|negative regulation of stress-activated MAPK cascade,0.001165|0.002134|0.002134|0.007166|0.009096,1|1|1|1|1,1030|514.9|514.9|143|111.9
423,4,0.6723,4.034,3247.0,0.0012380000000000002,0.9929309999999999,BBS2 KRT40 PSMB10 ZNF423,negative regulation of appetite by leptin-mediated signaling pathway|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation|regulation of cilium beat frequency involved in ciliary motility|cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation|cerebellar granule cell precursor proliferation,0.0009706|0.001165|0.001553|0.001553|0.001553,1|1|1|1|1,1287|1030|735.5|735.5|735.5
424,8,0.6232,17.45,4953.0,0.0034990000000000004,0.9996790000000001,CAB39 FRYL NF2 PDCD10 PTPN14 RALGAPB STK24 TAOK1,intrinsic apoptotic signaling pathway in response to oxidative stress|cell death in response to oxidative stress|negative regulation of cell migration|negative regulation of cell motility|regulation of protein kinase activity,2.012e-05|3.626e-05|0.0001187|0.0001393|0.00014,0.3174|0.286|0.6242|0.5494|0.4418,321.8|234|28.93|27.39|12.92
425,4,0.6243,3.7460000000000004,3300.0,0.001131,0.9929309999999999,ADCY10 BBS7 FEZF2 RABL6,pigment granule aggregation in cell center|primary palate development|forebrain anterior/posterior pattern specification|cell dedifferentiation|dedifferentiation,0.0005825|0.0005825|0.0007766|0.001359|0.001359,1|1|1|1|1,2574|2574|1716|858.1|858.1
426,4,0.6162,3.697,3425.0,0.001076,0.9929309999999999,BBS9 OTULINL SYDE2 WBP2NL,male pronucleus assembly|female pronucleus assembly|egg activation|organelle assembly|protein localization to cilium,0.0005825|0.0005825|0.001165|0.008227|0.01083,1|1|1|1|1,2574|2574|1030|13.19|93.61
427,14,0.6136,55.84,10870.0,0.005099,0.9999969999999999,COL6A2 KRTAP10-11 KRTAP10-3 KRTAP10-6 KRTAP10-8 KRTAP10-9 KRTAP12-1 KRTAP12-2 KRTAP12-3 KRTAP12-4 KRTAP19-3 KRTAP19-7 TMPRSS3 TRPM2,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,4.828e-19|2.989e-18|1.75e-17|1.383e-16|3.455e-16,7.616e-15|2.357e-14|9.201e-14|5.454e-13|1.09e-12,66.83|56.35|47.79|39.43|36.22
428,16,0.6096,73.16,10100.0,0.007169,0.999999,BCAR1 BCAR3 CRKL FERMT2 ILK ITGAV LIMS1 NCKAP1 PTK2 PXN RAC1 RAPGEF1 RAPH1 RSU1 SRC TLN1,vascular endothelial growth factor receptor signaling pathway|enzyme linked receptor protein signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|integrin-mediated signaling pathway|regulation of cell-substrate adhesion,9.391e-14|4.214e-13|7.953e-13|8.007e-13|2.126e-12,1.481e-09|3.323e-09|4.182e-09|3.158e-09|6.706e-09,126.9|19.5|24.8|91.94|47.45
429,13,0.6115,47.69,10100.0,0.0046890000000000005,0.999993,BCAS3 CSHL1 EPX HOXB9 LPO MKS1 MPO NME1 NME2 OR4D1 OR4D2 RSAD1 SEPT4,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|response to chemical|GTP biosynthetic process,9.624e-07|2.559e-06|2.416e-05|2.804e-05|2.854e-05,0.01518|0.02018|0.127|0.1106|0.09004,163.9|115.9|316.8|3.626|288
430,4,0.6079,3.647,3325.0,0.001093,0.9929309999999999,BCHE LYSMD3 MOSPD3 PLEKHA6,cocaine metabolic process|tropane alkaloid metabolic process|neuroblast differentiation|endoplasmic reticulum membrane organization|endoplasmic reticulum-plasma membrane tethering,0.0003883|0.0003883|0.001165|0.001359|0.001359,1|1|1|1|1,5149|5149|1030|858.1|858.1
431,24,0.6029,166.4,18470.0,0.008907,1.0,CEACAM5 CEACAM6 CEACAM7 CYP2A13 CYP2B6 LGALS14 PSG1 PSG11 PSG2 PSG3 PSG4 PSG6 PSG8 PSG9 PVR ZNF155 ZNF222 ZNF230 ZNF233 ZNF284 ZNF285 ZNF45 ZNF571 ZNF780B,female pregnancy|multi-multicellular organism process|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|cellular process|multi-organism reproductive process,2.469e-09|6.753e-09|3.56e-05|7.854e-05|0.0001872,3.894e-05|5.326e-05|0.1872|0.3097|0.5904,30.98|26.66|49.51|0.5115|5.55
432,4,0.6032,3.6189999999999998,3255.0,0.001108,0.9929309999999999,BCKDHB GNPDA2 IFT52 KCNB1,glucosamine catabolic process|N-acetylglucosamine catabolic process|intraciliary anterograde transport|organic acid catabolic process|glucosamine metabolic process,0.0005825|0.0007766|0.0007766|0.000812|0.0009706,1|1|1|1|1,2574|1716|1716|42.91|1287
433,12,0.5668,37.41,8201.0,0.004527000000000001,0.999986,BCL10 CYLD N4BP1 NFKB2 NFKBIA NFKBIB SPATA2 STUB1 TNFAIP3 TNIP1 TRAF2 TRAF3,pattern recognition receptor signaling pathway|regulation of DNA-binding transcription factor activity|protein deubiquitination|protein modification by small protein removal|protein modification by small protein conjugation or removal,6.969e-13|4.839e-11|1.437e-10|2.155e-10|1.222e-09,1.099e-08|3.816e-07|7.555e-07|8.499e-07|3.854e-06,87.32|29.27|39.89|37.59|13.83
434,8,0.6006,16.82,5410.0,0.00309,0.9996790000000001,ARHGAP45 BCL2 DNAJC3 HERPUD1 MANF MEF2C SYVN1 UBE2G2,response to endoplasmic reticulum stress|regulation of response to endoplasmic reticulum stress|response to unfolded protein|response to topologically incorrect protein|negative regulation of response to endoplasmic reticulum stress,1.771e-08|2.247e-08|3.125e-07|4.97e-07|7.02e-07,0.0002794|0.0001772|0.001643|0.00196|0.002215,49.89|121.1|61.66|54.77|167.9
435,9,0.6075,21.87,5926.0,0.0036659999999999996,0.9998530000000001,ATP13A1 BAX BCL2L1 BCL2L2 MARCH5 MCL1 PMAIP1 THAP3 WSB2,signal transduction in absence of ligand|extrinsic apoptotic signaling pathway in absence of ligand|intrinsic apoptotic signaling pathway|regulation of intrinsic apoptotic signaling pathway|positive regulation of intrinsic apoptotic signaling pathway,7.739e-10|7.739e-10|2.517e-09|3.579e-09|9.884e-09,1.221e-05|6.103e-06|1.323e-05|1.411e-05|3.118e-05,305.1|305.1|77.83|72.42|155.1
436,4,0.6341,3.805,3196.0,0.001186,0.9929309999999999,BCL7C FAM83C MYLK2 OCSTAMP,positive regulation of osteoclast proliferation|regulation of muscle filament sliding|regulation of osteoclast proliferation|skeletal muscle satellite cell differentiation|positive regulation of macrophage fusion,0.0005825|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1287|1287|1287|1030
437,6,0.6158,9.236,4085.0,0.00225,0.998474,BCL9L BMPR1A FOXA2 HNF1A HNF4A TCF7L2,pancreas development|endocrine system development|positive regulation of transcription by RNA polymerase II|endocrine pancreas development|positive regulation of nucleic acid-templated transcription,2.417e-09|2.046e-08|4.098e-08|1.939e-07|2.415e-07,3.812e-05|0.0001614|0.0002155|0.0007646|0.0007619,193.4|111.6|17.08|245.2|12.7
438,9,0.6271,22.58,5768.0,0.003886,0.9998530000000001,CLTC DLGAP5 GTSE1 KIF15 KNTC1 MAD2L1BP MAPRE1 TACC3 TRIP13,mitotic cell cycle|regulation of cell cycle process|regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation|regulation of chromosome separation,3.164e-11|3.545e-11|4.879e-11|7.956e-11|7.956e-11,4.991e-07|2.796e-07|2.565e-07|3.137e-07|2.51e-07,24.06|23.71|176|158.9|158.9
439,4,0.6131,3.679,3336.0,0.001099,0.9929309999999999,BDKRB2 COX7A1 PIK3C2G PROK2,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|positive regulation of cytosolic calcium ion concentration|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0003883|0.0003883|0.0009706|0.001124|0.001165,1|1|1|1|1,5149|5149|1287|36.39|1030
440,7,0.6179,12.98,5187.0,0.002489,0.9992989999999999,ACCSL BDNF CCDC34 COMMD9 ELF5 LIN7C PAMR1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway|regulation of brain-derived neurotrophic factor receptor signaling pathway|brain-derived neurotrophic factor receptor signaling pathway|collateral sprouting|positive regulation of non-membrane spanning protein tyrosine kinase activity,0.001019|0.001358|0.001698|0.002715|0.002715,1|1|1|1|1,1471|980.7|735.5|420.3|420.3
441,5,0.623,6.23,3744.0,0.001657,0.996692,ADIPOR2 BEND4 IRF8 MEF2D ZFP64,plasmacytoid dendritic cell differentiation|negative regulation of hepatic stellate cell migration|regulation of hepatic stellate cell migration|plasmacytoid dendritic cell activation|positive regulation of transcription by RNA polymerase II,0.0004854|0.0004854|0.000728|0.0009706|0.001844,1|1|1|1|1,4119|4119|2060|1373|10.25
442,4,0.6602,3.9610000000000003,3084.0,0.001279,0.9929309999999999,BEND5 CLCN6 DHRS4L2 GRP,neuropeptide signaling pathway|positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|psychomotor behavior|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of SMAD protein signal transduction,0.0005936|0.001698|0.001698|0.002037|0.002715,1|1|1|1|1,53.98|735.5|735.5|588.4|420.3
443,4,0.6285,3.7710000000000004,3360.0,0.001118,0.9929309999999999,BEND6 BSPH1 RETREG2 ZC3H14,negative regulation of mRNA polyadenylation|negative regulation of mRNA 3'-end processing|regulation of mRNA polyadenylation|sperm capacitation|regulation of mRNA 3'-end processing,0.001747|0.001941|0.003491|0.005233|0.00562,1|1|1|1|1,643.6|572.1|302.9|198|183.9
444,19,0.5729,97.97,12930.0,0.007499,1.0,BET1 BUD31 COPS6 CPSF4 CRCP LAMTOR4 LSM8 MCM7 MEPCE ORC5 PMPCB POP7 PSMC2 RBM28 RINT1 SEM1 SRRT TNPO3 ZNHIT1,nucleic acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|organic cyclic compound metabolic process,6.51e-08|5.824e-07|1.199e-06|1.413e-06|3.33e-06,0.001027|0.004593|0.006304|0.005572|0.01051,5.828|4.784|4.479|4.412|4.078
445,4,0.6031,3.6189999999999998,3096.0,0.001164,0.9929309999999999,AAED1 BICD2 C9orf47 MUSK,positive regulation of protein geranylgeranylation|regulation of protein geranylgeranylation|minus-end-directed organelle transport along microtubule|regulation of synaptic growth at neuromuscular junction|skeletal muscle acetylcholine-gated channel clustering,0.0002913|0.0002913|0.0008737|0.0008737|0.001165,1|1|1|1|1,6865|6865|1373|1373|980.7
446,21,0.4909,103.1,17430.0,0.005867,1.0,ADAM32 BIN3 C8orf58 CHRNA2 CHRNA6 CHRNB3 DEFA5 DMTN MSRA NAT1 PEBP4 PNOC PRSS55 RHOBTB2 SARAF SCARA3 SORBS3 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D,"TRAIL-activated apoptotic signaling pathway|synaptic transmission, cholinergic|extrinsic apoptotic signaling pathway via death domain receptors|glutamine transport|excitatory postsynaptic potential",1.159e-07|4.963e-06|8.849e-06|5.81e-05|6.321e-05,0.001827|0.03914|0.04653|0.2291|0.1994,429.1|99.01|80.45|214.5|40.22
447,6,0.6219,9.328,4160.0,0.002231,0.998474,BIRC5 ECT2 KIF23 NUF2 PRC1 RACGAP1,cell division|mitotic spindle organization|microtubule cytoskeleton organization involved in mitosis|spindle organization|mitotic cell cycle process,1.937e-10|2.087e-10|3.77e-10|9.876e-10|1.394e-09,3.056e-06|1.646e-06|1.982e-06|3.895e-06|4.399e-06,41.86|104.6|92.77|76.28|30.07
448,9,0.6241,22.47,5957.0,0.003746,0.9998530000000001,BIRC6 DNAJC7 EIF2AK1 HECTD1 KCMF1 PPP1R15B UBA6 UBR4 USP19,protein modification by small protein conjugation or removal|cellular protein modification process|protein modification process|macromolecule modification|protein ubiquitination,1.181e-06|1.685e-06|1.685e-06|2.931e-06|6.853e-06,0.01863|0.01329|0.008861|0.01156|0.02162,13.32|6.064|6.064|5.65|15.44
449,4,0.6881,4.128,3071.0,0.0013390000000000001,0.9929309999999999,BIVM COL4A2 KDELC1 PLA2G4A,phosphatidylglycerol catabolic process|platelet activating factor biosynthetic process|positive regulation of platelet activation|monoacylglycerol biosynthetic process|cardiolipin acyl-chain remodeling,0.0002913|0.0007281|0.0007281|0.001165|0.00131,1|1|1|1|1,6865|1716|1716|980.7|858.1
450,15,0.5428,56.99,11720.0,0.0048259999999999996,0.999999,BIRC3 CARD16 CCDC89 CEP126 CFAP300 DYNC2H1 MMP1 MMP10 MMP13 MMP20 MMP27 MMP3 MMP7 MMP8 SYT9,collagen catabolic process|collagen metabolic process|extracellular matrix disassembly|extracellular matrix organization|extracellular structure organization,2.249e-20|3.954e-19|5.803e-14|2.954e-12|3.023e-12,3.548e-16|3.119e-15|3.051e-10|1.165e-08|9.537e-09,269.4|189.9|136.5|30.33|30.25
451,19,0.737,126.0,12440.0,0.009999,1.0,BRIP1 CENPS CENPX FAAP100 FAAP20 FAAP24 FANCA FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM RFWD3 SLX4 UBE2T XRCC2,interstrand cross-link repair|DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress,3.264e-40|1.736e-29|2.423e-26|2.796e-26|9.696e-20,5.149e-36|1.369e-25|1.274e-22|1.103e-22|3.059e-16,312.6|36.92|25.05|24.86|11.15
452,4,0.6259,3.755,3384.0,0.001106,0.9929309999999999,ADAM23 BAG4 BLNK IMPACT,"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|response to benomyl|negative regulation of mRNA modification|cellular response to benomyl",0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
453,22,0.5678,131.2,14110.0,0.009178,1.0,AP3B1 AP3D1 ARL8B BLOC1S1 FNIP1 HTT LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MTMR9 NPC1 RAB7A SNAPIN VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41,lysosomal transport|vesicle-mediated transport|vacuolar transport|establishment of localization in cell|cellular localization,2.07e-19|5.325e-18|6.227e-18|2.145e-16|5.498e-16,3.265e-15|4.2e-14|3.274e-14|8.461e-13|1.735e-12,90.36|9.146|65.23|7.572|6.262
454,23,0.551,139.4,15780.0,0.008729,1.0,ARL8B BLOC1S1 BLOC1S2 BORCS5 BORCS6 BORCS7 BORCS8 DNAJC13 KXD1 MTMR6 MTMR9 NPC1 RAB7A SNAPIN VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR91,vesicle-mediated transport|lysosome localization|lysosomal transport|vacuolar transport|intracellular transport,2.525e-16|8.347e-16|3.69e-15|6.057e-14|1.001e-13,3.982e-12|6.584e-12|1.94e-11|2.388e-10|3.159e-10,8.689|149.2|73.93|53.37|9.558
455,4,0.6046,3.628,3417.0,0.001058,0.9929309999999999,BLVRA GOLGA3 HYAL4 NXN,chondroitin sulfate catabolic process|pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process|heme catabolic process,0.00291|0.003297|0.003297|0.003297|0.003297,1|1|1|1|1,367.8|321.8|321.8|321.8|321.8
456,13,0.6005,46.84,9936.0,0.00468,0.999993,BMF C15orf53 CHRNA7 DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M NIPA2 PLA2G4D PLA2G4E SNURF TGM5,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|regulation of postsynaptic membrane potential,8.982e-06|1.197e-05|1.539e-05|1.922e-05|4.24e-05,0.1417|0.09441|0.08089|0.07581|0.1338,588.4|490.4|420.3|367.8|44.13
457,4,0.6116,3.67,2950.0,0.001239,0.9929309999999999,BMP2K ETFRF1 FGFR1OP2 SLMAP,regulation of membrane depolarization during cardiac muscle cell action potential|regulation of membrane depolarization during action potential|regulation of voltage-gated sodium channel activity|regulation of clathrin-dependent endocytosis|regulation of membrane depolarization,0.0009706|0.001165|0.001553|0.003878|0.008517,1|1|1|1|1,1287|1030|735.5|271|119.7
458,4,0.6179,3.707,3021.0,0.001222,0.9929309999999999,BMP4 ISCA1 OR6B2 RPL39L,BMP signaling pathway involved in nephric duct formation|bud dilation involved in lung branching|BMP signaling pathway involved in ureter morphogenesis|renal system segmentation|pulmonary artery endothelial tube morphogenesis,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|0.245|0.2552|0.2663|0.2917,5149|5149|5149|5149|5149
459,8,0.6021,16.86,6399.0,0.002621,0.9996790000000001,BMP7 FAM209A FAM209B KCNB1 PCK1 RBM38 TFAP2C ZGPAT,cellular response to glucose stimulus|cellular response to hexose stimulus|cellular response to monosaccharide stimulus|cellular response to carbohydrate stimulus|cellular glucose homeostasis,0.0003327|0.0003514|0.000361|0.000442|0.0005545,1|1|1|1|1,73.55|71.51|70.53|63.56|56.58
460,4,0.6525,3.915,3352.0,0.001164,0.9929309999999999,BMPR1B CASP10 CXCR2 GPBAR1,cell surface bile acid receptor signaling pathway|interleukin-8-mediated signaling pathway|positive regulation of cholangiocyte proliferation|cell surface receptor signaling pathway|signal transduction,0.0004854|0.000728|0.000728|0.0009622|0.0009685,1|1|1|1|1,4119|2060|2060|6.628|4.008
461,13,0.6205,48.4,9086.0,0.0052840000000000005,0.999993,ACVR1 BAMBI BMPR1A BMPR2 FKBP1A IPO8 LRIG3 MIB1 NEO1 RGMB SMAD1 SMAD7 UBAC1,transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|BMP signaling pathway|cellular response to BMP stimulus|response to BMP,1.031e-13|6.811e-13|1.2e-11|2.998e-11|2.998e-11,1.627e-09|5.372e-09|6.307e-08|1.182e-07|9.459e-08,64.33|50.49|109.3|93.19|93.19
462,6,0.6245,9.367,4210.0,0.0022140000000000003,0.998474,BMS1 DDX21 HNRNPH1 PDCD11 SUPV3L1 TIMM23,RNA processing|rRNA processing|rRNA metabolic process|RNA metabolic process|ribosome biogenesis,5.572e-08|8.95e-07|1.038e-06|1.448e-06|2.34e-06,0.0008789|0.007059|0.005459|0.005711|0.007382,19.13|45.26|43.59|11.04|35.45
463,13,0.5932,46.27,8567.0,0.0053549999999999995,0.999993,BMT2 C12orf66 DEPDC5 ITFG2 KPTN MIOS NPRL2 SESN2 SZT2 TBC1D7 TSC1 TSC2 WDR24,regulation of TOR signaling|negative regulation of TOR signaling|cellular response to amino acid starvation|response to amino acid starvation|cellular response to nutrient levels,1.756e-30|1.046e-27|4.261e-22|6.016e-22|5.363e-20,2.771e-26|8.247e-24|2.241e-18|2.372e-18|1.692e-16,208|405.3|198|190.9|72.61
464,4,0.6032,3.6189999999999998,3363.0,0.001072,0.9929309999999999,ANTXR2 BNIP3L CYP2E1 FUT4,4-nitrophenol metabolic process|benzene metabolic process|carbon tetrachloride metabolic process|halogenated hydrocarbon metabolic process|response to ozone,0.0003883|0.0003883|0.0003883|0.0005825|0.0009706,1|1|1|1|1,5149|5149|5149|2574|1287
465,14,0.6244,56.82,9390.0,0.005997,0.9999969999999999,BOLA3 FDX1 GCSH GLRX5 IBA57 ISCA1 ISCA2 LIAS LIPT1 LIPT2 MECR METTL17 NFU1 SLC25A19,protein maturation|metallo-sulfur cluster assembly|iron-sulfur cluster assembly|protein lipoylation|protein maturation by iron-sulfur cluster transfer,1.182e-12|6.301e-12|6.301e-12|2.791e-11|5.133e-10,1.865e-08|4.969e-08|3.313e-08|1.101e-07|1.619e-06,48.63|319.8|319.8|980.7|392.3
466,9,0.619,22.28,6309.0,0.0035090000000000004,0.9998530000000001,BOP1 CYC1 EXOSC4 MRPL13 MTBP PUF60 RPL8 UTP23 VPS28,ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ribosome biogenesis|RNA processing,7.064e-07|3.156e-06|3.658e-06|8.206e-06|1.986e-05,0.01114|0.02489|0.01924|0.03236|0.06264,24.61|35.21|33.9|27.57|12.4
467,8,0.6124,17.15,6265.0,0.002723,0.9996790000000001,BPIFA1 BPIFA2 BPIFB1 DEFB115 DEFB116 FOXS1 MMP24 MYLK2,defense response to bacterium|defense response to other organism|antimicrobial humoral response|defense response|response to other organism,5.369e-06|1.577e-05|2.455e-05|7.277e-05|7.326e-05,0.08469|0.1244|0.1291|0.287|0.2311,29.85|12.47|49.51|9.09|9.077
468,9,0.6197,22.31,7786.0,0.0028510000000000002,0.9998530000000001,BPI BPIFB2 CPNE1 DLGAP4 GHRH HCK NNAT VSTM2L ZNF341,"lipopolysaccharide-mediated signaling pathway|secretion by cell|export from cell|secretion|positive regulation of circadian sleep/wake cycle, REM sleep",0.000106|0.0004735|0.0005711|0.0007254|0.0008734,1|1|1|1|1,134.6|9.655|9.19|8.627|2288
469,12,0.6039,39.86,9527.0,0.004155,0.999986,BPIFB4 CCM2L CPNE1 DUSP15 FOXS1 HCK MAP1LC3A MYLK2 NECAB3 NOL4L TM9SF4 XKR7,phagocytosis|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding|skeletal muscle satellite cell differentiation,0.0007972|0.001746|0.002327|0.002909|0.002909,1|1|1|1|1,15.79|858.1|572.1|429.1|429.1
470,8,0.6185,17.32,5097.0,0.003375,0.9996790000000001,ATM BRAP C16orf72 CHEK2 MDM2 PPM1D TP53 USP28,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|cellular response to gamma radiation|DNA damage checkpoint",3.481e-12|1.242e-10|4.26e-10|7.739e-10|1.916e-09,5.491e-08|9.793e-07|2.24e-06|3.052e-06|6.044e-06,116.4|144.8|112.2|305.1|82.31
471,8,0.608,17.03,5363.0,0.0031550000000000003,0.9996790000000001,BRAT1 DCTN6 FNTA INTS9 PPP2CA PPP2CB TTI2 WDR73,positive regulation of microtubule binding|regulation of microtubule binding|peptidyl-serine dephosphorylation|peptidyl-threonine dephosphorylation|response to lead ion,3.69e-06|8.691e-06|1.579e-05|3.626e-05|3.94e-05,0.0582|0.06854|0.08302|0.143|0.1243,858.1|514.9|367.8|234|223.9
472,6,0.6333,9.499,4097.0,0.002306,0.998474,BRF2 DCTN6 FNTA MAK16 PPP2CA TTI2,positive regulation of tubulin deacetylation|RNA metabolic process|cellular response to transforming growth factor beta stimulus|response to transforming growth factor beta|protein farnesylation,0.0006794|0.001055|0.001137|0.001242|0.001358,1|1|1|1|1,2942|7.36|38.71|37.01|980.7
473,23,0.5736,145.1,14420.0,0.009931,1.0,ARL8B FNIP1 GDAP2 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS RRAGA RRAGC SEH1L SNAPIN SPG21 TBC1D5 VPS16 VPS18 VPS29 VPS33A VPS35 VPS39 VPS41 WDR24 WDR59,positive regulation of TOR signaling|response to starvation|regulation of TOR signaling|cellular response to starvation|cellular response to amino acid starvation,1.769e-23|7.432e-20|7.645e-20|7.807e-19|1.637e-18,2.79e-19|5.862e-16|4.02e-16|3.079e-15|5.166e-15,229.1|49.96|99.49|55.96|111.9
474,10,0.6053,27.24,7824.0,0.00346,0.999933,BRINP2 CARNS1 CCNB1IP1 KIF26B LYRM1 MAP3K7CL NIPSNAP3B PCDHGA9 RNF114 SDR39U1,carnosine biosynthetic process|carnosine metabolic process|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.0009704|0.001455|0.00194|0.002424|0.002909,1|1|1|1|1,2060|1030|686.5|514.9|411.9
475,4,0.6262,3.7569999999999997,3420.0,0.0010949999999999998,0.9929309999999999,BRINP3 CSMD3 S100A13 SYNE1,interleukin-1 alpha production|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization|interleukin-1 production|mast cell activation involved in immune response,0.0003883|0.0007766|0.0007766|0.001941|0.004072,1|1|1|1|1,5149|1716|1716|572.1|257.4
476,14,0.6276,57.11,9583.0,0.005907,0.9999969999999999,BRIX1 CCT5 DROSHA EXOC3 ICE1 MRPL36 MRPS30 NUP155 RAD1 RPL37 TARS WDR70 ZFR ZNF622,ribosome biogenesis|ribonucleoprotein complex biogenesis|translation|peptide biosynthetic process|gene expression,2.978e-06|1.501e-05|0.0001432|0.0001821|0.000454,0.04698|0.1184|0.753|0.7179|1,20.68|14.76|14.3|13.43|4.397
477,4,0.6538,3.923,3386.0,0.0011539999999999999,0.9929309999999999,BRMS1L CARMIL3 FBXO34 SYNE2,nuclear migration along microfilament|nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration|nuclear migration along microtubule|modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration|cell motility involved in cerebral cortex radial glia guided migration,0.0005825|0.0007766|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|1716|1287|1030|735.5
478,4,0.6329,3.798,3139.0,0.0012050000000000001,0.9929309999999999,BSCL2 ISLR2 TNFSF8 TOP3B,"CD8-positive, alpha-beta T cell differentiation|DNA topological change|lipid droplet formation|CD8-positive, alpha-beta T cell activation|negative regulation of lipid catabolic process",0.001747|0.001941|0.002328|0.002522|0.00504,1|1|1|1|1,643.6|572.1|468.1|429.1|205.9
479,4,0.6237,3.742,2706.0,0.001377,0.9929309999999999,BTAF1 DRAP1 GTF2H5 WRAP53,telomerase RNA localization|telomerase RNA localization to Cajal body|telomere formation via telomerase|protein localization to Cajal body|protein localization to nuclear body,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
480,4,0.602,3.612,3267.0,0.001102,0.9929309999999999,BTBD10 FOXA3 LAMB1 PLA2G2D,"neuronal-glial interaction involved in cerebral cortex radial glia guided migration|CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|regulatory T cell differentiation|type B pancreatic cell proliferation|basement membrane assembly",0.0005825|0.0009706|0.001359|0.001941|0.002134,1|1|1|1|1,2574|1287|858.1|572.1|514.9
481,11,0.5647,31.06,7637.0,0.004039,0.999969,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 NOP9 PARN POP4 WDR43 WDR75,ncRNA processing|rRNA processing|rRNA metabolic process|ncRNA metabolic process|ribosome biogenesis,1.805e-13|3.489e-13|4.687e-13|8.836e-13|2.365e-12,2.847e-09|2.752e-09|2.465e-09|3.485e-09|7.461e-09,35.76|52.81|50.85|29.88|41.36
482,5,0.6735,6.735,3289.0,0.002038,0.996692,ANKRD17 BTG1 CNOT2 CNOT3 CNOT6,regulation of G1/S transition of mitotic cell cycle|nuclear-transcribed mRNA poly(A) tail shortening|regulation of mitotic cell cycle|regulation of cell cycle G1/S phase transition|negative regulation of mitotic cell cycle,1.573e-08|1.782e-08|1.944e-08|2.558e-08|2.122e-07,0.0002481|0.0001405|0.0001022|0.0001009|0.0006694,108.4|537.3|35.03|95.79|56.04
483,4,0.6131,3.678,3514.0,0.0010429999999999999,0.9929309999999999,BTG2 FAM69C MATN2 RASGRF2,dentate gyrus development|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|regulation of nuclear-transcribed mRNA poly(A) tail shortening|negative regulation of neural precursor cell proliferation|regulation of NMDA receptor activity,0.00291|0.00291|0.003297|0.004459|0.007938,1|1|1|1|1,367.8|367.8|321.8|234|128.7
484,4,0.6454,3.872,3011.0,0.001281,0.9929309999999999,BTG3 CNOT6 CNOT6L CNOT7,"nuclear-transcribed mRNA poly(A) tail shortening|RNA phosphodiester bond hydrolysis, exonucleolytic|negative regulation of mitotic cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint",7.134e-09|4.162e-08|4.294e-08|9.863e-08|1.036e-07,0.0001125|0.0003283|0.0002258|0.0003889|0.000327,671.6|359.2|70.05|266.3|261.8
485,9,0.6431,23.15,6785.0,0.003392,0.9998530000000001,FCHSD2 FOLR1 FOLR2 KCTD21 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,1.271e-06|4.446e-06|5.927e-06|9.52e-06|1.649e-05,0.02005|0.03507|0.03116|0.03754|0.05202,2060|823.8|686.5|514.9|374.5
486,11,0.6086,33.47,8302.0,0.004005,0.999969,BTN2A1 BTN2A2 GPX6 HIST1H1T OR14J1 OR2B6 OR2J2 OR2J3 SLC17A4 ZKSCAN4 ZSCAN16,cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|detoxification|detection of chemical stimulus involved in sensory perception of smell,2.224e-05|3.23e-05|3.878e-05|5.922e-05|9.255e-05,0.3509|0.2547|0.2039|0.2335|0.292,54.2|47.67|44.77|38.71|15.57
487,5,0.6136,6.136,4020.0,0.0015199999999999999,0.996692,BTNL8 CBY3 RUFY1 ZNF454 ZNF879,phosphatidylinositol biosynthetic process|T cell receptor signaling pathway|phosphatidylinositol metabolic process|regulation of endocytosis|glycerophospholipid biosynthetic process,0.02689|0.04317|0.04341|0.04971|0.05227,1|1|1|1|1,37.11|22.88|22.76|19.8|18.81
488,4,0.6263,3.758,3330.0,0.001124,0.9929309999999999,AK8 BTRC OR1J4 RALGPS1,regulation of Ral protein signal transduction|mammary gland epithelial cell proliferation|positive regulation of ubiquitin protein ligase activity|nucleoside monophosphate phosphorylation|positive regulation of circadian rhythm,0.0007766|0.002522|0.002716|0.002716|0.003491,1|1|1|1|1,1716|429.1|396.1|396.1|302.9
489,6,0.6618,9.927,3876.0,0.002546,0.998474,BUB1B BUB3 DLGAP5 KNTC1 MAPRE1 TRIP13,regulation of mitotic metaphase/anaphase transition|regulation of metaphase/anaphase transition of cell cycle|regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation|regulation of chromosome separation,1.6e-12|2.019e-12|2.343e-12|3.824e-12|3.824e-12,2.523e-08|1.592e-08|1.232e-08|1.508e-08|1.207e-08,286|272.4|264|238.4|238.4
490,15,0.6282,65.96,9974.0,0.00655,0.999999,ARCN1 BUD13 CCDC84 CWF19L2 DDX10 DPAGT1 HYOU1 NKAPD1 PPP2R1A RPS25 SRFBP1 SRPRA TRAPPC4 ZPR1 ZW10,RNA processing|endoplasmic reticulum to Golgi vesicle-mediated transport|RNA metabolic process|mRNA metabolic process|Golgi vesicle transport,1.743e-06|1.08e-05|6.334e-05|0.0001001|0.000161,0.0275|0.0852|0.333|0.3947|0.508,10.41|28.02|6.011|9.892|13.87
491,5,0.6311,6.311,3479.0,0.0018059999999999999,0.996692,BYSL PFDN1 PFDN6 RPL7L1 TBCC,negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|protein folding|blastocyst formation|blastocyst development,4.284e-06|6.401e-06|1.369e-05|3.48e-05|0.0002265,0.06758|0.05048|0.07198|0.1372|0.7145,686.5|549.2|54.2|222.6|84.93
492,12,0.602,39.73,9846.0,0.004009,0.999986,ABCB5 ADCYAP1R1 AEBP1 AGR3 BZW2 GHRHR GSDME HOXA11 KIAA0895 NME8 WIPF3 ZNF713,multicellular organismal reproductive process|multicellular organism reproduction|cAMP-mediated signaling|cell differentiation|cellular developmental process,6.436e-05|7.172e-05|0.0001625|0.000184|0.0002052,1|0.5657|0.8544|0.7256|0.6474,10.44|10.2|110.7|3.913|3.855
493,4,0.6176,3.705,3496.0,0.001056,0.9929309999999999,C10orf55 LIPM METTL9 MYOZ1,negative regulation of skeletal muscle tissue regeneration|skeletal muscle fiber adaptation|regulation of skeletal muscle tissue regeneration|skeletal muscle adaptation|negative regulation of calcineurin-NFAT signaling cascade,0.0003883|0.0009706|0.001553|0.002716|0.003104,1|1|1|1|1,5149|1287|735.5|396.1|343.2
494,4,0.6238,3.7430000000000003,3395.0,0.001099,0.9929309999999999,ACYP2 C10orf62 SERPINE2 USP13,mating plug formation|seminal vesicle epithelium development|seminal vesicle development|protein K6-linked deubiquitination|maintenance of unfolded protein,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
495,4,0.7246,4.348,3372.0,0.001285,0.9929309999999999,C10orf67 C4orf51 KCTD19 SIAE,protein homooligomerization|regulation of cellular process|protein complex oligomerization|cellular process|UNCLASSIFIED,0.03469|0.04148|0.04467|0.04971|0.08866,1|1|1|1|1,28.6|0|22.1|0.3325|3.751
496,4,0.6525,3.915,3406.0,0.001146,0.9929309999999999,C11orf1 KCTD7 SPDYE1 STXBP6,glutamate homeostasis|amino acid homeostasis|membrane hyperpolarization|regulation of SNARE complex assembly|cellular potassium ion homeostasis,0.001165|0.001359|0.002134|0.002134|0.00291,1|1|1|1|1,1030|858.1|514.9|514.9|367.8
497,22,0.6111,141.2,14880.0,0.009370999999999999,1.0,CCDC77 CCP110 CENPJ CEP120 CEP135 CEP152 CEP295 CEP41 CEP44 PCM1 PCNT PLK4 PPP1R35 RTTN SASS6 SPICE1 STIL TEDC1 TEDC2 TUBD1 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|microtubule cytoskeleton organization|centrosome duplication|centriole replication,2.013e-25|9.426e-25|8.681e-23|5.307e-22|7.438e-21,3.176e-21|7.434e-21|4.564e-19|2.093e-18|2.347e-17,138.3|121.7|28.12|267.5|366.3
498,39,0.5118,379.3,27140.0,0.01375,1.0,H2AFX HIST1H1A HIST1H1B HIST1H1C HIST1H1D HIST1H1E HIST1H2AA HIST1H2AC HIST1H2AD HIST1H2AG HIST1H2AI HIST1H2AJ HIST1H2BA HIST1H2BB HIST1H2BC HIST1H2BD HIST1H2BE HIST1H2BF HIST1H2BG HIST1H2BH HIST1H2BI HIST1H2BJ HIST1H2BK HIST1H2BL HIST1H2BM HIST1H2BN HIST1H2BO HIST1H3A HIST1H3D HIST1H3F HIST1H3G HIST1H3I HIST1H3J HIST1H4A HIST1H4I HIST1H4L HIST2H2AC HIST2H2BE HIST2H2BF,"regulation of gene expression, epigenetic|chromatin organization|chromosome organization|chromatin organization involved in negative regulation of transcription|negative regulation of gene expression, epigenetic",2.5e-08|4.533e-08|3.678e-07|5.608e-07|5.824e-07,0.0003943|0.0003575|0.001934|0.002212|0.001837,96.35|29.55|19.41|160.5|158.4
499,8,0.6231,17.45,4948.0,0.0035020000000000003,0.9996790000000001,BRAF DUSP4 ELAVL1 MAP2K1 MAPK1 PEA15 SOX10 SOX9,trachea development|endocrine system development|thyroid gland development|gland development|MAPK cascade,5.897e-08|9.456e-08|1.119e-07|1.704e-07|1.704e-07,0.0009302|0.0007458|0.0005884|0.000672|0.0005376,406.5|83.72|321.8|31.47|31.47
500,4,0.6513,3.908,3282.0,0.001187,0.9929309999999999,C11orf45 OIT3 STEAP1B TMEM161A,urate homeostasis|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|regulation of intrinsic apoptotic signaling pathway in response to DNA damage|positive regulation of DNA repair|negative regulation of response to DNA damage stimulus,0.0003883|0.006007|0.007359|0.01487|0.01602,1|1|1|1|1,5149|171.6|139.2|67.75|62.79
501,6,0.6411,9.616,4452.0,0.00215,0.998474,C11orf53 CKS1B IDE POU2F3 SOX4 STAM2,positive regulation of N-terminal peptidyl-lysine acetylation|regulation of N-terminal peptidyl-lysine acetylation|insulin catabolic process|pro-B cell differentiation|ascending aorta morphogenesis,0.0005824|0.0005824|0.001165|0.001456|0.001456,1|1|1|1|1,3432|3432|1144|858.1|858.1
502,11,0.6219,34.2,8234.0,0.0041259999999999995,0.999969,ANO1 CABP2 CTTN FADD FGF19 FGF4 FOLR2 MRGPRD MRGPRF MYEOV POLD4,"fibroblast growth factor receptor signaling pathway|positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation|positive regulation of cell population proliferation|cellular response to stimulus|negative regulation of extrinsic apoptotic signaling pathway",0.0008611|0.001067|0.00108|0.001229|0.001425,1|1|1|1|1,46.23|1872|8.036|2.489|35.66
503,4,0.6013,3.608,3178.0,0.001131,0.9929309999999999,C11orf87 EBF2 INPP5J NTM,negative regulation of microtubule polymerization|positive regulation of chromatin binding|inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation,0.002716|0.00291|0.003491|0.003878|0.003878,1|1|1|1|1,396.1|367.8|302.9|271|271
504,4,0.6053,3.6319999999999997,3295.0,0.001098,0.9929309999999999,ABCD2 C12orf40 CPNE8 SLC8B1,calcium export from the mitochondrion|long-chain fatty acid import into peroxisome|very long-chain fatty acid catabolic process|regulation of cardiac muscle cell membrane potential|positive regulation of unsaturated fatty acid biosynthetic process,0.0005825|0.0009706|0.001359|0.001553|0.001941,1|1|1|1|1,2574|1287|858.1|735.5|572.1
505,5,0.6203,6.202999999999999,3490.0,0.0017690000000000002,0.996692,C12orf45 CCDC59 PWP1 RBM19 UTP20,"negative regulation of peptidyl-serine phosphorylation of STAT protein|rRNA 5'-end processing|endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|histone H4-K20 trimethylation|endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",0.0009706|0.001456|0.001456|0.001456|0.00194,1|1|1|1|1,1373|823.8|823.8|823.8|588.4
506,31,0.568,264.1,22560.0,0.01154,1.0,C12orf65 DDX28 FOXRED1 GFM2 GRSF1 GTPBP10 GTPBP8 MALSU1 METTL17 MRM2 MRM3 MRPL1 MRPL44 MRPL50 MRPL58 MRPL9 MTERF3 MTERF4 MTFMT MTG1 MTG2 MTIF2 NGRN NSUN4 PTCD1 RMND1 RPUSD3 RPUSD4 TFB1M TRUB2 YBEY,ribosome biogenesis|ribonucleoprotein complex biogenesis|regulation of mitochondrial translation|regulation of mitochondrial gene expression|gene expression,4.264e-19|5.471e-17|1.72e-16|4.615e-16|3.138e-15,6.726e-15|4.315e-13|9.046e-13|1.82e-12|9.9e-12,30.02|21.43|204.4|177.2|6.686
507,6,0.6174,9.261000000000001,4654.0,0.0019809999999999997,0.998474,C12orf71 PRB1 PRB2 PRB4 PRH2 TAS2R19,regulation of lipid kinase activity|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|regulation of G1/S transition of mitotic cell cycle|regulation of cell division,0.0003327|0.0007606|0.0008027|0.001509|0.00192,1|1|1|1|1,73.55|48.12|46.81|33.87|29.93
508,13,0.5869,45.78,10290.0,0.004417,0.999993,C1QTNF3 C7 CDH10 CDH12 CDH6 CDH9 FBXO4 HCN1 OXCT1 PRLR SLC45A2 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,1.53e-08|6.712e-08|1.067e-06|3.087e-06|4.69e-06,0.0002414|0.0005294|0.005608|0.01217|0.0148,150.9|102.2|49.9|37.95|34.07
509,4,0.6855,4.113,3410.0,0.001202,0.9929309999999999,C14orf119 DNAH14 IGIP PCDHGB7,cilium-dependent cell motility|cilium or flagellum-dependent cell motility|biological regulation|homophilic cell adhesion via plasma membrane adhesion molecules|regulation of biological process,0.02157|0.02157|0.02306|0.03223|0.03244,1|1|1|1|1,46.39|46.39|0|30.83|0
510,4,0.6362,3.8169999999999997,3298.0,0.001153,0.9929309999999999,ADCY4 C14orf93 CEBPE MMP14,positive regulation of macromolecule metabolic process|response to odorant|positive regulation of metabolic process|astrocyte cell migration|cAMP biosynthetic process,0.0007721|0.0007766|0.001066|0.001165|0.002134,1|1|1|1|1,6.003|1716|5.538|1030|514.9
511,4,0.6456,3.8739999999999997,3157.0,0.001222,0.9929309999999999,C16orf71 DIXDC1 GPER1 GPR146,nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation|regulation of cardiac vascular smooth muscle cell differentiation|positive regulation of inositol trisphosphate biosynthetic process|apoptotic chromosome condensation,0.0003883|0.0005825|0.0007766|0.001165|0.001165,1|1|1|1|1,5149|2574|1716|1030|1030
512,18,0.6023,92.15,14260.0,0.006406,1.0,ALDH3A1 ALOX15B ALOXE3 C17orf51 CCDC144A CCDC144NL DRC3 FOXO3 GID4 KRT16 MFAP4 MIEF2 SLC47A2 TBC1D28 TNFSF12 TNFSF13 ZNF287 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|tumor necrosis factor-mediated signaling pathway|linoleic acid metabolic process,3.943e-05|3.943e-05|0.0001093|0.0001783|0.0001802,0.6219|0.311|0.5746|0.703|0.5686,254.3|254.3|143|27.46|109
513,15,0.6083,63.87,9571.0,0.006608,0.999999,BRIP1 C17orf53 FANCD2 FANCG FANCI MCM8 MCM9 RAD51 RAD51B RAD51C RAD51D RFWD3 SFR1 XRCC2 XRCC3,DNA recombination|DNA repair|recombinational repair|interstrand cross-link repair|double-strand break repair,2.396e-23|2.791e-23|3.855e-22|4.376e-22|2.019e-21,3.78e-19|2.201e-19|2.027e-18|1.726e-18|6.368e-18,74.7|36.43|137.5|229.9|76.47
514,4,0.6408,3.845,3001.0,0.001276,0.9929309999999999,ANKRD36B C17orf64 FAHD2A TRIM43,UNCLASSIFIED|biological_process|regulation of cellular process|cellular process|protein ubiquitination,0.008539|0.008539|0.04148|0.04971|0.1365,1|1|1|1|1,5.627|0.2884|0|0.3325|6.948
515,14,0.611,55.6,11230.0,0.004913,0.9999969999999999,C18orf32 CDH7 CHST9 CTIF DSC1 DSG1 DSG3 DSG4 SERPINB10 SERPINB2 SERPINB5 SERPINB7 ZNF396 ZNF397,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cornification|keratinization|cell-cell adhesion,7.196e-08|6.05e-07|9.451e-07|1.386e-05|1.648e-05,0.001135|0.004772|0.00497|0.05464|0.05199,44.04|28.4|52.07|26.04|14.31
516,4,0.6141,3.685,3221.0,0.00114,0.9929309999999999,C18orf54 IGDCC4 MC4R RTP5,regulation of grooming behavior|negative regulation of feeding behavior|diet induced thermogenesis|negative regulation of behavior|adaptive thermogenesis,0.001165|0.001941|0.002328|0.003297|0.003685,1|1|1|1|1,1030|572.1|468.1|321.8|286
517,5,0.629,6.29,4046.0,0.0015480000000000001,0.996692,ACR C19orf18 CPT1B ZNF132 ZNF324B,acrosome matrix dispersal|response to blue light|penetration of zona pellucida|carnitine shuttle|carnitine metabolic process,0.0004854|0.001698|0.002425|0.00291|0.003636,1|1|1|1|1,4119|686.5|457.7|374.5|294.2
518,4,0.6248,3.7489999999999997,2899.0,0.001288,0.9929309999999999,C19orf24 CXADR GJA1 TJP1,cell-cell junction organization|tissue homeostasis|regulation of bicellular tight junction assembly|maintenance of blood-brain barrier|multicellular organismal homeostasis,3.021e-06|5.523e-06|9.177e-06|1.778e-05|2.143e-05,0.04765|0.04356|0.04825|0.07011|0.0676,83.04|67.75|429.1|302.9|42.91
519,5,0.6127,6.127000000000001,3354.0,0.001818,0.996692,C19orf53 C1D METAP1 METAP2 POP4,protein initiator methionine removal|peptidyl-methionine modification|regulation of rhodopsin mediated signaling pathway|N-terminal protein amino acid modification|regulation of G protein-coupled receptor signaling pathway,4.712e-07|4.943e-06|1.777e-05|1.909e-05|0.0005055,0.007432|0.03898|0.09344|0.07526|1,2746|633.7|316.8|305.1|56.42
520,14,0.61,55.51,10270.0,0.005362,0.9999969999999999,C19orf66 P2RY11 ZNF433 ZNF441 ZNF442 ZNF443 ZNF490 ZNF563 ZNF564 ZNF625 ZNF627 ZNF69 ZNF709 ZNF878,regulation of transcription by RNA polymerase II|regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of cellular biosynthetic process|regulation of biosynthetic process,1.121e-09|4.937e-09|5.46e-09|9.096e-09|1.178e-08,1.768e-05|3.894e-05|2.871e-05|3.587e-05|3.715e-05,6.826|4.887|4.849|4.659|4.565
521,21,0.4992,104.8,13880.0,0.0074730000000000005,1.0,CHCHD3 CLPB CLUH CRLS1 DNAJC11 FAM136A HAX1 HTRA2 IMMP2L IMMT MFN2 MTCH2 MTX1 MTX2 PARL ROMO1 SAMM50 TIMM13 TIMM17A TMEM11 YME1L1,mitochondrion organization|inner mitochondrial membrane organization|mitochondrial membrane organization|protein localization to mitochondrion|protein targeting to mitochondrion,9.559e-21|2.68e-18|1.01e-16|2.432e-12|3.023e-11,1.508e-16|2.114e-14|5.313e-13|9.591e-09|9.537e-08,32.19|169.7|70.05|83.72|105.1
522,9,0.6137,22.09,7527.0,0.00292,0.9998530000000001,C19orf73 C5AR1 C5AR2 CABP5 EML2 FLT3LG KPTN SULT2A1 SULT2B1,complement component C5a signaling pathway|complement receptor mediated signaling pathway|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process,1.017e-06|1.776e-05|5.482e-05|5.92e-05|5.92e-05,0.01605|0.14|0.2883|0.2334|0.1868,2288|352.1|190.7|183.1|183.1
523,7,0.6028,12.66,4859.0,0.002591,0.9992989999999999,C1GALT1 CMAS GNE MGAT1 NANS SLC35A1 SLC39A9,nucleotide-sugar metabolic process|amino sugar metabolic process|N-acetylneuraminate metabolic process|carbohydrate derivative metabolic process|carbohydrate metabolic process,4.068e-07|5.051e-07|1.027e-05|1.394e-05|1.86e-05,0.006417|0.003984|0.05399|0.05496|0.05868,203.2|188.4|468.1|12.8|21.72
524,4,0.6725,4.035,3529.0,0.001139,0.9929309999999999,C1QC CTRC NCALD SLC2A5,regulation of systemic arterial blood pressure|fructose import across plasma membrane|fructose import|regulation of blood pressure|cellular response to fructose stimulus,0.0001363|0.0003883|0.0003883|0.000486|0.001165,1|1|1|1|1,106.2|5149|5149|55.66|1030
525,4,0.6164,3.698,3412.0,0.00108,0.9929309999999999,C1RL C2CD4A MMP9 PEAK1,regulation of vascular permeability involved in acute inflammatory response|negative regulation of epithelial cell differentiation involved in kidney development|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|positive regulation of receptor binding|cellular response to UV-A,0.0009706|0.001165|0.001359|0.002134|0.002328,1|1|1|1|1,1287|1030|858.1|514.9|468.1
526,9,0.6228,22.42,7098.0,0.003141,0.9998530000000001,C1S CLEC2B CLEC4C KLRC1 PRH2 TAS2R13 TAS2R20 TAS2R7 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|detection of chemical stimulus involved in sensory perception,1.523e-09|2.481e-09|2.717e-09|1.704e-08|3.621e-05,2.403e-05|1.957e-05|1.428e-05|6.72e-05|0.1142,254.3|223.3|217.9|134.6|18.83
527,10,0.6087,27.39,6529.0,0.004164999999999999,0.999933,BUB3 C1orf109 DHX33 DPAGT1 MYBBP1A OSGEP POP5 RPP21 SPATA5L1 WDR18,tRNA 5'-leader removal|tRNA processing|tRNA 5'-end processing|ncRNA processing|ncRNA 5'-end processing,2.218e-05|3.191e-05|3.23e-05|3.753e-05|5.334e-05,0.3499|0.2517|0.1698|0.148|0.1683,316.8|46.81|257.4|19.07|196.1
528,11,0.6022,33.12,8091.0,0.004065999999999999,0.999969,C1orf131 COG2 EPRS INTS7 NUP133 NVL RRP15 SDE2 SRP9 TBCE URB2,gene expression|ncRNA metabolic process|ribosome biogenesis|ribosomal large subunit biogenesis|ncRNA processing,3.43e-05|0.0001157|0.0006378|0.0006852|0.001359,0.541|0.9129|1|1|1,5.995|14.49|16.92|52.01|13
529,4,0.6325,3.795,3402.0,0.001112,0.9929309999999999,C1orf185 ODF1 REN ZNF76,renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin|response to cGMP,0.001213|0.001698|0.001698|0.00194|0.00194,1|1|1|1|1,1030|686.5|686.5|588.4|588.4
530,4,0.6278,3.767,3508.0,0.00107,0.9929309999999999,C1orf189 IFT172 NCMAP ZNF683,regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response|peripheral nervous system myelin formation|cellular response to ionomycin|response to ionomycin,0.0005825|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,2574|1716|1716|1030|1030
531,4,0.6273,3.764,3148.0,0.001191,0.9929309999999999,C1orf210 FOXF1 RTP5 ZNF197,right lung morphogenesis|embryonic ectodermal digestive tract morphogenesis|ectodermal digestive tract morphogenesis|lateral mesodermal cell differentiation|detection of wounding,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
532,5,0.6722,6.722,3170.0,0.0021100000000000003,0.996692,CWC25 NSRP1 PPIL1 SNRNP40 SNRPB2,"RNA splicing|mRNA processing|mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome",3.125e-09|7.388e-09|4.436e-08|1.836e-07|2.36e-07,4.929e-05|5.827e-05|0.0002333|0.0007241|0.0007444,50.6|42.55|29.68|22.31|54.56
533,4,0.6954,4.172,2943.0,0.0014119999999999998,0.9929309999999999,C1orf43 KIAA0100 KIAA1109 VAPA,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|phagocytosis|positive regulation by host of viral genome replication|negative regulation by host of viral genome replication,0.001165|0.001165|0.001485|0.001747|0.001747,1|1|1|1|1,1030|1030|31.59|643.6|643.6
534,12,0.5851,38.61,9691.0,0.003959000000000001,0.999986,C1orf50 CCDC30 CFAP57 ERMAP EXO5 FAM183A MFSD2A PPT1 ZFP69 ZFP69B ZNF684 ZNF691,lysophospholipid translocation|regulation of phosphatidylserine metabolic process|regulation of phosphatidylethanolamine metabolic process|lysophospholipid transport|photoreceptor cell morphogenesis,0.001164|0.001164|0.001164|0.001746|0.002909,1|1|1|1|1,1716|1716|1716|858.1|429.1
535,4,0.6293,3.7760000000000002,3227.0,0.001166,0.9929309999999999,C1QB C1orf52 CELA3A GJB4,gap junction-mediated intercellular transport|intercellular transport|olfactory behavior|synapse pruning|cell junction disassembly,0.001359|0.001553|0.001941|0.002328|0.002522,1|1|1|1|1,858.1|735.5|572.1|468.1|429.1
536,4,0.6247,3.748,3339.0,0.001119,0.9929309999999999,C1orf87 MYF5 PAX7 SEMA4C,muscle structure development|muscle cell differentiation|muscle organ development|positive regulation of skeletal muscle fiber development|regulation of skeletal muscle fiber development,4.438e-05|0.000779|0.0011|0.001941|0.002716,0.7|1|1|1|1,33.58|43.82|36.78|572.1|396.1
537,13,0.612,47.74,10670.0,0.004444,0.999993,CNBD2 CPNE1 FAM209A FAM209B FAM83C GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 WFDC11 WISP2,"positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding|regulation of circadian sleep/wake cycle, REM sleep",0.001261|0.001891|0.002521|0.00315|0.00315,1|1|1|1|1,1584|792.1|528.1|396.1|396.1
538,14,0.5759,52.41,11310.0,0.0046,0.9999969999999999,AVP C20orf202 HSPA12B LZTS3 OXT PLCB4 PRND RSPO4 SIRPA SIRPB1 SIRPG SPEF1 TGM3 ZNF343,maternal aggressive behavior|positive regulation of phagocytosis|aggressive behavior|female mating behavior|hyperosmotic salinity response,4.28e-06|1.165e-05|1.539e-05|1.922e-05|1.922e-05,0.06752|0.0919|0.08089|0.07581|0.06065,980.7|68.96|420.3|367.8|367.8
539,4,0.6138,3.6830000000000003,3404.0,0.001078,0.9929309999999999,ANKRD55 C20orf85 DDX4 SPATA18,mitophagy by induced vacuole formation|piRNA biosynthetic process|mitochondrial protein catabolic process|piRNA metabolic process|DNA methylation involved in gamete generation,0.0003883|0.001165|0.001165|0.003685|0.004072,1|1|1|1|1,5149|1030|1030|286|257.4
540,10,0.6235,28.06,6836.0,0.004076,0.999933,C21orf2 CCP110 CEP44 CEP97 CFAP97 CNTROB KATNB1 KIF2A NEK1 PCM1,organelle assembly|microtubule cytoskeleton organization|centrosome cycle|microtubule organizing center organization|centriole replication,3.925e-09|3.49e-08|4.61e-08|7.569e-08|1.491e-07,6.192e-05|0.0002752|0.0002424|0.0002985|0.0004703,20.51|24.26|104|91.53|298.5
541,4,0.6193,3.716,3280.0,0.001129,0.9929309999999999,AVP C21orf58 ITPRIP TMEM74B,negative regulation of apoptotic signaling pathway|maternal aggressive behavior|penile erection|negative regulation of female receptivity|positive regulation of cellular pH reduction,0.0007275|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,45.36|1716|1716|1287|1030
542,6,0.6461,9.692,4828.0,0.001998,0.998474,C22orf46 CSDC2 MEI1 PNPLA5 SEPT3 SULT4A1,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|triglyceride catabolic process|acylglycerol catabolic process,0.00726|0.00755|0.00755|0.008128|0.01102,1|1|1|1|1,143|137.3|137.3|127.1|92.77
543,5,0.6515,6.515,3654.0,0.001775,0.996692,C2CD5 CDK5 FIBP PTP4A1 TMEM94,positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|regulation of protein targeting|positive regulation of protein localization to membrane|positive regulation of glial cell apoptotic process,2.481e-05|3.48e-05|0.0001669|0.0004024|0.000728,0.3914|0.2745|0.8776|1|1,265.7|222.6|99.25|63.37|2060
544,4,0.6142,3.685,3300.0,0.001113,0.9929309999999999,ACOX2 C1QL2 C2orf16 HEPACAM,positive regulation of response to oxidative stress|fatty acid beta-oxidation using acyl-CoA oxidase|bile acid biosynthetic process|very long-chain fatty acid metabolic process|bile acid metabolic process,0.001553|0.003104|0.005813|0.006973|0.008131,1|1|1|1|1,735.5|343.2|177.5|147.1|125.6
545,8,0.6003,16.81,5239.0,0.003188,0.9996790000000001,ADAT2 DOLK FAM98B PYROXD1 RTCB RTRAF TRMT6 TRMT61A,"tRNA processing|tRNA metabolic process|ncRNA processing|ncRNA metabolic process|tRNA splicing, via endonucleolytic cleavage and ligation",2.241e-12|1.423e-11|2.41e-09|6.975e-09|3.127e-08,3.536e-08|1.122e-07|1.267e-05|2.75e-05|9.865e-05,117|85.34|35.76|29.88|514.9
546,5,0.6051,6.051,4110.0,0.001466,0.996692,C2orf68 SFTPB THNSL2 TRABD2A WBP1,2-oxobutyrate biosynthetic process|positive regulation of protein oxidation|regulation of protein oxidation|2-oxobutyrate metabolic process|short-chain fatty acid biosynthetic process,0.0004854|0.000728|0.000728|0.000728|0.001213,1|1|1|1|1,4119|2060|2060|2060|1030
547,5,0.6208,6.207999999999999,3473.0,0.001779,0.996692,C2orf69 EIF2AK4 GLUL QARS SLC1A5,cellular amino acid metabolic process|tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|L-glutamine import across plasma membrane,4.923e-05|7.927e-05|8.956e-05|9.313e-05|0.0005824,0.7766|0.6252|0.4709|0.3673|1,36.91|149.2|140.1|137.3|3432
548,4,0.604,3.6239999999999997,3131.0,0.001153,0.9929309999999999,C2orf78 GNAT1 HYAL1 ZNF502,cellular response to light stimulus|cellular response to radiation|positive regulation of hyaluranon cable assembly|regulation of hyaluranon cable assembly|positive regulation by host of viral release from host cell,0.0002004|0.0004454|0.0007766|0.0007766|0.001165,1|1|1|1|1,87.27|58.18|1716|1716|1030
549,6,0.6632,9.947000000000001,3972.0,0.002491,0.998474,DDX47 GAPDH NOP2 PHB2 USP5 WBP11,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,3.999e-05|4.47e-05|8.219e-05|0.0001783|0.0002214,0.6308|0.3525|0.4322|0.7033|0.6984,39.61|38.14|31.02|23.84|22.15
550,4,0.6513,3.908,3482.0,0.001118,0.9929309999999999,ATP2B2 C2orf91 CNPY1 GRIK1,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,7.749e-05|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,147.1|4119|4119|4119|4119
551,4,0.6148,3.6889999999999996,3255.0,0.001129,0.9929309999999999,ABHD16B AHSA1 C3orf30 LCN15,phosphatidylserine catabolic process|monoacylglycerol catabolic process|macromolecule depalmitoylation|monoacylglycerol metabolic process|glycerophospholipid catabolic process,0.0009706|0.001553|0.00291|0.00291|0.005813,1|1|1|1|1,1287|735.5|367.8|367.8|177.5
552,4,0.6022,3.613,3301.0,0.001091,0.9929309999999999,C3orf33 COL6A6 NOL3 SVBP,response to injury involved in regulation of muscle adaptation|inhibition of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of muscle atrophy|negative regulation of mitochondrial membrane permeability involved in apoptotic process|regulation of muscle atrophy,0.0003883|0.0005825|0.0005825|0.0009706|0.0009706,1|1|1|1|1,5149|2574|2574|1287|1287
553,16,0.6029,72.35,12190.0,0.005884,0.999999,COL6A2 KRTAP10-11 KRTAP10-3 KRTAP10-5 KRTAP10-8 KRTAP10-9 KRTAP12-1 KRTAP12-3 KRTAP12-4 KRTAP13-1 KRTAP13-2 KRTAP19-1 KRTAP19-3 KRTAP19-6 KRTAP19-7 KRTAP19-8,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,1.065e-28|1.266e-27|1.4e-26|2.341e-25|8.166e-25,1.68e-24|9.983e-24|7.362e-23|9.233e-22|2.576e-21,85.43|72.04|61.1|50.41|46.3
554,4,0.6413,3.8480000000000003,3397.0,0.001129,0.9929309999999999,C3orf80 DGLUCY GHSR PRR23C,negative regulation of locomotion involved in locomotory behavior|positive regulation of small intestinal transit|regulation of small intestinal transit|ghrelin secretion|regulation of hindgut contraction,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
555,5,0.6054,6.053999999999999,4113.0,0.001466,0.996692,C4orf3 HERC3 MYOZ2 UGT2B4 USP53,skeletal muscle fiber adaptation|skeletal muscle adaptation|negative regulation of calcineurin-NFAT signaling cascade|negative regulation of calcineurin-mediated signaling|cellular glucuronidation,0.001213|0.003394|0.003878|0.003878|0.004845,1|1|1|1|1,1030|316.8|274.6|274.6|216.8
556,5,0.6051,6.051,3767.0,0.001599,0.996692,C4orf46 CNN2 DUX4 TBC1D3B UQCRH,"mitochondrial electron transport, ubiquinol to cytochrome c|negative regulation of phagocytosis|negative regulation of G0 to G1 transition|regulation of G0 to G1 transition|interleukin-12-mediated signaling pathway",0.003636|0.005812|0.009672|0.01088|0.01136,1|1|1|1|1,294.2|179.1|105.6|93.61|89.54
557,4,0.6405,3.843,3235.0,0.001184,0.9929309999999999,C5 GNLY STON1 TLX2,"negative regulation of macrophage chemotaxis|negative regulation of macrophage migration|negative regulation of dendrite morphogenesis|humoral immune response|complement activation, alternative pathway",0.001359|0.001941|0.001941|0.002071|0.003104,1|1|1|1|1,858.1|572.1|572.1|26.68|343.2
558,4,0.638,3.8280000000000003,3490.0,0.001093,0.9929309999999999,C5orf30 DGAT2 KIAA1217 PROKR1,cellular response to oleic acid|fat pad development|response to oleic acid|monoacylglycerol biosynthetic process|cellular triglyceride homeostasis,0.0007766|0.001165|0.001359|0.001553|0.001553,1|1|1|1|1,1716|1030|858.1|735.5|735.5
559,12,0.5408,35.7,8085.0,0.004382,0.999986,FLII GNA13 LRRFIP2 LUZP1 MYH9 MYL12A MYL12B MYL6 ROCK1 ROCK2 SIAH1 TMOD3,muscle contraction|actomyosin structure organization|muscle system process|actin filament-based process|regulation of angiotensin-activated signaling pathway,2.548e-09|2.903e-09|7.032e-09|4.917e-07|1.864e-06,4.02e-05|2.289e-05|3.698e-05|0.001939|0.00588,42.38|82.51|35.63|17.22|1716
560,8,0.6113,17.12,6362.0,0.002676,0.9996790000000001,ADAMTS12 C1QTNF3 C5orf51 CDH6 FBXO4 PLCXD3 UGT3A1 UGT3A2,negative regulation of cellular response to hepatocyte growth factor stimulus|negative regulation of hepatocyte growth factor receptor signaling pathway|cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
561,4,0.608,3.648,3376.0,0.001077,0.9929309999999999,C5orf52 DCDC1 FZD3 OR10G7,positive regulation of neural precursor cell proliferation|neural precursor cell proliferation|canonical Wnt signaling pathway|regulation of neural precursor cell proliferation|non-canonical Wnt signaling pathway,6.711e-05|0.0001131|0.0001709|0.000183|0.0004334,1|0.8918|0.8984|0.7217|1,158.4|121.1|98.07|94.69|61.02
562,7,0.6122,12.86,5444.0,0.00235,0.9992989999999999,ATAT1 C6orf106 C6orf48 CLIC1 EGFL8 MSH5 TNXB,alpha-tubulin acetylation|meiotic mismatch repair|positive regulation of NLRP3 inflammasome complex assembly|elastic fiber assembly|dentate gyrus development,0.000728|0.001456|0.002425|0.00291|0.003636,1|1|1|1|1,2060|823.8|457.7|374.5|294.2
563,4,0.631,3.786,3240.0,0.001164,0.9929309999999999,C6orf201 CLEC2A FAM217A RAB3B,positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission|positive regulation of neurotransmitter uptake|regulation of catecholamine uptake involved in synaptic transmission|regulation of dopamine uptake involved in synaptic transmission,0.0007766|0.0007766|0.001165|0.001747|0.001747,1|1|1|1|1,1716|1716|1030|643.6|643.6
564,8,0.6087,17.04,6292.0,0.002695,0.9996790000000001,C6orf203 ENPP1 ENPP3 TAAR2 TAAR6 TAAR8 ULBP3 VNN2,nucleoside triphosphate catabolic process|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|negative regulation of hh target transcription factor activity,1.579e-05|0.0004635|0.0004635|0.0005545|0.0007765,0.2491|1|1|1|1,367.8|62.03|62.03|56.58|2574
565,7,0.6014,12.63,5443.0,0.002309,0.9992989999999999,C6orf222 C6orf48 HLA-DMB MSH5 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,2.731e-08|3.689e-08|8.743e-08|2.775e-07|4.895e-07,0.0004308|0.0002909|0.0004597|0.001094|0.001544,519.2|464.5|339.5|60.98|52.77
566,4,0.6355,3.813,3148.0,0.001207,0.9929309999999999,ARL6IP1 C6orf47 RETREG3 SCGB3A2,positive regulation of L-glutamate import across plasma membrane|endoplasmic reticulum tubular network formation|endoplasmic reticulum tubular network membrane organization|regulation of L-glutamate import across plasma membrane|regulation of endoplasmic reticulum tubular network organization,0.0007766|0.0009706|0.0009706|0.001359|0.001359,1|1|1|1|1,1716|1287|1287|858.1|858.1
567,5,0.6125,6.125,4008.0,0.0015220000000000001,0.996692,ATG2B C7orf25 GTPBP1 GTPBP2 WDR12,translational elongation|late nucleophagy|lysosomal microautophagy|piecemeal microautophagy of the nucleus|reticulophagy,0.0003725|0.001456|0.001456|0.001456|0.003152,1|1|1|1|1,65.9|823.8|823.8|823.8|343.3
568,6,0.6378,9.568,3580.0,0.002656,0.998474,C7orf26 INTS10 INTS13 INTS14 INTS5 SNRPB2,snRNA transcription by RNA polymerase II|snRNA transcription|ncRNA transcription|snRNA processing|snRNA metabolic process,2.288e-09|2.417e-09|7.169e-09|1.25e-07|2.677e-07,3.609e-05|1.906e-05|3.77e-05|0.0004928|0.0008445,196.1|193.4|146.1|286|219.1
569,7,0.6441,13.53,5113.0,0.0026309999999999997,0.9992989999999999,C7orf50 CNIH4 FOXD4 GJA3 NBEAL1 POGZ TSPYL5,gap junction-mediated intercellular transport|intercellular transport|protein-DNA complex assembly|protein-DNA complex subunit organization|kinetochore assembly,0.002376|0.002715|0.0031|0.004119|0.005086,1|1|1|1|1,490.4|420.3|23.17|20.01|210.2
570,10,0.6051,27.23,7564.0,0.003578,0.999933,ACR ANHX C8orf33 CHAMP1 MZF1 PARD6G PGBD2 RABL2B SLC27A5 ZNF672,acrosome matrix dispersal|sister chromatid biorientation|triglyceride mobilization|long-chain fatty acid import across plasma membrane|penetration of zona pellucida,0.0009704|0.00194|0.002424|0.002424|0.004844,1|1|1|1|1,2060|686.5|514.9|514.9|228.8
571,7,0.6004,12.61,5933.0,0.002116,0.9992989999999999,C8orf44 CNGB3 DSTN MTFR1 SGK3 TRIM55 UBE2W,actin filament fragmentation|diapedesis|actin filament depolymerization|positive regulation of actin filament depolymerization|actin filament severing,0.001698|0.002715|0.004409|0.004748|0.005425,1|1|1|1|1,735.5|420.3|245.2|226.3|196.1
572,5,0.6012,6.0120000000000005,4271.0,0.001403,0.996692,C8orf48 DCUN1D2 F10 F7 ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",1.06e-06|1.06e-06|1.06e-06|4.66e-06|5.506e-06,0.01672|0.008359|0.005573|0.01838|0.01737,1716|1716|1716|686.5|624.1
573,4,0.667,4.002,2808.0,0.001419,0.9929309999999999,C8orf59 FAM207A NUP50 ZNF277,ribosome biogenesis|ribonucleoprotein complex biogenesis|regulation of cellular response to stress|tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus,0.001539|0.002986|0.006373|0.00678|0.00678,1|1|1|1|1,31.02|22.15|15.03|151.4|151.4
574,4,0.6236,3.742,3118.0,0.001196,0.9929309999999999,C9 IPP ISOC1 PLLP,"complement activation, alternative pathway|inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation|polyol catabolic process",0.003878|0.004362|0.004845|0.004845|0.00702,1|1|1|1|1,274.6|242.3|216.8|216.8|147.1
575,4,0.6036,3.622,3414.0,0.001057,0.9929309999999999,C9orf135 CXCL8 ENTPD6 SPINT3,negative regulation of cell adhesion molecule production|regulation of entry of bacterium into host cell|regulation of cell adhesion molecule production|nucleoside diphosphate catabolic process|PERK-mediated unfolded protein response,0.001165|0.001553|0.002134|0.002522|0.002716,1|1|1|1|1,1030|735.5|514.9|429.1|396.1
576,4,0.6103,3.662,3481.0,0.001048,0.9929309999999999,C9orf50 DOK2 SMIM18 TEX15,negative regulation of transposition|regulation of transposition|male meiotic nuclear division|regulation of double-strand break repair via homologous recombination|homologous chromosome pairing at meiosis,0.005233|0.005233|0.009096|0.009289|0.01006,1|1|1|1|1,198|198|111.9|109.5|101
577,7,0.6051,12.71,5464.0,0.002314,0.9992989999999999,C9orf3 C9orf84 FBP1 FBP2 GOLGA2 PALM2 TXNDC8,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",5.936e-07|9.891e-07|2.076e-06|5.435e-06|7.705e-06,0.009363|0.007801|0.01092|0.02143|0.02431,2942|1961|1177|653.8|534.9
578,9,0.6042,21.75,7570.0,0.002858,0.9998530000000001,CA1 CA13 CA2 CA3 CNGB3 CYP7A1 FABP4 MCMDC2 PMP2,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|organic substance transport,2.056e-09|2.717e-09|1.525e-07|2.93e-05|8.726e-05,3.243e-05|2.143e-05|0.0008018|0.1155|0.2753,234.7|217.9|33.65|5.56|6.327
579,10,0.6185,27.83,8227.0,0.003363,0.999933,C5AR1 C5AR2 CA11 CRX EML2 FLT3LG FUT1 FUT2 SULT2A1 SULT2B1,complement component C5a signaling pathway|regulation of cell population proliferation|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,1.554e-06|5.094e-06|1.421e-05|1.421e-05|1.421e-05,0.02451|0.04018|0.07473|0.05604|0.04484,1872|7.991|416.1|416.1|416.1
580,9,0.6082,21.89,7409.0,0.002939,0.9998530000000001,CA8 CEBPD CYP7A1 MOS NPBWR1 NSMAF PPDPFL SGK3 SPIDR,positive regulation of lipid biosynthetic process|cellular response to alcohol|cellular response to stimulus|establishment of meiotic spindle orientation|signal transduction,0.0006224|0.0006367|0.0008713|0.0008734|0.001329,1|1|1|1|1,53.84|53.22|2.704|2288|3.118
581,8,0.6109,17.1,5681.0,0.002993,0.9996790000000001,ALG9 DPM1 DPM3 GANAB MOGS PRKCSH SLC35B4 UGGT1,glycoprotein metabolic process|protein N-linked glycosylation|carbohydrate derivative metabolic process|protein glycosylation|macromolecule glycosylation,5.313e-12|4.314e-11|5.215e-09|1.293e-08|1.293e-08,8.381e-08|3.403e-07|2.742e-05|5.1e-05|4.08e-05,48.44|171.6|17.91|53.19|53.19
582,4,0.6004,3.602,3439.0,0.001044,0.9929309999999999,CABP1 PRPH2 PTCH1 ZNF512,response to chlorate|neural plate axis specification|visual perception|sensory perception of light stimulus|epidermal cell fate specification,0.0005825|0.0005825|0.0006596|0.0006839|0.0007766,1|1|1|1|1,2574|2574|47.67|46.81|1716
583,10,0.6028,27.12,7511.0,0.003589,0.999933,BBS1 CABP2 CABP4 FOLR2 KRTAP5-9 MRGPRD MRGPRF P2RY6 POLD4 TBX10,visual perception|sensory perception of light stimulus|cellular response to pyrimidine ribonucleotide|response to pyrimidine ribonucleotide|cellular response to folic acid,0.0001835|0.0001935|0.001067|0.001067|0.001601,1|1|1|1|1,26|25.53|1872|1872|936.1
584,4,0.6726,4.035,3367.0,0.001194,0.9929309999999999,ARRDC1 CACFD1 PGK2 UCK1,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|ribonucleotide metabolic process,0.0007766|0.001165|0.001165|0.001165|0.001539,1|1|1|1|1,1716|1030|1030|1030|31.02
585,4,0.6005,3.603,3330.0,0.001078,0.9929309999999999,ACO1 CACNA1G HUS1B KRT32,response to nickel cation|meiotic DNA integrity checkpoint|response to iron(II) ion|citrate metabolic process|membrane depolarization during SA node cell action potential,0.0003883|0.0005825|0.001165|0.001165|0.001165,1|1|1|1|1,5149|2574|1030|1030|1030
586,11,0.6218,34.2,8856.0,0.0038380000000000003,0.999969,CACNG1 CACNG4 CACNG5 EPX LPO MKS1 MPO NME1 OR4D1 OR4D2 SEPT4,"hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|neurotransmitter receptor transport, postsynaptic endosome to lysosome|neurotransmitter receptor diffusion trapping|postsynaptic neurotransmitter receptor diffusion trapping",5.566e-07|1.481e-06|9.308e-06|1.421e-05|1.421e-05,0.00878|0.01168|0.04894|0.05604|0.04484,193.7|137|534.9|416.1|416.1
587,4,0.6736,4.041,3324.0,0.0012109999999999998,0.9929309999999999,CACNG6 FPR2 OTP PKDREJ,calcium ion transmembrane transport|calcium ion transport|metal ion transport|inorganic cation transmembrane transport|cardiac conduction,7.986e-06|1.673e-05|3.871e-05|0.0002075|0.0002174,0.126|0.132|0.2035|0.8181|0.6859,65.04|50.64|38.14|21.6|86.72
588,10,0.6462,29.08,6874.0,0.0042,0.999933,ATP5F1C CDC123 GTPBP4 KIN MCM10 PDSS1 PRPF18 RBM17 RPP38 UPF2,nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|organic cyclic compound metabolic process|nucleic acid metabolic process,3.271e-06|5.435e-06|6.102e-06|1.119e-05|1.58e-05,0.0516|0.04286|0.03208|0.04412|0.04983,6.06|5.674|5.589|5.165|6.459
589,4,0.6017,3.61,3381.0,0.001064,0.9929309999999999,ACSF2 CACUL1 FMNL1 SOST,cellular response to parathyroid hormone stimulus|response to parathyroid hormone|actin filament severing|cortical actin cytoskeleton organization|negative regulation of ossification,0.001941|0.002716|0.003104|0.007552|0.007552,1|1|1|1|1,572.1|396.1|343.2|135.5|135.5
590,7,0.6091,12.79,5739.0,0.002219,0.9992989999999999,BSND C1orf123 CADM4 CYP4X1 FAAH PCSK9 RAB3B,acylglycerol metabolic process|neutral lipid metabolic process|negative regulation of low-density lipoprotein particle receptor binding|sebaceous gland cell differentiation|glucosylceramide biosynthetic process,0.0005517|0.000562|0.0006794|0.001019|0.001019,1|1|1|1|1,56.04|55.51|2942|1471|1471
591,12,0.6082,40.14,9108.0,0.004376,0.999986,ANO1 CCDC36 CTTN FGF19 FGF4 FOLR2 GSTP1 MRGPRD MRGPRF MYEOV P2RY6 POLD4,cellular response to endogenous stimulus|regulation of ERK1 and ERK2 cascade|response to endogenous stimulus|positive regulation of ERK1 and ERK2 cascade|cellular response to organonitrogen compound,1.092e-05|1.255e-05|3.65e-05|0.0001576|0.0001932,0.1722|0.09897|0.1919|0.6214|0.6095,9.802|25.74|7.933|27.4|12.67
592,19,0.6037,103.2,14610.0,0.006998999999999999,1.0,AGR3 CALM1 EGR3 FKBP9 GHRHR LANCL2 NIPSNAP2 NUPR2 PHKG1 POM121L12 PSPH RNASET2 SEPT14 SLC29A4 SUMF2 VWC2 ZNF479 ZNF713 ZNF716,negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of calcium ion transmembrane transporter activity|negative regulation of release of sequestered calcium ion into cytosol|regulation of high voltage-gated calcium channel activity|positive regulation of sequestering of calcium ion,6.93e-05|8.693e-05|9.318e-05|0.0001064|0.0001206,1|0.6856|0.49|0.4197|0.3803,187.2|35.51|158.4|147.1|137.3
593,5,0.6244,6.244,3270.0,0.0019,0.996692,ASPM CALM2 DYNLRB1 NDE1 PAFAH1B1,spindle localization|G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition|regulation of microtubule motor activity|transport along microtubule,2.11e-07|3.242e-06|3.381e-06|3.672e-06|4.461e-06,0.003328|0.02557|0.01778|0.01448|0.01407,224.7|88.26|87.02|748.9|79.21
594,6,0.6467,9.7,4920.0,0.001963,0.998474,CALML4 GOLGA6B PLEKHO2 SCAMP2 SCAMP5 SLC24A1,macrophage apoptotic process|myeloid cell apoptotic process|inflammatory cell apoptotic process|response to light intensity|calcium ion import across plasma membrane,0.001165|0.002037|0.002328|0.00349|0.004942,1|1|1|1|1,1144|572.1|490.4|312|214.5
595,12,0.6076,40.1,9510.0,0.004188,0.999986,CCM2L CPNE1 DEFB115 DEFB116 DUSP15 FOXS1 HCK MYH7B MYLK2 NOL4L TM9SF4 XKR7,phagocytosis|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding|skeletal muscle satellite cell differentiation,0.0007972|0.001746|0.002327|0.002909|0.002909,1|1|1|1|1,15.79|858.1|572.1|429.1|429.1
596,8,0.6083,17.03,5873.0,0.002884,0.9996790000000001,CALU EDEM3 SAR1A SEC23IP SLC39A9 SURF4 TM9SF3 TMED7,"Golgi vesicle transport|Golgi organization|endoplasmic reticulum to Golgi vesicle-mediated transport|COPII-coated vesicle budding|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",9.211e-06|1.607e-05|4.796e-05|0.0003327|0.0004855,0.1453|0.1267|0.2522|1|1,26|57.21|39.4|73.55|60.57
597,5,0.6014,6.013999999999999,4202.0,0.001426,0.996692,ABCA9 CALY OR10Z1 PEBP4 TSN,positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|postsynaptic endocytosis,0.0004854|0.0004854|0.000728|0.000728|0.002425,1|1|1|1|1,4119|4119|2060|2060|457.7
598,4,0.6538,3.923,3422.0,0.001142,0.9929309999999999,ATP2B2 CAMK1G CCR2 TOPAZ1,regulation of cytosolic calcium ion concentration|regulation of cardiac conduction|cellular calcium ion homeostasis|calcium ion homeostasis|cellular divalent inorganic cation homeostasis,3.801e-05|7.749e-05|8.754e-05|9.565e-05|0.0001105,0.5995|0.6111|0.4603|0.3772|0.3485,38.38|147.1|28.94|28.08|26.75
599,4,0.621,3.7260000000000004,3390.0,0.0010949999999999998,0.9929309999999999,CAMK2B FAM114A2 MEGF9 TSPAN19,regulation of synapse structural plasticity|positive regulation of synapse maturation|regulation of skeletal muscle adaptation|regulation of synapse maturation|positive regulation of dendritic spine morphogenesis,0.001941|0.001941|0.002716|0.00291|0.003878,1|1|1|1|1,572.1|572.1|396.1|367.8|271
600,4,0.6261,3.7569999999999997,3431.0,0.001091,0.9929309999999999,CAMK2G FHOD3 MCCC2 PRR14,cortical actin cytoskeleton organization|cortical cytoskeleton organization|leucine catabolic process|leucine metabolic process|biotin metabolic process,3.663e-05|8.295e-05|0.001698|0.002183|0.002425,0.5778|0.6543|1|1|1,216.8|142|686.5|514.9|457.7
601,4,0.7006,4.203,3366.0,0.0012439999999999999,0.9929309999999999,CAMKK1 LDB2 MDGA1 NEBL,cardiac muscle thin filament assembly|regulation of synaptic membrane adhesion|spinal cord association neuron differentiation|cardiac myofibril assembly|dorsal spinal cord development,0.0007766|0.0009706|0.002522|0.003297|0.004072,1|1|1|1|1,1716|1287|429.1|321.8|257.4
602,13,0.613,47.81,8864.0,0.0053490000000000005,0.999993,CCDC12 CCDC130 CLASRP CRIPT CWF19L1 CWF19L2 DHX35 ESS2 FRA10AC1 GPATCH1 LENG1 PPIE WDR83,"RNA splicing|mRNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",3.401e-13|1.156e-10|2.53e-10|2.53e-10|2.706e-10,5.364e-09|9.117e-07|1.33e-06|9.976e-07|8.538e-07,35.03|26.19|36.72|36.72|36.36
603,12,0.631,41.64,9426.0,0.004388,0.999986,ACTR3B GIMAP2 GIMAP4 GIMAP6 OR9A2 PDIA4 ZNF212 ZNF282 ZNF398 ZNF425 ZNF783 ZNF786,"cellular process|regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",3.515e-05|0.001847|0.008326|0.008338|0.008398,0.5545|1|1|1|1,0.2216|3.982|2.973|2.972|2.968
604,4,0.6019,3.611,3363.0,0.00107,0.9929309999999999,CAP2 CATSPER3 NKIRAS2 SRRM5,epithelial cell-cell adhesion|sperm capacitation|cAMP-mediated signaling|regulation of adenylate cyclase activity|activation of adenylate cyclase activity,0.004604|0.006537|0.007744|0.008226|0.01015,1|1|1|1|1,228.8|158.4|132.9|124.8|100.5
605,4,0.6734,4.04,3320.0,0.001213,0.9929309999999999,CAPG GNLY STON1 TLX2,negative regulation of dendrite morphogenesis|enteric nervous system development|actin filament severing|barbed-end actin filament capping|mitotic chromosome condensation,0.002425|0.003878|0.003878|0.005571|0.00702,1|1|1|1|1,457.7|274.6|274.6|187.2|147.1
606,14,0.6075,55.29,10650.0,0.005149,0.9999969999999999,AQP5 DNAJC14 INHBE KRT1 KRT82 KRT84 KRT85 KRT86 OR10AD1 OR10P1 OR8S1 PPP1R1A RDH5 SLC38A4,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.085e-08|3.124e-07|7.139e-07|1.585e-06|4.012e-06,0.0001712|0.002464|0.003754|0.006252|0.01266,65.09|32.55|27.45|23.28|19.2
607,6,0.6078,9.117,4826.0,0.0018809999999999999,0.998474,ABCG5 CAPN13 FSHR OXER1 SIX3 STON1,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|regulation of acetylcholine metabolic process|neuroblast migration|negative regulation of intestinal cholesterol absorption|primary ovarian follicle growth,0.0002556|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,81.73|3432|3432|1716|1716
608,5,0.6018,6.018,3517.0,0.001703,0.996692,CAPN15 GATA6 HNF4A TCF7L2 UBE2Z,pancreas development|type B pancreatic cell differentiation|enteroendocrine cell differentiation|endocrine pancreas development|glandular epithelial cell differentiation,4.427e-07|1.19e-05|1.411e-05|4.441e-05|4.857e-05,0.006983|0.09386|0.07418|0.1751|0.1532,174|392.3|358.2|196.1|187.2
609,4,0.674,4.044,3409.0,0.001182,0.9929309999999999,CAPN7 CPA1 FMC1 STRA8,activation of meiosis|germline stem cell asymmetric division|asymmetric stem cell division|male germ-line stem cell asymmetric division|germ-line stem cell division,0.0009706|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1287|1287|1287|1287|1287
610,5,0.6412,6.412000000000001,3201.0,0.001993,0.996692,ANKRD17 CAPRIN1 G3BP1 SERBP1 USP10,positive regulation of stress granule assembly|positive regulation of MDA-5 signaling pathway|type I interferon production|regulation of stress granule assembly|regulation of I-kappaB kinase/NF-kappaB signaling,0.0008735|0.001456|0.001746|0.001746|0.002047,1|1|1|1|1,1716|858.1|686.5|686.5|28.25
611,5,0.6804,6.803999999999999,3006.0,0.002251,0.996692,CAP1 CAPZB CFL1 CORO1C WDR1,actin cytoskeleton organization|actin filament-based process|actin polymerization or depolymerization|actin filament organization|actin filament fragmentation,2.205e-07|4.227e-07|9.455e-07|1.038e-06|1.483e-06,0.003477|0.003333|0.004971|0.004094|0.00468,28.07|24.6|147.1|43.59|1471
612,8,0.608,17.02,5522.0,0.003065,0.9996790000000001,BCL10 CARD10 CYLD IKBKB MALT1 N4BP1 TNIP1 TRAF2,regulation of I-kappaB kinase/NF-kappaB signaling|pattern recognition receptor signaling pathway|regulation of protein modification process|I-kappaB kinase/NF-kappaB signaling|regulation of protein modification by small protein conjugation or removal,2.39e-10|1.234e-09|1.333e-08|1.905e-08|2.766e-08,3.771e-06|9.736e-06|7.01e-05|7.513e-05|8.727e-05,56.5|90.09|11.21|130.8|47.67
613,22,0.6021,139.1,17080.0,0.008055,1.0,ARPC1B C7orf43 CASTOR3 CYP3A4 CYP3A43 CYP3A5 CYP3A7 DLX6 FBXO24 GJC3 MOGAT3 MUC12 PILRA PILRB PVRIG SLC26A5 TECPR1 WNT2 ZKSCAN1 ZNF394 ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|retinoic acid metabolic process|estrogen metabolic process,6.955e-09|1.088e-07|6.982e-07|6.364e-06|9.471e-06,0.0001097|0.0008581|0.003671|0.0251|0.02988,206.5|420.3|59.44|89.16|77.42
614,7,0.6225,13.07,4842.0,0.0026850000000000003,0.9992989999999999,CARS GGPS1 GUK1 NEDD8 RABGGTA RABGGTB YARS,protein geranylgeranylation|protein prenylation|prenylation|tRNA aminoacylation for protein translation|tRNA aminoacylation,2.768e-06|6.521e-06|6.521e-06|0.0001108|0.0001252,0.04366|0.05143|0.03429|0.4369|0.3949,980.7|588.4|588.4|127.9|120.1
615,4,0.6838,4.103,2711.0,0.001507,0.9929309999999999,CASC1 KRAS LRMP SOX5,endocrine signaling|forebrain astrocyte development|forebrain astrocyte differentiation|positive regulation of mesenchymal stem cell differentiation|regulation of mesenchymal stem cell differentiation,0.0003883|0.0005825|0.0005825|0.0009706|0.001359,1|1|1|1|1,5149|2574|2574|1287|858.1
616,10,0.6131,27.59,6804.0,0.004027,0.999933,AATF CASC3 CDC6 DHX8 PSMB3 PSMD11 PSMD3 RPL19 RPL23 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|negative regulation of cell cycle process|DNA-dependent DNA replication|pre-replicative complex assembly,6.653e-10|1.119e-09|3.905e-09|1.936e-08|2.381e-08,1.049e-05|8.823e-06|2.053e-05|7.635e-05|7.513e-05,106.2|95.35|36.89|53.08|126.7
617,5,0.6002,6.002000000000001,4261.0,0.001403,0.996692,CASC4 CDC42EP5 GNB5 PPIB SNX22,protein folding|positive regulation by host of viral genome replication|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|positive regulation by host of viral process,0.001214|0.002183|0.003394|0.003636|0.003878,1|1|1|1|1,36.13|514.9|316.8|294.2|274.6
618,13,0.5605,43.72,10110.0,0.004296,0.999993,BICDL2 CASKIN1 CLDN6 CLDN9 CLUAP1 CORO7 HCFC1R1 KREMEN2 MMP25 OR1F1 PAQR4 TNFRSF12A ZNF500,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|collagen catabolic process|bicellular tight junction assembly|tight junction assembly|collagen metabolic process,0.0001075|0.0004172|0.0007416|0.0007917|0.0008173,1|1|1|1|1,140.1|68.42|50.73|49.04|48.23
619,4,0.6731,4.039,2968.0,0.001356,0.9929309999999999,CASKIN2 DYNC1LI2 NDE1 PAFAH1B2,centrosome localization|microtubule organizing center localization|anaphase|mitotic anaphase|M phase,1.49e-05|1.583e-05|0.0003516|0.0003516|0.000365,0.2351|0.1249|1|1|1,332.2|321.8|65.59|65.59|64.36
620,6,0.6096,9.144,4690.0,0.001941,0.998474,C11orf53 CASP1 CASP4 CRYAB KDELC2 TMEM136,positive regulation of tumor necrosis factor-mediated signaling pathway|pyroptosis|protein autoprocessing|positive regulation of cytokine-mediated signaling pathway|positive regulation of response to cytokine stimulus,3.672e-06|8.939e-06|1.528e-05|5.981e-05|7.749e-05,0.05793|0.07051|0.08035|0.2359|0.2445,748.9|457.7|343.3|168.1|147.1
621,4,0.6393,3.8360000000000003,2817.0,0.001356,0.9929309999999999,ABL1 CASP9 PTPN1 WT1,platelet-derived growth factor receptor-beta signaling pathway|cellular response to oxygen-containing compound|cellular response to endogenous stimulus|platelet-derived growth factor receptor signaling pathway|response to endogenous stimulus,1.272e-06|7.027e-06|9.666e-06|1.879e-05|2.249e-05,0.02007|0.05542|0.05083|0.07411|0.07096,1287|19.47|17.97|294.2|14.54
622,4,0.6369,3.821,3108.0,0.001225,0.9929309999999999,CASTOR1 CEBPB PABPC1L PCIF1,cellular response to amino acid stimulus|cellular response to acid chemical|cellular response to amino acid starvation|response to amino acid starvation|response to amino acid,6.415e-05|7.811e-05|9.344e-05|0.0001004|0.0001777,1|0.6161|0.4913|0.396|0.5606,156|141.1|128.7|124.1|92.77
623,7,0.605,12.71,4661.0,0.002711,0.9992989999999999,LDLR LDLRAP1 MYLIP NR1H2 SCD SREBF1 TMEM41A,regulation of cholesterol metabolic process|cholesterol homeostasis|sterol homeostasis|positive regulation of triglyceride biosynthetic process|regulation of triglyceride biosynthetic process,2.584e-09|1.028e-08|1.077e-08|1.343e-08|3.186e-08,4.076e-05|8.109e-05|5.663e-05|5.294e-05|0.0001005,202.9|141.8|140.1|679|490.4
624,4,0.621,3.7260000000000004,3594.0,0.001033,0.9929309999999999,CATSPER4 FAM76A IFI6 UBXN1,negative regulation of protein K48-linked deubiquitination|negative regulation of ubiquitin-specific protease activity|regulation of protein K48-linked deubiquitination|negative regulation of peptidase activity|negative regulation of protein deubiquitination,0.0005825|0.0005825|0.0007766|0.0009151|0.0009706,1|1|1|1|1,2574|2574|1716|40.38|1287
625,4,0.6021,3.613,3124.0,0.001152,0.9929309999999999,CAV1 CHURC1 CMA1 LTB4R,basement membrane organization|negative regulation of peptidyl-tyrosine autophosphorylation|negative regulation of inward rectifier potassium channel activity|cytokine precursor processing|insulin receptor internalization,1.146e-05|0.0003883|0.0003883|0.0005825|0.0005825,0.1808|1|1|1|1,381.4|5149|5149|2574|2574
626,4,0.6324,3.7939999999999996,3497.0,0.0010810000000000001,0.9929309999999999,C20orf173 CAVIN4 CSN3 EFCAB1,"protein deneddylation|positive regulation of calcium ion import|nucleotide-excision repair, DNA damage recognition|regulation of calcium ion import|lactation",0.002667|0.005571|0.005812|0.01039|0.01112,1|1|1|1|1,411.9|187.2|179.1|98.07|91.53
627,4,0.6576,3.946,3033.0,0.001296,0.9929309999999999,ADIPOR2 CBFA2T3 IRF8 PLCG2,response to lipopolysaccharide|response to molecule of bacterial origin|leukocyte differentiation|hemopoiesis|hematopoietic or lymphoid organ development,1.469e-05|1.715e-05|2.021e-05|8.476e-05|0.0001071,0.2317|0.1353|0.1063|0.3342|0.338,48.73|46.25|43.76|27|24.95
628,8,0.616,17.25,5242.0,0.0032700000000000003,0.9996790000000001,CBL LZTR1 NF1 RASA2 SHOC2 SOS1 SPRED1 SPRED2,regulation of intracellular signal transduction|fibroblast growth factor receptor signaling pathway|regulation of small GTPase mediated signal transduction|cellular response to fibroblast growth factor stimulus|response to fibroblast growth factor,3.005e-09|1.865e-08|5.675e-08|6.563e-08|8.043e-08,4.74e-05|0.0001471|0.0002984|0.0002588|0.0002537,11.65|127.1|39.36|91.94|87.27
629,7,0.6161,12.94,5797.0,0.002222,0.9992989999999999,BICD1 CBLB ETFBKMT IL17RE KLHL42 TMTC1 TSPAN11,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|regulation of proteinase activated receptor activity,0.0006794|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,2942|2942|2942|2942|2942
630,4,0.6707,4.024,3563.0,0.001125,0.9929309999999999,CBLC CC2D2A FPR3 TTC12,axoneme assembly|microtubule bundle formation|protein localization to ciliary transition zone|cilium assembly|cilium organization,8.892e-05|0.0001714|0.001747|0.001987|0.002243,1|1|1|1|1,132|94.47|643.6|27.24|25.62
631,8,0.9254,25.91,5129.0,0.005011,0.9996790000000001,CBLL1 METTL14 METTL3 RBM15 VIRMA WTAP YTHDF2 ZC3H13,mRNA methylation|mRNA modification|RNA methylation|RNA modification|macromolecule methylation,1.965e-17|1.563e-16|2.418e-16|2.435e-14|3.429e-13,3.1e-13|1.233e-12|1.271e-12|9.603e-11|1.082e-09,965.4|643.6|209.5|106|72.08
632,4,0.6245,3.747,3153.0,0.001184,0.9929309999999999,CBLN1 CES3 KCNS3 TPPP3,negative regulation of inhibitory synapse assembly|regulation of inhibitory synapse assembly|negative regulation of synapse assembly|positive regulation of long-term synaptic depression|cerebellar granule cell differentiation,0.0003883|0.0009706|0.001359|0.001359|0.001747,1|1|1|1|1,5149|1287|858.1|858.1|643.6
633,4,0.7365,4.419,3072.0,0.001433,0.9929309999999999,CBS GAS2 HOXB13 SAA4,initiation of primordial ovarian follicle growth|cysteine biosynthetic process from serine|cysteine biosynthetic process via cystathionine|homocysteine catabolic process|epithelial cell maturation involved in prostate gland development,0.0003883|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|2574|1716|1716|1716
634,13,0.5501,42.91,9635.0,0.004422,0.999993,AQP7 CBWD1 CBWD2 CNN2 CNTNAP3 CNTNAP3B FOXD4 OR2S2 PGM5 SLC6A7 SPATA31A6 SPATA31A7 ZNF658,actomyosin structure organization|cellular metabolic process|glycerol transport|urea transmembrane transport|proline transmembrane transport,0.00197|0.003159|0.005036|0.005664|0.005664,1|1|1|1|1,30.47|0|226.3|198|198
635,12,0.5805,38.31,8716.0,0.004364,0.999986,AQP7 CBWD1 CBWD2 CBWD5 CNTNAP3 CNTNAP3B FOXD4L4 FOXD4L5 PGM5 SPATA31A6 SPATA31A7 ZNF658,glycerol transport|urea transmembrane transport|cellular metabolic process|urea transport|polyol transport,0.00465|0.00523|0.005413|0.005809|0.007546,1|1|1|1|1,245.2|214.5|0|190.7|143
636,22,0.4831,111.6,16820.0,0.006575,1.0,ASL CASTOR3 CLDN3 CLIP2 GNAT3 GUSB PMS2 SPDYE1 TPST1 TRIM40 TRIM50 TYW1 VKORC1L1 ZNF107 ZNF117 ZNF138 ZNF273 ZNF479 ZNF679 ZNF727 ZNF736 ZNF92,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|peptidyl-tyrosine sulfation",0.001214|0.002473|0.002478|0.002506|0.003343,1|1|1|1|1,3.116|2.585|2.584|2.581|447.7
637,4,0.6941,4.165,3212.0,0.001292,0.9929309999999999,CCBE1 FZD1 NAGK SLC4A10,central nervous system neuron differentiation|positive regulation of lymphangiogenesis|canonical Wnt signaling pathway involved in osteoblast differentiation|N-acetylmannosamine metabolic process|mannosamine metabolic process,0.0004655|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,56.89|2574|2574|2574|2574
638,6,0.6249,9.374,3951.0,0.00236,0.998474,CCDC107 PTP4A2 SLC3A2 SLC7A1 SLC7A5 TRPM7,aromatic amino acid transport|amino acid import across plasma membrane|amino acid import|phenylalanine transport|L-alpha-amino acid transmembrane transport,7.676e-09|9.766e-08|1.81e-07|4.24e-07|4.435e-07,0.0001211|0.0007702|0.0009516|0.001672|0.001399,792.1|312|251.2|3432|183.9
639,10,0.6302,28.36,7096.0,0.0039700000000000004,0.999933,CDT1 CFDP1 CIAPIN1 GINS2 GINS3 KARS NUP93 ORC6 RPL13 ZC3H18,DNA replication initiation|DNA-dependent DNA replication|DNA replication|cellular macromolecule biosynthetic process|DNA strand elongation involved in DNA replication,1.236e-06|1.66e-06|6.12e-06|4.299e-05|4.43e-05,0.0195|0.01309|0.03218|0.1695|0.1398,143.7|42.46|30.4|7.466|216.8
640,4,0.6054,3.6319999999999997,3291.0,0.0011,0.9929309999999999,ATOH7 CCDC114 DUPD1 DUSP13,peptidyl-tyrosine dephosphorylation|protein dephosphorylation|dephosphorylation|optic nerve development|outer dynein arm assembly,0.0001623|0.0006596|0.001432|0.002716|0.004266,1|1|1|1|1,97.15|47.67|32.18|396.1|245.2
641,4,0.6957,4.1739999999999995,3381.0,0.00123,0.9929309999999999,CCDC117 FGA NT5DC3 SMTNL2,positive regulation of vasoconstriction|regulation of vasoconstriction|blood vessel diameter maintenance|regulation of tube diameter|regulation of tube size,1.49e-05|5.502e-05|0.000228|0.000228|0.0002316,0.2351|0.4339|1|0.8991|0.7306,332.2|168.8|81.73|81.73|81.08
642,4,0.6152,3.6910000000000003,3038.0,0.00121,0.9929309999999999,CCDC121 EDDM3B OR4E2 PLPPR5,positive regulation of filopodium assembly|phospholipid dephosphorylation|regulation of filopodium assembly|positive regulation of plasma membrane bounded cell projection assembly|positive regulation of neuron projection development,0.006007|0.008903|0.009289|0.02062|0.03033,1|1|1|1|1,171.6|114.4|109.5|48.57|32.79
643,9,0.6075,21.87,6197.0,0.003507,0.9998530000000001,C1D DIS3 EXOSC1 EXOSC10 EXOSC7 EXOSC8 MPHOSPH6 TENT4B ZCCHC7,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,6.57e-15|8.838e-15|4.495e-14|3.588e-13|6.419e-13,1.036e-10|6.97e-11|2.364e-10|1.415e-09|2.025e-09,70.41|67.8|55.14|42.38|39.37
644,7,0.6178,12.97,5656.0,0.002283,0.9992989999999999,ASTL C2orf49 CCDC138 CNNM4 IL1F10 LYG1 MGAT4A,prevention of polyspermy|negative regulation of fertilization|cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process,0.001019|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|980.7|980.7
645,9,0.6067,21.84,6010.0,0.00361,0.9998530000000001,CENPJ GTF3A MRPS31 MZT1 NUP58 POMP SKA3 USPL1 ZC3H13,microtubule nucleation by microtubule organizing center|microtubule nucleation|microtubule polymerization|microtubule polymerization or depolymerization|ncRNA transcription,3.558e-06|5.482e-05|0.0001121|0.0002399|0.0007571,0.05612|0.4324|0.5893|0.9459|1,915.3|190.7|130.8|88.01|48.69
646,7,0.6072,12.75,5531.0,0.002294,0.9992989999999999,C1QTNF3 CCDC152 CDH6 FBXO4 RANBP3L UGT3A1 UGT3A2,cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid|response to genistein|mesenchymal cell differentiation involved in bone development,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
647,6,0.6333,9.499,4596.0,0.0020570000000000002,0.998474,ADAMTS15 CCDC153 OR10G9 OR4D5 OR6M1 TMEM136,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.0001895|0.0002256|0.000252|0.0003108|0.000347,1|1|1|1|1,23.35|22|21.19|19.73|19
648,4,0.6492,3.895,3357.0,0.0011560000000000001,0.9929309999999999,CCDC159 EGF FAT4 HOGA1,branching morphogenesis of an epithelial tube|morphogenesis of a branching epithelium|morphogenesis of a branching structure|oxalate metabolic process|epidermal growth factor receptor signaling pathway via MAPK cascade,0.0002352|0.0003472|0.0003878|0.0003883|0.0003883,1|1|1|1|1,80.45|66.01|62.41|5149|5149
649,4,0.6436,3.862,3324.0,0.001158,0.9929309999999999,CALM3 CCDC166 CLDN24 MYO9A,cell junction assembly|negative regulation of high voltage-gated calcium channel activity|positive regulation of cyclic-nucleotide phosphodiesterase activity|positive regulation of ryanodine-sensitive calcium-release channel activity|regulation of cell communication by electrical coupling involved in cardiac conduction,0.0011|0.001165|0.001165|0.001941|0.001941,1|1|1|1|1,36.78|1030|1030|572.1|572.1
650,13,0.6092,47.52,10010.0,0.004714,0.999993,ABHD11 ASL CASTOR3 CLDN3 CYP3A5 GNAT3 NSUN5 SEMA3E TBL2 TRIM50 TYW1 ZNF736 ZNF92,arginine biosynthetic process via ornithine|'de novo' AMP biosynthetic process|alkaloid catabolic process|cellular response to L-arginine|arginine biosynthetic process,0.002037|0.002715|0.002715|0.002715|0.003392,1|1|1|1|1,735.5|490.4|490.4|490.4|367.8
651,9,0.7105,25.58,6243.0,0.004069,0.9998530000000001,CCDC174 CHCHD4 LSM3 RPL32 SEC13 SGO1 TAMM41 TRNT1 TSEN2,gene expression|RNA processing|ncRNA processing|establishment of protein localization to organelle|tRNA 3'-terminal CCA addition,9.098e-05|0.0004277|0.0007141|0.0007983|0.0008734,1|1|1|1|1,6.281|9.917|15.89|15.29|2288
652,15,0.6152,64.6,9555.0,0.006693999999999999,0.999999,AP3B1 EIPR1 HTT RAB14 RAB6A RGP1 RIC1 SYS1 VIPAS39 VPS33B VPS50 VPS51 VPS52 VPS53 VPS54,"endosomal transport|cytosolic transport|intracellular transport|establishment of localization in cell|retrograde transport, endosome to Golgi",5.932e-18|9.751e-18|1.067e-17|1.112e-16|4.578e-15,9.358e-14|7.69e-14|5.612e-14|4.384e-13|1.444e-11,57.19|81.86|12.93|8.708|107.7
653,4,0.6334,3.8,3335.0,0.0011359999999999999,0.9929309999999999,ANKRD29 CCDC182 NUDT16L1 OR2A14,negative regulation of double-strand break repair via nonhomologous end joining|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.00194|0.00442|0.004963|0.005341|0.006137,1|1|1|1|1,588.4|18.68|17.6|16.95|15.78
654,9,0.6114,22.01,7046.0,0.003106,0.9998530000000001,CCDC25 CCNB1IP1 CTDSP1 KIF26B LYRM1 MAP3K7CL NIPSNAP3B SDR39U1 SLC25A36,pyrimidine nucleotide transport|pyrimidine nucleotide import into mitochondrion|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.00131|0.00131|0.001746|0.002182|0.002618,1|1|1|1|1,1144|1144|762.8|572.1|457.7
655,7,0.6387,13.41,4743.0,0.0028120000000000003,0.9992989999999999,AHCYL1 FAM13B MAPK6 MAPKAPK5 SLC20A1 SLC4A2 SLC4A7,inorganic anion transport|bicarbonate transport|anion transmembrane transport|regulation of intracellular pH|regulation of cellular pH,1.602e-05|9.298e-05|0.0003643|0.0003907|0.0004537,0.2527|0.7333|1|1|1,55.86|140.1|19.27|66.87|61.94
656,6,0.6156,9.232999999999999,4576.0,0.002008,0.998474,CCDC28B PRAMEF11 PRAMEF12 PRAMEF14 PRAMEF18 PRAMEF20,negative regulation of cell differentiation|negative regulation of developmental process|negative regulation of apoptotic process|negative regulation of programmed cell death|positive regulation of cell population proliferation,1.705e-07|7.915e-07|8.758e-07|9.725e-07|1.112e-06,0.00269|0.006242|0.004605|0.003835|0.00351,26.9|19.73|19.33|18.92|18.41
657,4,0.6374,3.824,3282.0,0.001161,0.9929309999999999,CCDC3 HOXD10 HOXD11 HOXD9,peripheral nervous system neuron development|peripheral nervous system neuron differentiation|regionalization|proximal/distal pattern formation|hindlimb morphogenesis,2.572e-06|2.572e-06|1.482e-05|1.879e-05|1.879e-05,0.04057|0.02028|0.07795|0.07411|0.05929,858.1|858.1|48.57|294.2|294.2
658,20,0.605,114.9,15860.0,0.0071790000000000005,1.0,ARPC1B C7orf43 CYP3A43 CYP3A5 CYP3A7 DLX6 GRM3 MOGAT3 PILRA PILRB PON1 PON3 RNF148 SEMA3E TRIM50 WNT2 ZKSCAN1 ZNF804B ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|steroid metabolic process|lipoxygenase pathway,1.011e-06|2.886e-05|3.347e-05|9.019e-05|0.0001221,0.01595|0.2276|0.176|0.3557|0.3851,171.1|309.7|49.27|16.55|135.5
659,4,0.623,3.738,3345.0,0.001114,0.9929309999999999,CCDC42 PAFAH2 TRIM59 TSPYL1,negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleosome assembly|chromatin assembly|spermatid development|nucleosome organization,0.008903|0.02272|0.02881|0.02995|0.03014,1|1|1|1|1,114.4|44.01|34.56|33.22|33
660,12,0.6484,42.8,7878.0,0.005386999999999999,0.999986,CCDC115 CCDC47 EMC1 EMC2 EMC3 EMC4 EMC6 EMC7 EMC8 NCLN RAB5IF TMEM147,protein insertion into ER membrane by stop-transfer membrane-anchor sequence|tail-anchored membrane protein insertion into ER membrane|protein insertion into ER membrane|endoplasmic reticulum organization|protein insertion into membrane,4.914e-20|6.187e-19|5.652e-17|2.126e-16|4.954e-15,7.752e-16|4.879e-15|2.972e-13|8.386e-13|1.563e-11,1201|750.9|353.3|137.3|176.7
661,21,0.6012,126.2,14450.0,0.008637,1.0,CCDC77 CCP110 CENPJ CEP120 CEP135 CEP152 CEP295 CEP41 CEP44 MIIP PCM1 PPP1R35 RTTN SASS6 SPICE1 TBC1D31 TEDC1 TEDC2 TUBD1 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|centriole replication|centriole assembly|microtubule cytoskeleton organization,5.984e-21|2.235e-20|1.961e-18|9.564e-18|1.618e-17,9.439e-17|1.762e-16|1.031e-14|3.771e-14|5.104e-14,122.6|107.9|341.1|270.5|24.26
662,4,0.6677,4.006,2814.0,0.001417,0.9929309999999999,CCDC51 KLHL12 SLC25A46 STARD7,mitochondrial membrane fission|neural crest formation|membrane fission|mitochondrial fission|phosphatidylcholine biosynthetic process,0.0005825|0.002328|0.003104|0.004266|0.006973,1|1|1|1|1,2574|468.1|343.2|245.2|147.1
663,11,0.604,33.22,8931.0,0.0036969999999999998,0.999969,CCDC54 INSL6 MPL PDCD1LG2 PUM3 RLN1 RLN2 SAXO1 SPATA6L TPD52L3 TYRP1,basophil homeostasis|eosinophil homeostasis|acetoacetic acid metabolic process|positive regulation of platelet formation|monocyte homeostasis,0.001067|0.001067|0.001067|0.001601|0.001601,1|1|1|1|1,1872|1872|1872|936.1|936.1
664,8,0.6144,17.2,4850.0,0.0035229999999999997,0.9996790000000001,CCDC6 FBXO42 LCMT1 PPME1 PPP2CA PPP2CB PPP2R1A PPP2R2A,peptidyl-serine dephosphorylation|G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition|protein dephosphorylation|mitotic nuclear envelope reassembly,2.606e-08|1.568e-07|1.657e-07|8.564e-07|9.443e-07,0.0004111|0.001236|0.0008712|0.003377|0.002979,551.7|73.55|72.52|47.67|151.4
665,38,0.4888,343.6,27010.0,0.01253,1.0,ACAD9 ATPAF2 CARS2 COA7 COQ7 DARS2 DDX28 FOXRED1 GFM2 GRSF1 GTPBP10 GTPBP8 MCAT METTL17 MRM2 MRM3 MRPL58 MRPS33 MRRF MTERF4 MTFMT MTG1 MTIF2 MTIF3 MTO1 NDUFAF1 NDUFAF3 NDUFAF7 NOA1 NSUN4 NUBPL OXSM POLG SSBP1 TBRG4 TFB1M TRIT1 YBEY,mitochondrial gene expression|gene expression|mitochondrial translation|translation|ncRNA metabolic process,8.387e-19|3.457e-11|5.11e-11|1.141e-10|1.484e-10,1.323e-14|2.726e-07|2.687e-07|4.501e-07|4.681e-07,49.04|5.073|38.06|15.13|12.26
666,7,0.6045,12.69,4897.0,0.002578,0.9992989999999999,ANAPC10 HSPA13 NAF1 NOP10 SPCS3 TMA16 TRAPPC11,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|positive regulation of telomerase RNA localization to Cajal body|pseudouridine synthesis|regulation of telomerase RNA localization to Cajal body,9.891e-07|6.521e-06|1.343e-05|1.875e-05|1.875e-05,0.0156|0.05143|0.07059|0.07393|0.05914,1961|588.4|392.3|326.9|326.9
667,4,0.6185,3.7110000000000003,3308.0,0.001118,0.9929309999999999,CCDC70 DHRS12 NLK SPRY4,serine phosphorylation of STAT protein|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of cell morphogenesis involved in differentiation|negative regulation of fibroblast growth factor receptor signaling pathway|regulation of fibroblast growth factor receptor signaling pathway,0.001213|0.003636|0.003636|0.004604|0.007744,1|1|1|1|1,1030|294.2|294.2|228.8|132.9
668,4,0.7129,4.2780000000000005,2838.0,0.001501,0.9929309999999999,CCDC71L LRIF1 MKLN1 SMCHD1,"dosage compensation by inactivation of X chromosome|dosage compensation|inactivation of X chromosome by DNA methylation|inactivation of X chromosome by heterochromatin assembly|regulation of gene expression, epigenetic",4.323e-06|5.367e-06|0.0003883|0.0003883|0.0004161,0.06819|0.04233|1|1|1,643.6|572.1|5149|5149|60.22
669,4,0.6369,3.822,3123.0,0.001219,0.9929309999999999,CCDC74A CCDC74B CLSPN TMPRSS5,mitotic DNA replication checkpoint|DNA replication checkpoint|mitotic G2 DNA damage checkpoint|G2 DNA damage checkpoint|mitotic G2/M transition checkpoint,0.002134|0.003491|0.004459|0.00678|0.006973,1|1|1|1|1,514.9|302.9|234|151.4|147.1
670,17,0.4953,67.36,12530.0,0.005333,1.0,ARL13B CD200R1 CDV3 IMPG2 MTRNR2L8 NXPE3 OR5AC2 OR5H1 OR5H14 OR5H15 OR5H2 OR5H6 OR5K1 OR5K3 OR5K4 PROS1 STX19,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.167e-11|3.643e-11|5.066e-11|9.454e-11|1.313e-10,3.418e-07|2.873e-07|2.664e-07|3.728e-07|4.141e-07,24.72|23.3|22.43|20.89|20.12
671,7,0.6403,13.45,5345.0,0.002503,0.9992989999999999,CLDN25 FXYD6 HTR3A HTR3B NXPE4 POU2F3 TMEM136,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,8.064e-05|0.0003324|0.0003404|0.0004726|0.0004726,1|1|1|1|1,150.9|72.65|71.76|60.66|60.66
672,5,0.6584,6.584,3500.0,0.001872,0.996692,CCDC86 INTS5 NXF1 OSBP TMEM258,intracellular cholesterol transport|intracellular sterol transport|poly(A)+ mRNA export from nucleus|bile acid biosynthetic process|snRNA 3'-end processing,0.004845|0.005087|0.005571|0.007261|0.007744,1|1|1|1|1,216.8|205.9|187.2|142|132.9
673,4,0.6423,3.8539999999999996,3346.0,0.001147,0.9929309999999999,ANKRD31 CCDC88C CPT1B ZNF646,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination|positive regulation of meiotic DNA double-strand break formation|regulation of meiotic DNA double-strand break formation|apical constriction|response to blue light,0.0003883|0.0003883|0.0003883|0.0005825|0.001359,1|1|1|1|1,5149|5149|5149|2574|858.1
674,6,0.6125,9.187999999999999,4669.0,0.001959,0.998474,CCDC89 CREBZF P2RY2 P2RY6 PLEKHB1 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|cellular response to pyrimidine ribonucleotide|response to pyrimidine ribonucleotide,8.468e-06|8.263e-05|0.0003524|0.0005824|0.0005824,0.1336|0.6517|1|1|1,490.4|146.1|69.34|3432|3432
675,11,0.5706,31.39,9164.0,0.0034049999999999996,0.999969,C5AR1 CCDC9 CRX DKKL1 EML2 FLT3LG FUT1 SPACA4 SULT2A1 SULT2B1 TPRX1,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|complement component C5a signaling pathway|negative regulation of testosterone biosynthetic process,8.361e-05|9.028e-05|9.028e-05|0.001601|0.001601,1|0.712|0.4747|1|1,156|149.8|149.8|936.1|936.1
676,4,0.6261,3.7560000000000002,3441.0,0.001088,0.9929309999999999,CCDC90B MFSD6 PRSS38 RIMS3,calcium ion-regulated exocytosis of neurotransmitter|calcium-ion regulated exocytosis|synaptic vesicle exocytosis|regulation of synaptic vesicle exocytosis|antigen processing and presentation of exogenous peptide antigen via MHC class I,0.003104|0.007745|0.01122|0.01179|0.01583,1|1|1|1|1,343.2|132|90.33|85.81|63.56
677,5,0.6165,6.165,3706.0,0.001656,0.996692,ARHGAP11B CCDC9B CHRFAM7A CHRNA7 GOLGA8M,"synaptic transmission, cholinergic|excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|regulation of postsynaptic membrane potential|modulation of excitatory postsynaptic potential",5.002e-08|6.53e-07|7.788e-07|2.401e-06|7.597e-05,0.000789|0.00515|0.004095|0.009469|0.2397,396.1|160.9|151.4|103|152.6
678,22,0.5425,125.3,17660.0,0.0070290000000000005,1.0,APTX AQP7 BAG1 CCL21 CREB3 DNAI1 DNAJB5 FAM205A FAM219A FRMPD1 GALT GBA2 IL11RA KIF24 NPR2 OR13J1 OR2S2 SIGMAR1 SPAG8 TESK1 TOMM5 UBAP2,negative regulation of plasma membrane bounded cell projection assembly|chaperone cofactor-dependent protein refolding|'de novo' posttranslational protein folding|'de novo' protein folding|chaperone-mediated protein folding,0.0005288|0.0006699|0.0008691|0.001047|0.002041,1|1|1|1|1,62.41|55.07|48.01|43.54|30.69
679,13,0.6062,47.28,10430.0,0.004504,0.999993,CCL1 EPX HOXB9 LPO MKS1 MPO NME1 OR4D1 OR4D2 RSAD1 SEPT4 SGCA TBKBP1,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance,9.624e-07|2.559e-06|2.881e-05|4.182e-05|5.019e-05,0.01518|0.02018|0.1515|0.1649|0.1584,163.9|115.9|50.03|44.01|41.33
680,18,0.515,78.79,14100.0,0.005543,1.0,ALDOC C17orf50 C17orf75 CCL11 CCL13 CCL2 CCL7 DHRS11 EVI2A GAS2L2 LYRM9 NOS2 RDM1 SLC13A2 SLFN12 SLFN13 SPAG5 UNC119,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|cellular response to interferon-gamma,3.054e-09|3.73e-09|7.497e-08|1.466e-07|3.09e-07,4.817e-05|2.942e-05|0.0003942|0.0005783|0.000975,255|240.9|105.8|88.49|34.3
681,14,0.618,56.24,11170.0,0.0049960000000000004,0.9999969999999999,C17orf50 C17orf75 CCL13 CCL14 CCL2 CCL7 DHRS11 EVI2A GAS2L2 KRTAP4-8 LYRM9 RDM1 SLFN12 SLFN12L,monocyte chemotaxis|lymphocyte chemotaxis|lymphocyte migration|neutrophil chemotaxis|chemokine-mediated signaling pathway,2.659e-08|5.208e-08|2.51e-07|2.924e-07|3.227e-07,0.0004194|0.0004108|0.00132|0.001153|0.001018,134|112.1|74.22|71.32|69.52
682,4,0.6073,3.6439999999999997,3573.0,0.001016,0.9929309999999999,CCL17 DYTN KCTD6 NME3,UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process|guanosine-containing compound biosynthetic process|CTP biosynthetic process,0.002134|0.002328|0.002522|0.002716|0.00291,1|1|1|1|1,514.9|468.1|429.1|396.1|367.8
683,7,0.646,13.57,5852.0,0.002307,0.9992989999999999,CPB1 GPR171 P2RY12 P2RY13 SCHIP1 SERPINI1 SERPINI2,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration|initiation of movement involved in cerebral cortex radial glia guided migration|positive regulation of integrin activation by cell surface receptor linked signal transduction,1.63e-08|4.676e-07|0.0006794|0.0006794|0.001019,0.0002571|0.003688|1|1|1,630.5|187.8|2942|2942|1471
684,6,0.6009,9.013,4876.0,0.0018399999999999998,0.998474,CCL24 FAM185A SEMA3E TBL2 TRIM50 TYW1,regulation of cell shape|positive regulation of eosinophil migration|wybutosine biosynthetic process|wybutosine metabolic process|regulation of eosinophil migration,0.0008271|0.001456|0.001456|0.001456|0.002037,1|1|1|1|1,44.87|858.1|858.1|858.1|572.1
685,19,0.5582,95.46,14270.0,0.006629,1.0,CTSK EFNA1 GBA HRNR LCE1A LCE1B LCE1E LCE2A LCE3A LCE3D LCE3E LCE5A OR10J5 S100A12 S100A2 S100A9 SPRR1A SPRR2F SPRR2G,keratinization|skin development|keratinocyte differentiation|epidermal cell differentiation|epidermis development,1.992e-19|9.755e-19|1.443e-18|9.828e-18|2.503e-16,3.142e-15|7.694e-15|7.585e-15|3.876e-14|7.897e-13,57.55|36.79|48.53|41.16|31.19
686,15,0.5779,60.68,11800.0,0.005103,0.999999,C17orf50 C17orf75 CCL13 CCL2 CCL5 CCL7 DHRS11 EVI2A GAS2L2 GSDMB KRTAP4-8 LYRM9 RDM1 SLFN12 TAF15,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|regulation of natural killer cell chemotaxis|lymphocyte chemotaxis,1.878e-09|2.295e-09|4.62e-08|7.657e-08|9.043e-08,2.963e-05|1.81e-05|0.0002429|0.000302|0.0002853,285.1|269.2|118.2|454.3|98.9
687,4,0.6038,3.623,3170.0,0.001139,0.9929309999999999,CCNA1 PIK3C2A WASL WIPF2,actin filament-based movement|immune response-regulating cell surface receptor signaling pathway involved in phagocytosis|Fc-gamma receptor signaling pathway involved in phagocytosis|Fc-gamma receptor signaling pathway|Fc receptor mediated stimulatory signaling pathway,0.0002037|0.0002612|0.0002612|0.0002689|0.0002727,1|1|1|1|0.8604,86.53|76.28|76.28|75.16|74.62
688,7,0.6624,13.91,4706.0,0.002938,0.9992989999999999,CCNA2 CCNB1 CDC25B FBXO5 FOXM1 LIN37 LIN54,regulation of cell cycle|mitotic cell cycle phase transition|cell cycle phase transition|oocyte maturation|G2/M transition of mitotic cell cycle,2.277e-09|1.096e-08|1.256e-08|3.186e-08|7.882e-08,3.592e-05|8.643e-05|6.604e-05|0.0001256|0.0002487,17.22|51.62|50.21|490.4|84.06
689,6,0.6551,9.826,3598.0,0.002715,0.998474,CCNE2 CDK4 CKS1B E2F3 SKP2 UBE2Q1,G1 phase|mitotic G1 phase|mitotic cell cycle phase transition|cell cycle phase transition|mitotic interphase,2.525e-11|2.525e-11|3.168e-09|3.632e-09|3.651e-09,3.983e-07|1.991e-07|1.666e-05|1.432e-05|1.152e-05,653.8|653.8|60.22|58.58|173.8
690,13,0.6205,48.4,10080.0,0.004765999999999999,0.999993,BICDL2 CLDN6 CLDN9 CLUAP1 CORO7 HAGH HCFC1R1 KREMEN2 OR1F1 PAQR4 TNFRSF12A ZNF213 ZNF500,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|bicellular tight junction assembly|tight junction assembly|tight junction organization|apical junction assembly,9.225e-05|0.0006369|0.00068|0.0007244|0.0008415,1|1|1|1|1,150.9|54.63|52.81|51.1|47.29
691,8,0.6132,17.17,5638.0,0.0030280000000000003,0.9996790000000001,ATXN2L CCNI G3BP2 LARP1 LARP4 LARP4B LSM12 NUFIP2,positive regulation of translation|positive regulation of cellular amide metabolic process|stress granule assembly|regulation of translation|regulation of cellular amide metabolic process,1.642e-05|2.998e-05|3.036e-05|0.0003033|0.0004837,0.259|0.2365|0.1596|1|1,56.79|46.25|257.4|20.99|17.88
692,8,0.6622,18.54,5624.0,0.0032770000000000004,0.9996790000000001,LARP7 LSM3 LSM5 LSM6 LSM8 TMCO6 USB1 ZNF511,"RNA splicing|RNA processing|exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|mRNA processing",1.694e-09|2.143e-07|2.727e-07|3.221e-07|3.896e-07,2.672e-05|0.00169|0.001434|0.00127|0.001229,37.95|16.73|234|220.7|26.59
693,11,0.6459,35.52,7507.0,0.004696,0.999969,CCNK CINP DDX24 DICER1 DYNC1H1 EIF2S1 EIF5 NRDE2 PSMC1 WARS WDR25,posttranscriptional regulation of gene expression|RNA interference|stress granule assembly|cellular macromolecule biosynthetic process|macromolecule biosynthetic process,5.476e-06|3.096e-05|5.95e-05|8.807e-05|0.000101,0.08638|0.2442|0.3128|0.3473|0.3188,17.11|267.5|187.2|6.788|6.624
694,4,0.6116,3.67,3237.0,0.0011300000000000001,0.9929309999999999,CCNY CDK17 CREM FZD8,mitotic cell cycle phase transition|cell cycle phase transition|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling,0.001139|0.001203|0.001698|0.001698|0.002433,1|1|1|1|1,36.13|35.15|29.51|29.51|24.58
695,4,0.8411,5.046,2919.0,0.001721,0.9929309999999999,HLA-DQA1 HLA-DQB1 HLA-DRB1 HLA-DRB5,interferon-gamma-mediated signaling pathway|antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|cellular response to interferon-gamma,6.394e-13|2.976e-12|3.28e-12|3.441e-12|2.917e-11,1.009e-08|2.347e-08|1.724e-08|1.357e-08|9.202e-08,286|208|203.9|201.9|130.3
696,16,0.6118,73.41,12410.0,0.0058649999999999996,0.999999,ABHD14A ABHD14B CCR2 CCR3 CCR5 GNAT1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 MUSTN1 SEMA3G TLR9 ZNF502,cellular defense response|inflammatory response|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine,1.038e-05|2.91e-05|3.274e-05|4.621e-05|4.621e-05,0.1637|0.2295|0.1722|0.1822|0.1458,72.86|12.98|48.88|43.39|43.39
697,4,0.7171,4.302,3165.0,0.001354,0.9929309999999999,CCR6 GPR31 LPA TBXT,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|isotype switching to IgA isotypes|DN3 thymocyte differentiation,0.0001515|0.0001913|0.0001913|0.0004854|0.0004854,1|1|1|1|1,104.3|92.56|92.56|4119|4119
698,10,0.608,27.36,8028.0,0.0033880000000000004,0.999933,CCR2 CCR3 CCR5 CCR8 FAM198A IQCF5 SCN10A SCN11A SLC22A14 XCR1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,1.242e-10|2.204e-10|2.204e-10|2.354e-09|1.189e-08,1.959e-06|1.738e-06|1.159e-06|9.283e-06|3.752e-05,144.8|128.6|128.6|78.91|56.64
699,9,0.6001,21.61,7123.0,0.003017,0.9998530000000001,CCR2 CCR3 CCR5 CCR8 CCRL2 FAM198A SCN10A SCN11A VIPR1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,5.538e-11|9.834e-11|9.834e-11|1.053e-09|5.331e-09,8.735e-07|7.756e-07|5.171e-07|4.151e-06|1.682e-05,162.9|144.6|144.6|88.77|63.72
700,8,0.605,16.94,5649.0,0.002982,0.9996790000000001,CCT2 CNOT2 CPM CPSF6 FAM49A NUP107 RAB3IP SLC35E3,chaperone mediated protein folding independent of cofactor|posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery|messenger ribonucleoprotein complex assembly|RNA phosphodiester bond hydrolysis|mRNA alternative polyadenylation,0.0007765|0.001164|0.001552|0.001771|0.00194,1|1|1|1|1,2574|1287|858.1|31.2|643.6
701,13,0.6036,47.08,8895.0,0.00525,0.999993,CCT3 COPB2 ETF1 PSMA1 PSMA2 PSMA3 PSMA5 PSMA6 PSMB3 SMU1 SNRPD1 SNU13 VCP,proteasomal ubiquitin-independent protein catabolic process|positive regulation of canonical Wnt signaling pathway|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly,1.056e-14|3.725e-12|3.958e-12|3.958e-12|3.958e-12,1.666e-10|2.938e-08|2.081e-08|1.561e-08|1.249e-08,401.2|70.05|135.8|135.8|135.8
702,9,0.6004,21.61,5908.0,0.0036340000000000005,0.9998530000000001,CCT4 MSTO1 PDCD5 PFDN1 PFDN4 TCP1 TUBA1B TUBA1C TXNDC9,protein folding|RNA localization to nucleus|RNA localization to Cajal body|scaRNA localization to Cajal body|positive regulation of establishment of protein localization to telomere,1.888e-06|3.558e-06|3.558e-06|3.558e-06|1.117e-05,0.02978|0.02806|0.01871|0.01403|0.03524,40.15|915.3|915.3|915.3|457.7
703,6,0.6064,9.096,4043.0,0.002238,0.998474,CCT3 CCT4 CCT5 CCT6A MSTO1 TCP1,positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere|positive regulation of protein localization to Cajal body|regulation of protein localization to Cajal body|regulation of establishment of protein localization to chromosome,5.827e-16|8.476e-16|8.476e-16|8.476e-16|1.201e-15,9.192e-12|6.685e-12|4.457e-12|3.343e-12|3.788e-12,1716|1560|1560|1560|1430
704,8,0.6027,16.88,5198.0,0.0032259999999999997,0.9996790000000001,PDCD5 PFDN1 PFDN4 TBCA TUBA1B TUBA1C TUBB TXNDC9,negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|cytoskeleton-dependent intracellular transport|protein folding|cell division,1.198e-05|1.789e-05|4.584e-05|7.474e-05|0.0007055,0.1889|0.1411|0.241|0.2947|1,429.1|343.2|40.02|33.87|15.7
705,9,0.6254,22.51,6001.0,0.0037259999999999997,0.9998530000000001,APH1A CD109 IPO8 LEMD3 NCSTN PSEN1 PSENEN TGFBR1 TGFBR2,"Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing|amyloid precursor protein catabolic process|membrane protein ectodomain proteolysis",5.531e-12|1.677e-11|1.677e-11|8.107e-11|1.777e-10,8.725e-08|1.323e-07|8.817e-08|3.197e-07|5.605e-07,1308|915.3|915.3|572.1|457.7
706,11,0.6024,33.13,6677.0,0.004922,0.999969,BCAR1 CD151 CRKL ILK ITGA3 ITGAV ITGB1 ITGB5 PTK2 RAC1 SNX17,integrin-mediated signaling pathway|positive regulation of cell migration|positive regulation of cell motility|positive regulation of cellular component movement|positive regulation of locomotion,2.362e-14|2.3e-13|3.494e-13|4.31e-13|4.449e-13,3.727e-10|1.814e-09|1.837e-09|1.7e-09|1.404e-09,133.7|32.53|31.03|30.31|30.2
707,4,0.602,3.612,3283.0,0.0010960000000000002,0.9929309999999999,CD164L2 FLG2 NMT2 SELENBP1,N-terminal peptidyl-glycine N-myristoylation|N-terminal protein myristoylation|protein myristoylation|peptidyl-glycine modification|N-terminal protein lipidation,0.0005825|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1287|1287|1287|1030
708,14,0.5798,52.76,10420.0,0.005023,0.9999969999999999,CD19 CD79A CD79B CD81 DOCK2 EBF1 GNAI2 KLHL6 LDLRAP1 ODC1 PAX5 RAC2 RHOH SYK,leukocyte differentiation|lymphocyte activation|positive regulation of immune system process|cell activation|lymphocyte differentiation,2.671e-09|5.351e-09|9.359e-09|1.203e-08|1.506e-08,4.213e-05|4.221e-05|4.921e-05|4.746e-05|4.752e-05,27.23|24.58|11.74|11.4|33.22
709,13,0.6162,48.07,9450.0,0.005047,0.999993,ADGRG7 ARL13B CD200R1L CDV3 OR5AC2 OR5H1 OR5H14 OR5H15 OR5H2 OR5K1 OR5K3 OR5K4 PROS1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.584e-11|8.887e-11|1.194e-10|2.087e-10|2.8e-10,8.808e-07|7.009e-07|6.277e-07|8.231e-07|8.835e-07,28.74|27.08|26.08|24.28|23.38
710,4,0.6124,3.674,3154.0,0.001161,0.9929309999999999,CD244 KNSTRN OR10Z1 SLC36A1,positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport|proline transmembrane transport,0.0007766|0.0007766|0.001359|0.001359|0.001747,1|1|1|1|1,1716|1716|858.1|858.1|643.6
711,4,0.6149,3.69,3353.0,0.001097,0.9929309999999999,BSND CD247 GPX7 GUCA2B,positive regulation of guanylate cyclase activity|regulation of guanylate cyclase activity|positive regulation of protein localization to cell surface|positive regulation of purine nucleotide biosynthetic process|positive regulation of nucleotide biosynthetic process,0.001941|0.002522|0.003297|0.004266|0.004266,1|1|1|1|1,572.1|429.1|321.8|245.2|245.2
712,5,0.6383,6.382999999999999,4160.0,0.0015279999999999998,0.996692,CD300LG CFAP97D1 HAP1 HEXIM2 MPP3,"positive regulation of neurotrophin production|telomere maintenance via base-excision repair|regulation of neurotrophin production|base-excision repair, base-free sugar-phosphate removal|DNA dephosphorylation",0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
713,4,0.6058,3.635,3267.0,0.001109,0.9929309999999999,ANXA10 CD38 IFNK MBOAT1,artery smooth muscle contraction|tonic smooth muscle contraction|regulation of neuron projection development|vascular associated smooth muscle contraction|negative regulation of bone resorption,0.001941|0.002134|0.002655|0.003297|0.003491,1|1|1|1|1,572.1|514.9|23.51|321.8|302.9
714,4,0.6797,4.078,3177.0,0.001279,0.9929309999999999,CD48 FMO3 NMNAT2 PRELP,keratan sulfate catabolic process|keratan sulfate biosynthetic process|NAD biosynthetic process|pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process,0.002522|0.00562|0.00562|0.0062|0.0062,1|1|1|1|1,429.1|183.9|183.9|166.1|166.1
715,4,0.6171,3.7030000000000003,3244.0,0.001137,0.9929309999999999,ATF7 CD52 METTL7A PTGR1,lipoxin A4 metabolic process|response to antineoplastic agent|leukotriene B4 metabolic process|lipoxin metabolic process|respiratory burst,0.0009706|0.0009706|0.001359|0.001747|0.004266,1|1|1|1|1,1287|1287|858.1|643.6|245.2
716,14,0.6121,55.7,10470.0,0.0052770000000000004,0.9999969999999999,CD1B CD1E CD5L FCRL3 ITLN1 ITLN2 OR10J5 OR10T2 OR6K6 OR6N1 OR6N2 S100A2 SLAMF7 YY1AP1,"detection of chemical stimulus involved in sensory perception of smell|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|sensory perception of smell|detection of chemical stimulus involved in sensory perception|antigen processing and presentation, exogenous lipid antigen via MHC class Ib",7.908e-06|8.982e-06|1.052e-05|1.26e-05|1.539e-05,0.1247|0.07084|0.05531|0.0497|0.04854,16.68|588.4|15.72|15.13|420.3
717,11,0.6071,33.39,7991.0,0.00415,0.999969,C19orf66 CNN1 ICAM1 ICAM3 P2RY11 ZNF433 ZNF441 ZNF625 ZNF627 ZNF69 ZNF700,"regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of cellular biosynthetic process|regulation of biosynthetic process|regulation of transcription, DNA-templated",0.0001621|0.0001719|0.0002308|0.0002678|0.0006703,1|1|1|1|1,3.828|3.798|3.649|3.576|3.783
718,4,0.6797,4.078,3405.0,0.001194,0.9929309999999999,CD80 CHST12 GEM PEAR1,negative regulation of high voltage-gated calcium channel activity|positive regulation of T-helper 1 cell differentiation|recognition of apoptotic cell|regulation of T-helper 1 cell differentiation|dermatan sulfate biosynthetic process,0.001165|0.001359|0.001553|0.002134|0.002522,1|1|1|1|1,1030|858.1|735.5|514.9|429.1
719,6,0.6076,9.115,4851.0,0.001871,0.998474,CD84 EML2 FLT3LG SPHK2 SULT2A1 SULT2B1,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|regulation of mast cell degranulation|regulation of mast cell activation involved in immune response,2.29e-05|2.473e-05|2.473e-05|3.493e-05|3.718e-05,0.3613|0.1951|0.13|0.1377|0.1173,286|274.6|274.6|228.8|221.5
720,4,0.6109,3.665,2671.0,0.001366,0.9929309999999999,ATP6V0B CDC20 IPO13 PABPC1,"regulation of cellular catabolic process|regulation of catabolic process|positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.0002791|0.0004718|0.0007766|0.0007766|0.0009706,1|1|1|1|1,18.07|15.13|1716|1716|1287
721,4,0.6283,3.77,2867.0,0.001309,0.9929309999999999,CDC42EP1 DAD1 HCFC1R1 RPN1,protein N-linked glycosylation via asparagine|peptidyl-asparagine modification|viral protein processing|protein N-linked glycosylation|viral gene expression,1.4e-05|1.49e-05|2.313e-05|8.235e-05|0.0004209,0.2208|0.1175|0.1216|0.3248|1,343.2|332.2|264|137.3|59.87
722,14,0.6038,54.95,11500.0,0.004744,0.9999969999999999,ADCYAP1R1 AEBP1 AGR3 CDCA7L GHRHR HOXA6 HOXA7 HOXA9 KIAA0895 MYO1G NME8 PSPH SUGCT ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|cAMP-mediated signaling|anterior/posterior pattern specification|skeletal system morphogenesis,3.543e-05|7.551e-05|0.0002236|0.0003494|0.0004388,0.5589|0.5955|1|1|1,46.95|36.17|94.91|21.32|19.7
723,12,0.6016,39.71,9464.0,0.004168,0.999986,C1QTNF3 CDH10 CDH12 CDH18 CDH6 CDH9 FAM173B HCN1 OXCT1 SLC45A2 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,2.267e-11|1.42e-10|4.478e-09|1.696e-08|2.867e-08,3.576e-07|1.12e-06|2.354e-05|6.688e-05|9.046e-05,222.9|151|73.71|56.06|50.33
724,12,0.6181,40.8,9785.0,0.004142,0.999986,C18orf32 CDH20 CDH7 CTIF DSG3 DSG4 SERPINB10 SERPINB12 SERPINB2 SERPINB5 SERPINB7 SERPINB8,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|homophilic cell adhesion via plasma membrane adhesion molecules|regulation of endopeptidase activity,4.913e-09|6.208e-09|3.569e-08|4.658e-08|1.208e-07,7.75e-05|4.896e-05|0.0001876|0.0001837|0.0003812,38.8|37.28|27.63|47.43|22.42
725,13,0.6121,47.74,10750.0,0.004409000000000001,0.999993,CDH22 CNBD2 CPNE1 DUSP15 FOXS1 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 TM9SF4 XKR7,"positive regulation of multicellular organism growth|regulation of multicellular organism growth|phagocytosis|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response",0.000216|0.0007936|0.001024|0.001261|0.001891,1|1|1|1|1,96.01|48.75|14.58|1584|792.1
726,5,0.6375,6.375,4124.0,0.0015400000000000001,0.996692,BMP7 CDH4 FAM209A NPBWR2 PCK1,cellular response to steroid hormone stimulus|positive regulation of cell differentiation|nephrogenic mesenchyme morphogenesis|allantois development|positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,0.0004786|0.0006132|0.000728|0.000728|0.000728,1|1|1|1|1,58.01|14.94|2060|2060|2060
727,14,0.6157,56.03,10870.0,0.005117,0.9999969999999999,BICDL2 CDIP1 CLDN6 CLDN9 CLUAP1 CORO7 NMRAL1 OR1F1 PAQR4 PRSS21 PRSS27 SEPT12 ZNF213 ZNF500,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|bicellular tight junction assembly|tight junction assembly|tight junction organization|apical junction assembly,0.0001075|0.0007416|0.0007917|0.0008434|0.0009795,1|1|1|1|1,140.1|50.73|49.04|47.45|43.91
728,4,0.606,3.636,2719.0,0.0013310000000000002,0.9929309999999999,CCNK CDK10 NRDE2 TTC14,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues|regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues|positive regulation of phosphorylation of RNA polymerase II C-terminal domain|regulation of phosphorylation of RNA polymerase II C-terminal domain|traversing start control point of mitotic cell cycle,0.0003883|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,5149|5149|5149|1716|1287
729,6,0.6048,9.073,4659.0,0.001939,0.998474,CDK18 CHIT1 RGS18 RGS2 RGS21 TROVE2,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of G protein-coupled receptor signaling pathway|negative regulation of glycine import across plasma membrane,0.0004854|0.0004854|0.0004854|0.0005055|0.000728,1|1|1|1|1,4119|4119|4119|56.42|2060
730,4,0.6381,3.8289999999999997,3289.0,0.00116,0.9929309999999999,CDK3 CHST5 HEXDC MTSS1L,G0 to G1 transition|protein sulfation|N-acetylglucosamine metabolic process|sulfation|glucosamine-containing compound metabolic process,0.0001942|0.0008737|0.001941|0.002426|0.00262,1|1|1|1|1,1.03e+04|1287|542|429.1|396.1
731,7,0.6158,12.93,4605.0,0.002792,0.9992989999999999,ASPM CDK5RAP2 HMMR KIFC1 NDE1 PCNT TUBB4B,regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|microtubule cytoskeleton organization|organelle localization|ciliary basal body-plasma membrane docking,2.065e-09|2.998e-09|3.052e-09|5.046e-09|1.736e-08,3.258e-05|2.365e-05|1.605e-05|1.99e-05|5.478e-05,72.47|67.17|31.19|28.66|123.9
732,10,0.9681,43.56,6029.0,0.00715,0.999933,CDK5RAP3 DDRGK1 DNAJC21 EFL1 ODR4 UBA5 UFC1 UFL1 UFM1 UFSP2,protein ufmylation|protein K69-linked ufmylation|protein polyufmylation|reticulophagy|regulation of intracellular estrogen receptor signaling pathway,1.825e-18|2.051e-15|2.051e-15|5.028e-14|1.383e-11,2.879e-14|1.617e-11|1.078e-11|1.983e-10|4.362e-08,2060|2060|2060|858.1|239.5
733,11,0.5894,32.42,8301.0,0.0038799999999999998,0.999969,BTN2A2 CDKAL1 GPX6 HIST1H1T OR14J1 OR2B6 OR2J3 TRIM10 ZKSCAN4 ZNF165 ZSCAN31,cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|detoxification|response to toxic substance,2.224e-05|3.23e-05|3.878e-05|5.922e-05|0.0003294,0.3509|0.2547|0.2039|0.2335|1,54.2|47.67|44.77|38.71|21.45
734,12,0.6005,39.63,8843.0,0.00445,0.999986,ACCSL CAT CHRM4 ELF5 KCNC1 MYBPC3 OR4B1 OR4C13 OR4X1 PAMR1 SLC1A2 TP53I11,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|benzoyl-CoA metabolic process|protein targeting to peroxisome|establishment of protein localization to peroxisome,0.000197|0.0003809|0.001358|0.00138|0.00138,1|1|1|1|1,101.5|71.76|1471|36.78|36.78
735,4,0.7,4.2,2300.0,0.0018170000000000003,0.9929309999999999,CDK4 CDK6 CDKN2C MAU2,negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|G1/S transition of mitotic cell cycle|cell cycle G1/S phase transition|mitotic cell cycle process,5.904e-07|6.404e-07|9.332e-07|9.779e-07|1.241e-06,0.009313|0.005051|0.004907|0.003857|0.003916,144.4|140.4|123.6|121.6|30.07
736,10,0.6047,27.21,6338.0,0.004261,0.999933,CKAP5 CLTC GAK GTSE1 HAUS1 HAUS3 HAUS4 HAUS6 MYBL2 TACC3,mitotic cell cycle|cell cycle|spindle organization|mitotic cell cycle process|regulation of cell cycle,1.313e-12|2.035e-12|2.444e-12|6.671e-11|7.372e-11,2.072e-08|1.605e-08|1.285e-08|2.631e-07|2.326e-07,24.36|14.82|64.07|24.05|15.5
737,4,0.6097,3.658,3487.0,0.001046,0.9929309999999999,CDR2 NANOS1 POPDC3 RASGRF1,"cerebellar neuron development|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|regulation of Rac protein signal transduction|long-term memory",0.0007766|0.003297|0.003685|0.004072|0.00678,1|1|1|1|1,1716|321.8|286|257.4|151.4
738,22,0.6037,139.4,17490.0,0.007888,1.0,ALDH3A1 ALOX15 ALOX15B ALOXE3 CCDC144A CCDC144NL CDRT1 GID4 KRT16 MFAP4 MFSD6L MYH2 MYH4 MYH8 SHBG SLC16A13 TBC1D28 TMEM256 TNFSF12 TNFSF13 VAMP2 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,2.306e-07|2.306e-07|1.011e-06|2.104e-06|7.359e-06,0.003637|0.001818|0.005314|0.008296|0.02322,312|312|175.5|133.7|85.1
739,20,0.6024,114.5,15840.0,0.007157999999999999,1.0,ALDH3A1 ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CDRT15 CDRT15L2 KRT16 MFSD6L MYH2 MYH4 SHBG SLC16A13 TBC1D28 TMEM256 TNFSF12 TNFSF13 VAMP2 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,1.708e-07|1.708e-07|7.492e-07|1.56e-06|5.463e-06,0.002695|0.001347|0.003939|0.006152|0.01723,343.2|343.2|193.1|147.1|93.61
740,35,0.4777,284.3,27110.0,0.01035,1.0,CEACAM1 CEACAM3 CEACAM4 CEACAM5 CEACAM6 CXCL17 CYP2A13 CYP2B6 CYP2S1 EML2 IGFL1 KIR2DL1 LAIR2 LGALS14 PSG1 PSG11 PSG2 PSG3 PSG4 PSG5 PSG6 PSG8 PSG9 PVR ZNF155 ZNF222 ZNF225 ZNF226 ZNF230 ZNF233 ZNF235 ZNF284 ZNF285 ZNF45 ZNF780B,female pregnancy|multi-multicellular organism process|epoxygenase P450 pathway|exogenous drug catabolic process|drug catabolic process,1.519e-09|4.73e-09|9.95e-06|1.455e-05|1.829e-05,2.395e-05|3.731e-05|0.05232|0.05739|0.0577,24.22|20.85|81.3|70.69|65.04
741,4,0.6406,3.844,2911.0,0.001315,0.9929309999999999,CEBPA IRF8 MEF2D ZFP64,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",1.185e-05|3.869e-05|3.869e-05|3.879e-05|4.868e-05,0.1869|0.3052|0.2034|0.153|0.1536,17.08|12.7|12.7|12.69|11.99
742,8,0.6257,17.52,4788.0,0.0036340000000000005,0.9996790000000001,ASNS ATF4 EIF2AK4 GCN1 SLC38A2 SLC3A2 SLC7A5 TRPM7,cellular response to starvation|response to starvation|cellular response to nutrient levels|cellular response to amino acid starvation|response to amino acid starvation,4.156e-09|1.074e-08|1.242e-08|1.777e-08|2.049e-08,6.556e-05|8.469e-05|6.529e-05|7.009e-05|6.465e-05,67.04|55.24|53.63|128.7|124.1
743,4,0.6433,3.86,2990.0,0.001286,0.9929309999999999,CEBPZ DDX18 IMP4 NIFK,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|rRNA processing|maturation of LSU-rRNA|rRNA metabolic process|ribosome biogenesis",6.401e-06|2.019e-05|2.045e-05|2.257e-05|4.16e-05,0.101|0.1592|0.1075|0.08902|0.1313,549.2|47.53|294.2|45.77|37.22
744,7,0.6577,13.81,4871.0,0.0028190000000000003,0.9992989999999999,CLNS1A INTS4 NUMA1 POLD3 RPS3 SPCS2 THAP12,"positive regulation of microtubule polymerization|positive regulation of microtubule polymerization or depolymerization|DNA damage response, detection of DNA damage|regulation of microtubule polymerization|regulation of microtubule polymerization or depolymerization",5.199e-05|6.553e-05|8.064e-05|0.0001457|0.0003486,0.8201|0.5169|0.424|0.5746|1,189.8|168.1|150.9|111|70.9
745,4,0.6058,3.635,3141.0,0.001153,0.9929309999999999,APC2 C12orf40 CELSR2 PLPPR3,cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|organophosphate ester transport|positive regulation of very-low-density lipoprotein particle remodeling,0.0001645|0.0001645|0.0002809|0.0008632|0.001019,1|1|1|1|1,25.29|25.29|21.07|44.58|1471
746,6,0.6314,9.471,3985.0,0.002364,0.998474,CENPF DYNC1LI1 DYNC1LI2 DYNLRB1 NDE1 PAFAH1B1,anaphase|mitotic anaphase|M phase|mitotic M phase|mitotic spindle organization,1.685e-10|1.685e-10|1.849e-10|1.849e-10|2.087e-10,2.658e-06|1.329e-06|9.722e-07|7.292e-07|6.584e-07,109.3|109.3|107.3|107.3|104.6
747,4,0.6054,3.6319999999999997,3148.0,0.00115,0.9929309999999999,CEP104 CKS2 GNA14 TRPM3,phospholipase C-activating dopamine receptor signaling pathway|detection of temperature stimulus|sensory perception of temperature stimulus|dopamine receptor signaling pathway|positive regulation of cyclin-dependent protein serine/threonine kinase activity,0.001747|0.005233|0.005426|0.0062|0.006393,1|1|1|1|1,643.6|198|190.7|166.1|160.9
748,9,0.621,22.36,6342.0,0.003503,0.9998530000000001,CNIH4 DUX4 NBEAL1 NUTF2 POGZ RPL17 SNU13 ST20 TSPYL5,negative regulation of vascular endothelial growth factor production|protein localization to nuclear pore|cellular response to radiation|positive regulation of apoptotic DNA fragmentation|positive regulation of DNA catabolic process,0.00131|0.001746|0.002596|0.002618|0.003054,1|1|1|1|1,1144|762.8|25.86|457.7|381.4
749,8,0.6023,16.86,5129.0,0.0032670000000000004,0.9996790000000001,CEP55 CIT ECT2 IST1 KIF14 KIF1BP PDCD6IP VPS4B,cytoskeleton-dependent cytokinesis|cytokinesis|cell division|mitotic cytokinesis|mitotic cell cycle process,8.847e-14|1.751e-13|4.693e-12|1.015e-11|4.684e-11,1.395e-09|1.381e-09|2.467e-08|4.002e-08|1.478e-07,183.9|163.5|41.86|216.3|30.07
750,8,0.6017,16.85,7004.0,0.0023940000000000003,0.9996790000000001,AP3M1 CEP57L1 CYP2C9 NUTM2A PPP3CB SEMA4G SFTPA2 SRGN,maintenance of granzyme B location in T cell secretory granule|granzyme B localization to T cell secretory granule|maintenance of protease location in T cell secretory granule|maintenance of protein location in T cell secretory granule|protease localization to T cell secretory granule,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
751,6,0.6097,9.146,3872.0,0.002349,0.998474,CEP192 CEP85 FAM210A KIF18B NDC80 TRIM37,mitotic nuclear division|regulation of cell cycle process|centrosome duplication|chromosome segregation|nuclear division,2.1e-05|2.82e-05|4.687e-05|5.296e-05|8.816e-05,0.3313|0.2225|0.2464|0.2089|0.2781,49.27|17.78|196.1|36.01|30.29
752,9,0.6076,21.87,5884.0,0.003692,0.9998530000000001,ARMH3 CERS2 COL4A3BP ELOVL1 KDSR PI4KB SPTLC1 SPTLC2 SPTSSA,sphingolipid biosynthetic process|membrane lipid biosynthetic process|sphingolipid metabolic process|ceramide biosynthetic process|membrane lipid metabolic process,4.21e-13|2.906e-12|7.424e-12|9.007e-12|3.409e-11,6.641e-09|2.292e-08|3.904e-08|3.552e-08|1.075e-07,156|111.9|95.35|238.4|73.55
753,7,0.6485,13.62,4676.0,0.002895,0.9992989999999999,CERS2 CERS6 ELOVL1 FASN SPTSSA TECR TMEM189,lipid biosynthetic process|cellular lipid metabolic process|sphingolipid metabolic process|ceramide biosynthetic process|amide biosynthetic process,1.821e-11|5.477e-10|6.831e-10|1.966e-09|2.02e-09,2.872e-07|4.32e-06|3.592e-06|7.755e-06|6.372e-06,34.44|21.12|90.81|217.9|33.43
754,4,0.6511,3.907,2818.0,0.0013800000000000002,0.9929309999999999,CFAP20 FNBP4 RBM5 SFSWAP,"spliceosomal complex assembly|regulation of mRNA splicing, via spliceosome|regulation of mRNA processing|regulation of RNA splicing|ribonucleoprotein complex assembly",4.821e-05|0.0001505|0.0002845|0.0003172|0.0005122,0.7605|1|1|1|1,180.7|101|73.03|69.11|54.2
755,6,0.6279,9.418,4296.0,0.0021809999999999998,0.998474,CCT8 CFAP298 MCM3AP PAXBP1 SOD1 URB1,response to antipsychotic drug|positive regulation of chromosome organization|response to carbon monoxide|negative regulation of cholesterol biosynthetic process|negative regulation of cholesterol metabolic process,0.0008735|0.001064|0.001456|0.001746|0.001746,1|1|1|1|1,1716|39.45|858.1|686.5|686.5
756,14,0.6078,55.31,8438.0,0.006490999999999999,0.9999969999999999,BCAR1 CRKL ELMO2 FERMT2 ILK ITGA3 ITGAV ITGB1 ITGB5 PTK2 PXN RAC1 SNX17 TLN1,integrin-mediated signaling pathway|cell-matrix adhesion|cell-substrate adhesion|cell adhesion|biological adhesion,3.808e-18|7.513e-15|1.464e-13|6.939e-13|7.427e-13,6.007e-14|5.926e-11|7.696e-10|2.736e-09|2.343e-09,135.1|93.4|63.61|17.02|16.91
757,4,0.6667,4.0,3249.0,0.001227,0.9929309999999999,CFAP44 LRBA SH2D3A TLR10,toll-like receptor 10 signaling pathway|sperm axoneme assembly|MyD88-dependent toll-like receptor signaling pathway|axoneme assembly|JNK cascade,0.0003883|0.004459|0.0062|0.01525|0.01679,1|1|1|1|1,5149|234|166.1|66.01|59.87
758,21,0.6102,128.1,16610.0,0.007634999999999999,1.0,ALDH3A1 ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CFAP52 GID4 KRT16 MFAP4 MFSD6L MYH2 MYH4 MYH8 TBC1D28 TMEM256 TNFSF12 TNFSF13 VAMP2 ZNF287 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,1.992e-07|1.992e-07|8.734e-07|1.818e-06|6.364e-06,0.003142|0.001571|0.004592|0.007171|0.02008,326.9|326.9|183.9|140.1|89.16
759,4,0.6048,3.6289999999999996,3200.0,0.0011300000000000001,0.9929309999999999,BDNF CFAP61 HPSE LIN7C,positive regulation of brain-derived neurotrophic factor receptor signaling pathway|regulation of brain-derived neurotrophic factor receptor signaling pathway|heparan sulfate proteoglycan catabolic process|brain-derived neurotrophic factor receptor signaling pathway|proteoglycan catabolic process,0.0005825|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1716|1287|1287
760,8,0.6264,17.54,6002.0,0.0029059999999999997,0.9996790000000001,CCDC74B CFC1 CFC1B FAHD2A IL1F10 MZT2A POTEI TUBA3D,nodal signaling pathway|activin receptor signaling pathway|determination of left/right symmetry|determination of bilateral symmetry|specification of symmetry,1.198e-05|5.328e-05|0.0009825|0.001063|0.001079,0.1889|0.4203|1|1|1,429.1|190.7|42.2|40.54|40.22
761,8,0.6259,17.53,6353.0,0.002744,0.9996790000000001,CGAS COL19A1 DDX43 DPPA5 GJB7 KHDC1 KHDC1L KHDC3L,regulation of double-strand break repair|activation of cysteine-type endopeptidase activity involved in apoptotic process|regulation of DNA repair|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity,0.0004967|0.0005545|0.001129|0.00125|0.001548,1|1|1|1|1,59.87|56.58|39.3|37.31|33.43
762,5,0.6046,6.046,3966.0,0.001518,0.996692,CGB7 LHB SIGLEC11 ZNF320 ZNF808,hormone-mediated signaling pathway|progesterone biosynthetic process|olefinic compound biosynthetic process|progesterone metabolic process|C21-steroid hormone biosynthetic process,0.0004085|0.001213|0.003152|0.003636|0.00412,1|1|1|1|1,62.89|1030|343.3|294.2|257.4
763,6,0.6164,9.245,4569.0,0.002014,0.998474,CGGBP1 EPHA3 HTR1F POU1F1 VGLL3 ZNF654,fasciculation of motor neuron axon|fasciculation of sensory neuron axon|dsDNA loop formation|adenylate cyclase-inhibiting serotonin receptor signaling pathway|regulation of transcription by RNA polymerase II,0.0008735|0.001165|0.001746|0.002328|0.003028,1|1|1|1|1,1716|1144|686.5|490.4|5.309
764,4,0.6614,3.968,3404.0,0.0011619999999999998,0.9929309999999999,ABCB5 CH25H DYSF KCNQ4,monocyte activation involved in immune response|B cell chemotaxis|T-tubule organization|monocyte activation|plasma membrane repair,0.0005825|0.001359|0.001941|0.002134|0.002522,1|1|1|1|1,2574|858.1|572.1|514.9|429.1
765,6,0.6354,9.531,4608.0,0.002059,0.998474,AKR1C1 AKR1C3 CALML3 CALML5 CHAC1 FAM208B,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,7.067e-07|7.067e-07|2.59e-06|2.59e-06|2.59e-06,0.01115|0.005574|0.01362|0.01021|0.008171,2060|2060|915.3|915.3|915.3
766,4,0.6422,3.853,3230.0,0.001189,0.9929309999999999,CHAD DGKZ GUCY2D TMEM88,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|negative regulation of bone trabecula formation|regulation of bone trabecula formation|regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|receptor guanylyl cyclase signaling pathway,0.0003883|0.0005825|0.0005825|0.0009706|0.002134,1|1|1|1|1,5149|2574|2574|1287|514.9
767,9,0.6089,21.92,7407.0,0.002944,0.9998530000000001,CA13 CA2 CA3 CHCHD7 CHMP4C CYP7A1 NSMAF SGK3 SNX16,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|organic substance transport,6.56e-07|8.103e-07|9.005e-06|2.93e-05|8.726e-05,0.01035|0.006391|0.04735|0.1155|0.2753,176|163.5|26.92|5.56|6.327
768,4,0.6026,3.616,2876.0,0.0012519999999999999,0.9929309999999999,CHI3L2 MEF2C NFKB1 ZNF296,negative regulation of transcription by RNA polymerase II|sinoatrial valve morphogenesis|sinoatrial valve development|cellular response to lipopolysaccharide|cellular response to molecule of bacterial origin,0.000327|0.0003883|0.0003883|0.0004655|0.0005176,1|1|1|1|1,17.12|5149|5149|56.89|53.91
769,8,0.6339,17.75,5091.0,0.0034630000000000004,0.9996790000000001,CHMP1B CHMP3 CHMP5 IST1 STAMBP VPS4A VPS4B VTA1,multivesicular body assembly|multivesicular body organization|ESCRT III complex disassembly|ESCRT complex disassembly|endosome organization,2.634e-19|3.228e-19|2.111e-18|2.111e-18|1.156e-16,4.154e-15|2.546e-15|1.11e-14|8.323e-15|3.648e-13,600.7|581.3|1545|1545|234
770,19,0.6004,102.7,14120.0,0.007199,1.0,ANG BCL2L2 CEBPE CHMP4A CMA1 CMTM5 DHRS2 DHRS4 GZMH LTB4R LTB4R2 MYH6 OR10G2 OR11H4 OR5AU1 RNASE6 SLC7A7 SLC7A8 TM9SF1,leukotriene signaling pathway|L-alpha-amino acid transmembrane transport|antibacterial humoral response|L-amino acid transport|system process,1.686e-05|0.00129|0.00138|0.001473|0.001618,0.2659|1|1|1|1,433.6|38.71|37.38|36.13|3.719
771,8,0.6018,16.85,5002.0,0.0033469999999999997,0.9996790000000001,CHMP1B CHMP3 CHMP4B IST1 STAMBP VPS4A VPS4B VTA1,multivesicular body assembly|multivesicular body organization|endosome organization|viral budding|cytoskeleton-dependent cytokinesis,2.634e-19|3.228e-19|1.156e-16|1.938e-16|5.054e-16,4.154e-15|2.546e-15|6.08e-13|7.643e-13|1.594e-12,600.7|581.3|234|617.9|187.7
772,4,0.749,4.494,2650.0,0.0016879999999999998,0.9929309999999999,CHMP7 LEMD2 NUP35 PDE2A,mitotic nuclear envelope reassembly|mitotic nuclear membrane organization|nuclear envelope reassembly|nuclear membrane organization|nuclear envelope organization,6.799e-08|6.799e-08|8.02e-08|9.863e-08|2.802e-07,0.001072|0.0005362|0.0004217|0.0003889|0.000884,302.9|302.9|286|266.3|186.1
773,4,0.6305,3.783,3138.0,0.001201,0.9929309999999999,CHRM3 RUFY1 ZNF454 ZNF879,saliva secretion|regulation of vascular associated smooth muscle contraction|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|secretion by tissue|G protein-coupled acetylcholine receptor signaling pathway,0.001165|0.001747|0.001747|0.003491|0.003878,1|1|1|1|1,1030|643.6|643.6|302.9|271
774,4,0.6116,3.6689999999999996,3375.0,0.001084,0.9929309999999999,CHST1 GRINA HCK IFI27L2,leukocyte migration involved in immune response|respiratory burst after phagocytosis|respiratory burst involved in defense response|regulation of podosome assembly|galactose metabolic process,0.0005825|0.0007766|0.001553|0.002522|0.002716,1|1|1|1|1,2574|1716|735.5|429.1|396.1
775,4,0.6115,3.6689999999999996,3276.0,0.001116,0.9929309999999999,CHST10 GPRC5C STK39 ZACN,negative regulation of creatine transmembrane transporter activity|regulation of creatine transmembrane transporter activity|negative regulation of pancreatic juice secretion|chemokine (C-X-C motif) ligand 12 signaling pathway|maintenance of lens transparency,0.0005825|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1716|1287|1287
776,4,0.6053,3.6319999999999997,2952.0,0.001225,0.9929309999999999,AP1G2 BCL2L2 CHST2 TM9SF1,Golgi to vacuole transport|N-acetylglucosamine metabolic process|glucosamine-containing compound metabolic process|keratan sulfate biosynthetic process|signal transduction in absence of ligand,0.003878|0.003878|0.005233|0.00562|0.006007,1|1|1|1|1,271|271|198|183.9|171.6
777,27,0.6012,211.0,21920.0,0.009511,1.0,ABCC12 CES1 CES2 CES3 CES4A CES5A CHST5 CHST6 CLEC18A CLEC18B CLEC18C CMTM1 CPNE2 CTRB1 CTRB2 HSD11B2 IRX6 LCAT MT1A MT4 MTSS1L PDP2 PDPR PLA2G15 TMED6 TMEM170A ZNF23,detoxification of copper ion|stress response to copper ion|lipid catabolic process|detoxification of inorganic compound|stress response to metal ion,1.913e-06|1.913e-06|2.494e-06|2.62e-06|3.032e-06,0.03017|0.01508|0.01311|0.01033|0.009564,143|143|15.05|127.1|120.4
778,11,0.6102,33.56,7178.0,0.004639,0.999969,CENPS CENPX CHTF18 CHTF8 DSCC1 ETAA1 FAAP24 FANCM FEN1 MMS22L TRAIP,DNA-dependent DNA replication|DNA replication|DNA metabolic process|replication fork processing|DNA-dependent DNA replication maintenance of fidelity,7.9e-20|2.06e-18|2.529e-16|3.513e-14|1.112e-13,1.246e-15|1.625e-14|1.33e-12|1.385e-10|3.508e-10,96.51|69.09|26.37|288|234
779,7,0.6003,12.61,5586.0,0.002246,0.9992989999999999,C1orf123 FAM69A GBP5 IFI44 IFI44L TYW3 ZNF326,interleukin-18 production|interleukin-1 beta production|interleukin-1 production|positive regulation of NLRP3 inflammasome complex assembly|response to virus,0.0005824|0.002328|0.002909|0.002909|0.003253,1|1|1|1|1,3432|490.4|381.4|381.4|22.29
780,6,0.6377,9.566,4131.0,0.002304,0.998474,CIAO1 CIAO2B CIAPIN1 GLRX3 IREB2 SOD1,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|protein maturation by iron-sulfur cluster transfer|sulfur compound metabolic process|cellular iron ion homeostasis,3.502e-11|3.502e-11|1.118e-08|1.135e-08|7.459e-07,5.525e-07|2.762e-07|5.88e-05|4.477e-05|0.002353,597|597|686.5|46.51|153.7
781,9,0.6326,22.78,6145.0,0.003682,0.9998530000000001,CIAO1 CIAO2B HSCB LYRM4 NDOR1 NUBP2 SOD1 TIMM10 TIMM9,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|cellular component organization,3.747e-16|3.747e-16|2.225e-11|4.687e-08|1.078e-05,5.911e-12|2.955e-12|1.17e-07|0.0001848|0.034,597|597|43.41|457.7|3.566
782,4,0.6235,3.741,3057.0,0.001219,0.9929309999999999,CIB3 ZNF556 ZNF69 ZNF700,"cellular process|regulation of transcription by RNA polymerase II|negative regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription",0.00379|0.007187|0.01088|0.01665|0.01667,1|1|1|1|1,0|5.973|11.42|4.459|4.458
783,4,0.6621,3.9730000000000003,3162.0,0.0012519999999999999,0.9929309999999999,BAX BBC3 CILP PMAIP1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|mitochondrial outer membrane permeabilization|positive regulation of mitochondrial membrane permeability involved in apoptotic process|mitochondrial outer membrane permeabilization involved in programmed cell death|release of cytochrome c from mitochondria,3.295e-10|2.66e-09|3.65e-09|4.86e-09|6.311e-09,5.197e-06|2.098e-05|1.919e-05|1.917e-05|1.991e-05,2207|965.4|858.1|772.3|702.1
784,4,0.608,3.648,2871.0,0.001265,0.9929309999999999,ASPM CKAP2L KIF22 KIFC1,mitotic metaphase plate congression|metaphase plate congression|establishment of chromosome localization|chromosome localization|organelle localization,3.454e-05|5.156e-05|8.451e-05|8.892e-05|0.0001056,0.5448|0.4066|0.4444|0.3507|0.3332,214.5|174.5|135.5|132|25.08
785,4,0.6092,3.655,3260.0,0.001117,0.9929309999999999,CKB HTR3E IGFBP6 RETREG1,phosphocreatine metabolic process|phosphagen metabolic process|phosphagen biosynthetic process|phosphocreatine biosynthetic process|CDP-choline pathway,0.001213|0.001213|0.001213|0.001213|0.00194,1|1|1|1|1,1030|1030|1030|1030|588.4
786,13,0.5743,44.8,9825.0,0.004527000000000001,0.999993,CD19 CD79A CD79B CD81 CLBA1 DOCK2 EBF1 ELMO1 LDLRAP1 PAX5 RAC2 RHOH SYK,leukocyte differentiation|lymphocyte activation|positive regulation of immune system process|regulation of immune response|lymphocyte differentiation,1.447e-09|2.903e-09|3.925e-09|7.203e-09|9.135e-09,2.282e-05|2.29e-05|2.064e-05|2.84e-05|2.882e-05,29.17|26.34|12.57|11.73|35.59
787,10,0.6132,27.59,8077.0,0.003396,0.999933,CLCA1 CLCA4 FAM69A GBP5 GBP6 GNAT2 IFI44 KCNA10 MCOLN3 TMEM56,inorganic ion transmembrane transport|interleukin-18 production|chloride transmembrane transport|ion transmembrane transport|chloride transport,0.0001967|0.0009704|0.001003|0.001119|0.001127,1|1|1|1|1,12.41|2060|42.46|7.838|39.99
788,4,0.618,3.708,2845.0,0.0012980000000000001,0.9929309999999999,CLCC1 NUP35 NUP37 VRK2,tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|tRNA transport|ncRNA export from nucleus|mitotic nuclear envelope reassembly,1.778e-05|1.778e-05|2.091e-05|2.201e-05|3.884e-05,0.2804|0.1402|0.1099|0.08678|0.1225,302.9|302.9|278.3|271|201.9
789,6,0.6221,9.331,4669.0,0.00199,0.998474,A2M CLCN1 CLEC4D CLEC6A GYS2 SLCO1C1,regulation of innate immune response|regulation of response to biotic stimulus|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction,6.844e-05|0.0001653|0.0004726|0.0005054|0.0005137,1|1|1|1|1,33|24.46|59.7|57.69|57.21
790,21,0.6074,127.6,15990.0,0.007894,1.0,CEACAM5 CEACAM6 CYP2A13 CYP2A7 CYP2B6 KIR2DL1 KIR2DL3 LAIR2 PSG1 PSG11 PSG2 PSG3 PSG4 PSG5 PSG6 PSG8 PSG9 ZNF155 ZNF230 ZNF285 ZNF780B,female pregnancy|multi-multicellular organism process|epoxygenase P450 pathway|exogenous drug catabolic process|drug catabolic process,1.72e-11|5.459e-11|2.116e-06|3.1e-06|3.901e-06,2.713e-07|4.305e-07|0.01113|0.01223|0.01231,40.02|34.44|134.3|116.8|107.5
791,6,0.6129,9.193,4428.0,0.002066,0.998474,CLCNKA PRAMEF11 PRAMEF12 PRAMEF14 PRAMEF18 PRAMEF20,negative regulation of cell differentiation|negative regulation of developmental process|negative regulation of apoptotic process|negative regulation of programmed cell death|positive regulation of cell population proliferation,1.705e-07|7.915e-07|8.758e-07|9.725e-07|1.112e-06,0.00269|0.006242|0.004605|0.003835|0.00351,26.9|19.73|19.33|18.92|18.41
792,7,0.6378,13.39,4640.0,0.0028699999999999997,0.9992989999999999,CERS2 CERS6 ELOVL1 FASN HSD17B12 TECR TMEM189,lipid biosynthetic process|fatty-acyl-CoA biosynthetic process|cellular lipid metabolic process|fatty-acyl-CoA metabolic process|acyl-CoA biosynthetic process,1.821e-11|2.433e-10|5.477e-10|7.574e-10|9.83e-10,2.872e-07|1.919e-06|2.88e-06|2.987e-06|3.101e-06,34.44|379.6|21.12|280.2|261.5
793,8,0.6207,17.38,5045.0,0.003423,0.9996790000000001,BSG GPI HK2 PFKP PGD PGP SLC2A1 VDAC1,pyruvate metabolic process|carboxylic acid metabolic process|monosaccharide metabolic process|oxoacid metabolic process|organic acid metabolic process,6.49e-11|5.873e-09|6.766e-09|7.688e-09|9.963e-09,1.024e-06|4.632e-05|3.557e-05|3.032e-05|3.143e-05,165.8|19.35|63.56|18.6|17.92
794,4,0.6104,3.6630000000000003,3379.0,0.00108,0.9929309999999999,CLDN20 HEXA SLC9C2 TNFSF18,negative regulation of T-helper 17 cell lineage commitment|T cell proliferation involved in immune response|ganglioside catabolic process|regulation of T-helper 17 cell lineage commitment|regulation of dendritic cell chemotaxis,0.0007766|0.001165|0.001553|0.001553|0.002134,1|1|1|1|1,1716|1030|735.5|735.5|514.9
795,5,0.6289,6.289,4205.0,0.00149,0.996692,BTN2A2 CLDN22 GABBR1 INTU TXNDC5,neuron-glial cell signaling|tongue morphogenesis|negative regulation of keratinocyte proliferation|negative regulation of activated T cell proliferation|negative regulation of cell division,0.001456|0.002667|0.003394|0.003636|0.00412,1|1|1|1|1,823.8|411.9|316.8|294.2|257.4
796,20,0.524,99.55,15550.0,0.006346,1.0,ABHD11 ASL CASTOR3 CLDN3 CLDN4 CYP3A43 CYP3A5 CYP3A7 CYP51A1 FGL2 GNAT3 PILRB PON1 SEMA3E TBL2 TRIM50 TYW1 ZKSCAN1 ZNF92 ZSCAN25,demethylation|oxidative demethylation|steroid metabolic process|positive regulation of metallopeptidase activity|lipid hydroxylation,6.982e-07|1.385e-06|6.027e-06|2.757e-05|3.542e-05,0.01101|0.01093|0.03169|0.1087|0.1118,59.44|154.8|18.72|326.9|280.2
797,14,0.6113,55.63,10300.0,0.0053560000000000005,0.9999969999999999,ARL13B CDV3 CLDND1 MTRNR2L8 OR5AC2 OR5H1 OR5H14 OR5H15 OR5H2 OR5K1 OR5K3 OR5K4 PROS1 ST3GAL6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.278e-10|2.031e-10|2.726e-10|4.759e-10|6.379e-10,2.015e-06|1.602e-06|1.433e-06|1.877e-06|2.012e-06,26.69|25.15|24.22|22.55|21.71
798,9,0.6121,22.03,7017.0,0.0031219999999999998,0.9998530000000001,A2M CLEC12B CLEC4D CLEC6A GALNT8 KCNA6 PKP2 SLCO1B1 SLCO1C1,regulation of innate immune response|regulation of response to biotic stimulus|sodium-independent organic anion transport|bile acid and bile salt transport|regulation of defense response,6.437e-06|2.072e-05|2.586e-05|0.000106|0.0002959,0.1015|0.1634|0.136|0.4181|0.9336,29.34|21.74|286|134.6|10.92
799,19,0.5717,97.76,12570.0,0.007697,1.0,CLEC16A COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 FAM160B1 PTAR1 RAB1B RAB2A SLC10A7 SLC39A9 UNC50 VPS52 VPS54 YKT6,Golgi vesicle transport|endoplasmic reticulum to Golgi vesicle-mediated transport|protein transport|peptide transport|amide transport,1.489e-18|6.812e-16|1.874e-14|2.497e-14|3.472e-14,2.348e-14|5.372e-12|9.851e-11|9.846e-11|1.095e-10,35.58|55.3|11.11|10.9|10.65
800,8,0.6105,17.1,6374.0,0.002668,0.9996790000000001,C3AR1 CLEC1B CLEC4D GALNT8 KCNA1 KCNA6 KLRC1 TAS2R10,cell activation|immune response-regulating cell surface receptor signaling pathway|immune response-regulating signaling pathway|detection of mechanical stimulus involved in sensory perception of touch|positive regulation of myeloid dendritic cell activation,0.0004562|0.0007013|0.0007138|0.001164|0.001164,1|1|1|1|1,9.5|15.73|15.63|1287|1287
801,11,0.6032,33.17,7530.0,0.004374,0.999969,RPL10A RPL11 RPL12 RPL17 RPL23 RPL31 RPL37 RPL4 RPL9 RPLP2 RPS13,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,4.36e-26|7.385e-26|1.975e-25|2.859e-25|3.13e-25,6.878e-22|5.825e-22|1.038e-21|1.128e-21|9.875e-22,214.5|203.9|185.5|179.1|177.5
802,10,0.6142,27.64,7943.0,0.0034590000000000003,0.999933,C3AR1 CLEC2B CLEC4D CLEC4E CLEC6A GALNT8 KCNA1 KCNA6 KLRC1 PZP,immune response-regulating cell surface receptor signaling pathway|immune response-regulating signaling pathway|regulation of immune response|regulation of innate immune response|stimulatory C-type lectin receptor signaling pathway,1.807e-06|1.861e-06|4.78e-06|1.06e-05|2.134e-05,0.0285|0.01468|0.02514|0.04179|0.06731,20.97|20.85|10.95|26.4|53.73
803,5,0.6227,6.227,4421.0,0.001403,0.996692,ADAD1 CLEC4F FIGN KLHL2 PDE5A,cGMP catabolic process|adenosine to inosine editing|microtubule severing|cyclic nucleotide catabolic process|cGMP metabolic process,0.001456|0.002183|0.003152|0.003636|0.004604,1|1|1|1|1,823.8|514.9|343.3|294.2|228.8
804,6,0.6134,9.201,4810.0,0.0019039999999999999,0.998474,CLEC12B CLEC7A PRB4 PRH2 PZP TAS2R19,regulation of cell killing|detection of molecule of fungal origin|detection of fungus|natural killer cell inhibitory signaling pathway|cellular response to molecule of fungal origin,0.0004566|0.0005824|0.0008735|0.001165|0.001456,1|1|1|1|1,60.75|3432|1716|1144|858.1
805,10,0.604,27.18,7776.0,0.003474,0.999933,CLEC12A CLEC2B CLEC4C CLEC4D CLEC9A KLRC1 PRB4 PRH2 TAS2R13 TAS2R20,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|regulation of innate immune response|sensory perception of taste,0.0001476|0.0001894|0.0001984|0.0003922|0.000503,1|1|1|1|1,114.4|100.5|98.07|19.8|60.57
806,5,0.603,6.03,3281.0,0.001829,0.996692,CLINT1 MON2 OSBPL11 OSBPL9 VPS54,post-Golgi vesicle-mediated transport|Golgi vesicle transport|sterol transport|transport|cytosolic transport,2.85e-06|7.006e-05|0.0001405|0.0004999|0.0005192,0.04495|0.5526|0.7387|1|1,92.22|31.2|108.4|4.576|55.66
807,5,0.6019,6.019,3446.0,0.001739,0.996692,CLK1 CLK3 MAEA MKLN1 RANBP9,peptidyl-tyrosine phosphorylation|regulation of RNA splicing|peptidyl-tyrosine modification|enucleate erythrocyte development|protein autophosphorylation,0.0007647|0.0007853|0.0007956|0.0008735|0.001188,1|1|1|1|1,46.7|46.07|45.77|1716|37.31
808,20,0.6038,114.7,15090.0,0.007525,1.0,CLK2 CTSK EFNA4 FCRL3 FLG2 GBA HIST2H2AB ITLN2 LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A7A S100A8 S100A9 SLAMF7,neutrophil aggregation|defense response to fungus|sequestering of zinc ion|antimicrobial humoral response|response to fungus,4.824e-06|9.828e-06|1.205e-05|1.237e-05|2.197e-05,0.07609|0.07751|0.06334|0.04879|0.06932,1084|75.62|542|27.79|57.05
809,4,0.6597,3.958,3209.0,0.0012289999999999998,0.9929309999999999,CLK1 CLK4 ELOVL3 NR1H4,peptidyl-amino acid modification|peptidyl-tyrosine phosphorylation|regulation of RNA splicing|peptidyl-tyrosine modification|regulation of urea metabolic process,0.0002989|0.0003089|0.0003172|0.0003214|0.0003883,1|1|1|1|0.3603,17.65|70.05|69.11|68.65|5149
810,4,0.7018,4.211,2941.0,0.001426,0.9929309999999999,CFAP300 CLMP GJC1 TJP1,gap junction assembly|cell-cell junction assembly|cell communication by electrical coupling involved in cardiac conduction|cell-cell junction organization|cell communication by electrical coupling,2.119e-06|2.433e-06|6.401e-06|7.499e-06|1.087e-05,0.03343|0.01919|0.03365|0.02957|0.03428,1030|97.3|549.2|66.44|411.9
811,24,0.6103,168.4,17280.0,0.009626000000000001,1.0,C12orf65 CLPP CLPX DDX28 FASTKD2 GRSF1 GTPBP10 MALSU1 MPV17L2 MRM2 MRM3 MRPL1 MRPL44 MRPL50 MRPL58 MTERF3 MTG1 NGRN REXO2 RMND1 RPUSD3 RPUSD4 SLC30A9 TRUB2,regulation of mitochondrial translation|regulation of mitochondrial gene expression|positive regulation of mitochondrial translation|ribosome biogenesis|ribonucleoprotein complex biogenesis,4.898e-20|1.466e-19|3.768e-16|4.736e-14|1.685e-12,7.726e-16|1.156e-15|1.981e-12|1.868e-10|5.317e-09,297|257.4|353.3|28.43|20.3
812,4,0.6004,3.602,3466.0,0.001036,0.9929309999999999,CCDC28B CLSTN1 MTHFR SMIM1,response to vitamin B2|heterochromatin maintenance|heterochromatin organization involved in chromatin silencing|chromatin maintenance|tetrahydrofolate interconversion,0.0003883|0.0009706|0.001165|0.001359|0.002134,1|1|1|1|1,5149|1287|1030|858.1|514.9
813,11,0.6015,33.08,8622.0,0.0038130000000000004,0.999969,CLEC2B CLEC4C CLEC4D CLEC6A KLRC1 SLC2A3 TAS2R13 TAS2R20 TAS2R7 TAS2R8 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|detection of chemical stimulus involved in sensory perception,1.109e-11|2.026e-11|2.267e-11|2.206e-10|3.089e-06,1.75e-07|1.598e-07|1.192e-07|8.699e-07|0.009744,260|228.3|222.9|137.7|19.26
814,9,0.6264,22.55,7016.0,0.003196,0.9998530000000001,COL19A1 DDX43 DPPA5 FAM135A GABRR1 KHDC1 KHDC1L KHDC3L LGSN,activation of cysteine-type endopeptidase activity involved in apoptotic process|glutamine biosynthetic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity|regulation of presynaptic membrane potential,0.0007108|0.00131|0.001599|0.00198|0.002618,1|1|1|1|1,50.29|1144|33.16|29.72|457.7
815,4,0.6282,3.7689999999999997,3336.0,0.001126,0.9929309999999999,ARHGAP28 CLUL1 LRRC30 PTPRM,protein dephosphorylation|negative regulation of GTP binding|dephosphorylation|regulation of GTP binding|retinal ganglion cell axon guidance,0.0006596|0.0007766|0.001432|0.003104|0.003491,1|1|1|1|1,47.67|1716|32.18|343.2|302.9
816,5,0.6425,6.425,3938.0,0.001625,0.996692,BIVM CLYBL DLEU7 GPR183 SLITRK5,positive regulation of cobalamin metabolic process|regulation of cobalamin metabolic process|dendritic cell homeostasis|regulation of astrocyte chemotaxis|positive regulation of tetrapyrrole metabolic process,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
817,7,0.6186,12.99,5643.0,0.002291,0.9992989999999999,CMBL DNAH5 FAM173B OTULIN OTULINL ROPN1L SLC6A18,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|sperm motility|flagellated sperm motility|cilium movement involved in cell motility,4.434e-05|5.213e-05|0.0002925|0.0002925|0.0003455,0.6994|0.4112|1|1|1,201.9|185.5|76.28|76.28|70.05
818,4,0.6251,3.75,2361.0,0.0015810000000000002,0.9929309999999999,CMIP DHX29 EIF4G2 STK11,regulation of translational initiation|positive regulation of axonogenesis|positive regulation of translation|translational initiation|cell cycle arrest,9.807e-05|0.0001004|0.000265|0.0002925|0.0002966,1|0.7921|1|1|0.9357,125.6|124.1|75.72|72.01|71.51
819,16,0.5632,67.58,9428.0,0.007094,0.999999,ADSL CMPK1 COASY DTYMK GMPPB GMPS HMGCR HMGCS1 MAT2A MVD MVK PGD PMVK RPIA UBIAD1 YRDC,small molecule metabolic process|carbohydrate derivative metabolic process|nucleobase-containing small molecule metabolic process|ribose phosphate metabolic process|organophosphate metabolic process,4.449e-16|4.775e-15|1.072e-14|1.359e-14|7.903e-14,7.018e-12|3.766e-11|5.637e-11|5.36e-11|2.493e-10,11.9|16.63|27.44|37.64|17.2
820,11,0.6128,33.71,7079.0,0.004724,0.999969,DENND4C EXOC1 EXOC2 EXOC3 EXOC5 EXOC7 EXOC8 RAB10 RABIF RALGAPB SNAP23,post-Golgi vesicle-mediated transport|protein transport|peptide transport|amide transport|Golgi to plasma membrane transport,1.949e-13|3.485e-11|4.231e-11|5.288e-11|6.173e-11,3.075e-09|2.748e-07|2.225e-07|2.085e-07|1.947e-07,97.81|12.8|12.55|12.27|180
821,4,0.6342,3.805,3167.0,0.0011970000000000001,0.9929309999999999,CMTM8 KCNK3 RGMB TMEM229A,negative regulation of cytosolic calcium ion concentration|stabilization of membrane potential|cellular response to zinc ion|cochlea development|response to zinc ion,0.00291|0.003491|0.00504|0.009675|0.0116,1|1|1|1|1,367.8|302.9|205.9|105.1|87.27
822,4,0.6067,3.64,2972.0,0.00122,0.9929309999999999,CMTR1 RPL8 VARS VPS28,valyl-tRNA aminoacylation|positive regulation of ubiquitin-dependent endocytosis|regulation of ubiquitin-dependent endocytosis|cap mRNA methylation|cap1 mRNA methylation,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
823,4,0.6022,3.613,3513.0,0.001025,0.9929309999999999,AATK CMYA5 EVI5 ZNF620,"peptidyl-tyrosine autophosphorylation|retrograde transport, endosome to Golgi|activation of GTPase activity|peptidyl-tyrosine phosphorylation|cytosolic transport",0.003297|0.01756|0.02253|0.02843|0.02862,1|1|1|1|1,321.8|57.21|44.39|35.03|34.79
824,9,0.6011,21.64,5865.0,0.003665,0.9998530000000001,APH1A CNEP1R1 CTDNEP1 IPO8 LEMD3 NCSTN TGFBR1 TGFBR2 TGFBR3,pathway-restricted SMAD protein phosphorylation|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of transforming growth factor beta receptor signaling pathway|regulation of cellular response to transforming growth factor beta stimulus|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,3.218e-08|3.508e-08|1.589e-07|1.748e-07|2.806e-07,0.0005076|0.0002767|0.0008354|0.0006893|0.0008852,528.1|111.6|75.65|73.82|65.38
825,15,0.6047,63.5,12540.0,0.005025,0.999999,ADAM2 C8orf58 CHRNB3 DMTN NAT1 NAT2 PEBP4 RNF5 SARAF SCARA3 STC1 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D,TRAIL-activated apoptotic signaling pathway|glutamine transport|extrinsic apoptotic signaling pathway via death domain receptors|neutral amino acid transport|sodium ion transport,6.535e-08|1.282e-07|5.01e-06|8.75e-06|2.337e-05,0.001031|0.001011|0.02635|0.03451|0.07372,514.9|386.2|96.54|79.21|23.67
826,15,0.5457,57.3,10130.0,0.00561,0.999999,CNIH1 GOSR2 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23B SEC23IP SEC24A SEC31A TBC1D20 TRAPPC12 TRAPPC13 TRAPPC2L,"COPII-coated vesicle budding|vesicle budding from membrane|endoplasmic reticulum to Golgi vesicle-mediated transport|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi",3.055e-27|2.264e-25|8.484e-25|4.839e-22|4.839e-22,4.819e-23|1.785e-21|4.461e-21|1.908e-18|1.527e-18,235.4|160|91.07|217.9|217.9
827,4,0.604,3.6239999999999997,3134.0,0.001152,0.9929309999999999,CNIH2 MAP3K11 SNX17 TMEM179B,negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|negative regulation of anterograde synaptic vesicle transport|negative regulation of synaptic vesicle transport|regulation of anterograde synaptic vesicle transport,0.0003883|0.0003883|0.0003883|0.0003883|0.0007766,1|1|1|1|1,5149|5149|5149|5149|1716
828,4,0.6292,3.775,3381.0,0.001113,0.9929309999999999,CNMD F7 SPERT ZIC5,response to carbon dioxide|response to astaxanthin|response to Thyroid stimulating hormone|response to anticoagulant|response to genistein,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
829,4,0.6548,3.929,3472.0,0.0011279999999999999,0.9929309999999999,CNN3 LRP2 MEGF8 RAB27B,coronary vasculature development|epiboly involved in gastrulation with mouth forming second|epithelium development|positive regulation of neurogenesis|positive regulation of oligodendrocyte progenitor proliferation,2.792e-05|0.0003883|0.0005833|0.0006901|0.0007766,0.4404|1|1|1|1,239.5|5149|14.08|46.6|1716
830,7,0.616,12.94,5583.0,0.002306,0.9992989999999999,ASTL C2orf49 CNNM3 CNNM4 IL1F10 LYG1 MGAT4A,prevention of polyspermy|negative regulation of fertilization|cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process,0.001019|0.001019|0.001019|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|980.7|980.7
831,5,0.677,6.77,3332.0,0.002022,0.996692,ANKRD17 BTG1 CNOT2 CNOT3 CNOT8,regulation of G1/S transition of mitotic cell cycle|nuclear-transcribed mRNA poly(A) tail shortening|regulation of mitotic cell cycle|regulation of cell cycle G1/S phase transition|negative regulation of mitotic cell cycle,1.573e-08|1.782e-08|1.944e-08|2.558e-08|2.122e-07,0.0002481|0.0001405|0.0001022|0.0001009|0.0006694,108.4|537.3|35.03|95.79|56.04
832,4,0.6317,3.79,3312.0,0.00114,0.9929309999999999,CNR2 CYP7A1 FAM71F1 PTPRR,vestibular receptor cell morphogenesis|vestibular receptor cell development|vestibular receptor cell differentiation|negative regulation of action potential|cannabinoid signaling pathway,0.0005825|0.0007766|0.0007766|0.001359|0.001359,1|1|1|1|1,2574|1716|1716|858.1|858.1
833,4,0.6311,3.787,3395.0,0.001111,0.9929309999999999,CNTFR KIF24 MBOAT1 ZNF444,ciliary neurotrophic factor-mediated signaling pathway|brainstem development|suckling behavior|microtubule depolymerization|phosphatidylserine acyl-chain remodeling,0.001165|0.001553|0.002522|0.003491|0.004459,1|1|1|1|1,1030|735.5|429.1|302.9|234
834,4,0.6258,3.755,3248.0,0.001152,0.9929309999999999,CNTN5 COL6A2 GLIPR1L1 NMT2,N-terminal peptidyl-glycine N-myristoylation|N-terminal protein myristoylation|protein myristoylation|peptidyl-glycine modification|N-terminal protein lipidation,0.0005825|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1287|1287|1287|1030
835,4,0.6405,3.843,3159.0,0.001212,0.9929309999999999,CNTNAP2 FUCA2 PHACTR2 TAAR2,superior temporal gyrus development|clustering of voltage-gated potassium channels|protein localization to juxtaparanode region of axon|observational learning|imitative learning,0.0005825|0.0007766|0.0009706|0.001359|0.001359,1|1|1|1|1,2574|1716|1287|858.1|858.1
836,6,0.6324,9.486,3850.0,0.00245,0.998474,AMBRA1 CDK4 DYRK1A FAM117B FAM53C GLCCI1,circadian rhythm|cellular response to ionomycin|response to ionomycin|cellular response to phorbol 13-acetate 12-myristate|response to phorbol 13-acetate 12-myristate,0.000695|0.001746|0.001746|0.001746|0.001746,1|1|1|1|1,49.04|686.5|686.5|686.5|686.5
837,9,0.6048,21.77,7181.0,0.003015,0.9998530000000001,C9orf3 FBP1 FBP2 GNA14 KIF12 NUTM2G TXNDC8 ZNF484 ZNF510,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.271e-06|2.118e-06|4.446e-06|1.163e-05|1.649e-05,0.02005|0.01671|0.02338|0.04587|0.05202,2060|1373|823.8|457.7|374.5
838,8,0.6255,17.51,6090.0,0.00286,0.9996790000000001,ASCL1 GATA3 HAND2 INSM2 ISL1 LIN28B PHOX2B SOX11,sympathetic nervous system development|noradrenergic neuron differentiation|autonomic nervous system development|neuron differentiation|cardiac ventricle morphogenesis,1.188e-13|3.074e-12|4.68e-12|6.059e-09|1.004e-08,1.874e-09|2.425e-08|2.461e-08|2.389e-05|3.168e-05,612.9|1471|273.9|17.53|149.2
839,4,0.6151,3.6910000000000003,3185.0,0.001155,0.9929309999999999,COL16A1 FAM221B OR2S2 UNC13B,positive regulation of synaptic vesicle priming|dense core granule priming|presynaptic dense core vesicle exocytosis|neuronal dense core vesicle exocytosis|acrosomal vesicle exocytosis,0.0003883|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,5149|1716|1030|1030|858.1
840,7,0.6073,12.75,5657.0,0.0022440000000000003,0.9992989999999999,ANKRD13C COL24A1 FAM69A GBP5 IFI44 IFI44L TMEM56,interleukin-18 production|interleukin-1 beta production|protein retention in ER lumen|interleukin-1 production|positive regulation of NLRP3 inflammasome complex assembly,0.0006794|0.002715|0.003393|0.003393|0.003393,1|1|1|1|1,2942|420.3|326.9|326.9|326.9
841,4,0.6039,3.623,3087.0,0.001169,0.9929309999999999,COL27A1 OR1A2 OR1D5 SPNS3,growth plate cartilage chondrocyte development|chondrocyte development involved in endochondral bone morphogenesis|growth plate cartilage chondrocyte differentiation|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell,0.001165|0.001747|0.001941|0.00269|0.003023,1|1|1|1|1,1030|643.6|572.1|23.35|22
842,5,0.6286,6.2860000000000005,3886.0,0.001611,0.996692,BIVM CLYBL COL4A1 GPR183 SLITRK5,positive regulation of cobalamin metabolic process|regulation of cobalamin metabolic process|dendritic cell homeostasis|regulation of astrocyte chemotaxis|positive regulation of tetrapyrrole metabolic process,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
843,6,0.6133,9.2,4823.0,0.0018989999999999999,0.998474,COL4A3 COL4A4 CRYGA CRYGB CRYGC CRYGD,lens development in camera-type eye|visual perception|sensory perception of light stimulus|camera-type eye development|sensory perception,3.143e-09|1.867e-07|2.007e-07|8.574e-07|1.376e-06,4.958e-05|0.001472|0.001055|0.003381|0.004342,180.7|63.56|62.41|43.18|17.64
844,15,0.6052,63.55,11560.0,0.005452,0.999999,COL6A1 COL6A2 KRTAP10-1 KRTAP10-11 KRTAP10-3 KRTAP10-8 KRTAP10-9 KRTAP12-1 KRTAP12-3 KRTAP12-4 KRTAP13-1 KRTAP19-3 KRTAP19-6 KRTAP19-7 TMPRSS3,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,7.432e-21|5.412e-20|3.712e-19|3.533e-18|9.585e-18,1.172e-16|4.269e-16|1.952e-15|1.393e-14|3.024e-14,68.35|57.64|48.88|40.33|37.04
845,8,0.6034,16.9,5105.0,0.0032890000000000003,0.9996790000000001,BRAF DUSP4 MAFF MAP2K1 MAPK1 MITF SOX10 SOX9,regulation of multicellular organismal development|trachea development|endocrine system development|thyroid gland development|regulation of cell differentiation,3.385e-08|5.897e-08|9.456e-08|1.119e-07|1.166e-07,0.000534|0.0004651|0.0004972|0.0004413|0.0003677,13.67|406.5|83.72|321.8|11.43
846,10,0.6139,27.62,8182.0,0.003357,0.999933,C1orf50 CFAP57 COL9A2 ERMAP MFSD2A MPL PPT1 ZFP69B ZNF684 ZNF691,basophil homeostasis|eosinophil homeostasis|lysophospholipid translocation|regulation of phosphatidylserine metabolic process|regulation of phosphatidylethanolamine metabolic process,0.0009704|0.0009704|0.0009704|0.0009704|0.0009704,1|1|1|1|1,2060|2060|2060|2060|2060
847,5,0.6457,6.457000000000001,3554.0,0.001809,0.996692,COLCA2 POU2F3 SOX4 TFAP2B TP73,sympathetic nervous system development|aorta morphogenesis|kidney development|renal system development|urogenital system development,1.19e-05|2.185e-05|2.487e-05|2.732e-05|3.731e-05,0.1877|0.1724|0.1308|0.1077|0.1177,392.3|284.1|44.29|42.91|38.62
848,13,0.5628,43.9,11240.0,0.003882,0.999993,AARD C8orf76 COL14A1 COLEC10 CPNE3 ENPP2 FBXO32 KLHL38 MTSS1 NOV RNF139 SLC30A8 TNFRSF11B,chemotaxis|taxis|response to chemical|epithelial cell proliferation|negative regulation of animal organ morphogenesis,0.0005417|0.0005529|0.001239|0.00195|0.002182,1|1|1|1|1,10.06|10|2.828|30.85|686.5
849,8,0.6084,17.04,4990.0,0.0033909999999999995,0.9996790000000001,COP1 DDA1 DET1 DUSP4 DUSP5 JUNB STK40 TRIB1,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|regulation of proteasomal ubiquitin-dependent protein catabolic process,5.03e-08|9.845e-08|1.176e-07|2.165e-07|2.365e-07,0.0007934|0.0007765|0.0006183|0.0008538|0.0007461,101.7|85.55|81.73|69.87|68.31
850,17,0.5459,74.24,11810.0,0.006231,1.0,ABCE1 COPB2 EIF2S1 ETF1 ISY1 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 SMU1 SNRPD1 SNU13 SRP54 VCP,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,1.569e-16|1.451e-13|1.451e-13|1.451e-13|1.451e-13,2.474e-12|1.144e-09|7.629e-10|5.722e-10|4.578e-10,364.1|123.2|123.2|123.2|123.2
851,11,0.6944,38.19,7698.0,0.004922999999999999,0.999969,C16orf72 CAND1 COPS2 COPS3 COPS4 COPS6 COPS7A COPS7B COPS8 DDA1 GPS1,"protein deneddylation|nucleotide-excision repair, DNA damage recognition|transcription-coupled nucleotide-excision repair|post-translational protein modification|nucleotide-excision repair",8.957e-24|1.612e-21|6.53e-18|3.436e-17|9.615e-17,1.413e-19|1.271e-17|3.433e-14|1.355e-13|3.033e-13,1498|651.2|205.2|51.86|144
852,5,0.6134,6.1339999999999995,3938.0,0.001551,0.996692,C15orf53 CHRNA7 CORO2B GABRA5 TPM1,"regulation of postsynaptic membrane potential|system process|synaptic transmission, cholinergic|regulation of supramolecular fiber organization|chemical synaptic transmission",1.205e-06|9.599e-06|1.777e-05|5.964e-05|8.337e-05,0.01901|0.07571|0.09344|0.2352|0.263,123.6|10.1|316.8|32.95|29.42
853,10,0.6013,27.06,8103.0,0.0033200000000000005,0.999933,CORO6 CRYBA1 GAS2L2 LGALS9 LYRM9 NOS2 PIPOX TIAF1 TMEM97 VTN,regulation of leukocyte mediated cytotoxicity|protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome|peroxisomal transport,0.0008203|0.0008406|0.0008406|0.0008406|0.0008611,1|1|1|1|1,47.4|46.81|46.81|46.81|46.23
854,9,0.6297,22.67,7123.0,0.003165,0.9998530000000001,CFAP57 CORT CYP4Z1 ERMAP EXO5 ZFP69 ZFP69B ZNF684 ZNF691,"negative regulation of transcription by RNA polymerase II|resolution of meiotic recombination intermediates|meiotic chromosome separation|chromosome separation|negative regulation of transcription, DNA-templated",0.005814|0.00827|0.009571|0.0126|0.01549,1|1|1|1|1,7.611|127.1|109|81.73|5.33
855,11,0.6192,34.05,8530.0,0.003966,0.999969,CCM2L COX4I2 DEFB115 DEFB116 DUSP15 FOXS1 HCK MYLK2 NOL4L TM9SF4 XKR7,phagocytosis|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding|skeletal muscle satellite cell differentiation,0.0006051|0.001601|0.002134|0.002667|0.002667,1|1|1|1|1,17.23|936.1|624.1|468.1|468.1
856,13,0.6049,47.18,9588.0,0.004884,0.999993,COX14 COX18 COX6A1 FOXRED1 HIGD2A MRM2 MTFMT MTO1 NDUFA4 NOA1 SURF1 TBRG4 YBEY,mitochondrial respiratory chain complex assembly|mitochondrial cytochrome c oxidase assembly|respiratory chain complex IV assembly|cytochrome complex assembly|mitochondrion organization,4.391e-07|4.474e-07|7.098e-07|1.769e-06|6.147e-06,0.006927|0.003529|0.003732|0.006975|0.01939,62.74|216|182.8|132|17.33
857,11,0.5818,32.0,9293.0,0.003423,0.999969,C8orf44 CA1 CA8 CNGB3 CPA6 FABP12 GDAP1 MCMDC2 PMP2 SGK3 TRIM55,one-carbon metabolic process|nuclear cell cycle DNA replication initiation|cell cycle DNA replication initiation|mitotic DNA replication initiation|diapedesis,0.00021|0.003731|0.003731|0.003731|0.004263,1|1|1|1|1,96.01|312|312|312|267.5
858,4,0.6598,3.9589999999999996,3264.0,0.001209,0.9929309999999999,COX8C F10 F7 ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",7.067e-07|7.067e-07|7.067e-07|3.108e-06|3.672e-06,0.01115|0.005574|0.003716|0.01226|0.01159,2060|2060|2060|823.8|748.9
859,4,0.6353,3.812,3407.0,0.001115,0.9929309999999999,CDS1 CPE GLDN SQOR,"sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|clustering of voltage-gated sodium channels|hydrogen sulfide metabolic process|CDP-choline pathway",0.001165|0.001165|0.001359|0.001359|0.001553,1|1|1|1|1,1030|1030|858.1|858.1|735.5
860,4,0.6228,3.737,3150.0,0.001182,0.9929309999999999,CPEB3 ERC1 SLC6A12 WNT5B,regulation of synaptic plasticity|negative regulation of cytoplasmic translational elongation|positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|gamma-aminobutyric acid reuptake,0.0004757|0.0005825|0.0005825|0.0005825|0.0009706,1|1|1|1|1,56.27|2574|2574|2574|1287
861,12,0.6097,40.24,9455.0,0.004228,0.999986,ANXA2R C1QTNF3 C7 CDH6 FBXO4 HCN1 NNT OXCT1 SLC45A2 TMEM267 UGT3A1 UGT3A2,cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid|cellular homeostasis|positive regulation of hydrogen peroxide catabolic process,0.001164|0.001164|0.001164|0.001306|0.001746,1|1|1|1|1,1716|1716|1716|7.731|858.1
862,4,0.6316,3.79,3415.0,0.001106,0.9929309999999999,CPLX1 KTN1 NIPAL1 TTPA,ion transport|exocytic insertion of neurotransmitter receptor to postsynaptic membrane|vitamin E metabolic process|regulation of synaptic vesicle fusion to presynaptic active zone membrane|lipid transport,0.0003841|0.0009706|0.0009706|0.001747|0.001845,1|1|1|1|1,7.149|1287|1287|643.6|28.29
863,4,0.6723,4.034,3595.0,0.001118,0.9929309999999999,ATP2B2 CPNE9 LHFPL4 SLC6A1,regulation of cardiac conduction|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane|response to inorganic substance|transport across blood-brain barrier,7.749e-05|0.0001669|0.0001669|0.000177|0.0001789,1|1|0.8776|0.698|0.5645,147.1|99.25|99.25|22.8|95.79
864,4,0.6305,3.783,3241.0,0.001163,0.9929309999999999,ATP5S CPO CRYGA RSPH10B,"protoporphyrinogen IX biosynthetic process|protoporphyrinogen IX metabolic process|mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient",0.002425|0.00291|0.004845|0.006054|0.006054,1|1|1|1|1,457.7|374.5|216.8|171.6|171.6
865,11,0.6254,34.4,7508.0,0.004548,0.999969,ALAD ALAS1 COA7 CPOX DARS2 FECH HMBS PPOX SCO1 UROD UROS,protoporphyrinogen IX metabolic process|heme biosynthetic process|protoporphyrinogen IX biosynthetic process|porphyrin-containing compound biosynthetic process|tetrapyrrole biosynthetic process,4.637e-23|1.44e-20|2.891e-20|3.761e-20|3.761e-20,7.314e-19|1.136e-16|1.52e-16|1.483e-16|1.187e-16,1248|508.5|1335|442.9|442.9
866,4,0.6148,3.6889999999999996,3140.0,0.00117,0.9929309999999999,CPT1C HIST1H2AC HIST1H2BN ITPR2,carnitine metabolic process|cellular response to ethanol|amino-acid betaine metabolic process|inositol phosphate-mediated signaling|release of sequestered calcium ion into cytosol,0.001456|0.00165|0.001844|0.002426|0.004462,1|1|1|1|1,735.5|643.6|572.1|429.1|228.8
867,13,0.6113,47.68,9777.0,0.00484,0.999993,CD1B CD1E FCRL2 FCRL3 FMO2 ITLN1 ITLN2 OR10J5 OR6N1 OR6N2 OR6P1 SLAMF7 YY1AP1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",1.036e-05|1.775e-05|1.775e-05|5.898e-05|0.0001849,0.1634|0.14|0.09331|0.2326|0.5832,549.2|392.3|392.3|196.1|105.6
868,4,0.6225,3.735,2759.0,0.001348,0.9929309999999999,CD46 CR1L GLB1L2 SPPL3,regulation of complement activation|regulation of humoral immune response|regulation of immune response|interleukin-10 production|regulation of complement-dependent cytotoxicity,0.0001971|0.0002806|0.000635|0.0009706|0.001747,1|1|1|1|1,88.01|73.55|13.68|1287|643.6
869,4,0.6027,3.616,3242.0,0.001111,0.9929309999999999,CPS1 CRB2 CYP17A1 LVRN,carbamoyl phosphate biosynthetic process|carbamoyl phosphate metabolic process|ingression involved in gastrulation with mouth forming second|cellular response to oleic acid|citrulline biosynthetic process,0.0003883|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,5149|5149|5149|1716|1287
870,4,0.6793,4.0760000000000005,2719.0,0.001492,0.9929309999999999,WIZ ZBTB2 ZNF592 ZNF644,positive regulation of nuclear cell cycle DNA replication|positive regulation of DNA-dependent DNA replication|regulation of nuclear cell cycle DNA replication|cellular process|regulation of transcription by RNA polymerase II,0.001359|0.002522|0.00291|0.00379|0.007187,1|1|1|1|1,858.1|429.1|367.8|0|5.973
871,5,0.6034,6.034,3828.0,0.00157,0.996692,ADSSL1 APOPT1 CDC42BPB CRIP1 ZBTB42,prostate gland stromal morphogenesis|cellular response to UV-B|cellular response to antibiotic|response to UV-B|prostate gland morphogenesis,0.0004369|0.00131|0.002183|0.002619|0.003637,1|1|1|1|1,3432|858.1|490.4|403.8|286
872,4,0.6005,3.603,3152.0,0.001139,0.9929309999999999,COL6A6 CRIPAK KLHDC10 TUFT1,negative regulation of intracellular estrogen receptor signaling pathway|negative regulation of intracellular steroid hormone receptor signaling pathway|regulation of intracellular estrogen receptor signaling pathway|bone mineralization|response to estrogen,0.003297|0.007359|0.008517|0.009867|0.01525,1|1|1|1|1,321.8|139.2|119.7|103|66.01
873,4,0.6127,3.676,2910.0,0.001258,0.9929309999999999,ATP8B2 CRNN JAK3 REEP4,negative regulation of FasL production|regulation of FasL production|negative regulation of dendritic cell cytokine production|negative regulation of T-helper 1 cell differentiation|interleukin-4-mediated signaling pathway,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
874,4,0.6183,3.71,3242.0,0.00114,0.9929309999999999,CROT DIO3 GNAI1 SPO11,cellular modified amino acid metabolic process|negative regulation of eye photoreceptor cell development|regulation of eye photoreceptor cell development|thyroid hormone catabolic process|retinal cone cell apoptotic process,0.0005283|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,53.35|2574|2574|2574|2574
875,6,0.6235,9.353,4033.0,0.002307,0.998474,CRTC2 CRTC3 MITF SOX10 TFAP2A ZEB2,"positive regulation of transcription by RNA polymerase II|developmental pigmentation|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process",4.098e-08|1.457e-07|2.415e-07|2.415e-07|2.424e-07,0.0006465|0.001149|0.00127|0.0009523|0.0007647,17.08|271|12.7|12.7|12.69
876,4,0.6253,3.752,3317.0,0.001127,0.9929309999999999,CCPG1 CRYZ SEC22A SLC35A3,regulation of Rho guanyl-nucleotide exchange factor activity|UDP-galactose transmembrane transport|UDP-N-acetylglucosamine transmembrane transport|regulation of guanyl-nucleotide exchange factor activity|pyrimidine nucleotide-sugar transmembrane transport,0.0005825|0.0009706|0.001165|0.001941|0.002328,1|1|1|1|1,2574|1287|1030|572.1|468.1
877,9,0.838,30.17,5891.0,0.0050799999999999994,0.9998530000000001,CS DLAT LIPT1 MDH2 MPC1 MPC2 PDHB PDHX SLC25A1,acetyl-CoA biosynthetic process from pyruvate|acyl-CoA biosynthetic process|thioester biosynthetic process|purine nucleoside bisphosphate biosynthetic process|ribonucleoside bisphosphate biosynthetic process,5.531e-12|8.569e-12|8.569e-12|3.332e-11|3.332e-11,8.725e-08|6.758e-08|4.505e-08|1.314e-07|1.051e-07,1308|254.3|254.3|190.7|190.7
878,5,0.6832,6.832000000000001,2917.0,0.002329,0.996692,CSDE1 DHX29 EIF4A1 EIF4G2 STRAP,regulation of translational initiation|translational initiation|cellular nitrogen compound metabolic process|cytoplasmic translational initiation|regulation of translation,1.344e-06|6.866e-06|2.06e-05|3.493e-05|0.0001113,0.0212|0.05415|0.1083|0.1377|0.3511,125.6|72.01|6.045|228.8|27.98
879,8,0.6034,16.9,5415.0,0.003101,0.9996790000000001,AURKA CSE1L PPP6R3 PSMA7 RAE1 RPS21 RTF2 TPX2,protein export from nucleus|nuclear export|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|regulation of mitotic spindle organization,3.393e-05|4.392e-05|7.915e-05|9.882e-05|0.0001183,0.5352|0.3464|0.4162|0.3897|0.3731,45.16|41.36|33.82|31.35|127.1
880,8,0.6008,16.82,6442.0,0.002598,0.9996790000000001,C6orf203 CSF1 ENPP1 ENPP3 TAAR2 TAAR6 TAAR8 VNN2,nucleoside triphosphate catabolic process|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|positive regulation of macrophage colony-stimulating factor signaling pathway,1.579e-05|0.0004635|0.0004635|0.0005545|0.0007765,0.2491|1|1|1|1,367.8|62.03|62.03|56.58|2574
881,4,0.641,3.846,3287.0,0.001166,0.9929309999999999,CSF1R HOXC6 LRRC27 SLC2A2,macrophage colony-stimulating factor signaling pathway|positive regulation of macrophage proliferation|fructose transmembrane transport|intestinal hexose absorption|regulation of macrophage proliferation,0.0009706|0.001165|0.001165|0.001359|0.001359,1|1|1|1|1,1287|1030|1030|858.1|858.1
882,4,0.6984,4.19,3003.0,0.00139,0.9929309999999999,CSF2RB ETV6 GSE1 LMO2,interleukin-5-mediated signaling pathway|mesenchymal cell apoptotic process|vitellogenesis|interleukin-3-mediated signaling pathway|cellular response to interleukin-3,0.0005825|0.0005825|0.0009706|0.0009706|0.001359,1|1|1|1|1,2574|2574|1287|1287|858.1
883,8,0.6346,17.77,6382.0,0.00277,0.9996790000000001,AGO1 AGO3 AGO4 BEST4 CSF3R LURAP1 ZFP69 ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",4.605e-09|6.331e-09|8.44e-09|2.147e-08|2.147e-08,7.264e-05|4.993e-05|4.438e-05|8.466e-05|6.772e-05,1103|965.4|858.1|594.1|594.1
884,4,0.6228,3.737,2852.0,0.0013050000000000002,0.9929309999999999,C1orf43 CSK KIAA0100 KIAA1109,negative regulation of Golgi to plasma membrane protein transport|phagocytosis|negative regulation of low-density lipoprotein particle clearance|regulation of Golgi to plasma membrane protein transport|negative regulation of lipoprotein particle clearance,0.001359|0.001485|0.001553|0.002134|0.002134,1|1|1|1|1,858.1|31.59|735.5|514.9|514.9
885,5,0.618,6.18,3963.0,0.001553,0.996692,BCL2L10 CSNK1G1 DUOXA2 EPB42 PLA2G4D,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|hemoglobin metabolic process,0.001456|0.001698|0.00194|0.002183|0.00291,1|1|1|1|1,823.8|686.5|588.4|514.9|374.5
886,5,0.6268,6.268,3826.0,0.0016309999999999999,0.996692,CSNK1G2 HMGCL MSI2 SUCLA2 SUCLG1,tricarboxylic acid cycle|generation of precursor metabolites and energy|aerobic respiration|acyl-CoA metabolic process|thioester metabolic process,2.96e-05|7.325e-05|0.0001441|0.0002265|0.0002265,0.4668|0.5777|0.7578|0.8932|0.7145,242.3|30.74|107|84.93|84.93
887,4,0.6386,3.832,3306.0,0.001155,0.9929309999999999,CST6 HRASLS2 PRSS8 ZRANB3,DNA rewinding|negative regulation of endopeptidase activity|negative regulation of peptidase activity|DNA strand renaturation|replication fork protection,0.0004854|0.001398|0.001512|0.002183|0.002425,1|1|1|1|1,4119|33.62|32.31|514.9|457.7
888,5,0.6059,6.059,3845.0,0.0015689999999999999,0.996692,CTAGE1 KCNRG POSTN RNF6 SOHLH2,cellular response to vitamin K|negative regulation of cell development|response to vitamin K|bone regeneration|protein K27-linked ubiquitination,0.000728|0.0007299|0.001213|0.001213|0.001456,1|1|1|1|1,2060|46.81|1030|1030|823.8
889,5,0.6178,6.178,3028.0,0.00203,0.996692,C8orf33 CTC1 DCLRE1B STN1 TEN1,telomere capping|telomere maintenance|telomere organization|negative regulation of telomere maintenance via telomerase|negative regulation of telomere maintenance via telomere lengthening,4.121e-11|2.378e-08|2.66e-08|4.847e-08|1.075e-07,6.5e-07|0.0001876|0.0001398|0.0001911|0.0003392,619.4|114.3|111|420.3|315.2
890,6,0.6117,9.176,4918.0,0.0018579999999999998,0.998474,ATG4C BSND C1orf123 CTH CYP4X1 PCSK9,protein sulfhydration|protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine|negative regulation of low-density lipoprotein particle receptor binding|regulation of aortic smooth muscle cell differentiation|positive regulation of aortic smooth muscle cell differentiation,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
891,4,0.6461,3.877,3142.0,0.0012289999999999998,0.9929309999999999,CTNNA2 NAT8 SIX3 TRABD2A,head development|neuroblast migration|peptidyl-lysine N6-acetylation|positive regulation of protein oxidation|regulation of protein oxidation,0.0002192|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,19.6|5149|2574|2574|2574
892,8,0.6348,17.78,5831.0,0.003031,0.9996790000000001,ARRDC4 CTSO CYS1 IER5 ITPKA PTRH1 SALL3 TMEM82,positive regulation of cellular response to heat|intramembranous ossification|direct ossification|extracellular vesicle biogenesis|dendritic spine maintenance,0.0008734|0.00349|0.00349|0.003925|0.004796,1|1|1|1|1,2288|326.9|326.9|286|228.8
893,4,0.6285,3.7710000000000004,2904.0,0.0012929999999999999,0.9929309999999999,CTXN1 FUT6 PLIN3 UQCR11,N-glycan fucosylation|fucose catabolic process|positive regulation of sequestering of triglyceride|L-fucose catabolic process|L-fucose metabolic process,0.0005825|0.001941|0.001941|0.001941|0.001941,1|1|1|1|1,2574|572.1|572.1|572.1|572.1
894,6,0.625,9.374,4683.0,0.001993,0.998474,AKR1C1 AKR1C3 CALML3 CALML5 CUBN ITIH2,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,1.06e-06|1.06e-06|3.883e-06|3.883e-06|3.883e-06,0.01672|0.008359|0.02042|0.01531|0.01225,1716|1716|762.8|762.8|762.8
895,4,0.6396,3.838,2781.0,0.001374,0.9929309999999999,CUL4A GLMN RBX1 UBE2G1,"nucleotide-excision repair, DNA incision, 3'-to lesion|nucleotide-excision repair, preincision complex stabilization|nucleotide-excision repair, DNA duplex unwinding|nucleotide-excision repair, DNA damage recognition|global genome nucleotide-excision repair",7.146e-06|7.146e-06|7.795e-06|8.472e-06|1.067e-05,0.1127|0.05636|0.04098|0.03341|0.03367,490.4|490.4|468.1|447.7|396.1
896,9,0.6104,21.97,6016.0,0.003629,0.9998530000000001,FBXO5 LTV1 NUP43 PPIL4 PSMB1 RPS12 SF3B5 TCP1 WTAP,RNA localization|biological process involved in symbiotic interaction|anaphase-promoting complex-dependent catabolic process|negative regulation of DNA endoreduplication|translocation of peptides or proteins into host cell cytoplasm,0.0001028|0.0004529|0.0006512|0.0008734|0.0008734,1|1|1|1|1,30.92|9.769|52.61|2288|2288
897,9,0.6038,21.74,6501.0,0.0033229999999999996,0.9998530000000001,B4GALT1 BEST3 CUX1 MYCN MYOG PAX3 RAB3IP SOX8 ZBTB18,muscle organ development|skeletal muscle tissue development|skeletal muscle organ development|muscle structure development|positive regulation of transcription by RNA polymerase II,4.217e-06|1.741e-05|2.196e-05|2.924e-05|7.182e-05,0.06652|0.1373|0.1154|0.1153|0.2266,32.69|56.74|52.4|19.9|9.487
898,4,0.6112,3.667,2740.0,0.001333,0.9929309999999999,CWC22 SF3A1 SF3B1 SF3B3,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",4.776e-08|4.776e-08|4.967e-08|1.562e-07|3.112e-07,0.0007534|0.0003767|0.0002612|0.0006161|0.0009818,68.2|68.2|67.52|50.6|42.55
899,13,0.6096,47.55,10140.0,0.004654999999999999,0.999993,CXCL1 CXCL2 CXCL3 CXCL5 CXCL6 FAM47E PF4 SLC9B2 TMPRSS11B UGT2A3 UGT2B15 UGT2B4 UGT2B7,neutrophil chemotaxis|chemokine-mediated signaling pathway|granulocyte chemotaxis|neutrophil migration|cellular response to chemokine,5.957e-12|6.899e-12|9.156e-12|1.2e-11|1.367e-11,9.397e-08|5.441e-08|4.814e-08|4.73e-08|4.312e-08,123.4|120.3|114.5|109.3|106.8
900,4,0.6147,3.688,3061.0,0.0012,0.9929309999999999,CXCR4 DCTN1 TBCB UBA2,CXCL12-activated CXCR4 signaling pathway|C-X-C chemokine receptor CXCR4 signaling pathway|positive regulation of macrophage migration inhibitory factor signaling pathway|response to ultrasound|positive regulation of neuromuscular junction development,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
901,4,0.6151,3.69,3595.0,0.001023,0.9929309999999999,CASKIN2 CXXC5 LRRC27 MANSC4,cellular process|positive regulation of I-kappaB kinase/NF-kappaB signaling|regulation of I-kappaB kinase/NF-kappaB signaling|UNCLASSIFIED|biological_process,0.00379|0.03563|0.04655|0.08866|0.08866,1|1|1|1|1,0|27.83|21.19|3.751|0.5769
902,5,0.6038,6.037999999999999,3900.0,0.001542,0.996692,CYB561 HOXB5 HOXB9 PLEKHM1 TCERG1L,embryonic skeletal system morphogenesis|embryonic skeletal system development|anterior/posterior pattern specification|skeletal system morphogenesis|embryonic organ morphogenesis,0.000213|0.0003552|0.001004|0.001172|0.001947,1|1|1|1|1,87.64|67.52|39.8|36.78|28.41
903,4,0.6637,3.9819999999999998,2855.0,0.001389,0.9929309999999999,CYB5A CYB5R3 SEC23B UBE2F,L-ascorbic acid metabolic process|water-soluble vitamin metabolic process|vitamin metabolic process|monosaccharide metabolic process|protein neddylation,2.204e-06|0.0001004|0.000214|0.0004604|0.002716,0.03477|0.7921|1|1|1,936.1|124.1|84.41|57.21|396.1
904,15,0.6153,64.61,12210.0,0.005249,0.999999,KIR2DL1 LILRB5 NLRP12 SIGLEC5 VN1R4 ZFP28 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF610 ZNF665 ZNF701 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",3.838e-06|5.854e-06|5.871e-06|5.957e-06|1.257e-05,0.06055|0.04617|0.03087|0.02349|0.03964,4.978|4.087|4.086|4.08|3.788
905,5,0.7955,7.955,3102.0,0.00255,0.996692,CAB39 NRBP1 OXSR1 TSC22D2 WNK1,response to osmotic stress|chemokine (C-C motif) ligand 21 signaling pathway|regulation of potassium ion transmembrane transport|regulation of potassium ion transport|cellular hypotonic response,5.194e-07|7.067e-07|1.391e-06|2.059e-06|2.119e-06,0.008193|0.005574|0.007313|0.008121|0.006686,164.8|2060|117.7|103|1030
906,8,0.6019,16.85,5002.0,0.0033469999999999997,0.9996790000000001,COP1 DET1 DUSP4 DUSP5 JUNB STK40 TRIB1 TRIB2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|regulation of proteasomal ubiquitin-dependent protein catabolic process,5.03e-08|9.845e-08|1.176e-07|2.165e-07|2.365e-07,0.0007934|0.0007765|0.0006183|0.0008538|0.0007461,101.7|85.55|81.73|69.87|68.31
907,5,0.6507,6.507000000000001,3722.0,0.001741,0.996692,C6orf48 CYP21A2 MICB MSH5 TNXB,negative regulation of defense response to virus by host|meiotic mismatch repair|mineralocorticoid biosynthetic process|mineralocorticoid metabolic process|glucocorticoid biosynthetic process,0.0007766|0.001165|0.001359|0.001359|0.002328,1|1|1|1|1,1716|1030|858.1|858.1|468.1
908,8,0.624,17.47,6592.0,0.002637,0.9996790000000001,ATP9A BCAS1 CASS4 CTSZ CYP24A1 FAM209A FAM209B STX16,vitamin D receptor signaling pathway|vitamin D catabolic process|fatty acid omega-oxidation|negative regulation of plasminogen activation|actin filament reorganization,0.001552|0.001552|0.002328|0.002715|0.004264,1|1|1|1|1,858.1|858.1|514.9|429.1|257.4
909,5,0.6289,6.289,4105.0,0.001526,0.996692,CYP26A1 LDB3 OPN4 SEMA4G SNCG,thermotaxis|optokinetic behavior|detection of temperature stimulus involved in thermoception|diterpenoid catabolic process|retinoic acid catabolic process,0.000728|0.000728|0.001213|0.001456|0.001456,1|1|1|1|1,2060|2060|1030|823.8|823.8
910,14,0.6032,54.89,11320.0,0.0048130000000000004,0.9999969999999999,CALHM3 CYP26C1 CYP2C9 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ NUTM2A PTPN20 SFTPA1 SFTPA2 ZNF239,cellular response to type I interferon|response to type I interferon|defense response to symbiont|defense response to virus|type I interferon signaling pathway,1.412e-07|1.944e-07|1.082e-05|1.082e-05|1.388e-05,0.002227|0.001533|0.05688|0.04266|0.04379,85.28|78.46|27.76|27.76|64.9
911,21,0.6017,126.3,16060.0,0.007784,1.0,GRASP HOXC5 HOXC6 HOXC8 INHBE KRT1 KRT5 KRT6B KRT74 KRT78 KRT79 KRT82 KRT83 KRT84 KRT86 MARCH9 OR6C3 OS9 POU6F1 PPP1R1A RDH5,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.313e-17|1.008e-14|5.234e-14|2.576e-13|1.655e-12,2.072e-13|7.953e-11|2.752e-10|1.016e-09|5.221e-09,86.79|43.39|36.59|31.04|25.61
912,15,0.5332,55.98,12050.0,0.004611,0.999999,CALHM3 CYP2C19 CYP2C8 CYP2C9 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ NUTM2A PTPN20 RNLS SFTPA1 SFTPA2,omega-hydroxylase P450 pathway|cellular response to type I interferon|response to type I interferon|epoxygenase P450 pathway|exogenous drug catabolic process,6.835e-08|1.919e-07|2.643e-07|5.475e-07|8.028e-07,0.001078|0.001514|0.00139|0.002159|0.002533,457.7|79.59|73.23|205.9|179.1
913,7,0.6118,12.85,5582.0,0.002291,0.9992989999999999,BSND C1orf123 CYP4A11 CYP4X1 PCSK9 ZNF684 ZYG11B,negative regulation of low-density lipoprotein particle receptor binding|regulation of lipid transport|positive regulation of cellular protein catabolic process|lauric acid metabolic process|oxylipin metabolic process,0.0005824|0.000775|0.0008378|0.0008735|0.0008735,1|1|1|1|1,3432|46.39|44.58|1716|1716
914,10,0.6231,28.04,8018.0,0.0034770000000000005,0.999933,CFAP57 CYP4A22 CYP4Z1 ERMAP EXO5 MFSD2A ZFP69 ZFP69B ZNF684 ZNF691,lysophospholipid translocation|regulation of phosphatidylserine metabolic process|regulation of phosphatidylethanolamine metabolic process|lysophospholipid transport|lauric acid metabolic process,0.0009704|0.0009704|0.0009704|0.001455|0.001455,1|1|1|1|1,2060|2060|2060|1030|1030
915,10,0.6057,27.25,7204.0,0.003759,0.999933,CYP4F11 CYP4F12 CYP4F2 OR10H2 OR7C1 OR7C2 ZNF486 ZNF682 ZNF714 ZNF98,vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process|leukotriene B4 catabolic process|leukotriene catabolic process,2.878e-09|2.878e-09|4.604e-09|4.604e-09|4.604e-09,4.54e-05|2.27e-05|2.421e-05|1.815e-05|1.452e-05,1545|1545|1236|1236|1236
916,4,0.6349,3.8089999999999997,2752.0,0.0013779999999999999,0.9929309999999999,CYP4F22 WIZ ZBTB2 ZNF644,positive regulation of nuclear cell cycle DNA replication|positive regulation of DNA-dependent DNA replication|regulation of nuclear cell cycle DNA replication|regulation of transcription by RNA polymerase II|positive regulation of DNA replication,0.001359|0.002522|0.00291|0.007187|0.007938,1|1|1|1|1,858.1|429.1|367.8|5.973|128.7
917,4,0.6032,3.6189999999999998,3323.0,0.001085,0.9929309999999999,D2HGDH IL20RA SMAD9 VLDLR,glycoprotein transport|very-low-density lipoprotein particle clearance|reelin-mediated signaling pathway|response to chemical|low-density lipoprotein particle receptor catabolic process,0.0007766|0.001359|0.001941|0.002029|0.002134,1|1|1|1|1,1716|858.1|572.1|4.714|514.9
918,4,0.6981,4.189,3243.0,0.001287,0.9929309999999999,BBS9 DAAM1 S100A11 SPATA18,mitophagy by induced vacuole formation|mitochondrial protein catabolic process|negative regulation of DNA replication|positive regulation of smooth muscle cell migration|autophagy of mitochondrion,0.0003883|0.001165|0.00678|0.007552|0.008131,1|1|1|1|1,5149|1030|151.4|135.5|125.6
919,4,0.6228,3.737,3250.0,0.001146,0.9929309999999999,DACT1 LAMA3 ZNF396 ZSCAN30,embryonic hindgut morphogenesis|negative regulation of beta-catenin-TCF complex assembly|regulation of beta-catenin-TCF complex assembly|hindgut morphogenesis|hindgut development,0.0005825|0.0005825|0.0005825|0.001359|0.001553,1|1|1|1|1,2574|2574|2574|858.1|735.5
920,8,0.6036,16.9,6477.0,0.0025960000000000002,0.9996790000000001,CDH12 DAP DNAH5 FAM173B OTULINL PRLR ROPN1L SLC6A18,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|sperm motility|flagellated sperm motility|cilium movement involved in cell motility,0.000106|0.0001246|0.0006957|0.0006957|0.0008211,1|0.983|1|1|1,134.6|123.7|50.85|50.85|46.7
921,4,0.6468,3.8810000000000002,3046.0,0.001269,0.9929309999999999,ADCY6 ANKMY2 DAPP1 PTGES3,cellular response to vasopressin|response to vasopressin|telomerase holoenzyme complex assembly|negative regulation of urine volume|glucocorticoid receptor signaling pathway,0.0007766|0.0007766|0.0009706|0.001165|0.001359,1|1|1|1|1,1716|1716|1287|1030|858.1
922,12,0.578,38.15,8563.0,0.004423,0.999986,EXOSC5 GEMIN7 HNRNPL PSMC4 RBM42 RPS16 RPS19 SAE1 SNRPD2 SYMPK TBCB UBA2,"mRNA metabolic process|RNA processing|ribonucleoprotein complex biogenesis|RNA metabolic process|mRNA splicing, via spliceosome",3.492e-08|2.42e-07|4.192e-06|9.621e-06|2.148e-05,0.0005509|0.001909|0.02204|0.03794|0.06777,17.31|13.02|18.45|7.513|22.73
923,7,0.6203,13.03,4483.0,0.002888,0.9992989999999999,CCNA2 CCNB1 CDC25B DBF4 FBXO5 FOXM1 PKMYT1,mitotic cell cycle phase transition|cell cycle phase transition|mitotic cell cycle process|mitotic cell cycle|G2/M transition of mitotic cell cycle,1.07e-13|1.295e-13|4.684e-11|9.743e-11|3.346e-10,1.687e-09|1.021e-09|2.463e-07|3.842e-07|1.056e-06,72.26|70.29|30.07|27.06|105.1
924,10,0.6004,27.02,8205.0,0.003274,0.999933,DBH DPP7 ENTPD2 ENTR1 FAM69B LCN10 LCN15 LCN6 LCN8 SARDH,amine catabolic process|cellular biogenic amine catabolic process|sarcosine catabolic process|cellular biogenic amine metabolic process|cellular amine metabolic process,0.0001179|0.0001179|0.0009704|0.001043|0.001064,1|0.9302|1|1|1,128.7|128.7|2060|41.61|41.19
925,4,0.7094,4.256,3272.0,0.001296,0.9929309999999999,DBNDD1 GAS8 MC1R TCF25,positive regulation of protein localization to cilium|regulation of protein localization to cilium|positive regulation of protein kinase C signaling|regulation of microtubule binding|melanin biosynthetic process,0.001165|0.001747|0.002134|0.002134|0.002522,1|1|1|1|1,1030|643.6|514.9|514.9|429.1
926,9,0.606,21.82,5842.0,0.0037090000000000005,0.9998530000000001,BUB3 C1orf109 DAD1 DBR1 DHX33 DPAGT1 POP5 RPN1 SPATA5L1,protein N-linked glycosylation|protein N-linked glycosylation via asparagine|peptidyl-asparagine modification|protein glycosylation|macromolecule glycosylation,4.313e-06|8.356e-05|8.893e-05|0.0001323|0.0001323,0.06803|0.659|0.4676|0.5218|0.4174,91.53|152.6|147.6|28.37|28.37
927,5,0.6115,6.115,3723.0,0.0016350000000000002,0.996692,DCAF16 TRMT44 USP17L10 USP17L13 USP17L5,protein deubiquitination|protein modification by small protein removal|protein modification by small protein conjugation or removal|protein phosphopantetheinylation|macromolecule modification,2.461e-05|2.933e-05|3.042e-05|4.31e-05|9.674e-05,0.3882|0.2313|0.1599|0.17|0.3052,44.45|41.89|15.98|36.78|6.356
928,4,0.6527,3.9160000000000004,3293.0,0.001185,0.9929309999999999,CCL21 DCD RAB3C RADIL,killing of cells of other organism|antimicrobial humoral immune response mediated by antimicrobial peptide|cell killing|antimicrobial humoral response|negative regulation of dendritic cell dendrite assembly,0.0001028|0.0001534|0.0002071|0.0003472|0.0003883,1|1|1|1|1,122.6|99.98|85.81|66.01|5149
929,4,0.629,3.7739999999999996,3160.0,0.00119,0.9929309999999999,DCP1B ERC1 SLC6A12 WNT5B,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|gamma-aminobutyric acid reuptake|deadenylation-independent decapping of nuclear-transcribed mRNA|amino acid neurotransmitter reuptake,0.0005825|0.0005825|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|2574|1287|1030|858.1
930,7,0.6016,12.63,4741.0,0.00265,0.9992989999999999,DCTN3 EXOSC3 NOL6 RCL1 SMU1 TLN1 UBAP1,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|cleavage involved in rRNA processing|maturation of 5.8S rRNA|rRNA processing|rRNA metabolic process",3.204e-05|4e-05|6.553e-05|6.931e-05|7.744e-05,0.5053|0.3155|0.3446|0.2733|0.2443,245.2|217.9|168.1|33.95|32.69
931,6,0.6293,9.439,4456.0,0.0021079999999999996,0.998474,DCTN4 HARS LARS RARS SPDL1 TTC1,tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|tRNA metabolic process|cellular amino acid metabolic process,2.516e-07|3.017e-07|3.198e-07|1.375e-05|4.923e-05,0.003969|0.00238|0.001682|0.0542|0.1553,223.9|210.2|205.9|56.89|36.91
932,5,0.6496,6.496,3362.0,0.001923,0.996692,DCTN5 NDUFAB1 PALB2 RBBP6 SMG1,multicellular organism growth|somite development|cellular response to DNA damage stimulus|protein lipoylation|TORC1 signaling,0.0001515|0.0001515|0.0005302|0.001698|0.002425,1|1|1|1|1,104.3|104.3|15.7|686.5|457.7
933,7,0.619,13.0,4813.0,0.0026850000000000003,0.9992989999999999,CUL1 DCUN1D1 DCUN1D5 NAE1 SENP8 UBE2Q1 UBE2R2,protein modification by small protein conjugation or removal|protein neddylation|protein modification by small protein conjugation|cellular protein modification process|protein modification process,8.085e-10|1.343e-08|2.78e-08|1.466e-06|1.466e-06,1.275e-05|0.0001059|0.0001462|0.005781|0.004625,19.98|679|21.5|6.822|6.822
934,9,0.6509,23.43,6097.0,0.003817,0.9998530000000001,ARIH2 ARIH2OS CUL5 DCUN1D3 RNF7 SENP8 SOCS6 UBE2F UBE2R2,protein modification by small protein conjugation or removal|protein modification by small protein conjugation|post-translational protein modification|protein neddylation|cellular protein modification process,1.964e-11|2.782e-10|6.061e-09|4.594e-08|2.747e-07,3.099e-07|2.194e-06|3.187e-05|0.0001812|0.0008665,17.98|20.07|34.23|475.3|6.14
935,7,0.6081,12.77,5763.0,0.002205,0.9992989999999999,DCUN1D4 IDE IFIT1 IFIT1B LIPF LIPJ LIPK,cellular response to exogenous dsRNA|cellular response to dsRNA|lipid catabolic process|response to exogenous dsRNA|response to dsRNA,2.072e-05|2.958e-05|0.0001097|0.0001252|0.0001565,0.3268|0.2333|0.5769|0.4936|0.4938,309.7|255.8|29.03|120.1|107
936,9,0.6099,21.96,5928.0,0.003679,0.9998530000000001,FANCM NFATC2IP NSMCE1 NSMCE3 NSMCE4A RMI1 RMI2 SMC6 TRAIP,DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|DNA recombination|cellular response to stress,1.806e-12|3.886e-11|4.129e-11|1.481e-10|2.356e-08,2.849e-08|3.065e-07|2.171e-07|5.84e-07|7.432e-05,34.54|23.44|23.26|61.29|10.43
937,13,0.6099,47.57,9829.0,0.004804,0.999993,DDIT3 HOXC4 HOXC5 HOXC6 HOXC8 INHBE KRT82 KRT86 MARCH9 OS9 POU6F1 RDH5 TSPAN31,anterior/posterior pattern specification|regionalization|pattern specification process|intrinsic apoptotic signaling pathway in response to nitrosative stress|negative regulation of determination of dorsal identity,7.104e-06|3.742e-05|0.000112|0.001261|0.001891,0.1121|0.2951|0.589|1|1,30.61|19.93|14.98|1584|792.1
938,18,0.5877,89.92,11010.0,0.008073,1.0,COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 GET4 PTAR1 RGP1 RIC1 SYS1 UNC50 VPS51 VPS52 VPS54 YKT6,Golgi vesicle transport|establishment of protein localization|protein transport|peptide transport|intracellular transport,1.489e-18|1.402e-17|3.6e-16|4.898e-16|5.271e-16,2.348e-14|1.106e-13|1.893e-12|1.932e-12|1.663e-12,35.58|11.83|11.85|11.62|11.57
939,5,0.612,6.12,3406.0,0.0017879999999999999,0.996692,DDOST DHDDS GPN2 NUDC RPA2,protein N-linked glycosylation|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|nucleologenesis|polyprenol biosynthetic process,0.0002048|0.0005506|0.0006051|0.0008735|0.001165,1|1|1|1|1,91.53|8.296|8.096|1716|1144
940,5,0.7083,7.082999999999999,3278.0,0.00215,0.996692,DDX11 ESCO2 SGO1 SRSF10 ZWINT,sister chromatid segregation|nuclear chromosome segregation|sister chromatid cohesion|chromosome segregation|biological phase,1.454e-08|7.636e-08|1.425e-07|1.903e-07|1.951e-05,0.0002294|0.0006023|0.000749|0.0007503|0.06154,110.6|72.58|257.4|57.61|48.08
941,4,0.604,3.6239999999999997,2987.0,0.001209,0.9929309999999999,ACBD5 DDX19A DDX19B VPS37D,intracellular protein transport|poly(A)+ mRNA export from nucleus|protein transport|peptide transport|intracellular transport,5.031e-06|7.795e-06|2.563e-05|2.772e-05|2.824e-05,0.07936|0.06148|0.1347|0.1093|0.08909,21.17|468.1|14.08|13.8|13.74
942,10,0.6004,27.02,6838.0,0.003924,0.999933,ATM CHEK2 DDX31 MDM2 MDM4 PPM1D RPS27L TP53 USP28 WDR89,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|DNA damage checkpoint|DNA integrity checkpoint",6.951e-17|2.042e-15|1.129e-14|9.144e-14|1.337e-13,1.097e-12|1.611e-11|5.937e-11|3.606e-10|4.219e-10,139.6|182.5|141.3|103.7|98.07
943,4,0.6269,3.762,2725.0,0.001374,0.9929309999999999,DDX39A DDX39B THOC6 XPO4,protein export from nucleus|nuclear export|nucleocytoplasmic transport|nuclear transport|mRNA 3'-end processing,3.165e-09|4.478e-09|2.598e-08|2.719e-08|3.326e-07,4.993e-05|3.532e-05|0.0001366|0.0001072|0.001049,135.5|124.1|79.52|78.61|175.5
944,9,0.6099,21.95,6438.0,0.003389,0.9998530000000001,DDX41 DDX46 GEMIN5 IK LARS RACK1 RPS14 SLU7 TTC1,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|mRNA metabolic process|gene expression",8.53e-08|8.53e-08|8.954e-08|1.159e-07|1.332e-07,0.001346|0.0006728|0.0004708|0.0004569|0.0004202,37.89|37.89|37.51|19.78|8.375
945,4,0.6554,3.932,2968.0,0.00132,0.9929309999999999,DDX49 EIF3G KRI1 PPAN,ribonucleoprotein complex biogenesis|ribosome biogenesis|cellular component biogenesis|regulation of rRNA catabolic process|regulation of rRNA stability,2.654e-07|1.685e-05|0.0002968|0.0003883|0.0003883,0.004186|0.1329|1|1|1,44.29|46.52|7.625|5149|5149
946,4,0.6739,4.044,2929.0,0.001375,0.9929309999999999,DDX51 NOC4L URB1 URB2,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,6.955e-08|2.654e-07|8.154e-06|9.12e-06|3.683e-05,0.001097|0.002093|0.04287|0.03596|0.1162,62.03|44.29|59.41|57.21|35.76
947,5,0.6345,6.345,3599.0,0.001755,0.996692,DDX55 MAK16 PAK1IP1 RRP12 UTP4,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,3.432e-07|1.303e-06|2.019e-05|2.257e-05|9.061e-05,0.005414|0.01027|0.1061|0.08902|0.2858,49.63|35.43|47.53|45.77|28.6
948,13,0.6133,47.83,9486.0,0.005004,0.999993,ANLN DDX56 HUS1 LSM5 MRPL32 NUDCD3 POLD2 PSMA2 SEC61G TRA2B TWISTNB YAE1 YKT6,cellular component organization or biogenesis|DNA replication|macromolecule metabolic process|septin ring assembly|gene expression,0.000504|0.0006024|0.0006689|0.001261|0.001273,1|1|1|1|1,2.641|17.54|2.558|1584|4.348
949,8,0.7068,19.79,5644.0,0.0034840000000000006,0.9996790000000001,DCP2 DDX6 EDC3 EDC4 EIF4ENIF1 LSM14A PNRC2 XRN1,methylguanosine-cap decapping|nuclear-transcribed mRNA catabolic process|negative regulation of gene expression|RNA decapping|P-body assembly,1.694e-11|2.272e-11|2.387e-11|2.848e-11|2.848e-11,2.672e-07|1.792e-07|1.255e-07|1.123e-07|8.984e-08,858.1|78.81|21.36|735.5|735.5
950,11,0.6429,35.36,8157.0,0.004305,0.999969,HRASLS5 PLA2G16 RARRES3 RASGRP2 SCGB1D1 SCGB1D2 SCGB1D4 SCGB2A1 SCGB2A2 SLC22A10 SLC22A9,N-acylphosphatidylethanolamine metabolic process|androgen receptor signaling pathway|phosphatidylethanolamine metabolic process|intracellular steroid hormone receptor signaling pathway|steroid hormone mediated signaling pathway,1.163e-05|4.009e-05|0.000111|0.0002883|0.000562,0.1835|0.3162|0.5838|1|1,457.7|228.8|132.9|80.76|57.21
951,8,0.6005,16.82,6262.0,0.002671,0.9996790000000001,DEFA5 DEFB108B DEFB4A DEFB4B SOX7 TNFRSF10D ZNF705A ZNF705B,defense response to bacterium|killing of cells of other organism|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|antimicrobial humoral immune response mediated by antimicrobial peptide,0.000159|0.0003568|0.0003994|0.0005015|0.0005314,1|1|1|1|1,25.58|70.05|66.12|58.84|57.13
952,10,0.6042,27.19,7660.0,0.003527,0.999933,COX4I2 DEFB115 DEFB116 DEFB118 DEFB121 FOXS1 HCK MYLK2 TM9SF4 XKR7,response to bacterium|defense response to bacterium|innate immune response|defense response to other organism|defense response,1.142e-05|1.567e-05|2.432e-05|6.517e-05|0.0002911,0.1801|0.1236|0.1279|0.257|0.9183,14.34|23.88|12.26|9.978|7.272
953,6,0.6171,9.256,4651.0,0.0019809999999999997,0.998474,DEFB116 DEFB118 DEFB119 DEFB121 DEFB123 DEFB124,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|defense response,2.345e-11|1.847e-09|4.715e-09|1.614e-08|1.071e-07,3.699e-07|1.456e-05|2.479e-05|6.365e-05|0.0003379,59.7|28.68|24.52|19.96|14.54
954,4,0.6047,3.628,3501.0,0.001033,0.9929309999999999,ACAD10 C10orf113 DEFB125 SLC17A8,"neurotransmitter loading into synaptic vesicle|L-glutamate transmembrane transport|synaptic transmission, glutamatergic|fatty acid transmembrane transport|cochlea development",0.001747|0.004459|0.005426|0.008131|0.009675,1|1|1|1|1,643.6|234|190.7|125.6|105.1
955,7,0.6244,13.11,5159.0,0.002529,0.9992989999999999,DEFB131A FOLR1 FOLR2 KRTAP5-11 KRTAP5-9 P2RY6 TRIM49D1,cellular response to folic acid|keratinization|keratinocyte differentiation|folate import across plasma membrane|folate transmembrane transport,7.913e-07|1.023e-06|1.995e-06|2.768e-06|3.69e-06,0.01248|0.008066|0.01049|0.01092|0.01164,2574|45.56|38.42|1030|858.1
956,15,0.6196,65.06,9836.0,0.006551,0.999999,CCDC134 CNPY2 CPD FURIN HSP90B1 IGF1R IRS1 IRS2 KBTBD2 OST4 OSTC SSR1 SSR2 SSR3 STT3A,somatostatin signaling pathway|somatostatin receptor signaling pathway|phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling|response to endogenous stimulus,3.122e-08|3.122e-08|7.884e-07|9.486e-07|9.655e-07,0.0004925|0.0002463|0.004145|0.003741|0.003046,686.5|686.5|56.5|53.84|7.272
957,5,0.6915,6.915,4006.0,0.001719,0.996692,DELE1 EIF2AK1 OMA1 OPA3 TDGF1,HRI-mediated signaling|integrated stress response signaling|negative regulation of hemoglobin biosynthetic process|negative regulation of translational initiation by iron|regulation of translational initiation by iron,2.402e-10|9.118e-09|0.0004854|0.0004854|0.000728,3.789e-06|7.191e-05|1|1|1,3089|686.5|4119|4119|2060
958,6,0.6225,9.337,4829.0,0.001925,0.998474,C22orf46 DESI1 MEI1 SEPT3 SMDT1 TTLL12,protein desumoylation|peptidyl-lysine modification|calcium import into the mitochondrion|negative regulation of type I interferon-mediated signaling pathway|mitochondrial calcium ion transmembrane transport,0.002619|0.003131|0.00349|0.004361|0.00755,1|1|1|1|1,429.1|22.73|312|245.2|137.3
959,8,0.6078,17.02,5962.0,0.002839,0.9996790000000001,ARHGAP11B CHRFAM7A DEXI GOLGA8M NIPA2 SNURF TYRO3 WHAMM,negative regulation of acetylcholine-gated cation channel activity|regulation of acetylcholine-gated cation channel activity|regulation of kinetochore assembly|regulation of centromere complex assembly|cell-substrate adhesion,0.0008734|0.00131|0.001746|0.002618|0.002829,1|1|1|1|1,2288|1144|762.8|457.7|24.74
960,6,0.6165,9.248,4903.0,0.0018780000000000001,0.998474,CA1 CA2 CA3 DGAT1 FABP4 PMP2,one-carbon metabolic process|bicarbonate transport|organic anion transport|triglyceride metabolic process|acylglycerol metabolic process,1.569e-07|1.939e-07|8.816e-05|0.0002211|0.0003955,0.002475|0.001529|0.4636|0.8721|1,264|245.2|30.29|88.01|65.38
961,4,0.6368,3.821,3210.0,0.001186,0.9929309999999999,DGKD KLK11 SIGLEC12 SPIB,negative regulation of protein kinase C signaling|positive regulation of clathrin-dependent endocytosis|regulation of protein kinase C signaling|regulation of clathrin-dependent endocytosis|diacylglycerol metabolic process,0.0009706|0.001165|0.003685|0.003878|0.004846,1|1|1|1|1,1287|1030|286|271|214.5
962,4,0.6117,3.67,3124.0,0.00117,0.9929309999999999,DGKI LRRC73 NT5E YIPF3,adenosine biosynthetic process|AMP catabolic process|habituation|purine ribonucleoside monophosphate catabolic process|nonassociative learning,0.0003883|0.0005825|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|2574|1287|1030|858.1
963,9,0.6537,23.53,6154.0,0.0037990000000000003,0.9998530000000001,ACAT2 FDFT1 FDPS HSD17B7 LSS MSMO1 SC5D SQLE SREBF2,cholesterol metabolic process|secondary alcohol metabolic process|sterol metabolic process|secondary alcohol biosynthetic process|cholesterol biosynthetic process,8.895e-23|1.883e-22|2.878e-22|2.103e-20|2.103e-20,1.403e-18|1.485e-18|1.513e-18|8.292e-17|6.634e-17,167.4|154.8|148.2|411.9|411.9
964,8,0.6049,16.94,5857.0,0.002876,0.9996790000000001,DHCR7 FOLR1 FOLR2 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-9 P2RY6,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,3.863e-10|1.051e-09|2.77e-09|8.584e-09|1.415e-08,6.093e-06|8.293e-06|1.457e-05|3.385e-05|4.465e-05,54.68|46.11|39.1|32.26|29.63
965,4,0.6506,3.903,3339.0,0.001165,0.9929309999999999,CCDC61 DHDH GRIK5 LIPE,triglyceride catabolic process|acylglycerol catabolic process|neutral lipid catabolic process|glycerolipid catabolic process|triglyceride metabolic process,1.909e-05|3.48e-05|3.48e-05|8.861e-05|0.0001478,0.3011|0.2745|0.183|0.3494|0.4663,305.1|222.6|222.6|137.3|105.6
966,5,0.6519,6.519,3374.0,0.001923,0.996692,DHPS DOHH EIF5A RTCB TTC4,"peptidyl-lysine modification to peptidyl-hypusine|tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate|tRNA exon ligation|RNA exon ligation|gene expression",2.827e-07|0.0004854|0.0004854|0.0004854|0.000583,0.00446|1|1|1|1,4119|4119|4119|4119|7.537
967,4,0.6133,3.68,3051.0,0.001202,0.9929309999999999,DHRS3 RARG RPTN RXRA,retinoic acid receptor signaling pathway|bone morphogenesis|response to retinoic acid|hormone-mediated signaling pathway|transcription initiation from RNA polymerase II promoter,5.932e-06|0.0001419|0.0001684|0.0002462|0.0004706,0.09357|1|0.8853|0.9707|1,542|104|95.35|78.61|56.58
968,9,0.6302,22.69,7042.0,0.003203,0.9998530000000001,CCNB1IP1 DHX32 KIF26B LYRM1 MAP3K7CL NECAP2 NIPSNAP3B SDR39U1 SLC25A36,pyrimidine nucleotide transport|pyrimidine nucleotide import into mitochondrion|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.00131|0.00131|0.001746|0.002182|0.002618,1|1|1|1|1,1144|1144|762.8|572.1|457.7
969,7,0.603,12.66,6017.0,0.002095,0.9992989999999999,DHX40 LRRC46 MYCBPAP OSBPL7 SCRN2 TBKBP1 TBX21,negative regulation of T-helper 17 cell lineage commitment|negative regulation of T-helper 2 cell cytokine production|regulation of T-helper 17 cell lineage commitment|positive regulation of isotype switching to IgG isotypes|negative regulation of T cell cytokine production,0.001358|0.001698|0.002715|0.003393|0.003732,1|1|1|1|1,980.7|735.5|420.3|326.9|294.2
970,5,0.6047,6.047000000000001,3392.0,0.0017739999999999998,0.996692,PSMD6 SHQ1 THOC7 UBA3 UBE2M,protein neddylation|post-translational protein modification|protein modification by small protein conjugation|box H/ACA snoRNP assembly|endomitotic cell cycle,4.943e-06|5.33e-05|0.0006002|0.000728|0.0009706,0.07796|0.4203|1|1|1,633.7|34.23|15.05|2060|1373
971,7,0.6299,13.23,4767.0,0.002759,0.9992989999999999,DIAPH1 DIAPH3 FLII LRRFIP2 MYL6 PFN1 TMOD3,actin filament-based process|actin cytoskeleton organization|negative regulation of actin filament polymerization|actin polymerization or depolymerization|actin filament organization,4.231e-09|2.205e-07|9.455e-07|9.455e-07|1.038e-06,6.674e-05|0.001739|0.004971|0.003729|0.003275,29.52|28.07|147.1|147.1|43.59
972,5,0.6498,6.497999999999999,3752.0,0.001725,0.996692,DIMT1 MTREX PPWD1 UTP15 ZCCHC9,positive regulation of rRNA processing|regulation of rRNA processing|RNA processing|rRNA processing|rRNA metabolic process,3.108e-06|5.648e-06|1.965e-05|2.019e-05|2.257e-05,0.04902|0.04455|0.1033|0.07961|0.07121,823.8|588.4|17.85|47.53|45.77
973,7,0.6168,12.95,4330.0,0.002973,0.9992989999999999,DIP2B KIRREL1 MAP4K4 MOB4 NF2 PDCD10 TAOK1,regulation of stress-activated MAPK cascade|regulation of stress-activated protein kinase signaling cascade|regulation of MAPK cascade|regulation of protein modification process|regulation of protein kinase activity,2.275e-05|2.389e-05|4.214e-05|5.787e-05|7.226e-05,0.3588|0.1884|0.2216|0.2282|0.228,49.59|48.76|16.96|9.008|14.77
974,10,0.6102,27.46,7412.0,0.0036810000000000002,0.999933,AAGAB AFTPH AP1B1 AP1G1 AP1M1 AP1S1 HEATR5B RAB11A TBC1D14 TBCK,protein localization|protein transport|peptide transport|intracellular transport|amide transport,1.632e-10|4.434e-10|5.281e-10|5.506e-10|6.454e-10,2.575e-06|3.497e-06|2.777e-06|2.171e-06|2.036e-06,9.544|12.67|12.42|12.37|12.15
975,5,0.6188,6.188,3361.0,0.001832,0.996692,DIS3L2 HBS1L PELO TTC37 TUT7,nuclear-transcribed mRNA catabolic process|mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process,8.416e-11|1.358e-10|2.581e-10|2.081e-09|3.567e-09,1.327e-06|1.071e-06|1.357e-06|8.207e-06|1.125e-05,105.1|95.35|83.72|54.92|49.27
976,16,0.6104,73.25,12660.0,0.005737,0.999999,AGAP5 AGAP9 ANXA8L1 CXCL12 DKK1 GPRIN2 IFIT1B NUTM2A NUTM2B PTPN20 SFTPA2 SYT15 WASHC2C ZNF239 ZNF32 ZNF33B,regulation of dopamine secretion|regulation of catecholamine secretion|negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment|negative regulation of Wnt-Frizzled-LRP5/6 complex assembly|regulation of Wnt-Frizzled-LRP5/6 complex assembly,0.0003704|0.0008491|0.001552|0.001552|0.001552,1|1|1|1|1,73.55|47.67|1287|1287|1287
977,11,0.6251,34.38,8638.0,0.003954,0.999969,DLK2 FBXO9 GFRAL GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,2.586e-07|2.586e-07|3.882e-06|5.433e-06|5.565e-06,0.004079|0.00204|0.02041|0.02142|0.01756,255.3|255.3|936.1|748.9|86.41
978,8,0.6325,17.71,5743.0,0.003066,0.9996790000000001,B4GALT1 DLL1 MYCN MYOG PAX3 SOX8 TFAP2B ZBTB18,positive regulation of transcription by RNA polymerase II|muscle organ development|skeletal muscle tissue development|skeletal muscle organ development|positive regulation of nucleic acid-templated transcription,1.831e-08|2.647e-08|8.87e-08|1.209e-07|1.422e-07,0.0002888|0.0002088|0.0004664|0.0004769|0.0004486,14.94|45.97|85.1|78.61|11.11
979,4,0.6213,3.728,3451.0,0.001076,0.9929309999999999,DLL3 PRDX3 SERPINB7 SFXN2,positive regulation of platelet-derived growth factor production|serine import into mitochondrion|regulation of platelet-derived growth factor production|peptidyl-cysteine oxidation|negative regulation of endopeptidase activity,0.0005825|0.0007766|0.0007766|0.0007766|0.0008457,1|1|1|1|1,2574|1716|1716|1716|42.03
980,4,0.6357,3.8139999999999996,3558.0,0.001068,0.9929309999999999,CPNE9 DLL4 DTX3 SPATA31E1,Notch signaling pathway|blood vessel lumenization|regulation of neural retina development|negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|dorsal aorta morphogenesis,0.0002004|0.0005825|0.0007766|0.001359|0.001747,1|1|1|1|1,87.27|2574|1716|858.1|643.6
981,9,0.6193,22.29,6192.0,0.0035770000000000003,0.9998530000000001,ESR1 FOXA1 GATA3 GRHL2 LMX1B SPDEF TFAP2A TFAP2C TRPS1,"positive regulation of transcription by RNA polymerase II|regulation of transcription by RNA polymerase II|negative regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated",1.213e-09|7.878e-09|1.059e-08|1.264e-08|1.264e-08,1.913e-05|6.213e-05|5.57e-05|4.984e-05|3.988e-05,15.18|7.964|17.76|11.29|11.29
982,4,0.62,3.72,3213.0,0.0011539999999999999,0.9929309999999999,DEFB1 DMBX1 MMP20 SPATA25,collagen catabolic process|collagen metabolic process|positive regulation of flagellated sperm motility involved in capacitation|regulation of enamel mineralization|developmental process,4.647e-05|9.15e-05|0.0009706|0.001456|0.001669,0.733|0.7217|1|1|1,191.6|135|1373|823.8|3.595
983,4,0.6212,3.727,3334.0,0.001114,0.9929309999999999,DMKN FNDC8 GPR179 TMPRSS5,cornified envelope assembly|membrane assembly|membrane biogenesis|plasma membrane organization|visual perception,0.0009706|0.00678|0.007938|0.01909|0.04148,1|1|1|1|1,1287|151.4|128.7|52.54|23.84
984,4,0.6046,3.627,3325.0,0.0010869999999999999,0.9929309999999999,CHEK2 DMRT1 SUSD2 TRAPPC3L,negative regulation of cell cycle process|negative regulation of cell cycle|negative regulation of cell cycle G1/S phase transition|regulation of cell cycle process|signal transduction involved in intra-S DNA damage checkpoint,1.73e-05|8.344e-05|0.0001746|0.0002063|0.0003883,0.2729|0.6581|0.9178|0.8134|1,46.11|27.15|93.61|20.01|5149
985,11,0.6099,33.54,8531.0,0.003907,0.999969,CASS4 FAM209A FAM209B MTRNR2L3 NPBWR2 OPRL1 RBM38 SLC2A4RG STX16 TFAP2C ZGPAT,opioid receptor signaling pathway|negative regulation of signaling receptor activity|regulation of protein tyrosine kinase activity|neuropeptide signaling pathway|positive regulation of gastric acid secretion,1.705e-05|0.0005789|0.001149|0.001532|0.001601,0.2689|1|1|1|1,374.5|56.74|39.84|34.35|936.1
986,4,0.6301,3.78,3376.0,0.001116,0.9929309999999999,CD300LG DMRTA2 MPP3 RIIAD1,cerebral cortex regionalization|telencephalon regionalization|positive regulation of neuroblast proliferation|forebrain regionalization|neuron fate specification,0.001359|0.002522|0.004459|0.004459|0.005813,1|1|1|1|1,858.1|429.1|234|234|177.5
987,4,0.6048,3.6289999999999996,3216.0,0.001124,0.9929309999999999,DMXL2 ROGDI SQOR TRIM69,"sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|hydrogen sulfide metabolic process|vacuolar acidification|intracellular pH reduction",0.001165|0.001165|0.001359|0.004653|0.009482,1|1|1|1|1,1030|1030|858.1|223.9|107.3
988,6,0.6094,9.141,4233.0,0.002149,0.998474,DNAAF5 PIH1D1 POLR2M RPAP3 WDCP ZNHIT3,snoRNA localization|box C/D snoRNP assembly|small nucleolar ribonucleoprotein complex assembly|protein-containing complex assembly|protein-containing complex subunit organization,1.484e-06|3.178e-06|4.66e-06|0.0002411|0.0004615,0.0234|0.02506|0.0245|0.9507|1,1373|858.1|686.5|10.27|8.684
989,4,0.6003,3.602,3197.0,0.001123,0.9929309999999999,ANKRD33 DNAI2 KRT79 SLFN13,tRNA catabolic process|rRNA catabolic process|outer dynein arm assembly|negative regulation of transcription regulatory region DNA binding|ncRNA catabolic process,0.0005825|0.003878|0.004266|0.004459|0.0062,1|1|1|1|1,2574|271|245.2|234|166.1
990,5,0.6067,6.067,3161.0,0.0019100000000000002,0.996692,AHR ARNT DNAJA1 DNAJA2 STIP1,intracellular receptor signaling pathway|positive regulation of ATPase activity|regulation of ATPase activity|response to heat|cellular response to stress,8.754e-06|8.295e-05|0.0001591|0.0002219|0.0002469,0.1381|0.6543|0.8367|0.8752|0.779,63.05|142|101.7|85.81|9.388
991,5,0.6406,6.406000000000001,3362.0,0.0018960000000000001,0.996692,DNAJA3 HSPE1 LONP1 PAM16 SNRNP25,mitochondrion organization|activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|oxidation-dependent protein catabolic process|positive regulation of cysteine-type endopeptidase activity,0.000107|0.0001999|0.0004525|0.0004854|0.0005614,1|1|1|1|1,27.04|90.53|59.7|4119|53.49
992,14,0.6163,56.08,10340.0,0.005383,0.9999969999999999,CTSK HRNR LCE1A LCE1B LCE1E LCE2A LCE3A LCE3B LCE3C LCE3D LCE3E LCE5A S100A2 SPRR2G,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,3.797e-22|2.776e-21|1.912e-20|1.831e-19|4.982e-19,5.989e-18|2.189e-17|1.005e-16|7.219e-16|1.572e-15,78.11|65.87|55.86|46.09|42.33
993,5,0.6136,6.136,3525.0,0.0017329999999999997,0.996692,COLCA2 DNAJB6 POU2F3 TFAP2B TP73,cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|urea homeostasis|creatinine homeostasis,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
994,5,0.6013,6.013,3960.0,0.0015119999999999999,0.996692,DNAJB9 GNAT3 HYAL4 IFRD1 THAP5,myoblast fate determination|myoblast fate commitment|negative regulation of IRE1-mediated unfolded protein response|sensory perception of umami taste|sensory perception of sweet taste,0.000728|0.001456|0.001456|0.001698|0.001698,1|1|1|1|1,2060|823.8|823.8|686.5|686.5
995,7,0.6148,12.91,4741.0,0.002708,0.9992989999999999,AQR BUB1B DNAJC17 MFAP1 RPAP1 TUBGCP4 USP8,"regulation of protein catabolic process at postsynapse, modulating synaptic transmission|mitotic prometaphase|mitotic cell cycle|meiotic sister chromatid cohesion, centromeric|spindle organization",0.001358|0.001367|0.00159|0.001698|0.002447,1|1|1|1|1,980.7|35.24|11.6|735.5|26.15
996,9,0.6363,22.91,6022.0,0.003778,0.9998530000000001,DNAJC24 DPH1 DPH2 DPH3 DPH5 DPH6 DPH7 TPT1 TTC4,peptidyl-diphthamide biosynthetic process from peptidyl-histidine|peptidyl-diphthamide metabolic process|regulation of cytoplasmic translational elongation|peptidyl-histidine modification|regulation of translational elongation,7.409e-22|7.409e-22|3.663e-21|8.922e-21|1.362e-19,1.169e-17|5.844e-18|1.926e-17|3.518e-17|4.296e-16,2002|2002|1456|1232|762.8
997,4,0.6493,3.8960000000000004,3136.0,0.0012369999999999998,0.9929309999999999,AP3B1 BLOC1S6 DNAJC5B DTNBP1,synaptic vesicle transport along microtubule|synaptic vesicle cytoskeletal transport|anterograde synaptic vesicle transport|melanosome organization|pigment granule organization,2.66e-09|2.66e-09|2.66e-09|1.003e-08|1.114e-08,4.195e-05|2.098e-05|1.398e-05|3.953e-05|3.514e-05,965.4|965.4|965.4|594.1|572.1
998,11,0.605,33.27,7230.0,0.004567,0.999969,ANAPC13 ANAPC15 MAD2L1BP SGO1 SGO2 SKA1 SKA3 SPAG5 TRNAU1AP UBE2C UBE2S,cell division|anaphase|mitotic anaphase|M phase|mitotic M phase,1.457e-13|9.988e-11|9.988e-11|1.115e-10|1.115e-10,2.298e-09|7.877e-07|5.252e-07|4.399e-07|3.519e-07,34.25|71.55|71.55|70.21|70.21
999,10,0.6001,27.0,7305.0,0.0036729999999999996,0.999933,ARRDC4 CYS1 DNAL4 IER5 ITPKA PTRH1 SALL3 TCOF1 TMEM82 TSPAN17,"positive regulation of cellular response to heat|positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|nucleolar large rRNA transcription by RNA polymerase I|positive regulation of microtubule motor activity",0.0009704|0.00194|0.00194|0.00194|0.002424,1|1|1|1|1,2060|686.5|686.5|686.5|514.9
1000,4,0.6243,3.7460000000000004,3394.0,0.0011,0.9929309999999999,DNASE1L3 LYPD3 TNS4 TOGARAM1,"regulation of neutrophil mediated cytotoxicity|programmed cell death involved in cell development|apoptotic DNA fragmentation|DNA catabolic process, endonucleolytic|apoptotic nuclear changes",0.001359|0.001941|0.003297|0.004653|0.00504,1|1|1|1|1,858.1|572.1|321.8|223.9|205.9
1001,8,0.6045,16.93,5269.0,0.003193,0.9996790000000001,AASDHPPT ADAT2 DNLZ FDXR MRE11 PGS1 PTPMT1 TRMT61A,cardiolipin biosynthetic process|phosphatidylglycerol biosynthetic process|cardiolipin metabolic process|phosphatidylglycerol metabolic process|lipid biosynthetic process,1.807e-08|2.988e-08|7.944e-08|6.882e-07|0.0001317,0.000285|0.0002357|0.0004177|0.002714|0.4153,686.5|561.7|386.2|176.5|13.78
1002,6,0.6065,9.097999999999999,4653.0,0.001946,0.998474,DNM1L KLHL12 MFF MIEF1 OMA1 SLC25A46,mitochondrial fission|positive regulation of mitochondrial fission|mitochondrion organization|regulation of mitochondrion organization|regulation of mitochondrial fission,2.525e-11|1.562e-08|3.27e-08|5.064e-08|5.557e-08,3.983e-07|0.0001232|0.000172|0.0001997|0.0001753,653.8|605.7|37.55|88.58|381.4
1003,6,0.6004,9.006,4610.0,0.001945,0.998474,DNM3 FAM129A FCGR2A FMO3 ITLN2 SLAMF7,negative regulation of dendritic spine morphogenesis|synaptic vesicle budding from presynaptic endocytic zone membrane|dynamin family protein polymerization involved in mitochondrial fission|dynamin family protein polymerization involved in membrane fission|postsynaptic endocytosis,0.002037|0.002328|0.002619|0.002619|0.002909,1|1|1|1|1,572.1|490.4|429.1|429.1|381.4
1004,4,0.6444,3.866,2859.0,0.001347,0.9929309999999999,DNPEP LINS1 METTL23 PPIH,cognition|positive regulation of viral genome replication|protein peptidyl-prolyl isomerization|peptidyl-proline modification|regulation of viral genome replication,0.001211|0.0062|0.009482|0.01256|0.0164,1|1|1|1|1,35.03|166.1|107.3|80.45|61.29
1005,4,0.6261,3.7569999999999997,3516.0,0.001065,0.9929309999999999,AARD DNTT FBXL15 SLC30A8,sequestering of zinc ion|regulation of sequestering of zinc ion|sequestering of metal ion|zinc ion transmembrane transport|zinc ion transport,0.0009706|0.001165|0.002522|0.004846|0.00562,1|1|1|1|1,1287|1030|429.1|214.5|183.9
1006,7,0.6476,13.6,4106.0,0.00329,0.9992989999999999,KRAS MAPK1 NF1 NRAS RAF1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|Ras protein signal transduction|forebrain astrocyte development|forebrain astrocyte differentiation,1.302e-12|1.555e-08|1.933e-07|5.936e-07|5.936e-07,2.054e-08|0.0001226|0.001016|0.002341|0.001873,50.35|13.08|66.87|2942|2942
1007,5,0.6664,6.664,3762.0,0.0017640000000000002,0.996692,DOCK7 ITPRIPL2 MOB1A STK4 TAOK2,hippo signaling|intracellular signal transduction|positive regulation of phosphorylation|positive regulation of phosphorus metabolic process|positive regulation of phosphate metabolic process,6.151e-08|1.482e-05|5.445e-05|7.445e-05|7.445e-05,0.0009703|0.1169|0.2863|0.2936|0.2349,367.8|10.9|15.04|13.88|13.88
1008,19,0.6058,103.6,12260.0,0.008351,1.0,ALG12 ALG3 ALG8 ALG9 AUP1 DERL2 DNAJB11 DNAJC3 DPM1 DPM2 DPM3 HERPUD1 MANF MPDU1 SEL1L SLC33A1 SYVN1 UBE2G2 UBE2J1,protein N-linked glycosylation|glycoprotein metabolic process|mannosylation|protein glycosylation|macromolecule glycosylation,1.78e-17|6.596e-17|5.085e-15|4.234e-13|4.234e-13,2.808e-13|5.202e-13|2.674e-11|1.67e-09|1.336e-09,130.1|34.97|210.8|40.31|40.31
1009,4,0.6006,3.6039999999999996,3309.0,0.001085,0.9929309999999999,DOK1 FA2H HGSNAT MAP3K20,positive regulation of mitotic DNA damage checkpoint|sebaceous gland cell differentiation|glucosylceramide biosynthetic process|positive regulation of DNA damage checkpoint|regulation of mitotic DNA damage checkpoint,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1010,9,0.6138,22.1,6382.0,0.0034409999999999996,0.9998530000000001,CDT1 CFDP1 CIAPIN1 DONSON GINS1 GINS2 GINS3 NUP93 ORC6,DNA-dependent DNA replication|DNA replication|nuclear DNA replication|cell cycle DNA replication|DNA strand elongation involved in DNA replication,6.363e-11|4.543e-10|9.258e-09|9.884e-09|8.838e-08,1.004e-06|3.583e-06|4.868e-05|3.898e-05|0.0002788,70.77|50.66|157.8|155.1|361.3
1011,4,0.6196,3.718,3326.0,0.001114,0.9929309999999999,DPP9 GPR141 PEPD SMIM29,collagen catabolic process|collagen metabolic process|proteolysis|cellular amino acid metabolic process|carboxylic acid metabolic process,0.008517|0.01199|0.02163|0.05328|0.1515,1|1|1|1|1,119.7|84.41|7.989|18.45|6.218
1012,5,0.6122,6.122000000000001,4042.0,0.001509,0.996692,CA2 CHMP4C DPYSL2 SNX16 ZFAND1,positive regulation of anion transport|positive regulation of ion transport|vacuolar transport|regulation of anion transport|positive regulation of dipeptide transport,0.0001412|0.0003903|0.0005401|0.0006877|0.000728,1|1|1|1|1,24.62|17.43|54.56|14.37|2060
1013,4,0.6065,3.639,3262.0,0.001112,0.9929309999999999,DRD3 LNP1 MAATS1 TMPRSS7,"negative regulation of sodium:proton antiporter activity|musculoskeletal movement, spinal reflex action|gastric emptying|gastric motility|regulation of locomotion involved in locomotory behavior",0.0004369|0.0004369|0.0005825|0.0005825|0.0007281,1|1|1|1|1,3432|3432|2288|2288|1716
1014,4,0.6138,3.6830000000000003,2969.0,0.001235,0.9929309999999999,DDX46 DRD5 IK U2SURP,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",1.272e-05|1.272e-05|1.31e-05|3.085e-05|5.161e-05,0.2006|0.1003|0.06886|0.1217|0.1628,51.15|51.15|50.64|37.95|31.91
1015,4,0.6064,3.638,2772.0,0.001307,0.9929309999999999,CCND2 DRG2 IRF4 RWDD1,cytoplasmic translation|T-helper 17 cell lineage commitment|translation|T-helper 17 cell differentiation|peptide biosynthetic process,8.235e-05|0.001553|0.00205|0.002134|0.00232,1|1|1|1|1,137.3|735.5|26.82|514.9|25.18
1016,14,0.5815,52.91,11200.0,0.004691,0.9999969999999999,CHST9 CTIF DSC1 DSC3 DSG1 DSG2 DSG3 DSG4 HRH4 KIAA1328 SERPINB7 SYT4 ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,1.176e-12|1.646e-11|1.285e-10|3.248e-10|4.098e-10,1.856e-08|1.298e-07|6.757e-07|1.281e-06|1.293e-06,85.05|57.55|42.53|37.11|35.86
1017,7,0.662,13.9,4869.0,0.002839,0.9992989999999999,MRE11 ORC2 ORC3 ORC4 ORC5 ORC6 PNKP,DNA-dependent DNA replication|DNA replication|DNA replication initiation|pre-replicative complex assembly|DNA metabolic process,7.578e-15|7.557e-14|1.159e-12|8.178e-12|1.167e-10,1.195e-10|5.96e-10|6.095e-09|3.225e-08|3.682e-07,106.2|76|342.1|226.3|26.37
1018,6,0.6335,9.502,3937.0,0.0024010000000000004,0.998474,BUB1B DSN1 KNTC1 MAD1L1 ZWILCH ZWINT,anaphase|mitotic anaphase|M phase|mitotic M phase|mitotic spindle organization,2.237e-13|2.237e-13|2.5e-13|2.5e-13|2.89e-13,3.529e-09|1.764e-09|1.315e-09|9.859e-10|9.118e-10,131.2|131.2|128.7|128.7|125.6
1019,12,0.6135,40.49,9499.0,0.004234,0.999986,CRISP1 CRISP2 DST GSTA1 GSTA3 GSTA4 IL17A IL17F MLIP MUT RAB23 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,2.586e-07|2.586e-07|3.882e-06|5.433e-06|5.565e-06,0.004079|0.00204|0.02041|0.02142|0.01756,255.3|255.3|936.1|748.9|86.41
1020,29,0.6057,245.9,22530.0,0.01077,1.0,AIFM3 APOBEC3A APOBEC3C APOBEC3D APOBEC3G APOL1 CRYBA4 CYTH4 DGCR6L DRICH1 FOXRED2 GSTT2B MGAT3 MIF MPPE1 RFPL2 RFPL3 SDF2L1 SEC14L3 SEC14L4 SEC14L6 SEPT5 SLC5A1 SLC5A4 TST USP18 VPREB1 YPEL1 ZNF74,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,3.603e-09|6.537e-09|6.537e-09|6.537e-09|6.537e-09,5.683e-05|5.156e-05|3.437e-05|2.578e-05|2.062e-05,274.6|228.8|228.8|228.8|228.8
1021,4,0.607,3.642,3246.0,0.001118,0.9929309999999999,BBS5 DTD2 G6PC2 SCN2A,intrinsic apoptotic signaling pathway in response to osmotic stress|aminoacyl-tRNA metabolism involved in translational fidelity|regulation of translational fidelity|melanosome transport|pigment granule transport,0.0005825|0.002716|0.004072|0.004266|0.004459,1|1|1|1|1,2574|396.1|257.4|245.2|234
1022,10,0.6146,27.66,7340.0,0.003743,0.999933,COG2 DTL EPRS INTS7 NUP133 NVL RRP15 SDE2 TBCE URB2,gene expression|ncRNA metabolic process|ribosome biogenesis|ribosomal large subunit biogenesis|cellular macromolecule biosynthetic process,1.375e-05|7.517e-05|0.0004696|0.000562|0.0006023,0.2168|0.5929|1|1|1,6.595|15.93|18.61|57.21|6.222
1023,9,0.632,22.75,7141.0,0.003168,0.9998530000000001,CCNB1IP1 DTWD1 KIAA1257 KIF26B LYRM1 MAP3K7CL NIPSNAP3B SDR39U1 SLC25A36,pyrimidine nucleotide transport|pyrimidine nucleotide import into mitochondrion|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.00131|0.00131|0.001746|0.002182|0.002618,1|1|1|1|1,1144|1144|762.8|572.1|457.7
1024,4,0.6152,3.6910000000000003,3432.0,0.001072,0.9929309999999999,ACTRT2 CBY3 DTWD2 HMHB1,positive regulation of interferon-gamma production|tRNA modification|regulation of interferon-gamma production|tRNA processing|RNA modification,0.01314|0.01756|0.021|0.02558|0.0328,1|1|1|1|1,76.85|57.21|47.67|39.01|30.29
1025,4,0.606,3.636,3349.0,0.001082,0.9929309999999999,ASIC4 DUS3L HDHD3 SSFA2,tRNA dihydrouridine synthesis|behavioral fear response|behavioral defense response|fear response|multicellular organismal response to stress,0.0008737|0.004073|0.004218|0.004654|0.009582,1|1|1|1|1,1373|254.3|245.2|221.5|105.6
1026,10,0.6109,27.49,6640.0,0.004111,0.999933,C1orf109 DHX33 MYBBP1A NOL9 PAK1IP1 POP5 RPP21 RPP40 SPATA5L1 WDR18,"ribosome biogenesis|ribonucleoprotein complex biogenesis|tRNA 5'-leader removal|tRNA 5'-end processing|RNA phosphodiester bond hydrolysis, endonucleolytic",3.704e-09|2.685e-08|4.594e-08|7.944e-08|7.998e-08,5.843e-05|0.0002118|0.0002416|0.0003133|0.0002523,37.22|26.57|475.3|386.2|92.56
1027,7,0.6507,13.66,4344.0,0.0031260000000000003,0.9992989999999999,LZTR1 NF1 PTPN11 SHOC2 SOS1 SPRED1 SPRED2,fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus|regulation of intracellular signal transduction|response to fibroblast growth factor|cellular response to growth factor stimulus,9.355e-09|3.296e-08|3.486e-08|4.041e-08|1.802e-07,0.0001476|0.00026|0.0001833|0.0001593|0.0005685,145.3|105.1|11.65|99.73|29.25
1028,4,0.6031,3.6189999999999998,3078.0,0.0011710000000000002,0.9929309999999999,CCNB1IP1 DUXA SLC25A40 ZNF286A,chiasma assembly|homologous chromosome pairing at meiosis|reciprocal meiotic recombination|reciprocal homologous recombination|homologous recombination,0.001359|0.01006|0.01102|0.01102|0.01141,1|1|1|1|1,858.1|101|91.94|91.94|88.77
1029,5,0.7092,7.0920000000000005,3822.0,0.001847,0.996692,DVL1 FZD5 LGR4 LRP5 WLS,canonical Wnt signaling pathway|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|morphogenesis of an epithelium,8.031e-12|2.511e-11|2.511e-11|7.446e-11|2.42e-08,1.267e-07|1.981e-07|1.32e-07|2.936e-07|7.633e-05,204.3|59.01|59.01|49.15|39.91
1030,7,0.615,12.92,5341.0,0.0024059999999999997,0.9992989999999999,C6orf48 HLA-DMB MSH5 NUDT3 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,2.731e-08|3.689e-08|8.743e-08|2.775e-07|4.895e-07,0.0004308|0.0002909|0.0004597|0.001094|0.001544,519.2|464.5|339.5|60.98|52.77
1031,5,0.6151,6.151,4134.0,0.001482,0.996692,DYDC1 IFIT1B LIPM OPALIN SAMD8,ceramide phosphoethanolamine biosynthetic process|ceramide phosphoethanolamine metabolic process|sphingomyelin biosynthetic process|chromatin silencing at telomere|sphingomyelin metabolic process,0.000728|0.000728|0.00194|0.002425|0.003636,1|1|1|1|1,2060|2060|588.4|457.7|294.2
1032,12,0.6028,39.78,8123.0,0.00486,0.999986,CNIH1 GOSR2 MON2 RAB1A RAB1B SAR1A SEC23IP SEC31A SURF4 TM9SF3 TRAPPC12 TRAPPC13,Golgi vesicle transport|COPII-coated vesicle budding|endoplasmic reticulum to Golgi vesicle-mediated transport|vesicle budding from membrane|COPII vesicle coating,5.032e-16|5.999e-15|3.846e-14|7.883e-14|1.026e-12,7.938e-12|4.732e-11|2.022e-10|3.109e-10|3.237e-09,43.34|171.6|70.05|116.6|163.5
1033,8,0.6196,17.35,6352.0,0.0027170000000000002,0.9996790000000001,A2M C3AR1 CLEC4D CLEC6A DYRK4 GALNT8 KCNA5 KCNA6,regulation of innate immune response|export from cell|regulation of response to biotic stimulus|regulation of immune response|immune response-activating cell surface receptor signaling pathway,0.0001873|0.00033|0.0004488|0.0005327|0.0005588,1|1|1|1|1,24.75|10.34|18.34|9.121|17.01
1034,5,0.6486,6.486000000000001,4187.0,0.0015429999999999999,0.996692,DZIP1 MN1 RXFP2 SOHLH2 ZAR1L,germ cell development|oocyte differentiation|cellular process involved in reproduction in multicellular organism|oogenesis|gamete generation,1.951e-05|4.239e-05|4.988e-05|0.0001478|0.0003665,0.3077|0.3343|0.2623|0.5829|1,48.08|200.9|35.01|105.6|17.81
1035,9,0.6191,22.29,6775.0,0.0032700000000000003,0.9998530000000001,HIST1H2AD HLA-F OR14J1 OR2J3 PSORS1C2 TCF19 TRIM10 TRIM26 ZKSCAN4,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway,3.626e-05|4.962e-05|0.0001295|0.0001733|0.0003514,0.5719|0.3913|0.681|0.6832|1,234|198|119.7|103|71.51
1036,8,0.62,17.36,6165.0,0.002801,0.9996790000000001,ARMC1 ATXN7L3B CCNB1IP1 EAPP KIF26B MAP3K7CL PCDHB12 SDR39U1,ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|renal vesicle formation|chiasma assembly,0.001552|0.00194|0.002328|0.002715|0.002715,1|1|1|1|1,858.1|643.6|514.9|429.1|429.1
1037,4,0.611,3.6660000000000004,3566.0,0.001025,0.9929309999999999,EBLN2 TGM4 TMEM104 TTC39B,negative regulation of cholesterol storage|regulation of cholesterol storage|negative regulation of lipid storage|regulation of cholesterol efflux|regulation of lipid storage,0.001941|0.003297|0.004266|0.0062|0.01025,1|1|1|1|1,572.1|321.8|245.2|166.1|99.01
1038,10,0.619,27.86,7660.0,0.003614,0.999933,CCDC137 DDX31 DNAJC21 EBNA1BP2 GNL1 PINX1 RBM34 RPF1 WDR89 ZNF622,ribosomal large subunit biogenesis|ribosome biogenesis|ribonucleoprotein complex biogenesis|ganglion mother cell fate determination|positive regulation of telomeric DNA binding,7.483e-06|2.093e-05|7.7e-05|0.001601|0.001601,0.118|0.1651|0.4049|1|1,78.01|22.56|16.11|936.1|936.1
1039,4,0.6122,3.673,3166.0,0.0011560000000000001,0.9929309999999999,CBLB ECHDC3 MTRNR2L4 SPATA46,negative regulation of signaling receptor activity|regulation of signaling receptor activity|positive regulation of T cell anergy|positive regulation of lymphocyte anergy|regulation of platelet-derived growth factor receptor-alpha signaling pathway,6.415e-05|0.0005337|0.0009706|0.0009706|0.001165,1|1|1|1|1,156|53.08|1287|1287|1030
1040,4,0.6393,3.8360000000000003,3223.0,0.001186,0.9929309999999999,ECI2 RIPK1 TUBB2A TUBB2B,neuron migration|regulation of ATP:ADP antiporter activity|ripoptosome assembly|positive regulation of axon guidance|positive regulation of interleukin-6-mediated signaling pathway,0.0001938|0.0003883|0.0003883|0.0007766|0.0007766,1|1|1|1|1,88.77|5149|5149|1716|1716
1041,19,0.6065,103.7,13910.0,0.007379000000000001,1.0,ANG CEBPE DHRS2 EDDM3A EDDM3B MYH6 OR10G3 OR11G2 OR11H4 OR4E2 OR4M2 OR5AU1 OR6S1 RNASE1 RNASE3 RNASE4 RNASE7 SLC7A8 TM9SF1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,8.785e-08|1.308e-07|1.685e-07|2.716e-07|3.49e-07,0.001386|0.001032|0.0008857|0.001071|0.001101,17.21|16.21|15.61|14.54|14
1042,10,0.6112,27.5,7257.0,0.0037649999999999997,0.999933,ALG12 ALG9 EDEM2 EDEM3 SERP1 SURF4 SYVN1 TM9SF3 TXNDC11 UBE2J1,glycoprotein metabolic process|ubiquitin-dependent ERAD pathway|protein glycosylation|macromolecule glycosylation|carbohydrate derivative metabolic process,7.715e-11|4.129e-08|5.704e-08|5.704e-08|7.165e-08,1.217e-06|0.0003257|0.0002999|0.0002249|0.000226,38.75|109.8|42.55|42.55|14.33
1043,4,0.6036,3.622,3289.0,0.001097,0.9929309999999999,EDNRA MUC16 RFNG RNF150,endothelin receptor signaling pathway|artery smooth muscle contraction|tonic smooth muscle contraction|enteric nervous system development|vascular associated smooth muscle contraction,0.001553|0.001941|0.002134|0.003104|0.003297,1|1|1|1|1,735.5|572.1|514.9|343.2|321.8
1044,5,0.604,6.04,3762.0,0.001599,0.996692,BTN2A2 EEA1 OR2J3 ZKSCAN4 ZNF165,synaptic vesicle to endosome fusion|synaptic vesicle endosomal processing|viral RNA genome replication|negative regulation of activated T cell proliferation|early endosome to late endosome transport,0.0009706|0.002667|0.003394|0.003636|0.005812,1|1|1|1|1,1373|411.9|316.8|294.2|179.1
1045,10,0.6047,27.21,7891.0,0.003428,0.999933,BMP7 CASS4 EEF1A2 FAM209A FAM209B MTRNR2L3 PPDPF RBM38 TFAP2C ZGPAT,negative regulation of signaling receptor activity|regulation of kinase activity|regulation of protein tyrosine kinase activity|regulation of transferase activity|nephrogenic mesenchyme morphogenesis,0.0004747|0.0006462|0.0009434|0.001019|0.001455,1|1|1|1|1,62.41|9.073|43.82|8.037|1030
1046,4,0.6445,3.867,3190.0,0.001208,0.9929309999999999,B3GALT5 EEF1AKMT3 FAM107B SCGB2A2,poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process|androgen receptor signaling pathway|oligosaccharide biosynthetic process|cellular polysaccharide biosynthetic process,0.002522|0.002716|0.003685|0.006007|0.009289,1|1|1|1|1,429.1|396.1|286|171.6|109.5
1047,4,0.6329,3.798,2903.0,0.001303,0.9929309999999999,EEF1B2 GOSR2 NPLOC4 NSF,"intra-Golgi vesicle-mediated transport|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi|vesicle coating|COPII-coated vesicle budding",1.879e-05|5.859e-05|5.859e-05|6.606e-05|7.196e-05,0.2964|0.4621|0.308|0.2605|0.227,294.2|163.5|163.5|153.7|147.1
1048,8,0.6566,18.39,4726.0,0.0038619999999999995,0.9996790000000001,ASNS ATF4 EIF2AK4 GCN1 SLC3A2 SLC7A1 SLC7A5 TRPM7,aromatic amino acid transport|integrated stress response signaling|amino acid import across plasma membrane|amino acid import|cellular response to starvation,2.147e-08|5.094e-08|2.727e-07|5.051e-07|5.397e-07,0.0003386|0.0004017|0.001434|0.001992|0.001703,594.1|429.1|234|188.4|53.63
1049,5,0.6626,6.626,3614.0,0.001825,0.996692,CCDC86 EEF1G INTS5 OSBP TMEM258,cellular biosynthetic process|organic substance biosynthetic process|biosynthetic process|cellular macromolecule biosynthetic process|intracellular cholesterol transport,0.001343|0.001535|0.00166|0.004598|0.004845,1|1|1|1|1,6.082|5.876|5.759|7.466|216.8
1050,4,0.612,3.6719999999999997,2796.0,0.001308,0.9929309999999999,EEF2 EIF3G PPAN SF3A2,ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|ribonucleoprotein complex biogenesis|cellular protein-containing complex assembly|U2-type prespliceosome assembly,3.217e-06|3.581e-06|4.583e-05|0.000283|0.0007766,0.05075|0.02824|0.241|1|1,81.3|78.41|33.22|17.98|1716
1051,10,0.6026,27.12,6902.0,0.0039030000000000002,0.999933,CNIH4 DUX4 EIF2S1 HSPE1 NBEAL1 NUTF2 RPL17 RPL37 SNU13 ST20,translational initiation|rRNA processing|rRNA metabolic process|ribosome biogenesis|translation,4.032e-05|0.0002309|0.0002577|0.0004696|0.0007152,0.6361|1|1|1|1,43.21|23.76|22.88|18.61|16.09
1052,7,0.8885,18.66,3795.0,0.004875,0.9992989999999999,EEFSEC GPX4 PSTK SECISBP2 SEPHS2 SEPSECS TXNRD1,translational readthrough|selenocysteine incorporation|translational elongation|peptide metabolic process|selenocysteinyl-tRNA(Sec) biosynthetic process,2.307e-12|2.307e-12|5.06e-08|2.488e-07|1.483e-06,3.638e-08|1.819e-08|0.0002661|0.000981|0.00468,1471|1471|94.15|27.39|1471
1053,18,0.6017,92.06,13440.0,0.0067870000000000005,1.0,CD1B CD1C CD1E CTSK EFNA4 FCRL3 GBA ITLN2 LCE3E OR10J5 OR10T2 OR6K6 OR6N1 S100A12 S100A2 S100A9 SLAMF7 YY1AP1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",3.122e-08|6.683e-08|6.683e-08|3.773e-07|2.014e-06,0.0004925|0.0005271|0.0003514|0.001488|0.006354,686.5|490.4|490.4|245.2|132
1054,4,0.6045,3.627,3450.0,0.001048,0.9929309999999999,EFCAB12 PLPP3 SCARA3 SH3GLB1,canonical Wnt signaling pathway involved in positive regulation of wound healing|canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion|canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration|protein localization to vacuolar membrane|positive regulation of membrane tubulation,0.0003883|0.0003883|0.0003883|0.0003883|0.001165,1|1|1|1|1,5149|5149|5149|5149|1030
1055,4,0.6241,3.7439999999999998,3389.0,0.001101,0.9929309999999999,EFCAB13 REG1A RTL10 SULT6B1,cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration|positive regulation of acinar cell proliferation,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1056,7,0.6172,12.96,5781.0,0.002231,0.9992989999999999,ABCA8 CSH2 EFCAB3 LIMD2 METTL2B MIF4GD PRR29,sphingomyelin biosynthetic process|sphingomyelin metabolic process|growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|positive regulation of cholesterol efflux,0.002715|0.005086|0.007114|0.007452|0.007452,1|1|1|1|1,420.3|210.2|147.1|140.1|140.1
1057,4,0.6372,3.823,3464.0,0.0011,0.9929309999999999,EFCAB5 LIPM MRC1 ZFYVE27,endoplasmic reticulum tubular network formation|modulation by symbiont of host defense response|response to host defenses|response to defenses of other organism|response to host,0.0009706|0.001747|0.002328|0.002328|0.002328,1|1|1|1|1,1287|643.6|468.1|468.1|468.1
1058,4,0.6247,3.748,3070.0,0.001216,0.9929309999999999,EFCAB9 HAGHL HBQ1 HBZ,oxygen transport|gas transport|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification,3.391e-06|5.932e-06|1.313e-05|2.547e-05|0.0001309,0.05349|0.04679|0.06902|0.1004|0.4129,735.5|542|355.1|251.2|108.4
1059,4,0.6359,3.815,3396.0,0.00112,0.9929309999999999,EFEMP1 PHTF1 PRB4 RAB31,"post-embryonic eye morphogenesis|post-embryonic animal organ morphogenesis|positive regulation of phagocytosis, engulfment|positive regulation of membrane invagination|post-embryonic animal morphogenesis",0.001553|0.001941|0.002716|0.002716|0.00291,1|1|1|1|1,735.5|572.1|396.1|396.1|367.8
1060,8,0.604,16.91,5760.0,0.002919,0.9996790000000001,GRWD1 LENG1 LENG8 NUP62 PNKP SNRNP70 SYMPK TSEN34,"RNA splicing|mRNA processing|DNA excision|nucleotide-excision repair, DNA damage removal|mRNA export from nucleus",0.0004067|0.0006727|0.0007765|0.0007765|0.000817,1|1|1|1|1,18.98|15.96|2574|2574|46.39
1061,4,0.6112,3.667,3181.0,0.001149,0.9929309999999999,CFAP97D1 EFNB3 GRIN2D NME1,"adult locomotory behavior|adult behavior|locomotory behavior|trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission|axon choice point recognition",7.811e-05|0.0002462|0.0004655|0.0007766|0.001553,1|1|1|1|1,141.1|78.61|56.89|1716|735.5
1062,7,0.6186,12.99,4742.0,0.002724,0.9992989999999999,EFTUD2 EIF4A3 KPNB1 PSMB3 SF3A1 SMU1 SNRNP200,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",1.458e-08|1.458e-08|1.53e-08|6.344e-08|1.491e-07,0.0002299|0.000115|8.047e-05|0.0002502|0.0004702,48.71|48.71|48.23|36.14|30.39
1063,4,0.6576,3.946,3461.0,0.0011359999999999999,0.9929309999999999,AKR1A1 AZIN2 EHD3 FABP3,positive regulation of ion transport|carboxylic acid metabolic process|oxoacid metabolic process|organic acid metabolic process|positive regulation of transport,0.0001603|0.0002538|0.000285|0.0003185|0.0003649,1|1|1|1|1,21.79|18.65|17.94|17.28|16.5
1064,14,0.5914,53.82,10280.0,0.005193,0.9999969999999999,ACCSL BDNF CAT CHRM4 COMMD9 EHF ELF5 OR4B1 OR4C13 OR4C3 OR4X1 PAMR1 SLC1A2 TP53I11,hydrogen peroxide catabolic process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|hydrogen peroxide metabolic process,0.0002593|0.0003175|0.0003971|0.0004575|0.0005008,1|1|1|1|1,88.77|11.68|11|10.59|62.79
1065,4,0.6444,3.866,3299.0,0.001168,0.9929309999999999,EHHADH MAIP1 PCDH15 TIMD4,protein insertion into mitochondrial inner membrane from matrix|protein insertion into membrane from inner side|equilibrioception|calcium import into the mitochondrion|establishment of protein localization to organelle,0.0009706|0.0009706|0.001747|0.002328|0.002787,1|1|1|1|1,1287|1287|643.6|468.1|22.93
1066,6,0.6234,9.352,3702.0,0.002512,0.998474,EIF1 EIF2AK4 PDAP1 PPP1R15B RNF25 URM1,regulation of translational initiation|regulation of translation|regulation of cellular amide metabolic process|posttranscriptional regulation of gene expression|GCN2-mediated signaling,1.344e-06|0.0001113|0.0001783|0.0003564|0.0008735,0.0212|0.8778|0.9377|1|1,125.6|27.98|23.84|18.83|1716
1067,5,0.608,6.08,3162.0,0.001913,0.996692,EIF2A EIF2AK4 PPP1R15B PUS3 RNF25,ER-nucleus signaling pathway|negative regulation of translational initiation in response to stress|regulation of translational initiation|response to amino acid starvation|regulation of translation,1.569e-07|1.06e-06|1.344e-06|1.392e-06|1.525e-06,0.002475|0.008359|0.007065|0.00549|0.004811,264|1716|125.6|124.1|37.31
1068,9,0.6142,22.11,5925.0,0.003706,0.9998530000000001,BIRC6 DNAJC7 EIF2AK1 EIF2B4 HECTD1 KCMF1 PPP1R15B UBA6 UBR4,protein ubiquitination|cellular protein metabolic process|protein modification by small protein conjugation|protein metabolic process|protein modification by small protein conjugation or removal,6.853e-06|7.326e-06|1.127e-05|2.294e-05|3.385e-05,0.1081|0.05778|0.05925|0.09045|0.1068,15.44|5.025|13.94|4.34|11.1
1069,7,0.6197,13.01,4921.0,0.00263,0.9992989999999999,EIF2B5 LSG1 NMD3 OPA1 PSMD2 RFC4 TRA2A,ribosome localization|ribosomal subunit export from nucleus|rRNA-containing ribonucleoprotein complex export from nucleus|establishment of organelle localization|response to curcumin,1.037e-05|1.037e-05|1.185e-05|0.0002399|0.0006794,0.1636|0.08178|0.0623|0.9461|1,452.6|452.6|420.3|22.23|2942
1070,11,0.6109,33.6,8352.0,0.003997,0.999969,CYBC1 DDC EIF2D FDX1 KCNK13 NAT8L RDH10 RPH3A TNFRSF19 UCKL1 WNT8A,small molecule metabolic process|neural crest cell differentiation|primary lung bud formation|positive regulation of retinoic acid biosynthetic process|positive regulation of isoprenoid metabolic process,0.0009429|0.001034|0.001067|0.001067|0.001067,1|1|1|1|1,5.768|42.07|1872|1872|1872
1071,4,0.609,3.654,2521.0,0.001443,0.9929309999999999,EIF1 EIF2AK4 EIF2S2 PDAP1,regulation of translational initiation|translational initiation|male germ cell proliferation|GCN2-mediated signaling|positive regulation of translational initiation in response to starvation,9.807e-05|0.0002925|0.0005825|0.0005825|0.0005825,1|1|1|1|1,125.6|72.01|2574|2574|2574
1072,7,0.6357,13.35,4617.0,0.002874,0.9992989999999999,EIF3A EIF3D EIF3E EIF3F EIF3G EIF3H EIF3M,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|translational initiation|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization,6.275e-21|2.634e-19|6.903e-18|6.313e-17|8.378e-17,9.898e-17|2.077e-15|3.63e-14|2.49e-13|2.643e-13,1126|600.7|144|108.4|104.5
1073,8,0.6083,17.03,4975.0,0.003401,0.9996790000000001,EIF3B PSMA1 PSMA2 PSMB1 PSMG1 PSMG2 PSMG3 PSMG4,cellular protein-containing complex assembly|protein-containing complex assembly|protein-containing complex subunit organization|proteasome assembly|cellular component assembly,9.533e-12|3.235e-10|1.232e-09|2.606e-08|3.907e-08,1.504e-07|2.551e-06|6.476e-06|0.0001028|0.0001233,23.98|15.4|13.03|551.7|8.447
1074,10,0.6055,27.25,6949.0,0.0038950000000000005,0.999933,EIF3CL NARS NEDD8 NUTF2 PSMA2 RPL17 SMU1 SNRPD1 SNU13 YARS,"gene expression|ribonucleoprotein complex biogenesis|RNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",2.002e-06|2.493e-06|4.301e-06|1.449e-05|1.449e-05,0.03159|0.01966|0.02261|0.05716|0.04573,6.852|20.13|8.196|24.8|24.8
1075,7,0.6493,13.63,4626.0,0.00293,0.9992989999999999,EIF3D EIF3E EIF3F EIF3G EIF3H EIF3I EIF3M,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|cytoplasmic translation|translational initiation|ribonucleoprotein complex assembly,7.851e-22|3.297e-20|1.218e-17|9.419e-16|6.569e-15,1.238e-17|2.601e-16|6.402e-14|3.714e-12|2.073e-11,1287|686.5|274.6|144|108.4
1076,7,0.6015,12.63,5047.0,0.00249,0.9992989999999999,DUX4 EIF4B NBEAL1 POGZ ST20 TSPYL5 UQCRH,eukaryotic translation initiation factor 4F complex assembly|cellular response to radiation|positive regulation of apoptotic DNA fragmentation|cellular protein-containing complex assembly|positive regulation of DNA catabolic process,0.001019|0.001532|0.002037|0.002251|0.002376,1|1|1|1|1,1471|33.24|588.4|10.28|490.4
1077,7,0.605,12.71,4736.0,0.002668,0.9992989999999999,DCP2 DDX6 EDC3 EDC4 EIF4E2 GIGYF2 XRN1,"exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|negative regulation of gene expression|nuclear-transcribed mRNA catabolic process|mRNA catabolic process",3.069e-10|3.821e-10|5.061e-10|1.739e-09|2.802e-09,4.84e-06|3.013e-06|2.661e-06|6.856e-06|8.839e-06,356.6|336.2|21.36|75.05|68.11
1078,5,0.6489,6.489,3385.0,0.0019079999999999998,0.996692,DHPS DOHH EIF5A EIF5AL1 RTCB,peptidyl-lysine modification to peptidyl-hypusine|positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|regulation of translational elongation,2.827e-07|7.067e-07|9.893e-07|3.672e-06|1.19e-05,0.00446|0.005574|0.005202|0.01448|0.03754,4119|2060|1648|748.9|392.3
1079,11,0.6199,34.09,7382.0,0.004584,0.999969,DUX4 EIF6 HSPE1 RPL11 RPL12 RPL13 RPL17 RPL37 RPL4 RPLP2 RPS13,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,2.764e-18|5.214e-17|7.685e-17|1.584e-16|2.079e-16,4.359e-14|4.112e-13|4.041e-13|6.248e-13|6.56e-13,117.8|156|148.3|134.9|130.2
1080,8,0.6138,17.19,5873.0,0.0029100000000000003,0.9996790000000001,C19orf66 ELAVL3 ICAM1 ICAM3 P2RY11 QTRT1 ZNF625 ZNF627,negative regulation of translational frameshifting|regulation of translational frameshifting|viral translational frameshifting|response to sulfur dioxide|response to type III interferon,0.0007765|0.0007765|0.0007765|0.0007765|0.001164,1|1|1|1|1,2574|2574|2574|2574|1287
1081,4,0.6697,4.018,3268.0,0.001225,0.9929309999999999,A1CF DUSP13 ELFN1 TTYH3,cytidine to uridine editing|base conversion or substitution editing|mRNA modification|negative regulation of phosphoprotein phosphatase activity|negative regulation of protein dephosphorylation,0.002522|0.004072|0.004846|0.01237|0.01333,1|1|1|1|1,429.1|257.4|214.5|81.73|75.72
1082,6,0.6258,9.387,4603.0,0.00203,0.998474,FSHR LHCGR OXER1 SIX3 STON1 TEX261,cellular response to gonadotropin stimulus|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|response to gonadotropin|activation of adenylate cyclase activity|ovulation cycle process,1.206e-05|2.443e-05|2.663e-05|6.35e-05|6.35e-05,0.1903|0.1927|0.14|0.2504|0.2003,403.8|46.81|264|167.4|167.4
1083,4,0.6015,3.609,3248.0,0.0011070000000000001,0.9929309999999999,ELMOD3 IFT22 PVRIG SRI,negative regulation of cardiac muscle contraction|intracellular sequestering of iron ion|sequestering of iron ion|negative regulation of striated muscle contraction|regulation of cell communication by electrical coupling involved in cardiac conduction,0.0009706|0.001359|0.001553|0.001553|0.001941,1|1|1|1|1,1287|858.1|735.5|735.5|572.1
1084,4,0.6126,3.676,3145.0,0.001164,0.9929309999999999,ANXA2R ELOA2 IL7R UGT3A1,negative regulation of T cell mediated cytotoxicity|positive regulation of T cell differentiation in thymus|lymph node development|interleukin-7-mediated signaling pathway|negative regulation of T cell apoptotic process,0.001941|0.002134|0.003685|0.003878|0.004266,1|1|1|1|1,572.1|514.9|286|271|245.2
1085,4,0.7321,4.393,2892.0,0.0015119999999999999,0.9929309999999999,DAPP1 EME1 MUS81 SLX4,response to intra-S DNA damage checkpoint signaling|response to DNA damage checkpoint signaling|response to DNA integrity checkpoint signaling|response to cell cycle checkpoint signaling|resolution of meiotic recombination intermediates,9.61e-11|3.295e-10|3.295e-10|3.295e-10|3.65e-09,1.516e-06|2.598e-06|1.732e-06|1.299e-06|1.152e-05,3862|2207|2207|2207|858.1
1086,5,0.6132,6.132000000000001,3676.0,0.001661,0.996692,DCTN4 EME2 LARS RBM22 RPS14,nucleic acid metabolic process|leucyl-tRNA aminoacylation|glutaminyl-tRNA aminoacylation|nucleobase-containing compound metabolic process|heterocycle metabolic process,0.0006324|0.000728|0.000728|0.001363|0.001758,1|1|1|1|1,7.382|2060|2060|6.06|5.674
1087,4,0.6196,3.717,3134.0,0.001182,0.9929309999999999,ADAMTS8 EML6 OR8B2 TMEM136,phosphate ion transmembrane transport|phosphate ion transport|inorganic anion transmembrane transport|inorganic anion transport|extracellular matrix organization,0.003104|0.004072|0.02272|0.03052|0.07233,1|1|1|1|1,343.2|257.4|44.01|32.59|13.48
1088,4,0.6175,3.705,3017.0,0.0012230000000000001,0.9929309999999999,EIF2D EN1 KCNK13 RDH10,embryonic forelimb morphogenesis|forelimb morphogenesis|embryonic limb morphogenesis|embryonic appendage morphogenesis|limb morphogenesis,1.49e-05|2.201e-05|0.0002004|0.0002004|0.0002806,0.2351|0.1736|1|0.7903|0.8851,332.2|271|87.27|87.27|73.55
1089,4,0.6297,3.778,2958.0,0.0012720000000000001,0.9929309999999999,ATP2C1 CLK2 ENC1 FAT1,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|Golgi calcium ion transport|Golgi calcium ion homeostasis|cellular manganese ion homeostasis|manganese ion homeostasis,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1090,4,0.6152,3.6910000000000003,3465.0,0.001062,0.9929309999999999,ENGASE IFT88 RASL11A ZMYM5,cellular response to gibberellin stimulus|gibberellic acid mediated signaling pathway|response to gibberellin|gibberellin mediated signaling pathway|positive regulation of transcription by RNA polymerase I,0.0003883|0.0003883|0.0003883|0.0003883|0.004653,1|1|1|1|1,5149|5149|5149|5149|223.9
1091,7,0.6094,12.8,5435.0,0.002343,0.9992989999999999,C1QTNF9 C1QTNF9B ENOX1 GJB2 GJB6 SOHLH2 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|cell-cell junction assembly,2.768e-06|3.558e-06|4.447e-06|2.279e-05|0.0008004,0.04366|0.02807|0.02338|0.08985|1,980.7|840.6|735.5|294.2|46.33
1092,4,0.6169,3.701,2792.0,0.00132,0.9929309999999999,DUSP22 ENPP7 IRF4 POU2AF1,lymphocyte activation involved in immune response|negative regulation of non-membrane spanning protein tyrosine kinase activity|positive regulation of sphingomyelin catabolic process|regulation of sphingomyelin catabolic process|positive regulation of intestinal cholesterol absorption,0.000184|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,91.13|5149|2574|2574|1716
1093,4,0.6018,3.611,3128.0,0.00115,0.9929309999999999,C17orf67 ENTPD5 KATNBL1 NEMP1,nucleoside diphosphate catabolic process|positive regulation of glycolytic process|'de novo' posttranslational protein folding|positive regulation of ATP metabolic process|'de novo' protein folding,0.002522|0.004846|0.007745|0.007938|0.008517,1|1|1|1|1,429.1|214.5|132|128.7|119.7
1094,4,0.6145,3.687,3040.0,0.001208,0.9929309999999999,EPB41 FOXL2NB LCE2A LCE3D,keratinization|keratinocyte differentiation|positive regulation of protein localization to cell cortex|epidermal cell differentiation|regulation of protein localization to cell cortex,0.0007212|0.001009|0.001359|0.001397|0.001941,1|1|1|1|1,45.56|38.42|858.1|32.59|572.1
1095,4,0.6366,3.819,3234.0,0.0011769999999999999,0.9929309999999999,C8orf76 CA2 EPB41L5 ESRP1,"substrate-dependent cell migration, cell attachment to substrate|regulation of inner ear auditory receptor cell fate specification|positive regulation of dipeptide transport|positive regulation of oligopeptide transport|positive regulation of dipeptide transmembrane transport",0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
1096,4,0.6134,3.68,3341.0,0.001098,0.9929309999999999,ANKRD28 CCL20 DENND2D EPGN,thymocyte migration|positive regulation of epidermal growth factor-activated receptor activity|positive regulation of MAPK cascade|calcium-mediated signaling using intracellular calcium source|telomere maintenance via telomerase,0.0005825|0.002716|0.003718|0.004653|0.005813,1|1|1|1|1,2574|396.1|19.8|223.9|177.5
1097,5,0.6814,6.814,3590.0,0.001889,0.996692,EPHA2 ERRFI1 GAB1 RASA1 SHB,vasculature development|tube development|circulatory system development|blood vessel morphogenesis|blood vessel development,9.77e-09|1.155e-07|1.239e-07|7.612e-07|1.59e-06,0.0001541|0.000911|0.0006517|0.003002|0.005016,40.22|24.49|24.14|40.58|33.69
1098,4,0.6074,3.6439999999999997,3247.0,0.001118,0.9929309999999999,BIN3 CD5L EPHX2 FCRLA,cell septum assembly|division septum assembly|actin cortical patch localization|stilbene metabolic process|olefinic compound catabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1099,8,0.6069,16.99,6353.0,0.0026609999999999997,0.9996790000000001,EPPIN FAM209B PKIG RBPJL SPATA25 TMEM189 WFDC6 WISP2,negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement|negative regulation of cAMP-dependent protein kinase activity|negative regulation of calcium ion import,0.001698|0.001698|0.001698|0.003393|0.003393,1|1|1|1|1,735.5|735.5|735.5|326.9|326.9
1100,9,0.634,22.82,6998.0,0.003243,0.9998530000000001,C6orf203 COL19A1 DDX43 FAM135A GABRR1 KHDC1 KHDC1L KHDC3L LGSN,activation of cysteine-type endopeptidase activity involved in apoptotic process|glutamine biosynthetic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity|regulation of mitochondrial transcription,0.0007108|0.00131|0.001599|0.00198|0.002182,1|1|1|1|1,50.29|1144|33.16|29.72|572.1
1101,4,0.6069,3.641,3143.0,0.0011539999999999999,0.9929309999999999,ERAP1 MAGI2 SYNC TNIK,asparaginyl-tRNA aminoacylation|planar cell polarity pathway involved in axis elongation|activation of JNKK activity|cell-cell signaling by wnt|Wnt signaling pathway,0.0009706|0.0009706|0.002667|0.002798|0.002798,1|1|1|1|1,1373|1373|411.9|23.6|23.6
1102,4,0.685,4.11,2726.0,0.001501,0.9929309999999999,ERBB2 ERBB3 FUT8 PHLDA2,ERBB2 signaling pathway|phosphatidylinositol 3-kinase signaling|ERBB signaling pathway|peripheral nervous system development|phosphatidylinositol-mediated signaling,1.583e-05|2.201e-05|7.196e-05|8.67e-05|9.574e-05,0.2498|0.1736|0.3784|0.3419|0.302,321.8|271|147.1|133.7|127.1
1103,4,0.6034,3.6210000000000004,3253.0,0.001109,0.9929309999999999,ERBIN HPCAL4 TEKT2 TRIM23,basal protein localization|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|negative regulation of nucleotide-binding oligomerization domain containing signaling pathway|negative regulation of monocyte chemotactic protein-1 production|regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,0.0003883|0.0007766|0.0007766|0.001359|0.001747,1|1|1|1|1,5149|1716|1716|858.1|643.6
1104,8,0.623,17.44,6366.0,0.002726,0.9996790000000001,ALG10 BICD1 ERGIC2 ETFBKMT KIAA1551 MANSC4 SYT10 TM7SF3,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|regulation of proteinase activated receptor activity,0.0007765|0.0007765|0.0007765|0.0007765|0.0007765,1|1|1|1|1,2574|2574|2574|2574|2574
1105,15,0.604,63.42,9818.0,0.006398,0.999999,ALG12 ALG9 AUP1 DERL2 DNAJB11 DNAJC3 HERPUD1 MANF SEC62 SEL1L SLC33A1 SYVN1 TMEM41B UBE2G2 UBE2J1,"response to endoplasmic reticulum stress|ubiquitin-dependent ERAD pathway|ERAD pathway|retrograde protein transport, ER to cytosol|endoplasmic reticulum to cytosol transport",4.201e-14|7.617e-14|2.561e-13|2.536e-12|2.536e-12,6.626e-10|6.007e-10|1.346e-09|9.999e-09|7.999e-09,47.9|128.1|106.8|403.8|403.8
1106,5,0.6058,6.058,3476.0,0.0017350000000000002,0.996692,ACTR10 ERH EXOC5 LIN52 TIMM9,retrograde axonal transport of mitochondrion|chaperone-mediated protein transport|protein insertion into mitochondrial inner membrane|Golgi vesicle transport|axonal transport of mitochondrion,0.0009706|0.00291|0.00291|0.003582|0.003878,1|1|1|1|1,1373|374.5|374.5|20.8|274.6
1107,4,0.6281,3.7689999999999997,3181.0,0.001181,0.9929309999999999,CNN2 ERVW-1 TBC1D3B UQCRH,"mitochondrial electron transport, ubiquinol to cytochrome c|negative regulation of phagocytosis|myoblast fusion|cell-cell fusion|syncytium formation by plasma membrane fusion",0.00291|0.004653|0.00504|0.0062|0.0062,1|1|1|1|1,367.8|223.9|205.9|166.1|166.1
1108,4,0.6292,3.775,3436.0,0.0010949999999999998,0.9929309999999999,ESYT3 FMN2 PLXND1 PROZ,homologous chromosome movement towards spindle pole in meiosis I anaphase|formin-nucleated actin cable organization|formin-nucleated actin cable assembly|meiotic chromosome movement towards spindle pole|polar body extrusion after meiotic divisions,0.0003883|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|1716|1716|1716|1287
1109,5,0.6244,6.244,4002.0,0.0015539999999999998,0.996692,ETFA ETFB ETFDH GBP7 PRKCD,fatty acid beta-oxidation using acyl-CoA dehydrogenase|fatty acid beta-oxidation|fatty acid oxidation|lipid oxidation|fatty acid catabolic process,1.962e-09|2.585e-07|7.232e-07|8.286e-07|8.85e-07,3.095e-05|0.002039|0.003802|0.003268|0.002792,1236|209.4|147.1|140.4|137.3
1110,4,0.6071,3.6430000000000002,2767.0,0.0013109999999999999,0.9929309999999999,ETS2 FOSL1 HIVEP1 MIDN,ectodermal cell fate commitment|ectoderm formation|positive regulation of transcription by RNA polymerase II|vitellogenesis|negative regulation of glucokinase activity,0.0003883|0.0005825|0.0007714|0.0009706|0.001165,1|1|1|1|1,5149|2574|12.81|1287|1030
1111,5,0.6238,6.2379999999999995,4033.0,0.001541,0.996692,ARHGEF10L ARMC1 EVA1B TMEM39A TMEM39B,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of viral genome replication|negative regulation of macroautophagy,1.319e-06|5.648e-06|7.2e-06|2.481e-05|3.302e-05,0.0208|0.04455|0.03786|0.09784|0.1042,1373|588.4|514.9|265.7|228.8
1112,4,0.6058,3.635,3132.0,0.0011560000000000001,0.9929309999999999,ALOX15B EVX1 KCTD11 USP43,cannabinoid biosynthetic process|endocannabinoid signaling pathway|lipoxin A4 biosynthetic process|spinal cord interneuron axon guidance|lipoxin A4 metabolic process,0.0003883|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|1716|1716|1716|1287
1113,4,0.6732,4.039,2548.0,0.001578,0.9929309999999999,ARNT EPAS1 HIF1A VHL,regulation of transcription from RNA polymerase II promoter in response to hypoxia|regulation of transcription from RNA polymerase II promoter in response to stress|regulation of transcription from RNA polymerase II promoter in response to oxidative stress|regulation of DNA-templated transcription in response to stress|cellular response to hypoxia,2.332e-10|9.547e-10|9.992e-10|1.171e-09|7.628e-09,3.679e-06|7.53e-06|5.254e-06|4.618e-06|2.407e-05,264|183.9|1404|174.5|108.4
1114,4,0.6227,3.736,3200.0,0.001163,0.9929309999999999,EXOC3L1 FGF23 MYO9A SYTL2,positive regulation of vitamin D 24-hydroxylase activity|regulation of vitamin D 24-hydroxylase activity|response to sodium phosphate|vitamin D catabolic process|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,0.0007766|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,1716|1716|1716|1716|1287
1115,5,0.6177,6.1770000000000005,4061.0,0.001515,0.996692,APOPT1 CEP170B EXOC3L4 GPR68 ZBTB42,positive regulation of osteoclast development|exocyst localization|negative regulation of monocyte differentiation|regulation of osteoclast development|regulation of monocyte differentiation,0.001165|0.001165|0.001553|0.002522|0.004072,1|1|1|1|1,1030|1030|735.5|429.1|257.4
1116,17,0.6056,82.36,11730.0,0.00695,1.0,BET1 BUD31 COPS6 EXOC4 LSM8 MCM7 MEPCE NUP205 PMPCB POP7 PSMC2 RBM28 RINT1 SEM1 SRRT TNPO3 ZNHIT1,nucleic acid metabolic process|protein transport|peptide transport|nucleobase-containing compound metabolic process|amide transport,2.246e-05|9.512e-05|0.0001077|0.0001095|0.0001241,0.3543|0.7502|0.5662|0.4317|0.3916,4.885|5.797|5.684|4.01|5.557
1117,6,0.6235,9.352,4477.0,0.002079,0.998474,ECHS1 EXOC6 JAK3 LDLRAP1 LRP8 MCEMP1,ammon gyrus development|negative regulation of FasL production|regulation of FasL production|positive regulation of receptor-mediated endocytosis involved in cholesterol transport|positive regulation of low-density lipoprotein particle clearance,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
1118,8,0.6287,17.6,5658.0,0.003093,0.9996790000000001,C1D DIS3 EXOSC1 EXOSC10 EXOSC8 EXOSC9 MPHOSPH6 ZCCHC7,"rRNA processing|rRNA metabolic process|maturation of 5.8S rRNA|ribosome biogenesis|RNA phosphodiester bond hydrolysis, exonucleolytic",4.491e-13|5.823e-13|1.187e-12|2.422e-12|3.085e-12,7.084e-09|4.593e-09|6.239e-09|9.551e-09|9.732e-09,69.31|66.74|367.8|54.28|299.3
1119,4,0.6041,3.625,3294.0,0.0010960000000000002,0.9929309999999999,F13B RIT1 RSPO4 SLC49A3,olfactory bulb axon guidance|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|striatal medium spiny neuron differentiation|somatic diversification of T cell receptor genes,0.0004854|0.000728|0.000728|0.001213|0.001456,1|1|1|1|1,4119|2060|2060|1030|823.8
1120,12,0.6058,39.98,8794.0,0.004514,0.999986,ACCS ACCSL CHRM4 CRY2 EHF ELF5 F2 FBXO3 MAPK8IP1 OR4B1 OR4X1 TP53I11,acute-phase response|acute inflammatory response|1-aminocyclopropane-1-carboxylate metabolic process|1-aminocyclopropane-1-carboxylate biosynthetic process|cellular response to blue light,0.0003269|0.0009671|0.001261|0.001261|0.001891,1|1|1|1|1,77.28|44.01|1584|1584|792.1
1121,4,0.6874,4.125,3617.0,0.0011359999999999999,0.9929309999999999,CD180 FABP2 SMCO1 ZNF202,B cell proliferation involved in immune response|positive regulation of lipopolysaccharide-mediated signaling pathway|intestinal lipid absorption|positive regulation of multi-organism process|regulation of lipopolysaccharide-mediated signaling pathway,0.001359|0.001747|0.002522|0.003878|0.00504,1|1|1|1|1,858.1|643.6|429.1|271|205.9
1122,4,0.6042,3.625,3404.0,0.0010609999999999999,0.9929309999999999,CPLANE1 DYNLL2 FABP6 JCHAIN,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|positive regulation of microtubule motor activity|protein localization to ciliary transition zone|positive regulation of respiratory burst",0.0007766|0.0007766|0.0009706|0.001747|0.001941,1|1|1|1|1,1716|1716|1287|643.6|572.1
1123,5,0.6034,6.034,3992.0,0.001506,0.996692,AEN ENPP3 FABP7 TAAR6 TAAR8,basophil activation involved in immune response|basophil activation|negative regulation of mast cell proliferation|regulation of mast cell proliferation|nucleic acid phosphodiester bond hydrolysis,0.000728|0.0009706|0.0009706|0.001213|0.002121,1|1|1|1|1,2060|1373|1373|1030|27.19
1124,4,0.6808,4.085,3295.0,0.001235,0.9929309999999999,FADS3 IL17B MAP4K2 PCK1,monocarboxylic acid metabolic process|pyruvate metabolic process|cellular glucose homeostasis|glucose metabolic process|carboxylic acid metabolic process,6.171e-05|6.997e-05|0.0001203|0.0001905|0.0002538,0.9733|0.5518|0.6324|0.7512|0.8007,30.05|149.2|113.2|89.54|18.65
1125,4,0.6989,4.194,3259.0,0.001282,0.9929309999999999,CALY FADS6 SLURP2 STK32C,positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|postsynaptic endocytosis,0.0003883|0.0003883|0.0005825|0.0005825|0.001941,1|1|1|1|1,5149|5149|2574|2574|572.1
1126,7,0.6198,13.02,5505.0,0.002353,0.9992989999999999,CNNM4 FAHD2A FAHD2B IL1F10 IL36G LYG1 TUBA3D,inflammatory response to antigenic stimulus|cell wall macromolecule catabolic process|response to bacterium|cell wall organization or biogenesis|cell wall macromolecule metabolic process,6.553e-05|0.001019|0.001344|0.001358|0.001358,1|1|1|1|1,168.1|1471|12.29|980.7|980.7
1127,5,0.638,6.38,3979.0,0.0015970000000000001,0.996692,CARNS1 FAIM KLK10 LRRC40 TEX12,carnosine biosynthetic process|carnosine metabolic process|meiotic DNA repair synthesis|histidine catabolic process|histidine metabolic process,0.0004854|0.000728|0.0009706|0.002183|0.002667,1|1|1|1|1,4119|2060|1373|514.9|411.9
1128,4,0.6107,3.6639999999999997,2958.0,0.001234,0.9929309999999999,FAM102A KIAA0100 KIAA1109 VAPA,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|positive regulation by host of viral genome replication|negative regulation by host of viral genome replication|negative regulation by host of viral process,0.001165|0.001165|0.001747|0.001747|0.00291,1|1|1|1|1,1030|1030|643.6|643.6|367.8
1129,14,0.6061,55.15,11000.0,0.0049759999999999995,0.9999969999999999,APEH CCR2 CCR3 CCR5 FAM107A IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 MUSTN1 SEMA3G TLR9,cellular defense response|inflammatory response|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine,6.772e-06|1.389e-05|2.141e-05|3.024e-05|3.024e-05,0.1068|0.1096|0.1126|0.1193|0.0954,83.27|14.83|55.86|49.59|49.59
1130,4,0.7157,4.294,2676.0,0.001598,0.9929309999999999,FAM126B FERMT1 TCF7L2 TTC7A,phosphatidylinositol phosphorylation|lipid phosphorylation|regulation of nucleocytoplasmic transport|negative regulation of timing of anagen|phosphatidylinositol metabolic process,4.821e-05|7.603e-05|0.0001746|0.0003883|0.0004655,0.7605|0.5997|0.9178|1|1,180.7|143|93.61|5149|56.89
1131,7,0.6031,12.67,5695.0,0.0022140000000000003,0.9992989999999999,FAM131A HRASLS HTR3D MUC4 SERPINI1 SLC51A TCTEX1D2,regulation of intraciliary retrograde transport|bile acid secretion|N-acylphosphatidylethanolamine metabolic process|intraciliary retrograde transport|maintenance of gastrointestinal epithelium,0.001019|0.002376|0.003393|0.005086|0.007114,1|1|1|1|1,1471|490.4|326.9|210.2|147.1
1132,4,0.6844,4.106,3106.0,0.001317,0.9929309999999999,CLCNKA FAM131C MMP23B SLC35E2B,blastocyst hatching|organism emergence from protective structure|hatching|excretion|collagen catabolic process,0.005233|0.005233|0.005233|0.007938|0.008517,1|1|1|1|1,198|198|198|128.7|119.7
1133,4,0.6034,3.62,3020.0,0.001194,0.9929309999999999,FAM13C OR56B1 RALGPS1 TRIM34,regulation of Ral protein signal transduction|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway|positive regulation of autophagy,0.0007766|0.008517|0.009867|0.0141|0.02367,1|1|1|1|1,1716|119.7|103|71.51|42.2
1134,4,0.6208,3.725,3359.0,0.001105,0.9929309999999999,ACOT12 ADGRV1 FAM151B FAM169A,maintenance of animal organ identity|self proteolysis|positive regulation of protein kinase C signaling|positive regulation of protein kinase A signaling|detection of mechanical stimulus involved in sensory perception of sound,0.001165|0.001747|0.002134|0.002716|0.003297,1|1|1|1|1,1030|643.6|514.9|396.1|321.8
1135,5,0.6395,6.395,3808.0,0.0016719999999999999,0.996692,CSH2 FAM153B GH2 KRTAP9-9 LGALS9,growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|response to growth hormone|positive regulation of receptor signaling pathway via JAK-STAT|positive regulation of receptor signaling pathway via STAT,1.087e-05|1.19e-05|3.128e-05|3.48e-05|4.239e-05,0.1714|0.09386|0.1645|0.1372|0.1337,411.9|392.3|235.4|222.6|200.9
1136,4,0.6315,3.7889999999999997,3261.0,0.001158,0.9929309999999999,ACBD3 FAM161B HTR3D SERP1,positive regulation of growth hormone secretion|regulation of growth hormone secretion|protein insertion into ER membrane|multicellular organism aging|serotonin receptor signaling pathway,0.001941|0.002716|0.00678|0.006973|0.007745,1|1|1|1|1,572.1|396.1|151.4|147.1|132
1137,4,0.651,3.906,2927.0,0.0013289999999999999,0.9929309999999999,FAM162A OR5K3 POLQ WDR5B,double-strand break repair via alternative nonhomologous end joining|somatic hypermutation of immunoglobulin genes|somatic diversification of immune receptors via somatic mutation|negative regulation of double-strand break repair via homologous recombination|positive regulation of release of cytochrome c from mitochondria,0.0009706|0.003104|0.003297|0.003878|0.00562,1|1|1|1|1,1287|343.2|321.8|271|183.9
1138,4,0.6407,3.844,3308.0,0.001158,0.9929309999999999,CDK18 CHI3L1 FAM163A SWT1,interleukin-8 production|chitin catabolic process|chitin metabolic process|glucosamine-containing compound catabolic process|amino sugar catabolic process,0.001359|0.001359|0.001359|0.001941|0.002716,1|1|1|1|1,858.1|858.1|858.1|572.1|396.1
1139,16,0.6042,72.5,12130.0,0.005926,0.999999,ACVRL1 AQP5 INHBE KRT1 KRT5 KRT6B KRT74 KRT79 KRT82 KRT84 KRT86 OR10P1 R3HDM2 RDH16 SDR9C7 STAC3,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.381e-14|2.914e-12|1.096e-11|3.947e-11|1.76e-10,2.178e-10|2.299e-08|5.763e-08|1.556e-07|5.554e-07,91.13|45.56|38.42|32.59|26.89
1140,18,0.5173,79.15,12860.0,0.006099,1.0,GMIP MEF2B ZNF100 ZNF101 ZNF124 ZNF14 ZNF195 ZNF253 ZNF43 ZNF443 ZNF486 ZNF492 ZNF682 ZNF714 ZNF737 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",8.003e-15|1.083e-12|1.088e-12|1.115e-12|3.879e-12,1.262e-10|8.541e-09|5.722e-09|4.396e-09|1.224e-08,7.522|5.615|5.614|5.605|5.204
1141,4,0.6227,3.736,3080.0,0.001208,0.9929309999999999,FAM174B LIN28B PHOX2B TRIM71,miRNA metabolic process|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA|dsRNA processing|RNA destabilization,7.146e-06|1.4e-05|1.778e-05|1.778e-05|2.091e-05,0.1127|0.1104|0.09348|0.07011|0.06596,490.4|343.2|302.9|302.9|278.3
1142,10,0.6184,27.83,7995.0,0.00346,0.999933,CCDC30 CFAP57 ERMAP EXO5 FAM183A MPL ZFP69 ZFP69B ZNF684 ZNF691,basophil homeostasis|eosinophil homeostasis|positive regulation of platelet formation|monocyte homeostasis|regulation of platelet formation,0.0009704|0.0009704|0.001455|0.001455|0.001455,1|1|1|1|1,2060|2060|1030|1030|1030
1143,6,0.6317,9.475,4652.0,0.0020280000000000003,0.998474,PRB1 PRB2 PRB4 PRH2 TAS2R19 TAS2R30,sensory perception of taste|regulation of lipid kinase activity|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|regulation of G1/S transition of mitotic cell cycle,0.0003144|0.0003327|0.0007606|0.0008027|0.001509,1|1|1|1|1,75.72|73.55|48.12|46.81|33.87
1144,9,0.6078,21.88,6709.0,0.003242,0.9998530000000001,FAM19A2 GLIPR1L1 INHBE KRT86 OR10P1 OR6C1 OR6C65 RDH16 SDR9C7,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.0005136|0.0006103|0.0006808|0.0008373|0.0009335,1|1|1|1|1,17.51|16.5|15.89|14.8|14.25
1145,4,0.6106,3.6639999999999997,3112.0,0.001173,0.9929309999999999,FAM19A5 RPL38 SCUBE1 UTP18,90S preribosome assembly|rRNA processing|rRNA metabolic process|ribosome biogenesis|axial mesoderm development,0.0002913|0.0004795|0.0005167|0.000778|0.001165,1|1|1|1|1,6865|52.81|50.85|41.36|980.7
1146,8,0.6454,18.07,5446.0,0.0032979999999999997,0.9996790000000001,ARMC7 CCDC84 DDX59 FAM204A PPIH RBM48 SCNM1 WDR25,UNCLASSIFIED|biological_process|cellular process|negative regulation of centrosome duplication|negative regulation of centrosome cycle,0.001664|0.001664|0.004058|0.005038|0.005038,1|1|1|1|1,4.689|0.4327|0.3325|214.5|214.5
1147,10,0.6056,27.25,7923.0,0.0034189999999999997,0.999933,AKAP2 FAM206A FBP1 FBP2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.271e-06|2.118e-06|4.446e-06|1.163e-05|1.649e-05,0.02005|0.01671|0.02338|0.04587|0.05202,2060|1373|823.8|457.7|374.5
1148,4,0.6739,4.044,3440.0,0.0011710000000000002,0.9929309999999999,C17orf107 FAM213A NEURL4 PALD1,regulation of osteoclast differentiation|cellular oxidant detoxification|peptidyl-tyrosine dephosphorylation|cellular detoxification|cellular response to toxic substance,0.01314|0.01851|0.02062|0.021|0.02234,1|1|1|1|1,76.85|54.2|48.57|47.67|44.77
1149,10,0.626,28.17,7630.0,0.003669,0.999933,ALDOC BPNT1 CCDC102A GML OR5AU1 PLEKHG4 PM20D1 PSD4 RTN3 WFDC11,"endoplasmic reticulum tubular network formation|regulation of oxidative phosphorylation uncoupler activity|cellular amide catabolic process|fructose 1,6-bisphosphate metabolic process|oxoacid metabolic process",0.002424|0.002424|0.002424|0.004844|0.007066,1|1|1|1|1,514.9|514.9|514.9|228.8|7.176
1150,8,0.6296,17.63,6408.0,0.0027370000000000003,0.9996790000000001,C6orf203 ENPP1 ENPP3 TAAR2 TAAR6 TCF21 VNN2 WISP3,nucleoside triphosphate catabolic process|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|nucleobase-containing small molecule biosynthetic process,1.185e-05|0.0003486|0.0003486|0.0004172|0.0006591,0.1869|1|1|1|1,420.3|70.9|70.9|64.66|51.17
1151,11,0.6105,33.58,7657.0,0.004354,0.999969,ANKFY1 ANKH ATP6V0A1 PPP1R21 RAB5C RABGEF1 RBSN TBCK TGFBRAP1 VPS45 VPS8,endosomal vesicle fusion|protein transport|peptide transport|anion transport|amide transport,1.863e-08|8.992e-08|1.047e-07|1.163e-07|1.248e-07,0.0002939|0.0007092|0.0005507|0.0004588|0.0003936,702.1|10.24|10.04|7.368|9.815
1152,15,0.5865,61.59,12080.0,0.005058,0.999999,CALHM3 CYP2C9 DUSP13 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ NUTM2A NUTM2B PTPN20 SAMD8 SFTPA1 SFTPA2,cellular response to type I interferon|response to type I interferon|defense response to symbiont|defense response to virus|type I interferon signaling pathway,1.919e-07|2.643e-07|1.463e-05|1.463e-05|1.73e-05,0.003028|0.002084|0.07692|0.05769|0.05459,79.59|73.23|25.91|25.91|60.57
1153,4,0.6163,3.698,3331.0,0.001106,0.9929309999999999,ASPSCR1 FAM241B NDUFA12 ZP1,"binding of sperm to zona pellucida|mitochondrial electron transport, NADH to ubiquinone|respiratory gaseous exchange by respiratory system|regulation of glucose import|sperm-egg recognition",0.00871|0.009675|0.009867|0.01102|0.01199,1|1|1|1|1,117|105.1|103|91.94|84.41
1154,6,0.6354,9.532,4128.0,0.002297,0.998474,CHERP DDX39B FAM32A HAUS8 SUGP1 UBA52,"mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",1.856e-05|5.682e-05|6.218e-05|6.218e-05|6.402e-05,0.2928|0.4481|0.3269|0.2452|0.202,19.78|14.88|34.1|34.1|33.76
1155,6,0.6272,9.407,3748.0,0.002496,0.998474,FAM49B NF2 PDCD10 PPM1F PTPN14 TAOK1,regulation of actin cytoskeleton organization|regulation of supramolecular fiber organization|regulation of actin filament-based process|regulation of organelle organization|regulation of cytoskeleton organization,1.338e-06|1.643e-06|2.037e-06|3.69e-06|5.916e-06,0.02111|0.01296|0.01071|0.01455|0.01866,38.57|36.61|34.67|14.45|26.45
1156,5,0.6263,6.263,3795.0,0.001643,0.996692,DNM1L FAM50B KLHL12 MIEF1 SLC25A46,mitochondrial fission|mitochondrial membrane fission|membrane fission|positive regulation of mitochondrial fission|regulation of mitochondrial fission,1.387e-08|2.827e-07|6.401e-06|8.046e-06|1.909e-05,0.0002188|0.00223|0.03365|0.03173|0.06021,588.4|4119|549.2|484.6|305.1
1157,4,0.6292,3.775,3266.0,0.001152,0.9929309999999999,AIMP1 FAM71B GPBAR1 SPARC,regulation of epithelial cell proliferation|negative regulation of endothelial cell proliferation|negative regulation of epithelial cell proliferation|regulation of endothelial cell proliferation|cell surface bile acid receptor signaling pathway,1.84e-05|2.792e-05|0.0002462|0.0002574|0.0003883,0.2902|0.2202|1|1|1,45.16|239.5|78.61|76.85|5149
1158,4,0.6123,3.674,3425.0,0.0010689999999999999,0.9929309999999999,FAM81A IL17RC WSCD2 ZNF169,interleukin-17-mediated signaling pathway|cellular response to interleukin-17|response to interleukin-17|positive regulation of cytokine production involved in inflammatory response|defense response to fungus,0.001941|0.001941|0.001941|0.004266|0.008517,1|1|1|1|1,572.1|572.1|572.1|245.2|119.7
1159,4,0.6717,4.03,3301.0,0.001216,0.9929309999999999,FADS3 FAM81B IL17B PCK1,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH|glycerol biosynthetic process from pyruvate|propionate catabolic process|cellular response to potassium ion starvation|response to methionine,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
1160,12,0.612,40.39,10290.0,0.003901,0.999986,AARD C8orf76 COL14A1 FAM83A FBXO32 KLHL38 MTSS1 NOV RNF139 SLC30A8 TRMT12 ZHX2,epithelial cell proliferation|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|negative regulation of sensory perception of pain|negative regulation of chondrocyte proliferation,0.001695|0.002037|0.002037|0.002715|0.003392,1|1|1|1|1,33.06|735.5|735.5|490.4|367.8
1161,24,0.5945,164.1,17540.0,0.009244,1.0,ANG BCL2L2 CEBPE CMA1 CMTM5 DHRS2 DHRS4 EDDM3A GZMH LTB4R LTB4R2 MYH6 OR10G2 OR10G3 OR11G2 OR11H4 OR11H6 OR4M2 OR5AU1 RNASE3 RNASE4 RNASE7 SLC7A8 TM9SF1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.483e-07|8.119e-07|1.041e-06|1.666e-06|2.132e-06,0.008649|0.006404|0.005475|0.006569|0.006725,13.62|12.84|12.36|11.51|11.08
1162,13,0.569,44.38,9939.0,0.0044340000000000004,0.999993,ANO1 CREM CTTN FADD FGF19 FGF3 FGF4 FOLR2 GSTP1 MRGPRD MRGPRF MYEOV POLD4,fibroblast growth factor receptor signaling pathway|cellular response to endogenous stimulus|negative regulation of extrinsic apoptotic signaling pathway|cellular response to fibroblast growth factor stimulus|response to fibroblast growth factor,1.814e-05|3.678e-05|3.853e-05|4.648e-05|5.41e-05,0.2862|0.2901|0.2026|0.1833|0.1707,58.68|8.294|45.26|42.43|40.28
1163,4,0.6272,3.763,3402.0,0.001102,0.9929309999999999,DOK2 FAM86B2 SMIM18 TEX15,methylation|negative regulation of transposition|regulation of transposition|male meiotic nuclear division|regulation of double-strand break repair via homologous recombination,0.001328|0.005233|0.005233|0.009096|0.009289,1|1|1|1|1,33.43|198|198|111.9|109.5
1164,4,0.6166,3.7,3194.0,0.0011539999999999999,0.9929309999999999,ACRBP FARP1 PRB4 RERG,retrograde trans-synaptic signaling by trans-synaptic protein complex|retrograde trans-synaptic signaling|trans-synaptic signaling by trans-synaptic complex|postsynaptic actin cytoskeleton organization|postsynaptic cytoskeleton organization,0.0009706|0.001941|0.002134|0.002716|0.003104,1|1|1|1|1,1287|572.1|514.9|396.1|343.2
1165,9,0.6148,22.13,5796.0,0.0037920000000000002,0.9998530000000001,BUB3 C1orf109 DAD1 DHX33 DPAGT1 FARSB HSPE1 POP5 SPATA5L1,protein N-linked glycosylation|phenylalanyl-tRNA aminoacylation|organonitrogen compound biosynthetic process|dolichol metabolic process|tRNA metabolic process,0.0004879|0.001746|0.001942|0.002618|0.002711,1|1|1|1|1,61.02|762.8|6.633|457.7|25.29
1166,9,0.61,21.96,6095.0,0.00358,0.9998530000000001,EIF3F FAU RPL12 RPL17 RPL27A RPL37 RPL4 RPLP2 RPS13,translational initiation|viral gene expression|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER,5.093e-20|2.55e-19|2.87e-18|4.232e-18|8.732e-18,8.033e-16|2.011e-15|1.509e-14|1.669e-14|2.755e-14,144|119.7|190.7|181.3|164.9
1167,4,0.6146,3.687,3389.0,0.001084,0.9929309999999999,FAXC GRHL1 NHSL1 RETNLB,desmosome organization|establishment of skin barrier|regulation of water loss via skin|regulation of keratinocyte differentiation|regulation of epidermal cell differentiation,0.002134|0.00504|0.005426|0.008131|0.01199,1|1|1|1|1,514.9|205.9|190.7|125.6|84.41
1168,4,0.6448,3.8689999999999998,3391.0,0.001137,0.9929309999999999,CAMKK1 FBLN2 FBXO41 RBP7,positive regulation of cell-substrate adhesion|regulation of cell-substrate adhesion|protein polyubiquitination|post-translational protein modification|extracellular matrix organization,0.02444|0.04167|0.06127|0.06847|0.07233,1|1|1|1|1,40.86|23.73|15.99|14.26|13.48
1169,11,0.609,33.5,8862.0,0.0037560000000000002,0.999969,FBLN5 GPR68 IFI27 PPP4R4 SERPINA1 SERPINA11 SERPINA12 SERPINA3 SERPINA4 SERPINA6 UBR7,negative regulation of hydrolase activity|negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity,8.313e-10|1.351e-09|1.708e-09|9.895e-09|3.373e-08,1.311e-05|1.066e-05|8.982e-06|3.902e-05|0.0001064,28.8|45.85|44.05|32.66|26.49
1170,5,0.645,6.45,3693.0,0.001739,0.996692,FBN3 OR1M1 OR7G1 OR7G3 ZNF266,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,9.63e-05|0.0001148|0.0001283|0.0001584|0.000177,1|0.9052|0.6746|0.6247|0.5584,28.02|26.4|25.43|23.67|22.8
1171,5,0.6742,6.742000000000001,3699.0,0.0018149999999999998,0.996692,FBXL18 OR10G2 PKP2 TCF3 TRAF5,desmosome assembly|maintenance of animal organ identity|B cell lineage commitment|immunoglobulin V(D)J recombination|bundle of His cell-Purkinje myocyte adhesion involved in cell communication,0.001456|0.001746|0.002037|0.002037|0.002037,1|1|1|1|1,858.1|686.5|572.1|572.1|572.1
1172,8,0.6022,16.86,5433.0,0.003085,0.9996790000000001,CIAO1 LYRM4 SLC25A37 TIMM10 TIMM10B TIMM22 TIMM29 TIMM9,protein insertion into mitochondrial inner membrane|protein insertion into mitochondrial membrane|establishment of protein localization to mitochondrial membrane|inner mitochondrial membrane organization|protein targeting to mitochondrion,7.9e-15|2.144e-13|5.022e-13|7.535e-12|1.07e-11,1.246e-10|1.691e-09|2.64e-09|2.972e-08|3.376e-08,1170|536.3|443.9|247.5|229.9
1173,8,0.602,16.86,6286.0,0.002668,0.9996790000000001,FAM173B FBXL7 NKD2 SLC6A18 SLC6A19 SLC6A3 TPPP TRIO,sodium ion transmembrane transport|sodium ion transport|amino acid transmembrane transport|inorganic cation transmembrane transport|amino acid transport,7.142e-06|2.128e-05|0.0004082|0.0006961|0.0008632,0.1127|0.1678|1|1|1,73.55|50.73|65.38|15.43|44.58
1174,12,0.6039,39.86,9665.0,0.004096,0.999986,AQP7 BAG1 CNTFR CREB3 FAM205A FBXO10 GALT GRHPR OR2S2 SIGMAR1 SPAG8 TOMM5,regulation of apoptotic process|regulation of programmed cell death|UDP-glucose catabolic process|regulation of cell death|nucleotide-sugar catabolic process,0.0009922|0.001113|0.001164|0.001637|0.001746,1|1|1|1|1,5.802|5.657|1716|5.194|858.1
1175,4,0.654,3.924,2993.0,0.001306,0.9929309999999999,FBXO22 KIF13B SP1 SP3,sequestering of nodal from receptor via nodal binding|positive regulation of hydrogen sulfide biosynthetic process|regulation of hydrogen sulfide biosynthetic process|positive regulation of sulfur metabolic process|negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
1176,4,0.6159,3.696,3525.0,0.001045,0.9929309999999999,FBXO43 KCNQ3 PGM2 RGS22,galactose catabolic process|negative regulation of meiotic nuclear division|membrane hyperpolarization|pentose-phosphate shunt|galactose metabolic process,0.001747|0.001941|0.002134|0.002716|0.002716,1|1|1|1|1,643.6|572.1|514.9|396.1|396.1
1177,6,0.6573,9.86,3989.0,0.0024579999999999997,0.998474,HNRNPF PCBP1 PRPF40A PSMF1 SON SRRM2,"RNA splicing|mRNA processing|mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.843e-08|4.345e-08|2.586e-07|6.994e-07|6.994e-07,0.0002908|0.0003427|0.00136|0.002758|0.002207,42.17|35.46|24.73|45.46|45.46
1178,4,0.6323,3.7939999999999996,3250.0,0.001163,0.9929309999999999,FBXW12 LST1 MUCL1 MYH7B,pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process|sodium-independent organic anion transport|heme catabolic process,0.00412|0.00412|0.00412|0.00412|0.00412,1|1|1|1|1,257.4|257.4|257.4|257.4|257.4
1179,12,0.617,40.72,9775.0,0.004138,0.999986,ERVV-2 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 SIGLEC11 VN1R4 ZNF415 ZNF665 ZNF880,zymogen activation|regulation of acute inflammatory response|Factor XII activation|positive regulation of acute inflammatory response to non-antigenic stimulus|antibacterial peptide production,0.0004948|0.0005153|0.002037|0.002037|0.002037,1|1|1|1|1,62.6|61.29|735.5|735.5|735.5
1180,4,0.6215,3.7289999999999996,3082.0,0.0012050000000000001,0.9929309999999999,CHIT1 FCMR FMO4 OR6N1,chitin catabolic process|chitin metabolic process|polysaccharide digestion|glucosamine-containing compound catabolic process|amino sugar catabolic process,0.001359|0.001359|0.001359|0.001941|0.002716,1|1|1|1|1,858.1|858.1|858.1|572.1|396.1
1181,4,0.6188,3.713,3032.0,0.00122,0.9929309999999999,C9orf16 FCN2 UCK1 ZBTB6,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|recognition of apoptotic cell,0.0007766|0.001165|0.001165|0.001165|0.001553,1|1|1|1|1,1716|1030|1030|1030|735.5
1182,4,0.6165,3.699,3066.0,0.001202,0.9929309999999999,ASB16 CD1B FCRL1 OR6K2,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",0.001165|0.001553|0.001553|0.00291|0.005233,1|1|1|1|1,1030|735.5|735.5|367.8|198
1183,4,0.6011,3.6069999999999998,3058.0,0.001175,0.9929309999999999,CD1B FCRL4 FMO1 VAMP4,"synaptic vesicle to endosome fusion|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|NADPH oxidation|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib",0.0007766|0.001165|0.001359|0.001553|0.001553,1|1|1|1|1,1716|1030|858.1|735.5|735.5
1184,9,0.6171,22.22,6737.0,0.003278,0.9998530000000001,FAM189B FCGR2B FCGR3A FCRL3 FCRL5 GBA HSPA6 ITLN2 TMCO1,negative regulation of B cell receptor signaling pathway|negative regulation of immunoglobulin production|regulation of B cell receptor signaling pathway|negative regulation of antigen receptor-mediated signaling pathway|negative regulation of production of molecular mediator of immune response,6.096e-06|2.029e-05|5.92e-05|8.356e-05|0.0001379,0.09616|0.16|0.3113|0.3295|0.4349,653.8|326.9|183.1|152.6|117.4
1185,4,0.654,3.924,3311.0,0.001181,0.9929309999999999,FDCSP HECA SLAMF8 TNS1,B-1 B cell lineage commitment|negative regulation of dendritic cell chemotaxis|negative regulation of neutrophil migration|B-1 B cell differentiation|negative regulation of respiratory burst,0.0003883|0.0003883|0.0009706|0.001165|0.001165,1|1|1|1|1,5149|5149|1287|1030|1030
1186,4,0.7077,4.246,3309.0,0.001279,0.9929309999999999,DOC2A FEM1A RBM11 SAMSN1,spontaneous neurotransmitter secretion|spontaneous synaptic transmission|negative regulation of B cell activation|regulation of calcium ion-dependent exocytosis|negative regulation of adaptive immune response,0.001165|0.001553|0.00678|0.008131|0.01025,1|1|1|1|1,1030|735.5|151.4|125.6|99.01
1187,4,0.6055,3.633,3184.0,0.001137,0.9929309999999999,FES OR5B12 PCARE RGL2,regulation of Ral protein signal transduction|protein localization to photoreceptor outer segment|protein localization to non-motile cilium|positive regulation of monocyte differentiation|photoreceptor cell outer segment organization,0.0007766|0.001359|0.002134|0.002328|0.002716,1|1|1|1|1,1716|858.1|514.9|468.1|396.1
1188,11,0.6222,34.22,9291.0,0.0036609999999999998,0.999969,C5AR1 C5AR2 CABP5 CRX FFAR3 FGF21 GPR32 KLK11 KLK3 SULT2A1 SULT2B1,complement receptor mediated signaling pathway|complement component C5a signaling pathway|inflammatory response|phospholipase C-activating G protein-coupled receptor signaling pathway|defense response,8.413e-08|1.864e-06|5.726e-06|2.508e-05|6.871e-05,0.001327|0.0147|0.03011|0.09889|0.2168,396.1|1716|17.3|52.01|7.272
1189,4,0.641,3.846,3532.0,0.001085,0.9929309999999999,FGG KBTBD3 S100A10 ZFYVE27,positive regulation of cell development|positive regulation of substrate adhesion-dependent cell spreading|regulation of substrate adhesion-dependent cell spreading|regulation of cell development|positive regulation of cell morphogenesis involved in differentiation,1.174e-05|2.668e-05|4.987e-05|5.354e-05|9.117e-05,0.1852|0.2104|0.2622|0.2111|0.2876,52.54|245.2|177.5|31.52|130.3
1190,24,0.6121,168.9,13960.0,0.01192,1.0,ADSL ADSS ATIC CAD DHFR DHODH FH FPGS GART GMPS IMPDH2 MTHFD1 NAMPT PAICS PFAS PPAT PPCDC RFK RPIA SDHA SDHB SDHC TFRC UMPS,ribonucleoside monophosphate biosynthetic process|nucleoside monophosphate biosynthetic process|nucleotide biosynthetic process|nucleoside phosphate biosynthetic process|ribonucleoside monophosphate metabolic process,3.613e-28|4.557e-27|2.191e-26|2.707e-26|8.757e-26,5.699e-24|3.594e-23|1.152e-22|1.068e-22|2.763e-22,273.2|217.3|54.6|53.9|167.8
1191,5,0.6041,6.041,3416.0,0.00176,0.996692,ARL8B FIG4 NPC1 VAC14 VPS18,viral entry into host cell|lysosomal transport|entry into host|phosphatidylinositol biosynthetic process|movement in host environment,0.0002499|0.0002847|0.0002899|0.0002951|0.0003163,1|1|1|1|0.9978,80.76|75.58|74.89|74.22|71.63
1192,8,0.6306,17.66,6433.0,0.0027300000000000002,0.9996790000000001,C9orf3 FBP1 FBP2 FKBP15 GNA14 TXNDC8 ZNF484 ZNF510,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.017e-06|1.695e-06|3.558e-06|9.31e-06|1.32e-05,0.01605|0.01337|0.01871|0.03671|0.04163,2288|1526|915.3|508.5|416.1
1193,4,0.6042,3.625,3320.0,0.001088,0.9929309999999999,FKBP1B KCTD6 RNF24 UBXN7,cellular protein modification process|protein modification process|macromolecule modification|cellular protein metabolic process|neuronal action potential propagation,0.0004631|0.0004631|0.0006141|0.0009812|0.001359,1|1|1|1|1,6.822|6.822|6.356|5.653|858.1
1194,4,0.6497,3.898,3389.0,0.001146,0.9929309999999999,DAGLA FLRT1 GRK4 SH3BP2,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|diacylglycerol catabolic process|trans-synaptic signaling by endocannabinoid,0.0009706|0.0009706|0.0009706|0.0009706|0.001456,1|1|1|1|1,1373|1373|1373|1373|823.8
1195,4,0.6084,3.65,3511.0,0.001036,0.9929309999999999,CAPN7 FLRT3 GJB7 MSH4,proepicardium cell migration involved in pericardium morphogenesis|meiotic mismatch repair|self proteolysis|pericardium morphogenesis|cell migration involved in heart development,0.0003883|0.001165|0.001747|0.001941|0.00291,1|1|1|1|1,5149|1030|643.6|572.1|367.8
1196,4,0.631,3.786,3093.0,0.001219,0.9929309999999999,FMO5 LHCGR OXER1 STON1,luteinizing hormone signaling pathway|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|cellular response to luteinizing hormone stimulus|response to luteinizing hormone|positive regulation of inositol trisphosphate biosynthetic process,0.0005825|0.0006839|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|46.81|1716|1287|1030
1197,5,0.6287,6.287000000000001,3963.0,0.00158,0.996692,CDK18 CHI3L1 FMOD PRELP RGS18,aminoglycan catabolic process|keratan sulfate catabolic process|aminoglycan metabolic process|carbohydrate derivative catabolic process|keratan sulfate biosynthetic process,3.904e-07|4.284e-06|5.359e-06|8.754e-06|2.045e-05,0.006158|0.03379|0.02818|0.03452|0.06451,181.7|686.5|74.44|63.05|294.2
1198,4,0.7009,4.205,3127.0,0.00134,0.9929309999999999,FNDC1 LPA OPRM1 PHACTR2,negative regulation of Wnt protein secretion|adenylate cyclase-inhibiting opioid receptor signaling pathway|regulation of Wnt protein secretion|positive regulation of response to nutrient levels|positive regulation of response to extracellular stimulus,0.0003883|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1716|1287|1287
1199,8,0.6013,16.84,5058.0,0.0033079999999999997,0.9996790000000001,ELMO2 FNDC3B ITGA3 ITGAV ITGB1 ITGB5 SNX17 TRAM2,integrin-mediated signaling pathway|formation of primary germ layer|cell-matrix adhesion|cell adhesion mediated by integrin|gastrulation,3.903e-08|6.337e-08|1.039e-07|1.253e-07|2.334e-07,0.0006157|0.0004998|0.0005462|0.0004942|0.0007363,105.1|92.77|81.73|308.9|66.44
1200,5,0.6153,6.153,4242.0,0.0014449999999999999,0.996692,AZIN2 FNDC5 HPCA KNCN ZBTB8A,response to ketamine|trans-Golgi network membrane organization|response to Aroclor 1254|cellular response to monosodium glutamate|positive regulation of polyamine transmembrane transport,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
1201,5,0.6122,6.122000000000001,3370.0,0.001808,0.996692,BRF2 FNTA FNTB MAK16 TTI2,protein farnesylation|protein prenylation|prenylation|regulation of rhodopsin mediated signaling pathway|MAPK cascade,7.066e-07|4.66e-06|4.66e-06|2.663e-05|0.0001519,0.01115|0.03675|0.0245|0.105|0.4791,2288|686.5|686.5|264|25.18
1202,8,0.6194,17.34,6051.0,0.00285,0.9996790000000001,FCHSD2 FOLH1 FOLR2 KCTD21 P2RY2 P2RY6 PLEKHB1 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|response to organic cyclic compound|response to organonitrogen compound|response to nitrogen compound,1.579e-05|0.0001537|0.0002106|0.0003313|0.0004578,0.2491|1|1|1|1,367.8|109.5|11.62|10.33|9.491
1203,5,0.6079,6.079,4170.0,0.001452,0.996692,FOSB GMFG RNF38 SCGB2B2 TCHHL1,actin filament debranching|negative regulation of Arp2/3 complex-mediated actin nucleation|negative regulation of actin nucleation|actin filament severing|response to corticosterone,0.000728|0.00194|0.002425|0.003878|0.005329,1|1|1|1|1,2060|588.4|457.7|274.6|196.1
1204,4,0.6274,3.764,2705.0,0.001385,0.9929309999999999,ERBB2 ERBB3 FOSL2 FUT8,ERBB2 signaling pathway|phosphatidylinositol 3-kinase signaling|ERBB signaling pathway|peripheral nervous system development|phosphatidylinositol-mediated signaling,1.583e-05|2.201e-05|7.196e-05|8.67e-05|9.574e-05,0.2498|0.1736|0.3784|0.3419|0.302,321.8|271|147.1|133.7|127.1
1205,4,0.6043,3.6260000000000003,3059.0,0.001181,0.9929309999999999,FOXD2 PIK3R5 PTPN6 ULK3,positive regulation of phosphatidylinositol 3-kinase signaling|regulation of phosphatidylinositol 3-kinase signaling|platelet activation|cell activation|abortive mitotic cell cycle,0.0001203|0.000228|0.0002845|0.0005631|0.0005825,1|1|1|1|1,113.2|81.73|73.03|14.25|2574
1206,8,0.7613,21.32,5538.0,0.003824,0.9996790000000001,FOXK1 FOXK2 GSK3A GSK3B GSKIP RANBP3 UBALD1 UBALD2,regulation of glucose metabolic process|regulation of cellular carbohydrate metabolic process|negative regulation of type B pancreatic cell development|regulation of carbohydrate metabolic process|negative regulation of glycogen (starch) synthase activity,8.043e-08|2.162e-07|7.913e-07|8.257e-07|1.319e-06,0.001269|0.001705|0.004161|0.003256|0.00416,87.27|67.75|2574|48.12|1716
1207,13,0.6008,46.86,10290.0,0.004521,0.999993,ALDOC C17orf50 CCL2 CCL7 FOXN1 GAS2L2 LYRM9 RDM1 SEBOX SLFN12 SPAG5 TIAF1 UNC119,regulation of natural killer cell chemotaxis|eosinophil chemotaxis|eosinophil migration|regulation of lymphocyte chemotaxis|protein localization to microtubule cytoskeleton,1.648e-05|6.244e-05|6.935e-05|0.0001278|0.0002827,0.26|0.4924|0.3646|0.504|0.8918,396.1|186.4|176|126.7|83.38
1208,4,0.6231,3.739,3341.0,0.001115,0.9929309999999999,CFAP57 FOXN3 OARD1 RNF150,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|craniofacial suture morphogenesis|mitotic G2 DNA damage checkpoint|G2 DNA damage checkpoint,0.0007766|0.001359|0.003878|0.004459|0.00678,1|1|1|1|1,1716|858.1|271|234|151.4
1209,8,0.6073,17.0,5648.0,0.002993,0.9996790000000001,DLL1 FOXO1 MYCN MYOG PAX3 SOX8 TFAP2B ZBTB18,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",1.422e-10|1.511e-09|1.511e-09|1.518e-09|2.39e-09,2.243e-06|1.191e-05|7.943e-06|5.987e-06|7.54e-06,17.08|12.7|12.7|12.69|11.99
1210,4,0.6144,3.687,3217.0,0.001142,0.9929309999999999,ASAP2 CABCOCO1 FOXP4 INSIG1,negative regulation of cargo loading into COPII-coated vesicle|regulation of cargo loading into COPII-coated vesicle|SREBP-SCAP complex retention in endoplasmic reticulum|negative regulation of SREBP signaling pathway|regulation of SREBP signaling pathway,0.0003883|0.0005825|0.0005825|0.0007766|0.001553,1|1|1|1|1,5149|2574|2574|1716|735.5
1211,4,0.7499,4.499,3126.0,0.001434,0.9929309999999999,FOXR1 PAFAH1B2 RPL22 RPP25,"regulation of translation at presynapse|regulation of translation at presynapse, modulating synaptic transmission|rRNA processing|rRNA metabolic process|regulation of translation at synapse",0.0003883|0.0003883|0.0009508|0.001024|0.001359,1|1|1|1|1,5149|5149|39.61|38.14|858.1
1212,4,0.6075,3.645,3356.0,0.001082,0.9929309999999999,ABCC12 CD276 FPGT LEPROT,negative regulation of growth hormone receptor signaling pathway|regulation of growth hormone receptor signaling pathway|negative regulation of protein localization to cell surface|fucose metabolic process|late endosome to vacuole transport via multivesicular body sorting pathway,0.0005825|0.001359|0.002716|0.003297|0.003491,1|1|1|1|1,2574|858.1|396.1|321.8|302.9
1213,17,0.5811,79.02,13670.0,0.005733,1.0,FPR1 FPR2 KIR2DL1 SIGLEC5 VN1R4 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF610 ZNF613 ZNF615 ZNF665 ZNF701 ZNF808 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.395e-07|3.522e-06|3.534e-06|3.589e-06|8.035e-06,0.002201|0.02778|0.01858|0.01415|0.02535,5.309|3.964|3.962|3.957|3.673
1214,4,0.6527,3.9160000000000004,3202.0,0.001218,0.9929309999999999,FRG2B HHIP ICAM5 USP25,negative regulation of ERAD pathway|regulation of ERAD pathway|epithelial tube branching involved in lung morphogenesis|neuroblast proliferation|regulation of fibroblast growth factor receptor signaling pathway,0.001359|0.004072|0.00504|0.005426|0.0062,1|1|1|1|1,858.1|257.4|205.9|190.7|166.1
1215,7,0.6085,12.78,4663.0,0.002724,0.9992989999999999,CRK CRKL DOCK5 PTPN12 RAPGEF1 RHOG TRIO,regulation of small GTPase mediated signal transduction|activation of GTPase activity|positive regulation of GTPase activity|regulation of GTPase activity|positive regulation of substrate adhesion-dependent cell spreading,2.157e-08|3.78e-08|6.819e-08|1.584e-07|3.387e-07,0.0003403|0.0002981|0.0003585|0.0006246|0.001069,44.99|101.5|35.62|30.02|210.2
1216,4,0.6563,3.938,3317.0,0.001183,0.9929309999999999,EPS15 FRMD4B ONECUT3 SMPD2,sphingomyelin catabolic process|receptor-mediated endocytosis of virus by host cell|endocytosis involved in viral entry into host cell|postsynaptic endocytosis|postsynaptic neurotransmitter receptor internalization,0.001359|0.001553|0.001553|0.001941|0.001941,1|1|1|1|1,858.1|735.5|735.5|572.1|572.1
1217,5,0.6149,6.149,4222.0,0.001451,0.996692,EPS8 FRMD5 KLRC1 TAS2R7 TAS2R9,"detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|CD8-positive, gamma-delta intraepithelial T cell differentiation",3.302e-05|4.239e-05|4.441e-05|0.0001131|0.0009706,0.5208|0.3343|0.2335|0.4459|1,228.8|200.9|196.1|121.1|1373
1218,11,0.6023,33.13,7444.0,0.004417,0.999969,AMOTL2 FRMD6 KIRREL1 LATS2 MAP4K4 NF2 PLXNA1 PTPN14 RNF146 SAV1 TAOK1,hippo signaling|anatomical structure morphogenesis|negative regulation of cell-matrix adhesion|negative regulation of cell adhesion|negative regulation of cell-substrate adhesion,5.046e-07|2.936e-05|0.0001899|0.0003938|0.0005129,0.007959|0.2315|0.9986|1|1,200.6|6.139|101.2|19.99|60.4
1219,4,0.6228,3.737,3399.0,0.0010960000000000002,0.9929309999999999,FRMD8 PRSS35 PUS10 TRAPPC3L,tRNA pseudouridine synthesis|primary miRNA processing|pseudouridine synthesis|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA,0.001165|0.002328|0.003685|0.006007|0.00678,1|1|1|1|1,1030|468.1|286|171.6|151.4
1220,12,0.6072,40.08,9444.0,0.004215,0.999986,FBXO9 FRS3 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP PRPH2 SPATS1 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,3.445e-07|3.445e-07|4.657e-06|6.518e-06|7.401e-06,0.005434|0.002717|0.02449|0.0257|0.02335,234|234|858.1|686.5|79.21
1221,4,0.6664,3.9989999999999997,3301.0,0.001207,0.9929309999999999,FRY GPC5 HEPN1 PAEP,negative regulation of sperm capacitation|regulation of sperm capacitation|regulation of binding of sperm to zona pellucida|negative regulation of tubulin deacetylation|negative regulation of cell maturation,0.0003883|0.0009706|0.001165|0.001359|0.001553,1|1|1|1|1,5149|1287|1030|858.1|735.5
1222,4,0.6137,3.682,3429.0,0.00107,0.9929309999999999,CLDN22 FSD1 HMSD MGAT5B,protein O-linked glycosylation via serine|calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|cytolysis|regulation of mitotic spindle organization|regulation of spindle organization,0.002134|0.004266|0.006586|0.007166|0.007938,1|1|1|1|1,514.9|245.2|156|143|128.7
1223,4,0.6136,3.682,2955.0,0.001241,0.9929309999999999,AK6 FSTL3 RPS7 WDR43,nucleoside monophosphate phosphorylation|nucleoside monophosphate metabolic process|ITP metabolic process|nucleotide biosynthetic process|nucleoside phosphate biosynthetic process,4.943e-06|0.0001441|0.000728|0.001224|0.001256,0.07796|1|1|1|1,633.7|107|2060|35.97|35.51
1224,4,0.6707,4.024,3308.0,0.001212,0.9929309999999999,FTCD MYOM3 PLXNA2 TMEM238,cerebellar granule cell precursor tangential migration|hindbrain tangential cell migration|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide,0.0005825|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1287|1287|1287
1225,4,0.6144,3.687,3124.0,0.001176,0.9929309999999999,FTL HIGD1A PERP TGM2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine|isopeptide cross-linking|peptidyl-glutamine modification|salivary gland cavitation|tube lumen cavitation,0.0005825|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,2574|1716|1287|1030|1030
1226,4,0.626,3.7560000000000002,2650.0,0.001411,0.9929309999999999,FUBP1 HNRNPD HNRNPUL1 KHSRP,"3'-UTR-mediated mRNA destabilization|RNA splicing, via transesterification reactions|mRNA destabilization|RNA destabilization|RNA splicing",5.367e-06|1.31e-05|1.778e-05|2.091e-05|3.085e-05,0.08466|0.1033|0.09348|0.08245|0.09733,572.1|50.64|302.9|278.3|37.95
1227,7,0.6141,12.9,5186.0,0.0024739999999999996,0.9992989999999999,FUT5 FUT6 PLIN3 UQCR11 ZNF555 ZNF556 ZNF77,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|fucose metabolic process|fucosylation,5.435e-06|5.435e-06|5.435e-06|1.51e-05|1.688e-05,0.08573|0.04286|0.02858|0.05955|0.05324,653.8|653.8|653.8|367.8|346.1
1228,18,0.6006,91.9,14760.0,0.006175,1.0,ADAM2 ADAM32 AP3M2 BIN3 C8orf58 CHRNA6 CHRNB3 DEFA5 DKK4 NAT1 NKX6-3 RNF170 RNF5 SCARA3 SLC20A2 SORBS3 TNFRSF10B TNFRSF10D,"sodium ion transport|glutamine transport|transmembrane transport|synaptic transmission, cholinergic|ion transmembrane transport",2.867e-05|4.425e-05|0.000206|0.0003676|0.0004997,0.4522|0.349|1|1|1,22.55|245.2|5.313|75.44|5.599
1229,8,0.6103,17.09,5341.0,0.00318,0.9996790000000001,CIAO1 FXN HSCB LONP1 LYRM4 TIMM10 TIMM9 WDR18,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|chaperone-mediated protein transport|protein insertion into mitochondrial inner membrane,1.631e-10|1.631e-10|6.987e-06|1.027e-05|1.027e-05,2.573e-06|1.286e-06|0.03674|0.04049|0.0324,447.7|447.7|27.91|468.1|468.1
1230,27,0.6067,212.9,20820.0,0.0101,1.0,APOBEC3A APOBEC3D APOBEC3G APOL1 CRYBA4 CRYBB3 CYTH4 DGCR6L FOXRED2 GAL3ST1 GSTT2B HPS1 ISX MIF MPPE1 RFPL2 RFPL3 SEC14L3 SEC14L4 SEC14L6 SEPT5 SLC5A1 SLC5A4 USP18 VPREB1 YPEL1 ZNF74,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,6.352e-07|1.009e-06|1.009e-06|1.009e-06|1.009e-06,0.01002|0.007956|0.005304|0.003978|0.003182,220.7|183.9|183.9|183.9|183.9
1231,4,0.6025,3.615,3212.0,0.0011220000000000002,0.9929309999999999,ARHGAP33 CDRT1 FXYD3 SFT2D2,anion transport|regulation of dendritic spine morphogenesis|ion transport|regulation of sodium ion transmembrane transporter activity|regulation of cardiac conduction,0.005032|0.008903|0.009817|0.01083|0.01102,1|1|1|1|1,6.754|114.4|5.361|93.61|91.94
1232,9,0.6075,21.87,5683.0,0.003821,0.9998530000000001,ANAPC13 ANAPC15 CCNF CDC16 FZR1 PRPF39 TRNAU1AP UBE2C UBE2S,protein K11-linked ubiquitination|cell division|anaphase-promoting complex-dependent catabolic process|protein polyubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process,1.128e-12|1.618e-10|1.975e-10|1.255e-09|1.278e-09,1.78e-08|1.276e-06|1.039e-06|4.948e-06|4.032e-06,394.5|32.56|131.5|42.64|42.51
1233,4,0.6144,3.687,3433.0,0.00107,0.9929309999999999,G6PC3 HAS3 PLCH2 TREML1,carbohydrate biosynthetic process|extracellular polysaccharide biosynthetic process|positive regulation of hyaluranon cable assembly|regulation of hyaluranon cable assembly|extracellular polysaccharide metabolic process,0.000265|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,75.72|1716|1716|1716|1716
1234,14,0.6114,55.64,10530.0,0.005241,0.9999969999999999,CD1C CIART CLK2 CTSK CTSS GABPB2 GBA HIST2H2AB HRNR S100A12 S100A2 S100A4 S100A5 S100A8,leukocyte activation|leukocyte activation involved in immune response|toll-like receptor signaling pathway|cell activation involved in immune response|cell activation,1.953e-05|4.343e-05|4.364e-05|4.476e-05|4.491e-05,0.3081|0.3425|0.2295|0.1765|0.1417,9.44|11.68|43.7|11.6|8.142
1235,4,0.6036,3.622,3147.0,0.001147,0.9929309999999999,GABRA1 GABRA6 GABRG2 PCDHGA6,"synaptic transmission, GABAergic|gamma-aminobutyric acid signaling pathway|chloride transmembrane transport|regulation of postsynaptic membrane potential|chloride transport",2.24e-09|1.114e-08|4.425e-07|4.839e-07|5.278e-07,3.533e-05|8.785e-05|0.002327|0.001908|0.001665,1030|572.1|159.2|154.5|150
1236,4,0.6339,3.803,2960.0,0.00128,0.9929309999999999,GADD45B MAP2K3 PPM1A PPM1B,N-terminal protein myristoylation|protein myristoylation|N-terminal protein lipidation|peptidyl-threonine dephosphorylation|negative regulation of NIK/NF-kappaB signaling,4.241e-07|4.241e-07|5.937e-07|7.795e-06|1.067e-05,0.00669|0.003345|0.003122|0.03074|0.03367,2574|2574|2060|468.1|396.1
1237,4,0.6145,3.687,3327.0,0.001104,0.9929309999999999,GADD45G MCTP2 RMDN1 TMEM129,"attachment of mitotic spindle microtubules to kinetochore|activation of MAPKKK activity|retrograde protein transport, ER to cytosol|endoplasmic reticulum to cytosol transport|attachment of spindle microtubules to kinetochore",0.002522|0.002716|0.003491|0.003491|0.004653,1|1|1|1|1,429.1|396.1|302.9|302.9|223.9
1238,23,0.6047,153.0,18220.0,0.008306000000000001,1.0,AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CLEC10A KCTD11 MFSD6L MYH2 MYH4 OR1D5 OR3A3 P2RX1 SHBG SLC2A4 TBC1D28 TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,8.355e-10|8.355e-10|5.633e-09|1.465e-08|7.582e-08,1.318e-05|6.59e-06|2.962e-05|5.778e-05|0.0002392,398|398|223.9|170.6|108.5
1239,9,0.6112,22.0,5662.0,0.0038590000000000005,0.9998530000000001,GALE GNPNAT1 MPI PGM3 PMM2 PPCDC RFK RPIA UGP2,nucleotide-sugar biosynthetic process|nucleotide-sugar metabolic process|nucleobase-containing small molecule metabolic process|small molecule metabolic process|carbohydrate derivative metabolic process,1.169e-15|1.387e-14|7.142e-12|9.53e-12|1.578e-11,1.844e-11|1.094e-10|3.755e-08|3.758e-08|4.98e-08,514.9|325.2|31.93|12.69|18.42
1240,4,0.6292,3.775,3491.0,0.001078,0.9929309999999999,ABCG5 CCDC80 CDC14A GALM,negative regulation of intestinal cholesterol absorption|negative regulation of intestinal lipid absorption|negative regulation of intestinal phytosterol absorption|galactose catabolic process via UDP-galactose|negative regulation of intestinal absorption,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
1241,12,0.6228,41.1,9635.0,0.0042380000000000004,0.999986,CHST9 CTIF DSG1 DSG3 DSG4 GALNT1 HRH4 KIAA1328 SERPINB7 ZNF396 ZNF397 ZNF521,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,3.685e-05|0.0001149|0.0002767|0.0004106|0.0004532,0.5812|0.9062|1|1|1,45.56|30.83|22.78|19.88|19.21
1242,6,0.6367,9.551,4271.0,0.002225,0.998474,GALNT11 LDLR LDLRAP1 MYLIP NR1H2 SREBF1,cholesterol homeostasis|sterol homeostasis|positive regulation of triglyceride biosynthetic process|regulation of triglyceride biosynthetic process|positive regulation of triglyceride metabolic process,4.422e-09|4.632e-09|7.676e-09|1.822e-08|3.15e-08,6.975e-05|3.653e-05|4.036e-05|7.186e-05|9.937e-05,165.4|163.5|792.1|572.1|468.1
1243,11,0.6087,33.48,8609.0,0.0038640000000000002,0.999969,CYP3A43 CYP3A7 DLX6 GALNT17 PON1 PON2 PON3 RNF148 SEMA3C SEMA3E WNT2,lipoxygenase pathway|icosanoid metabolic process|oxidative demethylation|mesenchymal cell differentiation|negative regulation of axon extension involved in axon guidance,1.454e-07|3.685e-05|6.488e-05|9.423e-05|0.0001165,0.002294|0.2906|0.3411|0.3716|0.3676,321.8|45.56|180.7|33|132
1244,4,0.6111,3.6660000000000004,3349.0,0.001091,0.9929309999999999,GALNT18 KLHL30 MADD PVR,susceptibility to T cell mediated cytotoxicity|susceptibility to natural killer cell mediated cytotoxicity|positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target|regulation of Rab protein signal transduction|positive regulation of natural killer cell mediated immune response to tumor cell,0.0005825|0.0007766|0.001359|0.001553|0.001553,1|1|1|1|1,2574|1716|858.1|735.5|735.5
1245,4,0.6101,3.661,3372.0,0.001082,0.9929309999999999,ADAM15 GALNT7 RPS6KB2 SYNPO2,response to hypobaric hypoxia|regulation of Rho-dependent protein serine/threonine kinase activity|cellular response to phorbol 13-acetate 12-myristate|response to phorbol 13-acetate 12-myristate|immune response to tumor cell,0.0007766|0.001165|0.001165|0.001165|0.001359,1|1|1|1|1,1716|1030|1030|1030|858.1
1246,8,0.6286,17.6,6016.0,0.0029100000000000003,0.9996790000000001,ANHX ZNF10 ZNF132 ZNF140 ZNF26 ZNF605 ZNF84 ZNF891,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",6.255e-08|6.461e-07|6.476e-07|6.551e-07|1.187e-06,0.0009866|0.005096|0.003405|0.002583|0.003745,7.964|5.945|5.944|5.935|5.51
1247,5,0.6487,6.487,3773.0,0.0017120000000000002,0.996692,CENPE GAR1 NAF1 RPL34 SPATA5,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|pseudouridine synthesis|rRNA processing|rRNA metabolic process,4.712e-07|3.108e-06|8.939e-06|2.019e-05|2.257e-05,0.007432|0.02451|0.047|0.07961|0.07121,2746|823.8|457.7|47.53|45.77
1248,21,0.5878,123.4,16400.0,0.007451999999999999,1.0,ABCC11 ABCC12 CES1 CES2 CES3 CES5A CHST5 CLEC18A CLEC18C CMTM1 IRX6 MT1A MT1B MT1F MT1G MT1H MT1X MT2A MT4 MTSS1L TMED6,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,1.137e-19|1.137e-19|2.413e-19|3.428e-19|2.137e-18,1.794e-15|8.97e-16|1.269e-15|1.352e-15|6.742e-15,514.9|514.9|457.7|433.6|329.5
1249,4,0.623,3.738,3082.0,0.001208,0.9929309999999999,BIVM GAS6 GPR183 PIBF1,regulation of natural killer cell activation|lymphocyte chemotaxis|regulation of lymphocyte activation|lymphocyte migration|regulation of leukocyte activation,1.984e-05|3.595e-05|6.835e-05|8.022e-05|0.0001056,0.3129|0.2835|0.3594|0.3163|0.3332,286|210.2|29.03|139.2|25.08
1250,6,0.6032,9.047,4668.0,0.001929,0.998474,GBP3 GBP4 GBP5 GBP6 GBP7 ST6GALNAC3,cellular response to interferon-gamma|response to interferon-gamma|defense response to protozoan|response to protozoan|innate immune response,6.044e-10|1.176e-09|7.001e-08|7.84e-08|2.249e-06,9.535e-06|9.278e-06|0.0003681|0.0003092|0.007095,93.11|81.27|367.8|353.1|17.51
1251,9,0.6002,21.61,6655.0,0.0032270000000000003,0.9998530000000001,BTN2A2 OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 TRIM10 TRIM26,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,8.016e-09|1.138e-08|1.422e-08|2.166e-08|2.704e-08,0.0001264|8.975e-05|7.475e-05|8.543e-05|8.529e-05,31.13|29.34|28.25|26.3|25.33
1252,4,0.6259,3.755,3229.0,0.001159,0.9929309999999999,GCC1 GPR32 KLK11 KLK6,complement receptor mediated signaling pathway|amyloid precursor protein metabolic process|protein autoprocessing|positive regulation of G protein-coupled receptor signaling pathway|collagen catabolic process,0.002716|0.004653|0.004846|0.005426|0.008517,1|1|1|1|1,396.1|223.9|214.5|190.7|119.7
1253,4,0.659,3.9539999999999997,3004.0,0.0013109999999999999,0.9929309999999999,CTSO GCFC2 ITPKA PCMTD1,intramembranous ossification|direct ossification|macromolecule metabolic process|dendritic spine maintenance|inositol metabolic process,0.00194|0.00194|0.002463|0.002667|0.00291,1|1|1|1|1,588.4|588.4|3.326|411.9|374.5
1254,5,0.6018,6.018,3891.0,0.0015400000000000001,0.996692,B3GNT2 B3GNT5 B4GALT3 GCNT2 SCUBE3,protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein biosynthetic process|glycoprotein metabolic process,9.832e-08|9.832e-08|1.209e-07|2.298e-07|5.384e-07,0.001551|0.0007754|0.0006356|0.0009064|0.001699,68.08|68.08|64.61|54.92|44.29
1255,5,0.6022,6.022,3922.0,0.001529,0.996692,FAM209B GDAP1L1 RALY RBPJL WISP2,glutathione metabolic process|cholesterol homeostasis|sterol homeostasis|lipid homeostasis|cellular modified amino acid metabolic process,0.01592|0.02022|0.02046|0.03588|0.04621,1|1|1|1|1,63.37|49.63|49.04|27.64|21.34
1256,11,0.606,33.33,8784.0,0.0037700000000000003,0.999969,BPIFB1 DEFB116 FAM83C FOXS1 GDF5 GGT7 HCK MYH7B MYLK2 TM9SF4 XKR7,regulation of multicellular organism growth|phagocytosis|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding,0.0005621|0.0006051|0.001601|0.002134|0.002667,1|1|1|1|1,57.61|17.23|936.1|624.1|468.1
1257,5,0.6262,6.2620000000000005,3727.0,0.001673,0.996692,GDPD4 LKAAEAR1 P2RY2 P2RY6 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|response to organophosphorus|cellular response to pyrimidine ribonucleotide,5.648e-06|5.517e-05|0.0002357|0.0004461|0.0004854,0.08909|0.4352|1|1|1,588.4|175.3|83.21|60.13|4119
1258,8,0.6121,17.14,5967.0,0.002856,0.9996790000000001,FOLR2 GDPD5 KRTAP5-7 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|keratinization|keratinocyte differentiation|purinergic nucleotide receptor signaling pathway|epidermal cell differentiation,2.029e-05|0.0001083|0.0001783|0.0001973|0.0002882,0.32|0.8545|0.9373|0.7782|0.9092,326.9|30.38|25.62|97.38|21.72
1259,5,0.6373,6.372999999999999,3532.0,0.001796,0.996692,GEMIN2 GEMIN4 GEMIN6 GEMIN7 TGS1,"spliceosomal snRNP assembly|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",3.515e-14|7.221e-11|8.629e-11|7.118e-10|7.118e-10,5.544e-10|5.695e-07|4.537e-07|2.807e-06|2.246e-06,528.1|108.4|104.5|68.2|68.2
1260,8,0.625,17.5,5117.0,0.0033979999999999995,0.9996790000000001,CIP2A GEN1 H2AFX HUS1 MAD2L2 RAD17 RHNO1 TOPBP1,cell cycle checkpoint|DNA repair|mitotic DNA replication checkpoint|DNA replication|regulation of cell cycle process,1.454e-09|2.066e-09|6.859e-09|8.551e-09|1.929e-08,2.294e-05|1.629e-05|3.607e-05|3.372e-05|6.085e-05,77.83|33.31|882.6|54.28|22.87
1261,4,0.618,3.708,3530.0,0.001047,0.9929309999999999,GFOD2 IFI6 RIPOR1 URGCP,negative regulation of Rho guanyl-nucleotide exchange factor activity|negative regulation of mitochondrial depolarization|negative regulation of guanyl-nucleotide exchange factor activity|negative regulation of membrane depolarization|establishment of Golgi localization,0.0005825|0.001359|0.001359|0.001553|0.001747,1|1|1|1|1,2574|858.1|858.1|735.5|643.6
1262,4,0.6753,4.052,3341.0,0.001208,0.9929309999999999,ASTL GFRA2 IGFBPL1 SCN9A,prevention of polyspermy|negative regulation of fertilization|cellular response to tumor cell|negative regulation of binding of sperm to zona pellucida|egg activation,0.0005825|0.0005825|0.0005825|0.0009706|0.001165,1|1|1|1|1,2574|2574|2574|1287|1030
1263,6,0.6167,9.25,4948.0,0.0018620000000000002,0.998474,C8orf44 CYP7A1 GGH MCMDC2 NSMAF SGK3,positive regulation of lipid biosynthetic process|response to ethanol|positive regulation of lipid metabolic process|tetrahydrofolylpolyglutamate metabolic process|regulation of lipid biosynthetic process,0.0002616|0.0006853|0.0008378|0.0008735|0.001358,1|1|1|1|1,80.76|49.39|44.58|1716|34.85
1264,4,0.6394,3.8369999999999997,3376.0,0.001132,0.9929309999999999,FASTKD1 GHDC NAV3 VSIG2,regulation of mitochondrial mRNA stability|negative regulation of microtubule depolymerization|negative regulation of interleukin-2 production|positive regulation of microtubule polymerization|regulation of microtubule depolymerization,0.001553|0.005426|0.00562|0.0062|0.0062,1|1|1|1|1,735.5|190.7|183.9|166.1|166.1
1265,17,0.6106,83.04,11480.0,0.007161,1.0,CHCHD3 CLPB DNAJC11 FAM136A GHITM HAX1 HTRA2 IMMP2L IMMT MTCH2 MTX1 MTX2 OCIAD1 PARL ROMO1 TIMM13 YME1L1,inner mitochondrial membrane organization|mitochondrion organization|mitochondrial membrane organization|membrane organization|protein localization to mitochondrion,7.554e-17|8.057e-15|1.344e-13|3.708e-07|6.449e-07,1.192e-12|6.355e-11|7.064e-10|0.001462|0.002035,186.4|29.16|69.23|10.14|59.1
1266,4,0.6127,3.676,3550.0,0.001032,0.9929309999999999,GHRL NIPAL3 SLC34A2 YWHAH,response to estrogen|response to hormone|hormone-mediated signaling pathway|ion transport|glucocorticoid catabolic process,8.892e-05|0.0002352|0.0002462|0.0003841|0.0003883,1|1|1|1|1,132|19.14|78.61|7.149|5149
1267,7,0.9996,20.99,4168.0,0.004994,0.999333,GID8 MAEA RANBP9 RMND5A UBE2H WDR26 YPEL5,proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process,4.147e-06|5.369e-06|2.939e-05|3.093e-05|3.345e-05,0.06542|0.04235|0.1545|0.122|0.1055,31.88|29.85|19.32|19.07|18.69
1268,4,0.6015,3.609,2744.0,0.00131,0.9929309999999999,DDX6 EIF4E2 GIGYF1 GIGYF2,positive regulation of miRNA mediated inhibition of translation|regulation of miRNA mediated inhibition of translation|negative regulation of translation|negative regulation of cellular amide metabolic process|positive regulation of gene silencing by miRNA,1.018e-06|1.018e-06|1.223e-06|1.899e-06|1.313e-05,0.01605|0.008027|0.006431|0.007489|0.04141,1471|1471|112.7|97.15|355.1
1269,4,0.633,3.798,3054.0,0.001239,0.9929309999999999,GIMAP4 GIMAP7 OR7G3 ZNF783,GTP metabolic process|guanosine-containing compound metabolic process|purine ribonucleoside metabolic process|purine ribonucleoside triphosphate metabolic process|purine nucleoside metabolic process,0.004846|0.007938|0.0116|0.01199|0.01218,1|1|1|1|1,214.5|128.7|87.27|84.41|83.04
1270,8,0.6076,17.01,5668.0,0.002984,0.9996790000000001,CDT1 DONSON GINS1 GINS2 GINS3 GINS4 NUP93 ORC6,DNA-dependent DNA replication|DNA replication|DNA strand elongation involved in DNA replication|DNA strand elongation|DNA metabolic process,6.011e-14|5.974e-13|8.234e-11|1.902e-10|9.025e-10,9.481e-10|4.711e-09|4.33e-07|7.502e-07|2.847e-06,92.89|66.5|542|429.1|23.07
1271,5,0.6572,6.572,4000.0,0.0016359999999999999,0.996692,KCNK7 OR10Z1 SPRR4 STMND1 SWT1,microtubule depolymerization|stabilization of membrane potential|protein depolymerization|microtubule polymerization or depolymerization|regulation of microtubule polymerization or depolymerization,0.004362|0.004362|0.008949|0.0128|0.02022,1|1|1|1|1,242.3|242.3|114.4|79.21|49.63
1272,4,0.6678,4.007,2798.0,0.001426,0.9929309999999999,ARHGEF7 GIT1 GIT2 PAK2,regulation of hydrolase activity|positive regulation of catalytic activity|positive regulation of GTPase activity|regulation of GTPase activity|positive regulation of molecular function,1.639e-05|2.243e-05|3.222e-05|5.354e-05|5.435e-05,0.2585|0.1769|0.1694|0.2111|0.1714,15.75|14.55|37.4|31.52|11.66
1273,5,0.6015,6.015,4520.0,0.001326,0.996692,CGA GJA10 IL2 ZKSCAN2 ZNF664,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle|mast cell cytokine production|regulation of T cell homeostatic proliferation,0.0006794|0.001019|0.001019|0.001019|0.001358,1|1|1|1|1,2942|1471|1471|1471|980.7
1274,4,0.6103,3.662,3207.0,0.0011380000000000001,0.9929309999999999,EDEM1 GJA8 SCML4 SSTR4,"trimming of terminal mannose on C branch|positive regulation of retrograde protein transport, ER to cytosol|somatostatin signaling pathway|somatostatin receptor signaling pathway|protein deglycosylation involved in glycoprotein catabolic process",0.0007766|0.0007766|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1716|1030|1030|1030
1275,9,0.6115,22.02,7137.0,0.0030670000000000003,0.9998530000000001,AGO1 AGO3 AGO4 GJA4 GJB3 GJB4 GJB5 LURAP1 ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",6.905e-09|9.492e-09|1.265e-08|3.218e-08|3.218e-08,0.0001089|7.486e-05|6.653e-05|0.0001269|0.0001015,980.7|858.1|762.8|528.1|528.1
1276,4,0.629,3.7739999999999996,3371.0,0.001116,0.9929309999999999,GLB1L GPR142 LGALS3BP TIMP2,regulation of Rap protein signal transduction|negative regulation of metallopeptidase activity|negative regulation of membrane protein ectodomain proteolysis|positive regulation of adenylate cyclase activity|regulation of metallopeptidase activity,0.0009706|0.001553|0.001747|0.002134|0.00291,1|1|1|1|1,1287|735.5|643.6|514.9|367.8
1277,4,0.6298,3.779,3457.0,0.0010890000000000001,0.9929309999999999,AFM GLDC PF4 ZBTB7C,protein transport within extracellular region|response to methylamine|response to lipoic acid|glycine decarboxylation via glycine cleavage system|glycine catabolic process,0.0003883|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,5149|5149|5149|1716|1287
1278,4,0.6398,3.839,3172.0,0.001206,0.9929309999999999,GLI2 PCDHA3 PCDHB7 PCDHGA12,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|floor plate formation,2.196e-06|8.061e-06|6.171e-05|0.0003824|0.0003883,0.03464|0.06358|0.3244|1|1,92.49|59.64|30.05|16.24|5149
1279,11,0.6104,33.57,8339.0,0.003999,0.999969,GLIPR1L1 GLIPR1L2 HOXC4 HOXC5 HOXC6 HOXC8 INHBE KCNC2 KRT82 KRT86 POU6F1,anterior/posterior pattern specification|regionalization|multicellular organism development|pattern specification process|anatomical structure development,0.0001621|0.0005632|0.0008088|0.001279|0.001401,1|1|1|1|1,27.13|17.66|3.071|13.28|2.844
1280,5,0.8969,8.969,3501.0,0.002548,0.996692,YWHAB YWHAE YWHAG YWHAQ YWHAZ,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|positive regulation of establishment of protein localization to mitochondrion,5.499e-15|5.499e-15|2.425e-14|7.602e-14|2.275e-13,8.674e-11|4.337e-11|1.275e-10|2.998e-10|7.176e-10,792.1|792.1|572.1|447.7|355.1
1281,4,0.6585,3.951,3154.0,0.001248,0.9929309999999999,GLT8D2 PROK1 SAA4 SNX29,acute-phase response|acute inflammatory response|positive regulation of cell division|circadian rhythm|activation of MAPK activity,0.008131|0.0141|0.01698|0.0271|0.03014,1|1|1|1|1,125.6|71.51|59.18|36.78|33
1282,4,0.6321,3.793,2891.0,0.001306,0.9929309999999999,ERBB3 FUT8 GMDS SLC35C1,GDP-L-fucose metabolic process|fucosylation|nucleotide-sugar metabolic process|carbohydrate derivative biosynthetic process|protein glycosylation in Golgi,4.241e-07|4.831e-06|2.201e-05|9.962e-05|0.0003883,0.00669|0.0381|0.1157|0.3928|1,2574|605.7|271|25.57|5149
1283,4,0.6482,3.889,3055.0,0.001268,0.9929309999999999,CHMP4A GMPR2 MGAT2 TM9SF1,monoacylglycerol biosynthetic process|autophagy|process utilizing autophagic mechanism|diacylglycerol biosynthetic process|posttranslational protein targeting to endoplasmic reticulum membrane,0.00194|0.002163|0.002163|0.002183|0.003152,1|1|1|1|1,588.4|26.92|26.92|514.9|343.3
1284,5,0.6061,6.061,3346.0,0.0018030000000000001,0.996692,GNA11 LPAR2 PDCL PLCB3 RIC8A,adenylate cyclase-modulating G protein-coupled receptor signaling pathway|G protein-coupled receptor signaling pathway|heterotrimeric G-protein complex assembly|cell-cell adhesion involved in gastrulation|signal transduction,1.232e-05|8.279e-05|0.0004854|0.0004854|0.0009685,0.1943|0.653|1|1|1,56.17|12.4|4119|4119|4.008
1285,6,0.6116,9.174,4377.0,0.0020859999999999997,0.998474,FUT5 FUT6 GNA15 PLIN3 UQCR11 ZNF77,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|fucose metabolic process|fucosylation,3.883e-06|3.883e-06|3.883e-06|1.079e-05|1.206e-05,0.06126|0.03063|0.02042|0.04256|0.03805,762.8|762.8|762.8|429.1|403.8
1286,9,0.6034,21.72,5999.0,0.003597,0.9998530000000001,ARHGEF12 GNA13 GNAI2 GNAI3 LPAR1 LPAR2 PDCL RHOA RIC8A,adenylate cyclase-modulating G protein-coupled receptor signaling pathway|G protein-coupled receptor signaling pathway|positive regulation of catalytic activity|positive regulation of lipase activity|positive regulation of molecular function,1.332e-10|2.615e-09|4.295e-09|2.239e-08|2.475e-08,2.101e-06|2.063e-05|2.258e-05|8.831e-05|7.808e-05,62.41|13.77|12.94|125.4|10.37
1287,8,0.6012,16.83,5177.0,0.0032310000000000004,0.9996790000000001,ARHGEF12 CMIP GNA13 GNB1 LPAR2 PDCL RHOA RIC8A,Ras protein signal transduction|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|Rho protein signal transduction|small GTPase mediated signal transduction|G protein-coupled receptor signaling pathway,3.838e-07|9.202e-07|1.583e-06|1.826e-06|1.83e-06,0.006054|0.007258|0.008325|0.0072|0.005774,58.51|46.81|126.6|39.3|11.62
1288,11,0.6062,33.34,7055.0,0.0046890000000000005,0.999969,AKT1 GNB2 MAPKAP1 MIOS MLST8 PDCL PDPK1 PIK3CA PIK3CB RICTOR WDR59,activation of protein kinase B activity|positive regulation of TOR signaling|activation of protein kinase activity|regulation of TOR signaling|TOR signaling,7.434e-12|2.53e-11|8.619e-11|1.34e-09|2.021e-09,1.173e-07|1.995e-07|4.532e-07|5.286e-06|6.377e-06,283.7|217.7|40.08|94.56|249.6
1289,4,0.613,3.678,3544.0,0.001034,0.9929309999999999,GNB3 HTR1D ITPRIPL1 TMEM138,intestine smooth muscle contraction|gastro-intestinal system smooth muscle contraction|adenylate cyclase-inhibiting serotonin receptor signaling pathway|blood circulation|circulatory system process,0.0009706|0.001359|0.001553|0.00206|0.003126,1|1|1|1|1,1287|858.1|735.5|26.75|21.63
1290,16,0.6002,72.02,12590.0,0.005674,0.999999,ANKRD7 C7orf43 CYP3A43 CYP3A5 CYP3A7 GNG11 MOGAT3 PILRA PILRB PON1 RASA4 TRIM50 WNT2 ZKSCAN1 ZSCAN21 ZSCAN25,oxidative demethylation|demethylation|lipid hydroxylation|steroid metabolic process|alcohol metabolic process,4.763e-07|1.588e-05|1.775e-05|3.31e-05|8.217e-05,0.007514|0.1252|0.09331|0.1305|0.2592,216.8|62.41|392.3|20.96|16.54
1291,4,0.6572,3.943,2768.0,0.001418,0.9929309999999999,CDC37L1 DNAJB6 HSF1 HSPA4,negative regulation of inclusion body assembly|regulation of inclusion body assembly|regulation of cellular response to heat|cellular response to nitroglycerin|positive regulation of transcription from RNA polymerase II promoter in response to heat stress,2.204e-06|5.367e-06|9.117e-05|0.0003883|0.0003883,0.03477|0.04233|0.4793|1|1,936.1|572.1|130.3|5149|5149
1292,9,0.6096,21.95,5882.0,0.003706,0.9998530000000001,GNB1 GNB2 GNG5 MAPKAP1 MLST8 PDCL PIK3CA PIK3CB RICTOR,activation of protein kinase activity|TOR signaling|activation of protein kinase B activity|positive regulation of TOR signaling|positive regulation of protein kinase activity,1.26e-07|3.124e-07|4.085e-07|8.666e-07|1.389e-06,0.001987|0.002464|0.002148|0.003418|0.004383,34.99|228.8|208|159.7|21.43
1293,4,0.6302,3.781,3449.0,0.001092,0.9929309999999999,ACSM4 GCKR GNG8 PURA,cellular response to pheromone|dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|negative regulation of glucokinase activity|negative regulation of hexokinase activity,0.0004854|0.0009706|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|1373|1373|823.8|823.8
1294,16,0.6007,72.08,12750.0,0.005606,0.999999,CYP3A43 CYP3A5 CYP3A7 DLX6 GNG11 GNGT1 PILRB PON1 PON3 RNF148 SEMA3E TRIM50 WNT2 ZKSCAN1 ZNF804B ZSCAN25,oxidative demethylation|demethylation|lipid hydroxylation|steroid metabolic process|lipoxygenase pathway,5.858e-07|1.949e-05|2.027e-05|4.368e-05|8.582e-05,0.00924|0.1537|0.1066|0.1723|0.2707,203.2|58.51|367.8|19.65|160.9
1295,4,0.6633,3.98,2898.0,0.001368,0.9929309999999999,GNL2 INTS11 NOL9 TRAPPC3,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis|endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",0.0005825|0.001539|0.002584|0.002986|0.003104,1|1|1|1|1,2574|31.02|23.84|22.15|343.2
1296,4,0.6537,3.9219999999999997,3158.0,0.0012369999999999998,0.9929309999999999,GNMT KCNK16 KCNK17 TUBB4A,stabilization of membrane potential|potassium ion transmembrane transport|potassium ion transport|sarcosine metabolic process|S-adenosylhomocysteine metabolic process,4.831e-06|0.0003561|0.0004019|0.0005825|0.0007766,0.0762|1|1|1|1,605.7|65.17|61.29|2574|1716
1297,4,0.6522,3.9130000000000003,3221.0,0.00121,0.9929309999999999,BNIP2 CELF6 GOLGA6D LINGO1,polyphosphate catabolic process|polyphosphate metabolic process|response to oxygen-glucose deprivation|mRNA splice site selection|spliceosomal complex assembly,0.001165|0.001359|0.002134|0.006393|0.01122,1|1|1|1|1,1030|858.1|514.9|160.9|90.33
1298,7,0.6109,12.83,4226.0,0.003017,0.9992989999999999,GOLGA7 KRAS NRAS RAF1 RCE1 SHOC2 ZDHHC5,MAPK cascade|intracellular signal transduction|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction,4.436e-10|1.324e-06|6.304e-06|6.969e-06|7.142e-06,6.998e-06|0.01044|0.03315|0.02748|0.02253,43.16|11.21|76.75|74.17|73.55
1299,6,0.6302,9.452,4283.0,0.002196,0.998474,ARHGAP11A ARHGAP11B CHRFAM7A GOLGA8H GOLGA8R WHAMM,endomembrane system organization|negative regulation of acetylcholine-gated cation channel activity|Golgi organization|regulation of acetylcholine-gated cation channel activity|actin filament reorganization,0.0002551|0.0005824|0.0006471|0.0008735|0.0032,1|1|1|1|1,21.1|3432|50.85|1716|343.2
1300,16,0.5912,70.95,10230.0,0.006862999999999999,0.999999,BNIP1 C19orf25 GOLT1B INPP5K NAPG NBAS RAB18 RAB3GAP1 RAB3GAP2 RINT1 SCFD1 SCFD2 STX18 TBC1D20 USE1 ZW10,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|Golgi vesicle transport|establishment of protein localization|protein localization|regulation of ER to Golgi vesicle-mediated transport",5.245e-13|8.454e-12|1.581e-10|3.006e-10|1.218e-09,8.273e-09|6.668e-08|8.314e-07|1.185e-06|3.842e-06,99.77|27.53|9.331|7.298|323.1
1301,4,0.6191,3.715,2830.0,0.001307,0.9929309999999999,GON4L PPP1R10 SS18L2 TOX4,negative regulation of mitotic DNA damage checkpoint|regulation of mitotic DNA damage checkpoint|negative regulation of DNA damage checkpoint|regulation of nucleobase-containing compound metabolic process|negative regulation of cell cycle checkpoint,0.0003883|0.0005825|0.001359|0.001436|0.001747,1|1|1|1|1,5149|2574|858.1|5.14|643.6
1302,11,0.6012,33.06,8837.0,0.003718,0.999969,FBLN5 GON7 GPR68 PPP4R4 SERPINA1 SERPINA11 SERPINA12 SERPINA3 SERPINA4 SERPINA9 UBR7,negative regulation of hydrolase activity|negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity,8.313e-10|1.351e-09|1.708e-09|9.895e-09|3.373e-08,1.311e-05|1.066e-05|8.982e-06|3.902e-05|0.0001064,28.8|45.85|44.05|32.66|26.49
1303,7,0.6154,12.92,4646.0,0.0027649999999999997,0.9992989999999999,GORASP2 MON2 SAR1A SEC23IP SPPL3 SURF4 TM9SF3,Golgi vesicle transport|Golgi organization|cellular localization|protein localization|COPII-coated vesicle budding,4.678e-06|1.009e-05|5.92e-05|0.0002223|0.0002501,0.07379|0.0796|0.3113|0.8766|0.789,29.72|65.38|5.878|6.817|84.06
1304,5,0.6155,6.155,4060.0,0.00151,0.996692,BBS5 GP2 SCN1A SCN2A SCN7A,neuronal action potential|membrane depolarization during action potential|transmission of nerve impulse|membrane depolarization|action potential,3.079e-08|3.737e-08|1.794e-07|1.794e-07|9.438e-07,0.0004857|0.0002947|0.0009433|0.0007075|0.002978,441.3|411.9|237.6|237.6|134.3
1305,4,0.6177,3.7060000000000004,3420.0,0.00108,0.9929309999999999,CCPG1 GP5 SGTB SYCP2L,regulation of Rho guanyl-nucleotide exchange factor activity|positive regulation of chaperone-mediated protein folding|positive regulation of protein folding|regulation of chaperone-mediated protein folding|regulation of guanyl-nucleotide exchange factor activity,0.0005825|0.0005825|0.0009706|0.001165|0.001941,1|1|1|1|1,2574|2574|1287|1030|572.1
1306,12,0.6106,40.3,9767.0,0.004099,0.999986,GP6 KIR2DL1 LAIR2 LILRB5 NLRP4 NLRP7 ZNF581 ZNF587 ZNF667 ZNF772 ZNF773 ZSCAN5B,cellular process|metabolic process|natural killer cell inhibitory signaling pathway|organic substance metabolic process|regulation of transcription by RNA polymerase II,0.0009339|0.00134|0.002521|0.00274|0.003067,1|1|1|1|1,0.4092|0|528.1|0|3.676
1307,4,0.6308,3.785,3330.0,0.0011330000000000001,0.9929309999999999,CCDC105 GPANK1 MRVI1 SCARA3,UV protection|cGMP-mediated signaling|cyclic-nucleotide-mediated signaling|response to UV|second-messenger-mediated signaling,0.002716|0.004459|0.01025|0.02919|0.04186,1|1|1|1|1,396.1|234|99.01|34.1|23.62
1308,11,0.6123,33.68,7173.0,0.004659,0.999969,AMOTL2 FRYL KIRREL1 LATS2 MAP4K4 NF2 PDCD10 PTPN14 RNF146 SAV1 TAOK1,hippo signaling|anatomical structure morphogenesis|regulation of protein kinase activity|regulation of cellular localization|regulation of protein localization,5.046e-07|1.671e-06|3.351e-05|4.21e-05|5.952e-05,0.007959|0.01318|0.1762|0.166|0.1878,200.6|7.016|11.75|11.2|10.41
1309,4,0.6214,3.728,3259.0,0.00114,0.9929309999999999,BIVM COL4A1 GPD2 TNFSF11,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|glycerophosphate shuttle|positive regulation of corticotropin-releasing hormone secretion|regulation of actin binding,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
1310,6,0.6025,9.037,4037.0,0.002227,0.998474,BUB3 DAD1 DPAGT1 FARSB GPN3 TXNL4A,protein N-linked glycosylation|phenylalanyl-tRNA aminoacylation|dolichol metabolic process|protein glycosylation|macromolecule glycosylation,0.0002048|0.001165|0.001746|0.002031|0.002031,1|1|1|1|1,91.53|1144|686.5|28.37|28.37
1311,4,0.631,3.786,3226.0,0.001169,0.9929309999999999,ELF2 GPR162 GPRC5A SP5,negative regulation of epidermal growth factor-activated receptor activity|post-anal tail morphogenesis|regulation of B cell receptor signaling pathway|regulation of epidermal growth factor-activated receptor activity|negative regulation of protein tyrosine kinase activity,0.003636|0.004362|0.006295|0.007502|0.007502,1|1|1|1|1,294.2|242.3|164.8|137.3|137.3
1312,8,0.6191,17.34,6373.0,0.002706,0.9996790000000001,FAM173B NKD2 OTULINL SLC6A18 SLC6A19 SLC6A3 TPPP TRIO,sodium ion transmembrane transport|sodium ion transport|amino acid transmembrane transport|inorganic cation transmembrane transport|amino acid transport,7.142e-06|2.128e-05|0.0004082|0.0006961|0.0008632,0.1127|0.1678|1|1|1,73.55|50.73|65.38|15.43|44.58
1313,4,0.6169,3.701,3366.0,0.0010960000000000002,0.9929309999999999,GPR176 GPR20 LGMN PDK2,vacuolar protein processing|negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus|regulation of response to external stimulus|negative regulation of inflammatory response,0.0005825|0.0006123|0.0006963|0.000727|0.001414,1|1|1|1|1,2574|49.51|46.39|13.07|32.38
1314,17,0.6001,81.62,12890.0,0.0062759999999999995,1.0,CD1B CD1E CTSK FCGR2B FCRL3 GBA ITLN2 KCNJ10 LCE3E OR10J5 PGLYRP3 S100A12 S100A2 S100A9 SLAMF7 VANGL2 YY1AP1,"regulation of T cell mediated cytotoxicity|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|immune system process|negative regulation of B cell receptor signaling pathway|antigen processing and presentation, exogenous lipid antigen via MHC class Ib",4.872e-06|1.341e-05|1.982e-05|2.297e-05|2.297e-05,0.07685|0.1058|0.1042|0.09059|0.07247,95.64|484.6|4.252|346.1|346.1
1315,19,0.6078,103.9,14400.0,0.007147,1.0,CTSK EFNA4 FCRL3 FLG2 GBA ITLN1 ITLN2 LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A4 S100A6 S100A7A S100A8 S100A9 SLAMF7 SPRR1A,antimicrobial humoral response|neutrophil aggregation|defense response to fungus|sequestering of zinc ion|skin development,2.906e-07|4.824e-06|9.828e-06|1.205e-05|2.154e-05,0.004585|0.03805|0.05167|0.04751|0.06794,34.74|1084|75.62|542|14.15
1316,6,0.6116,9.173,4596.0,0.001987,0.998474,CCDC36 GPR6 LTO1 MYEOV ZNF20 ZNF789,protein maturation by [4Fe-4S] cluster transfer|sphingosine-1-phosphate receptor signaling pathway|sphingolipid mediated signaling pathway|protein maturation by iron-sulfur cluster transfer|regulation of transcription by RNA polymerase II,0.002376|0.005086|0.005425|0.005425|0.006361,1|1|1|1|1,490.4|210.2|196.1|196.1|4.551
1317,7,0.6333,13.3,4610.0,0.002868,0.9992989999999999,MRPL18 NUP43 PDCD5 PPIL4 PSMB1 TCP1 WTAP,RNA localization|translocation of peptides or proteins into host cell cytoplasm|positive regulation of protein insertion into mitochondrial outer membrane|regulation of protein insertion into mitochondrial outer membrane|translocation of peptides or proteins into host,4.356e-05|0.0006794|0.0006794|0.0006794|0.0006794,0.6871|1|1|1|1,39.76|2942|2942|2942|2942
1318,11,0.6023,33.12,8441.0,0.003899,0.999969,ABCC6 ACSM1 ACSM2A ACSM2B ACSM5 C16orf45 CORO7 GPRC5B NOMO1 PRSS21 SEPT12,acyl-CoA metabolic process|thioester metabolic process|long-chain fatty acid metabolic process|fatty acid biosynthetic process|purine nucleoside bisphosphate metabolic process,1.116e-07|1.116e-07|2.551e-07|2.899e-07|3.808e-07,0.001761|0.0008805|0.001341|0.001143|0.001201,84.93|84.93|68.65|66.44|61.94
1319,8,0.6176,17.29,6481.0,0.0026550000000000002,0.9996790000000001,CCNB1IP1 DHX32 GPRC5D KIF26B LMO3 MAP3K7CL PRH2 SDR39U1,positive regulation of glucocorticoid receptor signaling pathway|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|renal vesicle formation,0.001164|0.001552|0.00194|0.002328|0.002715,1|1|1|1|1,1287|858.1|643.6|514.9|429.1
1320,4,0.6091,3.654,3265.0,0.001115,0.9929309999999999,GDPD3 GPRC6A NPC1L1 POLM,N-acylethanolamine metabolic process|alcohol metabolic process|ethanolamine-containing compound metabolic process|cellular response to sterol depletion|intestinal cholesterol absorption,0.001165|0.001539|0.001941|0.002134|0.002134,1|1|1|1|1,1030|31.02|572.1|514.9|514.9
1321,4,0.6632,3.9789999999999996,3522.0,0.001126,0.9929309999999999,CASTOR1 FAM118A GRAMD2A SUSD2,cellular response to L-arginine|response to L-arginine|endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization|regulation of store-operated calcium entry,0.0007766|0.001165|0.001359|0.002134|0.002716,1|1|1|1|1,1716|1030|858.1|514.9|396.1
1322,4,0.6016,3.609,2970.0,0.0012109999999999998,0.9929309999999999,EIF5A EIF5AL1 GREB1 PTGDS,positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|regulation of translational elongation|positive regulation of protein-containing complex disassembly,4.241e-07|5.937e-07|2.204e-06|7.146e-06|1.879e-05,0.00669|0.004683|0.01159|0.02818|0.05929,2574|2060|936.1|490.4|294.2
1323,4,0.6614,3.968,3399.0,0.001164,0.9929309999999999,CCDC89 GREM1 HESX1 WDR6,epithelial tube formation|tube formation|stem cell differentiation|negative regulation of osteoclast proliferation|negative regulation of bone trabecula formation,0.0002462|0.0003089|0.0003385|0.0005825|0.0005825,1|1|1|1|1,78.61|70.05|66.87|2574|2574
1324,4,0.6008,3.605,3163.0,0.0011359999999999999,0.9929309999999999,GRK7 PTBP3 ZBTB6 ZNF8,negative regulation of RNA metabolic process|negative regulation of nucleobase-containing compound metabolic process|erythrocyte maturation|negative regulation of RNA splicing|regulation of rhodopsin mediated signaling pathway,0.001182|0.001507|0.00291|0.005233|0.005233,1|1|1|1|1,11.08|10.2|367.8|198|198
1325,4,0.6673,4.004,3248.0,0.001228,0.9929309999999999,GPR37L1 GRM2 OR13J1 SAXO1,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|cold acclimation|G protein-coupled receptor signaling pathway|glutamate homeostasis,0.0001028|0.0006839|0.0007766|0.001027|0.001165,1|1|1|1|1,122.6|46.81|1716|11.62|1030
1326,13,0.6131,47.82,10410.0,0.004563,0.999993,C18orf32 CDH7 CTIF DSG1 DSG3 DSG4 PQLC1 SERPINB10 SERPINB2 SERPINB5 SERPINB7 ZNF396 ZNF397,homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of endopeptidase activity|negative regulation of peptidase activity|cell-cell adhesion via plasma-membrane adhesion molecules|negative regulation of proteolysis,2.151e-06|9.545e-06|1.115e-05|1.184e-05|3.555e-05,0.03394|0.07528|0.05862|0.0467|0.1122,41.11|28.02|26.92|26.51|19.96
1327,4,0.6225,3.735,3471.0,0.001073,0.9929309999999999,CPLX3 GRM7 SMOC1 ZNF106,negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|regulation of synaptic vesicle fusion to presynaptic active zone membrane|chemical synaptic transmission|anterograde trans-synaptic signaling,0.001165|0.001553|0.001747|0.002445|0.002445,1|1|1|1|1,1030|735.5|643.6|24.52|24.52
1328,13,0.6137,47.87,9869.0,0.004814,0.999993,ASL GRM8 INTS4 SEPT14 TRIM50 TYW1 ZNF138 ZNF273 ZNF479 ZNF679 ZNF727 ZNF736 ZNF92,regulation of transcription by RNA polymerase II|arginine biosynthetic process via ornithine|'de novo' AMP biosynthetic process|arginine biosynthetic process|wybutosine biosynthetic process,0.0007572|0.002037|0.002715|0.003392|0.003392,1|1|1|1|1,3.982|735.5|490.4|367.8|367.8
1329,4,0.6361,3.8169999999999997,3430.0,0.001109,0.9929309999999999,GRN HOXB5 OSBPL7 SLC25A47,positive regulation of lysosome organization|positive regulation of inflammatory response to wounding|negative regulation of neutrophil activation|acyl carnitine transmembrane transport|microglial cell activation involved in immune response,0.0003883|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1716|1287|1287
1330,4,0.6051,3.63,3414.0,0.00106,0.9929309999999999,DLG2 GRTP1 HRH1 TSKU,retrograde axonal protein transport|positive regulation of hair cycle|negative regulation of myofibroblast differentiation|ciliary body morphogenesis|corpus callosum morphogenesis,0.0005825|0.0005825|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|2574|1287|1287|1030
1331,16,0.6023,72.27,12240.0,0.005854,0.999999,ABHD11 ASL CASTOR3 CLDN3 GNAT3 GUSB SEMA3E TBL2 TRIM50 TYW1 ZNF138 ZNF479 ZNF679 ZNF727 ZNF736 ZNF92,arginine biosynthetic process via ornithine|'de novo' AMP biosynthetic process|cellular response to L-arginine|glucuronoside catabolic process|glucuronoside metabolic process,0.002472|0.003295|0.003295|0.004117|0.004117,1|1|1|1|1,605.7|403.8|403.8|302.9|302.9
1332,9,0.62,22.32,7036.0,0.003154,0.9998530000000001,AKAP2 GSN OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.451e-07|7.29e-07|8.768e-07|1.243e-06|1.494e-06,0.008598|0.00575|0.00461|0.004903|0.004713,25.94|24.45|23.54|21.92|21.11
1333,14,0.5729,52.13,11030.0,0.004693,0.9999969999999999,CRISP1 CRISP2 FBXO9 GSTA1 GSTA2 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP MUT PKHD1 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|glutathione metabolic process|xenobiotic metabolic process|cellular response to xenobiotic stimulus,1.412e-09|1.412e-09|8.043e-08|9.721e-07|1.133e-06,2.227e-05|1.114e-05|0.0004229|0.003834|0.003575,288|288|97.49|51.1|49.12
1334,12,0.6222,41.06,9409.0,0.004335,0.999986,CRISP1 CRISP2 FBXO9 GSTA1 GSTA3 GSTA4 GSTA5 IL17A IL17F MLIP MUT TFAP2D,glutathione metabolic process|glutathione derivative biosynthetic process|glutathione derivative metabolic process|xenobiotic metabolic process|cellular response to xenobiotic stimulus,3.732e-08|2.586e-07|2.586e-07|4.532e-07|5.285e-07,0.0005887|0.00204|0.00136|0.001787|0.001667,115.2|255.3|255.3|60.4|58.05
1335,7,0.603,12.66,5817.0,0.002167,0.9992989999999999,CALHM3 CYP17A1 GSTO1 GSTO2 MORN4 SORCS1 SORCS3,L-ascorbic acid metabolic process|cellular response to arsenic-containing substance|glutathione derivative biosynthetic process|glutathione derivative metabolic process|response to arsenic-containing substance,7.705e-06|2.072e-05|2.722e-05|2.722e-05|5.523e-05,0.1215|0.1634|0.1431|0.1073|0.1742,534.9|309.7|267.5|267.5|183.9
1336,4,0.6847,4.1080000000000005,2946.0,0.001389,0.9929309999999999,GSX2 PDGFRA SCFD2 TWIST2,regulation of cell migration|regulation of cell motility|platelet-derived growth factor receptor-alpha signaling pathway|regulation of locomotion|regulation of cellular component movement,0.0003091|0.0003777|0.0003883|0.0004307|0.0004787,1|1|1|1|1,17.45|16.31|5149|15.6|15.05
1337,16,0.6136,73.63,12400.0,0.005888,0.999999,ASL CASTOR3 CLDN3 GUSB SPDYE1 TMEM248 TRIM50 TYW1 ZKSCAN1 ZNF138 ZNF273 ZNF479 ZNF679 ZNF727 ZNF736 ZNF92,regulation of transcription by RNA polymerase II|arginine biosynthetic process via ornithine|cellular process|'de novo' AMP biosynthetic process|cellular response to L-arginine,0.0005263|0.002472|0.002925|0.003295|0.003295,1|1|1|1|1,3.748|605.7|0.5476|403.8|403.8
1338,4,0.6092,3.655,2770.0,0.001314,0.9929309999999999,DNAJA1 DNAJA2 GTSF1 STIP1,positive regulation of ATPase activity|regulation of ATPase activity|response to heat|response to temperature stimulus|negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,4.987e-05|9.574e-05|0.0001336|0.0003925|0.0005825,0.7867|0.7551|0.7024|1|1,177.5|127.1|107.3|62.03|2574
1339,4,0.6754,4.052,3442.0,0.001173,0.9929309999999999,ADGRV1 FAM151B FAM169A GUCA1C,regulation of cyclase activity|regulation of lyase activity|visual perception|sensory perception of light stimulus|maintenance of animal organ identity,3.454e-05|3.738e-05|0.0006596|0.0006839|0.001165,0.5448|0.2948|1|1|1,214.5|205.9|47.67|46.81|1030
1340,4,0.6376,3.826,3269.0,0.001166,0.9929309999999999,BATF2 BOLL CD47 GULP1,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|ATP export|monocyte extravasation|regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|regulation of Fc receptor mediated stimulatory signaling pathway,0.0005825|0.0007766|0.001165|0.001553|0.002328,1|1|1|1|1,2574|1716|1030|735.5|468.1
1341,25,0.601,180.3,18070.0,0.009854,1.0,C12orf65 CARS2 DDX28 FOXRED1 GRSF1 GTPBP10 GTPBP8 MCAT METTL17 MRM2 MRM3 MRPL58 MTFMT MTG1 MTIF2 MTIF3 MTO1 NGRN NOA1 NSUN3 NSUN4 PREPL RPUSD3 TFB1M YBEY,ribosome biogenesis|ncRNA metabolic process|rRNA modification|gene expression|RNA modification,5.797e-12|1.527e-11|1.955e-11|3.52e-11|3.601e-11,9.145e-08|1.204e-07|1.028e-07|1.388e-07|1.136e-07,23.86|16.85|118.8|6.16|37.28
1342,19,0.6132,104.9,14490.0,0.007164,1.0,CEACAM1 CEACAM5 CYP2A13 CYP2A7 GYPA KIR2DL1 KIR2DL3 LAIR2 PSG1 PSG11 PSG2 PSG3 PSG4 PSG5 PSG6 PSG8 PSG9 ZNF285 ZNF780B,female pregnancy|multi-multicellular organism process|multi-organism reproductive process|multi-organism process|reproductive process,4.527e-12|1.442e-11|2.348e-06|3.824e-06|3.274e-05,7.141e-08|1.138e-07|0.01234|0.01508|0.1033,46.02|39.61|8.246|7.721|5.753
1343,7,0.6001,12.6,5970.0,0.002102,0.9992989999999999,C5AR2 CABP5 GPR32 GYS1 SIGLEC12 SPIB SULT2B1,complement receptor mediated signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|complement component C5a signaling pathway|negative regulation of granulocyte chemotaxis|negative regulation of neutrophil chemotaxis,1.037e-05|0.0004918|0.001019|0.001358|0.001358,0.1636|1|1|1|1,452.6|59.44|1471|980.7|980.7
1344,4,0.6407,3.844,3311.0,0.001157,0.9929309999999999,ADPRHL1 GSG1L H1FNT SVOPL,spermatid nucleus elongation|protein de-ADP-ribosylation|regulation of postsynaptic neurotransmitter receptor internalization|sperm chromatin condensation|spermatid nucleus differentiation,0.0007766|0.001359|0.002522|0.002716|0.004072,1|1|1|1|1,1716|858.1|429.1|396.1|257.4
1345,4,0.6374,3.824,3299.0,0.001155,0.9929309999999999,ADAM10 H2AFV ISG20 POGLUT1,"regulation of Notch signaling pathway|constitutive protein ectodomain proteolysis|response to antineoplastic agent|axial mesoderm development|Notch receptor processing, ligand-dependent",8.143e-05|0.0002913|0.0007281|0.001165|0.001165,1|1|1|1|1,129.5|6865|1716|980.7|980.7
1346,5,0.6095,6.095,3746.0,0.00162,0.996692,H2AFX H2AFY2 H3F3B H3F3C HIST3H2A,negative regulation of chromosome condensation|subtelomeric heterochromatin organization|subtelomeric heterochromatin assembly|pericentric heterochromatin organization|pericentric heterochromatin assembly,9.711e-05|9.711e-05|9.711e-05|0.0001942|0.0001942,1|0.7659|0.5106|0.7659|0.6127,2.06e+04|2.06e+04|2.06e+04|6865|6865
1347,7,0.6151,12.92,4872.0,0.002637,0.9992989999999999,CERS2 CERS6 ELOVL1 HACD2 HSD17B12 TECR TMEM189,lipid biosynthetic process|long-chain fatty-acyl-CoA biosynthetic process|long-chain fatty-acyl-CoA metabolic process|fatty-acyl-CoA biosynthetic process|cellular lipid metabolic process,1.821e-11|4.121e-11|1.105e-10|2.433e-10|5.477e-10,2.872e-07|3.25e-07|5.808e-07|9.596e-07|1.728e-06,34.44|619.4|470.7|379.6|21.12
1348,4,0.6276,3.766,3174.0,0.001182,0.9929309999999999,GBP4 GBP7 HAL ST6GALNAC3,defense response to protozoan|response to protozoan|defense response to Gram-positive bacterium|cellular response to interferon-gamma|response to interferon-gamma,9.177e-06|9.911e-06|0.0001447|0.0003561|0.0004655,0.1448|0.07817|0.761|1|1,429.1|411.9|103|65.17|56.89
1349,8,0.6058,16.96,5725.0,0.0029460000000000003,0.9996790000000001,CHCHD1 CNIH4 DUX4 FOXD4 HAMP NBEAL1 ST20 TSPYL5,cellular response to radiation|cellular response to abiotic stimulus|cellular response to environmental stimulus|cellular response to ionizing radiation|response to radiation,3.556e-05|0.0001926|0.0001926|0.0003144|0.0005272,0.5609|1|1|1|1,43.63|24.52|24.52|75.72|17.36
1350,16,0.612,73.44,12100.0,0.006016,0.999999,CTSK FLG2 GBA HAPLN2 HIST2H2AB LCE3E PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A8 S100A9 SLAMF7 THEM5,neutrophil aggregation|antimicrobial humoral response|defense response to fungus|sequestering of zinc ion|response to fungus,2.964e-06|4.467e-06|4.646e-06|7.404e-06|1.041e-05,0.04675|0.03523|0.02443|0.0292|0.03284,1373|35.21|95.79|686.5|72.26
1351,10,0.6083,27.37,7216.0,0.0037689999999999998,0.999933,ACCS ACCSL COMMD9 EHF ELF5 HARBI1 OR4B1 OR4X1 PDHX TP53I11,1-aminocyclopropane-1-carboxylate metabolic process|1-aminocyclopropane-1-carboxylate biosynthetic process|mitochondrial acetyl-CoA biosynthetic process from pyruvate|acetyl-CoA biosynthetic process from pyruvate|acetyl-CoA biosynthetic process,0.0009704|0.0009704|0.002909|0.003877|0.007258,1|1|1|1|1,2060|2060|411.9|294.2|147.1
1352,12,0.618,40.79,7603.0,0.005319,0.999986,DHX9 GAK HAUS1 HAUS2 HAUS3 HAUS4 HAUS5 HAUS6 HAUS8 KIF18A TACC3 TUBGCP5,spindle organization|mitotic prometaphase|spindle assembly|biological phase|mitotic cell cycle phase,1.986e-18|4.235e-17|1.036e-16|1.849e-15|1.849e-15,3.133e-14|3.34e-13|5.446e-13|7.29e-12|5.832e-12,76.28|92.49|150.9|60.1|60.1
1353,5,0.6208,6.207999999999999,3740.0,0.0016530000000000002,0.996692,HBE1 OR51B4 OR52M1 OR52W1 OR56A1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.056e-06|1.336e-06|1.552e-06|2.059e-06|2.39e-06,0.01666|0.01054|0.008159|0.008121|0.00754,37.36|35.21|33.9|31.56|30.4
1354,5,0.6016,6.016,3720.0,0.00161,0.996692,HBG1 INHBE OR6C1 OR6C3 SLC4A8,positive regulation of synaptic vesicle exocytosis|oxygen transport|positive regulation of neurotransmitter secretion|long-chain fatty-acyl-CoA biosynthetic process|gas transport,0.002328|0.004361|0.005522|0.005812|0.005812,1|1|1|1|1,490.4|245.2|190.7|180.7|180.7
1355,4,0.6438,3.863,3021.0,0.001274,0.9929309999999999,HAGHL HBM HBQ1 HBZ,oxygen transport|gas transport|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification,1.866e-09|4.226e-09|1.361e-08|3.632e-08|4.162e-07,2.944e-05|3.333e-05|7.155e-05|0.0001432|0.001313,1103|813|532.6|376.7|162.6
1356,4,0.6435,3.861,3074.0,0.001251,0.9929309999999999,HCAR2 HCAR3 P2RX4 PITPNM2,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of secretion by cell,0.0005825|0.0005825|0.0005825|0.0009706|0.001132,1|1|1|1|1,2574|2574|2574|1287|36.26
1357,7,0.6019,12.64,5052.0,0.002489,0.9992989999999999,ARHGAP11A ARHGAP11B CHRFAM7A GOLGA8R HCN2 UBE2Q2L WHAMM,negative regulation of acetylcholine-gated cation channel activity|regulation of acetylcholine-gated cation channel activity|cellular response to cGMP|response to cGMP|actin filament reorganization,0.0006794|0.001019|0.002376|0.002715|0.003732,1|1|1|1|1,2942|1471|490.4|420.3|294.2
1358,4,0.6052,3.6310000000000002,3199.0,0.001131,0.9929309999999999,HDC MMP2 ZFP2 ZNF684,catechol-containing compound biosynthetic process|catecholamine biosynthetic process|phenol-containing compound biosynthetic process|cellular biogenic amine biosynthetic process|amine biosynthetic process,1.629e-05|1.629e-05|4.434e-05|5.767e-05|6.055e-05,0.2569|0.1285|0.2331|0.2274|0.191,343.2|343.2|201.9|176|171.6
1359,9,0.6177,22.24,6083.0,0.003632,0.9998530000000001,ATM DDX31 HDDC2 MDM2 MDM4 PPM1D RPS27L TP53 WDR89,"DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|signal transduction by p53 class mediator|mitotic G1 DNA damage checkpoint|mitotic G1/S transition checkpoint",3.426e-13|1.495e-12|3.481e-12|5.248e-11|5.638e-11,5.404e-09|1.179e-08|1.83e-08|2.069e-07|1.779e-07,173.8|134.6|116.4|173.4|170.8
1360,6,0.6852,10.28,4604.0,0.002222,0.998474,C17orf58 DND1 LRRC37A LRRC37A2 LRRC37A3 LRRC37B,UNCLASSIFIED|biological_process|cellular process|3'-UTR-mediated mRNA destabilization|negative regulation of gene silencing by miRNA,0.0002254|0.0002254|0.004476|0.005522|0.005812,1|1|1|1|1,6.252|0.1923|0.2216|190.7|180.7
1361,4,0.6102,3.661,3192.0,0.001143,0.9929309999999999,GPR68 HEATR4 LSS ZC3H12C,triterpenoid biosynthetic process|triterpenoid metabolic process|positive regulation of osteoclast development|negative regulation of monocyte differentiation|regulation of osteoclast development,0.0003883|0.0005825|0.001165|0.001553|0.002522,1|1|1|1|1,5149|2574|1030|735.5|429.1
1362,5,0.7495,7.495,3361.0,0.002218,0.996692,MCPH1 PIAS4 RBM4 RBM4B SRBD1,entrainment of circadian clock by photoperiod|photoperiodism|entrainment of circadian clock|regulation of circadian rhythm|circadian rhythm,2.185e-05|2.795e-05|2.96e-05|0.0003382|0.0004655,0.3447|0.2205|0.1556|1|1,284.1|249.6|242.3|69.23|58.84
1363,4,0.6595,3.957,3271.0,0.001206,0.9929309999999999,C22orf46 HEBP1 SEPT3 TTLL12,positive regulation of glutathione biosynthetic process|organic heteropentacyclic compound catabolic process|positive regulation of sulfur metabolic process|mycotoxin catabolic process|toxin catabolic process,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1364,7,0.6007,12.62,5816.0,0.002159,0.9992989999999999,CPB1 GPR171 HEG1 P2RY12 P2RY13 SERPINI1 SERPINI2,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|negative regulation of catalytic activity|negative regulation of molecular function|regulation of catalytic activity,1.63e-08|4.676e-07|7.845e-05|0.0003206|0.0004634,0.0002571|0.003688|0.4125|1|1,630.5|187.8|14.46|10.05|5.847
1365,6,0.6338,9.507,4399.0,0.002151,0.998474,HERC1 KDELR1 LYL1 PIK3R5 SPAST ULK3,cell activation|cellular developmental process|spindle disassembly|mitotic spindle disassembly|endoplasmic reticulum to Golgi vesicle-mediated transport,0.0001065|0.0007973|0.0008735|0.0008735|0.001344,1|1|1|1|1,12.67|4.818|1716|1716|35.03
1366,11,0.624,34.32,7865.0,0.004332,0.999969,OR11G2 OR11H4 OR4K1 OR4K2 OR4K5 OR4M1 OR4M2 OR4N4 OR4Q3 OR6S1 RNF145,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.466e-16|4.431e-16|6.429e-16|1.301e-15|1.887e-15,3.89e-12|3.494e-12|3.38e-12|5.132e-12|5.952e-12,42.46|40.01|38.52|35.87|34.54
1367,4,0.6752,4.051,3144.0,0.001284,0.9929309999999999,ANKRD65 BMT2 HES4 PROM1,positive regulation of nephron tubule epithelial cell differentiation|glomerular parietal epithelial cell differentiation|positive regulation of epithelial cell differentiation involved in kidney development|regulation of nephron tubule epithelial cell differentiation|negative regulation of TORC1 signaling,0.0007766|0.0007766|0.001553|0.002716|0.003491,1|1|1|1|1,1716|1716|735.5|396.1|302.9
1368,15,0.6067,63.71,12090.0,0.005228,0.999999,VN1R1 ZFP28 ZNF135 ZNF304 ZNF416 ZNF548 ZNF550 ZNF586 ZNF587 ZNF665 ZNF667 ZNF701 ZNF773 ZNF805 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",3.32e-12|1.879e-10|1.887e-10|1.925e-10|5.363e-10,5.238e-08|1.482e-06|9.921e-07|7.59e-07|1.692e-06,7.433|5.549|5.547|5.539|5.142
1369,5,0.6202,6.202000000000001,3444.0,0.0017929999999999999,0.996692,HEXIM1 LARP7 MEPCE PNISR PPP1R8,positive regulation of snRNA transcription by RNA polymerase II|regulation of snRNA transcription by RNA polymerase II|snRNA modification|positive regulation of protein localization to Cajal body|regulation of protein localization to Cajal body,7.067e-07|9.893e-07|1.696e-06|3.672e-06|3.672e-06,0.01115|0.007803|0.008915|0.01448|0.01159,2060|1648|1177|748.9|748.9
1370,8,0.6145,17.21,6807.0,0.002516,0.9996790000000001,C8orf44 CNGB3 CPA6 HEY1 MCMDC2 PMP2 SGK3 TRIM55,umbilical cord morphogenesis|umbilical cord development|negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation|nuclear cell cycle DNA replication initiation|cell cycle DNA replication initiation,0.001164|0.001164|0.001552|0.002715|0.002715,1|1|1|1|1,1287|1287|858.1|429.1|429.1
1371,5,0.6099,6.099,3873.0,0.001568,0.996692,HFE HIST1H1T SLC17A4 ZNF184 ZSCAN16,negative regulation of T cell antigen processing and presentation|cellular response to iron ion starvation|negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I|regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I|regulation of T cell antigen processing and presentation,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
1372,6,0.6019,9.027999999999999,4518.0,0.001989,0.998474,CFHR1 CHIT1 RGS18 RGS2 RGS21 TROVE2,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of G protein-coupled receptor signaling pathway|negative regulation of glycine import across plasma membrane,0.0004854|0.0004854|0.0004854|0.0005055|0.000728,1|1|1|1|1,4119|4119|4119|56.42|2060
1373,6,0.6751,10.13,4516.0,0.002232,0.998474,JAG2 LRP10 RBM47 SUSD6 TMEM127 WWP2,odontogenesis of dentin-containing tooth|regulation of Notch signaling pathway|epithelial cell apoptotic process involved in palatal shelf morphogenesis|odontogenesis|positive regulation of presynaptic membrane organization,0.0003324|0.000562|0.0006794|0.0006932|0.001019,1|1|1|1|1,72.65|55.51|2942|49.87|1471
1374,19,0.5867,100.3,15070.0,0.0065980000000000006,1.0,APTX AQP7 BAG1 CCL19 CCL21 CREB3 DNAJB5 FAM205A GALT GBA2 GLIPR2 KIF24 OR13J1 OR2S2 SIGMAR1 SPAG8 TESK1 TOMM5 UBAP2,regulation of dendritic cell dendrite assembly|positive regulation of dendritic cell antigen processing and presentation|negative regulation of dendritic cell apoptotic process|establishment of T cell polarity|establishment of lymphocyte polarity,8.035e-06|2.886e-05|2.886e-05|3.606e-05|4.405e-05,0.1267|0.2276|0.1518|0.1422|0.139,722.6|309.7|309.7|271|240.9
1375,29,0.6087,247.1,20180.0,0.01207,1.0,H2AFX HIST1H1A HIST1H1B HIST1H1C HIST1H1D HIST1H2AC HIST1H2AD HIST1H2BB HIST1H2BC HIST1H2BD HIST1H2BE HIST1H2BG HIST1H2BH HIST1H2BI HIST1H2BJ HIST1H2BK HIST1H2BL HIST1H2BM HIST1H2BN HIST1H2BO HIST1H3A HIST1H3B HIST1H3C HIST1H3D HIST1H3F HIST1H3G HIST1H3H HIST1H3I HIST1H4A,nucleosome assembly|chromatin assembly|nucleosome organization|chromatin assembly or disassembly|DNA packaging,1.928e-07|3.94e-07|4.514e-07|5.722e-07|9.573e-07,0.003042|0.003108|0.002373|0.002257|0.00302,176|138.2|132|121.9|102.5
1376,7,0.6115,12.84,5440.0,0.002349,0.9992989999999999,BTN2A2 HIST1H1T HIST1H4F OR2B6 SLC17A2 SLC17A4 ZNF184,sialic acid transport|sodium ion transmembrane transport|sodium ion transport|negative regulation of megakaryocyte differentiation|carboxylic acid transport,1.484e-06|0.0005137|0.001064|0.001746|0.002147,0.0234|1|1|1|1,1373|57.21|39.45|686.5|27.57
1377,6,0.6012,9.019,4352.0,0.0020629999999999997,0.998474,BTN2A2 HLA-A HLA-B HLA-C MICB OR2J3,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen",2.263e-09|2.263e-09|3.017e-09|1.562e-08|2.11e-08,3.57e-05|1.785e-05|1.586e-05|6.16e-05|6.655e-05,1287|1287|1144|605.7|542
1378,8,0.6054,16.95,6034.0,0.002794,0.9996790000000001,HLA-DRA OR14J1 OR2B6 OR2J3 PSORS1C2 TRIM10 TRIM26 ZKSCAN4,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway,4.658e-05|6.374e-05|0.0001663|0.0002224|0.0004507,0.7347|0.5027|0.8743|0.8769|1,208|176|106.4|91.53|63.56
1379,4,0.6491,3.8939999999999997,3059.0,0.001268,0.9929309999999999,C2 HLA-DQB2 HLA-E MSH5,positive regulation of alpha-beta T cell activation|interferon-gamma-mediated signaling pathway|adaptive immune response|positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|regulation of alpha-beta T cell activation,6.227e-05|7.603e-05|0.0001233|0.0001447|0.0001476,0.9822|0.5997|0.6483|0.5708|0.4656,158.4|143|23.8|103|102
1380,4,0.6146,3.688,2940.0,0.0012490000000000001,0.9929309999999999,HLF OR13C3 OR13C4 OR13C8,sensory perception|nervous system process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception,2.42e-05|9.602e-05|9.63e-05|0.0001148|0.0001283,0.3817|0.7573|0.5063|0.4526|0.4048,16.93|11.94|28.02|26.4|25.43
1381,11,0.605,33.28,8399.0,0.003936,0.999969,DEFB115 DEFB116 DUSP15 FOXS1 HCK HM13 MYLK2 NOL4L REM1 TM9SF4 XKR7,"phagocytosis|leukocyte migration involved in immune response|membrane protein proteolysis involved in retrograde protein transport, ER to cytosol|respiratory burst after phagocytosis|regulation of muscle filament sliding",0.0006051|0.001601|0.001601|0.002134|0.002667,1|1|1|1|1,17.23|936.1|936.1|624.1|468.1
1382,4,0.6085,3.6510000000000002,3321.0,0.0010949999999999998,0.9929309999999999,AVP HMCN1 ITPRIP OXT,maternal aggressive behavior|aggressive behavior|female mating behavior|hyperosmotic salinity response|regulation of female receptivity,2.828e-07|1.018e-06|1.272e-06|1.272e-06|1.272e-06,0.00446|0.008027|0.006688|0.005016|0.004013,3432|1471|1287|1287|1287
1383,4,0.6425,3.855,2719.0,0.0014119999999999998,0.9929309999999999,HNRNPAB HNRNPD HNRNPUL1 RBM5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",1.272e-05|1.272e-05|1.31e-05|3.085e-05|5.161e-05,0.2006|0.1003|0.06886|0.1217|0.1628,51.15|51.15|50.64|37.95|31.91
1384,4,0.6301,3.781,2909.0,0.001294,0.9929309999999999,HNRNPH3 QARS SLC1A5 SREK1,tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|RNA metabolic process|L-glutamine import across plasma membrane,5.293e-05|5.981e-05|6.219e-05|0.0001714|0.0004854,0.8349|0.4717|0.327|0.6757|1,179.1|168.1|164.8|10.3|4119
1385,11,0.6166,33.91,7639.0,0.004407,0.999969,IKBKB IL1R1 IL1RAP IRAK4 MYD88 RBCK1 RELA RNF31 TAB2 TRAF2 TRAF6,regulation of I-kappaB kinase/NF-kappaB signaling|I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|cellular response to interleukin-1|positive regulation of I-kappaB kinase/NF-kappaB signaling,4.207e-18|1.424e-17|3.428e-17|6.369e-17|1.035e-16,6.636e-14|1.123e-13|1.803e-13|2.512e-13|3.265e-13,70.63|196.1|94.76|88.26|83.49
1386,4,0.6025,3.615,3305.0,0.00109,0.9929309999999999,HOPX HSD3B2 SMIM12 UBL4B,mineralocorticoid biosynthetic process|mineralocorticoid metabolic process|androgen biosynthetic process|glucocorticoid biosynthetic process|glucocorticoid metabolic process,0.001359|0.001359|0.002134|0.002328|0.003104,1|1|1|1|1,858.1|858.1|514.9|468.1|343.2
1387,12,0.6031,39.81,9431.0,0.004192,0.999986,EPX HOXB5 HOXB6 HOXB7 HOXB8 HOXB9 LPO MPO OR4D1 OR4D2 PLEKHM1 SEPT4,embryonic skeletal system morphogenesis|embryonic skeletal system development|anterior/posterior pattern specification|skeletal system morphogenesis|embryonic organ morphogenesis,1.782e-09|6.284e-09|8.21e-08|1.206e-07|4.24e-07,2.811e-05|4.956e-05|0.0004317|0.0004755|0.001338,91.29|70.34|41.46|38.31|29.59
1388,4,0.6675,4.005,3382.0,0.00118,0.9929309999999999,CREM HOXC9 LASP1 LRRC23,retinoic acid receptor signaling pathway|proximal/distal pattern formation|embryonic skeletal system morphogenesis|glucose metabolic process|regulation of circadian rhythm,0.003878|0.006973|0.01832|0.02234|0.0231,1|1|1|1|1,271|147.1|54.77|44.77|43.27
1389,4,0.6001,3.6010000000000004,3177.0,0.001129,0.9929309999999999,CELA3B CES2 CMTM3 HOXD1,prostaglandin metabolic process|prostanoid metabolic process|sensory perception of pain|unsaturated fatty acid metabolic process|icosanoid metabolic process,0.007359|0.007359|0.01449|0.02004|0.02196,1|1|1|1|1,139.2|139.2|69.58|49.99|45.56
1390,4,0.6245,3.747,3208.0,0.001164,0.9929309999999999,EMID1 HOXD3 PXK RAB28,glossopharyngeal nerve morphogenesis|glossopharyngeal nerve development|negative regulation of ATPase activity|thyroid gland development|cranial nerve morphogenesis,0.0009706|0.001165|0.003685|0.004846|0.005813,1|1|1|1|1,1287|1030|286|214.5|177.5
1391,4,0.6782,4.069,3210.0,0.001263,0.9929309999999999,ETFA ETFB ETFDH HPGD,fatty acid beta-oxidation using acyl-CoA dehydrogenase|fatty acid metabolic process|fatty acid beta-oxidation|fatty acid oxidation|lipid oxidation,7.851e-10|6.549e-08|1.036e-07|2.902e-07|3.326e-07,1.238e-05|0.0005165|0.0005449|0.001144|0.001049,1545|62.98|261.8|183.9|175.5
1392,5,0.6498,6.497999999999999,3570.0,0.001812,0.996692,HRAS KRTAP5-1 KRTAP5-10 KRTAP5-3 KRTAP5-9,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,7.505e-08|1.471e-07|2.823e-07|6.042e-07|8.462e-07,0.001184|0.001161|0.001484|0.002383|0.002669,72.9|61.48|52.14|43.02|39.51
1393,19,0.6009,102.8,15090.0,0.006745,1.0,AQP7 CREB3 DNAI1 DNAJB5 FAM205A GALT IFNA1 IFNA16 IFNA21 IFNA4 IFNA6 IFNW1 KIF24 OR2S2 PRSS3 SIGMAR1 SPAG8 TOMM5 UBAP2,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,5.803e-14|1.195e-13|1.195e-13|2.676e-12|7.193e-12,9.153e-10|9.427e-10|6.285e-10|1.055e-08|2.269e-08,325.2|282.8|282.8|158.6|132.7
1394,5,0.629,6.29,4283.0,0.001463,0.996692,FNDC4 HS1BP3 IFT172 LBH NDUFAF2,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division|regulation of somatic stem cell division|positive regulation of somatic stem cell population maintenance,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
1395,4,0.603,3.6180000000000003,3080.0,0.00117,0.9929309999999999,HIGD2A HS3ST5 MRM2 TBRG4,glycosaminoglycan biosynthetic process|aminoglycan biosynthetic process|glycosaminoglycan metabolic process|aminoglycan metabolic process|mitochondrial mRNA processing,0.0002404|0.0002745|0.0005471|0.0006506|0.000728,1|1|1|1|1,82.38|76.99|54.2|49.63|2060
1396,4,0.6943,4.166,3137.0,0.001323,0.9929309999999999,GLIS2 HS3ST6 PRSS33 TPSG1,regulation of transcription from RNA polymerase II promoter involved in kidney development|protein kinase C signaling|hematopoietic stem cell homeostasis|blastocyst hatching|organism emergence from protective structure,0.0003883|0.003104|0.003104|0.005233|0.005233,1|1|1|1|1,5149|343.2|343.2|198|198
1397,8,0.612,17.14,6805.0,0.002506,0.9996790000000001,AK8 CERCAM ENTPD2 HSD17B3 LCN6 LCN8 SARDH USP20,nucleoside diphosphate metabolic process|sarcosine catabolic process|sarcosine metabolic process|small molecule metabolic process|purine ribonucleoside diphosphate catabolic process,0.0004744|0.0007765|0.001164|0.002093|0.002328,1|1|1|1|1,61.29|2574|1287|6.345|514.9
1398,21,0.6012,126.3,15880.0,0.007865,1.0,ACVRL1 AQP5 HOXC8 INHBE KRT1 KRT5 KRT6B KRT74 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT85 KRT86 OR10P1 OR6C1 OR6C3 RDH16 SDR9C7,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,4.033e-22|1.137e-18|8.205e-18|5.566e-17|5.217e-16,6.361e-18|8.971e-15|4.314e-14|2.195e-13|1.646e-12,104.1|52.07|43.91|37.24|30.73
1399,4,0.6585,3.951,2702.0,0.001456,0.9929309999999999,DNAJA1 DNAJA2 HSP90AA1 STIP1,response to heat|response to temperature stimulus|protein folding|protein refolding|positive regulation of ATPase activity,4.292e-07|2.157e-06|5.523e-06|5.932e-06|4.987e-05,0.006771|0.01701|0.02904|0.02339|0.1573,160.9|93.05|67.75|542|177.5
1400,10,0.6091,27.41,6827.0,0.003987,0.999933,HSPA5 RPL11 RPL12 RPL13 RPL17 RPL23 RPL35 RPL37 RPLP2 RPS13,protein targeting to ER|establishment of protein localization to endoplasmic reticulum|protein localization to endoplasmic reticulum|protein targeting to membrane|SRP-dependent cotranslational protein targeting to membrane,3.336e-23|4.676e-23|3.534e-22|4.11e-21|1.625e-20,5.261e-19|3.688e-19|1.858e-18|1.621e-17|5.126e-17,185.5|179.1|145|112.5|193.1
1401,14,0.5849,53.22,9675.0,0.005455,0.9999969999999999,RPL13A RPL14 RPL15 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL31 RPL37 RPL7 RPS15A,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,6.452e-33|1.25e-32|4.302e-32|6.851e-32|7.677e-32,1.018e-28|9.859e-29|2.262e-28|2.702e-28|2.422e-28,214.5|203.9|185.5|179.1|177.5
1402,5,0.6286,6.2860000000000005,3773.0,0.0016589999999999999,0.996692,HSPB2 HTR3A NXPE1 NXPE4 RAB39A,phagosome-lysosome fusion|Rab protein signal transduction|phagolysosome assembly|phagosome acidification|serotonin receptor signaling pathway,0.00291|0.003636|0.003878|0.00702|0.009672,1|1|1|1|1,374.5|294.2|274.6|147.1|105.6
1403,5,0.6089,6.0889999999999995,4242.0,0.00143,0.996692,CELF6 HSPB7 LINGO1 SEMA7A SKOR1,negative regulation of axonogenesis|negative regulation of neuron projection development|negative regulation of neurogenesis|negative regulation of nervous system development|regulation of axonogenesis,0.0001131|0.0004334|0.0004461|0.0004786|0.0005904,1|1|1|1|1,121.1|61.02|60.13|58.01|52.14
1404,5,0.628,6.28,3367.0,0.0018559999999999998,0.996692,DYNLRB1 HSPD1 HSPE1 NEDD1 PAFAH1B1,'de novo' protein folding|cilium assembly|cilium organization|plasma membrane bounded cell projection assembly|cell projection assembly,4.647e-05|6.106e-05|7.325e-05|0.0001155|0.0001275,0.733|0.4816|0.3851|0.4555|0.4023,191.6|32.69|30.74|26.35|25.48
1405,18,0.6001,91.82,13550.0,0.006714,1.0,CD1C CIART CTSK FCRL3 FLG2 HIST2H2AB HRNR HYDIN ITLN2 LCE3E PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A9 SLAMF7,leukocyte activation|immune response|antimicrobial humoral immune response mediated by antimicrobial peptide|leukocyte activation involved in immune response|cell activation involved in immune response,7.146e-05|7.848e-05|8.53e-05|0.0001242|0.0001279,1|0.6189|0.4485|0.4899|0.4037,7.774|4.915|35.29|9.615|9.554
1406,5,0.6013,6.013,3554.0,0.001684,0.996692,GEMIN4 GEMIN6 GEMIN7 HYPK SNUPN,spliceosomal snRNP assembly|import into nucleus|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|nucleocytoplasmic transport,8.214e-11|5.269e-09|3.785e-08|4.366e-08|1.286e-07,1.296e-06|4.156e-05|0.000199|0.0001722|0.0004056,422.5|143.3|86.72|83.63|63.61
1407,5,0.6648,6.648,3265.0,0.002026,0.996692,HSPD1 HSPE1 IARS2 LETM1 LONP1,chaperone-mediated protein complex assembly|'de novo' protein folding|mitochondrion organization|activation of cysteine-type endopeptidase activity involved in apoptotic process|mitochondrial transmembrane transport,1.19e-05|4.647e-05|0.000107|0.0001999|0.0002646,0.1877|0.3665|0.5625|0.7881|0.8347,392.3|191.6|27.04|90.53|78.46
1408,4,0.6098,3.659,3273.0,0.001114,0.9929309999999999,CCDC117 IBTK NT5DC3 RRAS,positive regulation of endothelial cell-matrix adhesion via fibronectin|regulation of endothelial cell-matrix adhesion via fibronectin|positive regulation of vasculogenesis|regulation of vasculogenesis|face morphogenesis,0.001165|0.001359|0.002522|0.003491|0.006007,1|1|1|1|1,1030|858.1|429.1|302.9|171.6
1409,7,0.6414,13.47,4168.0,0.003211,0.9992989999999999,ICMT KRAS MAPK1 NRAS RAF1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction,1.302e-12|1.555e-08|6.304e-06|6.969e-06|7.142e-06,2.054e-08|0.0001226|0.03315|0.02748|0.02253,50.35|13.08|76.75|74.17|73.55
1410,8,0.6232,17.45,5452.0,0.003181,0.9996790000000001,ID2 IPO5 POU2AF1 PRDM1 RC3H1 SMAD7 TCF12 TCF3,regulation of alpha-beta T cell differentiation|regulation of RNA metabolic process|regulation of nitrogen compound metabolic process|regulation of alpha-beta T cell activation|regulation of cellular macromolecule biosynthetic process,2.976e-06|8.956e-06|9.403e-06|1.027e-05|1.279e-05,0.04695|0.07063|0.04944|0.04048|0.04036,104|4.897|3.621|67.97|4.678
1411,9,0.6196,22.31,7122.0,0.0031149999999999997,0.9998530000000001,C9orf3 FBP1 FBP2 GNA14 NUTM2G TXNDC8 ZNF484 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.271e-06|2.118e-06|4.446e-06|1.163e-05|1.649e-05,0.02005|0.01671|0.02338|0.04587|0.05202,2060|1373|823.8|457.7|374.5
1412,4,0.6052,3.6310000000000002,3432.0,0.0010539999999999998,0.9929309999999999,BSPH1 CFAP65 IDUA PTHLH,spermatid development|spermatid differentiation|heparin catabolic process|dermatan sulfate catabolic process|multi-organism reproductive process,0.0003429|0.0003695|0.0003883|0.0003883|0.0004424,1|1|1|1|1,66.44|63.96|5149|5149|15.46
1413,5,0.6075,6.075,3723.0,0.001625,0.996692,CD1B IFI16 OR10J5 OR10T2 RGS4,"negative regulation of glycine import across plasma membrane|regulation of glycine import across plasma membrane|negative regulation of dopamine receptor signaling pathway|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|dorsal root ganglion development",0.000728|0.000728|0.0009706|0.001456|0.001698,1|1|1|1|1,2060|2060|1373|823.8|686.5
1414,8,0.6033,16.89,6364.0,0.002641,0.9996790000000001,CALHM3 CYP26C1 IFIT1 IFIT2 IFIT3 NUTM2A SFTPA2 ZNF485,type I interferon signaling pathway|cellular response to type I interferon|response to type I interferon|cellular response to interferon-alpha|response to interferon-alpha,2.169e-06|2.263e-06|2.884e-06|1.382e-05|4.268e-05,0.03422|0.01785|0.01516|0.05449|0.1346,113.6|111.9|103|396.1|214.5
1415,4,0.6228,3.737,3103.0,0.0012,0.9929309999999999,IFITM5 NR5A2 SOX17 VGLL2,tissue development|embryo development ending in birth or egg hatching|cellular response to leukemia inhibitory factor|response to leukemia inhibitory factor|animal organ morphogenesis,5.029e-05|0.0001077|0.0001126|0.0001151|0.0003753,0.7932|0.8491|0.5922|0.4541|1,11.89|24.91|117|115.7|16.35
1416,8,0.6266,17.54,5916.0,0.002949,0.9996790000000001,ASCL1 GATA3 HAND2 IGF2BP1 ISL1 LIN28B PHOX2B SOX11,sympathetic nervous system development|noradrenergic neuron differentiation|autonomic nervous system development|cardiac ventricle morphogenesis|neural crest cell development,1.188e-13|3.074e-12|4.68e-12|1.004e-08|1.693e-08,1.874e-09|2.425e-08|2.461e-08|3.96e-05|5.341e-05,612.9|1471|273.9|149.2|130.3
1417,4,0.6155,3.693,3441.0,0.00107,0.9929309999999999,ADPRM C6orf52 IGF2BP2 PTPRH,nucleobase-containing small molecule catabolic process|peptidyl-tyrosine dephosphorylation|negative regulation of translation|mRNA transport|negative regulation of cellular amide metabolic process,0.009675|0.02062|0.02653|0.03071|0.03071,1|1|1|1|1,105.1|48.57|37.58|32.38|32.38
1418,7,0.6014,12.63,4878.0,0.002575,0.9992989999999999,ABL1 BCR GAB2 PTPN1 QRFP SOS1 WT1,platelet-derived growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|enzyme linked receptor protein signaling pathway|platelet-derived growth factor receptor-beta signaling pathway|cellular response to organonitrogen compound,2.016e-07|2.103e-07|1.098e-06|4.447e-06|2.249e-05,0.00318|0.001658|0.005774|0.01754|0.07095,252.2|28.34|20.26|735.5|19.91
1419,4,0.682,4.092,3357.0,0.001215,0.9929309999999999,IGFBP1 NINJ1 THADA WDR38,tissue regeneration|regeneration|negative regulation of ATPase-coupled calcium transmembrane transporter activity|developmental growth|growth,6.041e-05|0.0003695|0.0009706|0.001746|0.001776,0.953|1|1|1|1,160.9|63.96|1287|29.09|28.84
1420,20,0.6021,114.4,16340.0,0.0069370000000000005,1.0,ABCA13 AEBP1 AGR3 EGR3 FKBP9 GCK GHRHR IGFBP3 MYL7 NIPSNAP2 NUPR2 PHKG1 PKD1L1 PSPH RNASET2 SEPT14 SUMF2 UPP1 VWC2 ZNF713,regulation of peptide hormone secretion|positive regulation of insulin-like growth factor receptor signaling pathway|cellular glucose homeostasis|positive regulation of peptide hormone secretion|regulation of hormone secretion,8.807e-05|0.0001132|0.0001327|0.0001948|0.0002008,1|0.8926|0.6979|0.7682|0.6336,16.87|144|30.86|27|13.57
1421,4,0.6587,3.952,3168.0,0.001243,0.9929309999999999,CHIT1 IGFN1 PEF1 TMEM81,positive regulation of protein monoubiquitination|regulation of protein monoubiquitination|chitin catabolic process|chitin metabolic process|polysaccharide digestion,0.001165|0.001359|0.001359|0.001359|0.001359,1|1|1|1|1,1030|858.1|858.1|858.1|858.1
1422,7,0.6192,13.0,5459.0,0.00237,0.9992989999999999,GPR87 IGSF10 P2RY14 PLSCR1 PLSCR2 TFDP2 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|plasma membrane phospholipid scrambling|phospholipid translocation|purinergic nucleotide receptor signaling pathway|lipid translocation,1.185e-05|2.279e-05|0.0001108|0.0001155|0.0001252,0.1869|0.1797|0.5826|0.4554|0.3949,420.3|294.2|127.9|125.2|120.1
1423,4,0.6244,3.747,2833.0,0.001317,0.9929309999999999,IGSF11 MITF TBX2 ZEB2,developmental pigmentation|pigmentation|negative regulation of transcription by RNA polymerase II|regulation of melanosome organization|negative regulation of cardiac chamber formation,2.201e-05|0.0001126|0.000327|0.0003883|0.0003883,0.3471|0.8883|1|1|1,271|117|17.12|5149|5149
1424,4,0.6463,3.878,3206.0,0.0012050000000000001,0.9929309999999999,IGSF23 OR2L5 OR51A7 RELL2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.00269|0.003023|0.003256|0.003746|0.004032,1|1|1|1|1,23.35|22|21.19|19.73|19
1425,7,0.6086,12.78,6170.0,0.002062,0.9992989999999999,AP3M1 CYP17A1 CYP2C9 IHH PPP3CB SEMA4G SRGN,regulation of biological quality|regulation of hormone levels|olefinic compound metabolic process|cell morphogenesis involved in differentiation|photoreceptor cell fate commitment,0.0003176|0.0005638|0.000583|0.0006343|0.0006794,1|1|1|1|0.5104,4.406|16.59|54.48|15.93|2942
1426,4,0.6865,4.119,3044.0,0.001348,0.9929309999999999,ERH IKZF2 IRAK2 PTGER4,JNK cascade|stress-activated MAPK cascade|stress-activated protein kinase signaling cascade|negative regulation of eosinophil extravasation|regulation of eosinophil extravasation,0.0001077|0.0001714|0.0002209|0.0003883|0.0003883,1|1|1|1|1,119.7|94.47|83.04|5149|5149
1427,20,0.601,114.2,15390.0,0.007347,1.0,ACVRL1 AQP5 IKZF4 KRT1 KRT5 KRT6B KRT7 KRT74 KRT75 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT86 OR10P1 OR2AP1 OR6C3 PPP1R1A,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,6.573e-25|3.552e-21|3.024e-20|2.412e-19|2.737e-18,1.037e-20|2.801e-17|1.59e-16|9.511e-16|8.636e-15,118.5|59.23|49.95|42.36|34.95
1428,18,0.5863,89.7,13910.0,0.006392,1.0,COL6A2 KCNJ6 KRTAP10-11 KRTAP10-3 KRTAP10-6 KRTAP10-8 KRTAP10-9 KRTAP12-1 KRTAP12-3 KRTAP12-4 KRTAP19-1 KRTAP19-3 KRTAP19-6 KRTAP19-7 KRTAP19-8 PCBP3 TMPRSS3 TRPM2,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,1.257e-21|1.072e-20|8.568e-20|9.755e-19|2.865e-18,1.982e-17|8.454e-17|4.505e-16|3.847e-15|9.038e-15,62.35|52.58|44.59|36.79|33.79
1429,5,0.6362,6.362,3327.0,0.0019030000000000002,0.996692,CEP192 CEP85 IL17D KIF18B KIF2C,microtubule polymerization or depolymerization|microtubule depolymerization|mitotic nuclear division|chromosome segregation|protein depolymerization,1.794e-07|8.046e-06|1.058e-05|2.676e-05|3.302e-05,0.00283|0.06346|0.05565|0.1055|0.1042,237.6|484.6|59.12|43.21|228.8
1430,4,0.607,3.642,3276.0,0.001108,0.9929309999999999,IL19 NOS1 SDS TMEM233,alpha-amino acid catabolic process|cellular amino acid catabolic process|reactive oxygen species metabolic process|retrograde trans-synaptic signaling by nitric oxide|retrograde trans-synaptic signaling by soluble gas,0.000183|0.0002548|0.0003272|0.000728|0.000728,1|1|1|1|1,94.69|79.98|70.41|2060|2060
1431,13,0.601,46.88,10200.0,0.004563,0.999993,CPA1 CPA2 EPHB6 FAM71F2 HYAL4 OR6V1 OR9A4 PRSS1 PRSS37 RNF148 TAS2R60 WNT16 WNT2,cardiac epithelial to mesenchymal transition|proteolysis|epithelial to mesenchymal transition|canonical Wnt signaling pathway|type IV hypersensitivity,0.0001278|0.0008146|0.0009158|0.001303|0.001891,1|1|1|1|1,126.7|6.145|45.26|37.72|792.1
1432,4,0.6304,3.782,3361.0,0.001121,0.9929309999999999,CXCL11 IL36RN UBOX5 UGT1A8,antimicrobial humoral response|cellular response to lipopolysaccharide|cellular response to molecule of bacterial origin|cellular response to biotic stimulus|flavone metabolic process,0.0003472|0.0004655|0.0005176|0.0006536|0.001359,1|1|1|1|1,66.01|56.89|53.91|47.9|858.1
1433,4,0.6256,3.7539999999999996,3421.0,0.001094,0.9929309999999999,IL37 PIK3C2G SULT1C2 SULT1C4,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process,9.177e-06|9.911e-06|9.911e-06|0.0002536|0.0002536,0.1448|0.07817|0.05211|1|0.8001,429.1|411.9|411.9|77.42|77.42
1434,7,0.6156,12.93,5766.0,0.002232,0.9992989999999999,CA2 CA3 CHCHD7 CYP7A1 IL4I1 SGK3 SNX16,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|response to ethanol,8.064e-05|9.298e-05|0.0001524|0.0008819|0.000955,1|0.7333|0.8011|1|1,150.9|140.1|25.96|5.106|42.33
1435,4,0.6438,3.863,2955.0,0.001302,0.9929309999999999,IL4R NFKB2 OR6C4 STAT6,interleukin-4-mediated signaling pathway|adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|cellular response to interleukin-4|regulation of type 2 immune response|response to interleukin-4,4.241e-07|8.725e-06|1.4e-05|1.49e-05|1.679e-05,0.00669|0.06881|0.07362|0.05877|0.05297,2574|58.07|343.2|332.2|312
1436,8,0.6003,16.81,5622.0,0.002972,0.9996790000000001,IL6R IL6ST JAK1 LIFR SBNO2 SLC39A1 SOCS3 STAT3,cellular response to interleukin-6|response to interleukin-6|interleukin-6-mediated signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|cellular response to cytokine stimulus,1.38e-15|2.462e-15|6.081e-14|2.15e-09|5.251e-09,2.176e-11|1.942e-11|3.197e-10|8.478e-06|1.657e-05,429.1|386.2|715.1|1545|17.9
1437,4,0.6434,3.86,2648.0,0.001451,0.9929309999999999,ILF2 OGA ZC3H10 ZFR,negative regulation of production of miRNAs involved in gene silencing by miRNA|N-acetylglucosamine metabolic process|negative regulation of gene silencing by miRNA|negative regulation of posttranscriptional gene silencing|negative regulation of gene silencing by RNA,0.003104|0.003878|0.003878|0.004072|0.004072,1|1|1|1|1,343.2|271|271|257.4|257.4
1438,4,0.6025,3.615,2708.0,0.00133,0.9929309999999999,ILF2 ILF3 NUP155 ZFR,protein localization to nuclear inner membrane|transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery|protein localization to nuclear envelope|atrial cardiac muscle cell to AV node cell signaling|atrial cardiac muscle cell action potential,0.0005825|0.001359|0.002134|0.00291|0.00291,1|1|1|1|1,2574|858.1|514.9|367.8|367.8
1439,6,0.6197,9.295,4798.0,0.001929,0.998474,CRYGA CRYGB CRYGC CRYGD ILKAP PRLH,lens development in camera-type eye|visual perception|sensory perception of light stimulus|camera-type eye development|eye development,3.143e-09|1.867e-07|2.007e-07|8.574e-07|1.493e-06,4.958e-05|0.001472|0.001055|0.003381|0.004709,180.7|63.56|62.41|43.18|37.51
1440,4,0.6531,3.9189999999999996,3371.0,0.001158,0.9929309999999999,IMMP1L LRSAM1 NAGA UBXN11,organonitrogen compound catabolic process|organic substance catabolic process|cellular catabolic process|catabolic process|carbohydrate derivative catabolic process,3.654e-05|0.0002502|0.0002709|0.0004838|0.0009018,0.5763|1|1|1|1,15.26|9.356|9.169|7.906|42.03
1441,6,0.6969,10.45,3903.0,0.002663,0.998474,SNAPC1 SNAPC2 SNAPC3 SNAPC5 SNRPA1 SNRPB2,transcription by RNA polymerase III|snRNA transcription by RNA polymerase III|snRNA transcription by RNA polymerase II|snRNA transcription|ncRNA transcription,1.175e-10|2.263e-09|2.288e-09|2.417e-09|7.169e-09,1.853e-06|1.785e-05|1.203e-05|9.53e-06|2.262e-05,429.1|1287|196.1|193.4|146.1
1442,11,0.6053,33.29,6861.0,0.0048130000000000004,0.999969,DHODH IPMK IPPK ITPK1 NAMPT PFAS PGM3 PPCDC PPCS RFK UGP2,organophosphate metabolic process|small molecule metabolic process|phosphate-containing compound metabolic process|phosphorus metabolic process|nucleobase-containing small molecule metabolic process,1.162e-15|7.557e-13|4.401e-12|5.135e-12|2.559e-11,1.832e-11|5.96e-09|2.314e-08|2.025e-08|8.074e-08,22.93|12.69|10.81|10.65|29.03
1443,4,0.6109,3.6660000000000004,3298.0,0.001108,0.9929309999999999,DGKH HTR2A INPP5F SIAH3,phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling|adult behavior|phosphatidylinositol catabolic process|glycerophospholipid biosynthetic process,9.574e-05|0.0001052|0.0002462|0.0003883|0.0006778,1|0.8299|1|1|1,127.1|121.1|78.61|5149|47.02
1444,9,0.6011,21.64,5704.0,0.003768,0.9998530000000001,INPPL1 KCTD5 MAPKAP1 MLST8 PDPK1 PIK3CA PIK3CB PIK3R1 RICTOR,activation of protein kinase B activity|activation of protein kinase activity|positive regulation of protein kinase B signaling|regulation of kinase activity|positive regulation of protein kinase activity,1.101e-09|1.374e-09|6.952e-09|1.109e-08|2.477e-08,1.737e-05|1.084e-05|3.655e-05|4.373e-05|7.814e-05,277.4|41.99|63.21|17.64|25.71
1445,4,0.6054,3.6319999999999997,2879.0,0.001257,0.9929309999999999,INS RPS21 TP53RK TSEN54,"ncRNA processing|ncRNA metabolic process|tRNA processing|RNA processing|endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",3.683e-05|6.278e-05|0.0002499|0.0003501|0.0003883,0.5809|0.4952|1|1|1,35.76|29.88|78.01|16.73|5149
1446,8,0.6015,16.84,6062.0,0.002763,0.9996790000000001,DDX56 EIF3B INTS1 LSM5 POLD2 PSMA2 RPA3 SEC61G,"nucleotide-excision repair, DNA gap filling|DNA-dependent DNA replication|mismatch repair|base-excision repair, gap-filling|nucleotide-excision repair, DNA incision, 5'-to lesion",3.94e-05|4.654e-05|8.257e-05|8.727e-05|9.706e-05,0.6215|0.3671|0.4342|0.3442|0.3062,223.9|39.81|151.4|147.1|139.2
1447,7,0.6288,13.21,4759.0,0.002759,0.9992989999999999,C7orf26 INTS1 INTS2 INTS5 INTS6 INTS7 INTS8,snRNA 3'-end processing|snRNA processing|snRNA metabolic process|ncRNA 3'-end processing|snRNA transcription by RNA polymerase II,1.531e-16|3.455e-16|1.511e-15|2.137e-15|1.438e-14,2.416e-12|2.725e-12|7.947e-12|8.428e-12|4.536e-11,569.4|490.4|375.6|353.1|252.2
1448,7,0.62,13.02,4840.0,0.002675,0.9992989999999999,CCT3 COPA INTS3 PSMB3 PSMB4 PSMD4 SF3B4,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|negative regulation of mitotic cell cycle phase transition,1.883e-08|2.86e-08|3.384e-07|4.559e-07|5.07e-07,0.000297|0.0002256|0.001779|0.001798|0.0016,121.3|109|57.97|53.74|52.3
1449,4,0.6051,3.6310000000000002,3422.0,0.001057,0.9929309999999999,C1QC IP6K3 PHOSPHO1 TBC1D32,retinal pigment epithelium development|smoothened signaling pathway involved in dorsal/ventral neural tube patterning|glycerophospholipid metabolic process|negative regulation of macrophage differentiation|bone mineralization involved in bone maturation,0.001165|0.001359|0.00153|0.001553|0.001553,1|1|1|1|1,1030|858.1|31.11|735.5|735.5
1450,7,0.6125,12.86,4685.0,0.0027300000000000002,0.9992989999999999,EIF3D EIF3E EIF3F EIF3H EIF3M IPO7 RPL27A,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|translational initiation|cytoplasmic translation|translation,1.381e-14|2.2e-13|8.999e-13|1.623e-11|3.052e-10,2.178e-10|1.735e-09|4.732e-09|6.401e-08|9.628e-07,919.4|490.4|123.4|196.1|45.97
1451,7,0.6196,13.01,5700.0,0.0022719999999999997,0.9992989999999999,HRASLS HTR3D IQCG MUC4 SLC51A TCTEX1D2 TM4SF19,regulation of intraciliary retrograde transport|bile acid secretion|N-acylphosphatidylethanolamine metabolic process|intraciliary retrograde transport|microtubule-based movement,0.001019|0.002376|0.003393|0.005086|0.005776,1|1|1|1|1,1471|490.4|326.9|210.2|16.81
1452,4,0.6341,3.805,3257.0,0.001164,0.9929309999999999,ARHGAP28 IQSEC1 SORCS3 ZNF282,negative regulation of GTP binding|positive regulation of focal adhesion disassembly|regulation of focal adhesion disassembly|regulation of small GTPase mediated signal transduction|positive regulation of GTPase activity,0.0007766|0.001359|0.001359|0.001494|0.002365,1|1|1|1|1,1716|858.1|858.1|31.49|24.93
1453,4,0.76,4.56,2804.0,0.0016190000000000002,0.9929309999999999,IRF2BP1 IRF2BP2 IRF2BPL VGLL4,"negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription|negative regulation of RNA biosynthetic process|negative regulation of RNA metabolic process|negative regulation of cellular macromolecule biosynthetic process",1.541e-05|1.55e-05|1.56e-05|2.113e-05|2.735e-05,0.2431|0.1223|0.08203|0.08333|0.08627,15.99|15.97|15.94|14.77|13.85
1454,5,0.6495,6.495,3540.0,0.001827,0.996692,DNAJC13 EPG5 IRF3 TBK1 TMEM173,toll-like receptor signaling pathway|pattern recognition receptor signaling pathway|positive regulation of type I interferon-mediated signaling pathway|positive regulation of interferon-alpha production|regulation of interferon-alpha production,4.983e-07|9.779e-07|2.967e-06|9.177e-06|1.4e-05,0.00786|0.007713|0.0156|0.03619|0.04417,152.9|121.6|792.1|429.1|343.2
1455,7,0.6437,13.52,4678.0,0.002873,0.9992989999999999,FXN HSCB LONP1 LYRM4 NFS1 TIMM10 WDR18,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|iron incorporation into metallo-sulfur cluster|metal incorporation into metallo-sulfur cluster|[2Fe-2S] cluster assembly,8.164e-11|8.164e-11|5.936e-07|5.936e-07|2.076e-06,1.288e-06|6.439e-07|0.003121|0.002341|0.006551,511.7|511.7|2942|2942|1177
1456,4,0.6692,4.015,3074.0,0.001301,0.9929309999999999,ISG20L2 MRPL24 PRCC SMG5,gene expression|cellular nitrogen compound metabolic process|RNA metabolic process|nucleic acid metabolic process|mRNA metabolic process,0.0001274|0.0007508|0.001769|0.004688|0.006537,1|1|1|1|1,9.421|6.045|9.66|6.92|14.84
1457,4,0.6176,3.705,3247.0,0.001137,0.9929309999999999,ACSL1 ISM2 ZNF548 ZSCAN22,positive regulation of long-chain fatty acid import across plasma membrane|positive regulation of long-chain fatty acid import into cell|response to oleic acid|regulation of long-chain fatty acid import across plasma membrane|adiponectin-activated signaling pathway,0.0005825|0.0007766|0.001359|0.001359|0.001553,1|1|1|1|1,2574|1716|858.1|858.1|735.5
1458,4,0.6508,3.905,2566.0,0.001515,0.9929309999999999,ITFG1 MON2 OSBPL9 VPS54,post-Golgi vesicle-mediated transport|cytosolic transport|neurofilament cytoskeleton organization|Golgi vesicle transport|Golgi to endosome transport,0.0002574|0.000313|0.001747|0.002177|0.003491,1|1|1|1|1,76.85|69.58|643.6|26|302.9
1459,4,0.614,3.6839999999999997,3274.0,0.001121,0.9929309999999999,ITGA10 RIMS2 SLC25A32 ZNF541,mitochondrial FAD transmembrane transport|folate import into mitochondrion|FAD transport|FAD transmembrane transport|spontaneous neurotransmitter secretion,0.0003883|0.0003883|0.0005825|0.0005825|0.001165,1|1|1|1|1,5149|5149|2574|2574|1030
1460,4,0.603,3.6180000000000003,3356.0,0.001074,0.9929309999999999,ATP2A1 FOXJ3 ITGA6 ITGB4,nail development|skin morphogenesis|hemidesmosome assembly|cell-substrate junction assembly|cell-substrate junction organization,1.555e-06|2.204e-06|2.572e-06|2.919e-05|3.048e-05,0.02452|0.01739|0.01352|0.1151|0.09617,1144|936.1|858.1|234|228.8
1461,4,0.6296,3.778,2932.0,0.001283,0.9929309999999999,ASCL1 DYNC1I2 ITGA8 SOX1,cell fate commitment involved in pattern specification|ventral spinal cord interneuron fate commitment|ventral spinal cord interneuron differentiation|spinal cord dorsal/ventral patterning|spinal cord patterning,2.204e-06|2.204e-06|2.967e-06|4.831e-06|5.932e-06,0.03477|0.01739|0.0156|0.01905|0.01871,936.1|936.1|792.1|605.7|542
1462,19,0.6237,106.7,12010.0,0.008775,1.0,ALG12 ALG3 ALG5 ALG6 ALG8 ALG9 DNAJC3 DOLPP1 DPM1 DPM2 DPM3 GANAB MPDU1 MPI OST4 PMM2 SEC63 STT3A UGP2,protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein metabolic process,1.014e-29|2.655e-25|2.655e-25|5.663e-25|8.247e-25,1.599e-25|2.094e-21|1.396e-21|2.233e-21|2.602e-21,192.2|63.83|63.83|60.57|44.29
1463,4,0.6031,3.6180000000000003,3215.0,0.001121,0.9929309999999999,GRAMD1B IQCF2 ITIH1 PRSS45,cellular response to cholesterol|cellular response to sterol|response to cholesterol|response to sterol|hyaluronan metabolic process,0.002619|0.003346|0.004073|0.004799|0.004944,1|1|1|1|1,403.8|312|254.3|214.5|208
1464,4,0.6535,3.9210000000000003,2767.0,0.001411,0.9929309999999999,NAIF1 SLC30A1 SLC39A10 SLC39A6,zinc ion transmembrane transport|zinc ion transport|cellular zinc ion homeostasis|zinc ion homeostasis|cellular transition metal ion homeostasis,8.026e-09|1.233e-08|2.314e-08|2.923e-08|6.932e-07,0.0001266|9.726e-05|0.0001217|0.0001153|0.002187,643.6|551.7|441.3|406.5|136.7
1465,9,0.6387,22.99,6941.0,0.003293,0.9998530000000001,CAPN5 FCHSD2 FOLR2 KCTD21 OMP P2RY2 P2RY6 PLEKHB1 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|response to organic cyclic compound|response to organonitrogen compound|response to nitrogen compound,2.029e-05|0.0001973|0.000366|0.0005733|0.0007894,0.32|1|1|1|1,326.9|97.38|10.33|9.181|8.436
1466,4,0.7025,4.215,3362.0,0.0012490000000000001,0.9929309999999999,IGDCC3 IZUMO4 TBC1D21 TRH,positive regulation of gamma-aminobutyric acid secretion|negative regulation of glutamate secretion|imidazole-containing compound metabolic process|histamine metabolic process|regulation of gamma-aminobutyric acid secretion,0.0007766|0.001165|0.001359|0.001359|0.001359,1|1|1|1|1,1716|1030|858.1|858.1|858.1
1467,6,0.6008,9.012,4435.0,0.002022,0.998474,CCDC107 JKAMP MICALL2 TMEM203 TMEM60 TRPM7,calcium-dependent cell-matrix adhesion|cell-substrate adhesion|cellular magnesium ion homeostasis|magnesium ion homeostasis|cellular divalent inorganic cation homeostasis,0.0008735|0.0012|0.001456|0.00349|0.007151,1|1|1|1|1,1716|37.11|858.1|312|14.86
1468,8,0.67,18.76,5694.0,0.003274,0.9996790000000001,ATP13A1 AUP1 JOSD1 STUB1 TM2D1 TM2D2 TM2D3 ZDHHC6,cellular response to misfolded protein|response to misfolded protein|protein quality control for misfolded or incompletely synthesized proteins|ubiquitin-dependent ERAD pathway|ERAD pathway,3.626e-05|4.268e-05|5.708e-05|0.0003804|0.0005427,0.5719|0.3366|0.3001|1|1,234|214.5|183.9|68.65|57.21
1469,4,0.6375,3.825,3200.0,0.001191,0.9929309999999999,GPR142 JPT1 LGALS3BP SSTR2,somatostatin signaling pathway|somatostatin receptor signaling pathway|peristalsis|phasic smooth muscle contraction|cellular response to estradiol stimulus,0.001165|0.001165|0.002328|0.003878|0.007166,1|1|1|1|1,1030|1030|468.1|271|143
1470,4,0.6444,3.867,3451.0,0.001117,0.9929309999999999,ADGRF3 KANK1 PLB1 TRIM54,negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization|negative regulation of lamellipodium morphogenesis|negative regulation of lamellipodium organization|glomerular visceral epithelial cell migration,0.0003299|0.0003385|0.0005825|0.001165|0.001359,1|1|1|1|1,67.75|66.87|2574|1030|858.1
1471,4,0.6226,3.736,2573.0,0.0014449999999999999,0.9929309999999999,KATNA1 KATNB1 KIF18A WDR62,microtubule cytoskeleton organization|microtubule-based process|microtubule severing|microtubule depolymerization|cytoskeleton organization,5.803e-07|2.339e-06|2.572e-06|4.831e-06|1.177e-05,0.009154|0.01845|0.01352|0.01905|0.03714,36.39|25.65|858.1|605.7|17.11
1472,6,0.625,9.375,4907.0,0.001902,0.998474,C1QTNF9 KBTBD7 KRTAP21-1 RNF6 VANGL1 ZAR1L,protein K27-linked ubiquitination|protein K6-linked ubiquitination|regulation of androgen receptor signaling pathway|negative regulation of axon extension|protein K48-linked ubiquitination,0.001746|0.002909|0.01073|0.01304|0.01678,1|1|1|1|1,686.5|381.4|95.35|78.01|60.22
1473,4,0.6194,3.716,3268.0,0.0011330000000000001,0.9929309999999999,ALDH1A2 GP1BA INCA1 KBTBD8,neural crest cell development|stem cell development|mesenchymal cell development|neural crest cell differentiation|stem cell differentiation,9.117e-05|9.807e-05|0.0001004|0.0001151|0.0003385,1|0.7735|0.528|0.4541|1,130.3|125.6|124.1|115.7|66.87
1474,4,0.6154,3.6919999999999997,3219.0,0.001143,0.9929309999999999,ADAT1 KCNA4 MGAT3 SULT1C3,negative regulation of lysosomal protein catabolic process|negative regulation of protein catabolic process in the vacuole|regulation of lysosomal protein catabolic process|positive regulation of protein localization to early endosome|regulation of protein localization to early endosome,0.0007766|0.0007766|0.001747|0.001941|0.001941,1|1|1|1|1,1716|1716|643.6|572.1|572.1
1475,4,0.6062,3.637,3132.0,0.001157,0.9929309999999999,EMC8 H3F3B H3F3C KCNAB2,negative regulation of chromosome condensation|subtelomeric heterochromatin organization|subtelomeric heterochromatin assembly|pericentric heterochromatin organization|pericentric heterochromatin assembly,0.0002913|0.0002913|0.0002913|0.0005825|0.0005825,1|1|1|1|1,6865|6865|6865|2288|2288
1476,6,0.6073,9.11,5254.0,0.001727,0.998474,ATP6V0D2 CNGB3 KCNB2 PMP2 PRDM14 TRIM55,cation transmembrane transport|histone H3-R26 methylation|inactivation of paternal X chromosome|inner cell mass cell fate commitment|germ-line stem cell population maintenance,0.0005564|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,16.17|3432|3432|1716|1144
1477,10,0.6019,27.08,7472.0,0.003602,0.999933,CTTN FOLR1 FOLR2 KRTAP5-11 KRTAP5-9 MRGPRD MRGPRF P2RY6 PLEKHB1 POLD4,cellular response to folic acid|folate import across plasma membrane|keratinization|folate transmembrane transport|keratinocyte differentiation,1.864e-06|6.518e-06|6.976e-06|8.687e-06|1.352e-05,0.0294|0.0514|0.03668|0.03426|0.04266,1716|686.5|30.38|572.1|25.62
1478,4,0.6301,3.781,3379.0,0.001115,0.9929309999999999,FLVCR2 GAS6 KCNIP1 SLC36A4,cation transport|transmembrane transport|cation transmembrane transport|ion transport|negative regulation of renal albumin absorption,2.618e-06|1.56e-05|0.0001167|0.0003841|0.0003883,0.04129|0.123|0.6134|1|1,24.93|15.94|24.25|7.149|5149
1479,8,0.6044,16.92,6395.0,0.002633,0.9996790000000001,CLEC6A GYS2 IAPP KCNJ8 MANSC4 PKP2 SLCO1B3 SLCO1C1,sodium-independent organic anion transport|ventricular cardiac muscle cell action potential|bile acid and bile salt transport|cardiac muscle cell action potential involved in contraction|cardiac muscle cell contraction,2.012e-05|3.324e-05|8.257e-05|0.0001021|0.0001238,0.3174|0.2622|0.4342|0.4028|0.3905,321.8|245.2|151.4|135.5|122.6
1480,8,0.6363,17.82,5959.0,0.002973,0.9996790000000001,ANKRD30A HSD17B7 MCM10 MTRNR2L7 PRPF18 ZNF25 ZNF33A ZNF37A,nuclear retention of unspliced pre-mRNA at the site of transcription|nuclear mRNA surveillance of spliceosomal pre-mRNA splicing|generation of catalytic spliceosome for second transesterification step|nuclear retention of pre-mRNA at the site of transcription|spliceosomal conformational changes to generate catalytic conformation,0.001164|0.001164|0.001164|0.002328|0.002715,1|1|1|1|1,1287|1287|1287|514.9|429.1
1481,4,0.6216,3.7289999999999996,3398.0,0.001094,0.9929309999999999,AEBP1 KCNK2 MYL7 SPAG6,positive regulation of cellular response to hypoxia|regulation of collagen fibril organization|regulation of cellular response to hypoxia|negative regulation of cardiac muscle cell proliferation|stabilization of membrane potential,0.0003883|0.001359|0.002522|0.00291|0.003491,1|1|1|1|1,5149|858.1|429.1|367.8|302.9
1482,8,0.6011,16.83,6664.0,0.002513,0.9996790000000001,CA1 CA13 CA2 CA3 KCNS2 PMP2 SLC26A7 SLC7A13,bicarbonate transport|organic anion transport|one-carbon metabolic process|ion transport|organic substance transport,2.764e-12|5.848e-10|1.144e-09|7.419e-06|3.197e-05,4.36e-08|4.613e-06|6.015e-06|0.02926|0.1009,306.5|45.43|264|6.255|7.118
1483,4,0.6428,3.8569999999999998,3121.0,0.001231,0.9929309999999999,KCTD12 PSMA4 TTK USP39,protein localization to meiotic spindle midzone|meiotic spindle assembly checkpoint|protein localization to meiotic spindle|meiotic spindle checkpoint|negative regulation of mitotic cell cycle phase transition,0.0003883|0.0003883|0.0003883|0.0005825|0.0007149,1|1|1|1|1,5149|5149|5149|2574|45.77
1484,4,0.6302,3.781,3340.0,0.0011279999999999999,0.9929309999999999,ERGIC2 KCTD14 KIAA1551 MANSC4,positive regulation of DNA methylation-dependent heterochromatin assembly|positive regulation of heterochromatin organization|positive regulation of heterochromatin assembly|positive regulation of chromatin assembly or disassembly|regulation of DNA methylation-dependent heterochromatin assembly,0.002328|0.002716|0.002716|0.00291|0.003104,1|1|1|1|1,468.1|396.1|396.1|367.8|343.2
1485,4,0.6228,3.737,3276.0,0.0011359999999999999,0.9929309999999999,BVES KCTD20 PTPRN2 TLR5,toll-like receptor 5 signaling pathway|sinoatrial node cell development|cardiac pacemaker cell development|sinoatrial node cell differentiation|sinoatrial node development,0.0003883|0.001165|0.001359|0.001359|0.001359,1|1|1|1|1,5149|1030|858.1|858.1|858.1
1486,4,0.6418,3.8510000000000004,2813.0,0.001363,0.9929309999999999,FAM49B KCTD9 PICALM PTPN14,positive regulation of memory T cell activation|regulation of memory T cell activation|clathrin-coated pit assembly|membrane bending|negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
1487,4,0.6232,3.739,2597.0,0.001434,0.9929309999999999,ARF4 KDELR1 KDELR2 SUCO,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|endoplasmic reticulum to Golgi vesicle-mediated transport|maintenance of protein localization in organelle",3.004e-07|1.555e-06|3.391e-06|3.527e-06|2.792e-05,0.004739|0.01226|0.01783|0.01391|0.08809,181.7|1144|735.5|78.81|239.5
1488,6,0.6241,9.361,4788.0,0.001946,0.998474,ARL9 KDR KIT PDGFRA SULT1B1 TMPRSS11B,hematopoietic progenitor cell differentiation|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of phosphatidylinositol 3-kinase signaling|peptidyl-tyrosine phosphorylation|peptidyl-tyrosine modification,1.597e-06|1.822e-06|4.732e-06|7.447e-06|7.903e-06,0.0252|0.01437|0.02488|0.02937|0.02493,118.4|113.2|81.73|70.05|68.65
1489,28,0.5927,224.1,20280.0,0.0109,1.0,C12orf65 CARS2 DARS2 DDX28 FOXRED1 GFM2 GRSF1 GTPBP10 GTPBP8 MALSU1 MRM2 MRM3 MRPL58 MRRF MTERF3 MTERF4 MTFMT MTG1 MTG2 MTIF2 NGRN NSUN4 PTCD1 RPUSD3 RPUSD4 SSBP1 TFB1M TRUB2,ribosome biogenesis|regulation of mitochondrial translation|regulation of mitochondrial gene expression|rRNA modification|ribonucleoprotein complex biogenesis,9.178e-15|1.572e-14|3.774e-14|2.285e-13|4.445e-13,1.448e-10|1.24e-10|1.984e-10|9.011e-10|1.402e-09,26.59|198|171.6|128.7|18.98
1490,4,0.6171,3.7030000000000003,3366.0,0.0010960000000000002,0.9929309999999999,DCTN3 EIF5A2 KCNU1 KIAA0930,polyamine homeostasis|positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|regulation of translational elongation,0.0003883|0.0009706|0.001165|0.002328|0.004266,1|1|1|1|1,5149|1287|1030|468.1|245.2
1491,9,0.6278,22.6,5744.0,0.003907,0.9998530000000001,CKAP5 CLTC DLGAP5 GAK GTSE1 KIF15 KNTC1 MAD2L1BP TACC3,mitotic cell cycle|regulation of cell cycle process|cell cycle|regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation,3.282e-09|3.624e-09|3.73e-09|1.433e-08|2.123e-08,5.177e-05|2.858e-05|1.961e-05|5.65e-05|6.699e-05,21.05|20.75|13.17|140.8|127.1
1492,9,0.615,22.14,7158.0,0.003076,0.9998530000000001,AK8 CERCAM DPP7 ENTPD2 LCN10 LCN15 LCN6 LCN8 TUBB4B,nucleoside diphosphate metabolic process|purine ribonucleoside diphosphate catabolic process|purine nucleoside diphosphate catabolic process|ribonucleoside diphosphate catabolic process|nucleoside diphosphate catabolic process,0.0006082|0.002618|0.002618|0.00349|0.005665,1|1|1|1|1,54.48|457.7|457.7|326.9|190.7
1493,4,0.6196,3.718,3371.0,0.001099,0.9929309999999999,CHIT1 IGFN1 KIAA1614 METTL13,chitin catabolic process|chitin metabolic process|polysaccharide digestion|glucosamine-containing compound catabolic process|amino sugar catabolic process,0.001019|0.001019|0.001019|0.001456|0.002038,1|1|1|1|1,1144|1144|1144|762.8|528.1
1494,7,0.6022,12.65,4355.0,0.002886,0.9992989999999999,AHCYL1 KIDINS220 MAPK6 MAPKAPK5 SLC20A1 SLC4A7 XPR1,phosphate ion transmembrane transport|inorganic anion transport|phosphate ion transport|anion transmembrane transport|cellular response to phosphate starvation,1.343e-05|1.602e-05|2.279e-05|0.0003643|0.0006794,0.2118|0.1264|0.1198|1|1,392.3|55.86|294.2|19.27|2942
1495,11,0.6099,33.54,7405.0,0.004496,0.999969,DUX4 HSPE1 NEDD1 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL37 RPLP2 RPS13,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,4.916e-14|6.91e-14|1.304e-13|1.655e-13|1.755e-13,7.754e-10|5.45e-10|6.856e-10|6.527e-10|5.536e-10,125.1|118.9|108.2|104.5|103.6
1496,12,0.6169,40.72,9905.0,0.004084,0.999986,CNBD2 CPNE1 FAM83C GGT7 GHRH HCK KIF3B MAP1LC3A MYH7B MYLK2 WFDC11 WISP2,"positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding|regulation of circadian sleep/wake cycle, REM sleep",0.001164|0.001746|0.002327|0.002909|0.002909,1|1|1|1|1,1716|858.1|572.1|429.1|429.1
1497,4,0.6016,3.61,3357.0,0.0010710000000000001,0.9929309999999999,APOB KIF3C PDGFD SLC37A2,positive regulation of monocyte extravasation|positive regulation of smooth muscle cell chemotaxis|triglyceride mobilization|regulation of monocyte extravasation|positive regulation of glomerular mesangial cell proliferation,0.0007766|0.0009706|0.0009706|0.0009706|0.001359,1|1|1|1|1,1716|1287|1287|1287|858.1
1498,18,0.6007,91.91,13690.0,0.006653,1.0,HOXC10 HOXC4 HOXC5 HOXC6 HOXC8 INHBE KIF5A KRT5 KRT6B KRT79 KRT82 KRT84 KRT86 MARCH9 OS9 POU6F1 PPP1R1A RDH5,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,5.718e-10|3.159e-08|8.479e-08|2.198e-07|6.66e-07,9.02e-06|0.0002492|0.0004458|0.0008669|0.002101,60.75|30.38|25.62|21.72|17.92
1499,4,0.6154,3.6919999999999997,3072.0,0.0011970000000000001,0.9929309999999999,ADCY6 ANKMY2 KIF7 RIC8B,cellular response to vasopressin|response to vasopressin|negative regulation of urine volume|cAMP biosynthetic process|cellular response to forskolin,0.0007766|0.0007766|0.001165|0.002134|0.002134,1|1|1|1|1,1716|1716|1030|514.9|514.9
1500,13,0.6066,47.32,10290.0,0.004564,0.999993,GPR32 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 SHISA7,regulation of immune response|regulation of immune system process|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of response to stimulus,4.42e-12|3.628e-10|4.104e-08|7.108e-08|3.509e-07,6.972e-08|2.862e-06|0.0002158|0.0002803|0.001107,14.33|9.513|551.7|441.3|4.163
1501,4,0.6081,3.6489999999999996,3265.0,0.001114,0.9929309999999999,DIABLO KITLG NOS1 TMEM233,extrinsic apoptotic signaling pathway|negative regulation of mast cell apoptotic process|regulation of mast cell apoptotic process|positive regulation of mast cell proliferation|retrograde trans-synaptic signaling by nitric oxide,0.0001999|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,90.53|4119|2060|2060|2060
1502,4,0.6564,3.938,3467.0,0.001132,0.9929309999999999,BEST4 CLEC2L FAAH KL,sebaceous gland cell differentiation|glucosylceramide biosynthetic process|central nervous system myelin maintenance|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway|glucosylceramide metabolic process,0.000728|0.000728|0.001213|0.001213|0.001456,1|1|1|1|1,2060|2060|1030|1030|823.8
1503,4,0.6313,3.7880000000000003,3448.0,0.0010949999999999998,0.9929309999999999,ARL5B KIF5B KLC1 SLC2A8,stress granule disassembly|ribonucleoprotein complex disassembly|organelle disassembly|positive regulation of voltage-gated sodium channel activity|ribonucleoprotein complex subunit organization,5.937e-07|1.018e-06|7.811e-05|0.0003883|0.0005501,0.009365|0.008027|0.4107|1|1,2060|1471|141.1|5149|52.27
1504,4,0.6114,3.6689999999999996,3471.0,0.001053,0.9929309999999999,CPNE5 KLC4 RAB22A RAD21L1,meiotic telomere tethering at nuclear periphery|meiotic attachment of telomere to nuclear envelope|telomere tethering at nuclear periphery|chromosome attachment to the nuclear envelope|replication-born double-strand break repair via sister chromatid exchange,0.001165|0.001165|0.001165|0.001553|0.001747,1|1|1|1|1,1030|1030|1030|735.5|643.6
1505,4,0.6063,3.638,3235.0,0.001121,0.9929309999999999,KLF11 KLHDC9 SCAMP5 TMPRSS11E,positive regulation of calcium ion-dependent exocytosis|regulation of transcription involved in G1/S transition of mitotic cell cycle|regulation of calcium ion-dependent exocytosis|negative regulation of endocytosis|positive regulation of regulated secretory pathway,0.003878|0.00678|0.008131|0.009289|0.01045,1|1|1|1|1,271|151.4|125.6|109.5|97.15
1506,4,0.6379,3.827,2880.0,0.001324,0.9929309999999999,AZIN1 METTL5 OAZ1 RFX6,regulation of polyamine transmembrane transport|polyamine biosynthetic process|polyamine metabolic process|cellular biogenic amine biosynthetic process|amine biosynthetic process,5.937e-07|3.391e-06|5.932e-06|2.313e-05|2.429e-05,0.009365|0.02674|0.03119|0.09122|0.07662,2060|735.5|542|264|257.4
1507,20,0.6015,114.3,16050.0,0.007055,1.0,ALDH3A1 ALOXE3 CCDC144A CCDC144NL DRC3 GID4 KRT16 LLGL1 MFAP4 MIEF2 MYH2 MYO15A SLC47A2 TBC1D28 TNFRSF13B TNFSF12 TNFSF13 TRPV2 ZNF624 ZSWIM7,tumor necrosis factor-mediated signaling pathway|establishment of skin barrier|regulation of water loss via skin|cellular response to tumor necrosis factor|multicellular organismal water homeostasis,0.0002865|0.0003416|0.0003946|0.002017|0.002622,1|1|1|1|1,23.54|78.46|72.65|11.86|26.87
1508,4,0.7067,4.24,2999.0,0.001408,0.9929309999999999,CASC1 KLHL29 LRMP SOX5,positive regulation of mesenchymal stem cell differentiation|regulation of mesenchymal stem cell differentiation|asymmetric neuroblast division|neuroblast division|asymmetric cell division,0.0009706|0.001359|0.001359|0.002716|0.003297,1|1|1|1|1,1287|858.1|858.1|396.1|321.8
1509,4,0.6065,3.639,3208.0,0.0011300000000000001,0.9929309999999999,KLK4 RRP36 VN1R1 ZNF548,"response to pheromone|amelogenesis|cleavage involved in rRNA processing|maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|maturation of SSU-rRNA",0.002134|0.004266|0.005426|0.007359|0.009867,1|1|1|1|1,514.9|245.2|190.7|139.2|103
1510,6,0.6108,9.161,4953.0,0.001842,0.998474,GP6 KLK11 KLK5 SIGLEC9 ZNF432 ZNF665,positive regulation of antibacterial peptide production|regulation of antibacterial peptide production|positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response,0.001456|0.001746|0.002037|0.002328|0.002328,1|1|1|1|1,858.1|686.5|572.1|490.4|490.4
1511,8,0.6078,17.02,6338.0,0.002671,0.9996790000000001,CLEC2B CLEC4C KLRB1 KLRC1 KLRC4 PRH2 TAS2R13 TAS2R20,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|regulation of immune response,9.21e-05|0.0001182|0.0001238|0.0003144|0.0005327,1|0.9322|0.6509|1|1,143|125.6|122.6|75.72|9.121
1512,10,0.6238,28.07,7727.0,0.003611,0.999933,BBS1 CTTN FGF19 FOLR2 KNOP1 MRGPRD MRGPRF MYEOV POLD4 TBC1D10C,cellular response to folic acid|negative regulation of bile acid biosynthetic process|negative regulation of bile acid metabolic process|folate import across plasma membrane|folate transmembrane transport,0.001455|0.00194|0.00194|0.002909|0.003393,1|1|1|1|1,1030|686.5|686.5|411.9|343.3
1513,4,0.6262,3.7569999999999997,3378.0,0.001108,0.9929309999999999,CLYBL KPNA5 PCDHGA5 RUBCNL,positive regulation of cobalamin metabolic process|regulation of cobalamin metabolic process|autophagosome-endosome fusion|positive regulation of tetrapyrrole metabolic process|positive regulation of vitamin metabolic process,0.0003883|0.0003883|0.0003883|0.0005825|0.0009706,1|1|1|1|1,5149|5149|5149|2574|1287
1514,7,0.6237,13.1,4796.0,0.002715,0.9992989999999999,AK6 CCDC59 IMP3 KRR1 NOP9 RBM19 WDR43,rRNA processing|rRNA metabolic process|cellular nitrogen compound metabolic process|ribosome biogenesis|nucleoside monophosphate phosphorylation,3.156e-06|3.658e-06|4.342e-06|8.206e-06|1.776e-05,0.04979|0.02885|0.02283|0.03236|0.05602,35.21|33.9|5.373|27.57|352.1
1515,19,0.6027,103.1,15110.0,0.006758,1.0,ALDH3A1 ALOXE3 CCDC144A CCDC144NL GID4 HS3ST3A1 KRT14 KRT16 KRT17 MFAP4 MYH2 MYO15A TBC1D28 TNFRSF13B TNFSF12 TNFSF13 TRPV2 ZNF287 ZNF624,intermediate filament cytoskeleton organization|intermediate filament-based process|hair cycle|molting cycle|cornification,1.598e-05|1.69e-05|8.439e-05|8.439e-05|0.0001575,0.2521|0.1333|0.4437|0.3328|0.497,63.76|62.54|35.73|35.73|28.78
1516,4,0.6147,3.688,3213.0,0.001144,0.9929309999999999,GJB6 KRT6C RASA3 ZFP90,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|maintenance of blood-brain barrier,0.001359|0.001553|0.001747|0.004072|0.00678,1|1|1|1|1,858.1|735.5|643.6|257.4|151.4
1517,19,0.6005,102.7,14540.0,0.006993999999999999,1.0,ACVRL1 FAM19A2 HOXC8 KRT1 KRT5 KRT71 KRT74 KRT75 KRT76 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT86 OR10P1 OR2AP1 POU6F1,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,7.349e-26|4.012e-22|3.428e-21|2.747e-20|3.137e-19,1.159e-21|3.164e-18|1.803e-17|1.083e-16|9.895e-16,131.6|65.81|55.5|47.07|38.84
1518,8,0.6609,18.51,5635.0,0.003264,0.9996790000000001,ATP13A1 AUP1 JOSD1 PCNX1 STUB1 TM2D1 TM2D2 TM2D3,cellular response to misfolded protein|response to misfolded protein|protein quality control for misfolded or incompletely synthesized proteins|ubiquitin-dependent ERAD pathway|ERAD pathway,3.626e-05|4.268e-05|5.708e-05|0.0003804|0.0005427,0.5719|0.3366|0.3001|1|1,234|214.5|183.9|68.65|57.21
1519,19,0.6028,103.1,15040.0,0.006788,1.0,AEBP1 AGR3 CALM1 EGR3 FKBP9 GHRHR GPCPD1 LANCL2 NIPSNAP2 NUPR2 PHKG1 PSPH RNASET2 SEPT14 SUMF2 VSTM2A VWC2 ZNF713 ZNF716,negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of calcium ion transmembrane transporter activity|negative regulation of release of sequestered calcium ion into cytosol|regulation of high voltage-gated calcium channel activity|positive regulation of sequestering of calcium ion,6.93e-05|8.693e-05|9.318e-05|0.0001064|0.0001206,1|0.6856|0.49|0.4197|0.3803,187.2|35.51|158.4|147.1|137.3
1520,4,0.6096,3.658,2810.0,0.001296,0.9929309999999999,KRTAP9-6 NLE1 RRS1 SDAD1,ribosomal large subunit biogenesis|ribosomal large subunit export from nucleus|ribosome localization|ribosomal subunit export from nucleus|rRNA-containing ribonucleoprotein complex export from nucleus,4.611e-07|1.696e-06|4.943e-06|4.943e-06|5.648e-06,0.007273|0.01337|0.02599|0.01949|0.01782,171.6|1177|633.7|633.7|588.4
1521,5,0.6642,6.642,3816.0,0.0017329999999999997,0.996692,HAPLN2 KRTCAP2 THBS3 TRIM46 TTC24,protein N-linked glycosylation via arginine|positive regulation of anterograde dense core granule transport|regulation of anterograde dense core granule transport|positive regulation of dense core granule transport|regulation of dense core granule transport,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1522,4,0.6252,3.7510000000000003,3501.0,0.001068,0.9929309999999999,AFAP1L2 KIAA0408 LACTB2 VNN1,pantothenate metabolic process|positive regulation of T cell differentiation in thymus|chronic inflammatory response|inflammatory response|negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.001553|0.002134|0.00291|0.003389|0.004072,1|1|1|1|1,735.5|514.9|367.8|20.76|257.4
1523,7,0.6047,12.7,4509.0,0.0028,0.9992989999999999,ASPM CDK5RAP2 HMMR KIFC1 NDE1 PFDN1 TUBB4B,microtubule cytoskeleton organization|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|organelle localization|spindle localization,3.223e-07|3.384e-07|4.559e-07|4.891e-07|7.352e-07,0.005085|0.002669|0.002397|0.001929|0.002319,25.99|57.97|53.74|23.88|160.5
1524,4,0.6211,3.727,3339.0,0.001112,0.9929309999999999,LALBA MSI1 SPATA33 ZNF641,lactose biosynthetic process|lactose metabolic process|disaccharide biosynthetic process|disaccharide metabolic process|oligosaccharide biosynthetic process,0.0007766|0.0007766|0.001165|0.002328|0.006007,1|1|1|1|1,1716|1716|1030|468.1|171.6
1525,5,0.62,6.2,4308.0,0.001434,0.996692,DBH ENTR1 LAMC3 MYMK SARDH,amine catabolic process|cellular biogenic amine catabolic process|cellular biogenic amine metabolic process|cellular amine metabolic process|amine metabolic process,2.636e-05|2.636e-05|0.0002357|0.0002404|0.0002646,0.4158|0.2079|1|0.9481|0.8347,257.4|257.4|83.21|82.38|78.46
1526,4,0.6154,3.6919999999999997,3300.0,0.001115,0.9929309999999999,ABCA3 CUL4A LAMP1 SMIM18,positive regulation of protein homooligomerization|regulation of protein homooligomerization|positive regulation of protein oligomerization|drug export|positive regulation of protein-containing complex assembly,0.0005825|0.0007766|0.0007766|0.0007766|0.0008731,1|1|1|1|1,2574|1716|1716|1716|41.36
1527,4,0.722,4.332,3337.0,0.0012929999999999999,0.9929309999999999,LAMP3 SCN7A STYXL1 TMEM222,negative regulation of stress granule assembly|regulation of stress granule assembly|negative regulation of hydrolase activity|response to interferon-alpha|neuronal action potential,0.0003883|0.001165|0.002861|0.004846|0.00562,1|1|1|1|1,5149|1030|22.63|214.5|183.9
1528,4,0.6001,3.6010000000000004,2958.0,0.001213,0.9929309999999999,ASPM CKAP2L KIFC1 LAP3,spindle organization|cell division|microtubule cytoskeleton organization|organelle localization|microtubule-based process,0.0007149|0.003335|0.004389|0.005179|0.008684,1|1|1|1|1,45.77|20.93|18.19|16.72|12.82
1529,4,0.6489,3.8930000000000002,3028.0,0.001281,0.9929309999999999,LAX1 ST7L TFAP2B WFDC12,cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|urea homeostasis|creatinine homeostasis,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
1530,4,0.6013,3.608,3373.0,0.001066,0.9929309999999999,LCA5L OPTN VN1R1 ZNF548,negative regulation of receptor recycling|parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|positive regulation of xenophagy|regulation of xenophagy|positive regulation of mitophagy in response to mitochondrial depolarization,0.0009706|0.0009706|0.001553|0.001553|0.001747,1|1|1|1|1,1287|1287|735.5|735.5|643.6
1531,11,0.6046,33.25,8224.0,0.004016,0.999969,CD1B CD1E FCRL2 FCRL3 FMO2 ITLN1 LCE4A OR10J5 OR6N1 OR6P1 SLAMF7,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",7.701e-06|1.319e-05|1.319e-05|4.386e-05|0.0001376,0.1215|0.104|0.06936|0.173|0.434,633.7|452.6|452.6|226.3|121.9
1532,5,0.6049,6.0489999999999995,3978.0,0.001515,0.996692,ABCA2 FAM69B LCN12 LCN6 LHX3,negative regulation of cholesterol esterification|medial motor column neuron differentiation|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
1533,7,0.6184,12.99,5598.0,0.002309,0.9992989999999999,LCN15 LCN6 LCN8 LCNL1 OR2AG2 PHPT1 STPG3,negative regulation of ATP citrate synthase activity|regulation of ATP citrate synthase activity|peptidyl-histidine dephosphorylation|negative regulation of T cell receptor signaling pathway|negative regulation of lyase activity,0.0006794|0.0006794|0.0006794|0.008127|0.008802,1|1|1|1|1,2942|2942|2942|127.9|117.7
1534,4,0.6099,3.659,2691.0,0.001354,0.9929309999999999,E2F3 LCORL SKP2 TCF19,G1 phase|mitotic G1 phase|mitotic interphase|interphase|G1/S transition of mitotic cell cycle,7.146e-06|7.146e-06|9.117e-05|9.117e-05|0.0002245,0.1127|0.05636|0.4793|0.3595|0.7081,490.4|490.4|130.3|130.3|82.38
1535,4,0.6149,3.69,3611.0,0.001019,0.9929309999999999,BDKRB2 CD2 LCP2 SUMF1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|positive regulation of myeloid dendritic cell activation|membrane raft polarization|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
1536,5,0.6374,6.374,3408.0,0.0018620000000000002,0.996692,ECHS1 LDHB MCAT MECR OXSM,monocarboxylic acid metabolic process|fatty acid beta-oxidation|carboxylic acid metabolic process|oxoacid metabolic process|organic acid metabolic process,5.851e-08|5.158e-07|6.196e-07|7.518e-07|9.055e-07,0.000923|0.004068|0.003258|0.002965|0.002857,33.39|174.5|20.73|19.93|19.2
1537,4,0.6326,3.7960000000000003,3334.0,0.001134,0.9929309999999999,LEAP2 MARK4 RFX2 TMX4,positive regulation of protein localization to centrosome|cilium assembly|regulation of protein localization to centrosome|cilium organization|plasma membrane bounded cell projection assembly,0.001553|0.001987|0.002134|0.002243|0.003036,1|1|1|1|1,735.5|27.24|514.9|25.62|21.96
1538,5,0.6094,6.093999999999999,3277.0,0.0018510000000000002,0.996692,KRAS MAP2K5 MAP3K2 MAPK7 RAF1,MAPK cascade|negative regulation of extrinsic apoptotic signaling pathway|cellular response to laminar fluid shear stress|positive regulation of protein kinase activity|positive regulation of protein metabolic process,3.201e-09|1.391e-06|2.119e-06|2.253e-06|2.344e-06,5.05e-05|0.01097|0.01114|0.008885|0.007394,50.35|117.7|1030|30.85|13.39
1539,11,0.6066,33.36,8938.0,0.00371,0.999969,CCL2 CRYBA1 GAS2L2 LGALS9 LGALS9B LYRM9 PIPOX SEBOX SPAG5 TIAF1 UNC119,"negative regulation of CD4-positive, alpha-beta T cell proliferation|regulation of CD4-positive, alpha-beta T cell proliferation|negative regulation of alpha-beta T cell proliferation|negative regulation of CD4-positive, alpha-beta T cell activation|regulation of alpha-beta T cell proliferation",1.421e-05|2.349e-05|2.349e-05|0.000144|0.0001616,0.2242|0.1853|0.1235|0.5678|0.5098,416.1|312|312|117|110.1
1540,8,0.6192,17.34,5136.0,0.0033539999999999998,0.9996790000000001,BRAF DUSP4 ELAVL1 MAP2K1 MAP2K2 MAPK1 PEA15 SOX10,regulation of Golgi inheritance|activation of MAPKK activity|regulation of MAPK cascade|regulation of MAP kinase activity|regulation of Golgi organization,1.344e-09|4.508e-09|3.978e-08|4.296e-08|4.367e-08,2.12e-05|3.556e-05|0.0002092|0.0001694|0.0001378,1931|183.9|22.26|41.66|454.3
1541,11,0.6063,33.35,8992.0,0.003686,0.999969,CALHM3 IFIT1 IFIT1B IFIT2 IFIT5 LHPP LIPA LIPJ NUTM2A SFTPA2 SORCS1,cellular response to type I interferon|response to type I interferon|defense response to symbiont|defense response to virus|type I interferon signaling pathway,4.694e-08|6.469e-08|3.658e-06|3.658e-06|6.341e-06,0.0007404|0.0005102|0.01923|0.01443|0.02,108.5|99.85|35.33|35.33|82.6
1542,6,0.6433,9.649,4055.0,0.002367,0.998474,CIP2A FEN1 LIG1 LIG3 NBN XRCC1,"DNA ligation involved in DNA repair|DNA ligation|DNA recombination|base-excision repair, gap-filling|base-excision repair",3.074e-12|1.271e-11|4.984e-11|7.629e-10|5.156e-09,4.85e-08|1.002e-07|2.621e-07|3.009e-06|1.627e-05,1471|936.1|68.96|294.2|177.5
1543,13,0.6238,48.65,10490.0,0.004605,0.999993,GPR32 KIR2DL1 KIR2DL3 LAIR1 LAIR2 LILRA1 LILRA4 LILRB1 LILRB2 LILRB4 LILRB5 NLRP4 NLRP9,immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of immune response|Fc receptor mediated inhibitory signaling pathway|regulation of immune system process,6.574e-11|1.328e-10|2.09e-10|8.72e-09|1.113e-08,1.037e-06|1.048e-06|1.099e-06|3.439e-05|3.511e-05,735.5|588.4|13.03|1103|8.648
1544,4,0.694,4.164,3480.0,0.001192,0.9929309999999999,FAM76A LIN28A LRP3 PRR16,positive regulation of translation|positive regulation of cellular amide metabolic process|positive regulation of gene expression|RNA 3' uridylation|miRNA catabolic process,0.000265|0.0003972|0.0005449|0.001165|0.001553,1|1|1|1|1,75.72|61.66|14.41|1030|735.5
1545,4,0.6155,3.693,3024.0,0.001216,0.9929309999999999,C9orf72 IFNK LINGO2 MOB3B,negative regulation of GTP binding|late endosome to lysosome transport|regulation of GTP binding|stress granule assembly|positive regulation of peptidyl-serine phosphorylation of STAT protein,0.0007766|0.0009706|0.003104|0.004072|0.004072,1|1|1|1|1,1716|1287|343.2|257.4|257.4
1546,11,0.5751,31.63,7948.0,0.003953,0.999969,FTSJ3 INTS2 LUC7L3 NUP85 PSMC5 PSMD12 RPL38 SAP30BP SRP68 TSEN54 UTP18,ncRNA processing|RNA processing|ncRNA metabolic process|gene expression|anaphase,1.744e-06|3.142e-06|4.168e-06|3.43e-05|7.242e-05,0.0275|0.02478|0.02191|0.1352|0.2285,21.67|12.17|18.11|5.995|35.78
1547,4,0.6067,3.64,3111.0,0.001166,0.9929309999999999,H2AFY2 LIPG RPL38 UTP18,triglyceride metabolic process|acylglycerol metabolic process|neutral lipid metabolic process|90S preribosome assembly|positive regulation of high-density lipoprotein particle clearance,8.892e-05|0.0001593|0.0001623|0.0003883|0.0005825,1|1|0.8533|1|1,132|98.07|97.15|5149|2574
1548,11,0.6081,33.45,8913.0,0.003729,0.999969,CALHM3 IFIT1 IFIT1B IFIT2 IFIT5 LIPJ LIPN NUTM2A SFTPA1 SFTPA2 SORCS1,cellular response to type I interferon|response to type I interferon|defense response to symbiont|defense response to virus|type I interferon signaling pathway,4.694e-08|6.469e-08|3.658e-06|3.658e-06|6.341e-06,0.0007404|0.0005102|0.01923|0.01443|0.02,108.5|99.85|35.33|35.33|82.6
1549,4,0.6139,3.6839999999999997,3051.0,0.0012029999999999999,0.9929309999999999,CDC42EP1 DAD1 HCFC1R1 LITAF,positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|negative regulation of NIK/NF-kappaB signaling|protein N-linked glycosylation via asparagine|peptidyl-asparagine modification,0.002716|0.00291|0.005233|0.006007|0.0062,1|1|1|1|1,396.1|367.8|198|171.6|166.1
1550,17,0.6061,82.43,12870.0,0.0063479999999999995,1.0,CIART CTSK ECM1 FCRL3 FLG2 GBA HIST2H2AB LCE3E LCE5A LIX1L PGLYRP3 S100A12 S100A2 S100A4 S100A6 S100A9 SLAMF7,antimicrobial humoral immune response mediated by antimicrobial peptide|autophagy|process utilizing autophagic mechanism|cell killing|skin development,7.052e-05|7.919e-05|7.919e-05|0.0001097|0.0001862,1|0.6246|0.4164|0.4327|0.5876,37.49|16.83|16.83|32.18|13.44
1551,4,0.6348,3.8089999999999997,3402.0,0.001116,0.9929309999999999,DNAH14 ENTPD5 LMBRD2 TMC5,nucleoside diphosphate catabolic process|adrenergic receptor signaling pathway|positive regulation of glycolytic process|'de novo' posttranslational protein folding|positive regulation of ATP metabolic process,0.002522|0.004653|0.004846|0.007745|0.007938,1|1|1|1|1,429.1|223.9|214.5|132|128.7
1552,4,0.6354,3.812,3372.0,0.001127,0.9929309999999999,ANO7 DECR2 LIN28A LMF1,calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|RNA 3' uridylation|calcium activated phosphatidylcholine scrambling|calcium activated phospholipid scrambling,0.0009706|0.0009706|0.001165|0.001165|0.001359,1|1|1|1|1,1287|1287|1030|1030|858.1
1553,4,0.6043,3.6260000000000003,3218.0,0.001123,0.9929309999999999,LMF2 RFPL3 SDF4 SLC5A1,zymogen granule exocytosis|alpha-glucoside transport|galactose transmembrane transport|fucose transmembrane transport|pentose transmembrane transport,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
1554,7,0.6034,12.67,4600.0,0.002739,0.9992989999999999,CNEP1R1 CTDNEP1 LMNA LMNB1 NDC1 SMPD4 TMPO,nuclear envelope organization|nucleus organization|endomembrane system organization|mitotic nuclear division|nuclear division,1.028e-08|9.043e-08|1.552e-07|3.795e-07|2.57e-06,0.0001622|0.0007132|0.0008162|0.001496|0.008107,141.8|81.16|30.14|56.31|34.61
1555,6,0.6312,9.468,4858.0,0.0019399999999999999,0.998474,AK4 ETFBKMT KLHL42 LMNTD1 TMTC1 TSPAN11,negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|regulation of generation of precursor metabolites and energy|ADP biosynthetic process,0.0005824|0.0005824|0.0005824|0.0009141|0.001746,1|1|1|1|1,3432|3432|3432|42.64|686.5
1556,4,0.6204,3.7230000000000003,3558.0,0.0010429999999999999,0.9929309999999999,CALHM2 DES LMOD1 NT5C1A,muscle contraction|muscle system process|pointed-end actin filament capping|purine nucleoside monophosphate catabolic process|adenosine metabolic process,0.0008321|0.001171|0.001553|0.001553|0.001941,1|1|1|1|1,42.38|35.63|735.5|735.5|572.1
1557,4,0.6529,3.917,3627.0,0.001076,0.9929309999999999,AMMECR1L GCKR LMOD2 TTC31,negative regulation of glucokinase activity|negative regulation of hexokinase activity|pointed-end actin filament capping|response to fructose|regulation of glucokinase activity,0.001165|0.001165|0.001553|0.001941|0.002134,1|1|1|1|1,1030|1030|735.5|572.1|514.9
1558,4,0.6507,3.904,3353.0,0.00116,0.9929309999999999,DMPK LMTK3 PGK2 TEAD2,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction|regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction|regulation of phosphatase activity|phosphorylation|regulation of dephosphorylation,0.0003883|0.0003883|0.0004655|0.0004732|0.0006596,1|1|1|1|1,5149|5149|56.89|15.11|47.67
1559,4,0.6056,3.634,2986.0,0.001212,0.9929309999999999,LNX1 PDGFRA SCFD2 TWIST2,platelet-derived growth factor receptor-alpha signaling pathway|metanephric glomerular capillary formation|metanephric glomerulus vasculature morphogenesis|metanephric glomerulus morphogenesis|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,0.0003883|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|1716|1716|1716|1716
1560,19,0.583,99.69,14350.0,0.0068790000000000006,1.0,CTSK GBA HRNR LCE1A LCE1B LCE1E LCE2A LCE3A LCE3E LCE5A PRR9 S100A12 S100A2 S100A4 S100A5 S100A8 S100A9 SPRR1A SPRR2G,keratinization|skin development|keratinocyte differentiation|epidermal cell differentiation|epidermis development,2.697e-15|7.135e-15|1.405e-14|6.945e-14|1.024e-12,4.254e-11|5.627e-11|7.389e-11|2.739e-10|3.232e-09,47.96|31.13|40.45|34.3|25.99
1561,4,0.6234,3.741,3492.0,0.001068,0.9929309999999999,LOXL1 MESP2 SCAMP2 THAP10,protein deamination|peptidyl-lysine oxidation|somite rostral/caudal axis specification|protein oxidation|embryonic axis specification,0.0003883|0.001165|0.002328|0.002522|0.007745,1|1|1|1|1,5149|1030|468.1|429.1|132
1562,5,0.6112,6.112,4345.0,0.001402,0.996692,GHRH HCK LPIN3 NECAB3 TRIM54,"peptide secretion|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|secretion by cell|respiratory burst after phagocytosis",0.0003609|0.0004854|0.000728|0.0009144|0.0009706,1|1|1|1|1,66.98|4119|2060|13.03|1373
1563,5,0.6498,6.497999999999999,3787.0,0.0017079999999999999,0.996692,DOCK7 LRCH1 MOB1A STK4 TAOK2,hippo signaling|intracellular signal transduction|positive regulation of phosphorylation|positive regulation of phosphorus metabolic process|positive regulation of phosphate metabolic process,6.151e-08|1.482e-05|5.445e-05|7.445e-05|7.445e-05,0.0009703|0.1169|0.2863|0.2936|0.2349,367.8|10.9|15.04|13.88|13.88
1564,21,0.6047,127.0,16500.0,0.00762,1.0,ARPC1B C7orf43 C7orf61 CLDN15 CYP3A43 CYP3A5 CYP3A7 FBXO24 LRCH4 MOGAT3 MUC12 PILRA PILRB PON3 SLC26A4 SLC26A5 WNT2 ZKSCAN1 ZNF394 ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|oxalate transport|sulfate transmembrane transport,1.188e-06|3.206e-05|3.928e-05|5.868e-05|0.0001514,0.01875|0.2529|0.2065|0.2314|0.4776,162.6|294.2|46.81|205.9|121.1
1565,14,0.6162,56.07,10290.0,0.005403,0.9999969999999999,CNN1 P2RY11 ZNF433 ZNF441 ZNF442 ZNF443 ZNF490 ZNF564 ZNF625 ZNF627 ZNF69 ZNF700 ZNF709 ZNF878,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.121e-09|3.388e-08|3.4e-08|3.457e-08|8.191e-08,1.768e-05|0.0002672|0.0001788|0.0001363|0.0002584,6.826|5.096|5.095|5.087|4.723
1566,6,0.6061,9.092,4782.0,0.001893,0.998474,LIPA LIPJ LIPK LIPM LRIT1 NUTM2B,lipid catabolic process|lipid metabolic process|cornification|organic substance catabolic process|catabolic process,7.179e-07|0.0001699|0.0004566|0.0006994|0.001334,0.01132|1|1|1|1,45.16|11.24|60.75|7.797|6.588
1567,4,0.6764,4.058,3077.0,0.001314,0.9929309999999999,FZD5 LGR4 LRP6 WLS,anterior/posterior axis specification|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|canonical Wnt signaling pathway,7.598e-08|8.481e-08|8.481e-08|1.754e-07|2.902e-07,0.001198|0.0006689|0.0004459|0.0006915|0.0009155,291.4|59.01|59.01|49.15|183.9
1568,9,0.619,22.28,6069.0,0.0036479999999999998,0.9998530000000001,EIF2S1 ERH LRR1 POLE2 PSMA3 PSMA6 PSMC6 RPS29 SNAPC1,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|DNA-dependent DNA replication|regulation of cellular amino acid metabolic process|S phase,6.835e-07|8.078e-07|1.004e-06|2.847e-06|2.847e-06,0.01078|0.006371|0.005279|0.01123|0.008983,9.679|9.445|47.18|105.6|105.6
1569,12,0.6039,39.86,9483.0,0.004175,0.999986,CRISP1 CRISP2 FBXO9 GSTA1 GSTA3 GSTA4 IL17A IL17F KLHL31 LRRC1 MLIP TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,3.445e-07|3.445e-07|4.657e-06|6.518e-06|7.401e-06,0.005434|0.002717|0.02449|0.0257|0.02335,234|234|858.1|686.5|79.21
1570,6,0.6224,9.335,4691.0,0.0019809999999999997,0.998474,ADCY8 GSDMC KCNQ3 LRRC2 WISP1 ZNF250,glucose mediated signaling pathway|sugar mediated signaling pathway|hexose mediated signaling|glucose homeostasis|carbohydrate homeostasis,0.001165|0.001165|0.001165|0.001252|0.001265,1|1|1|1|1,1144|1144|1144|36.32|36.13
1571,4,0.6004,3.603,3371.0,0.001065,0.9929309999999999,CALHM3 CYP17A1 LRRC20 SH2D4B,androgen biosynthetic process|glucocorticoid biosynthetic process|progesterone metabolic process|glucocorticoid metabolic process|ATP transport,0.002134|0.002328|0.00291|0.003104|0.003491,1|1|1|1|1,514.9|468.1|367.8|343.2|302.9
1572,5,0.6559,6.559,4037.0,0.0016179999999999999,0.996692,IGF1R LRRC28 LYSMD4 PGPEP1L TTC23,inactivation of MAPKK activity|dendritic spine maintenance|insulin-like growth factor receptor signaling pathway|peptidyl-tyrosine autophosphorylation|transcytosis,0.000728|0.002667|0.003394|0.00412|0.005329,1|1|1|1|1,2060|411.9|316.8|257.4|196.1
1573,4,0.6247,3.748,3206.0,0.001165,0.9929309999999999,LRRC29 MAB21L3 TGFB2 VEGFC,positive regulation of cell division|platelet degranulation|positive regulation of protein secretion|morphogenesis of embryonic epithelium|positive regulation of epithelial cell migration,0.0001101|0.0002352|0.000265|0.0002966|0.0003214,1|1|1|1|1,118.4|80.45|75.72|71.51|68.65
1574,24,0.6043,166.8,18320.0,0.009,1.0,AIFM3 APOBEC3A APOBEC3D APOBEC3G APOL1 CRYBA4 DGCR6 DGCR6L GSTT2B HIC2 KLHL22 MPPE1 RFPL2 RFPL3 RIMBP3 SDF2L1 SEC14L6 SEPT5 SLC5A1 SLC7A4 USP18 VPREB1 YPEL1 ZNF74,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,3.933e-07|6.247e-07|6.247e-07|6.247e-07|6.247e-07,0.006203|0.004927|0.003285|0.002463|0.001971,257.4|214.5|214.5|214.5|214.5
1575,9,0.6159,22.17,6993.0,0.003153,0.9998530000000001,ANKRD30A CREM MTRNR2L7 PRPF18 ZNF248 ZNF25 ZNF33A ZNF33B ZNF37A,"regulation of transcription by RNA polymerase II|regulation of gene expression|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",0.0002356|0.0009431|0.001199|0.001201|0.001211,1|1|1|1|1,5.309|3.288|3.964|3.962|3.957
1576,4,0.636,3.8160000000000003,2921.0,0.001301,0.9929309999999999,ATE1 ISL1 LRRC41 TFAP2B,negative regulation of neuron apoptotic process|cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|regulation of insulin secretion,0.0002966|0.0003883|0.0003883|0.0003883|0.0005069,1|1|1|1|1,71.51|5149|5149|5149|54.48
1577,5,0.6355,6.355,3846.0,0.001645,0.996692,ANAPC11 DCXR LRRC45 PYCR1 SLC25A10,glucose metabolic process|hexose metabolic process|monosaccharide metabolic process|D-xylose metabolic process|oxaloacetate(2-) transmembrane transport,0.0003163|0.0005758|0.0007628|0.0009706|0.001213,1|1|1|1|1,71.63|52.81|45.77|1373|1030
1578,4,0.6336,3.802,3361.0,0.001127,0.9929309999999999,LAMP3 LRRC58 SCN7A TMEM222,response to interferon-alpha|neuronal action potential|membrane depolarization during action potential|sodium ion homeostasis|negative regulation of proteasomal protein catabolic process,0.004846|0.00562|0.006007|0.007166|0.009482,1|1|1|1|1,214.5|183.9|171.6|143|107.3
1579,4,0.6289,3.773,3163.0,0.001188,0.9929309999999999,HTR2A KCNRG LRRC63 SPERT,negative regulation of potassium ion transport|regulation of potassium ion transport|phospholipase C-activating serotonin receptor signaling pathway|positive regulation of phosphatidylinositol biosynthetic process|regulation of phosphatidylinositol biosynthetic process,1.679e-05|0.0002071|0.0007766|0.0007766|0.001165,0.2649|1|1|1|1,312|85.81|1716|1716|1030
1580,9,0.6195,22.3,7320.0,0.00303,0.9998530000000001,C1orf123 CLCA4 FAM69A GBP5 GBP6 IFI44 IFI44L LRRC8C TMEM56,interleukin-18 production|response to other organism|response to external biotic stimulus|response to biotic stimulus|cellular response to interferon-gamma,0.0007765|0.001262|0.001269|0.001391|0.001627,1|1|1|1|1,2574|7.262|7.252|7.077|32.59
1581,4,0.6794,4.0760000000000005,3223.0,0.00126,0.9929309999999999,CNRIP1 LRRTM4 REG3G TEX37,cell wall disruption in other organism|negative regulation of keratinocyte differentiation|cytolysis by host of symbiont cells|cytolysis in other organism involved in symbiotic interaction|negative regulation of epidermis development,0.0009706|0.001553|0.002522|0.002522|0.002716,1|1|1|1|1,1287|735.5|429.1|429.1|396.1
1582,9,0.6061,21.82,6278.0,0.003453,0.9998530000000001,LARP7 LSM2 LSM3 LSM5 LSM6 LSM7 LSM8 TMCO6 ZNF511,"exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|RNA splicing|mRNA processing",2.034e-12|2.665e-12|3.605e-11|4.373e-11|1.445e-10,3.208e-08|2.102e-08|1.895e-07|1.725e-07|4.56e-07,346.7|326.9|187.6|39.36|33.1
1583,4,0.6002,3.6010000000000004,3499.0,0.001026,0.9929309999999999,CPLX1 KTN1 LSR TTPA,protein localization to cell junction|macromolecule localization|tricellular tight junction assembly|protein localization to tricellular tight junction|exocytic insertion of neurotransmitter receptor to postsynaptic membrane,0.0001101|0.0002358|0.0003883|0.0005825|0.0009706,1|1|1|1|1,118.4|8.076|5149|2574|1287
1584,4,0.6246,3.747,3177.0,0.001175,0.9929309999999999,FPR2 ITGA7 LTA ZNF615,positive regulation of chronic inflammatory response to antigenic stimulus|positive regulation of chronic inflammatory response|positive regulation of 1-phosphatidylinositol-3-kinase activity|regulation of 1-phosphatidylinositol-3-kinase activity|regulation of chronic inflammatory response to antigenic stimulus,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
1585,4,0.6038,3.623,3342.0,0.00108,0.9929309999999999,LUC7L RGS11 TPGS1 ZSCAN22,protein polyglutamylation|sperm axoneme assembly|peptidyl-glutamic acid modification|mRNA splice site selection|spliceosomal complex assembly,0.002716|0.004459|0.0062|0.006393|0.01122,1|1|1|1|1,396.1|234|166.1|160.9|90.33
1586,12,0.6098,40.25,9374.0,0.004264,0.999986,CLEC12A CLEC2B CLEC4C CLEC4D CLEC6A KLRC1 PRH2 PZP TAS2R13 TAS2R20 TAS2R7 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|regulation of innate immune response,5.956e-09|9.694e-09|1.061e-08|6.638e-08|2.437e-05,9.394e-05|7.646e-05|5.581e-05|0.0002618|0.07688,190.7|167.4|163.5|101|22
1587,16,0.6102,73.22,12140.0,0.00598,0.999999,FOXH1 GLI4 LY6D LY6K LYPD2 MAPK15 MROH6 NAPRT PSCA RHPN1 SLURP2 TSNARE1 ZNF16 ZNF250 ZNF696 ZNF707,pyridine nucleotide salvage|positive regulation of metaphase/anaphase transition of meiotic cell cycle|positive regulation of metaphase/anaphase transition of meiosis I|regulation of metaphase/anaphase transition of meiosis I|positive regulation of meiotic chromosome separation,0.001552|0.001552|0.001552|0.001552|0.001552,1|1|1|1|1,1287|1287|1287|1287|1287
1588,4,0.6452,3.8710000000000004,3026.0,0.001274,0.9929309999999999,HLA-F LY6G5B TRIM26 ZKSCAN3,interferon-gamma-mediated signaling pathway|cellular response to interferon-gamma|negative regulation of natural killer cell degranulation|response to interferon-gamma|negative regulation of natural killer cell cytokine production,7.603e-05|0.0003561|0.0003883|0.0004655|0.0005825,1|1|1|1|1,143|65.17|5149|56.89|2574
1589,6,0.6013,9.02,4543.0,0.0019760000000000003,0.998474,C6orf48 LY6G5C MICB MSH5 TAP2 TNXB,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent",1.206e-05|1.481e-05|2.663e-05|0.0003594|0.0005824,0.1903|0.1168|0.14|1|1,403.8|361.3|264|68.65|3432
1590,4,0.6438,3.863,3311.0,0.0011619999999999998,0.9929309999999999,LYAR NOX4 PRSS12 SLC36A4,proline import across plasma membrane|L-tryptophan transmembrane transport|L-proline transmembrane transport|L-proline import across plasma membrane|tryptophan transport,0.0005825|0.0005825|0.0005825|0.0005825|0.001165,1|1|1|1|1,2574|2574|2574|2574|1030
1591,8,0.6248,17.5,6299.0,0.002763,0.9996790000000001,CFC1 FAHD2A IL1F10 LYG1 LYG2 MGAT4A MRPL30 TUBA3D,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,7.913e-07|1.319e-06|1.319e-06|3.69e-06|3.69e-06,0.01248|0.0104|0.006933|0.01455|0.01164,2574|1716|1716|858.1|858.1
1592,11,0.6104,33.57,7402.0,0.004502,0.999969,CMAS GCLC GNE GSS NAMPT NANS PPCDC PPCS RFK SLC35A1 TPK1,small molecule metabolic process|nucleobase-containing small molecule metabolic process|cellular nitrogen compound metabolic process|cellular nitrogen compound biosynthetic process|organic substance biosynthetic process,9.727e-11|1.065e-07|1.453e-07|1.595e-07|6.898e-07,1.534e-06|0.0008401|0.0007641|0.0006288|0.002176,11.54|21.77|5.495|9.51|6.009
1593,4,0.6091,3.655,3184.0,0.001143,0.9929309999999999,CCDC138 DND1 FAM241B LYPD6,3'-UTR-mediated mRNA destabilization|negative regulation of gene silencing by miRNA|negative regulation of posttranscriptional gene silencing|negative regulation of gene silencing by RNA|negative regulation of gene silencing,0.003685|0.003878|0.004072|0.004072|0.00678,1|1|1|1|1,286|271|257.4|257.4|151.4
1594,4,0.6286,3.772,3500.0,0.001074,0.9929309999999999,ADAMDEC1 AZGP1 KLHL2 LYPLA1,"antigen processing and presentation of endogenous peptide antigen via MHC class Ib|negative regulation of Golgi to plasma membrane protein transport|antigen processing and presentation of peptide antigen via MHC class Ib|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway",0.001359|0.001359|0.001553|0.001747|0.001747,1|1|1|1|1,858.1|858.1|735.5|643.6|643.6
1595,4,0.6348,3.8089999999999997,3184.0,0.001192,0.9929309999999999,LYRM2 TIFA TMPRSS11A ZNF397,cytoplasmic pattern recognition receptor signaling pathway|I-kappaB kinase/NF-kappaB signaling|pattern recognition receptor signaling pathway|protein homooligomerization|positive regulation of I-kappaB kinase/NF-kappaB signaling,0.007938|0.01372|0.02463|0.03469|0.03563,1|1|1|1|1,128.7|73.55|40.54|28.6|27.83
1596,18,0.6119,93.62,13790.0,0.0067280000000000005,1.0,CLK2 CTSK FLG2 GBA HIST2H2AB LCE3E LCE5A LYSMD1 PGLYRP3 S100A12 S100A2 S100A3 S100A4 S100A5 S100A6 S100A7A S100A8 S100A9,neutrophil aggregation|defense response to fungus|antimicrobial humoral response|sequestering of zinc ion|response to fungus,3.838e-06|6.92e-06|7.692e-06|9.585e-06|1.549e-05,0.06054|0.05458|0.04045|0.0378|0.04886,1211|84.52|31.06|605.7|63.76
1597,4,0.6473,3.884,3194.0,0.0012109999999999998,0.9929309999999999,ALK MAB21L1 MYT1 PHOX2A,locus ceruleus development|trochlear nerve formation|trochlear nerve morphogenesis|response to environmental enrichment|oculomotor nerve formation,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
1598,5,0.6135,6.135,3715.0,0.001644,0.996692,ARL8B MACO1 TMEM131 TMEM131L TMEM39A,negative regulation of immature T cell proliferation in thymus|negative regulation of immature T cell proliferation|negative regulation of autophagosome maturation|neuronal signal transduction|negative regulation of T cell differentiation in thymus,0.001456|0.001698|0.001698|0.00194|0.002183,1|1|1|1|1,823.8|686.5|686.5|588.4|514.9
1599,5,0.6504,6.504,3899.0,0.001661,0.996692,HRASLS5 MACROD1 MAP4K2 NUDT22 TMEM179B,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|N-acylphosphatidylethanolamine metabolic process|purine-containing compound metabolic process|activation of MAPKKK activity,0.0009706|0.001698|0.002425|0.002893|0.003394,1|1|1|1|1,1373|686.5|457.7|23.21|316.8
1600,7,0.6254,13.13,4568.0,0.002858,0.9992989999999999,BUB1B DLGAP5 KNTC1 MAD2L1BP MAPRE1 TRIP13 ZWILCH,regulation of mitotic metaphase/anaphase transition|regulation of metaphase/anaphase transition of cell cycle|regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation|regulation of chromosome separation,5.584e-12|7.045e-12|8.178e-12|1.334e-11|1.334e-11,8.808e-08|5.556e-08|4.3e-08|5.262e-08|4.21e-08,245.2|233.5|226.3|204.3|204.3
1601,5,0.6301,6.301,4218.0,0.0014880000000000002,0.996692,LRRC28 LYSMD4 MAF1 PGPEP1L TTC23,cellular process|negative regulation of transcription by RNA polymerase III|negative regulation of transcription by RNA polymerase I|regulation of transcription by RNA polymerase III|regulation of transcription by RNA polymerase I,0.0009406|0.0009706|0.00194|0.005812|0.008467,1|1|1|1|1,0|1373|588.4|179.1|121.1
1602,5,0.6173,6.172999999999999,3951.0,0.001556,0.996692,BAIAP2 MAFG PYCR1 RAC3 SLC25A10,regulation of epidermal cell differentiation|regulation of epidermis development|positive regulation of cell morphogenesis involved in differentiation|regulation of cell morphogenesis involved in differentiation|regulation of cell differentiation,0.000137|0.0001692|0.0002267|0.0003318|0.0004559,1|1|1|1|1,112.5|101|86.9|71.51|8.712
1603,9,0.6093,21.93,6281.0,0.0034700000000000004,0.9998530000000001,CMAS GNE MAN1A2 MAN2A1 MGAT1 MGAT2 MGAT5 SLC35A1 SLC39A9,carbohydrate metabolic process|viral protein processing|protein glycosylation|macromolecule glycosylation|glycosylation,1.101e-09|5.366e-09|1.035e-07|1.035e-07|1.336e-07,1.736e-05|4.232e-05|0.0005444|0.0004083|0.0004216,27.65|192|38.68|38.68|36.71
1604,4,0.6361,3.8169999999999997,3186.0,0.001193,0.9929309999999999,C16orf89 CORO7 MAP3K6 ZNF500,Golgi to endosome transport|actin filament polymerization|activation of JUN kinase activity|activation of MAPKK activity|actin polymerization or depolymerization,0.003491|0.00678|0.008131|0.01102|0.01179,1|1|1|1|1,302.9|151.4|125.6|91.94|85.81
1605,4,0.6404,3.842,3481.0,0.0011,0.9929309999999999,C8orf82 KIAA0556 MAPK9 RAB2B,protein localization to tricellular tight junction|positive regulation of transcription factor catabolic process|regulation of transcription factor catabolic process|JUN phosphorylation|positive regulation of podosome assembly,0.0005825|0.0007766|0.0007766|0.0009706|0.001941,1|1|1|1|1,2574|1716|1716|1287|572.1
1606,9,0.6301,22.68,6018.0,0.003744,0.9998530000000001,AMOTL2 KIRREL1 LATS2 MARK2 MARK3 NF2 PTPN14 RNF146 SAV1,hippo signaling|regulation of hippo signaling|peptidyl-serine phosphorylation|peptidyl-serine modification|intracellular signal transduction,2.575e-07|3.9e-05|5.749e-05|8.262e-05|0.0002555,0.004061|0.3076|0.3023|0.3258|0.8059,245.2|228.8|37.72|33.33|7.265
1607,15,0.5808,60.99,12270.0,0.004935,0.999999,AVP HSPA12B LZTS3 OXT PLCB4 PRND PROKR2 RSPO4 SIRPA SIRPB1 SIRPG SMOX SPEF1 TGM3 TGM6,maternal aggressive behavior|positive regulation of phagocytosis|aggressive behavior|female mating behavior|hyperosmotic salinity response,4.938e-06|1.453e-05|1.775e-05|2.217e-05|2.217e-05,0.07789|0.1146|0.09331|0.08744|0.06995,915.3|64.36|392.3|343.2|343.2
1608,4,0.6251,3.75,3569.0,0.001047,0.9929309999999999,MAS1 MYADML2 NYAP1 PPP1R27,angiotensin-activated signaling pathway|positive regulation of inositol phosphate biosynthetic process|protein kinase C signaling|regulation of inositol phosphate biosynthetic process|negative regulation of phosphate metabolic process,0.002522|0.00291|0.003104|0.003297|0.00362,1|1|1|1|1,429.1|367.8|343.2|321.8|20.07
1609,15,0.5608,58.88,10640.0,0.00549,0.999999,ACVR2A BAMBI BMPR1A FKBP1A IPO8 LEMD3 LRIG1 LRIG3 MIB1 NEO1 RGMB SMAD1 SMAD6 SMAD7 SMURF2,regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|negative regulation of cellular response to growth factor stimulus,1.334e-17|8.33e-17|2.536e-16|3.97e-15|6.052e-15,2.104e-13|6.57e-13|1.333e-12|1.566e-11|1.909e-11,121.1|174.3|54.7|62.73|98.95
1610,4,0.6217,3.73,3269.0,0.001137,0.9929309999999999,ALLC FRMPD2 GPR3 MBL2,"allantoin catabolic process|allantoin metabolic process|cellular amide catabolic process|complement activation, lectin pathway|regulation of meiotic nuclear division",0.0003883|0.0007766|0.0009706|0.002134|0.0062,1|1|1|1|1,5149|1716|1287|514.9|166.1
1611,4,0.6199,3.72,2981.0,0.001243,0.9929309999999999,CXCL3 MBNL2 NMU UGT2B15,positive regulation of stomach fundus smooth muscle contraction|regulation of stomach fundus smooth muscle contraction|negative regulation of gastric emptying|regulation of gastric emptying|positive regulation of prolactin secretion,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
1612,4,0.6194,3.717,3290.0,0.001126,0.9929309999999999,MCAM NR2F1 PQLC2 RANBP3,vascular wound healing|glomerular filtration|renal filtration|angiogenesis involved in wound healing|renal system process,0.00131|0.002183|0.002329|0.002619|0.01666,1|1|1|1|1,858.1|490.4|457.7|403.8|60.22
1613,4,0.6259,3.755,3364.0,0.001113,0.9929309999999999,DIP2A GPR158 MCCC1 RTN4R,leucine catabolic process|neuronal signal transduction|leucine metabolic process|sulfur compound metabolic process|biotin metabolic process,0.001359|0.001553|0.001747|0.001895|0.001941,1|1|1|1|1,858.1|735.5|643.6|27.91|572.1
1614,6,0.6226,9.339,4636.0,0.0020050000000000003,0.998474,BTN2A1 BTN2A2 HLA-A MCCD1 NEU1 OR2J3,T cell receptor signaling pathway|antigen receptor-mediated signaling pathway|immune response-activating cell surface receptor signaling pathway|immune response-activating signal transduction|immune response-regulating cell surface receptor signaling pathway,2.351e-05|0.0001045|0.0003551|0.0003551|0.0004463,0.3708|0.8242|1|1|1,49.04|29.52|19.44|19.44|17.98
1615,7,0.6222,13.07,4909.0,0.002647,0.9992989999999999,MCM2 MCM3 MCM4 MCM5 MCM6 MCM7 ORC6,pre-replicative complex assembly involved in cell cycle DNA replication|pre-replicative complex assembly involved in nuclear cell cycle DNA replication|DNA replication initiation|double-strand break repair via break-induced replication|pre-replicative complex assembly,1.98e-19|1.98e-19|3.199e-19|1.224e-18|4.718e-18,3.124e-15|1.562e-15|1.682e-15|4.826e-15|1.488e-14,2207|2207|479|1471|316.8
1616,4,0.6436,3.862,3325.0,0.001157,0.9929309999999999,CCDC174 MCRIP1 PPP1R27 SLC25A10,oxaloacetate(2-) transmembrane transport|malate transmembrane transport|malate transport|oxaloacetate transport|thiosulfate transport,0.0009706|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1287|1287|1287|1287|1287
1617,8,0.6032,16.89,4999.0,0.003357,0.9996790000000001,ABL1 BCR GAB2 GRB2 LMO2 MYB PTPN11 SOS1,epidermal growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|ERBB signaling pathway|regulation of leukocyte activation|regulation of hematopoietic progenitor cell differentiation,2.927e-09|7.136e-09|1.061e-08|1.966e-08|2.805e-08,4.616e-05|5.628e-05|5.581e-05|7.753e-05|8.848e-05,205.9|29.76|147.1|25.08|114.4
1618,9,0.6143,22.12,6623.0,0.003319,0.9998530000000001,ARRDC4 CYS1 DNAL4 IER5 ITPKA MDK PTRH1 SALL3 TMEM82,positive regulation of cell morphogenesis involved in differentiation|regulation of cell morphogenesis involved in differentiation|positive regulation of cellular response to heat|glial cell projection elongation|positive regulation of inflammatory response to wounding,0.0005398|0.0007888|0.0008734|0.00131|0.00131,1|1|1|1|1,57.93|47.67|2288|1144|1144
1619,5,0.6319,6.319,3976.0,0.001583,0.996692,CD244 MDP1 OR10Z1 SLC36A1 SPRR4,fructosamine metabolic process|positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport,0.0008735|0.001165|0.001165|0.002037|0.002037,1|1|1|1|1,1716|1144|1144|572.1|572.1
1620,4,0.651,3.906,3326.0,0.00117,0.9929309999999999,C6orf48 MEA1 OARD1 SMIM29,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|purine nucleoside metabolic process|nucleoside metabolic process|glycosyl compound metabolic process,0.0005825|0.001019|0.009148|0.0155|0.01925,1|1|1|1|1,2288|1144|110.7|64.76|52.01
1621,4,0.6286,3.772,3203.0,0.001173,0.9929309999999999,HTR1B MEI4 NR2F1 PPFIBP2,"negative regulation of gamma-aminobutyric acid secretion|cellular response to temperature stimulus|negative regulation of serotonin secretion|regulation of gamma-aminobutyric acid secretion|negative regulation of synaptic transmission, GABAergic",0.0005825|0.001165|0.001165|0.001359|0.001359,1|1|1|1|1,2574|1030|1030|858.1|858.1
1622,5,0.6325,6.325,3685.0,0.001709,0.996692,HDDC2 MEIS2 PBX1 PBX2 PBX3,eye development|visual system development|sensory system development|pattern specification process|sensory organ development,5.048e-07|5.27e-07|5.617e-07|8.954e-07|2.625e-06,0.007963|0.004157|0.002953|0.003531|0.008282,45.02|44.53|43.82|38.95|29.69
1623,13,0.6147,47.94,10440.0,0.004562,0.999993,C18orf32 CHST9 CTIF DSC1 DSG1 DSG3 DSG4 HRH4 MEP1B SERPINB5 SERPINB7 ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,6.782e-07|3.087e-06|9.986e-06|1.693e-05|1.933e-05,0.0107|0.02435|0.05251|0.06677|0.06097,56.08|37.95|28.04|24.47|23.65
1624,13,0.6112,47.67,7512.0,0.006285,0.999993,ADSL AHCY COASY DTYMK GMPS MAT2A MVD MVK PGD PMVK RPIA TFRC YRDC,carbohydrate derivative metabolic process|small molecule metabolic process|nucleobase-containing small molecule metabolic process|organophosphate metabolic process|ribose phosphate metabolic process,2.03e-11|5.068e-11|1.907e-10|3.634e-10|5.917e-10,3.202e-07|3.998e-07|1.003e-06|1.433e-06|1.867e-06,15.75|10.74|24.56|15.88|32.43
1625,6,0.6036,9.054,4856.0,0.0018559999999999998,0.998474,ENPP3 METTL24 OLIG3 TAAR2 TAAR6 VNN2,basophil activation involved in immune response|basophil activation|negative regulation of mast cell proliferation|regulation of mast cell proliferation|spinal cord motor neuron migration,0.0008735|0.001165|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1144|1144|858.1|858.1
1626,4,0.653,3.918,3326.0,0.001174,0.9929309999999999,METTL25 MYF5 PAX7 SEMA4C,muscle structure development|muscle cell differentiation|muscle organ development|positive regulation of skeletal muscle fiber development|regulation of skeletal muscle fiber development,4.438e-05|0.000779|0.0011|0.001941|0.002716,0.7|1|1|1|1,33.58|43.82|36.78|572.1|396.1
1627,6,0.6135,9.202,4843.0,0.0018920000000000002,0.998474,ABCA8 CSH2 LIMD2 METTL2A METTL2B PRR29,tRNA methylation|RNA methylation|tRNA modification|tRNA processing|RNA modification,6.35e-05|0.0002676|0.0002925|0.0006192|0.001017,1|1|1|1|1,167.4|79.83|76.28|52.01|40.38
1628,4,0.6128,3.677,3176.0,0.0011539999999999999,0.9929309999999999,GNAT1 HYAL1 METTL6 ZNF502,cellular response to light stimulus|cellular response to radiation|positive regulation of hyaluranon cable assembly|regulation of hyaluranon cable assembly|positive regulation by host of viral release from host cell,0.0002004|0.0004454|0.0007766|0.0007766|0.001165,1|1|1|1|1,87.27|58.18|1716|1716|1030
1629,4,0.6067,3.64,3367.0,0.001077,0.9929309999999999,COL4A3 LINGO3 MEX3D SH3BP1,mRNA localization resulting in posttranscriptional regulation of gene expression|negative regulation of vascular endothelial cell proliferation|endothelial cell apoptotic process|intracellular mRNA localization|glomerular basement membrane development,0.0005825|0.001165|0.001747|0.001941|0.002328,1|1|1|1|1,2574|1030|643.6|572.1|468.1
1630,4,0.6132,3.679,3559.0,0.00103,0.9929309999999999,HPCAL1 ITGB1BP1 MFAP3L NMUR1,negative regulation of cell adhesion involved in substrate-bound cell migration|negative regulation of protein targeting to membrane|blood vessel endothelial cell proliferation involved in sprouting angiogenesis|integrin activation|negative regulation of fibroblast migration,0.0007766|0.001359|0.001553|0.001941|0.002134,1|1|1|1|1,1716|858.1|735.5|572.1|514.9
1631,4,0.6473,3.884,3296.0,0.001174,0.9929309999999999,ARHGAP31 MFSD1 ROPN1 SCHIP1,positive regulation of hippo signaling|regulation of hippo signaling|sperm capacitation|protein localization to organelle|protein localization to lysosome,0.001165|0.004072|0.005233|0.008433|0.00871,1|1|1|1|1,1030|257.4|198|13.02|117
1632,5,0.6308,6.308,3943.0,0.001593,0.996692,HPCAL4 MGST1 ZBTB8A ZFP69B ZNF684,cellular response to lipid hydroperoxide|response to lipid hydroperoxide|cellular response to hydroperoxide|Leydig cell differentiation|organic heteropentacyclic compound metabolic process,0.0004854|0.0009706|0.002183|0.002667|0.00412,1|1|1|1|1,4119|1373|514.9|411.9|257.4
1633,13,0.609,47.5,8783.0,0.005363000000000001,0.999993,CNIH1 GOSR2 RAB1A RAB1B SAR1A SCFD1 SEC23IP SEC31A SURF4 TM9SF3 TRAPPC12 TRAPPC13 TRAPPC2L,COPII-coated vesicle budding|vesicle budding from membrane|endoplasmic reticulum to Golgi vesicle-mediated transport|Golgi vesicle transport|COPII vesicle coating,7.882e-20|2.092e-18|2.228e-18|1.174e-17|1.676e-17,1.243e-15|1.65e-14|1.172e-14|4.631e-14|5.289e-14,203.7|138.4|80.83|44.01|201.2
1634,4,0.6411,3.847,3390.0,0.001131,0.9929309999999999,CSRP1 MICAL1 MPZL3 SPAG1,sulfur oxidation|cytoskeleton organization|blood coagulation|coagulation|hemostasis,0.0005825|0.0007676|0.001244|0.001261|0.001277,1|1|1|1|1,2574|12.83|34.56|34.33|34.1
1635,4,0.632,3.792,3228.0,0.0011710000000000002,0.9929309999999999,MICAL2 PDLIM7 SPECC1L SPTBN1,cytoskeleton organization|actin cytoskeleton organization|actin filament-based process|sulfur oxidation|organelle organization,1.177e-05|6.534e-05|9.671e-05|0.0005825|0.000909,0.1857|0.5153|0.5085|1|1,17.11|29.48|25.83|2574|5.762
1636,7,0.6736,14.15,4791.0,0.002935,0.9992989999999999,ACACA CHP1 FASN GPAT4 MIGA2 TMEM120B VKORC1L1,acyl-CoA metabolic process|thioester metabolic process|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process|nucleoside bisphosphate metabolic process,6.104e-06|6.104e-06|1.538e-05|1.538e-05|1.538e-05,0.09629|0.04815|0.08086|0.06064|0.04851,79.62|79.62|58.07|58.07|58.07
1637,7,0.6186,12.99,5135.0,0.002516,0.9992989999999999,CNIH4 FOXD4 GJA3 MINDY2 NBEAL1 POGZ TSPYL5,gap junction-mediated intercellular transport|intercellular transport|protein-DNA complex assembly|protein-DNA complex subunit organization|kinetochore assembly,0.002376|0.002715|0.0031|0.004119|0.005086,1|1|1|1|1,490.4|420.3|23.17|20.01|210.2
1638,17,0.6099,82.95,13730.0,0.005991,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 GHRHR HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MINDY4 MTURN NME8 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|lung goblet cell differentiation,1.364e-08|4.784e-08|8.993e-07|3.12e-06|6.393e-06,0.0002152|0.0003773|0.004728|0.0123|0.02017,64.44|49.65|27.04|20.89|807.6
1639,5,0.6016,6.016,4114.0,0.001457,0.996692,CA1 CA2 MIPOL1 SLC26A7 TMEM67,bicarbonate transport|one-carbon metabolic process|organic anion transport|positive regulation of dipeptide transport|positive regulation of oligopeptide transport,9.711e-08|3.85e-05|4.464e-05|0.000728|0.000728,0.001532|0.3037|0.2347|1|1,294.2|211.2|36.34|2060|2060
1640,6,0.6379,9.568999999999999,4910.0,0.0019399999999999999,0.998474,IL1F10 LYG1 LYG2 MGAT4A MITD1 MRPL30,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,4.24e-07|7.066e-07|7.066e-07|1.978e-06|1.978e-06,0.006689|0.005573|0.003716|0.0078|0.00624,3432|2288|2288|1144|1144
1641,4,0.6322,3.793,3269.0,0.0011560000000000001,0.9929309999999999,B4GALNT3 CLDN5 MIXL1 MRPS9,establishment of blood-retinal barrier|positive regulation of mesoderm development|positive regulation of establishment of endothelial barrier|regulation of mesoderm development|positive regulation of endothelial cell development,0.0003883|0.0005825|0.001359|0.001359|0.001359,1|1|1|1|1,5149|2574|858.1|858.1|858.1
1642,4,0.6084,3.65,3184.0,0.001142,0.9929309999999999,C12orf74 MKRN3 RANGRF SNX22,regulation of microtubule nucleation by Ran protein signal transduction|regulation of bundle of His cell action potential|regulation of membrane depolarization during cardiac muscle cell action potential|Ran protein signal transduction|regulation of membrane depolarization during action potential,0.0003883|0.0005825|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|2574|1287|1287|1030
1643,4,0.6424,3.8539999999999996,3342.0,0.001149,0.9929309999999999,MMAA PNLIPRP1 SLURP1 TMEM177,urokinase plasminogen activator signaling pathway|lipid catabolic process|short-chain fatty acid catabolic process|negative regulation of keratinocyte proliferation|neuromuscular process controlling posture,0.000728|0.002135|0.002425|0.003394|0.00412,1|1|1|1|1,2060|27.1|457.7|316.8|257.4
1644,17,0.6038,82.12,12060.0,0.006745999999999999,1.0,C12orf65 CLPP CLPX FASTKD2 GRSF1 GTPBP10 MMADHC MPV17L2 MRM2 MRM3 MRPL1 PDE12 REXO2 RMND1 RPUSD3 SLC30A9 STOML2,positive regulation of mitochondrial translation|ribosome biogenesis|regulation of mitochondrial translation|regulation of mitochondrial gene expression|ribonucleoprotein complex biogenesis,1.878e-09|5.166e-09|8.562e-09|1.446e-08|5.037e-08,2.963e-05|4.075e-05|4.502e-05|5.702e-05|0.0001589,285.1|25.54|186.4|161.5|18.24
1645,8,0.6206,17.38,4994.0,0.0034560000000000003,0.9996790000000001,CEP55 CIT IST1 KIF14 PDCD6IP VPS4A VPS4B VTA1,cytoskeleton-dependent cytokinesis|multivesicular body assembly|multivesicular body organization|cytokinesis|ESCRT III complex disassembly,3.523e-13|5.858e-13|6.802e-13|6.971e-13|9.321e-12,5.558e-09|4.62e-09|3.576e-09|2.749e-09|2.941e-08,160.9|429.1|415.2|143|1030
1646,4,0.65,3.9,3440.0,0.0011300000000000001,0.9929309999999999,C1orf123 CLEC10A MMRN2 SLC16A8,lactate transmembrane transport|lactate transport|negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of cell migration involved in sprouting angiogenesis|cell migration involved in sprouting angiogenesis,0.001165|0.001165|0.002183|0.002329|0.003056,1|1|1|1|1,980.7|980.7|490.4|457.7|343.2
1647,8,0.6096,17.07,4945.0,0.0034289999999999998,0.9996790000000001,CAB39 FRYL MOB2 NF2 PDCD10 RALGAPB STK24 TAOK1,intrinsic apoptotic signaling pathway in response to oxidative stress|cell death in response to oxidative stress|negative regulation of cell migration|negative regulation of cell motility|regulation of protein kinase activity,2.012e-05|3.626e-05|0.0001187|0.0001393|0.00014,0.3174|0.286|0.6242|0.5494|0.4418,321.8|234|28.93|27.39|12.92
1648,4,0.6119,3.6719999999999997,2923.0,0.001251,0.9929309999999999,MGAT2 MOB3C SLC39A9 THTPA,thiamine diphosphate metabolic process|thiamine metabolic process|monoacylglycerol biosynthetic process|thiamine-containing compound metabolic process|diacylglycerol biosynthetic process,0.000728|0.001213|0.00194|0.00194|0.002183,1|1|1|1|1,2060|1030|588.4|588.4|514.9
1649,4,0.6326,3.7960000000000003,3513.0,0.001077,0.9929309999999999,ACADL MOGAT1 RETREG2 WNT10A,"carnitine catabolic process|carnitine metabolic process, CoA-linked|amino-acid betaine catabolic process|long-chain fatty acid catabolic process|diacylglycerol biosynthetic process",0.0003883|0.0007766|0.0007766|0.001165|0.001747,1|1|1|1|1,5149|1716|1716|1030|643.6
1650,5,0.651,6.51,3576.0,0.001812,0.996692,MON1B RAB7A RMC1 WDR81 WDR91,early endosome to late endosome transport|vesicle-mediated transport between endosomal compartments|cytosolic transport|autophagy|process utilizing autophagic mechanism,1.782e-08|2.245e-08|3.82e-06|3.269e-05|3.269e-05,0.0002811|0.000177|0.02008|0.1289|0.1031,537.3|494.3|83.49|40.38|40.38
1651,7,0.6009,12.62,4303.0,0.002914,0.9992989999999999,COP1 FOSL1 HIVEP1 JUN JUNB STK40 TRIB1,regulation of DNA-binding transcription factor activity|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of multi-organism process|regulation of lipopolysaccharide-mediated signaling pathway|placenta blood vessel development,1.306e-05|1.382e-05|3.036e-05|4.608e-05|6.1e-05,0.206|0.109|0.1596|0.1817|0.1925,23.78|396.1|257.4|205.9|177.5
1652,5,0.6534,6.534,3827.0,0.0017,0.996692,ABCF2 DRG1 MPG TRMT2A ZC3H15,cytoplasmic translation|peripheral nervous system myelin maintenance|DNA dealkylation involved in DNA repair|depurination|myelin maintenance,0.0002048|0.002619|0.0032|0.003781|0.004942,1|1|1|1|1,91.53|429.1|343.2|286|214.5
1653,17,0.6009,81.72,10670.0,0.007573999999999999,1.0,ADSS ALAD ALAS1 ATIC DHODH FPGS GART GCLC GSS MTHFD1 NAMPT PFAS PPCDC PPCS RFK SLC20A1 TPK1,organonitrogen compound biosynthetic process|cellular nitrogen compound biosynthetic process|heterocycle biosynthetic process|aromatic compound biosynthetic process|nucleotide biosynthetic process,4.004e-17|2.849e-16|1.127e-14|1.268e-14|3.345e-14,6.316e-13|2.247e-12|5.926e-11|5.001e-11|1.055e-10,13.99|12.26|15.55|15.41|50.59
1654,9,0.6308,22.71,5929.0,0.003804,0.9998530000000001,LUZP1 MPRIP MYH9 MYL12A MYL12B MYL6 PPP1R12A ROCK1 ROCK2,regulation of myosin-light-chain-phosphatase activity|muscle contraction|muscle system process|regulation of angiotensin-activated signaling pathway|positive regulation of connective tissue replacement,6.905e-09|2.94e-08|6.875e-08|1.017e-06|1.695e-06,0.0001089|0.0002319|0.0003615|0.004011|0.005347,980.7|47.09|39.59|2288|1526
1655,9,0.6034,21.72,7182.0,0.003008,0.9998530000000001,DHRS11 EPOP GAS2L2 GSDMB MRM1 PIGS PIGW RDM1 SLFN12,GPI anchor biosynthetic process|GPI anchor metabolic process|glycolipid biosynthetic process|protein lipidation|lipoprotein biosynthetic process,9.446e-05|0.0001002|0.0003919|0.0006082|0.0006659,1|0.79|1|1|1,143|138.7|68.31|54.48|52.01
1656,27,0.6029,211.6,19540.0,0.01068,1.0,ATPAF2 CARS2 COA7 DARS2 DDX28 FOXRED1 GFM2 GTPBP10 GTPBP8 MCAT METTL17 MRM2 MRM3 MRPL58 MRRF MTERF4 MTFMT MTG1 MTG2 MTIF2 MTIF3 NSUN4 NUBPL PTCD1 SSBP1 TFB1M YBEY,ribosome biogenesis|mitochondrial gene expression|ribonucleoprotein complex biogenesis|rRNA methylation|ncRNA metabolic process,1.389e-11|1.6e-11|3.461e-10|7.314e-10|9.467e-10,2.192e-07|1.262e-07|1.82e-06|2.884e-06|2.987e-06,22.15|42.03|15.82|131.3|14.23
1657,6,0.6195,9.293,4282.0,0.002159,0.998474,CALM1 CCT6A EGR3 KRTAP5-2 MRPS17 MSTO1,negative regulation of high voltage-gated calcium channel activity|positive regulation of cyclic-nucleotide phosphodiesterase activity|positive regulation of ryanodine-sensitive calcium-release channel activity|regulation of gamma-delta T cell differentiation|regulation of cell communication by electrical coupling involved in cardiac conduction,0.001746|0.001746|0.002909|0.002909|0.002909,1|1|1|1|1,686.5|686.5|381.4|381.4|381.4
1658,7,0.6343,13.32,5038.0,0.00263,0.9992989999999999,MAK16 MRTO4 PPAN PWP2 RRP1 URB1 WDR18,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,5.069e-15|7.281e-14|4.491e-13|5.823e-13|1.494e-11,7.996e-11|5.743e-10|2.361e-09|2.296e-09|4.713e-08,62.03|44.29|69.31|66.74|41.71
1659,4,0.6247,3.748,3465.0,0.001078,0.9929309999999999,C20orf194 CAMK2A MS4A10 WASF1,peptidyl-threonine autophosphorylation|dendritic transport of mitochondrion|regulation of endocannabinoid signaling pathway|modification of postsynaptic actin cytoskeleton|lamellipodium morphogenesis,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
1660,4,0.6131,3.679,3274.0,0.00112,0.9929309999999999,COL13A1 FAM217B MSANTD4 TMEM14C,regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process|notochord development|heme biosynthetic process,0.0007766|0.0007766|0.0009706|0.003878|0.005426,1|1|1|1|1,1716|1716|1287|271|190.7
1661,4,0.6383,3.83,3123.0,0.001222,0.9929309999999999,MSH3 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|cytosol to endoplasmic reticulum transport|antigen processing and presentation of peptide antigen via MHC class I,7.816e-09|1.056e-08|2.504e-08|7.067e-07|1.205e-06,0.0001233|8.326e-05|0.0001316|0.002787|0.003802,726.9|650.4|475.3|2060|123.6
1662,14,0.607,55.24,10770.0,0.00509,0.9999969999999999,ABCC11 ABCC12 CES1 CES3 CES5A IRX6 MT1A MT1B MT1E MT1F MT1G MT1X MT2A MT4,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,2.729e-21|2.729e-21|5.794e-21|8.231e-21|5.139e-20,4.304e-17|2.152e-17|3.046e-17|3.246e-17|1.621e-16,735.5|735.5|653.8|619.4|470.7
1663,19,0.6001,102.6,14840.0,0.006848000000000001,1.0,ABCC11 ABCC12 CES1 CES2 CES3 CES5A CLEC18A CMTM1 HSD11B2 IRX6 MT1A MT1B MT1F MT1G MT1M MT1X MT2A MT4 TMED6,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,6.831e-20|6.831e-20|1.45e-19|2.059e-19|1.284e-18,1.078e-15|5.388e-16|7.622e-16|8.12e-16|4.051e-15,542|542|481.8|456.4|346.9
1664,4,0.6483,3.89,3146.0,0.001232,0.9929309999999999,EFNA2 GZMM MTFR1L NBL1,determination of dorsal identity|sequestering of BMP in extracellular matrix|determination of dorsal/ventral asymmetry|negative regulation of monocyte chemotaxis|maintenance of protein location in extracellular region,0.0009706|0.0009706|0.001165|0.001359|0.001553,1|1|1|1|1,1287|1287|1030|858.1|735.5
1665,9,0.6001,21.6,6363.0,0.0033740000000000003,0.9998530000000001,ATIC FPGS MTHFD1L MTHFD2 PDXK PFAS PPCDC SHMT2 SLC25A32,folic acid-containing compound metabolic process|pteridine-containing compound metabolic process|folic acid metabolic process|water-soluble vitamin metabolic process|dicarboxylic acid metabolic process,7.145e-16|5.558e-15|1.726e-13|4.55e-13|9.32e-13,1.127e-11|4.383e-11|9.077e-10|1.794e-09|2.94e-09,528.1|361.3|602.2|165.4|146.1
1666,8,0.6003,16.81,5839.0,0.002862,0.9996790000000001,ATIC MTHFD1L MTHFD2 MTHFS PDXK PPCDC SHMT2 SLC25A32,folic acid-containing compound metabolic process|pteridine-containing compound metabolic process|tetrahydrofolate metabolic process|folic acid metabolic process|water-soluble vitamin metabolic process,2.385e-16|1.856e-15|6.081e-14|7.68e-14|1.522e-13,3.762e-12|1.464e-11|3.197e-10|3.029e-10|4.802e-10,594.1|406.5|715.1|677.5|186.1
1667,7,0.6272,13.17,5410.0,0.0024219999999999997,0.9992989999999999,HOXB5 HOXB6 HOXB7 HOXB8 HOXB9 MTMR4 PLEKHM1,embryonic skeletal system morphogenesis|embryonic skeletal system development|anterior/posterior pattern specification|skeletal system morphogenesis|embryonic organ morphogenesis,4.822e-11|1.71e-10|2.273e-09|3.35e-09|1.194e-08,7.606e-07|1.349e-06|1.195e-05|1.321e-05|3.766e-05,156.5|120.6|71.07|65.67|50.73
1668,14,0.6085,55.37,11460.0,0.004797,0.9999969999999999,CELF4 CHST9 CTIF DSG1 DSG3 DSG4 HRH4 KIAA1328 MAPRE2 SERPINB5 SERPINB7 ZBTB7C ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,6.045e-05|0.0001877|0.0004502|0.0006665|0.0007352,0.9535|1|1|1|1,39.05|26.43|19.53|17.04|16.47
1669,4,0.6413,3.8480000000000003,3310.0,0.001158,0.9929309999999999,ARHGEF28 MTUS1 POMK STON1,carbohydrate phosphorylation|regulation of macrophage chemotaxis|regulation of macrophage migration|presynaptic endocytosis|synaptic vesicle endocytosis,0.005426|0.00562|0.008131|0.009867|0.009867,1|1|1|1|1,190.7|183.9|125.6|103|103
1670,6,0.6262,9.392999999999999,4676.0,0.002,0.998474,HRASLS IQCG MUC20 PDCD6 SLC51A TCTEX1D2,regulation of intraciliary retrograde transport|positive regulation of protein monoubiquitination|vascular endothelial growth factor receptor-2 signaling pathway|regulation of protein monoubiquitination|bile acid secretion,0.0008735|0.001746|0.001746|0.002037|0.002037,1|1|1|1|1,1716|686.5|686.5|572.1|572.1
1671,4,0.619,3.714,3307.0,0.001119,0.9929309999999999,ANKDD1A MUC21 PRF1 TRIM36,negative regulation of cell-cell adhesion|negative regulation of cell adhesion|regulation of cell-cell adhesion|regulation of cell adhesion|defense response to tumor cell,1.443e-05|5.028e-05|0.0001808|0.0008147|0.001746,0.2276|0.3966|0.9505|1|1,55.96|36.65|23.73|14.18|686.5
1672,6,0.6637,9.955,4247.0,0.002332,0.998474,BCL10 CARD10 CYLD IKBKB MALT1 MYBL1,regulation of DNA-binding transcription factor activity|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction|pattern recognition receptor signaling pathway,2.897e-06|3.618e-06|4e-06|4.1e-06|4.843e-06,0.04569|0.02854|0.02103|0.01617|0.01528,31.71|89.54|86.53|85.81|81.08
1673,5,0.6039,6.039,3644.0,0.00165,0.996692,ASCL1 DYNC1I2 MYCL NKX2-1 SOX1,forebrain neuron differentiation|forebrain generation of neurons|neuron fate commitment|dorsal/ventral pattern formation|neuron migration,1.512e-07|2.46e-07|3.127e-07|4.994e-07|1.864e-06,0.002384|0.00194|0.001644|0.00197|0.00588,252.2|213.1|196.1|167|106.5
1674,24,0.5704,157.4,18800.0,0.008284,1.0,ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A KCTD11 MFSD6L MYH1 MYH10 MYH13 MYH2 MYH4 MYH8 SHBG SLC16A11 SLC16A13 SPNS3 TMEM256 TNFSF12 TNFSF13 VAMP2 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,1.002e-09|1.002e-09|6.754e-09|1.756e-08|9.085e-08,1.581e-05|7.904e-06|3.551e-05|6.927e-05|0.0002866,381.4|381.4|214.5|163.5|104
1675,16,0.6083,72.99,12590.0,0.005749,0.999999,ABHD14A ABHD14B CCR5 CCR8 GLYCTK GNAT1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 MUSTN1 MYL3 SEMA3G TLR9,hyaluronan metabolic process|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|positive regulation of flagellated sperm motility involved in capacitation,0.0003312|0.001766|0.002222|0.002222|0.003102,1|1|1|1|1,78.01|32.59|28.93|28.93|429.1
1676,4,0.6649,3.989,3249.0,0.0012230000000000001,0.9929309999999999,MYLK OR1L6 SLC34A3 TRAF3IP1,aorta smooth muscle tissue morphogenesis|sodium-dependent phosphate transport|cellular hypotonic response|bleb assembly|cellular phosphate ion homeostasis,0.0007766|0.0007766|0.001747|0.001941|0.001941,1|1|1|1|1,1716|1716|643.6|572.1|572.1
1677,10,0.6016,27.07,7958.0,0.003382,0.999933,CRYBA1 LYRM9 MYO18A PIPOX SEBOX SEZ6 SPAG5 TIAF1 UNC119 VTN,L-lysine catabolic process to acetyl-CoA via L-pipecolate|regulation of receptor-mediated endocytosis|negative regulation of caveolin-mediated endocytosis|positive regulation of opsonization|asymmetric Golgi ribbon formation,0.0009704|0.001214|0.001455|0.001455|0.001455,1|1|1|1|1,2060|38.5|1030|1030|1030
1678,7,0.6237,13.1,5537.0,0.0023539999999999998,0.9992989999999999,DHRS11 GSDMB MRM1 MYO19 NME1 PIGS PIGW,GPI anchor biosynthetic process|GPI anchor metabolic process|glycolipid biosynthetic process|protein lipidation|lipoprotein biosynthetic process,5.523e-05|5.857e-05|0.0002297|0.0003568|0.0003907,0.8712|0.4619|1|1|1,183.9|178.3|87.83|70.05|66.87
1679,21,0.6022,126.5,15890.0,0.007875,1.0,ACVRL1 AQP5 HOXC8 KRT1 KRT5 KRT74 KRT75 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT86 OR10A7 OR10P1 OR2AP1 OR6C2 OR6C3 OR6C4 OR9K2,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,7.939e-20|1.171e-16|7.165e-16|4.14e-15|3.214e-14,1.252e-15|9.232e-13|3.767e-12|1.633e-11|1.014e-10,95.47|47.73|40.25|34.14|28.17
1680,4,0.6529,3.917,3109.0,0.001255,0.9929309999999999,DEXI GOLGA8M MYO1E TYRO3,post-embryonic hemopoiesis|vagina development|glomerular visceral epithelial cell development|glomerular basement membrane development|glomerular epithelial cell development,0.0009706|0.002134|0.002328|0.002328|0.002522,1|1|1|1|1,1287|514.9|468.1|468.1|429.1
1681,16,0.5596,67.15,12610.0,0.005285,0.999999,C15orf53 CHRNA7 DUOXA1 DUOXA2 EPB42 GABRA5 MYO5A MYO5C NIPA1 NIPA2 PLA2G4D PLA2G4E PPP1R14D SNURF TGM5 TMCO5A,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|regulation of postsynaptic membrane potential,1.341e-05|1.787e-05|2.297e-05|2.87e-05|7.831e-05,0.2116|0.141|0.1208|0.1132|0.2471,484.6|403.8|346.1|302.9|36.34
1682,4,0.629,3.7739999999999996,3423.0,0.001099,0.9929309999999999,HOPX MYOZ3 PCDHGB7 SMIM12,trophectodermal cell differentiation|chaperone-mediated protein complex assembly|blastocyst formation|blastocyst development|homophilic cell adhesion via plasma membrane adhesion molecules,0.003685|0.004266|0.007359|0.0189|0.03223,1|1|1|1|1,286|245.2|139.2|53.08|30.83
1683,4,0.6455,3.873,3374.0,0.001144,0.9929309999999999,HCN4 MYPN RHCG STAR,intermembrane lipid transfer|cellular response to cAMP|sterol transport|response to cAMP|cholesterol metabolic process,5.747e-05|7.482e-05|0.0001405|0.0002311|0.0003609,0.9065|0.5901|0.7387|0.9113|1,171.6|149.8|108.4|84.06|66.98
1684,9,0.6219,22.39,5954.0,0.003735,0.9998530000000001,DNAJC24 DOHH DPH1 DPH2 DPH5 DPH6 DPH7 N6AMT1 TTC4,peptidyl-diphthamide biosynthetic process from peptidyl-histidine|peptidyl-diphthamide metabolic process|regulation of cytoplasmic translational elongation|peptidyl-histidine modification|regulation of translational elongation,2.373e-18|2.373e-18|9.777e-18|2.143e-17|2.336e-16,3.744e-14|1.872e-14|5.141e-14|8.45e-14|7.368e-13,1716|1716|1248|1056|653.8
1685,4,0.668,4.008,2667.0,0.0014960000000000002,0.9929309999999999,LEMD2 NAA20 NAA25 VEZT,N-terminal peptidyl-methionine acetylation|peptidyl-methionine modification|N-terminal protein amino acid acetylation|N-terminal protein amino acid modification|protein acetylation,1.018e-06|2.967e-06|4.323e-06|1.146e-05|0.0002689,0.01605|0.0234|0.02273|0.0452|0.8482,1471|792.1|643.6|381.4|75.16
1686,4,0.613,3.678,3291.0,0.001114,0.9929309999999999,NAB1 RPF1 TMEM182 TMEM45B,ganglion mother cell fate determination|maturation of LSU-rRNA|endochondral ossification|replacement ossification|maturation of 5.8S rRNA,0.000728|0.00702|0.007502|0.007502|0.008708,1|1|1|1|1,2060|147.1|137.3|137.3|117.7
1687,4,0.7105,4.263,3118.0,0.001362,0.9929309999999999,FAM208A MORC2 NAPSA PPHLN1,positive regulation of DNA methylation-dependent heterochromatin assembly|positive regulation of heterochromatin organization|positive regulation of heterochromatin assembly|positive regulation of chromatin assembly or disassembly|regulation of DNA methylation-dependent heterochromatin assembly,1.103e-06|1.484e-06|1.484e-06|1.696e-06|1.922e-06,0.01739|0.01171|0.007805|0.006689|0.006065,1248|1056|1056|980.7|915.3
1688,7,0.6142,12.9,5130.0,0.002501,0.9992989999999999,BMS1 IMP4 NAT10 NOC4L NOL10 UTP25 UTP4,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,3.033e-11|3.791e-11|1.288e-10|6.137e-10|9.5e-10,4.784e-07|2.99e-07|6.774e-07|2.42e-06|2.997e-06,67.9|65.38|53.17|40.86|37.96
1689,6,0.6122,9.183,4553.0,0.002007,0.998474,CD1B FCRL3 NAXE POGK SLAMF7 YY1AP1,"positive regulation of protein serine/threonine phosphatase activity|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|membrane raft distribution|membrane raft localization|negative regulation of B cell receptor signaling pathway",0.0008735|0.001746|0.002037|0.002328|0.002328,1|1|1|1|1,1716|686.5|572.1|490.4|490.4
1690,4,0.603,3.6180000000000003,2829.0,0.001273,0.9929309999999999,NBEA POTEM TOMM40 USP10,protein deubiquitination|protein modification by small protein removal|autophagy|process utilizing autophagic mechanism|protein phosphopantetheinylation,0.001792|0.002013|0.002163|0.002163|0.002598,1|1|1|1|1,29.63|27.93|26.92|26.92|24.52
1691,5,0.6,6.0,3758.0,0.00159,0.996692,CAPZA1 CTSK HIST2H2AB HIST2H2BE NBPF3,intramembranous ossification|direct ossification|thyroid hormone generation|barbed-end actin filament capping|thyroid hormone metabolic process,0.001165|0.001165|0.002619|0.003346|0.003346,1|1|1|1|1,980.7|980.7|403.8|312|312
1692,14,0.6055,55.1,10750.0,0.0050880000000000005,0.9999969999999999,ASL CASTOR3 NCF1 PMS2 SPDYE1 TRIM50 TRIM73 TYW1 ZNF138 ZNF273 ZNF479 ZNF679 ZNF736 ZNF92,arginine biosynthetic process via ornithine|'de novo' AMP biosynthetic process|cellular response to L-arginine|arginine biosynthetic process|wybutosine biosynthetic process,0.002182|0.002908|0.002908|0.003634|0.003634,1|1|1|1|1,686.5|457.7|457.7|343.2|343.2
1693,7,0.6089,12.79,5697.0,0.002234,0.9992989999999999,ASTL CNNM4 IL1F10 IL1RN IL36G LYG1 NCK2,inflammatory response to antigenic stimulus|positive regulation of gene expression|inflammatory response|defense response|prevention of polyspermy,2.016e-07|0.0002281|0.0004597|0.0006643|0.001019,0.00318|1|1|1|1,252.2|10.98|17.8|8.311|1471
1694,5,0.6644,6.644,3646.0,0.001814,0.996692,DENND4A IRF8 MEF2D NCKAP1L SIK3,plasmacytoid dendritic cell differentiation|positive regulation of TORC2 signaling|regulation of TORC2 signaling|plasmacytoid dendritic cell activation|myeloid cell differentiation,0.0004854|0.000728|0.000728|0.0009706|0.001183,1|1|1|1|1,4119|2060|2060|1373|36.61
1695,7,0.6079,12.77,4613.0,0.002751,0.9992989999999999,C16orf72 DDX21 HSPA14 NCL NOLC1 PINX1 ZNHIT6,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,3.156e-06|3.658e-06|8.206e-06|2.291e-05|3.05e-05,0.04979|0.02885|0.04315|0.09033|0.09622,35.21|33.9|27.57|21.19|19.68
1696,9,0.6211,22.36,7068.0,0.003146,0.9998530000000001,C8orf44 CCNB1IP1 KIF26B MAP3K7CL NDRG3 NECAP2 PCDHGA9 RNF114 SDR39U1,spermatogenesis|male gamete generation|ureteric bud invasion|metanephric renal vesicle formation|reproductive process,0.001417|0.001562|0.001746|0.002182|0.002228,1|1|1|1|1,12.53|12.11|762.8|572.1|6.392
1697,19,0.603,103.1,14370.0,0.007107,1.0,AQP5 HOXC6 HOXC8 INHBE KRT1 KRT5 KRT6B KRT74 KRT77 KRT79 KRT82 KRT84 KRT86 NDUFA4L2 OR10A7 OR10P1 OR6C3 RDH16 SDR9C7,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,5.799e-16|2.334e-13|1.03e-12|4.335e-12|2.318e-11,9.148e-12|1.841e-09|5.418e-09|1.709e-08|7.312e-08,86.33|43.17|36.4|30.87|25.47
1698,4,0.6071,3.642,3354.0,0.001082,0.9929309999999999,AIFM3 NDEL1 NEK10 ZMYND12,microtubule-based transport|mucociliary clearance|mitotic centrosome separation|microtubule-based movement|neurofilament cytoskeleton organization,0.0005176|0.001165|0.001359|0.001708|0.001747,1|1|1|1|1,53.91|1030|858.1|29.42|643.6
1699,4,0.659,3.9539999999999997,3080.0,0.001279,0.9929309999999999,NEK11 PHLPP1 USP46 WDR20,cellular protein modification process|protein modification process|macromolecule modification|cellular protein metabolic process|protein deubiquitination,0.0004631|0.0004631|0.0006141|0.0009812|0.001085,1|1|1|1|1,6.822|6.822|6.356|5.653|37.04
1700,5,0.6261,6.261,4279.0,0.001458,0.996692,C1QTNF9 KBTBD7 NEK3 VANGL1 ZAR1L,"posttranscriptional gene silencing|pigmentation|Wnt signaling pathway, planar cell polarity pathway|regulation of establishment of planar polarity|non-canonical Wnt signaling pathway",0.01544|0.02142|0.02356|0.02761|0.03258,1|1|1|1|1,65.38|46.81|42.46|36.13|30.51
1701,4,0.6593,3.9560000000000004,3230.0,0.00122,0.9929309999999999,CSNK1A1L LCP1 NEK5 RCBTB2,positive regulation of podosome assembly|regulation of podosome assembly|actin filament network formation|actin crosslink formation|protein kinase A signaling,0.001941|0.002522|0.002522|0.00291|0.003297,1|1|1|1|1,572.1|429.1|429.1|367.8|321.8
1702,10,0.6005,27.02,7697.0,0.00349,0.999933,HOXC5 INHBE KRT82 KRT86 NELL2 OR6C1 OR6C3 OS9 RDH5 SLC4A8,"cornification|positive regulation of synaptic vesicle exocytosis|protein retention in ER lumen|negative regulation of retrograde protein transport, ER to cytosol|keratinization",0.00135|0.003877|0.004844|0.004844|0.005174,1|1|1|1|1,36.45|294.2|228.8|228.8|18.23
1703,12,0.627,41.38,8113.0,0.00506,0.999986,AK6 C18orf21 METAP1 NEPRO POP1 POP4 POP5 POP7 RPP14 RPP30 RPP38 RPP40,"tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|RNA phosphodiester bond hydrolysis, endonucleolytic",3.241e-22|1.171e-21|6.825e-21|1.254e-20|2.265e-16,5.113e-18|9.234e-18|3.589e-17|4.945e-17|7.144e-13,974.9|792.1|603.5|551|142.4
1704,4,0.6291,3.775,3128.0,0.001202,0.9929309999999999,NES NUDT3 OR2J2 PPT2,diphosphoinositol polyphosphate catabolic process|regulation of intermediate filament polymerization or depolymerization|positive regulation of intermediate filament depolymerization|regulation of intermediate filament depolymerization|adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.001165,1|1|1|1|1,5149|5149|5149|5149|1030
1705,4,0.6879,4.127,3287.0,0.001251,0.9929309999999999,CHRND CHRNG NEU2 PDE6D,"excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|regulation of postsynaptic membrane potential|system process|cellular oligosaccharide catabolic process",0.0001005|0.0001131|0.0002404|0.0004451|0.000728,1|0.8918|1|1|1,128.7|121.1|82.38|8.076|2060
1706,4,0.6217,3.73,3517.0,0.001057,0.9929309999999999,AREG KIAA1191 NEURL2 POU4F3,developmental growth involved in morphogenesis|dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis|epithelial cell proliferation involved in mammary gland duct elongation|thelarche|branch elongation involved in mammary gland duct branching,0.000184|0.0003883|0.0009706|0.001165|0.001165,1|1|1|1|1,91.13|5149|1287|1030|1030
1707,4,0.6118,3.6710000000000003,3156.0,0.001159,0.9929309999999999,MAB21L3 NEUROD6 TGFB2 VEGFC,positive regulation of cell division|platelet degranulation|positive regulation of protein secretion|morphogenesis of embryonic epithelium|positive regulation of epithelial cell migration,0.0001101|0.0002352|0.000265|0.0002966|0.0003214,1|1|1|1|1,118.4|80.45|75.72|71.51|68.65
1708,7,0.6276,13.18,5768.0,0.002274,0.9992989999999999,CCDC30 FST GAPT ITGA2 PLK2 RAB3C ZNF691,cell population proliferation|positive regulation of collagen binding|regulation of collagen binding|positive regulation of epithelial cell migration|positive regulation of binding,0.0004102|0.0006794|0.001019|0.001108|0.001515,1|1|1|1|1,18.5|2942|1471|39.23|33.43
1709,8,0.6066,16.99,6782.0,0.0024920000000000003,0.9996790000000001,HOXB9 LRRC46 MYCBPAP NFE2L3 OSBPL7 SCRN2 TBKBP1 TBX21,negative regulation of T-helper 17 cell lineage commitment|negative regulation of T-helper 2 cell cytokine production|regulation of T-helper 17 cell lineage commitment|positive regulation of isotype switching to IgG isotypes|negative regulation of T cell cytokine production,0.001552|0.00194|0.003103|0.003877|0.004264,1|1|1|1|1,858.1|643.6|367.8|286|257.4
1710,4,0.604,3.6239999999999997,3404.0,0.0010609999999999999,0.9929309999999999,ACSM4 GCKR NGEF PURA,dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|negative regulation of glucokinase activity|negative regulation of hexokinase activity|negative regulation of dendritic spine morphogenesis,0.0007766|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,1716|1716|1030|1030|858.1
1711,4,0.6136,3.681,3476.0,0.001056,0.9929309999999999,AOC2 ASPSCR1 NGFR TBKBP1,glucose homeostasis|carbohydrate homeostasis|positive regulation of odontogenesis of dentin-containing tooth|negative regulation of hair follicle development|positive regulation of odontogenesis,0.0005069|0.0005122|0.0005825|0.001165|0.001359,1|1|1|1|1,54.48|54.2|2574|1030|858.1
1712,4,0.6265,3.759,3236.0,0.001158,0.9929309999999999,CCDC181 F2RL2 MDH1 NHEJ1,malate metabolic process|oxaloacetate metabolic process|thrombin-activated receptor signaling pathway|positive regulation of ligase activity|regulation of ligase activity,0.001747|0.001941|0.001941|0.002134|0.002522,1|1|1|1|1,643.6|572.1|572.1|514.9|429.1
1713,5,0.6046,6.046,3909.0,0.0015400000000000001,0.996692,BTN3A2 HIST1H3A HIST1H4A HIST1H4B NHLRC1,negative regulation of megakaryocyte differentiation|interferon-gamma production|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization|positive regulation of histone exchange,0.0008737|0.001456|0.001601|0.001601|0.001747,1|1|1|1|1,1373|762.8|686.5|686.5|624.1
1714,6,0.6725,10.09,3953.0,0.002537,0.998474,CUL1 DCUN1D1 NAE1 NEDD8 UBA3 UBE2M,protein neddylation|post-translational protein modification|protein modification by small protein conjugation|protein modification by small protein conjugation or removal|cellular protein modification process,1.662e-15|3.07e-11|4.113e-09|1.605e-08|9.981e-06,2.622e-11|2.421e-07|2.162e-05|6.328e-05|0.03149,1320|57.05|25.09|19.98|6.822
1715,4,0.6427,3.8560000000000003,3441.0,0.001117,0.9929309999999999,C5orf63 ENTHD1 NIPAL2 RIDA,threonine catabolic process|L-threonine catabolic process to glycine|threonine metabolic process|G1 to G0 transition|magnesium ion transmembrane transport,0.001165|0.001165|0.001359|0.001941|0.003297,1|1|1|1|1,1030|1030|858.1|572.1|321.8
1716,18,0.6056,92.65,13670.0,0.006714,1.0,ADAMTSL4 CTSK ECM1 FCRL3 FLG2 GBA HIST2H2AB LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A3 S100A4 S100A5 S100A6 S100A9 SLAMF7,antimicrobial humoral immune response mediated by antimicrobial peptide|cell killing|skin development|regulation of water loss via skin|antimicrobial humoral response,8.53e-05|0.0001326|0.0002399|0.0002566|0.0002829,1|1|1|1|0.8925,35.29|30.29|12.65|89.74|23.3
1717,8,0.6071,17.0,6277.0,0.002694,0.9996790000000001,C6orf203 ENPP1 ENPP3 NKAIN2 TAAR2 TAAR6 TAAR8 VNN2,nucleoside triphosphate catabolic process|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|negative regulation of hh target transcription factor activity,1.579e-05|0.0004635|0.0004635|0.0005545|0.0007765,0.2491|1|1|1|1,367.8|62.03|62.03|56.58|2574
1718,9,0.6028,21.7,6761.0,0.003191,0.9998530000000001,BTN2A2 NKAPL OR14J1 OR2B6 OR2J3 TRIM10 ZKSCAN4 ZNF165 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.0007579|0.0008998|0.001003|0.001232|0.001373,1|1|1|1|1,15.57|14.67|14.13|13.15|12.67
1719,4,0.6929,4.157,2774.0,0.001492,0.9929309999999999,HNRNPD NKTR NUP58 SFSWAP,negative regulation of mRNA metabolic process|hepatocyte dedifferentiation|cellular response to putrescine|response to putrescine|positive regulation of telomerase RNA reverse transcriptase activity,0.0001126|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,117|5149|5149|5149|2574
1720,6,0.6008,9.012,4712.0,0.0019039999999999999,0.998474,DEPP1 NKX2-3 ZNF22 ZNF239 ZNF33B ZNF485,"regulation of transcription by RNA polymerase II|odontogenesis|post-embryonic digestive tract morphogenesis|regulation of cellular metabolic process|regulation of transcription, DNA-templated",0.0001685|0.0004971|0.0005824|0.0006808|0.0006968,1|1|1|1|1,6.637|58.18|3432|3.373|4.955
1721,4,0.6215,3.7289999999999996,3353.0,0.001108,0.9929309999999999,NKX6-1 PRSS54 RNF150 TNIP3,type B pancreatic cell maturation|glandular epithelial cell maturation|detection of glucose|positive regulation of type B pancreatic cell development|detection of hexose stimulus,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
1722,13,0.6019,46.95,10180.0,0.004581,0.999993,KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP13 ZSCAN5B,regulation of immune response|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of immune system process|interleukin-10-mediated signaling pathway,7.203e-09|4.104e-08|7.108e-08|2.489e-07|2.569e-06,0.0001136|0.0003237|0.0003738|0.0009817|0.008105,11.73|551.7|441.3|7.783|1471
1723,4,0.6037,3.622,3046.0,0.001185,0.9929309999999999,LILRA4 NLRP5 SHPK ZSCAN5B,negative regulation of toll-like receptor 7 signaling pathway|cellular response to interleukin-13|negative regulation of toll-like receptor 9 signaling pathway|response to interleukin-13|negative regulation of interferon-alpha production,0.0003883|0.0007766|0.0009706|0.0009706|0.001359,1|1|1|1|1,5149|1716|1287|1287|858.1
1724,5,0.6009,6.0089999999999995,3901.0,0.001534,0.996692,NLRP8 PRB1 PRB4 SPX TAS2R19,negative regulation of renal sodium excretion|positive regulation of gastro-intestinal system smooth muscle contraction|regulation of gastro-intestinal system smooth muscle contraction|long-chain fatty acid import into cell|negative regulation of heart rate,0.001165|0.002037|0.002037|0.0032|0.00349,1|1|1|1|1,1144|572.1|572.1|343.2|312
1725,8,0.6108,17.1,6571.0,0.00259,0.9996790000000001,C1QTNF3 C7 CDH6 NMI SLC45A2 UGT3A1 UGT3A2 ZNF232,negative regulation of NIK/NF-kappaB signaling|regulation of NIK/NF-kappaB signaling|cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid,4.962e-05|0.0006407|0.0007765|0.0007765|0.0007765,0.7827|1|1|1|1,198|52.54|2574|2574|2574
1726,4,0.6228,3.737,3005.0,0.001239,0.9929309999999999,AGAP5 AGAP6 NMRK1 SPATA31A6,positive regulation of GTPase activity|regulation of GTPase activity|NAD biosynthetic process|pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process,0.002365|0.003309|0.00562|0.0062|0.0062,1|1|1|1|1,24.93|21.02|183.9|166.1|166.1
1727,4,0.6326,3.7960000000000003,2699.0,0.0014,0.9929309999999999,GNAI2 GNAI3 LPAR1 NMT1,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|positive regulation of NAD(P)H oxidase activity|regulation of NAD(P)H oxidase activity|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|negative regulation of adenylate cyclase activity,2.902e-07|1.018e-06|2.204e-06|4.968e-06|6.525e-06,0.004578|0.008027|0.01159|0.01959|0.02058,183.9|1471|936.1|70.21|514.9
1728,5,0.6052,6.0520000000000005,3434.0,0.001754,0.996692,AK6 NOB1 PDCD2 RPS7 WDR43,nucleoside monophosphate phosphorylation|rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing,7.41e-06|3.999e-05|4.47e-05|8.219e-05|0.0001783,0.1169|0.3154|0.235|0.3241|0.5626,528.1|39.61|38.14|31.02|23.84
1729,5,0.6378,6.377999999999999,3631.0,0.001749,0.996692,BMS1 NOC3L PDCD11 RRP12 UTP20,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.305e-07|1.515e-07|3.432e-07|9.733e-07|1.303e-06,0.002059|0.001195|0.001805|0.003838|0.00411,63.37|61.02|49.63|38.14|35.43
1730,7,0.6237,13.1,4830.0,0.0026969999999999997,0.9992989999999999,FTSJ3 GNL2 NOL12 NOP2 RPF2 RPL28 RRS1,ribosome biogenesis|ribonucleoprotein complex biogenesis|ribosomal large subunit biogenesis|rRNA processing|rRNA metabolic process,1.288e-10|9.5e-10|5.934e-09|6.973e-09|8.397e-09,2.032e-06|7.492e-06|3.12e-05|2.75e-05|2.649e-05,53.17|37.96|163.5|56.58|54.48
1731,4,0.6091,3.655,3178.0,0.001146,0.9929309999999999,C5AR1 NOL4 TEKT5 TTC39C,complement component C5a signaling pathway|otolith morphogenesis|cell proliferation in hindbrain|otolith development|cilium assembly,0.0005825|0.0009706|0.001747|0.001747|0.001987,1|1|1|1|1,2574|1287|643.6|643.6|27.24
1732,9,0.6021,21.68,6316.0,0.0034100000000000003,0.9998530000000001,CUL1 EXOC4 LSM8 NOM1 NRF1 NUP205 PMPCB RBM28 TNPO3,intracellular protein transport|vesicle tethering involved in exocytosis|protein transport|peptide transport|protein processing involved in protein targeting to mitochondrion,0.0005227|0.0008734|0.002411|0.002593|0.002618,1|1|1|1|1,9.407|2288|6.257|6.135|457.7
1733,6,0.6086,9.13,4252.0,0.002136,0.998474,DDX41 NHP2 NOP16 RACK1 RPS14 THOC3,RNA processing|gene expression|ribosome biogenesis|ribosomal large subunit biogenesis|ribonucleoprotein complex biogenesis,5.682e-05|7.412e-05|8.219e-05|0.0001892|0.0002214,0.8962|0.5846|0.4322|0.746|0.6984,14.88|7.851|31.02|95.35|22.15
1734,6,0.6488,9.731,4644.0,0.0020859999999999997,0.998474,ISL2 LHX3 NEUROD1 NOSIP OTP OTX2,central nervous system development|forebrain development|neuron differentiation|endocrine system development|spinal cord motor neuron cell fate specification,1.507e-06|1.731e-06|1.806e-06|4.408e-06|4.66e-06,0.02377|0.01365|0.009497|0.01738|0.0147,17.32|36.13|16.7|83.72|686.5
1735,6,0.6091,9.137,5244.0,0.0017350000000000002,0.998474,COL14A1 COLEC10 CSMD3 NOV NOX5 TRHR,epithelial cell proliferation|chemotaxis|taxis|reductive iron assimilation|regulation of fusion of sperm to egg plasma membrane,0.0003994|0.000608|0.0006178|0.0006794|0.0006794,1|1|1|1|1,66.12|16.17|16.08|2942|2942
1736,7,0.6005,12.61,5485.0,0.002288,0.9992989999999999,C15orf53 NIPA2 NPAP1 PLA2G4D PLA2G4E SNURF TMOD2,phosphatidylinositol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid catabolic process|phosphatidylcholine acyl-chain remodeling,1.875e-05|2.722e-05|3.725e-05|4.58e-05|4.885e-05,0.2957|0.2146|0.1959|0.1806|0.1541,326.9|267.5|226.3|202.9|196.1
1737,7,0.6038,12.68,5311.0,0.002376,0.9992989999999999,BBS1 FOLR2 MRGPRD NPAS4 PITPNM1 POLD4 TBC1D10C,amide transport|cellular response to corticosterone stimulus|cellular response to folic acid|nitrogen compound transport|response to stimulus,0.0008835|0.001019|0.001019|0.001655|0.002037,1|1|1|1|1,7.712|1471|1471|6.534|2.424
1738,18,0.6095,93.26,12050.0,0.007654,1.0,ARL8B BLOC1S1 GNPTAB NPC1 NPC2 PSAP RAB7A SNAPIN SPG21 TMEM251 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41,lysosomal transport|vacuolar transport|intracellular transport|endosome to lysosome transport|establishment of localization in cell,1.182e-20|3.583e-19|2.674e-14|6.041e-14|6.6e-13,1.865e-16|2.826e-15|1.406e-10|2.382e-10|2.082e-09,109.4|78.96|10.85|143.2|7.333
1739,4,0.6816,4.09,3359.0,0.001213,0.9929309999999999,C11orf24 LOXL3 NPEPL1 NUDT2,fibronectin fibril organization|negative regulation of T-helper 17 cell lineage commitment|peptidyl-lysine oxidation|positive regulation of integrin-mediated signaling pathway|regulation of T-helper 17 cell lineage commitment,0.0003883|0.0007766|0.001165|0.001553|0.001553,1|1|1|1|1,5149|1716|1030|735.5|735.5
1740,10,0.6021,27.09,7525.0,0.003578,0.999933,ACCSL CAT EHF ELF5 FBXO3 MAPK8IP1 MYBPC3 SLC1A2 SNX29 TP53I11,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome,0.0001432|0.000277|0.001006|0.001006|0.001006,1|1|1|1|1,118.4|83.72|42.91|42.91|42.91
1741,4,0.6566,3.94,3243.0,0.00121,0.9929309999999999,GABPB2 HJV NR1D1 SV2A,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",5.646e-05|0.0001812|0.0001812|0.0001817|0.0002271,0.8907|1|0.9529|0.7164|0.7165,13.66|10.16|10.16|10.15|9.59
1742,4,0.6287,3.772,3276.0,0.001147,0.9929309999999999,NR1I2 RIPPLY3 TLL1 TMEM178A,exogenous drug catabolic process|drug catabolic process|pharyngeal system development|negative regulation of osteoclast differentiation|xenobiotic transport,0.004653|0.00504|0.005233|0.005813|0.007938,1|1|1|1|1,223.9|205.9|198|177.5|128.7
1743,4,0.6266,3.76,3109.0,0.0012050000000000001,0.9929309999999999,FCRL3 NR2C2 PAQR6 TTC24,positive regulation of protein serine/threonine phosphatase activity|negative regulation of B cell receptor signaling pathway|regulation of toll-like receptor 9 signaling pathway|negative regulation of immunoglobulin production|positive regulation of phosphoprotein phosphatase activity,0.0005825|0.001553|0.002328|0.00291|0.004266,1|1|1|1|1,2574|735.5|468.1|367.8|245.2
1744,5,0.6252,6.252000000000001,3785.0,0.001645,0.996692,NR4A2 NR5A2 SOX17 VGLL2 WT1,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|cardiac cell fate commitment",6.966e-07|3.056e-06|3.056e-06|3.065e-06|3.672e-06,0.01099|0.0241|0.01607|0.01209|0.01159,17.08|12.7|12.7|12.69|748.9
1745,5,0.6464,6.4639999999999995,3718.0,0.001731,0.996692,ACCSL MRGPRX1 MRGPRX3 MRGPRX4 NR4A3,response to chloroquine|positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway|pyruvate oxidation|positive regulation of mast cell cytokine production|positive regulation of monocyte aggregation,0.0004854|0.0004854|0.0004854|0.000728|0.0009706,1|1|1|1|1,4119|4119|4119|2060|1373
1746,4,0.614,3.6839999999999997,3370.0,0.00109,0.9929309999999999,COL2A1 CPLX3 NRAP PNLIP,cardiac muscle thin filament assembly|visual perception|sensory perception of light stimulus|anterior head development|regulation of synaptic vesicle fusion to presynaptic active zone membrane,0.0009706|0.001092|0.001132|0.001213|0.002183,1|1|1|1|1,1373|38.14|37.45|1030|514.9
1747,4,0.65,3.9,3324.0,0.001169,0.9929309999999999,ATP10B C11orf42 FAM205A NRCAM,lysosomal membrane organization|clustering of voltage-gated sodium channels|neuronal ion channel clustering|axonal fasciculation|neuron projection fasciculation,0.001165|0.001359|0.002328|0.004072|0.004072,1|1|1|1|1,1030|858.1|468.1|257.4|257.4
1748,5,0.6732,6.732,3401.0,0.00197,0.996692,RPA1 RPA2 RPA3 RPAIN WRN,DNA replication|telomere maintenance via semi-conservative replication|DNA-dependent DNA replication|DNA synthesis involved in DNA repair|nuclear DNA replication,3.875e-11|5.73e-10|1.653e-09|1.831e-09|2.584e-09,6.112e-07|4.519e-06|8.692e-06|7.221e-06|8.153e-06,65.14|301.8|75.83|222|202.9
1749,7,0.6211,13.04,5120.0,0.002534,0.9992989999999999,LSM5 MAD2L1 NSA2 RPF2 RPL18 RPL5 TTK,rRNA processing|rRNA metabolic process|ribosomal large subunit biogenesis|ribosome biogenesis|RNA processing,8.95e-07|1.038e-06|1.605e-06|2.34e-06|3.572e-06,0.01412|0.008188|0.008439|0.009228|0.01127,45.26|43.59|122.6|35.45|15.94
1750,19,0.6088,104.1,15130.0,0.006818,1.0,ALDH3A1 ALOXE3 CCDC144A CCDC144NL DRC3 GID4 HS3ST3A1 KRT16 MFAP4 MYO15A NT5M SLC47A1 SLC47A2 TBC1D28 TNFRSF13B TNFSF12 TRPV2 ZNF287 ZNF624,establishment of skin barrier|regulation of water loss via skin|xenobiotic transport|multicellular organismal water homeostasis|water homeostasis,0.0003093|0.0003574|0.0007522|0.002378|0.002903,1|1|1|1|1,82.38|76.28|51.49|28.21|25.43
1751,4,0.6173,3.7039999999999997,3398.0,0.001086,0.9929309999999999,CYB561D1 NRN1L NTN3 TNNT1,cellular component morphogenesis|slow-twitch skeletal muscle fiber contraction|voluntary skeletal muscle contraction|twitch skeletal muscle contraction|transition between fast and slow fiber,9.962e-05|0.0005825|0.0007766|0.0007766|0.001553,1|1|1|1|1,25.57|2574|1716|1716|735.5
1752,4,0.6353,3.812,3366.0,0.001129,0.9929309999999999,CA13 CA3 NTNG2 ZNF501,one-carbon metabolic process|bicarbonate transport|organic anion transport|basement membrane assembly|postsynaptic specialization assembly,2.313e-05|2.668e-05|0.001613|0.002134|0.002134,0.3649|0.2104|1|1|1,264|245.2|30.29|514.9|514.9
1753,4,0.6102,3.661,3368.0,0.001083,0.9929309999999999,INAVA NTPCR RAB3IL1 SUMF1,intestinal epithelial structure maintenance|adherens junction maintenance|nucleotide-binding oligomerization domain containing 2 signaling pathway|cytokine production involved in immune response|protein oxidation,0.001165|0.001359|0.001747|0.002328|0.002522,1|1|1|1|1,1030|858.1|643.6|468.1|429.1
1754,4,0.6117,3.67,3189.0,0.001147,0.9929309999999999,CHDH DOK4 EPPIN NTSR1,negative regulation of calcium ion transport|glycine betaine biosynthetic process from choline|glycine betaine biosynthetic process|glycine betaine metabolic process|positive regulation of gamma-aminobutyric acid secretion,5.156e-05|0.0005825|0.0005825|0.0005825|0.0007766,0.8133|1|1|1|1,174.5|2574|2574|2574|1716
1755,4,0.6403,3.842,3190.0,0.0012,0.9929309999999999,ERGIC3 NUB1 TRMO ZBTB26,"tRNA methylation|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|RNA methylation|tRNA modification|positive regulation of proteasomal ubiquitin-dependent protein catabolic process",0.008131|0.0166|0.01679|0.01756|0.01756,1|1|1|1|1,125.6|60.57|59.87|57.21|57.21
1756,8,0.6298,17.63,5768.0,0.003039,0.9996790000000001,MAK16 PPAN PWP2 RRP1 RSL1D1 UTP4 WDR12 WDR18,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,8.39e-17|1.675e-15|6.57e-15|8.838e-15|3.588e-13,1.323e-12|1.321e-11|3.455e-11|3.485e-11|1.132e-09,62.03|44.29|70.41|67.8|42.38
1757,4,0.6243,3.7460000000000004,3283.0,0.001137,0.9929309999999999,ASCL2 FTL NNAT NUCKS1,modulation by host of viral RNA-binding transcription factor activity|modulation by host of RNA binding by virus|spongiotrophoblast layer development|regulation of DNA strand elongation|modulation by host of viral transcription,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
1758,4,0.6265,3.759,3468.0,0.00108,0.9929309999999999,AP3M1 CFAP70 NUDT13 TMEM52,NADP catabolic process|pyridine nucleotide catabolic process|pyridine-containing compound catabolic process|microtubule-based movement|synaptic vesicle transport along microtubule,0.0007766|0.0009706|0.001553|0.001708|0.003297,1|1|1|1|1,1716|1287|735.5|29.42|321.8
1759,4,0.6465,3.8789999999999996,3325.0,0.001163,0.9929309999999999,FAM183A MPL NUDT19 SLC35F6,basophil homeostasis|eosinophil homeostasis|positive regulation of platelet formation|monocyte homeostasis|regulation of platelet formation,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
1760,4,0.6021,3.613,3353.0,0.001074,0.9929309999999999,C1QL1 CDHR2 COL22A1 NUDT6,negative regulation of cell growth involved in contact inhibition|intermicrovillar adhesion|brush border assembly|motor learning|regulation of microvillus length,0.0003883|0.0005825|0.001165|0.001359|0.001553,1|1|1|1|1,5149|2574|1030|858.1|735.5
1761,5,0.6578,6.577999999999999,3570.0,0.001834,0.996692,C12orf45 DDX51 NUFIP1 ZNHIT3 ZNHIT6,"box C/D snoRNP assembly|small nucleolar ribonucleoprotein complex assembly|snoRNA localization|ribonucleoprotein complex biogenesis|maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",1.132e-09|1.962e-09|9.893e-07|1.303e-06|6.401e-06,1.786e-05|1.547e-05|0.005202|0.005137|0.02019,1545|1236|1648|35.43|549.2
1762,5,0.7028,7.028,3412.0,0.002049,0.996692,NKTR NUP54 NUP58 NUP62 TMEM209,tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|tRNA transport|ncRNA export from nucleus|intracellular transport of virus,5.321e-08|5.321e-08|6.764e-08|7.297e-08|2.001e-07,0.0008393|0.0004196|0.0003556|0.0002878|0.0006312,363.4|363.4|334|325.2|228.8
1763,9,0.6072,21.86,6042.0,0.003594,0.9998530000000001,DHX33 GEMIN4 MYBBP1A NDE1 NUP88 PAFAH1B1 RPAIN TRAPPC1 TSR1,ribosome biogenesis|intracellular transport|regulation of microtubule motor activity|import into nucleus|establishment of organelle localization,8.206e-06|1.042e-05|1.32e-05|1.5e-05|1.648e-05,0.1294|0.0822|0.06939|0.05915|0.052,27.57|9.159|416.1|59.7|23.06
1764,6,0.6133,9.199,4116.0,0.002223,0.998474,MMS22L NUS1 PNISR REV3L RPF2 TTK,double-strand break repair via homologous recombination|recombinational repair|protein localization to meiotic spindle midzone|meiotic spindle assembly checkpoint|protein localization to meiotic spindle,0.0003665|0.0003809|0.0005824|0.0005824|0.0005824,1|1|1|1|1,67.97|66.65|3432|3432|3432
1765,4,0.6217,3.73,3378.0,0.0011,0.9929309999999999,CLRN2 NWD2 POU5F2 TMSB10,sequestering of actin monomers|negative regulation of actin filament polymerization|maintenance of protein location in cell|negative regulation of protein polymerization|maintenance of location in cell,0.002328|0.01179|0.01295|0.01449|0.01832,1|1|1|1|1,468.1|85.81|78.01|69.58|54.77
1766,8,0.6206,17.38,6040.0,0.002861,0.9996790000000001,CRYAB FXYD6 HTR3A HTR3B NXPE1 NXPE2 NXPE4 TMEM136,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,0.0001074|0.000442|0.0004526|0.0006281|0.0006281,1|1|1|1|1,132|63.56|62.79|53.08|53.08
1767,4,0.6105,3.6630000000000003,3144.0,0.001161,0.9929309999999999,CHMP1B OCLM RNF11 ZNF426,ESCRT III complex disassembly|ESCRT complex disassembly|midbody abscission|regulation of mitotic spindle assembly|viral budding via host ESCRT complex,0.002134|0.002134|0.003491|0.003878|0.004072,1|1|1|1|1,514.9|514.9|302.9|271|257.4
1768,4,0.6227,3.736,3264.0,0.001141,0.9929309999999999,LGALS13 ODAM PRX TIMM50,peripheral nervous system myelin maintenance|positive regulation of epithelial cell proliferation involved in wound healing|positive regulation of T cell apoptotic process|myelin maintenance|positive regulation of lymphocyte apoptotic process,0.001747|0.001941|0.00291|0.003297|0.003491,1|1|1|1|1,643.6|572.1|367.8|321.8|302.9
1769,4,0.6119,3.6710000000000003,3359.0,0.0010890000000000001,0.9929309999999999,ARL14EPL CCKAR ODF2 REN,cholecystokinin signaling pathway|renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of hormone secretion,0.000728|0.001213|0.001698|0.001698|0.001767,1|1|1|1|1,2060|1030|686.5|686.5|29.85
1770,12,0.614,40.52,9384.0,0.004289,0.999986,CRISP1 CRISP2 FBXO9 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP OPN5 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,3.445e-07|3.445e-07|4.657e-06|6.518e-06|7.401e-06,0.005434|0.002717|0.02449|0.0257|0.02335,234|234|858.1|686.5|79.21
1771,4,0.657,3.9419999999999997,2895.0,0.001356,0.9929309999999999,OR10G4 OR10G9 OR6X1 OR8D4,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.149e-07|2.723e-07|3.164e-07|4.205e-07|4.883e-07,0.00339|0.002147|0.001663|0.001658|0.001541,46.7|44.01|42.38|39.45|38
1772,5,0.604,6.04,3751.0,0.001603,0.996692,ADAMTS8 OR10G8 OR10G9 OR10S1 OR8B2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.056e-06|1.336e-06|1.552e-06|2.059e-06|2.39e-06,0.01666|0.01054|0.008159|0.008121|0.00754,37.36|35.21|33.9|31.56|30.4
1773,5,0.604,6.04,3814.0,0.001577,0.996692,NUTM2A OR10H3 OR10H4 SFTPA1 SFTPA2,"G protein-coupled serotonin receptor signaling pathway|serotonin receptor signaling pathway|respiratory gaseous exchange by respiratory system|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|cellular response to dopamine",2.96e-05|3.85e-05|6.219e-05|0.0001099|0.0001591,0.4668|0.3037|0.327|0.4332|0.502,242.3|211.2|164.8|123|101.7
1774,8,0.6159,17.24,5825.0,0.002944,0.9996790000000001,CYP4F11 CYP4F12 CYP4F2 OR10H1 OR10H2 OR10H5 OR7C1 OR7C2,vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process|leukotriene B4 catabolic process|leukotriene catabolic process,1.344e-09|1.344e-09|2.15e-09|2.15e-09|2.15e-09,2.12e-05|1.06e-05|1.13e-05|8.478e-06|6.782e-06,1931|1931|1545|1545|1545
1775,17,0.569,77.38,12820.0,0.005983,1.0,CD1B CD1C CD1E FCRL3 FMO2 ITLN1 ITLN2 KCNJ10 OR10J3 OR10J5 OR6N1 PGLYRP3 RXRG S100A12 S100A2 SLAMF7 YY1AP1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",3.122e-08|6.683e-08|6.683e-08|3.773e-07|2.014e-06,0.0004925|0.0005271|0.0003514|0.001488|0.006354,686.5|490.4|490.4|245.2|132
1776,4,0.6099,3.659,3182.0,0.001146,0.9929309999999999,HCN2 OR13C5 PLA2G4D PLA2G4E,phosphatidylinositol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid catabolic process|phosphatidylcholine acyl-chain remodeling,5.367e-06|7.795e-06|1.067e-05|1.313e-05|1.4e-05,0.08466|0.06148|0.05612|0.05176|0.04417,572.1|468.1|396.1|355.1|343.2
1777,22,0.6036,139.4,17440.0,0.007912,1.0,AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CLEC10A KCTD11 MFSD6L MYH2 MYH4 OR1A1 OR1G1 OR3A3 SHBG SLC2A4 TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,6.906e-10|6.906e-10|4.657e-09|1.212e-08|6.273e-08,1.089e-05|5.447e-06|2.449e-05|4.778e-05|0.0001979,416.1|416.1|234|178.3|113.5
1778,9,0.6183,22.26,7038.0,0.003144,0.9998530000000001,OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 OR1Q1 PALM2 TXNDC8,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,7.606e-11|1.146e-10|1.487e-10|2.435e-10|3.156e-10,1.2e-06|9.039e-07|7.819e-07|9.602e-07|9.958e-07,36.32|34.23|32.96|30.69|29.55
1779,4,0.6173,3.7039999999999997,3091.0,0.001194,0.9929309999999999,OR2B11 ZNF497 ZNF587 ZNF814,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",0.007187|0.01665|0.01667|0.01674|0.02068,1|1|1|1|1,5.973|4.459|4.458|4.451|4.132
1780,9,0.615,22.14,6662.0,0.003303,0.9998530000000001,BTN2A2 OR14J1 OR2B2 OR2B6 OR2J3 TRIM10 ZKSCAN4 ZNF165 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.482e-05|3.127e-05|3.621e-05|4.778e-05|5.528e-05,0.3915|0.2466|0.1904|0.1884|0.1744,20.76|19.56|18.83|17.54|16.89
1781,8,0.6222,17.42,5815.0,0.002978,0.9996790000000001,FOLR1 FOLR2 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-3 KRTAP5-9 P2RY6,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,1.56e-10|4.254e-10|1.123e-09|3.49e-09|5.763e-09,2.461e-06|3.355e-06|5.905e-06|1.376e-05|1.818e-05,60.75|51.23|43.45|35.85|32.93
1782,4,0.6358,3.815,3252.0,0.001169,0.9929309999999999,ARPC1B OR2L2 SHISA4 UROC1,formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide|formate metabolic process|histidine catabolic process,0.0009706|0.0009706|0.0009706|0.001359|0.001747,1|1|1|1|1,1287|1287|1287|858.1|643.6
1783,5,0.6071,6.071000000000001,3671.0,0.0016460000000000001,0.996692,NBEAL1 OR2T4 PPIAL4G TSPYL5 ZNF728,cellular response to gamma radiation|protein peptidyl-prolyl isomerization|response to gamma radiation|peptidyl-proline modification|cellular response to ionizing radiation,0.007502|0.01184|0.01352|0.01568|0.01664,1|1|1|1|1,137.3|85.81|74.89|64.36|60.57
1784,5,0.6373,6.372999999999999,3651.0,0.001738,0.996692,DIS3L2 LCN10 OR4C11 OR4P4 OR4S2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,9.63e-05|0.0001148|0.0001283|0.0001584|0.000177,1|0.9052|0.6746|0.6247|0.5584,28.02|26.4|25.43|23.67|22.8
1785,4,0.6353,3.812,3077.0,0.001234,0.9929309999999999,GXYLT1 OR4C6 RPRD1A SH2D2A,dephosphorylation of RNA polymerase II C-terminal domain|O-glycan processing|snRNA transcription by RNA polymerase II|snRNA transcription|vascular endothelial growth factor receptor signaling pathway,0.002328|0.01199|0.01372|0.01391|0.01391,1|1|1|1|1,468.1|84.41|73.55|72.52|72.52
1786,4,0.6395,3.8369999999999997,3216.0,0.001189,0.9929309999999999,LILRA1 OR4F6 SIGLEC12 TPRX1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.08311|0.08802|0.09127|0.09776|0.1014,1|1|1|1|1,11.68|11|10.59|9.864|9.5
1787,21,0.6043,126.9,15460.0,0.008119,1.0,ANG BCL2L2 CEBPE CMA1 CMTM5 DHRS2 EDDM3A EDDM3B GZMH LTB4R MYH6 OR10G2 OR10G3 OR11G2 OR11H4 OR4E2 OR4K13 OR5AU1 RNASE7 SLC7A8 TM9SF1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.951e-07|2.899e-07|3.727e-07|5.99e-07|7.684e-07,0.003078|0.002287|0.00196|0.002362|0.002424,15.57|14.67|14.13|13.15|12.67
1788,9,0.6039,21.74,6425.0,0.003363,0.9998530000000001,OR11G2 OR11H4 OR4K13 OR4K14 OR4M2 OR4N4 OR5AU1 RNASE4 RNF145,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,7.606e-11|1.146e-10|1.487e-10|2.435e-10|3.156e-10,1.2e-06|9.039e-07|7.819e-07|9.602e-07|9.958e-07,36.32|34.23|32.96|30.69|29.55
1789,4,0.6002,3.6010000000000004,3005.0,0.001194,0.9929309999999999,OR4L1 OR5AU1 RNASE6 RNASE9,RNA phosphodiester bond hydrolysis|nucleic acid phosphodiester bond hydrolysis|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception,0.0003878|0.001286|0.00269|0.003023|0.003256,1|1|1|1|1,62.41|33.99|23.35|22|21.19
1790,12,0.5806,38.32,8964.0,0.0042450000000000005,0.999986,FAM189B FCGR2B FCGR3A FCRL3 GBA HSPA6 ITLN2 SLAMF7 TMCO1 TSACC XCL1 YY1AP1,negative regulation of production of molecular mediator of immune response|regulation of immunoglobulin production|negative regulation of B cell receptor signaling pathway|negative regulation of immunoglobulin production|negative regulation of immune effector process,1.71e-06|8.433e-06|1.117e-05|3.713e-05|4.943e-05,0.02697|0.06651|0.05871|0.1464|0.156,132|75.72|490.4|245.2|41.19
1791,4,0.6369,3.821,3013.0,0.001263,0.9929309999999999,OR51I1 OR52B2 OR52M1 OR5P2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.149e-07|2.723e-07|3.164e-07|4.205e-07|4.883e-07,0.00339|0.002147|0.001663|0.001658|0.001541,46.7|44.01|42.38|39.45|38
1792,4,0.6369,3.821,3044.0,0.001251,0.9929309999999999,HBE1 OR51B4 OR52B6 OR56A1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.915e-05|4.671e-05|5.225e-05|6.46e-05|7.223e-05,0.6176|0.3684|0.2747|0.2548|0.2279,35.03|33|31.78|29.59|28.5
1793,4,0.637,3.822,3350.0,0.001137,0.9929309999999999,CTNNAL1 LZTFL1 OR5B17 TTC23,negative regulation of protein localization to ciliary membrane|regulation of protein localization to ciliary membrane|negative regulation of protein localization to cilium|regulation of protein localization to cilium|negative regulation of protein localization to cell periphery,0.0003883|0.0005825|0.0005825|0.001747|0.005233,1|1|1|1|1,5149|2574|2574|643.6|198
1794,18,0.6054,92.63,14020.0,0.006548999999999999,1.0,ARPC1B C7orf43 CYP3A4 CYP3A43 CYP3A5 CYP3A7 PILRA PILRB PON1 PVRIG RASA4 RASA4B SPDYE1 TRIM50 WNT2 ZKSCAN1 ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|steroid metabolic process|retinoic acid metabolic process,2.776e-09|5.572e-08|2.807e-07|1.914e-06|3.272e-06,4.379e-05|0.0004394|0.001476|0.007548|0.01032,255|519.2|73.42|23.12|110.1
1795,7,0.6223,13.07,5129.0,0.002535,0.9992989999999999,OR14J1 OR2B3 OR2J2 OR2J3 OR2W1 OR5V1 TRIM26,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,6.936e-10|9.869e-10|1.235e-09|1.887e-09|2.359e-09,1.094e-05|7.784e-06|6.492e-06|7.443e-06|7.444e-06,40.03|37.72|36.32|33.82|32.57
1796,5,0.63,6.3,3830.0,0.001638,0.996692,CASP1 CASP4 CRYAB KDELC2 OR6B3,positive regulation of tumor necrosis factor-mediated signaling pathway|pyroptosis|protein autoprocessing|positive regulation of cytokine-mediated signaling pathway|positive regulation of response to cytokine stimulus,2.204e-06|5.367e-06|9.177e-06|3.595e-05|4.658e-05,0.03477|0.04233|0.04825|0.1418|0.147,936.1|572.1|429.1|210.2|183.9
1797,6,0.6835,10.25,3883.0,0.002625,0.998474,CCNL1 CDK11A CTNNBL1 PPP1R8 PRPF19 WBP11,RNA processing|RNA splicing|mRNA processing|nucleic acid metabolic process|nucleobase-containing compound metabolic process,3.572e-06|5.21e-06|1.028e-05|1.037e-05|3.308e-05,0.05634|0.04109|0.05408|0.0409|0.1044,15.94|28.92|24.32|7.909|6.492
1798,17,0.6051,82.29,12890.0,0.006326,1.0,HOXC8 KRT1 KRT74 KRT75 KRT77 KRT78 KRT79 KRT82 KRT84 KRT86 OR10A7 OR10P1 OR2AP1 OR6C2 OR6C4 OR6C76 OR9K2,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.543e-16|6.27e-14|2.779e-13|1.174e-12|6.313e-12,2.433e-12|4.945e-10|1.461e-09|4.629e-09|1.992e-08,96.49|48.24|40.68|34.5|28.47
1799,13,0.6001,46.81,9710.0,0.004785,0.999993,CD1B CD1E FCGR2B FCGR3A FCRL3 ITLN2 KCNJ10 MNDA OR10J5 OR6K6 OR6N2 OR6Y1 SLAMF7,"regulation of immune response|regulation of T cell mediated cytotoxicity|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|regulation of B cell proliferation|negative regulation of B cell receptor signaling pathway",1.943e-06|2.062e-06|7.701e-06|8.77e-06|1.319e-05,0.03065|0.01626|0.04049|0.03458|0.04162,9.823|125.1|633.7|75.44|452.6
1800,4,0.6385,3.8310000000000004,2814.0,0.001355,0.9929309999999999,OR7A10 PRPF38A RPL17 SNU13,"mRNA metabolic process|RNA processing|rRNA processing|rRNA metabolic process|mRNA splicing, via spliceosome",0.0001504|0.0003501|0.0009508|0.001024|0.001277,1|1|1|1|1,22.26|16.73|39.61|38.14|34.1
1801,8,0.6115,17.12,5809.0,0.002931,0.9996790000000001,CYP4F11 CYP4F12 CYP4F2 OR10H2 OR7A5 OR7C1 OR7C2 ZNF98,vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process|leukotriene B4 catabolic process|leukotriene catabolic process,1.344e-09|1.344e-09|2.15e-09|2.15e-09|2.15e-09,2.12e-05|1.06e-05|1.13e-05|8.478e-06|6.782e-06,1931|1931|1545|1545|1545
1802,7,0.6202,13.02,5367.0,0.002415,0.9992989999999999,ADAMTS8 FXYD6 HTR3A KCNJ1 NXPE4 OR8B8 TMEM136,ion transmembrane transport|transmembrane transport|regulation of ion transmembrane transport|regulation of transmembrane transport|regulation of ion transmembrane transporter activity,0.0002113|0.0004678|0.0007247|0.000743|0.003441,1|1|1|1|1,11.2|9.109|15.22|15.09|21.96
1803,7,0.6131,12.87,4858.0,0.002636,0.9992989999999999,CDC6 CDT1 GINS2 GINS3 NUP93 ORC1 ORC6,DNA replication initiation|DNA-dependent DNA replication|DNA replication|pre-replicative complex assembly|mitotic cell cycle process,1.159e-12|5.392e-12|3.875e-11|4.002e-09|9.48e-09,1.828e-08|4.253e-08|2.037e-07|1.578e-05|2.991e-05,342.1|90.99|65.14|181.1|25.77
1804,20,0.6011,114.2,15770.0,0.0071719999999999996,1.0,AEBP1 AGR3 CALM1 EGR3 FKBP9 GCK GHRHR MYL7 NIPSNAP2 NUPR2 PHKG1 PSPH RNASET2 SEPT14 SLC29A4 SUMF2 VWC2 ZNF479 ZNF713 ZNF716,carbohydrate catabolic process|cellular carbohydrate metabolic process|generation of precursor metabolites and energy|negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of peptide hormone secretion,7.362e-06|3.635e-05|5.839e-05|8.418e-05|8.807e-05,0.1161|0.2867|0.307|0.332|0.2778,32.28|21.28|11.64|170.2|16.87
1805,5,0.6029,6.029,3989.0,0.001505,0.996692,KRT1 KRT84 MYF5 OSBPL8 PPP1R1A,cornification|protein localization to nuclear pore|keratinization|epithelium development|negative regulation of sequestering of triglyceride,0.0003056|0.0009706|0.001193|0.0014|0.001456,1|1|1|1|1,72.9|1373|36.45|11.26|823.8
1806,4,0.6337,3.802,3295.0,0.00115,0.9929309999999999,CETN3 FGF9 OSCP1 ROR1,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|negative regulation of cell differentiation involved in phenotypic switching|negative regulation of phenotypic switching|regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|regulation of cell differentiation involved in phenotypic switching,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
1807,4,0.6611,3.967,3437.0,0.00115,0.9929309999999999,DCSTAMP ENTHD1 OTOA TMCO2,positive regulation of macrophage fusion|regulation of macrophage fusion|osteoclast fusion|cellular response to macrophage colony-stimulating factor stimulus|response to macrophage colony-stimulating factor,0.001165|0.001165|0.001359|0.001747|0.001747,1|1|1|1|1,1030|1030|858.1|643.6|643.6
1808,4,0.6245,3.747,3541.0,0.0010550000000000002,0.9929309999999999,GM2A OTOL1 SLC30A5 TNFAIP6,otolith mineralization|cobalt ion transport|ganglioside catabolic process|otolith development|collagen-activated tyrosine kinase receptor signaling pathway,0.0005825|0.001553|0.001553|0.001747|0.002522,1|1|1|1|1,2574|735.5|735.5|643.6|429.1
1809,7,0.6501,13.65,4337.0,0.003128,0.9992989999999999,ICMT KRAS NRAS RAF1 RAP1GDS1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction,4.436e-10|1.324e-06|6.304e-06|6.969e-06|7.142e-06,6.998e-06|0.01044|0.03315|0.02748|0.02253,43.16|11.21|76.75|74.17|73.55
1810,4,0.6547,3.928,2776.0,0.0014089999999999999,0.9929309999999999,CNOT4 G3BP2 OTUD6B SRRD,positive regulation of stress granule assembly|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process|regulation of stress granule assembly,0.0005825|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|1716|1716|1287|1030
1811,5,0.6014,6.013999999999999,3322.0,0.001802,0.996692,DDX21 HSPA14 NCL PA2G4 ZNF622,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,2.34e-06|8.789e-06|6.931e-05|7.744e-05|0.0003072,0.03691|0.06932|0.3644|0.3054|0.969,35.45|25.31|33.95|32.69|20.43
1812,9,0.624,22.46,7022.0,0.003181,0.9998530000000001,CAPN5 FCHSD2 KCTD21 OMP P2RY2 P2RY6 PAAF1 PLEKHB1 UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|cellular response to pyrimidine ribonucleotide|response to pyrimidine ribonucleotide,2.029e-05|0.0001973|0.0008375|0.0008734|0.0008734,0.32|1|1|1|1,326.9|97.38|46.23|2288|2288
1813,7,0.6033,12.67,5220.0,0.002415,0.9992989999999999,DEFA5 DEFB108B DEFB4A DEFB4B PABPC4 SOX7 ZNF705B,defense response to bacterium|killing of cells of other organism|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|antimicrobial humoral immune response mediated by antimicrobial peptide,9.204e-05|0.0002556|0.0002862|0.0003594|0.0003809,1|1|1|1|1,29.85|81.73|77.13|68.65|66.65
1814,4,0.64,3.84,2916.0,0.001312,0.9929309999999999,KCNK7 MSTO1 PACS1 SSSCA1,mitochondrion distribution|stabilization of membrane potential|protein localization to Golgi apparatus|regulation of defense response to virus by virus|mitochondrion localization,0.002474|0.002619|0.004363|0.004363|0.007265,1|1|1|1|1,429.1|403.8|236.7|236.7|140.1
1815,4,0.601,3.6060000000000003,3362.0,0.0010689999999999999,0.9929309999999999,ADPRHL2 DCDC2B PAFAH1B3 TSSK3,peptidyl-serine ADP-deribosylation|protein de-ADP-ribosylation|cellular response to superoxide|cellular response to oxygen radical|response to superoxide,0.0003883|0.001359|0.003104|0.003104|0.003685,1|1|1|1|1,5149|858.1|343.2|343.2|286
1816,4,0.6025,3.615,2990.0,0.001204,0.9929309999999999,DEFB4A PABPC4 PAIP1 SOX7,regulation of mRNA stability|regulation of RNA stability|regulation of mRNA catabolic process|regulation of mRNA metabolic process|translation,0.0005229|0.000578|0.0006476|0.001613|0.00205,1|1|1|1|1,53.63|50.98|48.12|30.29|26.82
1817,4,0.6018,3.611,3555.0,0.0010119999999999999,0.9929309999999999,FABP6 FHOD3 PAIP2 TRIM36,cortical actin cytoskeleton organization|cortical cytoskeleton organization|cytoskeleton organization|actin filament network formation|cardiac myofibril assembly,3.663e-05|8.295e-05|0.001835|0.003152|0.00412,0.5778|0.6543|1|1|1,216.8|142|10.26|343.3|257.4
1818,4,0.6243,3.7460000000000004,2834.0,0.0013160000000000001,0.9929309999999999,FAM49B GOLGA7 PANK4 ZDHHC5,protein palmitoylation|protein lipidation|lipoprotein biosynthetic process|lipoprotein metabolic process|protein acylation,1.583e-05|0.0001028|0.0001126|0.0002105|0.0004454,0.2498|0.8109|0.5922|0.8303|1,321.8|122.6|117|85.1|58.18
1819,4,0.6195,3.717,3271.0,0.001132,0.9929309999999999,HTR1D PAPPA SLC25A34 SLC6A19,intestine smooth muscle contraction|gastro-intestinal system smooth muscle contraction|adenylate cyclase-inhibiting serotonin receptor signaling pathway|response to follicle-stimulating hormone|phasic smooth muscle contraction,0.0009706|0.001359|0.001553|0.003104|0.003878,1|1|1|1|1,1287|858.1|735.5|343.2|271
1820,5,0.6118,6.117999999999999,4221.0,0.001444,0.996692,MATN4 PAQR8 PKIG RBPJL WISP2,negative regulation of cAMP-dependent protein kinase activity|negative regulation of protein import|negative regulation of protein import into nucleus|regulation of cAMP-dependent protein kinase activity|negative regulation of nucleocytoplasmic transport,0.002425|0.003152|0.003152|0.005087|0.005087,1|1|1|1|1,457.7|343.3|343.3|205.9|205.9
1821,4,0.6333,3.8,3239.0,0.001169,0.9929309999999999,GOLGA6D OAZ2 PARP6 SNX22,negative regulation of polyamine transmembrane transport|regulation of polyamine transmembrane transport|protein auto-ADP-ribosylation|protein mono-ADP-ribosylation|polyamine biosynthetic process,0.0007766|0.001165|0.002328|0.002522|0.00291,1|1|1|1|1,1716|1030|468.1|429.1|367.8
1822,4,0.608,3.648,3174.0,0.001145,0.9929309999999999,DESI1 MEI1 PARVB PMM1,establishment or maintenance of cell polarity regulating cell shape|GDP-mannose biosynthetic process|protein desumoylation|GDP-mannose metabolic process|mannose metabolic process,0.0005825|0.001165|0.001747|0.001747|0.001941,1|1|1|1|1,2574|1030|643.6|643.6|572.1
1823,10,0.6119,27.54,7955.0,0.0034409999999999996,0.999933,ATXN7L3B CCNB1IP1 KIF26B LYRM1 PCDH10 PCDHB12 PCDHB13 PCDHGA9 RNF150 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,9.25e-07|5.129e-06|7.35e-05|0.0007693|0.0007877,0.01459|0.04045|0.3865|1|1,49.33|31.81|16.03|8.662|8.608
1824,24,0.5647,155.8,19160.0,0.00805,1.0,PCDHA1 PCDHA11 PCDHA13 PCDHA2 PCDHA3 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 PCDHB10 PCDHB11 PCDHB12 PCDHB13 PCDHB5 PCDHB7 PCDHGA10 PCDHGA2 PCDHGA5 PCDHGA6 PCDHGA7 PCDHGB1 PCDHGB3,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,3.574e-50|7.421e-46|5.971e-39|1.19e-32|1.381e-32,5.638e-46|5.853e-42|3.14e-35|4.693e-29|4.358e-29,123.3|79.52|40.07|21.66|21.52
1825,17,0.6062,82.45,13670.0,0.005982,1.0,PCDHA12 PCDHA13 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA9 PCDHB10 PCDHB13 PCDHB3 PCDHB4 PCDHB7 PCDHGA10 PCDHGA2 PCDHGA7 PCDHGB1 SLC22A5,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,1.288e-32|1.092e-29|4.851e-25|7.951e-21|8.782e-21,2.031e-28|8.609e-26|2.551e-21|3.135e-17|2.771e-17,116.1|74.84|37.71|20.38|20.25
1826,4,0.62,3.72,3481.0,0.001065,0.9929309999999999,KCTD6 PCED1A RNF24 TMEM19,negative regulation of smoothened signaling pathway|protein ubiquitination|regulation of intracellular estrogen receptor signaling pathway|protein modification by small protein conjugation|protein modification by small protein conjugation or removal,0.006393|0.007427|0.008517|0.009066|0.01409,1|1|1|1|1,160.9|13.9|119.7|12.54|9.988
1827,19,0.605,103.5,14510.0,0.007061,1.0,ACVRL1 AQP5 GRASP HOXC8 INHBE KRT1 KRT5 KRT6B KRT79 KRT82 KRT84 KRT86 OR10P1 OR6C3 PCED1B PPP1R1A RDH16 RDH5 SDR9C7,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,9.025e-12|9.669e-10|3.062e-09|9.317e-09|3.406e-08,1.424e-07|7.626e-06|1.61e-05|3.674e-05|0.0001074,67.15|33.57|28.31|24.01|19.81
1828,4,0.6148,3.6889999999999996,3345.0,0.001099,0.9929309999999999,PCNX2 SMCR8 ST5 WDR78,positive regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of protein-containing complex disassembly|axonemal dynein complex assembly,0.001019|0.002183|0.002474|0.005234|0.005379,1|1|1|1|1,1144|490.4|429.1|196.1|190.7
1829,5,0.6801,6.801,3306.0,0.0020469999999999998,0.996692,FGFR1OP2 MOB4 RAC1 SLMAP STRIP1,cortical cytoskeleton organization|negative regulation of interleukin-23 production|regulation of membrane depolarization during cardiac muscle cell action potential|mast cell chemotaxis|regulation of membrane depolarization during action potential,8.295e-05|0.000728|0.001213|0.001456|0.001456,1|1|1|1|1,142|2060|1030|823.8|823.8
1830,6,0.6015,9.022,4797.0,0.001872,0.998474,CTSK ECM1 LIX1L PCP4L1 PRR9 SPRR2G,intramembranous ossification|direct ossification|ossification|autophagy|process utilizing autophagic mechanism,0.002328|0.002328|0.002372|0.003212|0.003212,1|1|1|1|1,490.4|490.4|26.2|22.43|22.43
1831,4,0.6896,4.138,3061.0,0.0013460000000000002,0.9929309999999999,OSBPL5 PCTP SRRD TOM1L1,phospholipid transport|organophosphate ester transport|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process,0.0001255|0.0002499|0.0007766|0.0007766|0.0009706,1|1|1|1|1,110.7|78.01|1716|1716|1287
1832,5,0.624,6.24,4150.0,0.001498,0.996692,PDCD1 ZNF382 ZNF415 ZNF571 ZNF813,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|positive regulation of T cell apoptotic process",0.001122|0.003471|0.003475|0.003494|0.003636,1|1|1|1|1,6.371|4.756|4.755|4.748|294.2
1833,6,0.6194,9.292,4018.0,0.0023,0.998474,ARMC7 DHX9 PDCD7 RNPC3 SNRNP25 ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",4.218e-09|4.218e-09|4.429e-09|1.843e-08|4.345e-08,6.653e-05|3.326e-05|2.329e-05|7.269e-05|0.0001371,56.83|56.83|56.27|42.17|35.46
1834,6,0.6589,9.883,4667.0,0.0021079999999999996,0.998474,PDE3A SLCO1B1 SLCO1B3 SLCO1B7 SLCO1C1 TAS2R20,sodium-independent organic anion transport|bile acid and bile salt transport|organic hydroxy compound transport|monocarboxylic acid transport|carboxylic acid transport,9.675e-12|1.472e-10|4.57e-08|4.69e-08|3.269e-07,1.526e-07|1.161e-06|0.0002403|0.000185|0.001031,858.1|403.8|90.93|90.33|55.14
1835,5,0.6209,6.209,3527.0,0.0017519999999999999,0.996692,QRICH1 QSER1 SEPHS1 SPDEF ZNF652,selenocysteine biosynthetic process|lung goblet cell differentiation|lobar bronchus epithelium development|lobar bronchus development|selenocysteine metabolic process,0.000728|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,2060|1373|1030|823.8|823.8
1836,4,0.6074,3.6439999999999997,3400.0,0.001068,0.9929309999999999,FAM43A PDE4C SCARA3 TPRG1,cAMP catabolic process|UV protection|cyclic nucleotide catabolic process|cAMP metabolic process|purine ribonucleotide catabolic process,0.001941|0.002716|0.00291|0.004459|0.006973,1|1|1|1|1,572.1|396.1|367.8|234|147.1
1837,4,0.6368,3.821,3081.0,0.001236,0.9929309999999999,BCL2 DAZAP2 PDE6C RPLP1,positive regulation of protein phosphorylation|positive regulation of phosphorylation|negative regulation of cellular pH reduction|positive regulation of phosphorus metabolic process|positive regulation of phosphate metabolic process,0.0002538|0.000339|0.0003883|0.0004294|0.0004294,1|1|1|1|1,18.65|16.92|5149|15.62|15.62
1838,4,0.64,3.84,2533.0,0.001509,0.9929309999999999,CMIP PDE7A PRKAR1A STK11,negative regulation of reproductive process|regulation of reproductive process|positive regulation of vesicle transport along microtubule|regulation of vesicle transport along microtubule|negative regulation of epithelial cell proliferation involved in prostate gland development,4.821e-05|0.0003786|0.0009706|0.001165|0.001359,0.7605|1|1|1|1,180.7|63.17|1287|1030|858.1
1839,5,0.6044,6.044,4153.0,0.00145,0.996692,ADCYAP1R1 COX19 CYP2W1 GHRHR PDGFA,cAMP-mediated signaling|cyclic-nucleotide-mediated signaling|negative regulation of response to external stimulus|regulation of biological quality|cellular chemical homeostasis,2.481e-05|6.711e-05|0.0001848|0.0002796|0.0004585,0.3914|0.5293|0.9717|1|1,265.7|158.4|22.47|5.14|16.5
1840,5,0.659,6.59,2636.0,0.002484,0.996692,NAPG RAB10 SNAP23 STX4 STXBP3,exocytic process|vesicle docking|Golgi vesicle transport|neurotransmitter secretion|signal release from synapse,6.46e-10|3.273e-07|6.896e-07|9.742e-07|9.742e-07,1.019e-05|0.002582|0.003626|0.003842|0.003073,245.9|193.1|41.61|132.9|132.9
1841,28,0.6002,226.9,19970.0,0.0112,1.0,ACAD9 ATPAF2 CARS2 COA6 COA7 COQ7 DARS2 FOXRED1 GFM2 GTPBP10 GTPBP8 IBA57 MCAT METTL17 MRM2 MRM3 MTFMT MTG1 MTIF2 MTIF3 NDUFAF1 NDUFAF3 NDUFAF7 NSUN4 NUBPL POLG TFB1M YBEY,NADH dehydrogenase complex assembly|mitochondrial respiratory chain complex I assembly|mitochondrial respiratory chain complex assembly|cellular component biogenesis|rRNA methylation,6.523e-10|6.523e-10|7.297e-09|9.758e-08|1.103e-07,1.029e-05|5.145e-06|3.837e-05|0.0003848|0.000348,64.56|64.56|42.19|4.207|101.5
1842,4,0.7083,4.25,3552.0,0.001192,0.9929309999999999,GPR3 IFI6 PDIK1L SPATC1,negative regulation of mitochondrial depolarization|negative regulation of membrane depolarization|regulation of mitochondrial depolarization|release of cytochrome c from mitochondria|regulation of meiotic nuclear division,0.001359|0.001553|0.004072|0.004459|0.0062,1|1|1|1|1,858.1|735.5|257.4|234|166.1
1843,4,0.6112,3.667,2984.0,0.001224,0.9929309999999999,CD1B OR6K2 OR6K6 PDILT,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|detection of chemical stimulus involved in sensory perception of smell|antigen processing and presentation via MHC class Ib",0.001165|0.001553|0.001553|0.00269|0.00291,1|1|1|1|1,1030|735.5|735.5|23.35|367.8
1844,4,0.6043,3.6260000000000003,2809.0,0.001286,0.9929309999999999,ATP6V1F GINS1 PDRG1 UBL5,DNA strand elongation involved in nuclear cell cycle DNA replication|DNA strand elongation involved in cell cycle DNA replication|DNA strand elongation involved in mitotic DNA replication|mitotic DNA replication|inner cell mass cell proliferation,0.0003883|0.0003883|0.0003883|0.002716|0.00291,1|1|1|1|1,5149|5149|5149|396.1|367.8
1845,4,0.6196,3.718,3536.0,0.001048,0.9929309999999999,FAM78A MYOZ1 PDYN USP54,negative regulation of skeletal muscle tissue regeneration|skeletal muscle fiber adaptation|regulation of skeletal muscle tissue regeneration|skeletal muscle adaptation|negative regulation of calcineurin-NFAT signaling cascade,0.0003883|0.0009706|0.001553|0.002716|0.003104,1|1|1|1|1,5149|1287|735.5|396.1|343.2
1846,11,0.604,33.22,8686.0,0.0038,0.999969,ANXA2R C1QTNF3 C7 CCL28 CDH6 FBXO4 HCN1 NIM1K PDZD2 UGT3A1 UGT3A2,cytolysis|cellular homeostasis|cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid,0.0001527|0.0009016|0.001067|0.001067|0.001067,1|1|1|1|1,113.5|8.434|1872|1872|1872
1847,4,0.6125,3.675,3091.0,0.001185,0.9929309999999999,DSCAML1 OR10G9 OR6X1 PDZD3,negative regulation of guanylate cyclase activity|negative regulation of purine nucleotide biosynthetic process|negative regulation of nucleotide biosynthetic process|negative regulation of cGMP-mediated signaling|response to chemical,0.0007766|0.001359|0.001359|0.001359|0.002029,1|1|1|1|1,1716|858.1|858.1|858.1|4.714
1848,4,0.6273,3.764,3396.0,0.001105,0.9929309999999999,C20orf194 PDZD8 PLCB4 ZFYVE27,endoplasmic reticulum tubular network formation|mitochondrion-endoplasmic reticulum membrane tethering|endoplasmic reticulum tubular network organization|neurotrophin TRK receptor signaling pathway|mitochondrial calcium ion homeostasis,0.0009706|0.0009706|0.003104|0.004072|0.005233,1|1|1|1|1,1287|1287|343.2|257.4|198
1849,6,0.6015,9.022,4285.0,0.002095,0.998474,ABCE1 MAK16 PES1 RPL14 RPL18 RPL7,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ribosomal large subunit biogenesis,1.867e-11|1.384e-10|2.014e-09|2.426e-09|2.551e-09,2.945e-07|1.092e-06|1.059e-05|9.568e-06|8.047e-06,62.03|44.29|66.01|63.56|190.7
1850,4,0.7283,4.37,2809.0,0.001549,0.9929309999999999,LSM2 PDRG1 PFDN2 PFDN6,negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|protein folding|negative regulation of supramolecular fiber organization|regulation of supramolecular fiber organization,2.572e-06|3.843e-06|5.523e-06|0.0003385|0.001956,0.04057|0.03031|0.02904|1|1,858.1|686.5|67.75|66.87|27.46
1851,14,0.6078,55.31,11730.0,0.00468,0.9999969999999999,ADCYAP1R1 AEBP1 AGR2 AGR3 GCK GHRHR HOXA6 HOXA7 KIAA0895 MYO1G NME8 PGAM2 UBE2D4 URGCP,glycolytic process|ATP generation from ADP|ADP metabolic process|nucleoside diphosphate phosphorylation|nucleotide phosphorylation,4.057e-06|4.345e-06|6.747e-06|1.206e-05|1.265e-05,0.064|0.03427|0.03547|0.04758|0.03992,100.5|98.07|84.06|68.65|67.52
1852,4,0.6121,3.673,2971.0,0.001231,0.9929309999999999,EPO PGAM5 PINX1 PUM3,negative regulation of erythrocyte apoptotic process|regulation of erythrocyte apoptotic process|defense response to nematode|positive regulation of telomeric DNA binding|erythropoietin-mediated signaling pathway,0.0004854|0.0004854|0.000728|0.000728|0.001213,1|1|1|1|1,4119|4119|2060|2060|1030
1853,5,0.6399,6.399,3465.0,0.001838,0.996692,BRF2 FNTA GINS4 PGGT1B TTI2,protein geranylgeranylation|protein prenylation|prenylation|positive regulation of tubulin deacetylation|cellular response to transforming growth factor beta stimulus,1.978e-06|4.66e-06|4.66e-06|0.0005824|0.0008166,0.0312|0.03675|0.0245|1|1,1144|686.5|686.5|3432|45.16
1854,9,0.6191,22.29,5596.0,0.003954,0.9998530000000001,ALDOA GAPDH GPI PGAM1 PGD PGLS PKM SLC2A1 TPI1,monosaccharide metabolic process|NADH regeneration|glucose catabolic process to pyruvate|canonical glycolysis|glycolytic process through glucose-6-phosphate,3.694e-16|8.732e-16|8.732e-16|8.732e-16|1.06e-15,5.827e-12|6.887e-12|4.591e-12|3.444e-12|3.345e-12,101.7|508.5|508.5|508.5|490.4
1855,4,0.6261,3.7560000000000002,3289.0,0.0011380000000000001,0.9929309999999999,CAMKMT ILDR2 PGM1 STAG3,galactose catabolic process|galactose metabolic process|glycogen catabolic process|glucan catabolic process|cellular polysaccharide catabolic process,0.001747|0.002716|0.003685|0.003878|0.004072,1|1|1|1|1,643.6|396.1|286|271|257.4
1856,5,0.6146,6.146,3978.0,0.001539,0.996692,PHYKPL SIGLEC7 SIGLEC9 ZNF432 ZNF534,lysine catabolic process|lysine metabolic process|aspartate family amino acid catabolic process|collagen catabolic process|aspartate family amino acid metabolic process,0.003152|0.003394|0.005812|0.01064|0.01424,1|1|1|1|1,343.3|316.8|179.1|95.79|71.02
1857,4,0.6777,4.066,3232.0,0.001254,0.9929309999999999,LILRA1 PI3 SIGLEC12 TNNC2,copulation|skeletal muscle contraction|mating|actin-myosin filament sliding|muscle filament sliding,0.003104|0.006393|0.006393|0.007552|0.007552,1|1|1|1|1,343.2|160.9|160.9|135.5|135.5
1858,8,0.6046,16.93,6494.0,0.002594,0.9996790000000001,CLEC2B CLEC4D CLEC6A KCNA6 PIANP PRB4 PZP TAS2R20,regulation of immune response|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction|positive regulation of myeloid dendritic cell activation,0.0005327|0.0008755|0.0009359|0.0009513|0.001164,1|1|1|1|1,9.121|44.77|43.27|42.91|1287
1859,5,0.6114,6.114,3882.0,0.0015689999999999999,0.996692,CRYAB HTR3A NXPE1 NXPE4 PIH1D2,box C/D snoRNP assembly|tubulin complex assembly|small nucleolar ribonucleoprotein complex assembly|negative regulation of amyloid fibril formation|regulation of amyloid fibril formation,0.002183|0.002425|0.002667|0.003152|0.003878,1|1|1|1|1,514.9|457.7|411.9|343.3|274.6
1860,5,0.602,6.02,3990.0,0.001503,0.996692,OR1J1 OR1J4 PIP5KL1 RGS3 TOR1B,G protein-coupled receptor signaling pathway|negative regulation of protein phosphorylation|negative regulation of mitochondrial membrane potential|negative regulation of phosphorylation|negative regulation of membrane potential,0.002443|0.00283|0.003152|0.003565|0.003636,1|1|1|1|1,9.298|23.47|343.3|20.86|294.2
1861,8,0.6068,16.99,6051.0,0.002793,0.9996790000000001,OR1A1 OR1A2 OR1D5 OR1G1 OR3A1 P2RX1 PITPNA SPNS3,nervous system process|detection of chemical stimulus involved in sensory perception of smell|sensory perception|sensory perception of smell|detection of chemical stimulus involved in sensory perception,4.653e-08|2.467e-07|2.924e-07|3.303e-07|3.976e-07,0.000734|0.001946|0.001538|0.001303|0.001254,13.06|29.19|15.87|27.5|26.49
1862,4,0.6104,3.6630000000000003,3166.0,0.001153,0.9929309999999999,ADAM11 CRHR1 OR4D1 PIWIL3,corticotropin secretion|regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway|regulation of corticosterone secretion|cellular response to corticotropin-releasing hormone stimulus|response to corticotropin-releasing hormone,0.0003883|0.0003883|0.001165|0.001165|0.001165,1|1|1|1|1,5149|5149|1030|1030|1030
1863,9,0.6221,22.4,7479.0,0.002978,0.9998530000000001,C8orf76 CA1 CA13 CA2 CA3 CYP7A1 PKIA TMEM67 TMEM69,one-carbon metabolic process|bicarbonate transport|organic anion transport|small molecule metabolic process|positive regulation of dipeptide transport,3.42e-09|4.52e-09|3.007e-07|0.0005502|0.001455,5.395e-05|3.565e-05|0.001581|1|1,211.2|196.1|30.29|6.345|1030
1864,20,0.6012,114.2,15060.0,0.007509,1.0,CD1B CD1C CD1E CTSK EFNA4 FCRL3 GBA ITLN2 KCNJ10 LCE3E OR10J5 OR6K6 PGLYRP3 S100A12 S100A2 S100A4 S100A8 S100A9 SLAMF7 YY1AP1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",4.359e-08|9.33e-08|9.33e-08|5.264e-07|2.808e-06,0.0006876|0.0007358|0.0004906|0.002076|0.008858,617.9|441.3|441.3|220.7|118.8
1865,4,0.6274,3.764,3304.0,0.001135,0.9929309999999999,HSD3B2 NCMAP PLA2G2E ZNF683,regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response|peripheral nervous system myelin formation|cellular response to ionomycin|response to ionomycin,0.0005825|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,2574|1716|1716|1030|1030
1866,11,0.6226,34.24,8450.0,0.004026,0.999969,CCM2L DEFB116 DUSP15 FOXS1 HCK MYLK2 NOL4L PLAGL2 POFUT1 TM9SF4 XKR7,phagocytosis|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding|skeletal muscle satellite cell differentiation,0.0006051|0.001601|0.002134|0.002667|0.002667,1|1|1|1|1,17.23|936.1|624.1|468.1|468.1
1867,4,0.6659,3.995,2860.0,0.001391,0.9929309999999999,NFIA PLAT POLQ VPS36,double-strand break repair via alternative nonhomologous end joining|DNA replication|protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|smooth muscle cell migration|plasminogen activation,0.0009706|0.001032|0.001165|0.002134|0.002328,1|1|1|1|1,1287|38|1030|514.9|468.1
1868,4,0.6019,3.611,3068.0,0.001173,0.9929309999999999,HTR3A PLAUR POU2F3 TMEM136,urokinase plasminogen activator signaling pathway|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|positive regulation of homotypic cell-cell adhesion|negative regulation by host of viral transcription|regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,0.0005825|0.001359|0.001941|0.003104|0.003491,1|1|1|1|1,2574|858.1|572.1|343.2|302.9
1869,4,0.6494,3.897,3492.0,0.001112,0.9929309999999999,C19orf38 CPNE9 PLCD1 VANGL1,positive regulation of dendrite extension|regulation of dendrite extension|inositol phosphate metabolic process|regulation of anatomical structure morphogenesis|phosphatidylinositol-mediated signaling,0.004846|0.005426|0.0116|0.01215|0.01583,1|1|1|1|1,214.5|190.7|87.27|10.78|63.56
1870,4,0.61,3.66,3163.0,0.001153,0.9929309999999999,EVI5 IL4I1 PLCD4 TMEM213,L-phenylalanine catabolic process|L-phenylalanine metabolic process|erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process|erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process|aromatic amino acid family catabolic process,0.002328|0.002328|0.002328|0.002328|0.004072,1|1|1|1|1,468.1|468.1|468.1|468.1|257.4
1871,5,0.6183,6.183,3787.0,0.001626,0.996692,ABHD11 CASTOR3 CLDN3 EFNA2 PLEK,actin cytoskeleton reorganization|regulation of cell diameter|phospholipase C-inhibiting G protein-coupled receptor signaling pathway|positive regulation of inositol-polyphosphate 5-phosphatase activity|regulation of inositol-polyphosphate 5-phosphatase activity,0.0001099|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,123|4119|4119|4119|4119
1872,8,0.6042,16.92,4834.0,0.003476,0.9996790000000001,DEPDC5 NPRL2 PLEKHA1 PLEKHH3 PTEN TBC1D7 TSC1 TSC2,negative regulation of TOR signaling|negative regulation of intracellular signal transduction|regulation of TOR signaling|negative regulation of signal transduction|negative regulation of cell communication,3.085e-12|3.674e-11|1.646e-10|2.706e-08|4.492e-08,4.866e-08|2.898e-07|8.652e-07|0.0001067|0.0001417,299.3|36.63|130|14.12|13.12
1873,4,0.6215,3.7289999999999996,3178.0,0.001169,0.9929309999999999,GABRA5 PLEKHB2 POTEI SCTR,"cellular water homeostasis|diet induced thermogenesis|synaptic transmission, GABAergic|positive regulation of cAMP-mediated signaling|adaptive thermogenesis",0.001553|0.002328|0.003104|0.003491|0.003685,1|1|1|1|1,735.5|468.1|343.2|302.9|286
1874,4,0.6256,3.753,3164.0,0.001182,0.9929309999999999,LPA PLG TCP10 TCP10L2,positive regulation of fibrinolysis|negative regulation of fibrinolysis|negative regulation of cell-cell adhesion mediated by cadherin|regulation of fibrinolysis|low-density lipoprotein particle remodeling,0.0009706|0.002134|0.002134|0.00291|0.003491,1|1|1|1|1,1287|514.9|514.9|367.8|302.9
1875,19,0.6078,103.9,14460.0,0.007117,1.0,AQP5 HOXC5 HOXC6 HOXC8 INHBE KRT1 KRT5 KRT6B KRT79 KRT82 KRT84 KRT86 OR10P1 OR6C3 OR6C65 PPP1R1A RDH16 RDH5 SDR9C7,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,9.025e-12|9.669e-10|3.062e-09|9.317e-09|3.406e-08,1.424e-07|7.626e-06|1.61e-05|3.674e-05|0.0001074,67.15|33.57|28.31|24.01|19.81
1876,4,0.6662,3.997,3450.0,0.001155,0.9929309999999999,BVES PLN PTGES ZDHHC14,regulation of heart rate|cardiac muscle tissue development|negative regulation of calcium ion import into sarcoplasmic reticulum|regulation of the force of heart contraction by cardiac conduction|negative regulation of calcium ion binding,0.0001363|0.000313|0.0005825|0.0005825|0.0007766,1|1|1|1|1,106.2|69.58|2574|2574|1716
1877,6,0.6378,9.567,4863.0,0.001959,0.998474,ANKRD55 GZMK ITGA1 ITGA2 PLPP1 RNF138,positive regulation of phosphatase activity|positive regulation of dephosphorylation|integrin-mediated signaling pathway|cell-matrix adhesion|positive regulation of collagen binding,4.434e-05|0.0001284|0.0003455|0.0005653|0.0005824,0.6994|1|1|1|1,201.9|116.4|70.05|54.48|3432
1878,4,0.6024,3.614,3297.0,0.001092,0.9929309999999999,FAM111B PLPP7 WISP3 ZNF483,negative regulation of myotube differentiation|negative regulation of striated muscle cell differentiation|regulation of myotube differentiation|negative regulation of muscle cell differentiation|regulation of striated muscle cell differentiation,0.002183|0.004944|0.00596|0.008134|0.0119,1|1|1|1|1,490.4|208|171.6|124.8|84.75
1879,6,0.6278,9.417,4625.0,0.002027,0.998474,AMN1 BICD1 ETFBKMT KIAA1551 PLS1 SYT10,negative regulation of viral genome replication|actin filament bundle assembly|actin filament bundle organization|regulation of viral genome replication|negative regulation of viral process,0.0001511|0.0001735|0.0001914|0.0003568|0.0004352,1|1|1|1|1,109|101.5|96.46|70.05|63.27
1880,5,0.6309,6.309,3945.0,0.001593,0.996692,AQP5 IKZF4 KRT7 KRT86 PLTP,cornification|vitamin E biosynthetic process|protein homooligomerization|keratinization|vitamin E metabolic process,0.0003056|0.0004854|0.0007628|0.001193|0.001213,1|1|1|1|1,72.9|4119|45.77|36.45|1030
1881,9,0.6036,21.73,5631.0,0.003832,0.9998530000000001,ATRIP HUS1 RAD1 RAD17 RAD9A RFC5 RNASEH2A RNASEH2B RNASEH2C,DNA replication|regulation of signal transduction by p53 class mediator|DNA repair|nucleic acid phosphodiester bond hydrolysis|DNA damage checkpoint,8.749e-12|1.675e-10|8.809e-10|2.164e-09|3.809e-09,1.38e-07|1.321e-06|4.632e-06|8.533e-06|1.202e-05,53.2|63.05|27.2|40.78|74.08
1882,20,0.6009,114.2,15940.0,0.007092,1.0,ALDH3A1 ALOXE3 CCDC144A CCDC144NL DRC3 GID4 HS3ST3A1 KRT16 LLGL1 MFAP4 MIEF2 MYO15A PMP22 SLC47A2 TBC1D28 TNFRSF13B TNFSF12 TRPV2 ZNF287 ZNF624,establishment of skin barrier|regulation of water loss via skin|multicellular organismal water homeostasis|water homeostasis|epithelial cell migration,0.0003754|0.0004337|0.002877|0.00351|0.004113,1|1|1|1|1,74.89|69.34|25.65|23.11|21.28
1883,4,0.6505,3.903,3272.0,0.001189,0.9929309999999999,DSCAM PNLDC1 SLC25A39 SLC8B1,post-embryonic retina morphogenesis in camera-type eye|calcium export from the mitochondrion|regulation of chemotaxis|positive regulation of axon extension involved in axon guidance|regulation of cardiac muscle cell membrane potential,0.0005825|0.0005825|0.0006963|0.001553|0.001553,1|1|1|1|1,2574|2574|46.39|735.5|735.5
1884,5,0.6242,6.242000000000001,3382.0,0.001836,0.996692,NEDD8 PNN PSMA6 SCFD1 SRP54,"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition|exocrine pancreas development|protein deubiquitination|protein modification by small protein removal|SRP-dependent cotranslational protein targeting to membrane, translocation",0.000728|0.001456|0.001792|0.002013|0.002183,1|1|1|1|1,2060|823.8|29.63|27.93|514.9
1885,4,0.6121,3.673,3174.0,0.001153,0.9929309999999999,CACNA2D1 KREMEN1 OR5B2 PNPLA3,"triglyceride acyl-chain remodeling|cellular response to 3,3',5-triiodo-L-thyronine|response to 3,3',5-triiodo-L-thyronine|membrane depolarization during bundle of His cell action potential|calcium ion transmembrane transport via high voltage-gated calcium channel",0.0003883|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|2574|1716|1716|1716
1886,4,0.6258,3.755,3285.0,0.001139,0.9929309999999999,LBP PNRC1 SIRPG SPEF1,positive regulation of cytolysis|cell migration|positive regulation of respiratory burst involved in inflammatory response|lipopolysaccharide transport|localization of cell,0.0003883|0.0003993|0.0005825|0.0005825|0.0005927,1|1|1|1|1,5149|16.01|2574|2574|14
1887,7,0.6261,13.15,4989.0,0.002621,0.9992989999999999,INTS4 NUMA1 POLA2 POLD3 RPS3 SPCS2 UVRAG,cell cycle process|cell cycle|spindle organization|positive regulation of microtubule polymerization|positive regulation of microtubule polymerization or depolymerization,7.37e-06|2.645e-05|4.531e-05|5.199e-05|6.553e-05,0.1163|0.2086|0.2382|0.205|0.2067,13.75|10.58|39.23|189.8|168.1
1888,7,0.6026,12.66,4896.0,0.002571,0.9992989999999999,GRWD1 LENG1 NUP62 PNKP POLD1 SNRNP70 TSEN34,"base-excision repair, gap-filling|DNA replication|DNA damage response, detection of DNA damage|nucleic acid phosphodiester bond hydrolysis|base-excision repair",6.553e-05|7.828e-05|8.064e-05|0.0001087|0.0001735,1|0.6174|0.424|0.4285|0.5474,168.1|32.57|150.9|29.13|101.5
1889,8,0.6004,16.81,5625.0,0.002972,0.9996790000000001,ARRDC4 DNAL4 IER5 ITPKA POLR1E PWP1 TCOF1 TMEM82,"transcription by RNA polymerase I|nucleolar large rRNA transcription by RNA polymerase I|rRNA transcription|transcription, DNA-templated|nucleic acid-templated transcription",8.666e-07|1.695e-06|4.271e-05|5.975e-05|6.017e-05,0.01367|0.01337|0.2246|0.2356|0.1898,159.7|1526|217.9|16.55|16.52
1890,4,0.6691,4.013999999999999,2919.0,0.00137,0.9929309999999999,COPA INTS3 POMC PSMB4,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|positive regulation of neutrophil mediated killing of fungus|regulation of neutrophil mediated killing of fungus|regulation of G2/M transition of mitotic cell cycle,0.0001363|0.0001684|0.0005825|0.0005825|0.0005836,1|1|1|1|1,106.2|95.35|2574|2574|50.73
1891,4,0.6216,3.73,3694.0,0.001007,0.9929309999999999,NQO1 POMGNT1 SMIM18 TEX15,response to flavonoid|response to hydrogen sulfide|response to L-glutamine|response to tetrachloromethane|NADH oxidation,0.0007766|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,1716|1716|1287|1287|1030
1892,4,0.6027,3.616,3317.0,0.001086,0.9929309999999999,DGAT1 PMP2 POMT2 STAU2,positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|monoacylglycerol biosynthetic process|acylglycerol acyl-chain remodeling|positive regulation of protein glycosylation,0.0007766|0.0007766|0.001553|0.001747|0.001941,1|1|1|1|1,1716|1716|735.5|643.6|572.1
1893,4,0.6576,3.946,2889.0,0.0013599999999999999,0.9929309999999999,CXADR POTEC POTEF POTEM,AV node cell-bundle of His cell adhesion involved in cell communication|tissue homeostasis|regulation of AV node cell action potential|germ cell migration|cardiac muscle cell-cardiac muscle cell adhesion,0.0003883|0.0007339|0.0007766|0.001359|0.001553,1|1|1|1|1,5149|45.16|1716|858.1|735.5
1894,7,0.6036,12.68,5153.0,0.002447,0.9992989999999999,CCDC74B CFC1 CFC1B MZT2A POTEG POTEI TUBA3D,nodal signaling pathway|activin receptor signaling pathway|determination of left/right symmetry|determination of bilateral symmetry|specification of symmetry,8.988e-06|4e-05|0.0007399|0.0008004|0.0008127,0.1418|0.3155|1|1|1,490.4|217.9|48.23|46.33|45.97
1895,17,0.6058,82.38,13990.0,0.00584,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 GCK GHRHR HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MYO1G NME8 POU6F2 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|lobar bronchus epithelium development|lobar bronchus development,1.397e-06|3.811e-06|7.191e-06|1.078e-05|1.509e-05,0.02203|0.03006|0.03781|0.04251|0.04759,48.69|37.51|762.8|572.1|457.7
1896,5,0.6195,6.195,3422.0,0.001802,0.996692,EPRS GGPS1 GUK1 IARS2 PPA1,tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|small molecule metabolic process|tRNA metabolic process,1.26e-07|1.512e-07|1.602e-07|3.065e-06|6.919e-06,0.001988|0.001192|0.0008425|0.01209|0.02183,268.6|252.2|247.1|12.69|68.27
1897,5,0.6239,6.239,4079.0,0.001523,0.996692,CXCL17 KPTN NTN5 PPFIA3 ZNF155,synaptic vesicle docking|regulation of short-term neuronal synaptic plasticity|macrophage chemotaxis|negative regulation of TORC1 signaling|positive regulation of macrophage chemotaxis,0.00291|0.003394|0.003636|0.004362|0.004362,1|1|1|1|1,374.5|316.8|294.2|242.3|242.3
1898,21,0.6024,126.5,16720.0,0.007492,1.0,CASQ2 CD101 CYB561D1 FAM19A3 FAM69A GBP5 GNAI3 GNAT2 GSTM2 GSTM3 GSTM4 GSTM5 HSD3B1 IFI44 INKA2 KCNA10 PPM1J RHOC SLC22A15 TMEM56 UBL4B,glutathione derivative biosynthetic process|glutathione derivative metabolic process|nitrobenzene metabolic process|xenobiotic catabolic process|glutathione metabolic process,9.497e-09|9.497e-09|2.726e-08|3.527e-07|5.347e-07,0.0001498|7.491e-05|0.0001433|0.001391|0.001687,187.2|187.2|772.3|257.4|63.37
1899,4,0.6025,3.615,3223.0,0.001118,0.9929309999999999,PPM1L PTOV1 VSTM2B ZNF792,sphingolipid biosynthetic process|membrane lipid biosynthetic process|sphingolipid metabolic process|transmembrane receptor protein serine/threonine kinase signaling pathway|membrane lipid metabolic process,0.01928|0.02672|0.03128|0.0379|0.04035,1|1|1|1|1,52.01|37.31|31.78|26.14|24.52
1900,8,0.6127,17.15,5565.0,0.003064,0.9996790000000001,LUZP1 MPRIP PPP1R12A PPP1R12C ROCK1 ROCK2 SPECC1L SSH2,regulation of myosin-light-chain-phosphatase activity|actin cytoskeleton organization|regulation of angiotensin-activated signaling pathway|cytoskeleton organization|actin filament-based process,4.605e-09|5.753e-07|7.913e-07|1.025e-06|1.1e-06,7.264e-05|0.004537|0.004161|0.004041|0.003469,1103|24.56|2574|12.83|21.52
1901,5,0.6041,6.041,3934.0,0.001529,0.996692,APOPT1 BAG5 CRIP1 MOK PPP1R13B,intrinsic apoptotic signaling pathway|cell death|prostate gland stromal morphogenesis|negative regulation of protein refolding|regulation of protein refolding,0.0003089|0.0005555|0.0005825|0.0009706|0.0009706,1|1|1|1|1,70.05|14.32|2574|1287|1287
1902,7,0.6332,13.3,5076.0,0.002606,0.9992989999999999,ECHS1 JAK3 LDLR LDLRAP1 MCEMP1 PYCR2 REEP4,receptor-mediated endocytosis involved in cholesterol transport|intracellular cholesterol transport|intracellular sterol transport|low-density lipoprotein particle clearance|plasma lipoprotein particle clearance,9.891e-07|2.072e-05|2.279e-05|3.204e-05|8.064e-05,0.0156|0.1634|0.1198|0.1263|0.2544,1961|309.7|294.2|245.2|150.9
1903,8,0.6053,16.95,6289.0,0.002681,0.9996790000000001,FAM209B GGT7 MAP1LC3A MYLK2 PPP1R16B RIPOR3 WFDC6 WISP2,negative regulation of peptidyl-serine dephosphorylation|regulation of muscle filament sliding|skeletal muscle satellite cell differentiation|response to iron(II) ion|regulation of peptidyl-serine dephosphorylation,0.001358|0.001698|0.001698|0.002037|0.002037,1|1|1|1|1,980.7|735.5|735.5|588.4|588.4
1904,4,0.6437,3.862,2602.0,0.001477,0.9929309999999999,PPP1R11 PPP1R2 PPP1R7 SUGT1,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|regulation of dephosphorylation|negative regulation of phosphoprotein phosphatase activity,8.687e-07|1.446e-06|2.786e-06|4.705e-06|5.859e-05,0.0137|0.01141|0.01465|0.01855|0.1848,126.6|106.5|85.34|71.51|163.5
1905,4,0.6534,3.92,3268.0,0.0011949999999999999,0.9929309999999999,APBA1 PIP5K1B PPP2R5A PRKACG,gamma-aminobutyric acid secretion|negative regulation of lipid kinase activity|gamma-aminobutyric acid transport|chemical synaptic transmission|anterograde trans-synaptic signaling,0.0005825|0.001747|0.001941|0.002445|0.002445,1|1|1|1|1,2574|643.6|572.1|24.52|24.52
1906,5,0.6529,6.529,3662.0,0.001775,0.996692,DYNC1LI2 PPP2R5C PPP2R5D PPP2R5E SNRK,regulation of protein autophosphorylation|regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|protein dephosphorylation,1.425e-07|2.162e-06|3.596e-06|6.919e-06|1.167e-05,0.002247|0.01705|0.01891|0.02729|0.03681,257.4|101.3|85.22|68.27|57.21
1907,10,0.6103,27.46,6189.0,0.004404,0.999933,ANKRD52 CYB5R4 LCMT1 PPME1 PPP4R3A PPP6C PPP6R1 PPP6R3 PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|regulation of dephosphorylation|negative regulation of phosphoprotein phosphatase activity,3.685e-09|8.526e-09|2.511e-08|5.946e-08|5.084e-06,5.812e-05|6.725e-05|0.000132|0.0002345|0.01604,76.73|64.56|51.72|43.34|89.16
1908,8,0.6153,17.23,5976.0,0.002867,0.9996790000000001,ISL2 LHX3 LRP8 NEUROD1 OTP OTX2 PRDX6 SCLY,forebrain development|central nervous system development|neuron differentiation|ventral spinal cord development|generation of neurons,1.187e-07|3.258e-07|4.043e-07|6.592e-07|1.271e-06,0.001873|0.00257|0.002126|0.002599|0.00401,33.87|15.59|15.03|171.6|12.37
1909,4,0.691,4.146,2979.0,0.0013859999999999999,0.9929309999999999,PREB RPS7 TTC27 WDR43,rRNA processing|regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis|regulation of COPII vesicle coating|rRNA metabolic process|positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,0.0009508|0.0009706|0.0009706|0.001024|0.001165,1|1|1|1|1,39.61|1287|1287|38.14|1030
1910,9,0.6091,21.93,6204.0,0.003512,0.9998530000000001,EIF2S1 ETF1 PRELID1 PSMA1 PSMA3 PSMA5 PSMA6 PSMB3 SARS,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,3.277e-13|4.879e-11|4.879e-11|4.879e-11|4.879e-11,5.169e-09|3.848e-07|2.565e-07|1.924e-07|1.539e-07,520.1|176|176|176|176
1911,4,0.7147,4.288,3119.0,0.00137,0.9929309999999999,DPP3 PREP XPNPEP1 ZER1,proteolysis|protein metabolic process|organonitrogen compound metabolic process|bradykinin catabolic process|macromolecule metabolic process,9.709e-07|0.0003614|0.00108|0.001456|0.002463,0.01532|1|1|1|1,15.98|4.883|3.922|823.8|3.326
1912,4,0.6646,3.988,3156.0,0.001259,0.9929309999999999,PRG2 PRG3 PYGM ZFPL1,reactive oxygen species metabolic process|histamine biosynthetic process|basophil activation|imidazole-containing compound metabolic process|histamine metabolic process,0.0004889|0.0008735|0.001165|0.002037|0.002037,1|1|1|1|1,58.68|1716|1144|572.1|572.1
1913,4,0.6391,3.8339999999999996,3362.0,0.001137,0.9929309999999999,DCANP1 DNM3 OCLM PRG4,mastication|hard palate morphogenesis|negative regulation of saliva secretion|learned vocalization behavior|vestibulocochlear nerve formation,0.0007766|0.0007766|0.0007766|0.0007766|0.001165,1|1|1|1|1,1716|1716|1716|1716|1030
1914,7,0.6294,13.22,5718.0,0.002301,0.9992989999999999,FRS3 GUCA1A NCR2 PRICKLE4 PRPH2 RSPH9 TMEM217,detection of light stimulus|radial spoke assembly|detection of external stimulus|detection of abiotic stimulus|axonemal central apparatus assembly,0.0002711|0.001164|0.00118|0.001215|0.002328,1|1|1|1|1,81.73|1287|38.42|37.86|514.9
1915,7,0.6099,12.81,4588.0,0.002775,0.9992989999999999,CCNA2 CDC25B CDC7 DBF4 FBXO5 FOXM1 PKMYT1,mitotic cell cycle phase transition|cell cycle phase transition|mitotic cell cycle process|mitotic cell cycle|cell cycle process,1.07e-13|1.295e-13|4.684e-11|9.743e-11|1.047e-09,1.687e-09|1.021e-09|2.463e-07|3.842e-07|3.304e-06,72.26|70.29|30.07|27.06|19.25
1916,4,0.6555,3.9330000000000003,3005.0,0.0013039999999999998,0.9929309999999999,ADCY6 ANKMY2 PRKACA RIC8B,activation of protein kinase A activity|cellular response to glucagon stimulus|renal water homeostasis|response to glucagon|multicellular organismal water homeostasis,9.879e-06|2.045e-05|3.663e-05|3.85e-05|0.0001299,0.1558|0.1613|0.1926|0.1518|0.4097,433.6|294.2|216.8|211.2|112.8
1917,4,0.6299,3.78,2956.0,0.001273,0.9929309999999999,ARF3 OR8S1 PRKAG1 TUBA1A,intracellular transport|regulation of cAMP-dependent protein kinase activity|lipid biosynthetic process|establishment of localization in cell|cellular response to glucose starvation,0.001463|0.004072|0.004888|0.005547|0.009482,1|1|1|1|1,10.3|257.4|17.22|6.531|107.3
1918,33,0.6005,317.1,25000.0,0.012490000000000001,1.0,CLDN17 CLDN8 COL6A2 IL10RB KCNJ6 KRTAP10-11 KRTAP10-3 KRTAP10-8 KRTAP10-9 KRTAP11-1 KRTAP12-1 KRTAP12-3 KRTAP12-4 KRTAP13-1 KRTAP13-2 KRTAP13-3 KRTAP15-1 KRTAP19-1 KRTAP19-2 KRTAP19-3 KRTAP19-4 KRTAP19-5 KRTAP19-6 KRTAP19-7 KRTAP19-8 KRTAP20-1 KRTAP21-1 KRTAP21-2 KRTAP6-1 KRTAP6-2 OLIG1 TMEM50B TMPRSS3,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,1.895e-41|1.069e-39|5.412e-38|5.422e-36|4.193e-35,2.99e-37|8.432e-36|2.845e-34|2.138e-32|1.323e-31,67.01|56.51|47.92|39.54|36.32
1919,8,0.6049,16.94,6306.0,0.002672,0.9996790000000001,CCR2 CCR3 CCR5 CCR8 PRKAR2A SCN10A SCN11A SLC22A14,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,1.693e-08|2.686e-08|2.686e-08|1.798e-07|6.585e-07,0.000267|0.0002118|0.0001412|0.0007091|0.002078,130.3|115.7|115.7|71.02|50.98
1920,7,0.6447,13.54,4182.0,0.0032170000000000002,0.9992989999999999,KRAS MAPK1 NRAS PRKCE RAF1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|immune response-activating cell surface receptor signaling pathway|immune response-activating signal transduction|immune response-regulating cell surface receptor signaling pathway,4.436e-10|1.555e-08|1.087e-07|1.087e-07|1.6e-07,6.998e-06|0.0001226|0.0005717|0.0004288|0.0005047,43.16|13.08|32.4|32.4|29.96
1921,8,0.6358,17.8,6347.0,0.00279,0.9996790000000001,ALDOC LYRM9 PROCA1 RAB34 SEBOX SPAG5 TLCD1 UNC119,negative regulation of caveolin-mediated endocytosis|positive regulation of spindle assembly|negative regulation of clathrin-dependent endocytosis|regulation of caveolin-mediated endocytosis|regulation of metaphase plate congression,0.001164|0.002328|0.002328|0.003103|0.00349,1|1|1|1|1,1287|514.9|514.9|367.8|321.8
1922,4,0.6213,3.728,3247.0,0.001144,0.9929309999999999,FGF23 PROCR SYTL2 TMEM239,positive regulation of vitamin D 24-hydroxylase activity|regulation of vitamin D 24-hydroxylase activity|response to sodium phosphate|vitamin D catabolic process|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,0.0007766|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,1716|1716|1716|1716|1287
1923,7,0.6044,12.69,5513.0,0.002291,0.9992989999999999,AKR1C1 AKR1C3 AKR1C4 CALML3 CALML5 ITIH2 PROSER2,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,8.402e-10|8.402e-10|5.277e-09|5.277e-09|5.277e-09,1.325e-05|6.626e-06|2.775e-05|2.081e-05|1.665e-05,2207|2207|980.7|980.7|980.7
1924,7,0.6158,12.93,4812.0,0.002672,0.9992989999999999,CCT3 COPA PRPF3 PSMB3 PSMB4 PSMD4 SF3B4,regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase|regulation of hematopoietic stem cell differentiation,1.192e-06|1.192e-06|1.192e-06|1.192e-06|1.807e-06,0.01881|0.009404|0.00627|0.004702|0.005702,135.8|135.8|135.8|135.8|117.7
1925,9,0.6002,21.61,6073.0,0.003535,0.9998530000000001,DHX33 GEMIN4 MYBBP1A NUP88 PAFAH1B1 PRPF8 PSMB6 RPAIN TSR1,ribonucleoprotein complex biogenesis|ribosome biogenesis|import into nucleus|cellular component biogenesis|cellular metabolic process,7.064e-07|8.206e-06|1.5e-05|1.899e-05|0.0001229,0.01114|0.06472|0.07887|0.07488|0.3878,24.61|27.57|59.7|5.931|2.721
1926,4,0.6031,3.6189999999999998,3068.0,0.001175,0.9929309999999999,PRPH SEPT11 SEPT2 SNORC,intermediate filament cytoskeleton organization|intermediate filament-based process|cytoskeleton-dependent cytokinesis|cytokinesis|photoreceptor cell outer segment organization,6.463e-05|6.711e-05|0.0002219|0.0002796|0.003394,1|0.5293|1|1|1,161.5|158.4|85.81|76.28|316.8
1927,18,0.6087,93.13,14370.0,0.006422,1.0,ALDH3A1 ALOXE3 C17orf51 CCDC144A CCDC144NL DRC3 FOXO3 GID4 KRT16 MFAP4 MYO15A PRPSAP2 SLC47A2 TBC1D28 TNFRSF13B TNFSF12 TRPV2 ZNF624,tumor necrosis factor-mediated signaling pathway|establishment of skin barrier|regulation of water loss via skin|cellular response to tumor necrosis factor|response to tumor necrosis factor,0.0001783|0.0002495|0.0002883|0.001272|0.001722,1|1|1|1|1,27.46|91.53|84.75|13.84|12.44
1928,5,0.6076,6.0760000000000005,2921.0,0.002069,0.996692,CDK4 CDK6 MAU2 PRR12 STAG1,mitotic interphase|interphase|cell division|mitotic cell cycle process|G1 phase,1.205e-06|1.205e-06|4.793e-06|1.763e-05|1.784e-05,0.01901|0.009506|0.0252|0.06954|0.05627,130.3|130.3|27.91|20.04|326.9
1929,6,0.6002,9.003,5159.0,0.001738,0.998474,CALCOCO2 OSBPL7 PRAC1 PRR15L SCRN2 TBKBP1,xenophagy|positive regulation of autophagosome maturation|regulation of autophagy|regulation of autophagosome maturation|positive regulation of cellular catabolic process,0.001456|0.002037|0.003743|0.004361|0.00515,1|1|1|1|1,858.1|572.1|20.74|245.2|17.6
1930,5,0.631,6.31,4319.0,0.0014550000000000001,0.996692,C5AR2 IGSF23 MARK4 PRR19 ZNF461,complement component C5a signaling pathway|negative regulation of granulocyte chemotaxis|negative regulation of neutrophil chemotaxis|negative regulation of neutrophil migration|positive regulation of protein localization to centrosome,0.000728|0.0009706|0.0009706|0.001213|0.00194,1|1|1|1|1,2060|1373|1373|1030|588.4
1931,4,0.6164,3.698,2988.0,0.001233,0.9929309999999999,CCT8 CFAP298 PAXBP1 PRR27,positive regulation of chromosome organization|regulation of chromosome organization|positive regulation of myoblast proliferation|positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere,0.0004307|0.001124|0.001747|0.002134|0.002328,1|1|1|1|1,59.18|36.39|643.6|514.9|468.1
1932,4,0.6198,3.719,3434.0,0.0010789999999999999,0.9929309999999999,DDIAS IQCF2 PRRT3 SARDH,sarcosine catabolic process|sarcosine metabolic process|regulation of DNA stability|choline catabolic process|choline metabolic process,0.0003883|0.0005825|0.0009706|0.001359|0.001941,1|1|1|1|1,5149|2574|1287|858.1|572.1
1933,4,0.6058,3.635,2919.0,0.00124,0.9929309999999999,PDGFRA PRRX1 SCFD2 TWIST2,embryonic cranial skeleton morphogenesis|cranial skeletal system development|roof of mouth development|embryonic skeletal system morphogenesis|embryonic skeletal system development,3.316e-05|7.196e-05|0.0001126|0.0001282|0.000214,0.523|0.5676|0.5922|0.5055|0.6751,219.1|147.1|117|109.5|84.41
1934,4,0.6018,3.611,3082.0,0.001167,0.9929309999999999,ITGAL JAML PRSS22 SYNDIG1,cellular extravasation|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|mononuclear cell migration|memory T cell extravasation|T cell activation,2.919e-05|3.454e-05|0.0001593|0.0005825|0.0008254,0.4604|0.2724|0.8376|1|1,234|214.5|98.07|2574|42.55
1935,5,0.6336,6.336,3835.0,0.001645,0.996692,ATP6V0A2 KCNK5 NOTCH1 PRSS42 SUCLA2,succinyl-CoA pathway|positive regulation of aorta morphogenesis|regulation of aorta morphogenesis|venous endothelial cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1936,5,0.6058,6.058,3798.0,0.001588,0.996692,CCNB1IP1 NDRG3 PCDHGA9 PRTFDC1 RNF114,reproductive process|reproduction|spermatogenesis|male gamete generation|gamete generation,0.0001111|0.000112|0.0001828|0.0002022|0.0003665,1|0.8832|0.9613|0.7972|1,11.51|11.48|22.55|21.79|17.81
1937,8,0.6289,17.61,5717.0,0.003062,0.9996790000000001,CLSPN EIF3I GNL2 PSMB2 SF3A3 SNIP1 TRAPPC3 UTP11,ribonucleoprotein complex biogenesis|cellular component biogenesis|negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|protein-containing complex assembly,1.726e-05|0.000113|0.0006281|0.0007745|0.001012,0.2722|0.891|1|1|1,22.15|5.719|53.08|47.67|7.702
1938,4,0.7809,4.685,2231.0,0.002088,0.9929309999999999,PSMB5 PSMB6 PSMB7 THAP1,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,6.311e-09|1.373e-07|1.373e-07|1.373e-07|1.373e-07,9.955e-05|0.001083|0.0007219|0.0005415|0.0004332,702.1|237.6|237.6|237.6|237.6
1939,6,0.6029,9.044,4574.0,0.001968,0.998474,HLA-DMB HLA-DPB1 HLA-DRB1 OR2B6 PSMB8 TAP1,antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation|peptide antigen assembly with MHC class II protein complex,3.12e-10|3.872e-10|4.642e-10|9.451e-10|1.06e-06,4.921e-06|3.054e-06|2.441e-06|3.727e-06|0.003344,96.42|92.27|88.92|76.96|1716
1940,8,0.6554,18.35,5348.0,0.003409,0.9996790000000001,PSMC5 PSMD1 PSMD11 PSMD12 PSMD3 PSMD6 PSMD7 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly,3.467e-19|7.9e-19|3.763e-17|3.763e-17|3.763e-17,5.469e-15|6.231e-15|1.978e-13|1.484e-13|1.187e-13,212.3|190.7|277.2|277.2|277.2
1941,8,0.6039,16.91,5287.0,0.0031780000000000003,0.9996790000000001,PSMC5 PSMD1 PSMD11 PSMD12 PSMD13 PSMD3 PSMD4 PSMD6,regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase|regulation of hematopoietic stem cell differentiation,1.672e-20|1.672e-20|1.672e-20|1.672e-20|4.905e-20,2.637e-16|1.318e-16|8.789e-17|6.592e-17|1.547e-16,316.8|316.8|316.8|316.8|274.6
1942,7,0.6203,13.03,4699.0,0.0027559999999999998,0.9992989999999999,CCNA2 CCNB1 CDC25B FBXO5 FOXM1 LIN54 PSME3,regulation of cell cycle|cell cycle|mitotic cell cycle phase transition|cell cycle phase transition|oocyte maturation,2.277e-09|6.5e-09|1.096e-08|1.256e-08|3.186e-08,3.592e-05|5.127e-05|5.762e-05|4.953e-05|0.0001005,17.22|14.82|51.62|50.21|490.4
1943,5,0.6012,6.0120000000000005,3907.0,0.001532,0.996692,C1QTNF9 PSPC1 RNF6 ZMYM2 ZMYM5,protein K27-linked ubiquitination|protein K6-linked ubiquitination|regulation of androgen receptor signaling pathway|negative regulation of axon extension|protein K48-linked ubiquitination,0.001456|0.002425|0.008949|0.01088|0.014,1|1|1|1|1,823.8|457.7|114.4|93.61|72.26
1944,4,0.7089,4.253,2788.0,0.001519,0.9929309999999999,OSBPL11 OSBPL9 PTDSS1 VKORC1L1,sterol transport|organic hydroxy compound transport|protein carboxylation|peptidyl-glutamic acid carboxylation|phosphatidylserine biosynthetic process,8.451e-05|0.0003257|0.0007766|0.0007766|0.0009706,1|1|1|1|1,135.5|68.2|1716|1716|1287
1945,5,0.6112,6.112,4067.0,0.001497,0.996692,BBOF1 GALNT16 PTGDR PTGER2 TSHR,negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus|negative regulation of inflammatory response|negative regulation of immune response|negative regulation of defense response,1.609e-07|2.08e-07|8.574e-07|1.129e-06|1.996e-06,0.002538|0.00164|0.004508|0.004453|0.006298,66.01|61.85|43.18|40.26|34.85
1946,4,0.6006,3.603,3032.0,0.001184,0.9929309999999999,C9orf16 PTGES2 UCK1 ZBTB6,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|cyclooxygenase pathway,0.0007766|0.001165|0.001165|0.001165|0.002328,1|1|1|1|1,1716|1030|1030|1030|468.1
1947,8,0.6298,17.64,5976.0,0.002934,0.9996790000000001,OR14J1 OR2B3 OR2B6 OR2J3 OR2W1 PSORS1C2 TRIM10 TRIM26,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.467e-07|3.303e-07|3.976e-07|5.646e-07|6.79e-07,0.003892|0.002605|0.00209|0.002227|0.002142,29.19|27.5|26.49|24.66|23.75
1948,11,0.6128,33.7,8615.0,0.003887,0.999969,ANXA2R C1QTNF3 C7 CCL28 FBXO4 FGF10 HCN1 NIM1K TMEM267 UGT3A1 UGT3A2,cytolysis|regulation of fibroblast proliferation|cellular homeostasis|lung proximal/distal axis specification|semicircular canal fusion,0.0001527|0.0008611|0.0009016|0.001067|0.001067,1|1|1|1|1,113.5|46.23|8.434|1872|1872
1949,4,0.6013,3.608,3057.0,0.001176,0.9929309999999999,OR4X1 OR51I1 OTOG PTH,positive regulation of osteoclast proliferation|L-arabinose metabolic process|arabinose metabolic process|sensory perception|regulation of osteoclast proliferation,0.000728|0.000728|0.000728|0.0009867|0.001213,1|1|1|1|1,2060|2060|2060|12.7|1030
1950,4,0.6586,3.952,3093.0,0.001273,0.9929309999999999,EEF1A2 PPDPF PTK6 ZGPAT,negative regulation of protein tyrosine kinase activity|negative regulation of peptidyl-tyrosine phosphorylation|regulation of epidermal growth factor receptor signaling pathway|regulation of ERBB signaling pathway|regulation of protein tyrosine kinase activity,1.4e-05|4.185e-05|0.0001101|0.0001282|0.0001282,0.2208|0.3301|0.5791|0.5055|0.4044,343.2|194.3|118.4|109.5|109.5
1951,6,0.6265,9.398,3637.0,0.002569,0.998474,PLEKHA1 PLEKHH3 PTEN PTPN13 TSC1 TSC2,negative regulation of protein kinase B signaling|phosphatidylinositol biosynthetic process|negative regulation of cell size|regulation of phosphatidylinositol 3-kinase signaling|negative regulation of intracellular signal transduction,2.677e-07|3.261e-06|4.66e-06|4.732e-06|4.793e-06,0.004222|0.02572|0.0245|0.01866|0.01512,219.1|92.77|686.5|81.73|27.91
1952,4,0.6061,3.637,3285.0,0.001103,0.9929309999999999,PPP4R4 PTPN21 SERPINA11 SLC24A4,regulation of protein serine/threonine phosphatase activity|negative regulation of hydrolase activity|amelogenesis|blastocyst hatching|organism emergence from protective structure,0.0003883|0.002861|0.004266|0.005233|0.005233,1|1|1|1|1,5149|22.63|245.2|198|198
1953,4,0.6214,3.728,3393.0,0.0010949999999999998,0.9929309999999999,CRYZ OXT PTPRA SLC35A3,positive regulation of hindgut contraction|regulation of cell junction assembly|regulation of hindgut contraction|maternal aggressive behavior|positive regulation of female receptivity,0.0003883|0.0005446|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|52.54|2574|1716|1716
1954,7,0.6388,13.42,5542.0,0.002409,0.9992989999999999,C6orf203 ENPP3 PTPRK TAAR2 TAAR6 TAAR8 VNN2,basophil activation involved in immune response|basophil activation|negative regulation of mast cell proliferation|regulation of mitochondrial transcription|regulation of mast cell proliferation,0.001019|0.001358|0.001358|0.001698|0.001698,1|1|1|1|1,1471|980.7|980.7|735.5|735.5
1955,5,0.6314,6.314,4066.0,0.001547,0.996692,LYRM9 PROCA1 PTRH2 RAB34 TLCD1,positive regulation of anoikis|phagosome-lysosome fusion|phagolysosome assembly|phospholipid homeostasis|negative regulation of anoikis,0.00194|0.00291|0.003878|0.00412|0.004604,1|1|1|1|1,588.4|374.5|274.6|257.4|228.8
1956,9,0.6004,21.61,6468.0,0.003322,0.9998530000000001,DDX41 GEMIN5 IK LARS PTTG1 RBM22 RPS14 SLU7 TTC1,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|mRNA metabolic process|nucleic acid metabolic process",8.53e-08|8.53e-08|8.954e-08|1.159e-07|1.57e-07,0.001346|0.0006728|0.0004708|0.0004569|0.0004952,37.89|37.89|37.51|19.78|8.202
1957,4,0.6353,3.812,2963.0,0.001281,0.9929309999999999,PKP2 PTX4 TCF3 TRAF5,desmosome assembly|maintenance of animal organ identity|positive regulation of DNA-binding transcription factor activity|B cell lineage commitment|immunoglobulin V(D)J recombination,0.001213|0.001456|0.001692|0.001698|0.001698,1|1|1|1|1,1030|823.8|30.51|686.5|686.5
1958,4,0.6158,3.695,3262.0,0.001129,0.9929309999999999,INSM2 KRTAP19-4 OLIG1 PXMP4,protein import into peroxisome membrane|peroxisomal membrane transport|oligodendrocyte development|neuron fate commitment|neuron differentiation,0.004459|0.005813|0.008903|0.01237|0.01401,1|1|1|1|1,234|177.5|114.4|81.73|10.02
1959,4,0.6558,3.935,3328.0,0.001178,0.9929309999999999,COL4A2 ESYT3 PROZ PYGB,endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization|collagen-activated tyrosine kinase receptor signaling pathway|collagen-activated signaling pathway|glycogen catabolic process,0.001359|0.002134|0.002522|0.003104|0.003685,1|1|1|1|1,858.1|514.9|429.1|343.2|286
1960,4,0.6013,3.608,2894.0,0.001242,0.9929309999999999,COPS9 QPCT UBE2Q1 UBE2R2,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|peptidyl-glutamine modification|prolactin secretion|negative regulation of protein neddylation|protein polyubiquitination",0.0005825|0.0009706|0.0009706|0.001165|0.001449,1|1|1|1|1,2574|1287|1287|1030|31.98
1961,11,0.6002,33.01,8652.0,0.0037920000000000002,0.999969,BCAS4 CNBD2 FAM209A FAM209B GGT7 MAP1LC3A MYLK2 R3HDML SLC13A3 WFDC11 WISP2,regulation of muscle filament sliding|alpha-ketoglutarate transport|skeletal muscle satellite cell differentiation|tricarboxylic acid transport|response to iron(II) ion,0.002667|0.002667|0.002667|0.003199|0.003199,1|1|1|1|1,468.1|468.1|468.1|374.5|374.5
1962,4,0.6591,3.955,3148.0,0.0012519999999999999,0.9929309999999999,FUT8 GMDS RAB15 SLC35C1,GDP-L-fucose metabolic process|fucosylation|nucleotide-sugar metabolic process|carbohydrate derivative biosynthetic process|protein glycosylation in Golgi,4.241e-07|4.831e-06|2.201e-05|9.962e-05|0.0003883,0.00669|0.0381|0.1157|0.3928|1,2574|605.7|271|25.57|5149
1963,4,0.6071,3.6430000000000002,3224.0,0.001126,0.9929309999999999,ACSM6 KAZN NRG2 RAB32,melanosome assembly|pigment granule maturation|endosome to pigment granule transport|endosome to melanosome transport|cellular pigment accumulation,0.001165|0.002134|0.002134|0.002134|0.002522,1|1|1|1|1,1030|514.9|514.9|514.9|429.1
1964,6,0.6167,9.25,4193.0,0.002195,0.998474,CLASRP CNOT3 GPATCH1 LENG1 LENG8 TSEN34,mRNA metabolic process|RNA splicing|mRNA processing|RNA metabolic process|tRNA-type intron splice site recognition and cleavage,1.856e-05|0.0001497|0.000249|0.0004821|0.001165,0.2928|1|1|1|1,19.78|25.3|21.28|8.587|1144
1965,27,0.6023,211.4,21440.0,0.009742,1.0,CEACAM7 CLC CYP2A13 CYP2B6 FFAR2 FFAR3 IFNL1 IFNL3 LGALS13 LGALS14 PSG6 PSG8 RAB4B ZNF155 ZNF222 ZNF230 ZNF284 ZNF285 ZNF302 ZNF382 ZNF45 ZNF546 ZNF569 ZNF571 ZNF585B ZNF599 ZNF780B,"regulation of gene expression|regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",3.131e-07|2.998e-06|3.064e-06|3.076e-06|3.137e-06,0.004939|0.02365|0.01611|0.01213|0.009897,2.915|3.845|3.28|3.279|3.275
1966,8,0.6381,17.87,6764.0,0.002628,0.9996790000000001,BNIP2 FBXL22 MYO5C PLEKHO2 PPIB RAB8B SCAMP2 SNX22,macrophage apoptotic process|Golgi vesicle fusion to target membrane|polyphosphate catabolic process|polyphosphate metabolic process|myeloid cell apoptotic process,0.001552|0.00194|0.002328|0.002715|0.002715,1|1|1|1|1,858.1|643.6|514.9|429.1|429.1
1967,9,0.6118,22.03,7096.0,0.0030859999999999998,0.9998530000000001,AKAP2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 RABEPK TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.482e-05|3.127e-05|3.621e-05|4.778e-05|5.528e-05,0.3915|0.2466|0.1904|0.1884|0.1744,20.76|19.56|18.83|17.54|16.89
1968,6,0.6014,9.021,3763.0,0.002384,0.998474,ATM MDM2 MRE11 NBN RAD50 TP53,regulation of signal transduction by p53 class mediator|mitotic DNA damage checkpoint|mitotic DNA integrity checkpoint|DNA double-strand break processing|DNA damage checkpoint,8.252e-13|2.055e-11|2.477e-11|2.984e-11|9.285e-11,1.302e-08|1.621e-07|1.303e-07|1.177e-07|2.929e-07,105.1|168.3|161.9|624.1|123.5
1969,7,0.6312,13.26,5449.0,0.002421,0.9992989999999999,C6orf203 ENPP3 RAET1G RAET1L TAAR6 ULBP2 ULBP3,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|cell killing|lymphocyte mediated immunity,7.001e-08|8.743e-08|2.742e-07|7.142e-06|6.471e-05,0.001104|0.0006896|0.001442|0.02817|0.2042,367.8|339.5|226.3|73.55|34.75
1970,4,0.6196,3.718,3284.0,0.0011279999999999999,0.9929309999999999,EGFLAM HMX2 RAI14 TTC23L,"peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|positive regulation of mRNA splicing, via spliceosome|positive regulation of mRNA processing|positive regulation of RNA splicing|chondroitin sulfate metabolic process",0.001359|0.004653|0.006586|0.007552|0.007552,1|1|1|1|1,858.1|223.9|156|135.5|135.5
1971,4,0.6155,3.693,3131.0,0.001175,0.9929309999999999,CCDC107 FZD1 RAC3 RALGAPA2,canonical Wnt signaling pathway involved in osteoblast differentiation|central nervous system neuron differentiation|canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation|mesenchymal stem cell differentiation|receptor transactivation,0.000728|0.0007712|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|45.51|1373|1030|823.8
1972,12,0.6009,39.66,9826.0,0.0040100000000000005,0.999986,CDC37L1 DDX58 INSL6 MPL PDCD1LG2 PLPP6 RANBP6 RLN1 RLN2 SAXO1 SPATA6L TYRP1,basophil homeostasis|eosinophil homeostasis|acetoacetic acid metabolic process|positive regulation of platelet formation|monocyte homeostasis,0.001164|0.001164|0.001164|0.001746|0.001746,1|1|1|1|1,1716|1716|1716|858.1|858.1
1973,4,0.6557,3.9339999999999997,2953.0,0.001327,0.9929309999999999,ATXN10 RANGAP1 RRP7A TOMM22,cellular response to vasopressin|response to vasopressin|organelle organization|outer mitochondrial membrane organization|protein insertion into mitochondrial outer membrane,0.0007766|0.0007766|0.000909|0.0009706|0.0009706,1|1|1|1|1,1716|1716|5.762|1287|1287
1974,10,0.6203,27.91,6319.0,0.004384000000000001,0.999933,AMOTL2 KIRREL1 MAP4K4 NF2 NRP1 PDCD10 PLXNA1 RAP2B RNF146 TAOK1,regulation of cell migration|regulation of cell motility|regulation of locomotion|regulation of cellular component movement|semaphorin-plexin signaling pathway,7.885e-08|1.25e-07|1.691e-07|2.155e-07|1.193e-06,0.001244|0.0009861|0.0008891|0.00085|0.003764,14.81|13.84|13.24|12.77|147.8
1975,9,0.617,22.21,7389.0,0.00299,0.9998530000000001,PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 RAPGEF6 SEPT8 SLC22A4 SLC22A5,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|carnitine transmembrane transport|carnitine transport,4.691e-09|4.018e-08|1.153e-06|2.542e-06|3.558e-06,7.399e-05|0.0003169|0.006062|0.01002|0.01122,68.51|44.18|22.26|1144|915.3
1976,4,0.6223,3.734,3390.0,0.001098,0.9929309999999999,C17orf107 PALD1 RASGEF1A TBX1,vagus nerve morphogenesis|positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|mesenchymal cell apoptotic process|vagus nerve development,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
1977,14,0.6006,54.66,11190.0,0.004850999999999999,0.9999969999999999,ADAP2 C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EVI2A GAS2L2 LYRM9 RASL10B RDM1 SLFN12 SLFN14,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|lymphocyte migration,2.825e-07|3.295e-07|3.251e-06|5.408e-06|1.772e-05,0.004457|0.002599|0.01709|0.02133|0.05591,259.6|245.2|107.6|90.07|59.64
1978,4,0.6075,3.645,3207.0,0.0011330000000000001,0.9929309999999999,GRIN2C PSMB9 RASSF2 TREML2,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade|epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity|directional locomotion|excitatory chemical synaptic transmission|regulation of immune system process,0.0003883|0.0003883|0.0007766|0.001941|0.002121,1|1|1|1|1,5149|5149|1716|572.1|9.081
1979,4,0.6364,3.818,3114.0,0.001222,0.9929309999999999,PSPC1 RAX2 ZMYM2 ZMYM5,"regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process|negative regulation of transcription, DNA-templated",0.01665|0.01667|0.01674|0.02068|0.0216,1|1|1|1|1,4.459|4.458|4.451|4.132|7.995
1980,11,0.6033,33.18,7351.0,0.00448,0.999969,ATP5F1A C18orf21 HAUS1 NARS RBFA RPL17 RTTN SKA1 VPS4A ZNF236 ZNF407,centrosome cycle|actomyosin contractile ring contraction|contractile ring contraction|microtubule organizing center organization|cell cycle process,0.001011|0.001067|0.001067|0.001296|0.001803,1|1|1|1|1,42.55|1872|1872|37.45|6.999
1981,4,0.6934,4.1610000000000005,2684.0,0.0015429999999999999,0.9929309999999999,CHERP RBM17 RBM26 U2SURP,"mRNA processing|mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",3.112e-07|1.307e-06|4.076e-06|1.272e-05|1.272e-05,0.004909|0.01031|0.02143|0.05015|0.04012,42.55|29.68|22.31|51.15|51.15
1982,4,0.713,4.2780000000000005,2638.0,0.001614,0.9929309999999999,DDX39B RBM33 THOC6 XPO4,viral mRNA export from host cell nucleus|translocation of molecules into host|protein export from nucleus|nuclear export|nucleocytoplasmic transport,1.272e-06|1.555e-06|1.662e-06|2.157e-06|8.061e-06,0.02007|0.01226|0.008741|0.008506|0.02543,1287|1144|101.6|93.05|59.64
1983,8,0.604,16.91,5512.0,0.00305,0.9996790000000001,AURKA CSE1L PSMA7 RAE1 RBM39 RPS21 RTF2 TPX2,protein export from nucleus|nuclear export|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|regulation of mitotic spindle organization,3.393e-05|4.392e-05|7.915e-05|9.882e-05|0.0001183,0.5352|0.3464|0.4162|0.3897|0.3731,45.16|41.36|33.82|31.35|127.1
1984,8,0.6049,16.94,5464.0,0.003081,0.9996790000000001,C1D DIS3 EXOSC1 EXOSC7 EXOSC8 RBM7 TENT4B ZCCHC7,ncRNA catabolic process|ncRNA metabolic process|RNA catabolic process|rRNA processing|rRNA metabolic process,6.802e-13|5.179e-11|8.656e-11|1.2e-10|1.499e-10,1.073e-08|4.084e-07|4.551e-07|4.731e-07|4.729e-07,415.2|34.86|62.79|59.41|57.21
1985,4,0.615,3.69,3354.0,0.0010960000000000002,0.9929309999999999,RBMS1 SCAMP2 SERTM1 TSSK3,post-Golgi vesicle-mediated transport|DNA replication|Golgi vesicle transport|spermatogenesis|male gamete generation,0.02596|0.05178|0.0749|0.1024|0.1058,1|1|1|1|1,38.42|19|13|9.396|9.081
1986,10,0.6008,27.03,8395.0,0.0032020000000000004,0.999933,GP6 KIR2DL1 LAIR2 LILRB5 NLRP4 RDH13 ZNF329 ZNF581 ZNF587 ZNF772,response to high light intensity|natural killer cell inhibitory signaling pathway|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|response to light intensity,0.001601|0.002134|0.004795|0.005858|0.006389,1|1|1|1|1,936.1|624.1|234|187.2|170.2
1987,4,0.6046,3.627,3132.0,0.0011539999999999999,0.9929309999999999,REEP1 SFTPB THNSL2 WBP1,2-oxobutyrate biosynthetic process|2-oxobutyrate metabolic process|short-chain fatty acid biosynthetic process|serine family amino acid catabolic process|endoplasmic reticulum tubular network organization,0.0003883|0.0005825|0.0009706|0.00291|0.003104,1|1|1|1|1,5149|2574|1287|367.8|343.2
1988,4,0.6648,3.989,3312.0,0.0012,0.9929309999999999,EFNA2 FGF22 KCNC3 REM2,transmembrane receptor protein tyrosine kinase signaling pathway|olfactory bulb development|olfactory lobe development|enzyme linked receptor protein signaling pathway|osteoclast differentiation,0.003704|0.006007|0.006393|0.007137|0.007938,1|1|1|1|1,19.84|171.6|160.9|14.18|128.7
1989,10,0.6095,27.43,7809.0,0.0034909999999999997,0.999933,CLEC2B CLEC4D CLEC6A KLRC1 RERGL SLCO1C1 TAS2R13 TAS2R20 TAS2R7 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|detection of chemical stimulus involved in sensory perception,2.535e-09|4.127e-09|4.52e-09|2.832e-08|5.92e-05,3.998e-05|3.255e-05|2.376e-05|0.0001117|0.1868,228.8|200.9|196.1|121.1|16.95
1990,4,0.6238,3.7430000000000003,2827.0,0.001318,0.9929309999999999,CCNF E2F3 RFC1 TCF19,cell cycle process|DNA clamp unloading|re-entry into mitotic cell cycle|G2 phase|mitotic G2 phase,0.0005419|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,14.44|2574|2574|1716|1716
1991,6,0.601,9.015,3929.0,0.002283,0.998474,RAD17 RAD9A RFC2 RFC3 RFC5 TIMELESS,DNA replication|regulation of DNA replication|DNA repair|regulation of signal transduction by p53 class mediator|regulation of DNA-dependent DNA replication,5.6e-12|2.966e-11|3.018e-10|5.008e-10|5.832e-10,8.833e-08|2.339e-07|1.587e-06|1.975e-06|1.84e-06,76|156|38.86|87.56|280.2
1992,4,0.6046,3.627,3190.0,0.0011330000000000001,0.9929309999999999,KRT26 LASP1 RFFL UBR1,regulation of TOR signaling|negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|ubiquitin-dependent protein catabolic process via the N-end rule pathway|regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|proteasome-mediated ubiquitin-dependent protein catabolic process,0.0001419|0.0007766|0.0007766|0.001165|0.001458,1|1|1|1|1,104|1716|1716|1030|31.88
1993,14,0.6101,55.52,11180.0,0.004928,0.9999969999999999,GPR32 KIR2DL1 KIR2DL3 KIR3DL1 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 NLRP4 NLRP9 RFPL4A ZSCAN5B,regulation of immune response|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of immune system process|immune response,1.711e-08|5.128e-08|8.881e-08|5.761e-07|2.011e-06,0.0002699|0.0004045|0.000467|0.002272|0.006343,10.95|514.9|411.9|7.265|6.266
1994,4,0.6209,3.725,2924.0,0.001269,0.9929309999999999,CNN1 OR7C2 RFX1 SYCE2,negative regulation of vascular associated smooth muscle cell proliferation|synaptonemal complex assembly|synaptonemal complex organization|negative regulation of smooth muscle cell proliferation|homologous chromosome pairing at meiosis,0.004072|0.004459|0.00504|0.008903|0.01006,1|1|1|1|1,257.4|234|205.9|114.4|101
1995,4,0.6149,3.6889999999999996,3451.0,0.001066,0.9929309999999999,OSTN RFX8 SPTLC3 SULT1C4,negative regulation of dendrite extension|alcohol metabolic process|negative regulation of glucose import|ethanol catabolic process|sphingoid biosynthetic process,0.0007766|0.001539|0.002328|0.002522|0.00291,1|1|1|1|1,1716|31.02|468.1|429.1|367.8
1996,5,0.6272,6.272,3662.0,0.0017050000000000001,0.996692,FUT6 PLIN3 RFXANK UQCR11 ZNF77,N-glycan fucosylation|fucose catabolic process|positive regulation of sequestering of triglyceride|L-fucose catabolic process|L-fucose metabolic process,0.000728|0.002425|0.002425|0.002425|0.002425,1|1|1|1|1,2060|457.7|457.7|457.7|457.7
1997,4,0.6096,3.658,3274.0,0.001113,0.9929309999999999,COL6A2 MTRF1 RGS10 SNORC,regulation of translational termination|G protein-coupled acetylcholine receptor signaling pathway|acetylcholine receptor signaling pathway|response to amphetamine|cellular response to acetylcholine,0.002328|0.003878|0.005813|0.0062|0.0062,1|1|1|1|1,468.1|271|177.5|166.1|166.1
1998,13,0.6064,47.3,9698.0,0.004841,0.999993,CD1B CD1E FCRL3 ITLN1 ITLN2 MNDA OR10J5 OR10T2 OR6K6 OR6N1 OR6N2 RGS13 SLAMF7,"detection of chemical stimulus involved in sensory perception of smell|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|sensory perception of smell|G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception",7.908e-06|8.982e-06|1.052e-05|1.085e-05|1.26e-05,0.1247|0.07084|0.05531|0.04277|0.03976,16.68|588.4|15.72|7.748|15.13
1999,5,0.6122,6.122000000000001,3783.0,0.001611,0.996692,FAM129A OR6N1 RGS16 RGS8 SLAMF7,G protein-coupled receptor signaling pathway|regulation of dopamine receptor signaling pathway|positive regulation of GTPase activity|G protein-coupled acetylcholine receptor signaling pathway|regulation of GTPase activity,0.002443|0.00291|0.003889|0.004845|0.005427,1|1|1|1|1,9.298|374.5|19.95|216.8|16.81
2000,10,0.6042,27.19,6353.0,0.004248,0.999933,CIP2A H2AFX HUS1 MAD2L2 RAD1 RAD17 RAD9A RFC5 RHNO1 TOPBP1,cell cycle checkpoint|regulation of signal transduction by p53 class mediator|DNA replication|DNA repair|DNA damage checkpoint,7.414e-13|9.506e-13|8.749e-12|8.82e-12|2.246e-11,1.169e-08|7.497e-09|4.6e-08|3.478e-08|7.084e-08,76.28|73.55|53.2|31.09|88.9
2001,4,0.6011,3.6060000000000003,3285.0,0.001094,0.9929309999999999,AATF CACNG1 CACNG4 RHBDF2,cardiac conduction|multicellular organismal signaling|calcium ion transmembrane transport|negative regulation of superoxide anion generation|regulation of heart contraction,0.0001309|0.0002574|0.0005122|0.0005825|0.0008053,1|1|1|1|1,108.4|76.85|54.2|2574|43.09
2002,8,0.6185,17.32,6101.0,0.002823,0.9996790000000001,AGO1 AGO3 AGO4 GJB4 ZFP69 ZFP69B ZMYM4 ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",4.605e-09|6.331e-09|8.44e-09|2.147e-08|2.147e-08,7.264e-05|4.993e-05|4.438e-05|8.466e-05|6.772e-05,1103|965.4|858.1|594.1|594.1
2003,4,0.636,3.8160000000000003,3355.0,0.0011330000000000001,0.9929309999999999,NDUFV3 PNRC1 RHO ROPN1B,absorption of visible light|light absorption|thermotaxis|detection of temperature stimulus involved in thermoception|thermoception,0.0003883|0.0003883|0.0005825|0.0009706|0.001359,1|1|1|1|1,5149|5149|2574|1287|858.1
2004,4,0.7089,4.253,3247.0,0.0013050000000000002,0.9929309999999999,HSBP1L1 IFI27L2 RHOV SLC16A10,thyroid-stimulating hormone secretion|heat acclimation|cellular heat acclimation|Cdc42 protein signal transduction|thyroid hormone transport,0.0003883|0.001165|0.001165|0.001553|0.002134,1|1|1|1|1,5149|1030|1030|735.5|514.9
2005,6,0.6535,9.802,3813.0,0.0025559999999999997,0.998474,CCNE2 CKS1B E2F3 RIF1 SKP2 UBE2Q1,G1 phase|mitotic G1 phase|cell cycle|mitotic cell cycle phase transition|cell cycle phase transition,4.847e-08|4.847e-08|6.32e-07|1.284e-06|1.432e-06,0.0007645|0.0003823|0.003323|0.005064|0.004517,420.3|420.3|12.7|41.29|40.17
2006,4,0.6046,3.628,3355.0,0.001077,0.9929309999999999,FRMD8 PRSS35 PUS10 RIMS1,tRNA pseudouridine synthesis|acrosomal vesicle exocytosis|modulation of inhibitory postsynaptic potential|positive regulation of inhibitory postsynaptic potential|primary miRNA processing,0.001165|0.001359|0.001359|0.001359|0.002328,1|1|1|1|1,1030|858.1|858.1|858.1|468.1
2007,4,0.6397,3.838,3273.0,0.001168,0.9929309999999999,DEFB119 DEFB121 RIMS4 SLPI,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|GDP-mannose biosynthetic process,1.888e-05|0.0001664|0.0002649|0.000487|0.001165,0.2979|1|1|1|1,44.77|21.51|18.39|14.97|1030
2008,4,0.6075,3.645,3189.0,0.001139,0.9929309999999999,PLEKHG4 PTGES RIOK3 TMEM68,cellular response to dsDNA|response to dsDNA|negative regulation of MDA-5 signaling pathway|regulation of MDA-5 signaling pathway|regulation of fever generation,0.0005825|0.0005825|0.0009706|0.001553|0.001941,1|1|1|1|1,2574|2574|1287|735.5|572.1
2009,15,0.6173,64.81,10980.0,0.005852,0.999999,B4GALT1 BEST3 CPM FAM49A FGF8 FRS2 LRRC10 LYZ MYCN MYOG PAX3 RAB3IP SLC35E3 SOX8 ZBTB18,developmental induction|positive regulation of animal organ morphogenesis|muscle structure development|striated muscle tissue development|muscle organ development,1.127e-06|1.841e-06|1.425e-05|3.459e-05|4.275e-05,0.01777|0.01452|0.07494|0.1364|0.1349,158.4|132.9|14.92|20.72|19.61
2010,22,0.6097,140.8,16190.0,0.008602,1.0,ANG BCL2L2 CEBPE CMA1 CMTM5 DHRS2 DHRS4 EDDM3A GZMH LTB4R LTB4R2 MYH6 OR10G2 OR10G3 OR11H4 OR4E2 OR5AU1 RNASE3 RNASE7 RNASE8 SLC7A8 TM9SF1,defense response to Gram-positive bacterium|defense response to fungus|leukotriene signaling pathway|RNA phosphodiester bond hydrolysis|defense response to bacterium,4.167e-06|1.554e-05|2.275e-05|2.84e-05|2.845e-05,0.06574|0.1226|0.1196|0.112|0.08975,37.45|65.31|374.5|22.69|13.57
2011,14,0.6143,55.9,10460.0,0.0053,0.9999969999999999,CD1B CD1E FCRL3 FMO2 ITLN1 ITLN2 OR10J3 OR10J5 OR10T2 OR6K6 OR6N1 OR6N2 SLAMF7 YY1AP1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.268e-07|6.017e-07|7.482e-07|1.13e-06|1.403e-06,0.006732|0.004746|0.003934|0.004455|0.004426,18.68|17.6|16.95|15.78|15.2
2012,9,0.6272,22.58,5984.0,0.0037479999999999996,0.9998530000000001,APH1A IPO8 LEMD3 NCSTN PSEN1 PSENEN RNF111 TGFBR1 TGFBR2,"Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing|amyloid precursor protein catabolic process|membrane protein ectodomain proteolysis",5.531e-12|1.677e-11|1.677e-11|8.107e-11|1.777e-10,8.725e-08|1.323e-07|8.817e-08|3.197e-07|5.605e-07,1308|915.3|915.3|572.1|457.7
2013,4,0.6582,3.949,2807.0,0.001401,0.9929309999999999,CCDC107 PTP4A2 RNF121 TRPM7,calcium-dependent cell-matrix adhesion|cellular magnesium ion homeostasis|magnesium ion homeostasis|necroptotic process|programmed necrotic cell death,0.0005825|0.0009706|0.002328|0.004846|0.006007,1|1|1|1|1,2574|1287|468.1|214.5|171.6
2014,4,0.6827,4.096,3062.0,0.001332,0.9929309999999999,PPP2R5D PPP2R5E RNF181 SNRK,regulation of protein autophosphorylation|regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|cellular protein modification process|protein modification process,3.454e-05|0.000214|0.0003007|0.0004631|0.0004631,0.5448|1|1|1|1,214.5|84.41|71.02|6.822|6.822
2015,4,0.6086,3.6510000000000002,3077.0,0.001182,0.9929309999999999,HIST1H3B HIST1H3H RNF183 SIVA1,activation-induced cell death of T cells|positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|T cell apoptotic process|apoptotic process|lymphocyte apoptotic process,0.0006796|0.001165|0.001747|0.001967|0.002135,1|1|1|1|1,1716|936.1|605.7|22.58|490.4
2016,4,0.6775,4.065,2929.0,0.001382,0.9929309999999999,ETV6 FLI1 RNF216 TRIM8,"protein catabolic process at synapse|protein catabolic process, modulating synaptic transmission|mesenchymal cell apoptotic process|vitellogenesis|positive regulation of nucleic acid-templated transcription",0.0003883|0.0003883|0.0005825|0.0009706|0.001845,1|1|1|1|1,5149|5149|2574|1287|9.523
2017,5,0.6068,6.068,3950.0,0.0015300000000000001,0.996692,IL7R PHLPP1 RNF219 USP46 WDR20,protein modification by small protein conjugation or removal|protein deubiquitination|regulation of T cell anergy|righting reflex|regulation of lymphocyte anergy,0.001168|0.001792|0.00194|0.00194|0.00194,1|1|1|1|1,11.99|29.63|588.4|588.4|588.4
2018,4,0.7161,4.296,3027.0,0.0014140000000000001,0.9929309999999999,FAM19A2 KRT76 MYL6B RNF41,negative regulation of mitophagy|negative regulation of autophagy of mitochondrion|regulation of mitophagy|sebaceous gland development|regulation of establishment of cell polarity,0.0008737|0.001165|0.00131|0.00131|0.003346,1|1|1|1|1,1373|980.7|858.1|858.1|312
2019,4,0.6151,3.6910000000000003,3258.0,0.001129,0.9929309999999999,CYP2W1 DAGLB MICALL2 RNF43,Wnt receptor catabolic process|endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|trans-synaptic signaling by endocannabinoid,0.0005825|0.0007766|0.0007766|0.0007766|0.001165,1|1|1|1|1,2574|1716|1716|1716|1030
2020,5,0.6747,6.747000000000001,3421.0,0.001963,0.996692,CIAO2B CIAPIN1 GLRX3 IREB2 TAX1BP1,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|protein maturation by iron-sulfur cluster transfer|sulfur compound metabolic process|cellular iron ion homeostasis,1.782e-08|1.782e-08|6.401e-06|5.686e-05|0.0001099,0.0002811|0.0001405|0.03365|0.2242|0.3466,537.3|537.3|549.2|33.49|123
2021,16,0.6089,73.07,12820.0,0.0056549999999999994,0.999999,ADCYAP1R1 AEBP1 AGR2 AGR3 GHRHR HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN NME8 RP9 URGCP,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|lung goblet cell differentiation,9.67e-09|3.395e-08|6.407e-07|2.229e-06|5.642e-06,0.0001525|0.0002677|0.003369|0.008789|0.0178,68.47|52.75|28.73|22.19|858.1
2022,12,0.6013,39.68,8267.0,0.004764,0.999986,RPL13A RPL14 RPL17 RPL18 RPL18A RPL19 RPL21 RPL23 RPL23A RPL27 RPL7 RPS15A,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.285e-28|4.05e-28|1.179e-27|1.762e-27|1.944e-27,3.605e-24|3.194e-24|6.198e-24|6.949e-24|6.134e-24,214.5|203.9|185.5|179.1|177.5
2023,6,0.6019,9.027999999999999,4469.0,0.0020109999999999998,0.998474,ALDOC CCDC102A PM20D1 RAET1L RPL22L1 WRN,positive regulation of strand invasion|regulation of strand invasion|regulation of oxidative phosphorylation uncoupler activity|cellular amide catabolic process|protein localization to nucleolus,0.0005824|0.0005824|0.001456|0.001456|0.002328,1|1|1|1|1,3432|3432|858.1|858.1|490.4
2024,5,0.62,6.2,3623.0,0.001704,0.996692,ISY1 MRPL3 RPL24 TRMT10C ZBTB11,mRNA metabolic process|mitochondrial gene expression|gene expression|generation of catalytic spliceosome for second transesterification step|RNA processing,0.0003665|0.0004655|0.000583|0.000728|0.0008457,1|1|1|1|1,17.81|58.84|7.537|2060|13.39
2025,7,0.6235,13.09,4970.0,0.00262,0.9992989999999999,MAD2L1 RPL18 RPL23A RPL35A RPL5 RPS15A RPS24,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,8.847e-14|1.187e-13|2.053e-13|2.523e-13|2.653e-13,1.395e-09|9.362e-10|1.08e-09|9.949e-10|8.371e-10,183.9|174.8|159|153.5|152.2
2026,6,0.612,9.18,4289.0,0.00213,0.998474,CHERP FAM32A RPL36 SUGP1 UBL5 YJU2,"mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA processing",2.586e-07|6.994e-07|6.994e-07|7.273e-07|1.06e-06,0.00408|0.005517|0.003678|0.002868|0.003345,24.73|45.46|45.46|45.02|18.59
2027,8,0.6024,16.87,5585.0,0.003002,0.9996790000000001,BOP1 CYC1 EXOSC4 PUF60 RPL30 RPL37A RPL8 VPS28,ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ribosome biogenesis|RNA processing,3.725e-09|1.84e-08|2.214e-08|6.114e-08|2.143e-07,5.876e-05|0.0001451|0.0001164|0.0002411|0.000676,33.22|49.51|47.67|38.77|16.73
2028,4,0.6181,3.7089999999999996,3330.0,0.0011099999999999999,0.9929309999999999,FBLN5 LYPD4 RPL3L SFN,regulation of epidermal cell division|regulation of removal of superoxide radicals|keratinocyte development|elastic fiber assembly|negative regulation of keratinocyte proliferation,0.0009706|0.001698|0.002667|0.00291|0.003394,1|1|1|1|1,1373|686.5|411.9|374.5|316.8
2029,13,0.6108,47.64,8952.0,0.005279,0.999993,RPL14 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL4 RPL6 RPL7 RPS15A RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,1.209e-30|2.24e-30|7.093e-30|1.094e-29|1.217e-29,1.907e-26|1.767e-26|3.729e-26|4.316e-26|3.84e-26,214.5|203.9|185.5|179.1|177.5
2030,12,0.6085,40.16,8244.0,0.004834000000000001,0.999986,RPL14 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL37 RPL4 RPL7 RPL7A,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.285e-28|4.05e-28|1.179e-27|1.762e-27|1.944e-27,3.605e-24|3.194e-24|6.198e-24|6.949e-24|6.134e-24,214.5|203.9|185.5|179.1|177.5
2031,12,0.6243,41.21,8189.0,0.004992,0.999986,HSPE1 RPL11 RPL12 RPL13 RPL17 RPL23 RPL37 RPL4 RPL9 RPLP0 RPLP2 RPS13,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,5.207e-25|8.818e-25|2.357e-24|3.412e-24|3.735e-24,8.214e-21|6.955e-21|1.239e-20|1.345e-20|1.178e-20,196.7|186.9|170.1|164.2|162.7
2032,9,0.6007,21.62,5898.0,0.0036420000000000003,0.9998530000000001,ALG1 ALG2 DAD1 DPAGT1 HYOU1 RPN1 RPN2 SLC39A7 TMEM258,protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein biosynthetic process,4.352e-16|1.221e-12|1.221e-12|1.748e-12|5.346e-12,6.865e-12|9.626e-09|6.418e-09|6.895e-09|1.686e-08,213.6|66.19|66.19|62.82|53.39
2033,7,0.6089,12.79,4364.0,0.002912,0.9992989999999999,POP5 POP7 RPP14 RPP21 RPP25L RPP40 SSB,tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|tRNA processing,2.483e-22|7.851e-22|3.792e-21|6.52e-21|5.464e-16,3.916e-18|6.192e-18|1.994e-17|2.571e-17|1.724e-12,1584|1287|980.7|895.4|156
2034,6,0.6368,9.552,4164.0,0.002282,0.998474,RBM42 RPS11 RPS16 RPS19 RPS9 SNRPD2,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,7.781e-09|9.482e-09|1.37e-08|1.573e-08|1.628e-08,0.0001227|7.479e-05|7.205e-05|6.205e-05|5.135e-05,143|135.9|123.7|119.4|118.4
2035,4,0.6337,3.802,2795.0,0.001355,0.9929309999999999,CDT1 RPL13 RPS15 ZC3H18,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,0.0001336|0.0001476|0.0001777|0.0001905|0.0001938,1|1|0.9343|0.7512|0.6113,107.3|102|92.77|89.54|88.77
2036,4,0.6726,4.0360000000000005,2917.0,0.0013779999999999999,0.9929309999999999,RPL6 RPS2 RPS3A RPSA,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,5.228e-10|6.374e-10|9.218e-10|1.059e-09|1.095e-09,8.247e-06|5.027e-06|4.847e-06|4.175e-06|3.455e-06,214.5|203.9|185.5|179.1|177.5
2037,9,0.6009,21.63,6268.0,0.0034289999999999998,0.9998530000000001,EIF3E EIF3H INTS8 MRPL13 RPL30 RPL7 RPS20 RPS23 UTP23,translational initiation|translation|peptide biosynthetic process|amide biosynthetic process|peptide metabolic process,1.066e-11|2.928e-11|4.524e-11|2.635e-10|2.961e-10,1.682e-07|2.309e-07|2.378e-07|1.039e-06|9.341e-07,96.01|41.71|39.16|30.34|29.83
2038,4,0.6531,3.918,2809.0,0.001389,0.9929309999999999,CCT2 INTS3 PSMB4 RPS27,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|cellular protein-containing complex assembly|anaphase|mitotic anaphase,0.0001363|0.0001684|0.000283|0.0003516|0.0003516,1|1|1|1|1,106.2|95.35|17.98|65.59|65.59
2039,4,0.6546,3.928,2965.0,0.0013189999999999999,0.9929309999999999,RPS2 RPS27A RPS3A RPSA,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,5.228e-10|6.374e-10|9.218e-10|1.059e-09|1.095e-09,8.247e-06|5.027e-06|4.847e-06|4.175e-06|3.455e-06,214.5|203.9|185.5|179.1|177.5
2040,4,0.6168,3.701,2682.0,0.001374,0.9929309999999999,CHMP2A LENG1 NUP62 RPS5,regulation of mitotic spindle organization|regulation of spindle organization|regulation of centrosome duplication|mitotic metaphase plate congression|regulation of centrosome cycle,1.984e-05|2.429e-05|2.919e-05|3.454e-05|3.454e-05,0.3129|0.1916|0.1535|0.1362|0.109,286|257.4|234|214.5|214.5
2041,9,0.6126,22.05,6746.0,0.00325,0.9998530000000001,ACCSL BDNF CAT EHF ELF5 FBXO3 PAMR1 RPS6KL1 SLC1A2,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome,0.0001195|0.0002312|0.0008406|0.0008406|0.0008406,1|1|1|1|1,129.1|91.33|46.81|46.81|46.81
2042,7,0.618,12.98,4891.0,0.002639,0.9992989999999999,RPL17 RPL18A RPS14 RPS15A RPS3 RPS6 RPS8,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,6.346e-17|8.93e-17|1.689e-16|2.145e-16|2.275e-16,1.001e-12|7.043e-13|8.878e-13|8.46e-13|7.176e-13,214.5|203.9|185.5|179.1|177.5
2043,19,0.6208,106.2,11570.0,0.009064000000000001,1.0,FNIP1 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS MLST8 MTOR RRAGA RRAGC SEH1L SPG21 TBC1D5 VPS18 VPS33A VPS39 VPS41 WDR24 WDR59,positive regulation of TOR signaling|response to starvation|cellular response to starvation|cellular response to amino acid starvation|response to amino acid starvation,1.78e-27|3.88e-26|7.049e-25|1.455e-24|2.19e-24,2.808e-23|3.06e-22|3.706e-21|5.738e-21|6.909e-21,302.5|69.78|79.04|162.6|156.7
2044,5,0.6235,6.235,3802.0,0.001633,0.996692,C2CD5 CDK5 FIBP RPUSD2 TMEM94,positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|regulation of protein targeting|positive regulation of protein localization to membrane|positive regulation of glial cell apoptotic process,2.481e-05|3.48e-05|0.0001669|0.0004024|0.000728,0.3914|0.2745|0.8776|1|1,265.7|222.6|99.25|63.37|2060
2045,7,0.61,12.81,4109.0,0.003097,0.9992989999999999,ADSL DHFR DTYMK GMPS RRM1 RRM2 YRDC,nucleotide biosynthetic process|nucleoside phosphate biosynthetic process|deoxyribonucleotide biosynthetic process|nucleotide metabolic process|nucleoside phosphate metabolic process,3.734e-09|3.981e-09|1.956e-08|8.415e-08|9.422e-08,5.89e-05|3.14e-05|0.0001028|0.0003318|0.0002973,64.24|63.41|588.4|34.13|33.36
2046,6,0.6026,9.039,4148.0,0.002168,0.998474,DCTN5 NPIPB6 PALB2 RBBP6 RRN3 SMG1,multicellular organism growth|somite development|cellular response to DNA damage stimulus|nucleic acid metabolic process|TORC1 signaling,0.0002267|0.0002267|0.00103|0.001733|0.002909,1|1|1|1|1,86.9|86.9|13.08|6.151|381.4
2047,4,0.6166,3.7,3354.0,0.001099,0.9929309999999999,FAM177A1 KLHL38 RRNAD1 VPS13B,rRNA methylation|rRNA modification|RNA methylation|biological regulation|regulation of biological process,0.00562|0.007938|0.01679|0.02306|0.03244,1|1|1|1|1,183.9|128.7|59.87|0|0
2048,5,0.6311,6.311,3725.0,0.0016870000000000001,0.996692,ATRIP CCDC12 EXOSC7 RRP9 SACM1L,U5 snRNA 3'-end processing|U1 snRNA 3'-end processing|polyadenylation-dependent mRNA catabolic process|nuclear polyadenylation-dependent mRNA catabolic process|rRNA processing,0.0009706|0.0009706|0.001213|0.001213|0.001571,1|1|1|1|1,1373|1373|1030|1030|31.68
2049,5,0.6151,6.151,4191.0,0.001462,0.996692,PHTF1 PPM1J PTPN22 RSBN1 TGIF1,phosphoanandamide dephosphorylation|positive regulation of granzyme B production|regulation of granzyme B production|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,0.0004854|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|1373|1373|1373|1373
2050,5,0.6014,6.013999999999999,3984.0,0.001504,0.996692,CYP4A22 CYP4Z1 RSPO1 ZFP69 ZNF684,lauric acid metabolic process|lipid hydroxylation|medium-chain fatty acid metabolic process|linoleic acid metabolic process|icosanoid biosynthetic process,0.000728|0.00194|0.003636|0.005329|0.01112,1|1|1|1|1,2060|588.4|294.2|196.1|91.53
2051,4,0.6317,3.79,3190.0,0.001184,0.9929309999999999,RSPO2 ST8SIA2 VIP VIPR2,negative regulation of smooth muscle cell proliferation|regulation of smooth muscle cell proliferation|epinephrine secretion|negative regulation of animal organ morphogenesis|positive regulation of epinephrine secretion,3.048e-05|0.0002536|0.0003883|0.0005825|0.0005825,0.4809|1|1|1|1,228.8|77.42|5149|2574|2574
2052,8,0.639,17.89,5031.0,0.003532,0.9996790000000001,CHTF18 CHTF8 DSCC1 MMS22L POLE2 RTEL1 TRAIP USP37,DNA-dependent DNA replication|DNA replication|telomere maintenance via semi-conservative replication|nuclear DNA replication|cell cycle DNA replication,6.011e-14|5.974e-13|1.958e-12|1.264e-11|1.371e-11,9.481e-10|4.711e-09|1.029e-08|4.985e-08|4.325e-08,92.89|66.5|330|221.9|218.2
2053,8,0.6186,17.32,5448.0,0.00316,0.9996790000000001,AQR HAUS2 MFAP1 RPAP1 RTF1 TUBGCP4 TUBGCP5 USP8,spindle assembly|mitotic prometaphase|microtubule nucleation|spindle organization|microtubule polymerization,5.066e-06|2.998e-05|4.268e-05|7.189e-05|8.727e-05,0.07991|0.2365|0.2244|0.2835|0.2753,84.87|46.25|214.5|34.33|147.1
2054,4,0.6185,3.7110000000000003,3393.0,0.00109,0.9929309999999999,ANKIB1 CAPG GDF10 RTN2,actin filament severing|negative regulation of amyloid-beta formation|negative regulation of amyloid precursor protein catabolic process|barbed-end actin filament capping|mitotic chromosome condensation,0.003878|0.004604|0.005329|0.005571|0.00702,1|1|1|1|1,274.6|228.8|196.1|187.2|147.1
2055,8,0.6151,17.22,6472.0,0.002648,0.9996790000000001,ADAMTS7 CSPG4 GOLGA6B MAP2K5 PLEKHO2 RAB8B SCAMP2 SLC24A1,negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|macrophage apoptotic process|activation of MAPK activity|Golgi vesicle fusion to target membrane,0.001164|0.001164|0.001552|0.001587|0.00194,1|1|1|1|1,1287|1287|858.1|33|643.6
2056,4,0.6098,3.659,3094.0,0.001178,0.9929309999999999,GPAT2 MRPS5 PTGES3 RUFY2,telomerase holoenzyme complex assembly|piRNA biosynthetic process|glucocorticoid receptor signaling pathway|fatty acid metabolic process|corticosteroid receptor signaling pathway,0.0009706|0.001165|0.001359|0.001494|0.001553,1|1|1|1|1,1287|1030|858.1|31.49|735.5
2057,5,0.6268,6.268,4120.0,0.001515,0.996692,CMBL DNAH5 FAM173B ROPN1L RUSC2,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|sperm motility|flagellated sperm motility|cilium movement involved in cell motility,1.778e-05|2.091e-05|0.0001177|0.0001177|0.0001391,0.2804|0.1649|0.6189|0.4641|0.4389,302.9|278.3|114.4|114.4|105.1
2058,4,0.6385,3.8310000000000004,3334.0,0.001145,0.9929309999999999,INSM2 PXMP4 ROBO3 RWDD3,positive regulation of hypoxia-inducible factor-1alpha signaling pathway|regulation of hypoxia-inducible factor-1alpha signaling pathway|chemoattraction of axon|axon midline choice point recognition|axon choice point recognition,0.0003883|0.0003883|0.0009706|0.001165|0.001553,1|1|1|1|1,5149|5149|1287|1030|735.5
2059,11,0.6245,34.35,7598.0,0.004487,0.999969,ARHGEF12 BTBD9 GNA13 LPAR2 LUZP1 MYO9A MYO9B RHOA RHOC RIC8A ROCK2,positive regulation of hydrolase activity|Rho protein signal transduction|regulation of hydrolase activity|positive regulation of catalytic activity|small GTPase mediated signal transduction,8.395e-12|1.315e-10|8.481e-10|1.7e-09|2.002e-09,1.324e-07|1.037e-06|4.459e-06|6.702e-06|6.317e-06,21.69|153.5|12.88|11.91|42.88
2060,4,0.6297,3.778,3193.0,0.001179,0.9929309999999999,RIOK1 RUNDC3B SAMD9 STEAP4,copper ion import|endosomal vesicle fusion|positive regulation of rRNA processing|regulation of rRNA processing|protein homotrimerization,0.001359|0.001747|0.002134|0.00291|0.003104,1|1|1|1|1,858.1|643.6|514.9|367.8|343.2
2061,5,0.6087,6.087000000000001,3919.0,0.001547,0.996692,BPIFA3 FAM209A NDFIP1 SAMHD1 WFDC11,DNA strand resection involved in replication fork processing|dATP catabolic process|dGTP catabolic process|negative regulation of isotype switching to IgE isotypes|dGTP metabolic process,0.000728|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|1373|1373|1373|1030
2062,4,0.6213,3.728,2843.0,0.001306,0.9929309999999999,CCDC86 POLA2 SART1 WDR74,maturation of 5S rRNA|positive regulation of cytotoxic T cell differentiation|regulation of cytotoxic T cell differentiation|rRNA processing|rRNA metabolic process,0.0003883|0.0005825|0.0007766|0.0009508|0.001024,1|1|1|1|1,5149|2574|1716|39.61|38.14
2063,4,0.6023,3.614,3301.0,0.001091,0.9929309999999999,ANKRD45 SAYSD1 SLC16A14 SVBP,regulation of metallopeptidase activity|negative regulation of endothelial cell migration|negative regulation of epithelial cell migration|negative regulation of protein ubiquitination|negative regulation of protein modification by small protein conjugation or removal,0.00291|0.01045|0.01372|0.01545|0.01775,1|1|1|1|1,367.8|97.15|73.55|65.17|56.58
2064,18,0.6003,91.85,13740.0,0.006622,1.0,COL6A2 IL10RB KRTAP10-1 KRTAP10-11 KRTAP10-3 KRTAP10-8 KRTAP10-9 KRTAP12-1 KRTAP12-3 KRTAP12-4 KRTAP13-1 KRTAP13-2 KRTAP19-1 KRTAP19-3 KRTAP19-6 KRTAP19-7 KRTAP19-8 TMPRSS3,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,2.496e-26|2.949e-25|3.24e-24|5.369e-23|1.864e-22,3.938e-22|2.326e-21|1.704e-20|2.117e-19|5.88e-19,71.94|60.67|51.45|42.45|38.99
2065,4,0.6584,3.95,3699.0,0.001065,0.9929309999999999,FRMD4B SCARB1 SNPH TMEM171,lipopolysaccharide transport|regulation of phosphatidylcholine catabolic process|detection of lipopolysaccharide|cholesterol import|sterol import,0.0005825|0.0007766|0.0009706|0.001359|0.001359,1|1|1|1|1,2574|1716|1287|858.1|858.1
2066,7,0.6049,12.7,5001.0,0.002526,0.9992989999999999,ARHGAP11A ARHGAP11B CHRFAM7A GOLGA8R SCG5 UBE2Q2L WHAMM,negative regulation of acetylcholine-gated cation channel activity|regulation of acetylcholine-gated cation channel activity|actin filament reorganization|plasma membrane tubulation|regulation of small GTPase mediated signal transduction,0.0006794|0.001019|0.003732|0.004748|0.005063,1|1|1|1|1,2942|1471|294.2|226.3|17.99
2067,5,0.6102,6.102,3746.0,0.001622,0.996692,EIF2D FDX1 KCNK13 MRC2 SCIN,ferredoxin metabolic process|ribosome disassembly|cellular response to forskolin|response to forskolin|positive regulation of megakaryocyte differentiation,0.0009706|0.002183|0.002667|0.002667|0.00291,1|1|1|1|1,1373|514.9|411.9|411.9|374.5
2068,4,0.6446,3.8680000000000003,3488.0,0.001105,0.9929309999999999,C1QC CTRC FABP3 SCMH1,positive regulation of long-chain fatty acid import into cell|regulation of phosphatidylcholine biosynthetic process|negative regulation of macrophage differentiation|regulation of long-chain fatty acid import into cell|negative regulation of granulocyte differentiation,0.0007766|0.001165|0.001553|0.001747|0.002134,1|1|1|1|1,1716|1030|735.5|643.6|514.9
2069,4,0.6012,3.6069999999999998,3290.0,0.001093,0.9929309999999999,HOXD10 IL1F10 RASGRP4 SCN3A,spinal cord motor neuron cell fate specification|peripheral nervous system neuron development|peripheral nervous system neuron differentiation|neuronal action potential|neuron fate specification,0.002134|0.002522|0.002522|0.00562|0.005813,1|1|1|1|1,514.9|429.1|429.1|183.9|177.5
2070,4,0.6221,3.733,3088.0,0.001204,0.9929309999999999,GGTLC2 GSTT2B RHBDD3 SCX,glutathione metabolic process|sulfur compound biosynthetic process|cellular modified amino acid metabolic process|deltoid tuberosity development|tendon formation,6.227e-05|0.0004706|0.0005283|0.0007766|0.0007766,0.9822|1|1|1|1,158.4|56.58|53.35|1716|1716
2071,6,0.6227,9.341000000000001,4804.0,0.001936,0.998474,CPNE1 PI3 SDC4 SERINC3 WFDC11 WFDC3,antibacterial humoral response|immune system process|antimicrobial humoral response|negative regulation of endopeptidase activity|negative regulation of peptidase activity,4.909e-07|7.052e-06|8.871e-06|3.356e-05|3.776e-05,0.007744|0.05562|0.04664|0.1324|0.1191,177.5|7.229|66.01|42.03|40.38
2072,5,0.6209,6.209,3500.0,0.001766,0.996692,HAUS2 SDHAF3 TUBGCP3 TUBGCP4 TUBGCP5,spindle assembly|microtubule nucleation|mitotic prometaphase|microtubule polymerization|spindle organization,2.115e-09|2.004e-08|2.277e-08|5.776e-08|7.374e-08,3.335e-05|0.0001581|0.0001197|0.0002278|0.0002326,181.1|514.9|98.66|353.1|73.23
2073,12,0.6053,39.95,9667.0,0.004105,0.999986,CNBD2 FAM209A FAM209B FAM83C GGT7 HCK MAP1LC3A MYH7B MYLK2 WFDC11 WFDC3 WISP2,antibacterial humoral response|response to bacterium|leukocyte migration involved in immune response|respiratory burst after phagocytosis|regulation of muscle filament sliding,0.00054|0.0005907|0.001746|0.002327|0.002909,1|1|1|1|1,59.18|9.561|858.1|572.1|429.1
2074,5,0.6736,6.736000000000001,3422.0,0.001959,0.996692,HSPA13 SEC11A SPCS1 SPCS3 TGFBR2,signal peptide processing|protein processing|protein maturation|viral protein processing|peptide metabolic process,3.121e-09|6.263e-06|1.633e-05|3.85e-05|0.0001722,4.923e-05|0.0494|0.08585|0.1518|0.5433,1030|70.61|51.06|211.2|23.01
2075,5,0.6245,6.245,4079.0,0.001525,0.996692,CYP2F1 HIST1H4I MGST1 SEC11C ZNF611,xenobiotic metabolic process|cellular response to xenobiotic stimulus|response to xenobiotic stimulus|trichloroethylene metabolic process|cellular response to lipid hydroperoxide,0.0003667|0.0003963|0.0004397|0.0004854|0.0004854,1|1|1|1|1,66.44|63.86|60.57|4119|4119
2076,8,0.606,16.97,5554.0,0.003037,0.9996790000000001,ATR COPB2 ISY1 RPN1 SEC61A1 SRPRB TOPBP1 U2SURP,toxin transport|negative regulation of extracellular matrix assembly|establishment of protein localization to organelle|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,0.0001984|0.0009704|0.001122|0.001303|0.001396,1|1|1|1|1,98.07|2060|13.76|37.11|35.82
2077,14,0.6077,55.3,10910.0,0.005029,0.9999969999999999,ABHD11 ASL CASTOR3 CLDN3 CLDN4 CYP3A5 GNAT3 SEMA3A SEMA3E TRIM50 TYW1 ZKSCAN1 ZNF92 ZSCAN25,positive regulation of metallopeptidase activity|regulation of metallopeptidase activity|calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|negative regulation of axon extension involved in axon guidance|regulation of axon extension involved in axon guidance,1.381e-05|5.898e-05|0.000124|0.0001849|0.0002737,0.2178|0.4652|0.6519|0.729|0.8633,457.7|196.1|130.8|105.6|85.81
2078,17,0.6044,82.2,13430.0,0.006067,1.0,CYP3A43 CYP3A5 CYP3A7 DLX6 GNG11 MOGAT3 PILRA PILRB PON1 PON2 PON3 SEMA3D SEMA3E ZKSCAN1 ZNF804B ZSCAN21 ZSCAN25,lipoxygenase pathway|oxidative demethylation|lipid hydroxylation|demethylation|lipid metabolic process,4.479e-07|7.107e-07|2.297e-05|2.361e-05|3.016e-05,0.007065|0.005605|0.1208|0.09309|0.09514,227.2|191.3|346.1|55.07|6.94
2079,5,0.623,6.23,3999.0,0.001551,0.996692,ENPP3 SEMA6D TAAR5 TAAR6 TAAR8,basophil activation involved in immune response|basophil activation|negative regulation of mast cell proliferation|regulation of mast cell proliferation|negative regulation of mast cell activation involved in immune response,0.000728|0.0009706|0.0009706|0.001213|0.002183,1|1|1|1|1,2060|1373|1373|1030|514.9
2080,4,0.601,3.6060000000000003,3110.0,0.001155,0.9929309999999999,CREM FAM84B POU5F1B SEMG1,positive regulation of serine-type peptidase activity|positive regulation of serine-type endopeptidase activity|negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement,0.0005825|0.0005825|0.0007281|0.0007281|0.0007281,1|1|1|1|1,2288|2288|1716|1716|1716
2081,9,0.6018,21.66,7134.0,0.00302,0.9998530000000001,FAM209B GGT7 MAP1LC3A MYLK2 SEMG2 WFDC11 WFDC6 WFDC8 WISP2,antibacterial humoral response|regulation of endopeptidase activity|regulation of peptidase activity|positive regulation of serine-type peptidase activity|positive regulation of serine-type endopeptidase activity,0.0002309|0.0004581|0.0005517|0.001552|0.001552,1|1|1|1|1,88.77|18.21|17.09|858.1|858.1
2082,7,0.6094,12.8,5747.0,0.002216,0.9992989999999999,IL1F10 IL1RN IL36G LYG1 RNF149 SCTR SEPT10,inflammatory response to antigenic stimulus|inflammatory response|defense response|cell wall macromolecule catabolic process|cytokine-mediated signaling pathway,2.016e-07|0.0004597|0.0006643|0.001019|0.001159,0.00318|1|1|1|1,252.2|17.8|8.311|1471|12.94
2083,26,0.6023,195.7,19990.0,0.009670999999999999,1.0,APOBEC3A APOBEC3D APOBEC3G APOL1 APOL5 CRYBA4 CRYBB1 CRYBB3 FOXRED2 GSTT2B MIF MPPE1 RFPL2 RFPL3 SEC14L3 SEC14L4 SEC14L6 SEPT5 SERHL2 SLC5A1 SLC5A4 SUSD2 TBC1D10A TCN2 VPREB1 ZNF74,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,6.352e-07|1.009e-06|1.009e-06|1.009e-06|1.009e-06,0.01002|0.007956|0.005304|0.003978|0.003182,220.7|183.9|183.9|183.9|183.9
2084,8,0.611,17.11,6387.0,0.002665,0.9996790000000001,C15orf53 EPB42 NIPA2 PLA2G4D PLA2G4E SERINC4 TMEM62 WDR76,phosphatidylinositol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid catabolic process|phosphatidylcholine acyl-chain remodeling,1.875e-05|2.722e-05|3.725e-05|4.58e-05|4.885e-05,0.2957|0.2146|0.1959|0.1806|0.1541,326.9|267.5|226.3|202.9|196.1
2085,4,0.6468,3.8810000000000002,3364.0,0.00115,0.9929309999999999,CALCOCO2 CCL7 SERPINA10 VAT1L,response to interferon-gamma|xenophagy|positive regulation of natural killer cell chemotaxis|positive regulation of autophagosome maturation|regulation of natural killer cell chemotaxis,0.0004655|0.0009706|0.001359|0.001359|0.001747,1|1|1|1|1,56.89|1287|858.1|858.1|643.6
2086,7,0.6155,12.93,5446.0,0.002362,0.9992989999999999,BTN2A2 HIST1H1T OR2B6 SERPINB9 SLC17A2 SLC17A4 TUBB2A,sialic acid transport|sodium ion transmembrane transport|sodium ion transport|protection from natural killer cell mediated cytotoxicity|carboxylic acid transport,1.484e-06|0.0005137|0.001064|0.002037|0.002147,0.0234|1|1|1|1,1373|57.21|39.45|572.1|27.57
2087,4,0.6684,4.011,2696.0,0.0014810000000000001,0.9929309999999999,SF3A1 SF3B1 SF3B2 SF3B3,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",4.776e-08|4.776e-08|4.967e-08|1.562e-07|3.112e-07,0.0007534|0.0003767|0.0002612|0.0006161|0.0009818,68.2|68.2|67.52|50.6|42.55
2088,4,0.6314,3.7880000000000003,3200.0,0.001179,0.9929309999999999,CD84 CTSK FMO2 SFI1,drug metabolic process|negative regulation of granulocyte macrophage colony-stimulating factor production|negative regulation of interleukin-18 production|oxygen metabolic process|NADPH oxidation,5.293e-05|0.0004854|0.0009706|0.0009706|0.001698,0.8349|1|1|1|1,179.1|4119|1373|1373|686.5
2089,12,0.6135,40.49,8912.0,0.004511,0.999986,CD19 CD79A CD79B CD81 DOCK2 EBF1 ODC1 PAX5 RAC2 RHOH SFXN1 SYK,leukocyte differentiation|lymphocyte activation|lymphocyte differentiation|mononuclear cell differentiation|leukocyte activation,7.345e-10|1.477e-09|5.276e-09|1.239e-08|1.958e-08,1.159e-05|1.165e-05|2.774e-05|4.885e-05|6.176e-05,31.42|28.36|38.33|33.12|13.55
2090,5,0.6036,6.0360000000000005,4644.0,0.001295,0.996692,C19orf12 DNAI1 GJA9 HSD11B1 SGMS2,ceramide phosphoethanolamine biosynthetic process|ceramide phosphoethanolamine metabolic process|sphingomyelin biosynthetic process|glucocorticoid biosynthetic process|sphingomyelin metabolic process,0.0008735|0.0008735|0.002328|0.00349|0.004361,1|1|1|1|1,1716|1716|490.4|312|245.2
2091,6,0.6213,9.32,4323.0,0.0021449999999999998,0.998474,ECHS1 JAK3 LDLRAP1 MCEMP1 REEP4 SH2B1,negative regulation of FasL production|regulation of FasL production|positive regulation of receptor-mediated endocytosis involved in cholesterol transport|positive regulation of low-density lipoprotein particle clearance|negative regulation of dendritic cell cytokine production,0.0005824|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|3432|1716|1716|1716
2092,4,0.6258,3.755,3348.0,0.001118,0.9929309999999999,ABHD4 FUCA1 SH2B3 SUCLG2,negative regulation of Kit signaling pathway|regulation of Kit signaling pathway|monocyte homeostasis|thrombopoietin-mediated signaling pathway|succinyl-CoA metabolic process,0.0003883|0.0003883|0.0005825|0.001165|0.001165,1|1|1|1|1,5149|5149|2574|1030|1030
2093,6,0.6013,9.019,4613.0,0.001946,0.998474,AKAP2 C9orf84 FAM129B PALM2 SH2D3C TXNDC8,acrosome assembly|secretory granule organization|JNK cascade|cellular component assembly involved in morphogenesis|positive regulation of peptidyl-serine phosphorylation,0.003297|0.006973|0.01679|0.01794|0.02119,1|1|1|1|1,321.8|147.1|59.87|55.96|47.24
2094,8,0.6217,17.41,5893.0,0.002938,0.9996790000000001,C8orf33 CHAMP1 MZF1 PARD6G PGBD2 RABL2B SH3BP5L ZNF672,"sister chromatid biorientation|attachment of mitotic spindle microtubules to kinetochore|protein localization to microtubule|protein localization to kinetochore|protein localization to chromosome, centromeric region",0.001552|0.005038|0.005424|0.006197|0.008512,1|1|1|1|1,858.1|214.5|198|171.6|122.6
2095,6,0.6301,9.451,4361.0,0.002157,0.998474,C7orf50 CNIH4 FOXD4 NBEAL1 SH3RF2 TSPYL5,regulation of protein ubiquitination|regulation of protein modification by small protein conjugation or removal|cellular response to gamma radiation|negative regulation of JNK cascade|negative regulation of stress-activated MAPK cascade,0.00151|0.001998|0.008996|0.01073|0.01361,1|1|1|1|1,33|28.6|114.4|95.35|74.62
2096,4,0.6095,3.657,3354.0,0.0010869999999999999,0.9929309999999999,CTNNAL1 KBTBD4 SHANK1 TTC9C,determination of affect|sensory processing|habituation|synaptic growth at neuromuscular junction|nonassociative learning,0.0003883|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|1287|1287|1030|858.1
2097,4,0.619,3.714,3188.0,0.001161,0.9929309999999999,ATG4C HMGCS2 MS4A6A SHISAL2A,"isoprenoid biosynthetic process via mevalonate|farnesyl diphosphate biosynthetic process, mevalonate pathway|farnesyl diphosphate biosynthetic process|farnesyl diphosphate metabolic process|ketone body biosynthetic process",0.0005825|0.0005825|0.0009706|0.001165|0.001941,1|1|1|1|1,2574|2574|1287|1030|572.1
2098,4,0.6062,3.637,3406.0,0.001064,0.9929309999999999,ATP2A1 CD8B SHISAL2B TMEM163,positive regulation of actin filament-based movement|positive regulation of cardiac muscle cell contraction|positive regulation of calcium ion import into sarcoplasmic reticulum|maintenance of mitochondrion location|zinc ion import into synaptic vesicle,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
2099,9,0.6064,21.83,6064.0,0.0035759999999999998,0.9998530000000001,CRNKL1 ESF1 NAA20 NOP56 SHLD1 SIVA1 TRMT6 VPS16 XRN2,RNA processing|ncRNA processing|ribonucleoprotein complex biogenesis|ncRNA metabolic process|gene expression,1.986e-05|2.291e-05|3.05e-05|4.603e-05|9.098e-05,0.3132|0.1807|0.1604|0.1815|0.287,12.4|21.19|19.68|17.7|6.281
2100,13,0.6079,47.42,10730.0,0.004389,0.999993,ERVV-2 KLK11 KLK3 SIGLEC10 SIGLEC12 SIGLEC5 VN1R4 ZNF415 ZNF534 ZNF610 ZNF665 ZNF701 ZNF880,zymogen activation|negative regulation of response to wounding|Factor XII activation|antibacterial peptide production|antimicrobial peptide production,0.0004948|0.00177|0.002037|0.002037|0.002037,1|1|1|1|1,62.6|32.33|735.5|735.5|735.5
2101,15,0.615,64.57,12140.0,0.005278,0.999999,FPR1 SIGLEC5 SIGLEC8 VN1R4 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF610 ZNF665 ZNF677 ZNF701 ZNF841 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.046e-07|2.162e-06|2.168e-06|2.201e-06|4.708e-06,0.001649|0.01705|0.0114|0.008678|0.01485,5.84|4.36|4.359|4.352|4.04
2102,4,0.6346,3.807,2540.0,0.001492,0.9929309999999999,CMIP PRKAR1A SIK2 STK11,negative regulation of reproductive process|regulation of reproductive process|protein autophosphorylation|positive regulation of vesicle transport along microtubule|regulation of vesicle transport along microtubule,4.821e-05|0.0003786|0.0004808|0.0009706|0.001165,0.7605|1|1|1|1,180.7|63.17|55.96|1287|1030
2103,4,0.6575,3.945,3224.0,0.001219,0.9929309999999999,FRMPD2 NMT2 SELENOO SLA2,protein nucleotidylation|protein adenylylation|N-terminal peptidyl-glycine N-myristoylation|N-terminal protein myristoylation|protein myristoylation,0.0005825|0.0005825|0.0005825|0.0009706|0.0009706,1|1|1|1|1,2574|2574|2574|1287|1287
2104,11,0.6002,33.01,8153.0,0.0040219999999999995,0.999969,ARL11 LCE1B LCE2A LCE3A LCE3B LCE3C LCE3D LCE3E LCE5A RC3H1 SPRR2G,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,1.509e-16|6.765e-16|2.894e-15|1.585e-14|3.365e-14,2.381e-12|5.335e-12|1.522e-11|6.249e-11|1.061e-10,74.56|62.87|53.32|44|40.41
2105,5,0.6477,6.477,3923.0,0.001644,0.996692,HAPLN2 OR6K6 SLAMF1 THBS3 TTC24,negative regulation of CD40 signaling pathway|cell adhesion|biological adhesion|myeloid dendritic cell activation involved in immune response|establishment of blood-nerve barrier,0.000728|0.0009229|0.00094|0.0009706|0.001213,1|1|1|1|1,2060|12.99|12.91|1373|1030
2106,8,0.6198,17.35,6622.0,0.0026079999999999996,0.9996790000000001,EPPIN GHRH MAP1LC3A PKIG RBPJL SLC12A5 TMEM189 WISP2,"positive regulation of circadian sleep/wake cycle, REM sleep|thermosensory behavior|negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|regulation of circadian sleep/wake cycle, REM sleep",0.0007765|0.0007765|0.00194|0.00194|0.00194,1|1|1|1|1,2574|2574|643.6|643.6|643.6
2107,7,0.6464,13.57,5462.0,0.002473,0.9992989999999999,NKD2 SLC12A7 SLC6A18 SLC6A19 SLC6A3 TPPP TRIO,sodium ion transmembrane transport|inorganic cation transmembrane transport|sodium ion transport|cation transmembrane transport|inorganic ion transmembrane transport,7.142e-06|1.979e-05|2.128e-05|3.015e-05|3.546e-05,0.1127|0.1561|0.1119|0.1189|0.1119,73.55|20.57|50.73|18.47|17.72
2108,22,0.6024,139.1,17520.0,0.007861,1.0,AIPL1 ALDH3A1 ALOX15 ALOX15B ALOXE3 ASGR1 CCDC144A CLEC10A KCTD11 MFSD6L MYH2 MYH4 OR3A1 SHBG SLC13A5 SLC2A4 SPNS3 TBC1D28 TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,2.306e-07|2.306e-07|1.011e-06|2.104e-06|7.359e-06,0.003637|0.001818|0.005314|0.008296|0.02322,312|312|175.5|133.7|85.1
2109,4,0.6502,3.9010000000000002,3399.0,0.001144,0.9929309999999999,CHST9 GPX2 RIT2 SLC14A2,regulation of Cdc42 protein signal transduction|urea transmembrane transport|urea transport|one-carbon compound transport|chondroitin sulfate biosynthetic process,0.001553|0.001747|0.001941|0.00291|0.00504,1|1|1|1|1,735.5|643.6|572.1|367.8|205.9
2110,4,0.6191,3.714,3198.0,0.001157,0.9929309999999999,NLRP11 NLRP13 SLC17A7 ZNF329,neurotransmitter loading into synaptic vesicle|regulation of synaptic vesicle endocytosis|phosphate ion transport|L-glutamate transmembrane transport|regulation of synaptic vesicle recycling,0.001747|0.003491|0.004072|0.004459|0.00504,1|1|1|1|1,643.6|302.9|257.4|234|205.9
2111,4,0.6343,3.806,3417.0,0.0011099999999999999,0.9929309999999999,ABHD16B DYNC2LI1 FBLN2 SLC1A6,phosphatidylserine catabolic process|monoacylglycerol catabolic process|aspartate transmembrane transport|L-glutamate import|L-aspartate transmembrane transport,0.0009706|0.001553|0.001941|0.002328|0.002328,1|1|1|1|1,1287|735.5|572.1|468.1|468.1
2112,5,0.6138,6.138,4108.0,0.0014880000000000002,0.996692,AMY2A AMY2B GNAT2 SLC1A7 TMEM56,polysaccharide digestion|carbohydrate metabolic process|detection of light stimulus involved in sensory perception|detection of light stimulus involved in visual perception|neurotransmitter reuptake,0.001698|0.005087|0.005329|0.005329|0.005571,1|1|1|1|1,686.5|17.38|196.1|196.1|187.2
2113,4,0.6431,3.859,3163.0,0.001215,0.9929309999999999,SLC24A3 ZNF497 ZNF551 ZNF814,regulation of gene expression|regulation of transcription by RNA polymerase II|regulation of macromolecule metabolic process|bone mineralization|regulation of metabolic process,0.003137|0.007187|0.008771|0.009867|0.01223,1|1|1|1|1,4.227|5.973|3.269|103|3.008
2114,6,0.6067,9.1,4478.0,0.002023,0.998474,FUT5 FUT6 PLIN3 SLC25A23 UQCR11 ZNF556,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|fucose metabolic process|fucosylation,3.883e-06|3.883e-06|3.883e-06|1.079e-05|1.206e-05,0.06126|0.03063|0.02042|0.04256|0.03805,762.8|762.8|762.8|429.1|403.8
2115,5,0.6238,6.2379999999999995,4252.0,0.001462,0.996692,ADGRB2 FOXRED2 SEC14L6 SELENOM SLC25A38,corticosterone secretion|glycine import into mitochondrion|glucocorticoid secretion|corticosteroid hormone secretion|steroid hormone secretion,0.0004854|0.0004854|0.000728|0.0009706|0.001456,1|1|1|1|1,4119|4119|2060|1373|823.8
2116,14,0.6091,55.43,10830.0,0.005078,0.9999969999999999,CPA1 OR2A5 OR9A2 PRSS37 PRSS58 TAS2R39 TAS2R40 TAS2R60 ZNF212 ZNF282 ZNF398 ZNF425 ZNF783 ZNF786,sensory perception of bitter taste|sensory perception of taste|sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus involved in sensory perception of bitter taste,3.251e-06|1.388e-05|2.123e-05|0.0002614|0.0002971,0.05128|0.1095|0.1116|1|0.9372,107.6|64.9|13.57|12.11|81.73
2117,6,0.6688,10.03,4027.0,0.002478,0.998474,CCNL1 CDK11A CTNNBL1 MMP23B PPP1R8 PRPF19,RNA processing|macromolecule metabolic process|RNA splicing|nucleic acid metabolic process|mRNA processing,0.0001278|0.000223|0.000258|0.0002613|0.000428,1|1|1|1|1,12.75|3.326|21.69|6.591|18.24
2118,4,0.6306,3.784,3214.0,0.001173,0.9929309999999999,ATP1A2 REN S100A8 SLC26A9,negative regulation of calcium:sodium antiporter activity|olfactory cortex development|regulation of lipid transport|response to lipid|regulation of anion transport,0.0004854|0.0004854|0.0005192|0.0006024|0.0006877,1|1|1|1|1,4119|4119|55.66|15.03|14.37
2119,4,0.6121,3.673,3160.0,0.001158,0.9929309999999999,ARL6 C12orf71 LRRC14 SLC32A1,neurotransmitter loading into synaptic vesicle|gamma-aminobutyric acid transport|glycine transport|melanosome transport|pigment granule transport,0.001747|0.001941|0.002328|0.004266|0.004459,1|1|1|1|1,643.6|572.1|468.1|245.2|234
2120,4,0.638,3.8280000000000003,3199.0,0.001192,0.9929309999999999,PDCD6 SLC34A1 SLC51A TCTEX1D2,anion transport|ion transport|arsenate ion transmembrane transport|positive regulation of phosphate transmembrane transport|regulation of phosphate transmembrane transport,0.0001527|0.0003841|0.0003883|0.0003883|0.0003883,1|1|1|1|1,9.005|7.149|5149|5149|5149
2121,4,0.6743,4.046,3406.0,0.001184,0.9929309999999999,COL9A1 CTGF MESP2 SLC35D3,UDP-N-acetylgalactosamine transmembrane transport|UDP-glucuronic acid transmembrane transport|UDP-N-acetylglucosamine transmembrane transport|pyrimidine nucleotide-sugar transmembrane transport|somite rostral/caudal axis specification,0.0005825|0.0005825|0.0008737|0.001747|0.001747,1|1|1|1|1,2288|2288|1373|624.1|624.1
2122,5,0.6076,6.0760000000000005,3852.0,0.0015710000000000001,0.996692,CENPE GAR1 RPL34 SLC35F2 SPATA5,lateral attachment of mitotic spindle microtubules to kinetochore|microtubule plus-end directed mitotic chromosome migration|snoRNA guided rRNA pseudouridine synthesis|mitotic chromosome movement towards spindle pole|rRNA processing,0.0004854|0.0004854|0.0009706|0.001213|0.001571,1|1|1|1|1,4119|4119|1373|1030|31.68
2123,4,0.6223,3.734,2881.0,0.001291,0.9929309999999999,NBEAL1 NEDD8 RPL18 SLC35G6,protein neddylation|protein localization|macromolecule localization|cellular macromolecule catabolic process|cellular iron ion homeostasis,0.002716|0.00425|0.006901|0.01112|0.01314,1|1|1|1|1,396.1|7.158|6.057|11.29|76.85
2124,4,0.6035,3.6210000000000004,3161.0,0.001141,0.9929309999999999,AGA P2RY14 PLSCR1 SLC44A2,cell activation|immune effector process|glycerophospholipid biosynthetic process|glycerolipid biosynthetic process|phospholipid biosynthetic process,0.0005631|0.0005801|0.0006778|0.0008053|0.0009222,1|1|1|1|1,14.25|14.11|47.02|43.09|40.22
2125,10,0.6043,27.19,7794.0,0.003468,0.999933,CARNS1 CCNB1IP1 KIF26B MAP3K7CL MCOLN3 NIPSNAP3B PCDHGA9 RNF114 SDR39U1 TMEM100,carnosine biosynthetic process|carnosine metabolic process|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.0009704|0.001455|0.00194|0.002424|0.002909,1|1|1|1|1,2060|1030|686.5|514.9|411.9
2126,4,0.6005,3.603,3232.0,0.001111,0.9929309999999999,ACSS2 SLC4A11 SYNJ2BP TRAF3IP3,borate transmembrane transport|borate transport|acetyl-CoA biosynthetic process from acetate|acetate biosynthetic process|acetate metabolic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
2127,4,0.6908,4.145,3680.0,0.001123,0.9929309999999999,CLDN22 MGAT5B SLC4A3 SLC7A2,transport across blood-brain barrier|vascular transport|vascular process in circulatory system|L-arginine import across plasma membrane|L-lysine transport,0.0001077|0.0001101|0.0008457|0.001165|0.001359,1|0.8686|1|1|1,119.7|118.4|42.03|1030|858.1
2128,11,0.602,33.11,8723.0,0.0037719999999999997,0.999969,C3AR1 CLEC2B CLEC4C CLEC4D CLEC6A GALNT8 KCNA1 KCNA6 KLRC1 PRH2 PZP,immune response-regulating cell surface receptor signaling pathway|immune response-regulating signaling pathway|regulation of immune response|regulation of innate immune response|stimulatory C-type lectin receptor signaling pathway,3.246e-06|3.343e-06|1.002e-05|1.645e-05|2.921e-05,0.0512|0.02637|0.0527|0.06487|0.09215,19.07|18.95|9.95|24|48.84
2129,8,0.6079,17.02,4811.0,0.003514,0.9996790000000001,ASNS EIF2AK4 GCN1 SLC3A2 SLC7A1 SLC7A11 SLC7A5 TRPM7,amino acid import across plasma membrane|amino acid import|L-alpha-amino acid transmembrane transport|L-amino acid transport|aromatic amino acid transport,6.128e-10|1.381e-09|4.508e-09|5.871e-09|2.147e-08,9.666e-06|1.089e-05|2.371e-05|2.315e-05|6.772e-05,312|251.2|183.9|171.6|594.1
2130,4,0.663,3.978,3291.0,0.001204,0.9929309999999999,DUOXA1 RTP1 SLC51A SLC7A14,organic substance transport|anion transport|ion transport|organic acid transport|positive regulation of hydrogen peroxide biosynthetic process,0.0001238|0.0001527|0.0003841|0.001108|0.001165,1|1|1|1|1,9.491|9.005|7.149|36.65|1030
2131,4,0.6451,3.8710000000000004,3362.0,0.001147,0.9929309999999999,HUNK PPP2R3A PXYLP1 SLC9A3,regulation of cell migration involved in somitogenic axis elongation|positive regulation of heparan sulfate proteoglycan biosynthetic process|regulation of heparan sulfate proteoglycan biosynthetic process|somatic muscle development|positive regulation of proteoglycan biosynthetic process,0.0005825|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|1716|1716|1716|1287
2132,4,0.6257,3.7539999999999996,3239.0,0.001155,0.9929309999999999,RETSAT RNF103 SLC9B1 TEX37,"endoplasmic reticulum mannose trimming|protein alpha-1,2-demannosylation|protein demannosylation|protein deglycosylation|retinol metabolic process",0.004072|0.004846|0.004846|0.006393|0.009482,1|1|1|1|1,257.4|214.5|214.5|160.9|107.3
2133,4,0.6546,3.928,3369.0,0.0011619999999999998,0.9929309999999999,OCM OCM2 SLCO2B1 ZMYND12,sodium-independent icosanoid transport|pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process|sodium-independent organic anion transport,0.0003883|0.003297|0.003297|0.003297|0.003297,1|1|1|1|1,5149|321.8|321.8|321.8|321.8
2134,4,0.6075,3.645,3265.0,0.001112,0.9929309999999999,FLVCR2 GAS6 SLCO3A1 ZNF782,negative regulation of renal albumin absorption|negative regulation of oligodendrocyte apoptotic process|regulation of renal albumin absorption|cellular response to vitamin K|regulation of oligodendrocyte apoptotic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
2135,10,0.6057,27.26,8030.0,0.0033740000000000003,0.999933,AGO1 AGO3 AGO4 BEST4 ERMAP LURAP1 ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",9.86e-09|1.355e-08|1.807e-08|4.594e-08|4.594e-08,0.0001555|0.0001069|9.5e-05|0.0001812|0.0001449,882.6|772.3|686.5|475.3|475.3
2136,4,0.6755,4.053,3497.0,0.001155,0.9929309999999999,RSPO4 SLIT3 SPO11 THPO,female gonad development|development of primary female sexual characteristics|female sex differentiation|gonad development|development of primary sexual characteristics,0.0001151|0.0001282|0.0001684|0.0006181|0.0006536,1|1|0.8853|1|1,115.7|109.5|95.35|49.27|47.9
2137,4,0.6139,3.6830000000000003,3122.0,0.001175,0.9929309999999999,ATG16L1 ATG4B MYOC SLN,ERBB2-ERBB3 signaling pathway|protein delipidation|skeletal muscle hypertrophy|macroautophagy|ERBB3 signaling pathway,0.0003883|0.0003883|0.0003883|0.0005229|0.0005825,1|1|1|1|1,5149|5149|5149|53.63|2574
2138,5,0.6459,6.459,3342.0,0.001923,0.996692,BRAP PLAA SLTM UBC USP14,ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process|proteolysis involved in cellular protein catabolic process|cellular protein catabolic process,0.0003304|0.0003432|0.0003641|0.0004581|0.0005363,1|1|1|1|1,19.32|19.07|18.69|17.28|16.37
2139,4,0.6469,3.8810000000000002,2683.0,0.00144,0.9929309999999999,SMG5 SMG6 SMG7 SMG8,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|nuclear-transcribed mRNA catabolic process|mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process",1.251e-09|8.625e-09|1.266e-08|2.119e-08|1.128e-07,1.973e-05|6.802e-05|6.658e-05|8.354e-05|0.0003559,171.6|105.1|95.35|83.72|54.92
2140,17,0.6046,82.23,10710.0,0.007597,1.0,BRIP1 FANCD2 FANCF FANCG FANCI FANCL MCM8 MCM9 RAD51 RAD51B RAD51C RAD51D RFWD3 SFR1 UBE2T XRCC2 XRCC3,interstrand cross-link repair|DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|double-strand break repair,1.087e-26|2.207e-26|1.45e-23|1.649e-23|2.019e-20,1.715e-22|1.74e-22|7.625e-20|6.502e-20|6.371e-17,245.2|36.7|24.91|24.72|67.97
2141,17,0.5641,76.72,13570.0,0.005608,1.0,SMIM17 VN1R1 ZFP28 ZNF135 ZNF211 ZNF264 ZNF304 ZNF416 ZNF460 ZNF548 ZNF550 ZNF586 ZNF587 ZNF665 ZNF667 ZNF701 ZNF805,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",3.348e-12|2.419e-10|2.429e-10|2.481e-10|7.337e-10,5.281e-08|1.908e-06|1.277e-06|9.784e-07|2.315e-06,7.027|5.246|5.244|5.237|4.861
2142,4,0.6188,3.713,2830.0,0.001306,0.9929309999999999,GORASP2 SMIM19 SPPL3 TM9SF3,signal peptide processing|positive regulation of calcineurin-NFAT signaling cascade|positive regulation of calcineurin-mediated signaling|protein localization to membrane|positive regulation of calcium-mediated signaling,0.002522|0.003491|0.003491|0.003959|0.006393,1|1|1|1|1,429.1|302.9|302.9|19.18|160.9
2143,26,0.6006,195.2,20140.0,0.009574,1.0,ABCC6 ACSM1 ACSM2B ACSM3 ACSM5 BFAR C16orf45 CA5A CORO7 ITGAD ITGAL ITGAX LAT MPV17L MYH11 NOMO1 NOMO2 SCNN1B SEPT1 SEPT12 SMIM22 SULT1A2 VKORC1 ZNF500 ZNF747 ZNF785,purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process|nucleoside bisphosphate metabolic process|acyl-CoA metabolic process|thioester metabolic process,5.955e-07|5.955e-07|5.955e-07|6.337e-06|6.337e-06,0.009394|0.004697|0.003131|0.02499|0.01999,30.97|30.97|30.97|33.97|33.97
2144,27,0.602,211.3,20720.0,0.01007,1.0,APOBEC3A APOBEC3D APOBEC3G APOL1 CRYBA4 CRYBB1 CRYBB3 DGCR6L FOXRED2 GAL3ST1 GSTT2B ISX LRRC75B MIF MPPE1 RFPL2 RFPL3 SEC14L3 SEC14L4 SEC14L6 SEPT5 SGSM1 SLC5A1 SLC5A4 USP18 VPREB1 ZNF74,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,6.352e-07|1.009e-06|1.009e-06|1.009e-06|1.009e-06,0.01002|0.007956|0.005304|0.003978|0.003182,220.7|183.9|183.9|183.9|183.9
2145,6,0.6009,9.013,4963.0,0.001808,0.998474,CNBD2 CPNE1 GHRH SNAI1 SPAG4 WFDC11,"positive regulation of circadian sleep/wake cycle, REM sleep|negative regulation of cell differentiation involved in embryonic placenta development|regulation of circadian sleep/wake cycle, REM sleep|regulation of cell differentiation involved in embryonic placenta development|negative regulation of vitamin D biosynthetic process",0.0005824|0.0005824|0.001456|0.001456|0.001746,1|1|1|1|1,3432|3432|858.1|858.1|686.5
2146,4,0.6382,3.8289999999999997,2597.0,0.001468,0.9929309999999999,DDX39B RBM33 SNRPA THOC6,viral mRNA export from host cell nucleus|translocation of molecules into host|RNA splicing|mRNA processing|mRNA 3'-end processing,1.272e-06|1.555e-06|3.085e-05|5.161e-05|0.0001126,0.02007|0.01226|0.1622|0.2035|0.3553,1287|1144|37.95|31.91|117
2147,4,0.6475,3.885,3454.0,0.001121,0.9929309999999999,DCAKD ETNPPL SNTA1 ST8SIA4,regulation of vasoconstriction by circulating norepinephrine|regulation of vasoconstriction by norepinephrine|negative regulation of peptidyl-cysteine S-nitrosylation|regulation of peptidyl-cysteine S-nitrosylation|coenzyme A biosynthetic process,0.0003883|0.0003883|0.001165|0.001747|0.002328,1|1|1|1|1,5149|5149|1030|643.6|468.1
2148,4,0.6681,4.0089999999999995,3630.0,0.001101,0.9929309999999999,KCNAB1 RALYL SNTG1 TBC1D17,diaphragm development|negative regulation of delayed rectifier potassium channel activity|negative regulation of voltage-gated potassium channel activity|regulation of delayed rectifier potassium channel activity|negative regulation of potassium ion transmembrane transporter activity,0.001747|0.002522|0.002716|0.004266|0.004459,1|1|1|1|1,643.6|429.1|396.1|245.2|234
2149,4,0.6109,3.665,3056.0,0.0011949999999999999,0.9929309999999999,FAM207A SLC2A13 SNX11 ZNF277,myo-inositol transport|polyol transport|positive regulation of amyloid-beta formation|positive regulation of amyloid precursor protein catabolic process|regulation of amyloid-beta formation,0.0009706|0.002522|0.003878|0.00504|0.006973,1|1|1|1|1,1287|429.1|271|205.9|147.1
2150,4,0.6413,3.8480000000000003,2972.0,0.001289,0.9929309999999999,JAK3 REEP4 SNX18 TMEFF1,negative regulation of FasL production|regulation of FasL production|negative regulation of dendritic cell cytokine production|negative regulation of T-helper 1 cell differentiation|interleukin-4-mediated signaling pathway,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
2151,4,0.6093,3.656,3320.0,0.001097,0.9929309999999999,HTR3D HTR3E SERP1 SNX24,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,2.313e-05|9.574e-05|9.807e-05|0.0001363|0.0001363,0.3649|0.7551|0.5156|0.5376|0.4301,264|127.1|125.6|106.2|106.2
2152,4,0.6113,3.668,2636.0,0.001385,0.9929309999999999,POP7 RPP21 SOAT1 SSB,tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|tRNA processing,1.537e-09|2.66e-09|5.554e-09|7.134e-09|1.096e-06,2.425e-05|2.098e-05|2.92e-05|2.813e-05|0.003457,1188|965.4|735.5|671.6|117
2153,4,0.6637,3.9819999999999998,3271.0,0.001213,0.9929309999999999,ASPDH LY6D PSCA SOCS7,phosphatidylinositol phosphorylation|regulation of phosphatidylinositol 3-kinase activity|regulation of lipid kinase activity|lipid phosphorylation|phosphatidylinositol metabolic process,8.02e-05|8.295e-05|0.0001197|0.0001264|0.0007712,1|0.6543|0.6291|0.4985|1,144.5|142|117.7|114.4|45.51
2154,4,0.6336,3.802,3159.0,0.001199,0.9929309999999999,CDK5RAP1 FOXS1 SOGA1 SUMO2,tRNA methylthiolation|positive regulation of translational fidelity|mitochondrial tRNA modification|mitochondrial RNA modification|mitochondrial tRNA processing,0.0005825|0.0009706|0.001941|0.001941|0.002716,1|1|1|1|1,2574|1287|572.1|572.1|396.1
2155,8,0.6169,17.27,6569.0,0.002616,0.9996790000000001,ARHGEF26 CPB1 P2RY14 PLSCR1 PLSCR2 SOGA3 TM4SF18 TM4SF4,plasma membrane phospholipid scrambling|phospholipid translocation|lipid translocation|regulation of membrane lipid distribution|phospholipid transport,3.036e-05|0.0001475|0.0001666|0.0002232|0.0005785,0.4789|1|0.8761|0.8804|1,257.4|111.9|105.1|90.33|55.36
2156,4,0.6435,3.861,3334.0,0.0011539999999999999,0.9929309999999999,FILIP1 RSPH10B2 SOSTDC1 STEAP1B,negative regulation of determination of dorsal identity|mammary gland bud morphogenesis|regulation of determination of dorsal identity|morphogenesis of an epithelial bud|negative regulation of cell fate commitment,0.0005825|0.0007766|0.0009706|0.001553|0.002716,1|1|1|1|1,2574|1716|1287|735.5|396.1
2157,13,0.6107,47.63,10340.0,0.004575,0.999993,C17orf50 CCL13 CCL2 CCL7 GAS2L2 LGALS9 LYRM9 PIPOX SEBOX SLFN12 SPAG5 TIAF1 UNC119,eosinophil chemotaxis|eosinophil migration|cellular response to interferon-gamma|monocyte chemotaxis|response to interferon-gamma,2.222e-07|2.591e-07|2.49e-06|2.559e-06|4.22e-06,0.003505|0.002044|0.01309|0.01009|0.01331,279.6|264|40.11|115.9|35.01
2158,4,0.6063,3.638,3206.0,0.001131,0.9929309999999999,MINDY4 SPATA3 SPHK2 VMO1,sphinganine-1-phosphate biosynthetic process|histone H2B-K12 acetylation|histone H2A-K5 acetylation|sphinganine-1-phosphate metabolic process|negative regulation of histone deacetylase activity,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
2159,4,0.6279,3.767,3218.0,0.001167,0.9929309999999999,GPR32 KLK11 KLK6 SPATA8,complement receptor mediated signaling pathway|amyloid precursor protein metabolic process|protein autoprocessing|positive regulation of G protein-coupled receptor signaling pathway|collagen catabolic process,0.002716|0.004653|0.004846|0.005426|0.008517,1|1|1|1|1,396.1|223.9|214.5|190.7|119.7
2160,4,0.6269,3.761,3185.0,0.0011769999999999999,0.9929309999999999,FTCD KRTAP10-3 KRTAP10-8 SPATC1L,keratinization|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide|keratinocyte differentiation,0.0007212|0.0009706|0.0009706|0.0009706|0.001009,1|1|1|1|1,45.56|1287|1287|1287|38.42
2161,6,0.6545,9.818,4082.0,0.002392,0.998474,DHX9 RNPC3 SNRNP25 SPC24 SPC25 ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",1.613e-06|1.613e-06|1.677e-06|5.21e-06|1.028e-05,0.02544|0.01272|0.008815|0.02054|0.03245,38.97|38.97|38.59|28.92|24.32
2162,4,0.621,3.7260000000000004,3333.0,0.001114,0.9929309999999999,LPIN3 ORC2 SPDYA TNNT2,G1/S transition of mitotic cell cycle|cell cycle G1/S phase transition|regulation of muscle filament sliding speed|regulation of muscle filament sliding|mitotic cell cycle phase transition,0.0002245|0.0002316|0.0005825|0.0009706|0.001139,1|1|1|1|1,82.38|81.08|2574|1287|36.13
2163,5,0.6116,6.1160000000000005,3922.0,0.001553,0.996692,FAM209A FAM209B RIPOR3 SPEG WFDC6,muscle cell differentiation|cellular process|muscle organ development|muscle structure development|UNCLASSIFIED,0.04505|0.04971|0.05346|0.08656|0.08866,1|1|1|1|1,21.91|0.3325|18.39|11.19|3.751
2164,4,0.6801,4.081,3382.0,0.001202,0.9929309999999999,DCLRE1C KRT27 SPEM2 TMIGD1,protection from non-homologous end joining at telomere|telomere maintenance in response to DNA damage|V(D)J recombination|telomere capping|hair follicle morphogenesis,0.001553|0.002134|0.003297|0.003878|0.00562,1|1|1|1|1,735.5|514.9|321.8|271|183.9
2165,4,0.6173,3.7039999999999997,3345.0,0.001103,0.9929309999999999,NT5C1A RNASE12 SPG11 ST8SIA2,phagosome-lysosome fusion involved in apoptotic cell clearance|phagolysosome assembly involved in apoptotic cell clearance|phagosome maturation involved in apoptotic cell clearance|purine nucleoside monophosphate catabolic process|adenosine metabolic process,0.0003883|0.0005825|0.0005825|0.001553|0.001941,1|1|1|1|1,5149|2574|2574|735.5|572.1
2166,4,0.623,3.738,3239.0,0.00115,0.9929309999999999,DBNDD1 NRG4 PTH SPG7,positive regulation of osteoclast proliferation|regulation of osteoclast proliferation|negative regulation of bone mineralization involved in bone maturation|hormone-mediated apoptotic signaling pathway|negative regulation of apoptotic process in bone marrow cell,0.000728|0.001213|0.001213|0.001213|0.001456,1|1|1|1|1,2060|1030|1030|1030|823.8
2167,4,0.6657,3.9939999999999998,3290.0,0.00121,0.9929309999999999,GALK1 MIF4GD SPHK1 UBE2O,polyol metabolic process|galactitol metabolic process|regulation of endosomal vesicle fusion|glycolytic process from galactose|sphingoid catabolic process,0.0002174|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,83.72|5149|5149|5149|5149
2168,4,0.612,3.6719999999999997,3389.0,0.00108,0.9929309999999999,SPHKAP TCAIM TOX2 TSHZ2,"cellular process|regulation of transcription by RNA polymerase II|UNCLASSIFIED|biological_process|regulation of transcription, DNA-templated",0.00379|0.07957|0.08866|0.08866|0.1341,1|1|1|1|1,0|3.982|3.751|0.5769|2.973
2169,15,0.6097,64.02,11620.0,0.0054659999999999995,0.999999,APTX AQP7 CREB3 DNAJA1 DNAJB5 FAM205A GALT OR13J1 OR2S2 SIGMAR1 SPAG8 SPINK4 TESK1 TOMM5 UBAP2,response to unfolded protein|response to topologically incorrect protein|UDP-glucose catabolic process|protein localization to mitochondrion|polynucleotide 3' dephosphorylation,0.0002332|0.0003284|0.001455|0.001665|0.002182,1|1|1|1|1,24.66|21.91|1373|33.49|686.5
2170,6,0.6099,9.149,4985.0,0.0018280000000000002,0.998474,GHRH LBP MAP1LC3A MYH13 SPINT4 WFDC6,"response to nutrient levels|response to extracellular stimulus|positive regulation of circadian sleep/wake cycle, REM sleep|positive regulation of cytolysis|positive regulation of respiratory burst involved in inflammatory response",0.0001354|0.0001611|0.0004854|0.0004854|0.000728,1|1|1|1|1,24.96|23.54|4119|4119|2060
2171,4,0.6105,3.6630000000000003,3294.0,0.001108,0.9929309999999999,EMILIN2 SLC27A5 SPIRE1 ZBTB45,formin-nucleated actin cable organization|formin-nucleated actin cable assembly|triglyceride mobilization|polar body extrusion after meiotic divisions|long-chain fatty acid import across plasma membrane,0.0007766|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1287|1287|1287
2172,22,0.6042,139.6,13970.0,0.009859,1.0,ARL8B BLOC1S1 FNIP1 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 NPC1 RAB7A RRAGA RRAGC SNAPIN SPG21 TBC1D5 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41,cellular protein localization|cellular macromolecule localization|protein localization|lysosomal transport|cellular localization,9.612e-17|1.025e-16|2.947e-16|2.258e-15|3.425e-15,1.516e-12|8.084e-13|1.55e-12|8.903e-12|1.081e-11,10.28|10.24|8.242|77.3|6.235
2173,13,0.6186,48.25,8690.0,0.0055060000000000005,0.999993,CNIH1 GOSR2 RAB18 RAB1A RAB1B SCFD1 SEC23IP TRAPPC1 TRAPPC11 TRAPPC12 TRAPPC13 TRAPPC2L TRAPPC4,"endoplasmic reticulum to Golgi vesicle-mediated transport|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi|vesicle coating|COPII-coated vesicle budding",6.159e-21|3.264e-20|3.264e-20|5.459e-20|7.882e-20,9.716e-17|2.574e-16|1.716e-16|2.153e-16|2.487e-16,88.91|226.3|226.3|212.8|203.7
2174,10,0.6038,27.17,7494.0,0.0036030000000000003,0.999933,ACCSL CAT EHF ELF5 F2 FBXO3 MAPK8IP1 PAMR1 SLC1A2 TCP11L1,hydrogen peroxide catabolic process|acute-phase response|hydrogen peroxide metabolic process|acute inflammatory response|protein targeting to peroxisome,0.0001691|0.0003269|0.0003269|0.0009671|0.001186,1|1|1|1|1,109.3|77.28|77.28|44.01|39.61
2175,4,0.6345,3.807,3256.0,0.001165,0.9929309999999999,LIPE SPRR1B SPRR4 UNC5C,triglyceride catabolic process|acylglycerol catabolic process|neutral lipid catabolic process|glycerolipid catabolic process|triglyceride metabolic process,1.909e-05|3.48e-05|3.48e-05|8.861e-05|0.0001478,0.3011|0.2745|0.183|0.3494|0.4663,305.1|222.6|222.6|137.3|105.6
2176,4,0.6841,4.105,2985.0,0.001369,0.9929309999999999,OR8S1 PUS7L SLC38A4 SPRYD4,pseudouridine synthesis|amino acid transmembrane transport|amino acid transport|carboxylic acid transmembrane transport|organic acid transmembrane transport,0.003685|0.01756|0.02558|0.02748|0.02767,1|1|1|1|1,286|57.21|39.01|36.26|36.01
2177,4,0.6212,3.727,3268.0,0.0011359999999999999,0.9929309999999999,HTR1A PCDHA13 SLC25A2 SPTSSB,mitochondrial L-ornithine transmembrane transport|regulation of serine C-palmitoyltransferase activity|L-ornithine transmembrane transport|adenylate cyclase-inhibiting serotonin receptor signaling pathway|ornithine transport,0.0007766|0.001165|0.001359|0.001553|0.001553,1|1|1|1|1,1716|1030|858.1|735.5|735.5
2178,7,0.6159,12.93,4783.0,0.002689,0.9992989999999999,DIAPH1 DIAPH3 FLII PFN1 SRF TMOD3 XPO6,actin cytoskeleton organization|actin filament-based process|actin filament organization|cytoskeleton organization|supramolecular fiber organization,1.931e-09|4.231e-09|8.397e-09|2.697e-07|4.192e-07,3.045e-05|3.337e-05|4.415e-05|0.001064|0.001322,33.69|29.52|54.48|14.66|24.64
2179,5,0.6147,6.147,3005.0,0.0020350000000000004,0.996692,ARIH1 CAND1 CUL3 KEAP1 UBE2M,protein modification by small protein conjugation|protein modification by small protein conjugation or removal|post-translational protein modification|protein ubiquitination|cellular protein modification process,1.024e-07|3.188e-07|4.781e-07|8.243e-06|6.797e-05,0.001616|0.002514|0.002514|0.0325|0.2144,25.09|19.98|45.64|22.23|6.822
2180,6,0.6095,9.142999999999999,4136.0,0.002199,0.998474,AMD1 AZIN1 ODC1 PDXK SLC4A7 SRM,polyamine biosynthetic process|polyamine metabolic process|cellular biogenic amine biosynthetic process|amine biosynthetic process|cellular biogenic amine metabolic process,6.111e-12|1.768e-11|2.46e-10|2.706e-10|8.772e-09,9.64e-08|1.394e-07|1.293e-06|1.067e-06|2.767e-05,980.7|722.6|352.1|343.2|138.7
2181,7,0.6089,12.79,5031.0,0.0025280000000000003,0.9992989999999999,DDX41 DDX46 GEMIN5 PHAX SRFBP1 SRP19 TTC1,"RNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA processing",5.226e-05|0.0001076|0.0001076|0.0001108|0.0001278,0.8243|0.8487|0.5658|0.4368|0.4032,9.2|29.23|29.23|28.94|12.75
2182,5,0.616,6.16,3721.0,0.001648,0.996692,EXOC1 GAR1 SPATA5 SRP72 YTHDC1,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|protein transport|peptide transport|amide transport,0.0009706|0.002667|0.003225|0.003413|0.003641,1|1|1|1|1,1373|411.9|8.446|8.282|8.098
2183,4,0.6185,3.7110000000000003,2670.0,0.001384,0.9929309999999999,PCBP1 SON SRPK1 SRRM2,"RNA splicing|mRNA processing|mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome",1.562e-07|3.112e-07|1.307e-06|4.076e-06|1.272e-05,0.002464|0.002455|0.006875|0.01607|0.04012,50.6|42.55|29.68|22.31|51.15
2184,4,0.607,3.642,3324.0,0.001092,0.9929309999999999,IMMP1L LRSAM1 SRPK2 UBXN11,ubiquitin-dependent endocytosis|nuclear speck organization|cellular protein metabolic process|protein processing involved in protein targeting to mitochondrion|R-loop disassembly,0.0007766|0.0009706|0.0009812|0.001165|0.001165,1|1|1|1|1,1716|1287|5.653|1030|1030
2185,4,0.6655,3.9930000000000003,3292.0,0.001208,0.9929309999999999,LUC7L NDUFV3 POU4F1 SRR,negative regulation of transcription elongation by RNA polymerase I|regulation of transcription elongation from RNA polymerase I promoter|proprioception involved in equilibrioception|D-serine biosynthetic process|D-amino acid biosynthetic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2186,4,0.6241,3.7439999999999998,3230.0,0.001155,0.9929309999999999,C6orf203 HOXD12 SSBP2 TMC7,"regulation of mitochondrial transcription|regulation of mitochondrial gene expression|embryonic digit morphogenesis|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription",0.0009706|0.006007|0.01122|0.01665|0.01667,1|1|1|1|1,1287|171.6|90.33|4.459|4.458
2187,6,0.6275,9.413,4494.0,0.002085,0.998474,CCDC74B CFC1 CFC1B POTEI SSBP3 TUBA3D,nodal signaling pathway|anterior/posterior pattern specification|activin receptor signaling pathway|regionalization|pattern specification process,6.423e-06|2.042e-05|2.86e-05|7.24e-05|0.0001676,0.1013|0.161|0.1504|0.2855|0.5289,572.1|49.75|254.3|32.38|24.34
2188,4,0.6246,3.747,3301.0,0.001131,0.9929309999999999,SCRN3 SSTR3 TIMM21 TRIM56,interferon-beta production|hormone-mediated apoptotic signaling pathway|somatostatin signaling pathway|somatostatin receptor signaling pathway|type I interferon production,0.0007766|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1287|1030|1030|1030
2189,11,0.6058,33.32,7992.0,0.00414,0.999969,AQP7 CBWD2 CNTNAP3 CNTNAP3B FOXD4L5 OR2S2 PGM5 SPATA31A6 SPATA31A7 ST3GAL1 ZNF658,"memory B cell differentiation|immunological memory formation process|immunological memory process|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|regulation of activated CD8-positive, alpha-beta T cell apoptotic process",0.001067|0.001601|0.001601|0.001601|0.002134,1|1|1|1|1,1872|936.1|936.1|936.1|624.1
2190,4,0.6154,3.6919999999999997,3121.0,0.001179,0.9929309999999999,CFC1 MRPL30 ST6GAL2 TUBA3D,nodal signaling pathway|sialylation|activin receptor signaling pathway|oligosaccharide metabolic process|mitochondrial translational elongation,0.002522|0.004072|0.005426|0.01256|0.01717,1|1|1|1|1,429.1|257.4|190.7|80.45|58.51
2191,12,0.6163,40.67,9772.0,0.004135,0.999986,C18orf32 CDH7 CNDP2 CTIF DSG1 DSG3 DSG4 SERPINB10 SERPINB2 SERPINB5 SERPINB7 ST8SIA3,homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of endopeptidase activity|negative regulation of peptidase activity|cell-cell adhesion via plasma-membrane adhesion molecules|negative regulation of proteolysis,2.151e-06|9.545e-06|1.115e-05|1.184e-05|3.555e-05,0.03394|0.07528|0.05862|0.0467|0.1122,41.11|28.02|26.92|26.51|19.96
2192,4,0.6048,3.6289999999999996,3285.0,0.001101,0.9929309999999999,REP15 SERPINE2 STAP2 ZSWIM4,mating plug formation|seminal vesicle epithelium development|seminal vesicle development|negative regulation of plasminogen activation|regulation of timing of cell differentiation,0.0003883|0.0003883|0.0005825|0.001359|0.001553,1|1|1|1|1,5149|5149|2574|858.1|735.5
2193,4,0.6326,3.7960000000000003,3291.0,0.001149,0.9929309999999999,HOXD11 HOXD9 STC2 TMEM237,regionalization|tissue development|pattern specification process|peripheral nervous system neuron development|peripheral nervous system neuron differentiation,0.001414|0.002236|0.002479|0.002522|0.002522,1|1|1|1|1,32.38|8.918|24.34|429.1|429.1
2194,8,0.6034,16.89,6297.0,0.002669,0.9996790000000001,C6orf48 HLA-DMB MSH5 NCR3 NUDT3 PSORS1C2 STK19 TNXB,diphosphoinositol polyphosphate catabolic process|positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|peptide antigen assembly with MHC class II protein complex|MHC class II protein complex assembly|adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,0.0006794|0.001358|0.001698|0.001698|0.002037,1|1|1|1|1,2942|980.7|735.5|735.5|588.4
2195,4,0.6023,3.614,3187.0,0.0011300000000000001,0.9929309999999999,CCDC190 DAOA ESM1 STK32B,positive regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of D-amino-acid oxidase activity|regulation of D-amino-acid oxidase activity|regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of oxidoreductase activity,0.0003883|0.0003883|0.0003883|0.0009706|0.005426,1|1|1|1|1,5149|5149|5149|1287|190.7
2196,7,0.6084,12.78,5211.0,0.002439,0.9992989999999999,CFAP53 LHX3 MGAT1 NEUROD1 OTP OTX2 STMN1,brain development|head development|forebrain development|pattern specification process|endocrine system development,3.224e-06|4.241e-06|7.838e-06|1.192e-05|1.223e-05,0.05086|0.03345|0.04121|0.04701|0.03858,17.28|16.33|27.1|24.34|62.79
2197,4,0.6127,3.676,3330.0,0.0011,0.9929309999999999,GSTO2 SFRP5 STMN3 TMEM243,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis|regulation of Wnt signaling pathway involved in digestive tract morphogenesis|negative regulation of Rac protein signal transduction|L-ascorbic acid metabolic process|negative regulation of intracellular signal transduction,0.0003883|0.0003883|0.0007766|0.002328|0.003335,1|1|1|1|1,5149|5149|1716|468.1|20.93
2198,4,0.6445,3.867,2884.0,0.001335,0.9929309999999999,SIK2 SIK3 STK11 STRADA,protein phosphorylation|phosphorylation|regulation of TORC1 signaling|phosphate-containing compound metabolic process|phosphorus metabolic process,1.234e-06|6.121e-06|2.313e-05|7.371e-05|7.797e-05,0.01946|0.04827|0.1216|0.2907|0.246,30.11|20.15|264|10.81|10.65
2199,4,0.6114,3.668,3087.0,0.001184,0.9929309999999999,DEXI MPHOSPH10 PPIP5K1 STRC,inositol metabolic process|inositol phosphate biosynthetic process|auditory receptor cell stereocilium organization|detection of mechanical stimulus involved in sensory perception of sound|auditory receptor cell morphogenesis,0.002328|0.00291|0.003297|0.003297|0.003685,1|1|1|1|1,468.1|367.8|321.8|321.8|286
2200,4,0.6419,3.852,3499.0,0.001097,0.9929309999999999,ETV7 MSH3 OLR1 STX6,removal of nonhomologous ends|synaptic vesicle to endosome fusion|replication fork arrest|meiotic mismatch repair|maintenance of DNA repeat elements,0.0003883|0.0007766|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|1716|1287|1030|858.1
2201,4,0.6036,3.622,3201.0,0.001127,0.9929309999999999,ANKRD23 LYG1 RNF149 SUCNR1,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|regulation of angiotensin metabolic process|renin secretion into blood stream|cell wall macromolecule catabolic process|cell wall organization or biogenesis,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
2202,8,0.6118,17.13,6584.0,0.002589,0.9996790000000001,CA1 CA2 CA3 CYP7A1 FABP4 SGK3 SNX16 SULF1,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|organic substance transport,4.38e-07|5.411e-07|5.071e-06|7.419e-06|3.197e-05,0.006909|0.004268|0.02666|0.02926|0.1009,198|183.9|30.29|6.255|7.118
2203,4,0.6214,3.728,3402.0,0.001092,0.9929309999999999,GALNS MCHR1 SARDH SUN2,sarcosine catabolic process|sarcosine metabolic process|nuclear migration along microfilament|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
2204,4,0.6086,3.6519999999999997,3199.0,0.001137,0.9929309999999999,ASAP2 PIPOX SEZ6L2 SUN5,L-lysine catabolic process to acetyl-CoA via L-pipecolate|L-lysine catabolic process|L-lysine catabolic process to acetyl-CoA|L-lysine metabolic process|synapse maturation,0.0003883|0.0009706|0.0009706|0.0009706|0.002522,1|1|1|1|1,5149|1287|1287|1287|429.1
2205,5,0.606,6.06,3098.0,0.001946,0.996692,HEATR3 MDM2 SURF2 TP53 XPO7,cellular response to actinomycin D|response to actinomycin D|cellular response to UV-C|protein localization to nucleus|cellular response to antibiotic,4.712e-07|7.067e-07|1.696e-06|5.171e-06|5.648e-06,0.007432|0.005574|0.008915|0.02039|0.01782,2746|2060|1177|75.35|588.4
2206,11,0.6054,33.3,9202.0,0.003597,0.999969,C5AR1 C5AR2 CABP5 FFAR3 FGF21 FUT2 GPR32 KLK3 SULT2B1 VN1R4 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|inflammatory response|phospholipase C-activating G protein-coupled receptor signaling pathway|defense response,8.413e-08|1.864e-06|5.726e-06|2.508e-05|6.871e-05,0.001327|0.0147|0.03011|0.09889|0.2168,396.1|1716|17.3|52.01|7.272
2207,13,0.6028,47.02,9406.0,0.00496,0.999993,COA7 COX14 FOXRED1 MRM2 MTG1 MTO1 NSUN3 NSUN4 PET117 PREPL SURF1 TACO1 YBEY,mitochondrial cytochrome c oxidase assembly|respiratory chain complex IV assembly|mitochondrial respiratory chain complex assembly|cytochrome complex assembly|RNA methylation,1.412e-09|2.585e-09|4.077e-09|8.589e-09|2.36e-07,2.227e-05|2.038e-05|2.144e-05|3.387e-05|0.0007444,288|243.7|78.43|176|73.69
2208,4,0.604,3.6239999999999997,3107.0,0.0011619999999999998,0.9929309999999999,MYO1A OR2AP1 OR6C2 TAGLN2,sensory perception|nervous system process|microvillus assembly|detection of chemical stimulus involved in sensory perception of smell|microvillus organization,0.0004092|0.001147|0.002328|0.00269|0.002716,1|1|1|1|1,15.87|11.19|468.1|23.35|396.1
2209,5,0.625,6.25,3962.0,0.0015710000000000001,0.996692,ARHGAP31 CD200R1 IFT57 SLC9C1 TAGLN3,negative regulation of T cell migration|negative regulation of macrophage migration|microtubule-based movement|negative regulation of neuroinflammatory response|negative regulation of lymphocyte migration,0.001698|0.002425|0.002814|0.003394|0.003636,1|1|1|1|1,686.5|457.7|23.54|316.8|294.2
2210,4,0.6139,3.6830000000000003,3200.0,0.001147,0.9929309999999999,LOR RETREG2 TANK ZC3H14,positive regulation of ubiquitin-specific protease activity|lysine biosynthetic process|lysine biosynthetic process via aminoadipic acid|L-lysine catabolic process to acetyl-CoA via saccharopine|L-lysine catabolic process,0.000728|0.000728|0.000728|0.0009706|0.001213,1|1|1|1|1,2060|2060|2060|1373|1030
2211,7,0.6067,12.74,5247.0,0.002416,0.9992989999999999,BTN2A1 BTN2A2 HLA-A HLA-C MICB OR2J3 TAPBP,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|adaptive immune response|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",2.731e-08|3.689e-08|8.743e-08|6.324e-07|1.878e-06,0.0004308|0.0002909|0.0004597|0.002494|0.005926,519.2|464.5|339.5|22.67|116.1
2212,8,0.6156,17.24,5584.0,0.003069,0.9996790000000001,ATXN2L G3BP2 LARP1 LARP4 LARP4B LSM12 NUFIP2 PUM1,regulation of translation|regulation of cellular amide metabolic process|positive regulation of translation|positive regulation of cellular amide metabolic process|stress granule assembly,6.913e-06|1.294e-05|1.642e-05|2.998e-05|3.036e-05,0.109|0.1021|0.08632|0.1182|0.09577,27.98|23.84|56.79|46.25|257.4
2213,4,0.6144,3.6860000000000004,2538.0,0.001446,0.9929309999999999,ADAR RBM7 XRN1 ZFC3H1,ncRNA catabolic process|RNA metabolic process|ncRNA metabolic process|nucleic acid metabolic process|nucleobase-containing compound metabolic process,1.49e-05|3.655e-05|6.278e-05|0.0001385|0.0003048,0.2351|0.2882|0.3301|0.5462|0.9615,332.2|12.88|29.88|9.227|7.574
2214,4,0.6094,3.656,3162.0,0.001152,0.9929309999999999,CLEC5A PRSS58 TAS2R3 WEE2,female pronucleus assembly|negative regulation of oocyte maturation|regulation of meiosis I|regulation of oocyte maturation|negative regulation of cell maturation,0.0005825|0.0007766|0.0009706|0.001359|0.001553,1|1|1|1|1,2574|1716|1287|858.1|735.5
2215,10,0.6195,27.88,7934.0,0.003493,0.999933,CLEC2B KLRC1 KLRC4 PRB4 PRH2 RERG TAS2R13 TAS2R20 TAS2R30 TAS2R46,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|detection of chemical stimulus involved in sensory perception,2.535e-09|4.127e-09|4.52e-09|2.832e-08|5.92e-05,3.998e-05|3.255e-05|2.376e-05|0.0001117|0.1868,228.8|200.9|196.1|121.1|16.95
2216,4,0.6028,3.617,3170.0,0.001137,0.9929309999999999,BTBD7 CDK18 KLHL20 TATDN3,protein K33-linked ubiquitination|regulation of branching involved in salivary gland morphogenesis|Golgi to endosome transport|response to interferon-alpha|regulation of transcription involved in G1/S transition of mitotic cell cycle,0.0003883|0.001553|0.003491|0.004846|0.00678,1|1|1|1|1,5149|735.5|302.9|214.5|151.4
2217,8,0.6141,17.19,6530.0,0.00262,0.9996790000000001,DUPD1 DUSP13 NUTM2A PALD1 RASGEF1A SFTPA1 SFTPA2 TBATA,peptidyl-tyrosine dephosphorylation|protein dephosphorylation|respiratory gaseous exchange by respiratory system|dephosphorylation|toll-like receptor signaling pathway,7.912e-06|6.378e-05|0.0001733|0.0002017|0.0006796,0.1248|0.503|0.9109|0.7952|1,72.86|35.76|103|24.13|50.98
2218,4,0.6218,3.7310000000000003,3271.0,0.001137,0.9929309999999999,FAM129A IGFN1 TBC1D15 ZC3H12C,"retina layer formation|retina morphogenesis in camera-type eye|neural retina development|RNA phosphodiester bond hydrolysis, endonucleolytic|synapse assembly",0.005233|0.01199|0.01352|0.01736|0.01947,1|1|1|1|1,198|84.41|74.62|57.85|51.49
2219,5,0.6008,6.007999999999999,3834.0,0.0015609999999999999,0.996692,ANKRD45 FMO2 ITLN1 SLAMF7 TBX19,drug metabolic process|response to nematode|oxygen metabolic process|NADPH oxidation|protein homotrimerization,7.927e-05|0.001165|0.001165|0.002037|0.004651,1|1|1|1|1,149.2|1144|1144|572.1|228.8
2220,4,0.61,3.66,2732.0,0.001334,0.9929309999999999,MITF SOX10 TBX3 TFAP2A,negative regulation of apoptotic process|negative regulation of transcription by RNA polymerase II|negative regulation of programmed cell death|negative regulation of cell death|melanocyte differentiation,3.494e-06|3.719e-06|3.801e-06|5.567e-06|7.146e-06,0.05511|0.02933|0.01999|0.02195|0.02254,23.19|22.83|22.71|20.64|490.4
2221,4,0.6219,3.7310000000000003,3411.0,0.00109,0.9929309999999999,NCMAP PLA2G2E TC2N ZNF683,regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response|peripheral nervous system myelin formation|cellular response to ionomycin|response to ionomycin,0.0005825|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,2574|1716|1716|1030|1030
2222,4,0.6476,3.886,3240.0,0.0011949999999999999,0.9929309999999999,SERPINA11 SYNDIG1L TCL1B TMEM63C,glomerular filtration|renal filtration|positive regulation of peptidyl-serine phosphorylation|renal system process|regulation of peptidyl-serine phosphorylation,0.00291|0.003104|0.02119|0.02215|0.02786,1|1|1|1|1,367.8|343.2|47.24|45.16|35.76
2223,4,0.6391,3.8339999999999996,3273.0,0.001167,0.9929309999999999,EVA1B HPCAL4 TCTEX1D1 TMEM39B,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of viral genome replication|negative regulation of macroautophagy,0.001359|0.00291|0.003297|0.0062|0.007166,1|1|1|1|1,858.1|367.8|321.8|166.1|143
2224,4,0.6208,3.725,3368.0,0.001102,0.9929309999999999,AGO1 CFH EVA1B TCTEX1D4,"miRNA loading onto RISC involved in gene silencing by miRNA|regulation of complement-dependent cytotoxicity|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated",0.001553|0.001747|0.001747|0.001941|0.002716,1|1|1|1|1,735.5|643.6|643.6|572.1|396.1
2225,8,0.6225,17.43,6378.0,0.002719,0.9996790000000001,ATP12A C1QTNF9 C1QTNF9B GJB2 GJB6 RNF6 SIAH3 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|cell-cell junction assembly,3.69e-06|4.743e-06|5.928e-06|3.036e-05|0.001063,0.0582|0.03741|0.03117|0.1197|1,858.1|735.5|643.6|257.4|40.54
2226,4,0.6539,3.923,2695.0,0.001449,0.9929309999999999,DLG5 PKN2 TEAD1 TP53BP2,intracellular signal transduction|apical junction assembly|cell-cell junction assembly|cell-cell junction organization|zonula adherens assembly,3.44e-05|6.606e-05|0.0002316|0.0004912|0.0005825,0.5427|0.521|1|1|1,13.08|153.7|81.08|55.36|2574
2227,4,0.6235,3.741,3306.0,0.0011279999999999999,0.9929309999999999,GPR142 LGALS3BP SSTR2 TECTA,somatostatin signaling pathway|somatostatin receptor signaling pathway|peristalsis|phasic smooth muscle contraction|cellular response to estradiol stimulus,0.001165|0.001165|0.002328|0.003878|0.007166,1|1|1|1|1,1030|1030|468.1|271|143
2228,18,0.6039,92.39,14190.0,0.006451,1.0,APTX AQP7 CREB3 DNAJB5 FAM205A GALT GBA2 IFNA1 IFNA16 IFNW1 NPR2 OR13J1 OR2S2 SIGMAR1 SPAG8 TESK1 TOMM5 UBAP2,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,9.794e-07|1.435e-06|1.435e-06|7.241e-06|1.203e-05,0.01545|0.01132|0.007548|0.02855|0.03795,171.6|149.2|149.2|83.72|70.05
2229,5,0.6694,6.694,3277.0,0.002032,0.996692,GNB1L TELO2 TTI1 TTI2 WDR73,regulation of TOR signaling|positive regulation of TORC2 signaling|regulation of TORC2 signaling|positive regulation of TORC1 signaling|telomere maintenance via telomerase,0.0002357|0.000728|0.000728|0.004362|0.007261,1|1|1|1|1,83.21|2060|2060|242.3|142
2230,4,0.622,3.7319999999999998,3055.0,0.001217,0.9929309999999999,ERN1 TCF3 TENT2 TRAF5,regulation of RNA metabolic process|regulation of nucleobase-containing compound metabolic process|negative regulation of miRNA metabolic process|negative regulation of miRNA catabolic process|cellular response to absence of light,0.0001976|0.0002796|0.0004854|0.0004854|0.0004854,1|1|1|1|1,5.51|5.14|4119|4119|4119
2231,4,0.6129,3.678,3220.0,0.0011380000000000001,0.9929309999999999,EVA1B TENT5B TMEM39A TMEM39B,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|negative regulation of cellular catabolic process|negative regulation of catabolic process,7.916e-07|3.391e-06|4.323e-06|7.519e-06|1.414e-05,0.01249|0.02674|0.02273|0.02965|0.04462,1716|735.5|643.6|61.05|49.35
2232,4,0.6235,3.741,3301.0,0.001129,0.9929309999999999,ARHGAP25 C2orf78 COCH TESK2,actin cytoskeleton organization|actin filament-based process|focal adhesion assembly|cell-substrate junction assembly|cell-substrate junction organization,0.003774|0.004888|0.00562|0.00871|0.008903,1|1|1|1|1,19.65|17.22|183.9|117|114.4
2233,6,0.6029,9.044,4003.0,0.002247,0.998474,CIP2A FEN1 LIG1 POLQ RHNO1 TEX30,DNA recombination|base-excision repair|DNA replication|recombinational repair|DNA repair,4.982e-07|8.572e-07|1.053e-06|4.565e-06|1.468e-05,0.007859|0.00676|0.005539|0.018|0.04632,52.54|152.2|43.43|85.69|22.2
2234,4,0.6112,3.667,3414.0,0.00107,0.9929309999999999,ELOVL7 NOX5 RELT TGFA,epithelial cell proliferation|anatomical structure formation involved in morphogenesis|reductive iron assimilation|regulation of fusion of sperm to egg plasma membrane|angiogenesis,0.0001151|0.0002939|0.0003883|0.0003883|0.001379,1|1|1|1|1,115.7|17.75|5149|5149|32.79
2235,7,0.6246,13.12,5192.0,0.002513,0.9992989999999999,ASCL1 IGF2BP1 ISL1 LIN28B PHOX2B SOX11 TGIF2,regulation of neuron differentiation|noradrenergic neuron differentiation|positive regulation of neuron differentiation|sympathetic nervous system development|autonomic nervous system development,1.653e-09|2.879e-09|1.736e-08|4.847e-08|4.676e-07,2.608e-05|2.271e-05|9.13e-05|0.0001911|0.001475,75.83|1261|123.9|420.3|187.8
2236,4,0.6219,3.7310000000000003,3085.0,0.0012050000000000001,0.9929309999999999,REG3G SIX3 TEX261 TGOLN2,neuroblast migration|optic vesicle morphogenesis|regulation of neural retina development|proximal/distal axis specification|cell wall disruption in other organism,0.0003883|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1716|1287|1287
2237,4,0.634,3.804,3137.0,0.001208,0.9929309999999999,DEFB121 DEFB123 DEFB124 THEM4,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|defense response,1.888e-05|0.0001664|0.0002649|0.000487|0.001238,0.2979|1|1|1|1,44.77|21.51|18.39|14.97|10.91
2238,5,0.6508,6.507999999999999,3387.0,0.001912,0.996692,DDX39B RBM33 THOC5 THOC6 THOC7,viral mRNA export from host cell nucleus|translocation of molecules into host|mRNA 3'-end processing|mRNA export from nucleus|mRNA-containing ribonucleoprotein complex export from nucleus,3.298e-13|4.764e-13|1.856e-09|4.588e-09|4.588e-09,5.203e-09|3.758e-09|9.759e-06|1.809e-05|1.448e-05,2060|1831|187.2|148.4|148.4
2239,9,0.6121,22.03,6957.0,0.003149,0.9998530000000001,CAPN5 FCHSD2 KCTD21 OMP P2RY2 P2RY6 PLEKHB1 THRSP UCP3,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|phospholipase C-activating G protein-coupled receptor signaling pathway|cellular response to pyrimidine ribonucleotide|response to pyrimidine ribonucleotide,2.029e-05|0.0001973|0.0008375|0.0008734|0.0008734,0.32|1|1|1|1,326.9|97.38|46.23|2288|2288
2240,6,0.6059,9.088,4525.0,0.001999,0.998474,OCM2 SCGB1D1 SCGB1D2 SCGB2A1 SLC22A9 TIGD3,short-chain fatty acid import|short-chain fatty acid transport|UNCLASSIFIED|biological_process|sodium-independent organic anion transport,0.0008735|0.001165|0.003791|0.003791|0.004942,1|1|1|1|1,1716|1144|5.002|0.3846|214.5
2241,4,0.6343,3.806,2478.0,0.0015279999999999998,0.9929309999999999,DNAJC9 TIMELESS TIPIN USP37,replication fork arrest|regulation of DNA replication|replication fork protection|negative regulation of DNA-dependent DNA replication|DNA replication checkpoint,4.241e-07|6.404e-07|1.555e-06|4.831e-06|4.831e-06,0.00669|0.005051|0.008174|0.01905|0.01524,2574|140.4|1144|605.7|605.7
2242,10,0.6062,27.28,7964.0,0.0034049999999999996,0.999933,FAM209A FAM209B FAM83C GGT7 MMP9 MYLK2 R3HDML TLDC2 WFDC11 WISP2,negative regulation of peptidase activity|negative regulation of proteolysis|regulation of peptidase activity|negative regulation of hydrolase activity|regulation of muscle filament sliding,0.0002182|0.0005204|0.001143|0.001165|0.002424,1|1|1|1|1,24.23|17.96|13.67|13.58|514.9
2243,4,0.6004,3.602,3379.0,0.0010630000000000001,0.9929309999999999,SQOR TEX9 TLN2 ZNF280D,"sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|hydrogen sulfide metabolic process|cell-cell junction assembly|cell-cell junction organization",0.001165|0.001165|0.001359|0.02463|0.03582,1|1|1|1|1,1030|1030|858.1|40.54|27.68
2244,4,0.6296,3.778,3356.0,0.0011220000000000002,0.9929309999999999,CCDC8 HTR2B RASGRF2 TLR6,regulation of catalytic activity|toll-like receptor 6 signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB signaling|regulation of molecular function|detection of diacyl bacterial lipopeptide,0.0002235|0.0003883|0.000486|0.0005685|0.0005825,1|1|1|1|1,8.186|5149|55.66|6.48|2574
2245,4,0.6583,3.95,2985.0,0.001318,0.9929309999999999,CFAP300 CLMP GJC1 TM6SF1,gap junction assembly|cell communication by electrical coupling involved in cardiac conduction|cell communication by electrical coupling|cell communication involved in cardiac conduction|cardiac conduction,2.119e-06|6.401e-06|1.087e-05|4.647e-05|0.0002174,0.03343|0.05048|0.05714|0.1832|0.6859,1030|549.2|411.9|191.6|86.72
2246,4,0.6186,3.7119999999999997,3561.0,0.001039,0.9929309999999999,LMNTD2 MPP4 TMBIM1 WFIKKN1,negative regulation of Fas signaling pathway|positive regulation of blood vessel remodeling|regulation of Fas signaling pathway|regulation of blood vessel remodeling|positive regulation of tissue remodeling,0.0003883|0.0005825|0.0007766|0.001359|0.002328,1|1|1|1|1,5149|2574|1716|858.1|468.1
2247,16,0.6064,72.77,10430.0,0.006906999999999999,0.999999,ALG12 ALG3 ALG9 AUP1 DERL1 DERL2 DNAJC3 DPM1 FAF2 HERPUD1 MANF SEL1L SLC33A1 SYVN1 UBE2G2 UBE2J1,"ubiquitin-dependent ERAD pathway|ERAD pathway|retrograde protein transport, ER to cytosol|endoplasmic reticulum to cytosol transport|protein exit from endoplasmic reticulum",2.229e-18|1.043e-17|1.256e-17|1.256e-17|9.517e-17,3.516e-14|8.228e-14|6.604e-14|4.953e-14|3.002e-13,154.5|128.7|530|530|375.4
2248,4,0.6115,3.6689999999999996,3082.0,0.001186,0.9929309999999999,PILRA PVRIG SRI TMC1,regulation of calcium ion transmembrane transport|vestibular reflex|calcium ion transport|regulation of calcium ion transport|regulation of metal ion transport,0.0003299|0.0007766|0.0008389|0.0008593|0.0009293,1|1|1|1|1,67.75|1716|42.2|41.69|40.07
2249,6,0.6112,9.167,4055.0,0.0022489999999999997,0.998474,COMMD3 RAB7A RMC1 WASHC4 WDR81 WDR91,early endosome to late endosome transport|vesicle-mediated transport between endosomal compartments|cytosolic transport|vesicle-mediated transport|autophagy,3.56e-08|4.485e-08|7.597e-06|4.32e-05|6.464e-05,0.0005616|0.0003537|0.03995|0.1704|0.2039,447.7|411.9|69.58|8.765|33.65
2250,13,0.6078,47.41,9635.0,0.004883,0.999993,DAND5 P2RY11 TMED1 ZNF433 ZNF441 ZNF443 ZNF490 ZNF564 ZNF625 ZNF627 ZNF69 ZNF709 ZNF878,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",7.633e-09|1.726e-07|1.732e-07|1.758e-07|3.869e-07,0.0001204|0.001362|0.0009105|0.0006934|0.001221,6.739|5.031|5.029|5.022|4.662
2251,4,0.6312,3.787,2672.0,0.001411,0.9929309999999999,GORASP2 TMED10 TMED2 TMED9,COPI-coated vesicle budding|COPI coating of Golgi vesicle|Golgi transport vesicle coating|Golgi vesicle budding|Golgi organization,2.306e-10|2.306e-10|2.306e-10|7.851e-10|1.986e-09,3.638e-06|1.819e-06|1.213e-06|3.096e-06|6.264e-06,2574|2574|2574|1545|152.6
2252,4,0.605,3.63,3352.0,0.0010789999999999999,0.9929309999999999,TECRL TMEM125 TRIM9 ZDHHC2,positive regulation of postsynaptic membrane organization|positive regulation of endosome to plasma membrane protein transport|positive regulation of AMPA glutamate receptor clustering|negative regulation of SNARE complex assembly|regulation of postsynaptic membrane organization,0.0005825|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,2574|2574|2574|1716|1287
2253,4,0.62,3.72,3050.0,0.001215,0.9929309999999999,HCAR2 P2RX4 TMEM132B TMEM233,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of secretion by cell,0.0005825|0.0005825|0.0005825|0.0009706|0.001132,1|1|1|1|1,2574|2574|2574|1287|36.26
2254,11,0.6051,33.28,8361.0,0.003954,0.999969,ANO1 CTTN FGF19 FGF4 FOLR2 MRGPRD MRGPRF MYEOV PITPNM1 POLD4 TMEM134,fibroblast growth factor receptor signaling pathway|cellular response to folic acid|cellular response to fibroblast growth factor stimulus|response to fibroblast growth factor|negative regulation of bile acid biosynthetic process,0.0008611|0.001601|0.001615|0.001787|0.002134,1|1|1|1|1,46.23|936.1|33.43|31.73|624.1
2255,4,0.648,3.888,2985.0,0.001297,0.9929309999999999,KIF22 LHX3 STMN1 TMEM135,medial motor column neuron differentiation|negative regulation of thrombin-activated receptor signaling pathway|regulation of thrombin-activated receptor signaling pathway|somatic motor neuron differentiation|negative regulation of guanyl-nucleotide exchange factor activity,0.0005825|0.0007766|0.0007766|0.001165|0.001359,1|1|1|1|1,2574|1716|1716|1030|858.1
2256,11,0.6066,33.36,9173.0,0.003616,0.999969,C5AR1 C5AR2 CABP5 FFAR3 FGF21 GPR32 KLK11 KLK3 SIGLEC11 SULT2B1 VN1R4,complement receptor mediated signaling pathway|complement component C5a signaling pathway|inflammatory response|phospholipase C-activating G protein-coupled receptor signaling pathway|defense response,8.413e-08|1.864e-06|5.726e-06|2.508e-05|6.871e-05,0.001327|0.0147|0.03011|0.09889|0.2168,396.1|1716|17.3|52.01|7.272
2257,8,0.6033,16.89,6172.0,0.002723,0.9996790000000001,BTN2A2 HIST1H1T OR2B6 OR2J3 TMEM14B TRIM10 TRIM26 TRIM39,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|negative regulation of viral process,2.722e-05|3.725e-05|9.729e-05|0.0001302|0.0004352,0.4293|0.2938|0.5115|0.5133|1,267.5|226.3|136.8|117.7|63.27
2258,6,0.6041,9.062000000000001,5157.0,0.00175,0.998474,DNAI1 FAM205A FAM219A FNDC1 SPAG8 TMEM151B,UNCLASSIFIED|biological_process|outer dynein arm assembly|epithelial cilium movement involved in extracellular fluid movement|axonemal dynein complex assembly,0.003791|0.003791|0.006391|0.01015|0.01073,1|1|1|1|1,5.002|0.3846|163.5|101|95.35
2259,4,0.6541,3.925,3153.0,0.00124,0.9929309999999999,EPS15 ONECUT3 SMPD2 TMEM158,sphingomyelin catabolic process|receptor-mediated endocytosis of virus by host cell|endocytosis involved in viral entry into host cell|postsynaptic endocytosis|postsynaptic neurotransmitter receptor internalization,0.001359|0.001553|0.001553|0.001941|0.001941,1|1|1|1|1,858.1|735.5|735.5|572.1|572.1
2260,7,0.6183,12.98,4182.0,0.003085,0.9992989999999999,IER3IP1 SCYL1 TAPT1 TBC1D20 TMEM167A UNC50 YIPF5,regulation of ER to Golgi vesicle-mediated transport|vesicle-mediated transport|localization|protein localization|Golgi vesicle transport,1.343e-05|0.0001392|0.0001422|0.0002223|0.0002382,0.2118|1|0.7476|0.8766|0.7513,392.3|7.513|3.547|6.817|22.29
2261,5,0.6537,6.537000000000001,4162.0,0.001564,0.996692,CYP2W1 DAGLB MICALL2 RSPH10B TMEM184A,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|trans-synaptic signaling by endocannabinoid|trans-synaptic signaling by lipid,0.0009706|0.0009706|0.0009706|0.001456|0.001456,1|1|1|1|1,1373|1373|1373|823.8|823.8
2262,5,0.6306,6.306,3658.0,0.001716,0.996692,CHIC2 CYLD STUB1 TMEM185B TNFAIP3,"regulation of necroptotic process|nucleotide-binding oligomerization domain containing signaling pathway|nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway|regulation of programmed necrotic cell death|protein K63-linked deubiquitination",1.909e-05|2.185e-05|2.331e-05|2.331e-05|2.795e-05,0.3011|0.1724|0.1226|0.09192|0.08819,305.1|284.1|274.6|274.6|249.6
2263,9,0.6191,22.29,6639.0,0.0033369999999999997,0.9998530000000001,DAND5 STX10 TMEM205 ZNF443 ZNF490 ZNF625 ZNF627 ZNF69 ZNF844,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.416e-05|0.0001004|0.0001006|0.0001015|0.0001663,0.2234|0.7916|0.5287|0.4004|0.5246,6.194|4.624|4.623|4.616|4.285
2264,17,0.6068,82.52,13350.0,0.00613,1.0,APTX AQP7 CREB3 DNAJB5 FAM205A GALT IFNA1 IFNA16 IFNA21 IFNW1 NPR2 OR2S2 SIGMAR1 SPAG8 TESK1 TMEM215 TOMM5,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,3.33e-09|5.491e-09|5.491e-09|4.62e-08|9.043e-08,5.252e-05|4.331e-05|2.887e-05|0.0001822|0.0002853,242.3|210.7|210.7|118.2|98.9
2265,4,0.6532,3.9189999999999996,3664.0,0.001066,0.9929309999999999,CAPN13 KHK RNF183 TMEM236,fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|response to sucrose|glyceraldehyde-3-phosphate metabolic process|response to disaccharide,0.001165|0.001165|0.001747|0.001747|0.001747,1|1|1|1|1,1030|1030|643.6|643.6|643.6
2266,5,0.6197,6.197,3421.0,0.0018030000000000001,0.996692,FOXA2 HNF1A HNF4A TCF7L2 TMEM245,pancreas development|endocrine pancreas development|regulation of hormone secretion|endocrine system development|regulation of hormone levels,8.079e-10|9.711e-08|1.653e-07|2.214e-06|2.22e-06,1.274e-05|0.0007659|0.0008691|0.008733|0.007004,232.1|294.2|59.7|100.5|30.97
2267,4,0.6173,3.7039999999999997,3307.0,0.001116,0.9929309999999999,ACYP1 GALNT16 RDH12 TMEM38A,cellular detoxification of aldehyde|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|protein O-linked glycosylation via threonine|release of sequestered calcium ion into cytosol by endoplasmic reticulum|cellular response to caffeine,0.001747|0.001747|0.001941|0.001941|0.002134,1|1|1|1|1,643.6|643.6|572.1|572.1|514.9
2268,14,0.6029,54.87,11080.0,0.004915999999999999,0.9999969999999999,SMIM17 VN1R1 ZFP28 ZNF135 ZNF211 ZNF264 ZNF304 ZNF416 ZNF460 ZNF548 ZNF550 ZNF587 ZNF805 ZNF814,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.121e-09|3.388e-08|3.4e-08|3.457e-08|8.191e-08,1.768e-05|0.0002672|0.0001788|0.0001363|0.0002584,6.826|5.096|5.095|5.087|4.723
2269,6,0.6217,9.325,4731.0,0.001962,0.998474,CLEC4C KLRC1 LTBR TAS2R7 TAS2R9 TMEM52B,"detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|CD8-positive, gamma-delta intraepithelial T cell differentiation",4.946e-05|6.35e-05|6.651e-05|0.0001692|0.001165,0.7803|0.5008|0.3497|0.6673|1,190.7|167.4|163.5|101|1144
2270,10,0.6183,27.82,8030.0,0.0034439999999999996,0.999933,C1orf123 CFAP57 ERMAP EXO5 FAM183A TMEM53 ZFP69 ZFP69B ZNF684 ZNF691,"negative regulation of transcription by RNA polymerase II|cellular process|negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription|negative regulation of RNA biosynthetic process",0.005814|0.009612|0.01549|0.01556|0.01562,1|1|1|1|1,7.611|0.4433|5.33|5.322|5.313
2271,5,0.6053,6.053,4240.0,0.001422,0.996692,C8orf44 CNGB3 SGK3 TMEM64 UBE2W,positive regulation of bone resorption|cellular response to misfolded protein|response to misfolded protein|positive regulation of osteoclast differentiation|protein quality control for misfolded or incompletely synthesized proteins,0.005087|0.005571|0.006054|0.006778|0.00702,1|1|1|1|1,205.9|187.2|171.6|152.6|147.1
2272,17,0.6057,82.38,13320.0,0.006131,1.0,AGAP5 AGAP9 ANXA8L1 GPRIN2 NUTM2A NUTM2B PTPN20 RET SFTPA2 SYT15 TMEM72 WASHC2C ZNF22 ZNF239 ZNF32 ZNF33B ZNF485,posterior midgut development|positive regulation of metanephric glomerulus development|regulation of metanephric glomerulus development|positive regulation of metanephros development|cellular process,0.002472|0.002472|0.002472|0.002472|0.002925,1|1|1|1|1,605.7|605.7|605.7|605.7|0.5476
2273,14,0.6027,54.85,11340.0,0.0048,0.9999969999999999,CD101 CLCA4 FAM19A3 FAM69A GBP5 GBP6 GNAT2 GSTM2 GSTM5 IFI44 KCNA10 MCOLN3 RHOC TMEM56,glutathione derivative biosynthetic process|glutathione derivative metabolic process|glutathione metabolic process|interleukin-18 production|skeletal muscle satellite cell migration,0.0001006|0.0001006|0.0007936|0.001261|0.001891,1|0.7934|1|1|1,144|144|48.75|1584|792.1
2274,4,0.6004,3.602,3290.0,0.001091,0.9929309999999999,CEP126 ITGA10 TMEM80 ZNF821,non-motile cilium assembly|cilium assembly|cilium organization|plasma membrane bounded cell projection assembly|cell projection assembly,3.048e-05|0.001987|0.002243|0.003036|0.003243,0.4809|1|1|1|1,228.8|27.24|25.62|21.96|21.23
2275,4,0.6271,3.763,3601.0,0.001042,0.9929309999999999,DDIAS PRRT3 SARDH TMEM8A,sarcosine catabolic process|sarcosine metabolic process|regulation of DNA stability|choline catabolic process|choline metabolic process,0.0003883|0.0005825|0.0009706|0.001359|0.001941,1|1|1|1|1,5149|2574|1287|858.1|572.1
2276,18,0.6061,92.73,14310.0,0.006423000000000001,1.0,APTX AQP7 BAG1 CREB3 DNAJB5 FAM205A GALT GBA2 IFNA16 IFNK OR13J1 OR2S2 SIGMAR1 SPAG8 TESK1 TMEM8B TOMM5 UBAP2,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|chaperone cofactor-dependent protein refolding|'de novo' posttranslational protein folding,0.0001647|0.0002135|0.0002135|0.0004458|0.0005788,1|1|1|1|1,114.4|99.49|99.49|67.3|58.68
2277,11,0.621,34.15,8862.0,0.0038299999999999996,0.999969,FBXO9 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F PGC PKHD1 TFAP2D TMEM217,positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response|regulation of antimicrobial humoral response|positive regulation of humoral immune response,1.265e-08|1.806e-08|1.806e-08|4.301e-08|2.654e-07,0.0001995|0.0001425|9.497e-05|0.0001696|0.0008374,858.1|735.5|735.5|514.9|257.4
2278,7,0.602,12.64,5375.0,0.00234,0.9992989999999999,C8orf44 CARNS1 CCNB1IP1 NDRG3 PCDHGA9 RNF114 TMEM9B,spermatogenesis|male gamete generation|carnosine biosynthetic process|reproductive process|reproduction,0.0006145|0.0006785|0.0006794|0.0006934|0.000699,1|1|1|1|1,16.11|15.57|2942|8.218|8.201
2279,4,0.6424,3.8539999999999996,3197.0,0.001201,0.9929309999999999,CKS2 GNA14 TMOD1 TRPM3,pointed-end actin filament capping|phospholipase C-activating dopamine receptor signaling pathway|lens fiber cell development|lens fiber cell differentiation|detection of temperature stimulus,0.001553|0.001747|0.002716|0.00504|0.005233,1|1|1|1|1,735.5|643.6|396.1|205.9|198
2280,4,0.6026,3.616,2962.0,0.001216,0.9929309999999999,EPS15L1 MEF2B SMIM7 TMUB1,negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of ERBB signaling pathway|ubiquitin-dependent ERAD pathway|regulation of epidermal growth factor receptor signaling pathway|ERAD pathway,0.009482|0.01045|0.01468|0.01698|0.01756,1|1|1|1|1,107.3|97.15|68.65|59.18|57.21
2281,10,0.6019,27.08,7975.0,0.0033759999999999997,0.999933,AOC2 AOC3 HEXIM2 KRT25 KRT26 KRT9 KRTAP4-2 PLEKHM1 TMUB2 TUBG2,keratinization|keratinocyte differentiation|epidermal cell differentiation|cornification|skin development,3.013e-06|5.86e-06|1.114e-05|2.027e-05|2.353e-05,0.04753|0.04622|0.05856|0.07994|0.07422,36.45|30.74|26.07|54.68|21.51
2282,13,0.602,46.95,10910.0,0.004277,0.999993,ADA BPIFA3 CPNE1 GGT7 GHRH HCK KIAA1755 LBP MAP1LC3A MYLK2 WFDC11 WFDC6 ZNF341,"regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle|regulation of inflammatory response|response to external stimulus|response to isoquinoline alkaloid",5.287e-05|7.812e-05|0.0001689|0.000181|0.0001937,0.8339|0.6161|0.8879|0.7136|0.6111,201.9|163.5|13.3|4.79|101
2283,4,0.6188,3.713,2986.0,0.001239,0.9929309999999999,ARMC1 EAPP SDR39U1 TNNI1,transition between fast and slow fiber|intracellular distribution of mitochondria|positive regulation of transcription elongation from RNA polymerase II promoter|regulation of skeletal muscle adaptation|negative regulation of transcription elongation from RNA polymerase II promoter,0.001553|0.001747|0.002716|0.002716|0.003104,1|1|1|1|1,735.5|643.6|396.1|396.1|343.2
2284,4,0.6097,3.658,3361.0,0.001084,0.9929309999999999,CATIP SLC2A13 SPDYA TOGARAM2,myo-inositol transport|nuclear division|organelle fission|polyol transport|positive regulation of amyloid-beta formation,0.0009706|0.001613|0.001905|0.002522|0.003878,1|1|1|1|1,1287|30.29|27.83|429.1|271
2285,5,0.6329,6.329,4259.0,0.00148,0.996692,DBH ENTR1 MYMK SARDH TOLLIP,amine catabolic process|cellular biogenic amine catabolic process|cellular biogenic amine metabolic process|cellular amine metabolic process|amine metabolic process,2.636e-05|2.636e-05|0.0002357|0.0002404|0.0002646,0.4158|0.2079|1|0.9481|0.8347,257.4|257.4|83.21|82.38|78.46
2286,4,0.647,3.8819999999999997,2843.0,0.0013599999999999999,0.9929309999999999,EIF3D THOC5 TOMM20 TOMM22,protein targeting to mitochondrion|protein transmembrane transport|establishment of protein localization to mitochondrion|protein localization to mitochondrion|protein import,4.658e-05|5.327e-05|8.235e-05|9.807e-05|0.0003472,0.7348|0.4202|0.433|0.3867|1,183.9|171.6|137.3|125.6|66.01
2287,5,0.6158,6.1579999999999995,3952.0,0.001552,0.996692,CIZ1 NTMT1 PIP5KL1 TOR1A TOR1B,protein localization to nucleus|chaperone cofactor-dependent protein refolding|'de novo' posttranslational protein folding|'de novo' protein folding|nuclear membrane organization,5.171e-06|2.96e-05|3.85e-05|4.647e-05|8.295e-05,0.08157|0.2334|0.2024|0.1832|0.2617,75.35|242.3|211.2|191.6|142
2288,19,0.6005,102.7,14280.0,0.0071200000000000005,1.0,CD1B CD1C CD1E CTSK EFNA4 FCRL3 FMO2 GBA ITLN1 ITLN2 LCE3E OR10J5 OR6N1 PGLYRP3 S100A12 S100A2 S100A9 SLAMF7 YY1AP1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|antigen processing and presentation via MHC class Ib|antigen processing and presentation of endogenous antigen",4.359e-08|9.33e-08|9.33e-08|5.264e-07|2.808e-06,0.0006876|0.0007358|0.0004906|0.002076|0.008858,617.9|441.3|441.3|220.7|118.8
2289,4,0.6741,4.045,3444.0,0.00117,0.9929309999999999,CDK18 NPEPL1 TOR3A UTRN,response to denervation involved in regulation of muscle adaptation|response to muscle inactivity involved in regulation of muscle adaptation|response to muscle inactivity|response to inactivity|response to stimulus involved in regulation of muscle adaptation,0.002328|0.002328|0.002522|0.003104|0.003491,1|1|1|1|1,468.1|468.1|429.1|343.2|302.9
2290,5,0.6113,6.1129999999999995,3605.0,0.0016879999999999998,0.996692,ASCL1 DYNC1I2 NKX2-1 SOX1 TOX3,forebrain neuron differentiation|forebrain generation of neurons|neuron fate commitment|dorsal/ventral pattern formation|neuron migration,1.512e-07|2.46e-07|3.127e-07|4.994e-07|1.864e-06,0.002384|0.00194|0.001644|0.00197|0.00588,252.2|213.1|196.1|167|106.5
2291,8,0.6005,16.81,6482.0,0.002581,0.9996790000000001,CORO6 GAS2L2 LGALS9 LYRM9 PIPOX TMEM97 TP53I13 VTN,"L-lysine catabolic process to acetyl-CoA via L-pipecolate|positive regulation of activated T cell autonomous cell death|regulation of activated T cell autonomous cell death|positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response|regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",0.0007765|0.0007765|0.0007765|0.001164|0.001164,1|1|1|1|1,2574|2574|2574|1287|1287
2292,4,0.629,3.7739999999999996,2925.0,0.001285,0.9929309999999999,ITGA3 JAG1 TNS4 TP63,urogenital system development|skin development|negative regulation of epithelial cell differentiation|positive regulation of Notch signaling pathway|positive regulation of osteoblast differentiation,1.51e-05|2.576e-05|2.919e-05|4.498e-05|5.679e-05,0.2382|0.2031|0.1535|0.1774|0.1792,48.27|40.33|234|187.2|166.1
2293,4,0.6123,3.674,3084.0,0.001187,0.9929309999999999,CENPE GAR1 RPL34 TPCN2,lateral attachment of mitotic spindle microtubules to kinetochore|microtubule plus-end directed mitotic chromosome migration|snoRNA guided rRNA pseudouridine synthesis|rRNA processing|mitotic chromosome movement towards spindle pole,0.0003883|0.0003883|0.0007766|0.0009508|0.0009706,1|1|1|1|1,5149|5149|1716|39.61|1287
2294,4,0.6068,3.641,3336.0,0.001088,0.9929309999999999,HYKK SLC7A2 TACSTD2 TPM2,negative regulation of branching involved in ureteric bud morphogenesis|L-arginine import across plasma membrane|L-lysine transport|negative regulation of ruffle assembly|L-lysine transmembrane transport,0.0005825|0.001165|0.001359|0.001359|0.001359,1|1|1|1|1,2574|1030|858.1|858.1|858.1
2295,4,0.6983,4.19,2547.0,0.001637,0.9929309999999999,OSGEP TP53RK TPRKB YRDC,tRNA threonylcarbamoyladenosine metabolic process|tRNA threonylcarbamoyladenosine modification|tRNA processing|tRNA metabolic process|ncRNA processing,2.66e-09|2.828e-07|1.096e-06|2.786e-06|3.683e-05,4.195e-05|0.00223|0.005762|0.01099|0.1162,965.4|3432|117|85.34|35.76
2296,13,0.6045,47.15,10210.0,0.004584,0.999993,CRISP1 CRISP2 FBXO9 GSTA1 GSTA3 GSTA4 IL17A IL17F MLIP MUT RAB23 TFAP2D ZNF451,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|glutathione metabolic process,3.445e-07|3.445e-07|4.657e-06|6.518e-06|7.401e-06,0.005434|0.002717|0.02449|0.0257|0.02335,234|234|858.1|686.5|79.21
2297,10,0.6009,27.04,7770.0,0.0034590000000000003,0.999933,ALDOC C17orf75 CCL2 LYRM9 PIGS RDM1 SEBOX SPAG5 TLCD1 UNC119,negative regulation of caveolin-mediated endocytosis|negative regulation of natural killer cell chemotaxis|negative regulation of lymphocyte chemotaxis|helper T cell extravasation|positive regulation of spindle assembly,0.001455|0.001455|0.00194|0.00194|0.002909,1|1|1|1|1,1030|1030|686.5|686.5|411.9
2298,9,0.6102,21.97,7272.0,0.003005,0.9998530000000001,ACKR2 CCR3 CCR8 FAM198A SCN10A SCN11A SLC22A14 TRANK1 VIPR1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,3.354e-06|4.748e-06|4.748e-06|1.981e-05|5.24e-05,0.05291|0.03745|0.02496|0.07812|0.1653,97.76|86.78|86.78|53.26|38.23
2299,4,0.6427,3.8560000000000003,3482.0,0.001104,0.9929309999999999,ARHGEF37 HTR1E MDGA1 TRAP1,negative regulation of cellular respiration|translational attenuation|negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|regulation of synaptic membrane adhesion,0.0005824|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,3432|1716|1144|1144|858.1
2300,4,0.6084,3.65,2913.0,0.001248,0.9929309999999999,AP1G1 RAB11A TRAPPC10 TRAPPC9,vesicle organization|establishment of vesicle localization|vesicle localization|intracellular transport|Golgi vesicle transport,5.298e-08|3.801e-06|4.389e-06|2.824e-05|2.844e-05,0.0008357|0.02998|0.02308|0.1114|0.08972,66.44|76.85|73.2|13.74|39.01
2301,13,0.6201,48.36,8847.0,0.0054210000000000005,0.999993,CNIH1 RAB1A RAB1B SCFD1 SEC23IP TRAPPC1 TRAPPC11 TRAPPC12 TRAPPC13 TRAPPC2L TRAPPC3 TRAPPC4 TRAPPC5,"endoplasmic reticulum to Golgi vesicle-mediated transport|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi|vesicle coating|COPII-coated vesicle budding",1.046e-23|4.639e-23|4.639e-23|8.186e-23|1.228e-22,1.65e-19|3.659e-19|2.439e-19|3.228e-19|3.875e-19,96.99|251.5|251.5|236.5|226.3
2302,4,0.6023,3.614,2974.0,0.00121,0.9929309999999999,KIF22 LHX3 STMN1 TRAPPC6B,medial motor column neuron differentiation|negative regulation of thrombin-activated receptor signaling pathway|regulation of thrombin-activated receptor signaling pathway|somatic motor neuron differentiation|negative regulation of guanyl-nucleotide exchange factor activity,0.0005825|0.0007766|0.0007766|0.001165|0.001359,1|1|1|1|1,2574|1716|1716|1030|858.1
2303,10,0.6024,27.11,6640.0,0.004054,0.999933,ATP5F1A C18orf21 HAUS1 NARS PIK3C3 RPL17 RTTN SKA1 TRAPPC8 ZNF407,autophagy of peroxisome|protein localization to phagophore assembly site|organelle assembly|autophagosome assembly|autophagosome organization,1.923e-05|2.218e-05|0.0003653|0.0004338|0.0004747,0.3034|0.175|1|1|1,343.3|316.8|10.55|65.38|62.41
2304,11,0.6133,33.73,6845.0,0.004888,0.999969,CRLS1 DNAJC11 OPA1 PGS1 PTPMT1 ROMO1 TAMM41 TIMM13 TIMM44 TRIAP1 YME1L1,cardiolipin biosynthetic process|phosphatidylglycerol biosynthetic process|cardiolipin metabolic process|phosphatidylglycerol metabolic process|inner mitochondrial membrane organization,8.298e-14|1.809e-13|8.416e-13|2.705e-11|3.433e-08,1.309e-09|1.427e-09|4.425e-09|1.067e-07|0.0001083,880.1|720.1|495.1|226.3|121.9
2305,7,0.6116,12.84,5073.0,0.002518,0.9992989999999999,FOLR1 FOLR2 KRTAP5-11 KRTAP5-9 P2RY6 TRIM48 TRIM49D1,cellular response to folic acid|keratinization|keratinocyte differentiation|folate import across plasma membrane|folate transmembrane transport,7.913e-07|1.023e-06|1.995e-06|2.768e-06|3.69e-06,0.01248|0.008066|0.01049|0.01092|0.01164,2574|45.56|38.42|1030|858.1
2306,4,0.6461,3.8760000000000003,3466.0,0.001115,0.9929309999999999,CPLX3 GRM7 TRIM60 ZNF106,negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|regulation of synaptic vesicle fusion to presynaptic active zone membrane|chemical synaptic transmission|anterograde trans-synaptic signaling,0.001165|0.001553|0.001747|0.002445|0.002445,1|1|1|1|1,1030|735.5|643.6|24.52|24.52
2307,6,0.6172,9.258,4022.0,0.0022890000000000002,0.998474,ADAT2 METTL1 SSB TRMT10A WDR4 XPOT,tRNA modification|tRNA processing|RNA modification|tRNA metabolic process|ncRNA processing,1.121e-11|7.213e-11|2.489e-10|3.387e-10|2.476e-08,1.768e-07|5.689e-07|1.309e-06|1.335e-06|7.81e-05,190.7|130|101|94.82|39.73
2308,10,0.6282,28.27,6683.0,0.0041990000000000005,0.999933,C1orf109 DHX33 MYBBP1A POP5 RPP21 SPATA5L1 TIMM10 TRMT112 UTP4 WDR18,ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis|ncRNA metabolic process|rRNA processing,2.677e-07|9.681e-07|1.386e-06|2.322e-06|5.206e-06,0.004222|0.007636|0.007288|0.009158|0.01643,31.02|23.84|22.15|19.92|31.68
2309,13,0.6027,47.01,10900.0,0.0042829999999999995,0.999993,ADAM28 BIN3 C8orf58 CHRNA2 PEBP4 PRSS55 RHOBTB2 SORBS3 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D TRMT9B,TRAIL-activated apoptotic signaling pathway|extrinsic apoptotic signaling pathway via death domain receptors|extrinsic apoptotic signaling pathway|activation of NF-kappaB-inducing kinase activity|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,1.644e-08|1.269e-06|2.543e-05|6.935e-05|0.0002971,0.0002593|0.01001|0.1337|0.2735|0.9372,792.1|148.5|52.23|176|81.24
2310,27,0.607,213.0,19600.0,0.01073,1.0,C12orf65 CARS2 DDX28 FOXRED1 GRSF1 GTPBP10 GTPBP8 MALSU1 MCAT METTL17 MRM2 MRM3 MRPL1 MRPL58 MTERF3 MTFMT MTG1 MTIF2 MTIF3 MTO1 NGRN NOA1 NSUN4 RMND1 RPUSD3 TFB1M YBEY,ribosome biogenesis|ribonucleoprotein complex biogenesis|gene expression|ncRNA metabolic process|translation,9.178e-15|4.445e-13|1.416e-11|4.046e-11|5.585e-11,1.448e-10|3.506e-09|7.446e-08|1.596e-07|1.762e-07,26.59|18.98|6.057|15.65|19.15
2311,4,0.6273,3.764,3143.0,0.001193,0.9929309999999999,CWC25 DDX52 TEFM TRPA1,transcription elongation from mitochondrial promoter|detection of chemical stimulus involved in sensory perception of pain|thermoception|RNA metabolic process|mitochondrial transcription,0.0003883|0.0007766|0.001359|0.001769|0.002716,1|1|1|1|1,5149|1716|858.1|9.66|396.1
2312,4,0.6997,4.198,3300.0,0.001268,0.9929309999999999,ODF1 REN TRPM5 ZNF76,renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin|response to cGMP,0.001213|0.001698|0.001698|0.00194|0.00194,1|1|1|1|1,1030|686.5|686.5|588.4|588.4
2313,4,0.6339,3.803,2903.0,0.0013050000000000002,0.9929309999999999,CLNS1A SNRPD1 SNRPD2 TSEN15,spliceosomal snRNP assembly|RNA splicing|mRNA processing|mRNA metabolic process|ribonucleoprotein complex assembly,3.148e-08|1.562e-07|3.112e-07|1.307e-06|3.217e-06,0.0004966|0.001232|0.001636|0.005156|0.01015,396.1|50.6|42.55|29.68|81.3
2314,5,0.6123,6.122999999999999,4011.0,0.0015199999999999999,0.996692,FAM129A ITLN1 METTL13 SLAMF7 TSKS,response to nematode|regulation of phosphate metabolic process|regulation of phosphorus metabolic process|protein homotrimerization|negative regulation of phosphate metabolic process,0.0007766|0.001808|0.001808|0.003104|0.00362,1|1|1|1|1,1716|9.588|9.588|343.2|20.07
2315,4,0.6343,3.806,3438.0,0.001103,0.9929309999999999,ANKRD29 CCDC182 NUDT16L1 TSPAN16,negative regulation of double-strand break repair via nonhomologous end joining|regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair|negative regulation of DNA repair|negative regulation of response to DNA damage stimulus,0.001553|0.006007|0.006586|0.006973|0.01602,1|1|1|1|1,735.5|171.6|156|147.1|62.79
2316,5,0.6542,6.542000000000001,4406.0,0.0014789999999999998,0.996692,CLDN24 KLHL2 RGS10 SMIM14 TSPAN5,G protein-coupled acetylcholine receptor signaling pathway|blastocyst hatching|organism emergence from protective structure|hatching|acetylcholine receptor signaling pathway,0.004845|0.006537|0.006537|0.006537|0.007261,1|1|1|1|1,216.8|158.4|158.4|158.4|142
2317,4,0.6021,3.613,3291.0,0.001094,0.9929309999999999,DCAF13 DNAJB2 SLC39A11 TSPYL6,negative regulation of protein deubiquitination|regulation of chaperone-mediated protein folding|negative regulation of inclusion body assembly|regulation of protein folding|regulation of protein deubiquitination,0.0009706|0.001165|0.002328|0.002522|0.002716,1|1|1|1|1,1287|1030|468.1|429.1|396.1
2318,4,0.6218,3.7310000000000003,3523.0,0.0010550000000000002,0.9929309999999999,GHRH TTBK1 ZNF341 ZSWIM1,"positive regulation of circadian sleep/wake cycle, REM sleep|positive regulation of astrocyte activation|regulation of astrocyte activation|regulation of circadian sleep/wake cycle, REM sleep|growth hormone secretion",0.0003883|0.0003883|0.0009706|0.0009706|0.001359,1|1|1|1|1,5149|5149|1287|1287|858.1
2319,6,0.604,9.06,4733.0,0.001906,0.998474,BBS5 CRYGA CRYGB CRYGC CRYGD TTC30A,visual perception|sensory perception of light stimulus|lens development in camera-type eye|camera-type eye development|sensory perception,8.078e-10|8.841e-10|3.143e-09|8.574e-07|1.376e-06,1.274e-05|6.973e-06|1.653e-05|0.003381|0.004342,79.46|78.01|180.7|43.18|17.64
2320,4,0.603,3.6180000000000003,3130.0,0.001152,0.9929309999999999,HOXD11 HOXD12 TTC30A TTC30B,intraciliary transport|protein transport along microtubule|microtubule-based protein transport|transport along microtubule|microtubule-based transport,4.185e-05|6.8e-05|6.8e-05|0.0003472|0.0005176,0.6602|0.5363|0.3575|1|1,194.3|151.4|151.4|66.01|53.91
2321,7,0.6435,13.51,4727.0,0.002843,0.9992989999999999,ATXN2L CNOT11 CNOT4 CNOT9 G3BP2 LSM12 NUFIP2,"nuclear-transcribed mRNA poly(A) tail shortening|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint|signal transduction involved in mitotic DNA integrity checkpoint|signal transduction involved in mitotic DNA damage checkpoint",6.224e-08|8.572e-07|9.006e-07|9.006e-07|9.006e-07,0.0009818|0.00676|0.004735|0.003552|0.002841,383.8|152.2|149.6|149.6|149.6
2322,6,0.6408,9.611,4830.0,0.0019809999999999997,0.998474,C22orf46 CSDC2 PNPLA5 SEPT3 SULT4A1 TTC38,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|triglyceride catabolic process|acylglycerol catabolic process,0.00726|0.00755|0.00755|0.008128|0.01102,1|1|1|1|1,143|137.3|137.3|127.1|92.77
2323,5,0.6004,6.004,3264.0,0.001831,0.996692,ASPM HMMR NDE1 TTC5 TUBB4B,regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|spindle localization|regulation of mitotic cell cycle phase transition|regulation of cell cycle phase transition,9.711e-06|1.215e-05|7.482e-05|8.574e-05|0.0001105,0.1532|0.09585|0.3934|0.3381|0.3485,60.87|56.42|149.8|29.14|26.75
2324,19,0.6055,103.5,14830.0,0.0069180000000000005,1.0,AQP7 BAG1 CCL21 CREB3 DNAJB5 FAM205A GALT IFNA1 IFNA16 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNW1 OR2S2 SIGMAR1 SPAG8 TOMM5,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,2.881e-19|7.303e-19|7.303e-19|4.139e-17|1.511e-16,4.545e-15|5.76e-15|3.84e-15|1.632e-13|4.767e-13,433.6|377|377|211.5|177
2325,4,0.6571,3.943,3245.0,0.0012109999999999998,0.9929309999999999,PTPN3 TTC9 WNT5A ZNF280B,chemoattraction of serotonergic neuron axon|planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation|negative regulation of cell proliferation in midbrain|planar cell polarity pathway involved in pericardium morphogenesis|planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2326,6,0.6265,9.397,4546.0,0.002058,0.998474,CFC1 FAHD2A IL1F10 POTEI TUBA3D TUBA3E,nodal signaling pathway|activin receptor signaling pathway|inflammatory response to antigenic stimulus|microtubule cytoskeleton organization|mitotic cell cycle,0.003781|0.008128|0.01044|0.01057|0.01861,1|1|1|1|1,286|127.1|98.07|12.13|9.021
2327,4,0.6253,3.752,3207.0,0.001166,0.9929309999999999,ANKRD13C NECTIN3 ST3GAL3 TUBB1,ganglioside biosynthetic process via lactosylceramide|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|ganglioside biosynthetic process|sialylation,0.001165|0.001941|0.00291|0.003297|0.004072,1|1|1|1|1,1030|572.1|367.8|321.8|257.4
2328,4,0.6545,3.927,2734.0,0.00143,0.9929309999999999,HSPE1 NEDD1 PAFAH1B1 TUBGCP2,mitotic prometaphase|biological phase|mitotic cell cycle phase|cell cycle phase|ciliary basal body-plasma membrane docking,2.196e-06|7.878e-06|7.878e-06|7.878e-06|0.0001309,0.03464|0.06213|0.04142|0.03107|0.4129,92.49|60.1|60.1|60.1|108.4
2329,6,0.6063,9.095,4959.0,0.0018260000000000001,0.998474,CRYBA1 LYRM9 PIPOX RAB11FIP4 TWF1 VTN,L-lysine catabolic process to acetyl-CoA via L-pipecolate|regulation of actin phosphorylation|positive regulation of G1 to G0 transition|regulation of G1 to G0 transition|smooth muscle cell-matrix adhesion,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
2330,4,0.6673,4.004,2714.0,0.001469,0.9929309999999999,ANKRD17 CNOT4 G3BP1 TXLNA,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|positive regulation of stress granule assembly|positive regulation of MDA-5 signaling pathway|type I interferon production,0.0003299|0.0004209|0.0005825|0.0009706|0.001165,1|1|1|1|1,67.75|59.87|2574|1287|1030
2331,5,0.6212,6.212000000000001,3561.0,0.001737,0.996692,ELOVL1 MARCH6 TMEM189 TXNDC15 UBE2J2,"ubiquitin-dependent ERAD pathway|ERAD pathway|response to endoplasmic reticulum stress|fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid",0.0001369|0.0001956|0.001548|0.00194|0.00194,1|1|1|1|1,109.8|91.53|31.93|588.4|588.4
2332,10,0.6173,27.78,7850.0,0.003517,0.999933,ATXN7L3B CCNB1IP1 KIF26B LYRM1 MAP3K7CL NECAP2 NIPSNAP3B SDR39U1 TXNDC16 ZNF286A,ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|cellular process|renal vesicle formation,0.00194|0.002424|0.002909|0.003349|0.003393,1|1|1|1|1,686.5|514.9|411.9|0.3989|343.3
2333,10,0.6031,27.14,7817.0,0.0034509999999999996,0.999933,DPP7 ENTPD2 FAM69B LCN10 LCN15 LCN6 LCN8 PHPT1 TUBB4B UAP1L1,negative regulation of ATP citrate synthase activity|regulation of ATP citrate synthase activity|peptidyl-histidine dephosphorylation|purine ribonucleoside diphosphate catabolic process|purine nucleoside diphosphate catabolic process,0.0009704|0.0009704|0.0009704|0.002909|0.002909,1|1|1|1|1,2060|2060|2060|411.9|411.9
2334,4,0.637,3.822,3219.0,0.001183,0.9929309999999999,FADS3 PLCB4 UBAC2 ZFYVE27,"endoplasmic reticulum tubular network formation|negative regulation of retrograde protein transport, ER to cytosol|negative regulation of protein exit from endoplasmic reticulum|regulation of retrograde protein transport, ER to cytosol|endoplasmic reticulum tubular network organization",0.0009706|0.001941|0.002134|0.002716|0.003104,1|1|1|1|1,1287|572.1|514.9|396.1|343.2
2335,4,0.6686,4.012,3379.0,0.001183,0.9929309999999999,C10orf67 FOXI2 GPR4 UBAP1L,glomerular mesangial cell development|mesangial cell development|glomerular mesangial cell differentiation|mesangial cell differentiation|glomerular mesangium development,0.001165|0.001359|0.001359|0.001553|0.001747,1|1|1|1|1,1030|858.1|858.1|735.5|643.6
2336,6,0.6253,9.379,4394.0,0.002124,0.998474,ABL1 BCR GAB2 PTPN1 QRFP UBASH3B,transmembrane receptor protein tyrosine kinase signaling pathway|platelet-derived growth factor receptor signaling pathway|enzyme linked receptor protein signaling pathway|platelet-derived growth factor receptor-beta signaling pathway|negative regulation of protein kinase activity,6.138e-08|1.154e-07|3.233e-07|3.178e-06|3.081e-05,0.0009683|0.0009098|0.0017|0.01253|0.09721,33.07|294.2|23.64|858.1|43.27
2337,5,0.7083,7.082999999999999,3428.0,0.0020559999999999997,0.996692,BRAP PLAA UBB UBC USP14,modulation by symbiont of host defense response|response to host defenses|response to defenses of other organism|response to host|ubiquitin-dependent protein catabolic process,3.178e-06|5.506e-06|5.506e-06|5.506e-06|6.57e-06,0.05013|0.04343|0.02895|0.02171|0.02073,858.1|624.1|624.1|624.1|25.76
2338,4,0.6361,3.8169999999999997,3383.0,0.001124,0.9929309999999999,MX1 RIMS3 ROPN1B UBE2L6,synaptic vesicle cycle|vesicle-mediated transport in synapse|membrane fusion|ISG15-protein conjugation|synaptic vesicle budding from presynaptic endocytic zone membrane,0.0002004|0.0002316|0.0003172|0.001359|0.001553,1|1|1|1|1,87.27|81.08|69.11|858.1|735.5
2339,5,0.617,6.17,3618.0,0.001698,0.996692,NFIA PLAT UBE3A VPS36 ZER1,proteolysis|proteolysis involved in cellular protein catabolic process|cellular protein catabolic process|protein catabolic process|regulation of proteolysis,7.34e-05|0.0002342|0.0002744|0.0003497|0.0004321,1|1|1|1|1,12.78|20.73|19.65|18.09|16.84
2340,5,0.6517,6.517,4379.0,0.001483,0.996692,ARNTL2 DCLRE1C ITPR2 MANSC4 UBE3B,protection from non-homologous end joining at telomere|telomere maintenance in response to DNA damage|V(D)J recombination|cellular response to ethanol|positive regulation of circadian rhythm,0.00194|0.002667|0.00412|0.00412|0.004362,1|1|1|1|1,588.4|411.9|257.4|257.4|242.3
2341,4,0.6071,3.6430000000000002,2630.0,0.001379,0.9929309999999999,C16orf72 DDA1 UBE4B VCPIP1,protein ubiquitination|protein modification by small protein conjugation|granzyme-mediated apoptotic signaling pathway|protein modification by small protein conjugation or removal|endoplasmic reticulum membrane fusion,0.0001827|0.0002475|0.0003883|0.0004856|0.0005825,1|1|1|1|1,20.85|18.81|5149|14.98|2574
2342,4,0.6063,3.638,2705.0,0.0013390000000000001,0.9929309999999999,C16orf72 UBE4B UBL7 VCPIP1,granzyme-mediated apoptotic signaling pathway|endoplasmic reticulum membrane fusion|proteolysis|Golgi reassembly|protein-DNA covalent cross-linking repair,0.0003883|0.0005825|0.0009386|0.0009706|0.001359,1|1|1|1|1,5149|2574|11.98|1287|858.1
2343,4,0.6612,3.967,3104.0,0.001273,0.9929309999999999,PSPC1 UBQLN1 ZMYM2 ZMYM5,negative regulation of store-operated calcium channel activity|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|regulation of store-operated calcium channel activity|regulation of ER-associated ubiquitin-dependent protein catabolic process|positive regulation of ERAD pathway,0.0003883|0.001747|0.001941|0.002134|0.00291,1|1|1|1|1,5149|643.6|572.1|514.9|367.8
2344,4,0.6011,3.6069999999999998,3069.0,0.0011710000000000002,0.9929309999999999,HOXC4 HOXC6 PCNP UBXN2A,embryonic skeletal system development|anterior/posterior pattern specification|regionalization|proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process,0.000214|0.0006065|0.001414|0.001458|0.00166,1|1|1|1|1,84.41|49.75|32.38|31.88|29.85
2345,5,0.6274,6.274,4021.0,0.0015539999999999998,0.996692,ARL11 C1QTNF9 COMMD6 KRTAP21-1 UCHL3,hair follicle development|skin epidermis development|hair cycle process|molting cycle process|negative regulation of NF-kappaB transcription factor activity,0.01807|0.01903|0.01903|0.01903|0.02118,1|1|1|1|1,55.66|52.81|52.81|52.81|47.34
2346,4,0.6218,3.7310000000000003,3353.0,0.001109,0.9929309999999999,LMO3 UCP1 ZADH2 ZNF776,regulation of fat cell differentiation|positive regulation of glucocorticoid receptor signaling pathway|regulation of glucocorticoid receptor signaling pathway|positive regulation of peroxisome proliferator activated receptor signaling pathway|cellular response to cold,0.0002352|0.0005825|0.001747|0.001747|0.002134,1|1|1|1|1,80.45|2574|643.6|643.6|514.9
2347,9,0.6167,22.2,6748.0,0.0032700000000000003,0.9998530000000001,FOLR1 FOLR2 KRTAP5-11 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 UCP2 UCP3,cellular response to folic acid|keratinization|response to organonitrogen compound|folate import across plasma membrane|folate transmembrane transport,1.554e-06|4.693e-06|4.903e-06|5.433e-06|7.241e-06,0.02451|0.03701|0.02578|0.02142|0.02285,1872|33.14|11.27|748.9|624.1
2348,8,0.6211,17.39,5220.0,0.00331,0.9996790000000001,CEP55 CIT IST1 KIF14 KIF1BP PDCD6IP UEVLD VPS4B,cytoskeleton-dependent cytokinesis|cytokinesis|cell division|mitotic cytokinesis|mitotic cell cycle process,5.339e-11|9.452e-11|1.328e-09|4.76e-09|9.48e-09,8.422e-07|7.455e-07|6.983e-06|1.877e-05|2.991e-05,153.2|136.2|35.88|173.1|25.77
2349,5,0.6006,6.006,3964.0,0.001509,0.996692,MBLAC1 TMCO5A UFSP1 ZNF394 ZSCAN21,cellular process|response to stimulus|regulation of transcription by RNA polymerase II|biological_process|UNCLASSIFIED,0.0009406|0.08193|0.1218|0.135|0.135,1|1|1|1|1,0|0|3.186|0.6923|3.001
2350,4,0.6445,3.867,3328.0,0.001158,0.9929309999999999,COL4A1 F7 UBXN4 UGGT2,response to organonitrogen compound|response to nitrogen compound|ERAD pathway|response to amino acid|response to acid chemical,5.545e-06|7.771e-06|0.0001177|0.0001777|0.0002425,0.08746|0.06129|0.6189|0.7007|0.765,20.66|18.98|114.4|92.77|79.21
2351,4,0.6186,3.7119999999999997,3306.0,0.001119,0.9929309999999999,FBXL15 PLEKHA6 SERPINA3 UNC13D,granuloma formation|natural killer cell degranulation|germinal center formation|chronic inflammatory response|neutrophil degranulation,0.0005825|0.001165|0.001747|0.00291|0.003204,1|1|1|1|1,2574|1030|643.6|367.8|21.36
2352,4,0.6247,3.748,2932.0,0.001273,0.9929309999999999,RPL24 TRMT10C UNG ZBTB11,"base-excision repair, AP site formation via deaminated base removal|assembly of large subunit precursor of preribosome|mitochondrial tRNA 3'-end processing|mitochondrial tRNA 5'-end processing|mitochondrial RNA 5'-end processing",0.0003883|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|1716|1716|1716|1287
2353,4,0.6145,3.687,3061.0,0.0012,0.9929309999999999,HAGHL HBM HBQ1 UNKL,oxygen transport|gas transport|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification,3.391e-06|5.932e-06|1.313e-05|2.547e-05|0.0001309,0.05349|0.04679|0.06902|0.1004|0.4129,735.5|542|355.1|251.2|108.4
2354,5,0.6338,6.337999999999999,3835.0,0.001645,0.996692,CASP1 CASP4 CRYAB KDELC2 UPK2,positive regulation of tumor necrosis factor-mediated signaling pathway|pyroptosis|protein autoprocessing|positive regulation of cytokine-mediated signaling pathway|positive regulation of response to cytokine stimulus,2.204e-06|5.367e-06|9.177e-06|3.595e-05|4.658e-05,0.03477|0.04233|0.04825|0.1418|0.147,936.1|572.1|429.1|210.2|183.9
2355,4,0.6524,3.915,3558.0,0.0010960000000000002,0.9929309999999999,KRTAP20-3 MCIDAS SLC36A4 USF3,proline import across plasma membrane|L-tryptophan transmembrane transport|L-proline transmembrane transport|L-proline import across plasma membrane|tryptophan transport,0.0005825|0.0005825|0.0005825|0.0005825|0.001165,1|1|1|1|1,2574|2574|2574|2574|1030
2356,12,0.605,39.93,8877.0,0.0044659999999999995,0.999986,ACCSL ANO3 BDNF CAT CHRM4 COMMD9 EHF ELF5 OR4B1 OR4X1 PAMR1 SLC1A2,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|benzoyl-CoA metabolic process|protein targeting to peroxisome|establishment of protein localization to peroxisome,0.000197|0.0003809|0.001358|0.00138|0.00138,1|1|1|1|1,101.5|71.76|1471|36.78|36.78
2357,8,0.6194,17.34,5202.0,0.003312,0.9996790000000001,BIRC6 HECTD1 KCMF1 PLAA UBA6 UBR4 USP15 VCPIP1,protein modification by small protein conjugation or removal|protein ubiquitination|protein modification by small protein conjugation|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process,6.182e-09|5.86e-08|1.074e-07|6.254e-07|6.668e-07,9.752e-05|0.0004622|0.0005645|0.002466|0.002104,17.48|20.85|18.81|24.15|23.84
2358,5,0.6162,6.162000000000001,2994.0,0.0020469999999999998,0.996692,BRAP C16orf72 MDM2 TP53 USP42,cellular response to actinomycin D|response to actinomycin D|cellular response to UV-C|cellular response to antibiotic|response to UV-C,7.066e-07|1.06e-06|2.543e-06|8.468e-06|1.079e-05,0.01115|0.008359|0.01337|0.03339|0.03405,2288|1716|980.7|490.4|429.1
2359,10,0.6048,27.22,6854.0,0.003944,0.999933,AATF CDC6 DHX8 NLE1 NSRP1 PSMD11 PSMD3 UTP6 ZNF207 ZNF830,regulation of mitotic cell cycle|negative regulation of mitotic cell cycle|negative regulation of mitotic cell cycle phase transition|negative regulation of cell cycle phase transition|negative regulation of cell cycle,1.799e-09|1.812e-09|3.995e-08|5.59e-08|8.785e-08,2.838e-05|1.429e-05|0.0002101|0.0002204|0.0002772,24.52|42.03|45.77|42.73|21.72
2360,4,0.636,3.8160000000000003,3305.0,0.00115,0.9929309999999999,ADAMDEC1 KRT39 LBX1 VIT,spinal cord development|neuron fate determination|spinal cord motor neuron differentiation|regulation of cell adhesion|cell fate determination,0.0001563|0.001747|0.006007|0.007137|0.008517,1|1|1|1|1,99.01|643.6|171.6|14.18|119.7
2361,4,0.6098,3.659,3037.0,0.0012,0.9929309999999999,DIMT1 MTREX PPWD1 VPS37C,"RNA processing|rRNA processing|snRNA catabolic process|rRNA metabolic process|mRNA splicing, via spliceosome",0.0003501|0.0009508|0.0009706|0.001024|0.001277,1|1|1|1|1,16.73|39.61|1287|38.14|34.1
2362,4,0.6008,3.605,3311.0,0.001085,0.9929309999999999,JUND PPP1R14C SIGLEC12 VSIG10L,osteoblast development|positive regulation of osteoblast differentiation|negative regulation of phosphoprotein phosphatase activity|negative regulation of protein dephosphorylation|cellular response to calcium ion,0.003685|0.01218|0.01237|0.01333|0.0166,1|1|1|1|1,286|83.04|81.73|75.72|60.57
2363,19,0.6108,104.5,14440.0,0.007162999999999999,1.0,CTSK FCRL3 FLG2 GBA ITLN2 KCNJ10 LCE3E LCE5A OR10J5 PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A7A S100A8 S100A9 SLAMF7 SPRR2G,neutrophil aggregation|defense response to fungus|sequestering of zinc ion|antimicrobial humoral response|glial cell differentiation,4.824e-06|9.828e-06|1.205e-05|1.237e-05|1.761e-05,0.07609|0.07751|0.06334|0.04879|0.05555,1084|75.62|542|27.79|25.36
2364,18,0.5733,87.71,14550.0,0.005978,1.0,KIR2DL1 SIGLEC5 VN1R4 ZNF175 ZNF28 ZNF320 ZNF347 ZNF415 ZNF432 ZNF528 ZNF534 ZNF610 ZNF613 ZNF665 ZNF677 ZNF701 ZNF808 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",7.419e-11|4.888e-09|4.908e-09|5.01e-09|1.439e-08,1.17e-06|3.855e-05|2.581e-05|1.976e-05|4.541e-05,6.287|4.694|4.692|4.686|4.35
2365,4,0.6011,3.6069999999999998,3148.0,0.001141,0.9929309999999999,DYDC2 LIPK SH3PXD2A VWA2,calcium-independent cell-matrix adhesion|osteoclast fusion|chromatin silencing at telomere|multinuclear osteoclast differentiation|cell-cell fusion,0.0009706|0.001359|0.001941|0.001941|0.0062,1|1|1|1|1,1287|858.1|572.1|572.1|166.1
2366,12,0.6014,39.69,9443.0,0.004175,0.999986,ANXA2R C1QTNF3 C7 CDH6 FBXO4 FGF10 HCN1 OXCT1 SLC1A3 SLC45A2 UGT3A1 UGT3A2,regulation of fibroblast proliferation|lung proximal/distal axis specification|semicircular canal fusion|urothelial cell proliferation|positive regulation of urothelial cell proliferation,0.00103|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,42.38|1716|1716|1716|1716
2367,7,0.6357,13.35,5495.0,0.0024170000000000003,0.9992989999999999,C1QTNF9 C1QTNF9B GJB2 GJB6 RNF6 SPATA13 WASF3,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|lamellipodium assembly,2.768e-06|3.558e-06|4.447e-06|2.279e-05|6.916e-05,0.04366|0.02807|0.02338|0.08985|0.2182,980.7|840.6|735.5|294.2|163.5
2368,4,0.7013,4.208,3416.0,0.001227,0.9929309999999999,DHX57 GPR75 WDPCP ZNF512,regulation of embryonic cell shape|septin cytoskeleton organization|glomerular visceral epithelial cell migration|tongue morphogenesis|auditory receptor cell morphogenesis,0.0007766|0.0009706|0.001359|0.002134|0.003685,1|1|1|1|1,1716|1287|858.1|514.9|286
2369,4,0.6495,3.897,3191.0,0.001217,0.9929309999999999,NMUR1 PACS1 RAB40C WDR37,protein localization to plasma membrane|protein localization to cell periphery|protein localization to membrane|inositol phosphate-mediated signaling|protein localization to Golgi apparatus,0.0005391|0.0007724|0.003959|0.004846|0.005813,1|1|1|1|1,52.81|44.01|19.18|214.5|177.5
2370,4,0.6291,3.7739999999999996,3369.0,0.001117,0.9929309999999999,CTBS CTGF WDR41 ZNF429,chitin catabolic process|chitin metabolic process|glucosamine-containing compound catabolic process|oligosaccharide catabolic process|amino sugar catabolic process,0.001019|0.001019|0.001456|0.002038|0.002038,1|1|1|1|1,1144|1144|762.8|528.1|528.1
2371,7,0.6021,12.64,5625.0,0.0022370000000000003,0.9992989999999999,HRASLS HTR3D MUC4 PDCD6 SLC51A TCTEX1D2 WDR53,regulation of intraciliary retrograde transport|positive regulation of protein monoubiquitination|vascular endothelial growth factor receptor-2 signaling pathway|regulation of protein monoubiquitination|bile acid secretion,0.001019|0.002037|0.002037|0.002376|0.002376,1|1|1|1|1,1471|588.4|588.4|490.4|490.4
2372,6,0.6431,9.647,4194.0,0.002288,0.998474,NAF1 NOP10 SPCS3 TMA16 TRAPPC11 WDR55,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|positive regulation of telomerase RNA localization to Cajal body|pseudouridine synthesis|regulation of telomerase RNA localization to Cajal body,7.066e-07|4.66e-06|9.595e-06|1.34e-05|1.34e-05,0.01115|0.03675|0.05045|0.05284|0.04227,2288|686.5|457.7|381.4|381.4
2373,8,0.6172,17.28,6267.0,0.0027429999999999998,0.9996790000000001,C8orf44 CCNB1IP1 MCOLN3 NDRG3 PCDHGA9 RNF114 TMEM100 WDYHV1,spermatogenesis|male gamete generation|reproductive process|reproduction|gamete generation,0.0009636|0.001063|0.00131|0.00132|0.001901,1|1|1|1|1,14.09|13.62|7.191|7.176|11.13
2374,10,0.6053,27.24,7859.0,0.003445,0.999933,BCAS4 CNBD2 FAM209A FAM209B GGT7 R3HDML SLC13A3 WFDC11 WFDC9 WISP2,negative regulation of peptidase activity|antibacterial humoral response|negative regulation of proteolysis|regulation of peptidase activity|negative regulation of hydrolase activity,0.0002182|0.0003696|0.0005204|0.001143|0.001165,1|1|1|1|1,24.23|71.02|17.96|13.67|13.58
2375,11,0.614,33.77,8633.0,0.003887,0.999969,CLEC2B CLEC4C KLRC1 KLRC4 PRB4 PRH2 PZP RERG TAS2R13 TAS2R20 TAS2R30,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|detection of chemical stimulus involved in sensory perception,1.023e-06|1.481e-06|1.586e-06|6.341e-06|0.001901,0.01614|0.01168|0.008341|0.02501|1,156|137|133.7|82.6|11.56
2376,9,0.6299,22.68,6091.0,0.003699,0.9998530000000001,AMOTL2 KIRREL1 LATS2 MARK2 NF2 PTPN14 RNF146 SAV1 WWC2,hippo signaling|regulation of organ growth|regulation of hippo signaling|negative regulation of organ growth|regulation of developmental growth,2.575e-07|7.573e-06|3.9e-05|8.893e-05|0.0002935,0.004061|0.05972|0.2051|0.3507|0.926,245.2|75.44|228.8|147.6|21.59
2377,16,0.607,72.84,11950.0,0.00604,0.999999,CD1C CD1E CTSK EFNA4 FCGR2B FCGR3A FCRL3 GBA ITLN2 LCE3E S100A12 S100A2 S100A9 SLAMF7 XCL1 YY1AP1,regulation of T cell mediated cytotoxicity|regulation of T cell mediated immunity|regulation of leukocyte mediated cytotoxicity|immune system process|regulation of inflammatory response,2.662e-08|4.083e-07|4.288e-07|8.022e-07|1.655e-06,0.00042|0.003221|0.002255|0.003163|0.00522,135.5|66.01|65.17|4.97|14.97
2378,5,0.6106,6.106,4274.0,0.001423,0.996692,BANF2 BFSP1 CST11 PCSK2 XKR6,insulin processing|islet amyloid polypeptide processing|enkephalin processing|insulin metabolic process|phosphatidylserine exposure on apoptotic cell surface,0.0004854|0.0004854|0.000728|0.001456|0.002183,1|1|1|1|1,4119|4119|2060|823.8|514.9
2379,4,0.6249,3.7489999999999997,3295.0,0.001134,0.9929309999999999,HSBP1L1 IFI27L2 MAST4 XPC,"UV-damage excision repair, DNA incision|pyrimidine dimer repair by nucleotide-excision repair|heat acclimation|cellular heat acclimation|pyrimidine dimer repair",0.0003883|0.0009706|0.001165|0.001165|0.001941,1|1|1|1|1,5149|1287|1030|1030|572.1
2380,8,0.621,17.39,5164.0,0.003346,0.9996790000000001,CNOT1 CNOT10 CNOT11 EIF3K EIF3L EIF4E2 GGNBP2 GPBP1,gene silencing by RNA|nuclear-transcribed mRNA poly(A) tail shortening|regulation of translation|gene silencing|regulation of cellular amide metabolic process,2.459e-08|9.949e-08|1.014e-07|2.053e-07|2.23e-07,0.0003879|0.0007847|0.0005332|0.0008096|0.0007034,118.4|335.8|34.98|68.65|29.8
2381,5,0.6261,6.261,3958.0,0.001575,0.996692,OR1J1 OR1J4 OR1L1 OR1Q1 XRRA1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.056e-06|1.336e-06|1.552e-06|2.059e-06|2.39e-06,0.01666|0.01054|0.008159|0.008121|0.00754,37.36|35.21|33.9|31.56|30.4
2382,4,0.6448,3.8689999999999998,3153.0,0.001222,0.9929309999999999,CDK18 RGS18 RGS2 YOD1,regulation of G protein-coupled receptor signaling pathway|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|negative regulation of anion transport,0.0003048|0.0003883|0.0003883|0.0003883|0.000578,1|1|1|1|1,70.53|5149|5149|5149|50.98
2383,4,0.6302,3.781,3188.0,0.001182,0.9929309999999999,CARNS1 FAIM TEX12 ZBTB12,carnosine biosynthetic process|carnosine metabolic process|meiotic DNA repair synthesis|histidine catabolic process|histidine metabolic process,0.0003883|0.0005825|0.0007766|0.001747|0.002134,1|1|1|1|1,5149|2574|1716|643.6|514.9
2384,4,0.6088,3.653,3213.0,0.0011330000000000001,0.9929309999999999,GALNT16 PTGDR PTGER2 ZBTB25,cellular response to prostaglandin E stimulus|negative regulation of inflammatory response to antigenic stimulus|cellular response to prostaglandin stimulus|regulation of inflammatory response to antigenic stimulus|response to prostaglandin E,7.2e-06|1.044e-05|1.19e-05|1.265e-05|1.528e-05,0.1136|0.0823|0.06257|0.04989|0.04821,514.9|59.41|392.3|55.66|343.3
2385,4,0.6021,3.612,3001.0,0.001199,0.9929309999999999,SIK2 STK11 STRADA ZBTB3,protein phosphorylation|cell cycle arrest|phosphorylation|protein autophosphorylation|positive regulation of vesicle transport along microtubule,0.0001441|0.0002966|0.0004732|0.0004808|0.0009706,1|1|1|1|1,22.58|71.51|15.11|55.96|1287
2386,6,0.6024,9.036,4124.0,0.00218,0.998474,CCND2 IRF4 MAF NFKB1 POU2AF1 ZBTB38,"positive regulation of transcription by RNA polymerase II|positive regulation of nitrogen compound metabolic process|positive regulation of cellular metabolic process|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated",3.975e-06|1.078e-05|1.519e-05|1.713e-05|1.713e-05,0.0627|0.08502|0.07985|0.06754|0.05404,14.23|6.735|6.36|10.58|10.58
2387,9,0.6102,21.97,6922.0,0.0031550000000000003,0.9998530000000001,AVIL HOXC5 HOXC6 HOXC8 INHBE KRT86 METTL7B SHMT2 ZBTB39,regulation of diacylglycerol biosynthetic process|glycine biosynthetic process from serine|L-serine catabolic process|regulation of cellular biosynthetic process|glycine biosynthetic process,0.0008734|0.00131|0.002182|0.003021|0.003054,1|1|1|1|1,2288|1144|572.1|3.345|381.4
2388,7,0.6606,13.87,4696.0,0.002936,0.9992989999999999,AQP7 DMAC1 EXOSC3 HAUS6 RCL1 RPS6 SNAPC3,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|cleavage involved in rRNA processing|maturation of 5.8S rRNA|rRNA processing|rRNA metabolic process",3.204e-05|4e-05|6.553e-05|6.931e-05|7.744e-05,0.5053|0.3155|0.3446|0.2733|0.2443,245.2|217.9|168.1|33.95|32.69
2389,7,0.6181,12.98,4587.0,0.002813,0.9992989999999999,ADAT2 FAM98B PYROXD1 RTCB RTRAF TRMT61A ZBTB8OS,"tRNA processing|tRNA metabolic process|tRNA splicing, via endonucleolytic cleavage and ligation|RNA splicing, via endonucleolytic cleavage and ligation|ncRNA processing",5.636e-13|3.585e-12|1.805e-11|2.256e-11|6.137e-10,8.891e-09|2.828e-08|9.489e-08|8.895e-08|1.936e-06,133.7|97.53|784.6|735.5|40.86
2390,6,0.6123,9.185,4600.0,0.0019879999999999997,0.998474,C6orf48 MSH5 NUDT3 STK19 TNXB ZBTB9,diphosphoinositol polyphosphate catabolic process|adenosine 5'-(hexahydrogen pentaphosphate) catabolic process|adenosine 5'-(hexahydrogen pentaphosphate) metabolic process|diadenosine hexaphosphate catabolic process|diadenosine hexaphosphate metabolic process,0.0004854|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,4119|823.8|823.8|823.8|823.8
2391,4,0.6285,3.7710000000000004,3247.0,0.001157,0.9929309999999999,ADORA2B REPIN1 ZC2HC1B ZNF843,G protein-coupled adenosine receptor signaling pathway|G protein-coupled purinergic receptor signaling pathway|excretion|activation of adenylate cyclase activity|purinergic nucleotide receptor signaling pathway,0.001941|0.001941|0.007938|0.008131|0.009289,1|1|1|1|1,572.1|572.1|128.7|125.6|109.5
2392,4,0.6242,3.745,3023.0,0.001234,0.9929309999999999,AP1G2 C17orf50 ZC3H3 ZFC3H1,positive regulation of activin receptor signaling pathway|regulation of mRNA polyadenylation|Golgi to vacuole transport|regulation of activin receptor signaling pathway|regulation of mRNA 3'-end processing,0.001553|0.003491|0.003878|0.004846|0.00562,1|1|1|1|1,735.5|302.9|271|214.5|183.9
2393,5,0.6156,6.156000000000001,4066.0,0.001508,0.996692,KCNA1 SLCO1B1 SLCO1B3 SLCO1C1 ZDBF2,sodium-independent organic anion transport|bile acid and bile salt transport|organic hydroxy compound transport|monocarboxylic acid transport|pigment catabolic process,6.644e-09|5.321e-08|4.053e-06|4.132e-06|7.2e-06,0.0001048|0.0004196|0.02131|0.0163|0.02271,772.3|363.4|81.83|81.3|514.9
2394,8,0.6013,16.84,6362.0,0.002633,0.9996790000000001,FAM173B NKD2 SLC6A18 SLC6A19 SLC6A3 TPPP TRIO ZDHHC11,sodium ion transmembrane transport|sodium ion transport|amino acid transmembrane transport|inorganic cation transmembrane transport|amino acid transport,7.142e-06|2.128e-05|0.0004082|0.0006961|0.0008632,0.1127|0.1678|1|1|1,73.55|50.73|65.38|15.43|44.58
2395,4,0.6447,3.8680000000000003,3073.0,0.001254,0.9929309999999999,PHLPP1 USP46 WDR20 ZDHHC24,cellular protein modification process|protein modification process|macromolecule modification|cellular protein metabolic process|protein deubiquitination,0.0004631|0.0004631|0.0006141|0.0009812|0.001085,1|1|1|1|1,6.822|6.822|6.356|5.653|37.04
2396,4,0.6236,3.741,3282.0,0.0011359999999999999,0.9929309999999999,ANO7 DECR2 PTPRM ZFAND2B,"calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|calcium activated phosphatidylcholine scrambling|calcium activated phospholipid scrambling|SRP-dependent cotranslational protein targeting to membrane, translocation",0.0009706|0.0009706|0.001165|0.001359|0.001747,1|1|1|1|1,1287|1287|1030|858.1|643.6
2397,12,0.6173,40.74,10300.0,0.0039299999999999995,0.999986,AARD C8orf76 COL14A1 FBXO32 KLHL38 MTSS1 NOV PPDPFL RNF139 SLC30A8 TRMT12 ZFHX4,epithelial cell proliferation|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|negative regulation of sensory perception of pain|negative regulation of chondrocyte proliferation,0.001695|0.002037|0.002037|0.002715|0.003392,1|1|1|1|1,33.06|735.5|735.5|490.4|367.8
2398,4,0.6152,3.6910000000000003,3461.0,0.0010630000000000001,0.9929309999999999,APOD KIF3C RITA1 ZFYVE28,negative regulation of lipoprotein oxidation|negative regulation of lipoprotein lipid oxidation|negative regulation of smooth muscle cell-matrix adhesion|regulation of lipoprotein oxidation|regulation of lipoprotein lipid oxidation,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
2399,7,0.6147,12.91,5600.0,0.002294,0.9992989999999999,CLCA4 FAM69A GBP5 IFI44 IFI44L PLA2G12A ZFYVE9,interleukin-18 production|interleukin-1 beta production|interleukin-1 production|positive regulation of NLRP3 inflammasome complex assembly|response to virus,0.0006794|0.002715|0.003393|0.003393|0.004509,1|1|1|1|1,2942|420.3|326.9|326.9|19.1
2400,4,0.6,3.6,3130.0,0.001146,0.9929309999999999,ACR SEC14L3 TBC1D10A ZHX3,acrosome matrix dispersal|penetration of zona pellucida|activation of cysteine-type endopeptidase activity|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen,0.0003883|0.001941|0.003104|0.003491|0.003878,1|1|1|1|1,5149|572.1|343.2|302.9|271
2401,6,0.6252,9.378,4191.0,0.002226,0.998474,CFAP298 MCM3AP PAXBP1 PWP2 URB1 WRB,rRNA processing|rRNA metabolic process|positive regulation of myoblast proliferation|ribosome biogenesis|regulation of myoblast proliferation,0.001571|0.001692|0.002183|0.002538|0.003152,1|1|1|1|1,31.68|30.51|514.9|24.81|343.3
2402,8,0.6063,16.98,6353.0,0.0026579999999999998,0.9996790000000001,ZIK1 ZNF135 ZNF256 ZNF304 ZNF550 ZNF587 ZNF773 ZNF814,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",6.255e-08|6.461e-07|6.476e-07|6.551e-07|1.187e-06,0.0009866|0.005096|0.003405|0.002583|0.003745,7.964|5.945|5.944|5.935|5.51
2403,12,0.6053,39.95,9569.0,0.004147,0.999986,NLRP4 ZFP28 ZIM3 ZNF135 ZNF304 ZNF548 ZNF587 ZNF667 ZNF71 ZNF773 ZNF814 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of gene expression|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",1.328e-09|3.109e-08|3.141e-08|3.151e-08|3.2e-08,2.094e-05|0.0002452|0.0001652|0.0001243|0.000101,7.3|4.227|5.45|5.448|5.441
2404,9,0.6282,22.61,6526.0,0.0034439999999999996,0.9998530000000001,DDX41 GEMIN5 IK LARS RBM22 RPS14 SLU7 TTC1 ZMAT2,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|mRNA metabolic process|RNA splicing",8.599e-10|8.599e-10|9.115e-10|1.738e-09|4.995e-09,1.356e-05|6.782e-06|4.792e-06|6.854e-06|1.576e-05,45.46|45.46|45.02|23.08|33.73
2405,7,0.6216,13.05,4525.0,0.002868,0.9992989999999999,ATM MDM2 MDM4 PPM1D RPL22 TP53 ZMAT3,"DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint",2.084e-11|7.162e-11|1.454e-10|2.584e-09|2.759e-09,3.287e-07|5.649e-07|7.644e-07|1.019e-05|8.705e-06,186.2|144.2|124.7|202.9|199.5
2406,12,0.6034,39.83,8807.0,0.00449,0.999986,CNN1 P2RY11 ZNF121 ZNF433 ZNF441 ZNF443 ZNF490 ZNF564 ZNF625 ZNF627 ZNF69 ZNF700,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",5.136e-08|8.69e-07|8.714e-07|8.836e-07|1.806e-06,0.0008102|0.006854|0.004582|0.003484|0.005697,6.637|4.955|4.953|4.946|4.591
2407,12,0.6044,39.89,9490.0,0.004176,0.999986,VN1R1 ZFP28 ZNF154 ZNF256 ZNF304 ZNF416 ZNF548 ZNF550 ZNF586 ZNF587 ZNF667 ZNF805,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.328e-09|3.141e-08|3.151e-08|3.2e-08|7.142e-08,2.094e-05|0.0002477|0.0001657|0.0001262|0.0002253,7.3|5.45|5.448|5.441|5.05
2408,11,0.6045,33.25,8972.0,0.0036829999999999996,0.999969,GP6 KIR2DL1 KLK11 LAIR2 NLRP4 ZNF160 ZNF211 ZNF460 ZNF581 ZNF587 ZSCAN5B,cellular process|regulation of transcription by RNA polymerase II|natural killer cell inhibitory signaling pathway|immune response-inhibiting cell surface receptor signaling pathway|cellular metabolic process,3.515e-05|0.001847|0.002327|0.00523|0.005413,0.5545|1|1|1|1,0.2216|3.982|572.1|214.5|0
2409,5,0.6095,6.095,3682.0,0.001648,0.996692,OR1M1 OR7G1 OR7G3 ZNF177 ZNF266,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,9.63e-05|0.0001148|0.0001283|0.0001584|0.000177,1|0.9052|0.6746|0.6247|0.5584,28.02|26.4|25.43|23.67|22.8
2410,10,0.6148,27.67,8329.0,0.003303,0.999933,C5AR1 C5AR2 CABP5 FFAR3 GPR32 IGFL1 KLK3 SULT2A1 SULT2B1 ZNF221,complement receptor mediated signaling pathway|complement component C5a signaling pathway|inflammatory response|phospholipase C-activating G protein-coupled receptor signaling pathway|defense response,6.313e-08|1.554e-06|3.409e-06|1.888e-05|3.65e-05,0.0009959|0.01225|0.01792|0.07444|0.1151,432.1|1872|18.87|56.74|7.933
2411,13,0.6129,47.81,10360.0,0.004582999999999999,0.999993,CHST9 CTIF DSC1 DSG1 DSG3 DSG4 HRH4 KIAA1328 MAPRE2 SERPINB7 ZNF24 ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,6.782e-07|3.087e-06|9.986e-06|1.693e-05|1.933e-05,0.0107|0.02435|0.05251|0.06677|0.06097,56.08|37.95|28.04|24.47|23.65
2412,4,0.6878,4.127,2796.0,0.00147,0.9929309999999999,WIZ ZBTB2 ZNF292 ZNF644,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",0.0002494|0.0008022|0.0008032|0.0008078|0.001088,1|1|1|1|1,7.964|5.945|5.944|5.935|5.51
2413,8,0.6043,16.92,6179.0,0.002724,0.9996790000000001,BTN2A2 HIST1H1T OR2B6 SLC17A1 SLC17A2 SLC17A4 ZNF184 ZNF322,sialic acid transport|sodium ion transmembrane transport|sodium ion transport|carboxylic acid transport|organic anion transport,1.344e-09|7.142e-06|2.128e-05|6.104e-05|0.0001524,2.12e-05|0.05633|0.1119|0.2407|0.4807,1765|73.55|50.73|35.45|25.96
2414,4,0.6053,3.6319999999999997,2996.0,0.001208,0.9929309999999999,AQP7 CBWD5 FOXD4L4 ZNF334,glycerol transport|urea transmembrane transport|urea transport|polyol transport|one-carbon compound transport,0.001553|0.001747|0.001941|0.002522|0.00291,1|1|1|1|1,735.5|643.6|572.1|429.1|367.8
2415,4,0.6369,3.822,3003.0,0.001268,0.9929309999999999,NAT8 PCDHB8 PCDHGA8 ZNF354A,nucleolar fragmentation|homophilic cell adhesion via plasma membrane adhesion molecules|peptidyl-lysine N6-acetylation|cell-cell adhesion via plasma-membrane adhesion molecules|nucleolus organization,0.0003883|0.0003972|0.0005825|0.0009436|0.001359,1|1|1|1|1,5149|61.66|2574|39.76|858.1
2416,9,0.6065,21.83,6728.0,0.0032259999999999997,0.9998530000000001,BTN2A2 OR14J1 OR2B6 OR2J3 TRIM10 TRIM26 ZKSCAN4 ZNF165 ZNF391,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|negative regulation of viral process,4.658e-05|6.374e-05|0.0001663|0.0002224|0.0007415,0.7347|0.5027|0.8743|0.8769|1,208|176|106.4|91.53|49.21
2417,13,0.6061,47.27,10390.0,0.004517,0.999993,CALHM3 DUPD1 DUSP13 GPRIN2 NUTM2A NUTM2B PTPN20 SFTPA1 SFTPA2 SYT15 ZNF239 ZNF488 ZNF503,peptidyl-tyrosine dephosphorylation|protein dephosphorylation|respiratory gaseous exchange by respiratory system|dephosphorylation|toll-like receptor signaling pathway,3.961e-05|0.000313|0.0004785|0.0009709|0.001862,0.6248|1|1|1|1,44.84|22|63.37|14.85|31.37
2418,34,0.6054,339.7,27180.0,0.01231,1.0,ARHGAP33 CEACAM7 CLC CYP2A13 CYP2B6 FFAR2 FFAR3 HKR1 LGALS13 LGALS14 LGALS7B MAG U2AF1L4 UPK1A ZFP14 ZFP82 ZNF155 ZNF302 ZNF382 ZNF383 ZNF461 ZNF540 ZNF546 ZNF566 ZNF568 ZNF569 ZNF571 ZNF573 ZNF585B ZNF599 ZNF607 ZNF780B ZNF790 ZNF792,"regulation of transcription by RNA polymerase II|regulation of gene expression|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",4.853e-10|3.247e-09|8.142e-08|8.183e-08|8.387e-08,7.656e-06|2.561e-05|0.0004281|0.0003227|0.0002646,4.551|3.019|3.397|3.396|3.392
2419,10,0.6119,27.53,7967.0,0.003436,0.999933,ATXN7L3B CCNB1IP1 KIF26B MAP3K7CL NECAP2 RAB22A SDR39U1 TXNDC16 ZNF286A ZNF512B,ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|renal vesicle formation|chiasma assembly,0.00194|0.002424|0.002909|0.003393|0.003393,1|1|1|1|1,686.5|514.9|411.9|343.3|343.3
2420,6,0.624,9.36,5091.0,0.001831,0.998474,CA8 CEBPD EFCAB1 PPDPFL SPIDR ZNF513,cellular response to camptothecin|response to camptothecin|regulation of establishment of protein localization to chromosome|cellular response to hydroxyurea|response to hydroxyurea,0.001456|0.001746|0.003781|0.003781|0.004071,1|1|1|1|1,858.1|686.5|286|286|264
2421,4,0.6179,3.707,3253.0,0.001135,0.9929309999999999,FAM163B IFNL3 PLEKHF1 ZNF514,receptor signaling pathway via JAK-STAT|receptor signaling pathway via STAT|negative regulation of viral genome replication|positive regulation of intrinsic apoptotic signaling pathway|endosome organization,0.007745|0.007938|0.01064|0.0116|0.01506,1|1|1|1|1,132|128.7|95.35|87.27|66.87
2422,10,0.6139,27.62,7166.0,0.003829,0.999933,CXADR OR11G2 OR4K1 OR4K2 OR4K5 OR4M1 OR4M2 OR4N4 RNF145 ZNF519,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.487e-10|3.743e-10|4.853e-10|7.934e-10|1.028e-09,3.923e-06|2.952e-06|2.552e-06|3.129e-06|3.242e-06,32.69|30.8|29.66|27.62|26.6
2423,11,0.6149,33.82,8721.0,0.003854,0.999969,KIR2DL1 NLRP4 ZNF304 ZNF524 ZNF550 ZNF581 ZNF587 ZNF667 ZNF772 ZNF773 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of gene expression",1.208e-06|1.464e-05|1.467e-05|1.485e-05|2.251e-05,0.01906|0.1154|0.07715|0.05858|0.071,5.973|4.459|4.458|4.451|3.523
2424,14,0.6028,54.85,11050.0,0.004928,0.9999969999999999,VN1R1 ZFP28 ZNF211 ZNF264 ZNF304 ZNF416 ZNF460 ZNF543 ZNF548 ZNF587 ZNF667 ZNF772 ZNF805 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",2.458e-11|1.04e-09|1.044e-09|1.064e-09|2.753e-09,3.878e-07|8.205e-06|5.491e-06|4.195e-06|8.684e-06,7.395|5.521|5.519|5.511|5.116
2425,4,0.6058,3.635,3230.0,0.001121,0.9929309999999999,ZNF544 ZNF8 ZNF837 ZSCAN22,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",0.0002494|0.0008022|0.0008032|0.0008078|0.001088,1|1|1|1|1,7.964|5.945|5.944|5.935|5.51
2426,16,0.6117,73.4,12940.0,0.005625,0.999999,ERVV-2 KIR2DL1 KIR2DL3 SIGLEC12 SIGLEC5 VN1R4 ZNF28 ZNF415 ZNF528 ZNF534 ZNF578 ZNF610 ZNF613 ZNF665 ZNF701 ZNF880,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",8.261e-06|1.138e-05|0.0001121|0.0001124|0.0001138,0.1303|0.08977|0.5893|0.4431|0.359,4.685|0.3129|3.497|3.496|3.491
2427,4,0.6103,3.662,3209.0,0.001137,0.9929309999999999,SERPINA11 SRARP TCL1B ZNF554,positive regulation of intracellular estrogen receptor signaling pathway|positive regulation of intracellular steroid hormone receptor signaling pathway|cellular process|regulation of intracellular estrogen receptor signaling pathway|regulation of intracellular steroid hormone receptor signaling pathway,0.002522|0.00291|0.00379|0.008517|0.01698,1|1|1|1|1,429.1|367.8|0|119.7|59.18
2428,4,0.6549,3.929,2947.0,0.001328,0.9929309999999999,STX10 TMEM205 ZNF121 ZNF562,"vesicle docking|vesicle fusion|organelle membrane fusion|retrograde transport, endosome to Golgi|organelle fusion",0.01256|0.01583|0.01698|0.01756|0.02081,1|1|1|1|1,80.45|63.56|59.18|57.21|48.12
2429,4,0.633,3.798,3383.0,0.001119,0.9929309999999999,GPC5 PAEP RAB17 ZNF584,negative regulation of sperm capacitation|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|regulation of sperm capacitation|regulation of binding of sperm to zona pellucida,0.0003883|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,5149|2574|1716|1287|1030
2430,15,0.6107,64.12,12180.0,0.005222999999999999,0.999999,KIR2DL1 SIGLEC5 VN1R4 ZNF28 ZNF415 ZNF480 ZNF528 ZNF534 ZNF600 ZNF610 ZNF665 ZNF677 ZNF701 ZNF83 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.751e-08|4.836e-07|4.851e-07|4.931e-07|1.135e-06,0.0002761|0.003814|0.002551|0.001944|0.003582,5.973|4.459|4.458|4.451|4.132
2431,11,0.6009,33.05,8816.0,0.003725,0.999969,C1orf123 CCDC30 CFAP57 ERMAP EXO5 PPT1 ZFP69 ZFP69B ZNF606 ZNF684 ZNF691,positive regulation of pinocytosis|regulation of transcription by RNA polymerase II|lysosomal lumen acidification|protein depalmitoylation|pinocytosis,0.003877|0.004562|0.005327|0.005327|0.00581,1|1|1|1|1,294.2|3.982|205.9|205.9|187.2
2432,17,0.6024,81.92,13910.0,0.005842,1.0,ERVV-2 KIR2DL1 SIGLEC5 VN1R4 ZNF175 ZNF28 ZNF415 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF613 ZNF614 ZNF665 ZNF701 ZNF880,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",9.148e-09|3.101e-07|3.226e-07|3.237e-07|3.294e-07,0.0001443|0.002445|0.001696|0.001277|0.001039,5.752|0.2216|4.294|4.293|4.287
2433,15,0.6186,64.95,12140.0,0.0053100000000000005,0.999999,KIR2DL1 SIGLEC5 VN1R4 ZNF28 ZNF415 ZNF432 ZNF528 ZNF534 ZNF610 ZNF613 ZNF614 ZNF649 ZNF665 ZNF701 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.751e-08|4.836e-07|4.851e-07|4.931e-07|1.135e-06,0.0002761|0.003814|0.002551|0.001944|0.003582,5.973|4.459|4.458|4.451|4.132
2434,18,0.612,93.64,13710.0,0.006764,1.0,AGR3 EGR3 FKBP9 GHRHR NIPSNAP2 NUPR2 PHKG1 PSPH RNASET2 SEPT14 SLC29A4 SUMF2 VWC2 ZNF479 ZNF679 ZNF713 ZNF716 ZNF736,protein peptidyl-prolyl isomerization|peptidyl-proline modification|somatotropin secreting cell development|epinephrine uptake|regulation of calcium ion transmembrane transporter activity,0.0009603|0.001667|0.001843|0.002763|0.003005,1|1|1|1|1,45.16|33.87|1084|542|24.92
2435,6,0.6078,9.116,4603.0,0.001971,0.998474,AGPAT5 LHX3 NEUROD1 OTP OTX2 ZNF669,forebrain development|endocrine system development|brain development|head development|pituitary gland development,1.731e-06|4.408e-06|2.453e-05|3.057e-05|6.96e-05,0.0273|0.03477|0.129|0.1206|0.2196,36.13|83.72|18.43|17.42|159.7
2436,4,0.641,3.846,3416.0,0.0011220000000000002,0.9929309999999999,CTRL FAM69C SFI1 ZNF70,ciliary basal body-plasma membrane docking|negative regulation of phosphatase activity|negative regulation of dephosphorylation|G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition,0.01851|0.021|0.02215|0.0271|0.02748,1|1|1|1|1,54.2|47.67|45.16|36.78|36.26
2437,12,0.622,41.05,10000.0,0.004077,0.999986,APOC2 C5AR1 CBLC CCDC61 CEACAM19 EML2 IGFL1 IGFL2 IGFL3 IGFL4 PGLYRP1 PVR,positive regulation of phospholipase activity|regulation of phospholipase activity|positive regulation of lipase activity|regulation of lipase activity|defense response to Gram-positive bacterium,0.0005952|0.0008203|0.0008425|0.001491|0.00155,1|1|1|1|1,56.27|47.67|47.02|35.03|34.33
2438,4,0.6048,3.6289999999999996,3312.0,0.001092,0.9929309999999999,COL9A2 ISCU OXT ZNF784,positive regulation of hindgut contraction|negative regulation of iron ion import across plasma membrane|regulation of hindgut contraction|maternal aggressive behavior|regulation of iron ion import across plasma membrane,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
2439,4,0.6262,3.7569999999999997,3215.0,0.001164,0.9929309999999999,HRASLS HTR3D TMEM259 ZNF827,N-acylphosphatidylethanolamine metabolic process|positive regulation of ERAD pathway|regulation of ERAD pathway|phosphatidylethanolamine metabolic process|positive regulation of response to endoplasmic reticulum stress,0.001941|0.00291|0.004072|0.0062|0.007359,1|1|1|1|1,572.1|367.8|257.4|166.1|139.2
2440,5,0.6202,6.202000000000001,4186.0,0.0014759999999999999,0.996692,FAM198A KRBOX1 VIPR1 ZNF197 ZNF860,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",0.01314|0.01665|0.01667|0.01674|0.02068,1|1|1|1|1,76.85|4.459|4.458|4.451|4.132
2441,4,0.6105,3.6630000000000003,3070.0,0.001189,0.9929309999999999,KIF5A KRT81 SLC35B4 ZNF93,UDP-xylose transmembrane transport|negative regulation of transposon integration|regulation of transposon integration|anterograde dendritic transport of neurotransmitter receptor complex|UDP-N-acetylglucosamine transmembrane transport,0.0003883|0.0005825|0.0005825|0.0009706|0.001165,1|1|1|1|1,5149|2574|2574|1287|1030
2442,10,0.6378,28.7,6467.0,0.004405,0.999933,HAUS1 NARS RPL17 RTTN SKA1 TXNL4A VPS4A WDR7 ZNF236 ZNF407,cell division|cell cycle|centrosome cycle|actomyosin contractile ring contraction|contractile ring contraction,6.208e-05|0.0002669|0.0008299|0.0009704|0.0009704,0.9792|1|1|1|1,16.74|7.408|46.81|2060|2060
2443,4,0.6589,3.9539999999999997,3346.0,0.0011769999999999999,0.9929309999999999,MLF1 SLC9C1 TRIM59 ZP2,prevention of polyspermy|negative regulation of fertilization|egg activation|myeloid progenitor cell differentiation|regulation of fertilization,0.0005825|0.0005825|0.001165|0.001359|0.002522,1|1|1|1|1,2574|2574|1030|858.1|429.1
2444,9,0.6208,22.35,5916.0,0.003752,0.9998530000000001,BIRC6 HECTD1 KCMF1 PPP1R15B UBA6 UBR4 USP19 VCPIP1 ZRANB1,protein modification by small protein conjugation or removal|cellular protein modification process|protein modification process|macromolecule modification|protein ubiquitination,3.505e-10|3.165e-08|3.165e-08|5.972e-08|1.703e-07,5.528e-06|0.0002497|0.0001664|0.0002355|0.0005374,17.76|6.822|6.822|6.356|18.53
2445,4,0.6023,3.614,3288.0,0.0010949999999999998,0.9929309999999999,DNAJB9 MYOM3 RBM43 ZSCAN2,negative regulation of IRE1-mediated unfolded protein response|regulation of IRE1-mediated unfolded protein response|negative regulation of endoplasmic reticulum unfolded protein response|regulation of endoplasmic reticulum unfolded protein response|negative regulation of response to endoplasmic reticulum stress,0.001165|0.003104|0.003297|0.0062|0.009096,1|1|1|1|1,1030|343.2|321.8|166.1|111.9
2446,13,0.6009,46.87,10540.0,0.004418,0.999993,GP6 KIR2DL1 LAIR2 LILRB5 NLRP4 ZNF304 ZNF581 ZNF587 ZNF667 ZNF772 ZNF773 ZSCAN5A ZSCAN5B,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",9.242e-05|0.0003207|0.0007371|0.0007386|0.000746,1|1|1|1|1,4.551|0.38|3.397|3.396|3.392
2447,4,0.6296,3.7769999999999997,3026.0,0.0012439999999999999,0.9929309999999999,FZD5 LGR4 WLS ZSWIM5,cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|anterior/posterior axis specification|canonical Wnt signaling pathway,1.954e-05|1.954e-05|3.363e-05|4.185e-05|0.0001028,0.3082|0.1541|0.1768|0.1651|0.3243,44.26|44.26|36.86|194.3|122.6
